patient [podg]     0.15436307
To [qlco]     0.16061635
Hepatocellular carcinoma [neop]     0.19775002
Result [ftcn]     0.2378139
Conclusion [idcn]     0.3020798
studies [mnob]     0.33210307
Risk factor [qnco]     0.33708718
Method [inpr]     0.36985067
Associated [qlco]     0.414858
year [tmco]     0.4193784
Not [ftcn]     0.45824483
include [ftcn]     0.49140364
High [qlco]     0.49221706
Liver [bpoc]     0.51839334
Background [cnce]     0.5253673
Aim [idcn]     0.54294235
Show [inpr]     0.5445926
1+ [qnco]     0.5484678
Compare [acty]     0.5744378
+2 [qnco]     0.58098054
Tumor [neop]     0.5890457
Case [ftcn]     0.59395766
Evaluable [ftcn]     0.6047947
Significance [qnco]     0.6077592
treatment [ftcn]     0.61181504
<3 [qnco]     0.6244357
Using [ftcn]     0.6308863
>5 [qnco]     0.63448673
Group [idcn]     0.6374341
More [ftcn]     0.64732844
This [euka]     0.6487272
Risk [qlco]     0.6494282
Cirrhosis [dsyn]     0.65365833
Survival [acty]     0.655789
Age [orga]     0.6586462
[c] [qnco]     0.66635865
Factor [ftcn]     0.6717415
Relate [orch]     0.6719878
Two [qnco]     0.6811993
Rate [acty]     0.68626106
One [qnco]     0.6908676
Analysis [lbpr]     0.6950038
development [phsf]     0.70128286
Increase [qnco]     0.70339626
Perform [ftcn]     0.7039262
Effect [qlco]     0.7108751
Only [qnco]     0.7141201
Independence [idcn]     0.71985793
Data [idcn]     0.72790843
Pathologic [bmod]     0.7307194
Review [inpr]     0.73354864
Clinical [qlco]     0.7459291
Incidence [qnco]     0.75388724
Found [qnco]     0.75627345
Level [qlco]     0.7622971
investigate [ftcn]     0.76687026
used [fndg]     0.769021
Role [socb]     0.77149206
Outcome [ftcn]     0.77616364
Identifiable [qlco]     0.7767903
resect [topp]     0.7780464
Overall [inpr]     0.7827894
Disease [dsyn]     0.7872634
Most [qnco]     0.7914595
Suggest [idcn]     0.79700863
cause [ftcn]     0.7993143
Cancer [neop]     0.80063736
Analyzed [resa]     0.8076504
Recurrence [phpr]     0.8127299
Increase [ftcn]     0.81375295
Multivariate Analysis [qnco]     0.8244683
month [tmco]     0.8269249
Diagnosis [fndg]     0.8286882
base [ftcn]     0.8290417
Report [inpr]     0.830104
Associate [menp]     0.8329495
Hepatic [blor]     0.8340214
*^patient [podg]     0.8347375
Positive [qnco]     0.8379744
Assess [acty]     0.84783274
Present [qnco]     0.8482022
Common [qnco]     0.8556581
% total [qnco]     0.8575423
Follow-up [fndg]     0.86554617
Time [tmco]     0.87135494
Three [qnco]     0.8756646
Virus [virs]     0.8760585
Reservation [acty]     0.87882596
Major [qlco]     0.88683164
*Difference [qnco]     0.8888563
Observation [ftcn]     0.8933441
Hepatitis C virus [virs]     0.9028803
Different [qlco]     0.91693914
Rights [qlco]     0.91954494
Presence [topp]     0.9221664
Object [inpr]     0.925245
TREAT [topp]     0.9265711
median [spco]     0.93102086
*Number [qnco]     0.93960315
detect [fndg]     0.9409739
Hepatitis B Virus [virs]     0.9451122
Potential [qlco]     0.9465005
Control [grup]     0.9483584
use [ftcn]     0.9488242
Mortalities [qnco]     0.9511604
Correlated [qlco]     0.9516291
Occur [acty]     0.95209837
studies [lbpr]     0.95398045
Mean [qnco]     0.956819
Liver Transplant [topp]     0.96303356
Lower [spco]     0.9644804
diagnose [fndg]     0.96738863
Prognosis [hlca]     0.9688501
Liver disease [dsyn]     0.97031647
less [inpr]     0.97080636
Prevalence [qnco]     0.9727715
reveal [qlco]     0.97326416
period [tmco]     0.9747456
Infection, NOS [dsyn]     0.97722584
Recent [tmco]     0.97872084
Frequent [tmco]     0.98424697
Non [ftcn]     0.9852593
Evidence [ftcn]     0.98882115
Further [spco]     0.9893324
Population [qnco]     0.9913834
Feature [qlco]     0.99707407
consider [idcn]     0.99707407
Early [tmco]     0.9986391
Confidence Interval [qnco]     1.0033683
Find [ftcn]     1.0200636
Male [fndg]     1.0200636
Expression [topp]     1.0244783
Receive [qlco]     1.0311857
Long-term [tmco]     1.0362852
Specific [qlco]     1.0449195
Characteristic [qlco]     1.0460838
complicate [patf]     1.0472512
Predictor [idcn]     1.0519527
Therapies [ftcn]     1.0543227
Model [inpr]     1.0561087
Type [qlco]     1.0561087
First [qnco]     1.0579021
Serum [bdsu]     1.0585015
low [qlco]     1.0585015
Addition [ftcn]     1.0591018
Similar [qlco]     1.0609076
/40 [tmco]     1.0621157
Combination [qlco]     1.0621157
Death [orgf]     1.0675938
Ranges [qnco]     1.0688207
New [tmco]     1.0694354
Involved [ftcn]     1.071903
Four [qnco]     1.073142
confirm [qlco]     1.0750073
Induce [ftcn]     1.0775069
Lesion [fndg]     1.0838194
Poor [grpa]     1.0870104
Mechanical [ftcn]     1.0870104
progress [patf]     1.0876514
Invasion [fndg]     1.0915176
Provide [acty]     1.0921652
Advance [qlco]     1.0967265
surgeries [bmod]     1.1000142
Change [ftcn]     1.1000142
examinations [fndg]     1.1019988
Published [ocac]     1.1033269
Cohort [popg]     1.1059954
23 [qnco]     1.1073358
Stage [tmco]     1.1073358
Histologic [ftcn]     1.110705
Individual [popg]     1.110705
Hepatectomies [topp]     1.1127392
Possible [qlco]     1.1141007
Better [qlco]     1.1141007
Cholangiocarcinoma [neop]     1.1154664
IMPACT [gngm]     1.1195894
Conduct [inbe]     1.1209725
Known [qlco]     1.123752
malignancies [neop]     1.127955
Estimate [qnco]     1.127955
Liver Cirrhosis [dsyn]     1.129365
High Risk [qlco]     1.129365
NEG [qlco]     1.1307796
infect [ftcn]     1.1343365
Purpose [ftcn]     1.1350514
Subject [grup]     1.1350514
Old [tmco]     1.1350514
odd ratio [qnco]     1.1350514
Large [qnco]     1.1364847
Contribute [acty]     1.1364847
followed [tmco]     1.1408132
Postoperative [tmco]     1.141539
limit [ftcn]     1.1429938
Managed [ocac]     1.1459184
Primary [qlco]     1.1496019
Several [qnco]     1.1496019
Curative [cnce]     1.1503425
Single [popg]     1.1503425
Pre-operative [tmco]     1.1510842
Hepatitis B [dsyn]     1.1518272
31 [inpr]     1.1608441
Select [acty]     1.161604
Hepatitis C Infection [dsyn]     1.1623652
Following [tmco]     1.1661917
Cirrhotic [qlco]     1.1661917
Present [idcn]     1.1661917
Relationship [qlco]     1.1677316
Severe [qlco]     1.1677316
Current [tmco]     1.1685038
Human [humn]     1.1692772
Transplant [topp]     1.1692772
size tumor [spco]     1.170052
Well [qlco]     1.171606
Consecutive [qlco]     1.171606
Five [qnco]     1.1755149
strategies [menp]     1.176301
Survival Rate [qnco]     1.1794596
Fibrosis [patf]     1.1818436
Sex [orgf]     1.1826411
Obtain [ftcn]     1.1866513
Various [irda]     1.1882658
Marker [clna]     1.1906989
Response [orga]     1.1939642
Pattern [spco]     1.1947844
greater [qnco]     1.1972543
Play [dora]     1.2005696
establish [qlco]     1.2022368
Decrease [qnco]     1.2030727
Liver Cancer [neop]     1.2055904
prognostic [inpr]     1.2081227
Chronic liver disease [dsyn]     1.2098192
screen [hlca]     1.2106699
Understand [menp]     1.2106699
65 [inpr]     1.2115223
Prognostic Factor [clna]     1.2115223
Therapeutic [topp]     1.2123764
Epidemiologic [bmod]     1.2227584
Cell [cell]     1.2236348
Improved [qlco]     1.2245132
Surgical [hlca]     1.226275
Enhance [acty]     1.226275
Score [qnco]     1.226275
Approach [spco]     1.2271587
Tissue [tisu]     1.228044
Chronic infection [dsyn]     1.2289312
Center [spco]     1.2307111
intrahepatic [spco]     1.2307111
aetiology [ftcn]     1.2307111
Small [qnco]     1.2307111
Morbidities [qnco]     1.2316039
Multiple [qnco]     1.2316039
Test [lbpr]     1.2397218
Variability [qlco]     1.2461423
Complete [qlco]     1.2498542
Image [diap]     1.2517221
Available [ftcn]     1.2526591
Material [sbst]     1.2526591
Reduced [qlco]     1.2554823
criteria [inpr]     1.2564274
Six [qnco]     1.2564274
Gene [gngm]     1.2573746
/day [tmco]     1.2583239
Often [tmco]     1.2592752
55 [inpr]     1.2611842
liver resection [topp]     1.2631017
Female [fndg]     1.2631017
Hazard Ratio [qnco]     1.266962
System [ftcn]     1.266962
Target [ftcn]     1.2689053
Men [popg]     1.26988
Histories [ocdi]     1.2728179
HCV [virs]     1.2728179
APPEAR [qlco]     1.2738014
Local [spco]     1.2757756
With [qlco]     1.2787536
Hepatitis C [dsyn]     1.2797508
>90 [qnco]     1.2807504
Genotype [orga]     1.2847717
Main [qlco]     1.2847717
Initial [tmco]     1.2857828
Value [qnco]     1.2857828
Defined [cnce]     1.2857828
Diagnostic [fndg]     1.2857828
pathogenesis [ftcn]     1.2878122
Indicated [fndg]     1.2908742
Leading [tmco]     1.2908742
Metastasis [neop]     1.2908742
Differential [celf]     1.2918998
size [spco]     1.293958
Hepatitis B infection [dsyn]     1.2949908
Nodule [acab]     1.2970638
experience [menp]     1.298104
Predictability [idcn]     1.3022901
Area [geoa]     1.3022901
Contrast [qlco]     1.3043983
Calculate [ftcn]     1.3043983
Molecular [qlco]     1.3054563
Ratio [qnco]     1.3054563
Status [qlco]     1.3065168
Represent [acty]     1.3075799
free [ftcn]     1.3086456
Women [popg]     1.3086456
Novel [tmco]     1.3097141
radiofrequency ablation [topp]     1.3118587
Long [qlco]     1.3129351
Need [qlco]     1.3140141
progress [ftcn]     1.3140141
Viral [ftcn]     1.318357
Exposure NOS [inpo]     1.3205448
Obese [dsyn]     1.3227439
Sample [sbst]     1.324954
Comparison [acty]     1.324954
Affect [ftcn]     1.3294084
vascular [bpoc]     1.3294084
absence [qnco]     1.3294084
Disease-Free Survival [qnco]     1.3294084
69 [inpr]     1.3294084
Divide [ftcn]     1.3305291
univariate analysis [resa]     1.3316528
PREVENT [phsu]     1.3350413
Post [tmco]     1.3350413
informant [idcn]     1.3361768
Make [ftcn]     1.3361768
condition [dsyn]     1.3373151
ALCOHOL [orch]     1.3384565
Collected [idcn]     1.3407483
Rare [tmco]     1.3407483
Characterization [acty]     1.3418987
Cumulative [qlco]     1.3430523
LTD [ortf]     1.3430523
Child [aggp]     1.3453685
Database [inpr]     1.3465313
match [resa]     1.3476971
Literature [inpr]     1.3476971
Region [geoa]     1.3488662
Hepatitis C, Chronic [dsyn]     1.3488662
Affect [menp]     1.3488662
Hepatocellular [qlco]     1.3500384
Decrease [qlco]     1.3523923
detect [topp]     1.3523923
Diameter [qnco]     1.353574
Benefit [qnco]     1.353574
surgical resection [topp]     1.3559473
elevate [qlco]     1.3571388
Normal [qlco]     1.3595315
recurrence tumor [neop]     1.3607329
Hepatic [dsyn]     1.3619375
Non-alcoholic Fatty Liver Disease [dsyn]     1.3619375
Parameter [fndg]     1.3631456
Measurable [qlco]     1.3631456
lack [qlco]     1.3655719
Future [tmco]     1.3655719
68 [inpr]     1.3655719
computed tomography [diap]     1.3692368
retrospective [resa]     1.3692368
Diabetes [dsyn]     1.3704654
Likely [qlco]     1.3704654
Classified [clas]     1.3704654
Previous [tmco]     1.3729329
Regressing [patf]     1.3729329
malignancies [qlco]     1.3741721
Assess [hlca]     1.3816817
Mutate [genf]     1.3816817
Article [inpr]     1.382946
Carcinogenesis [neop]     1.3842139
surveillance [ftcn]     1.3854856
occurrence [ftcn]     1.3867612
Relevance [qlco]     1.3880404
Logistic Regression [resa]     1.3880404
Same [qlco]     1.3893234
Required [ftcn]     1.3893234
Biomarker [clna]     1.3919008
Eight [qnco]     1.3919008
Seven [qnco]     1.3957958
Adult [aggp]     1.397102
HCC [neop]     1.397102
Link [inpr]     1.3984121
Adjusted [ftcn]     1.3997262
Seen [qlco]     1.3997262
Hepatitis B, Chronic [dsyn]     1.4023663
Efficacy [qlco]     1.4023663
Liver function [ortf]     1.4023663
Needed [qlco]     1.4036924
DI [orgf]     1.4050225
Help [socb]     1.4050225
In [qnco]     1.4103842
1/2 [inpr]     1.411735
Health [idcn]     1.4171808
chronic [tmco]     1.418553
71 [inpr]     1.418553
Hepatocyte [cell]     1.4199295
Area [spco]     1.4199295
Poor prognosis [fndg]     1.4199295
trend [tmco]     1.4213104
Retrospective Studies [resa]     1.4213104
Alone [qnco]     1.4226958
Proportion [qnco]     1.4226958
Part [spco]     1.4240855
Strong [qlco]     1.4240855
Extrahepatic [spco]     1.4254797
Statistical Significance [qnco]     1.4254797
PREVENT [topp]     1.4268783
Countries [geoa]     1.4268783
Young [tmco]     1.4311017
Design [acty]     1.4325187
Clarified [acty]     1.4339403
overall survival rate [qnco]     1.4382331
Biliary [ftcn]     1.4411188
Statistic [ocdi]     1.4411188
research [resa]     1.4425689
carried [acty]     1.4425689
Activate [acty]     1.4440238
biopsied [diap]     1.4454837
Grade [clas]     1.4454837
Highly [qlco]     1.4498928
Late [tmco]     1.4513725
Specimen [sbst]     1.4513725
Second [qnco]     1.4513725
Activate [dora]     1.4528573
Arterial [bpoc]     1.4528573
Image [inpr]     1.4543471
Record [inpr]     1.4558421
Currently [tmco]     1.4573423
I- [inch]     1.4588476
recommend [idcn]     1.4603581
Gender [orga]     1.4603581
Sensitive [qnco]     1.4603581
Case-Control Studies [resa]     1.461874
Test [inpr]     1.4633952
Hepatocarcinogenesis [neop]     1.4649217
Interaction [ftcn]     1.4664537
Form [qlco]     1.467991
Alcohol consumption [inbe]     1.467991
Out [spco]     1.4695338
Nine [qnco]     1.4695338
Index [inpr]     1.4695338
HCC [gngm]     1.4710821
Inflammation [patf]     1.4726359
subgroup [virs]     1.4726359
Duration [tmco]     1.4741952
Process [bpoc]     1.4741952
Predictability [qlco]     1.4757603
Liver Biopsy [diap]     1.4789073
Ablation [topp]     1.4820775
Hepatitis, Chronic [dsyn]     1.4820775
monitor [hlca]     1.4820775
Multivariate Analyses [qnco]     1.4820775
Frequencies [qnco]     1.4836712
Continual [idcn]     1.4852709
Percutaneous [spco]     1.4884878
Nonalcoholic steatohepatitis [dsyn]     1.4917288
sustain [ftcn]     1.4917288
/mL [qnco]     1.4917288
Identification [menp]     1.4933585
Genet [topp]     1.4949943
Major [socb]     1.4966362
Third [qnco]     1.4982843
Set [ftcn]     1.4982843
investigate [hlca]     1.4999388
Phase [tmco]     1.5049403
Values [qlco]     1.508307
Of [spco]     1.5100001
European [popg]     1.5100001
Good [qlco]     1.5116999
larger [qnco]     1.5134064
Unknown [qlco]     1.5134064
short [qlco]     1.5151196
Curve [spco]     1.5168395
Profile [lbpr]     1.5185664
Direct [qlco]     1.5185664
World [popg]     1.5203001
Few [qnco]     1.5237885
Approximate [qlco]     1.5255431
Margin [spco]     1.5255431
ng/mL [qnco]     1.5255431
infect [dsyn]     1.5255431
GIVEN [cnce]     1.527305
Carcinoma [neop]     1.5308503
Applied [hlca]     1.5308503
Intrahepatic Cholangiocarcinoma [neop]     1.5308503
Benign [qlco]     1.5326338
Promote [acty]     1.5344247
Support [medd]     1.5344247
97 [inpr]     1.5344247
United States [geoa]     1.5344247
Then [tmco]     1.536223
Pathway [moft]     1.536223
Very [qlco]     1.536223
function [ftcn]     1.536223
baseline [bodm]     1.536223
provides [food]     1.5380288
indication [idcn]     1.5398421
Complex [qlco]     1.5416632
modalities [idcn]     1.5416632
Best [qlco]     1.5416632
Ultrasound [diap]     1.5453281
Moderate [qlco]     1.5471722
described [idcn]     1.5490242
Knowledge [inpr]     1.5490242
Option [ftcn]     1.5490242
Class [inpr]     1.5508842
Magnetic Resonance Imaging [diap]     1.5508842
Decade [qnco]     1.5527521
methodology [inpr]     1.5546281
Regulated [gora]     1.5546281
Technique [ftcn]     1.5546281
account [idcn]     1.5546281
week [tmco]     1.5546281
virologic [ftcn]     1.5565122
Immunohistochemical [lbpr]     1.5565122
influential [idcn]     1.5565122
Steatosis [patf]     1.5584046
Order [inpr]     1.5584046
Distributed [idcn]     1.5603052
Immunohistochemistry [lbpr]     1.5603052
Advance [medd]     1.5603052
1/5 [qnco]     1.5622143
Chemotherapies [topp]     1.5622143
China [geoa]     1.5622143
High Prevalence [qnco]     1.5641316
Log [inpr]     1.5641316
Mediate [socb]     1.5679921
g% [qnco]     1.5718871
Bile duct [bpoc]     1.5718871
Blood Transfusion [topp]     1.5738478
Mortality rate [qnco]     1.5738478
Recurrence free survival [fndg]     1.5738478
Metabolic syndrome [dsyn]     1.5738478
End Stage Liver Disease [dsyn]     1.5738478
search [inpr]     1.5738478
Japan [geoa]     1.5758173
function [phsf]     1.5758173
Pre [tmco]     1.577796
worse [qlco]     1.577796
Medical [ftcn]     1.577796
Ultrasonography [diap]     1.5797836
liver tumor [neop]     1.5797836
Assay [lbpr]     1.5797836
Focus [spco]     1.5817803
Course [tmco]     1.5817803
Difficult [qlco]     1.5817803
Past [tmco]     1.5817803
Site [spco]     1.5837864
Aggression [mobd]     1.5858016
Degree [qlco]     1.5858016
Series [qnco]     1.5858016
Critical [qlco]     1.5878264
Classification [clas]     1.5878264
Nation [inpr]     1.5898604
RANDOM [resa]     1.5898604
Operable [hlca]     1.5898604
Wide [spco]     1.5919042
Stain [lbpr]     1.5939577
Metastases [neop]     1.5939577
Organ [bpoc]     1.5939577
prospective [resa]     1.5960208
Portal Vein [bpoc]     1.5980939
Highest [qlco]     1.5980939
Standard [qlco]     1.5980939
Care [acty]     1.5980939
Observation [resa]     1.5980939
/B [qnco]     1.5980939
Specific [qnco]     1.6001768
Carrier [fndg]     1.6001768
demographic [ocdi]     1.6022698
Tool [mnob]     1.6022698
Point [qnco]     1.6022698
Control Group [grup]     1.6022698
Optimal [qlco]     1.6043729
Last [qlco]     1.6043729
Rank [inpr]     1.6043729
Proliferating [patf]     1.6064862
practice [menp]     1.6064862
Average [qnco]     1.6064862
Annual [tmco]     1.6064862
Event [evnt]     1.610744
Viral hepatitis [dsyn]     1.610744
CT [gngm]     1.610744
Drug [phsu]     1.610744
reduction [npop]     1.6128887
treatment [topp]     1.6128887
Spectrum [qnco]     1.6128887
Histologic [bmod]     1.6128887
Now [tmco]     1.6128887
Safeties [hcpp]     1.615044
controversies [socb]     1.615044
Remaining [qlco]     1.615044
failure liver [dsyn]     1.61721
Person [popg]     1.619387
Proven [qlco]     1.619387
Issue [fndg]     1.619387
Genome [gngm]     1.619387
If [qlco]     1.619387
Improved [cnce]     1.6215749
Author [prog]     1.6215749
Incidence Rate [qnco]     1.6215749
applicable [hlca]     1.625984
Cellular [cell]     1.625984
intervention [hlca]     1.625984
Transarterial Chemoembolization [topp]     1.625984
Liver tissue [bpoc]     1.625984
Polymorphic [genf]     1.625984
Non-cirrhotic [qlco]     1.6282055
Intraoperative [tmco]     1.6282055
promise [idcn]     1.6304383
Recipient [humn]     1.6304383
General Population [popg]     1.6326828
Fibrosis, Liver [dsyn]     1.6326828
Old age [fndg]     1.6349388
Histopathologic [ftcn]     1.6349388
Challenge [clna]     1.6349388
Exist [cnce]     1.6349388
alpha fetoprotein levels [lbtr]     1.6372067
Equal [qlco]     1.6372067
Platelet Count [lbpr]     1.6372067
Metabolic [ftcn]     1.6394864
hepatobiliary [bdsy]     1.6417783
Problem [fndg]     1.6440823
Expectancy [idcn]     1.6463984
Concern [idcn]     1.6463984
Exhibit [inpr]     1.6463984
Component [mnob]     1.6487272
People [popg]     1.6487272
Accurate [qlco]     1.6487272
mice [mamm]     1.6487272
Portal [blor]     1.6510683
proposal [idcn]     1.6510683
Poorly [qlco]     1.6534222
Fold [spco]     1.6534222
Format [biof]     1.6534222
reflect [menp]     1.655789
Clear [qlco]     1.655789
Accuracy [qlco]     1.655789
Chemoembolization [topp]     1.655789
Manifest [ftcn]     1.6581687
Measurable [qnco]     1.6581687
Blood [tisu]     1.6581687
Percent [qnco]     1.6605616
Natural History [ocdi]     1.6605616
depend [medd]     1.6605616
Burden [idcn]     1.6629676
Variant [qlco]     1.665387
Probabilities [qnco]     1.665387
Inflammatory [ftcn]     1.665387
Children [aggp]     1.6678201
Dose [qnco]     1.6678201
Alteration [ftcn]     1.6678201
Extent [spco]     1.6678201
Measurable [ftcn]     1.6702669
Heterogeneity [qlco]     1.6702669
Appropriate [qlco]     1.6727275
Symptom [ftcn]     1.6727275
Alteration [idcn]     1.6727275
Microvascular [ftcn]     1.6727275
Stage [ftcn]     1.675202
Diabetes Mellitus [dsyn]     1.675202
Operable [tmco]     1.675202
Biochemical [ftcn]     1.6776909
Blood loss [patf]     1.6776909
allow [socb]     1.6776909
Cutoff [ftcn]     1.680194
Regression Analysis [inpr]     1.680194
interferon therapy [topp]     1.6827116
Non-invasive [ftcn]     1.6827116
Antiviral Therapy [topp]     1.6827116
Routine [qlco]     1.685244
Hazard [qlco]     1.685244
Therapies [topp]     1.685244
Apoptosis [celf]     1.685244
Insulin Resistance [patf]     1.685244
Primary sclerosing cholangitis [dsyn]     1.685244
perioperative [tmco]     1.6877912
Note [clna]     1.6877912
Relative [famg]     1.6877912
Stratified [qlco]     1.6903534
Taiwan [geoa]     1.6903534
Sequence [nusq]     1.6929308
Subsequent [tmco]     1.6929308
End [spco]     1.6929308
TREAT [ftcn]     1.6929308
depend [qlco]     1.6929308
derivation [qlco]     1.6929308
thi [euka]     1.6929308
Guide [prog]     1.6929308
overexpress [genf]     1.6929308
Variation [qlco]     1.6929308
Early Detection [diap]     1.6929308
Antiviral [phsu]     1.6955236
Smoking [inbe]     1.6955236
accept [qlco]     1.7007562
Copyright [inpr]     1.7007562
Primary liver cancer [neop]     1.7007562
Pathologic [ftcn]     1.7007562
Technique [inpr]     1.7007562
Aspect [qnco]     1.7033962
Study, Prospective [resa]     1.7060525
Carcinogen [hops]     1.7060525
Ascites [fndg]     1.7087251
Exclude [idcn]     1.7087251
Consequence [ftcn]     1.7087251
Interval [tmco]     1.7087251
Receiver Operating Characteristic [qnco]     1.7114142
Program [cnce]     1.7114142
Abilities [orga]     1.7114142
chinese [lang]     1.7141201
III [inpr]     1.7141201
Asian [popg]     1.7141201
Body Mass Index [diap]     1.7141201
Enhance [topp]     1.7141201
Alcoholic liver disease [dsyn]     1.716843
Proportion [qlco]     1.716843
Curative treatment [fndg]     1.719583
Trial [resa]     1.719583
Agent [chvf]     1.719583
Guideline [inpr]     1.719583
Activate [ftcn]     1.7223405
Favorable [qlco]     1.7251155
Loss [qnco]     1.7251155
Essential [qlco]     1.7251155
Segment [spco]     1.7251155
Detail [qlco]     1.7251155
transmission [idcn]     1.7251155
Participant [popg]     1.7279084
summary [inpr]     1.7279084
Allele [gngm]     1.7307193
Administration [ocac]     1.7307193
Adjacent [spco]     1.7307193
Host [orgm]     1.7307193
Ii [aapp]     1.7335486
Location [spco]     1.7335486
Concentrate [menp]     1.7335486
Introduction [hlca]     1.7335486
Tumor Progression [neop]     1.7335486
Percentage [qnco]     1.7363966
Life [idcn]     1.7363966
Science [ocdi]     1.7363966
Radiologic [bmod]     1.7363966
weight [orga]     1.7392632
Prolonged [tmco]     1.7392632
Asia [geoa]     1.7421489
Modified [ftcn]     1.7421489
Effort [orgf]     1.7421489
Differential [qlco]     1.7421489
Metastatic [ftcn]     1.7421489
Solitary [qnco]     1.7421489
State [geoa]     1.7450539
Taken [cnce]     1.7479783
Quantitation [qnco]     1.7479783
Western [spco]     1.7479783
Mass [fndg]     1.7479783
Variety [cnce]     1.7509228
R- [spco]     1.7509228
Simple [qlco]     1.7509228
choice [inbe]     1.7509228
procedures [inpr]     1.7538873
Public Health [bmod]     1.756872
Co-infection [dsyn]     1.7598776
Unresectable [clna]     1.7598776
Meta-Analysis [inpr]     1.7598776
Tumour [neop]     1.7598776
*Volume [qnco]     1.7598776
General [spco]     1.762904
Biologic [bmod]     1.762904
susceptibilities [clna]     1.762904
Minor [popg]     1.762904
Invasion [qlco]     1.762904
Primary Carcinoma [neop]     1.762904
Relative Risk [qnco]     1.762904
Response [fndg]     1.7659518
document [hlca]     1.7659518
Context [fndg]     1.7659518
Lung [bpoc]     1.7659518
Large tumor [qlco]     1.7659518
Date [tmco]     1.769021
Alcohol intake [inbe]     1.769021
Removable [qlco]     1.769021
In Vitro [inpr]     1.769021
Postoperative Complications [patf]     1.769021
secondary [neop]     1.769021
Reach [orgf]     1.769021
Malignant tumor [neop]     1.769021
Japanese [popg]     1.772112
MRI [diap]     1.772112
Insight [menp]     1.772112
Right [spco]     1.7752253
Certain [qlco]     1.7752253
origin [clas]     1.7752253
Appearance [orga]     1.7752253
Reliability [qnco]     1.7752253
0/5 [qnco]     1.7752253
basel [hcro]     1.778361
Transcatheter [spco]     1.778361
Paper [mnob]     1.778361
Core [spco]     1.778361
LED [mnob]     1.7815195
ACT [topp]     1.7815195
Special [qlco]     1.7815195
Transfused [topp]     1.7815195
Liver normal [fndg]     1.7815195
Unique [qlco]     1.7815195
CONSIST [idcn]     1.7815195
Repeat [ftcn]     1.7815195
Asymptomatic [fndg]     1.7815195
Work [ocac]     1.7847012
Central [spco]     1.7847012
Set [menp]     1.7847012
Viral Load [fndg]     1.7847012
In Vivo [spco]     1.7847012
Recurrence [tmco]     1.7879063
Quality [qlco]     1.7879063
Control [ftcn]     1.7879063
1-7 [gngm]     1.7879063
predictive factor [inpr]     1.7879063
Goal [inpr]     1.7879063
suppress [ftcn]     1.7879063
Inject [topp]     1.7879063
bleed [patf]     1.7879063
convention [qlco]     1.7911353
Adjusted [inbe]     1.7911353
TEN [dsyn]     1.7911353
Viruses [virs]     1.7911353
acute [tmco]     1.7911353
clinical characteristics [clna]     1.7943884
3 5 [qnco]     1.7943884
2 5 [qnco]     1.7943884
indication [irda]     1.7943884
Orthotopic liver transplant [topp]     1.7976662
Clinical Significance [fndg]     1.7976662
Early Diagnosis [diap]     1.7976662
Donor [popg]     1.7976662
follow [tmco]     1.7976662
Viral infection [dsyn]     1.7976662
Address [inpr]     1.8009688
Tumor cell [cell]     1.8042967
Cohort Studies [qnco]     1.8042967
Pair [qlco]     1.8042967
P53 [gngm]     1.8042967
Low Risk [fndg]     1.8076504
tissue tumor [tisu]     1.8076504
expression gene [genf]     1.8110301
Steatohepatitis [dsyn]     1.8110301
Primary Tumor [neop]     1.8110301
Delay [tmco]     1.8110301
effectiveness treatment [qlco]     1.8110301
complicate [ftcn]     1.8110301
Global [spco]     1.8110301
Meet [idcn]     1.8144364
Early Stage [clas]     1.8144364
Serum alpha-fetoprotein [lbpr]     1.8144364
Comprehension [qlco]     1.8178695
Excess [qlco]     1.8178695
Smaller [qlco]     1.8178695
liver injury [inpo]     1.8178695
Aflatoxin [hops]     1.8178695
Line [spco]     1.8213301
Valid [resa]     1.8213301
Portal vein thrombosis [dsyn]     1.8213301
Age-Years [tmco]     1.8213301
Amount [qnco]     1.8213301
familial [famg]     1.8213301
Abdominal [blor]     1.8213301
2-3 [resa]     1.8248184
At risk [qlco]     1.8248184
Subtype [clas]     1.8248184
3 Months [tmco]     1.8248184
Clinical Data [inpr]     1.8283349
Hypertension, Portal [dsyn]     1.8283349
Diet [food]     1.8283349
Categories [inpr]     1.8283349
Exposed [clna]     1.8283349
Over [spco]     1.8283349
Transformation [celf]     1.8283349
General [tmco]     1.8283349
Determinant [ftcn]     1.8318803
Extensibility [qlco]     1.8318803
ALCOHOL [podg]     1.8318803
Survey [inpr]     1.8318803
Surrounded [spco]     1.8318803
PubMed [inpr]     1.8318803
Share [socb]     1.8318803
alternate [cnce]     1.8318803
Onset [qlco]     1.8354547
far [spco]     1.8354547
Extend [ftcn]     1.8354547
Hepatitis B Virus-Related Hepatocellular Carcinoma [neop]     1.8390589
Hepatoblastoma [neop]     1.8390589
refer [ftcn]     1.8390589
Left [spco]     1.8426932
Hypothesis [idcn]     1.8426932
Arrest [dsyn]     1.8426932
Hepatitis Virus [virs]     1.8426932
Operable [ftcn]     1.8426932
LISS [lbpr]     1.8463581
Hepatology [bmod]     1.8463581
modulate [spco]     1.8463581
Attention [menp]     1.8463581
Perform [inbe]     1.8463581
Others [fndg]     1.8500543
Stratification [resa]     1.8500543
Italy [geoa]     1.8500543
Test [ftcn]     1.8500543
Administer [ftcn]     1.8500543
Mild [qlco]     1.8500543
Million [qnco]     1.8500543
INTERN [idcn]     1.8500543
Neoplasm [neop]     1.853782
RNA [nnon]     1.853782
Consumption [acty]     1.853782
Length [qnco]     1.853782
Success [qlco]     1.853782
Able [orga]     1.853782
man [fndg]     1.853782
Animal [anim]     1.853782
Male gender [fndg]     1.853782
refer [idcn]     1.8575423
c group [clas]     1.8575423
Combination [mnob]     1.8575423
Protocol [inpr]     1.8575423
Probably [idcn]     1.8575423
Hepatitis C Virus Antibodies [imft]     1.8575423
admitted [hlca]     1.8613353
Infiltrate [patf]     1.8613353
Spread [qlco]     1.8651617
Adequate [qlco]     1.8651617
Healthy Control [qlco]     1.8651617
Attempt [evnt]     1.8651617
suspect [idcn]     1.8651617
Serologic [ftcn]     1.8690221
mostly [idcn]     1.8690221
Find [sosy]     1.8690221
Ireland [geoa]     1.8690221
Rare [qlco]     1.8690221
Serious [qlco]     1.8690221
Section [spco]     1.872917
accelerate [ftcn]     1.872917
Recurrent Hepatocellular Carcinoma [neop]     1.872917
anatomic [qlco]     1.872917
Update [tmco]     1.872917
Abnormal [qlco]     1.872917
Disease Progression [patf]     1.872917
Dynamic [ftcn]     1.872917
categorization [acty]     1.872917
Interest [menp]     1.872917
Alcohol abuse [mobd]     1.872917
Necrosis [ortf]     1.8768474
Parenchyma [bpoc]     1.8768474
stage tumor [clna]     1.8768474
Employ [fndg]     1.8768474
Cure [cnce]     1.8768474
Life Style [socb]     1.8768474
communes [geoa]     1.8808136
expression level [idcn]     1.8808136
Uncommon [qlco]     1.8808136
arising [qlco]     1.8808136
Transplant Recipients [podg]     1.8808136
Without [qlco]     1.8808136
case report [inpr]     1.8848163
Containing [ftcn]     1.8848163
overview [inpr]     1.8848163
Living Donor [popg]     1.8848163
Aberrant [qlco]     1.8848163
Epidemiologic Studies [resa]     1.8848163
Hepatitis B e antigen [imft]     1.8888563
{Non-patient} [clna]     1.8888563
Cell Line [cell]     1.8888563
For [qlco]     1.8888563
Review, Systematic [inpr]     1.8888563
Great [qnco]     1.8929342
Structural [spco]     1.8929342
surgical treatment [hlca]     1.8929342
Directly [qlco]     1.8929342
suffer [mobd]     1.8929342
Focal Nodular Hyperplasia [dsyn]     1.8929342
Questionnaire [inpr]     1.8929342
Superior [spco]     1.8929342
Focal [spco]     1.8929342
Take [hlca]     1.8929342
Diverse [qlco]     1.8970509
Survival [phsu]     1.8970509
Term [tmco]     1.8970509
Early Hepatocellular Carcinoma [neop]     1.8970509
logistic [ocac]     1.8970509
Utilities [orgt]     1.9012067
apparent [idcn]     1.9012067
Half [qnco]     1.9012067
Fraction [qnco]     1.9012067
Radical [chvs]     1.9012067
Child-Pugh Score [inpr]     1.9012067
Hepatic fibrosis [dsyn]     1.9054029
enable [menp]     1.9054029
Stage [qlco]     1.9054029
Neoplastic [qlco]     1.9054029
Possibly [qlco]     1.9054029
options treatment [topp]     1.9054029
Intense [qlco]     1.9054029
Attributable [menp]     1.9054029
Isolate [ftcn]     1.9054029
Scale [medd]     1.90964
Give [ftcn]     1.90964
inhibited [menp]     1.90964
Behavior [inbe]     1.90964
Hand [bpoc]     1.90964
Oxidative Stress [comd]     1.90964
damage liver [patf]     1.90964
Multi [qnco]     1.90964
Scan [diap]     1.90964
Ethanol [orch]     1.9139187
newly [idcn]     1.9139187
Maximum [qnco]     1.9139187
Elderly [popg]     1.9139187
a group [clas]     1.9139187
Reason [idcn]     1.9139187
Retrospective Cohort Study [resa]     1.9139187
Damage [inpo]     1.9139187
morphological [qlco]     1.9139187
Phenotype [orga]     1.9182401
Immune [ftcn]     1.9182401
Not significant [fndg]     1.9182401
Societies [orgt]     1.9182401
Replicate [genf]     1.9226049
Plasma [bdsu]     1.9226049
Source [fndg]     1.9226049
injuries [inpo]     1.9226049
Entity [enty]     1.9226049
Acquire [tmco]     1.9226049
Expand [spco]     1.9226049
Integral [genf]     1.9226049
Heavy [qlco]     1.9226049
ETHNIC [popg]     1.9226049
Epidemic [phpr]     1.9226049
Signal [celf]     1.9226049
elevate [topp]     1.9226049
Group 1 [inpr]     1.9226049
Unit [qnco]     1.9226049
hepatic steatosis [dsyn]     1.9226049
Seropositive [qlco]     1.9226049
Aware [menp]     1.9226049
Registries [inpr]     1.927014
Hypertension [dsyn]     1.927014
Session [evnt]     1.927014
Biliary Tract [bpoc]     1.927014
Subset [clas]     1.927014
Population Based Study [resa]     1.927014
Basis [ftcn]     1.927014
Pathologist [prog]     1.927014
Thousand [qnco]     1.927014
MO [idcn]     1.927014
Medical record [inpr]     1.9314684
Close [ftcn]     1.9314684
Serum alpha-fetoprotein level [lbtr]     1.9314684
Intermediate [spco]     1.9314684
Excel [qlco]     1.9314684
H+ [elii]     1.9314684
Tumorigenesis [neop]     1.9314684
Fatty Liver [dsyn]     1.9314684
Natural [idcn]     1.9359689
untreated [fndg]     1.9359689
Colorectal [spco]     1.9359689
Study Design [resa]     1.9359689
Double [ftcn]     1.9359689
Adjuvant [chvf]     1.9359689
/min [tmco]     1.9359689
Dietary [food]     1.9359689
Concomitant [tmco]     1.9359689
Normal Tissue [tisu]     1.9405165
Abnormal [cgab]     1.9405165
Persistence [tmco]     1.9405165
Rapidly [qlco]     1.9405165
cancer registries [inpr]     1.9405165
Whole [qnco]     1.9405165
Clinical Trial [resa]     1.9405165
Extract [topp]     1.9451122
Consensus [socb]     1.9451122
Sensitive [ftcn]     1.9451122
vaccinate [topp]     1.9451122
inhibited [qlco]     1.9451122
RE [idcn]     1.9451122
MEDLINE [inpr]     1.9451122
Program [inpr]     1.9451122
fail [ftcn]     1.9451122
Numeric [qnco]     1.9451122
Pathogen [orgm]     1.9497571
italian [lang]     1.9497571
Place [spco]     1.9497571
Partial [qnco]     1.9497571
Prior [tmco]     1.9497571
Calculate [acty]     1.9497571
Antigen [imft]     1.9497571
Focused [spco]     1.9544523
Chronic viral hepatitis [dsyn]     1.9544523
multiple regression [qlco]     1.9544523
Liver parenchyma [bpoc]     1.9544523
Gallbladder [bpoc]     1.9544523
search [acty]     1.9544523
Mr. [cnce]     1.9544523
Region [spco]     1.9544523
Jaundice [patf]     1.9544523
demographic [idcn]     1.9591987
Display [ftcn]     1.9591987
American [popg]     1.9591987
Differential Diagnosis [diap]     1.9639976
Simultaneous [tmco]     1.9639976
Colorectal Cancer [neop]     1.9639976
Department [orgt]     1.9639976
Immunosuppression [topp]     1.9639976
Failure [ftcn]     1.9639976
lymph node metastasis [neop]     1.9639976
Cigarette smoke [hops]     1.9639976
Hepatic tumor [neop]     1.9639976
systematic [ftcn]     1.9639976
Endoscope [diap]     1.9639976
Markedly [qlco]     1.9639976
Laparoscopic [diap]     1.9639976
Question [inpr]     1.9688501
mark [qlco]     1.9688501
pathophysiology [ftcn]     1.9688501
Nodular [qlco]     1.9688501
Group 2 [inpr]     1.9688501
Typical [qlco]     1.9688501
compensate [qlco]     1.9688501
Approval [qlco]     1.9688501
Comorbidities [idcn]     1.9688501
resect [qlco]     1.9737574
Induction [ftcn]     1.9737574
SO [geoa]     1.9737574
Together [qlco]     1.9737574
Experimental [qlco]     1.9737574
concept [idcn]     1.9737574
Relate [famg]     1.9737574
High grade [qlco]     1.9737574
Adenocarcinoma [neop]     1.9737574
Discovery [acty]     1.9737574
Attributable [idcn]     1.9787208
Chronic inflammation [patf]     1.9787208
4 5 [qnco]     1.9787208
Serum sample [bdsu]     1.9787208
Rapid [qlco]     1.9787208
Disorder [dsyn]     1.9787208
Oncogene [hops]     1.9787208
Fifth [qnco]     1.9837416
lobe [bpoc]     1.9837416
Single Nucleotide Polymorphism [nusq]     1.9837416
Entire [qnco]     1.9837416
Microscope [qlco]     1.9837416
White [popg]     1.9837416
Environmental [spco]     1.9837416
Eligibility [idcn]     1.9837416
Alcoholic Cirrhosis [dsyn]     1.9837416
{Graft} [bodm]     1.9837416
Plus [qlco]     1.9837416
Cancer related [fndg]     1.9837416
Incidence [idcn]     1.9837416
Final [tmco]     1.9888211
Fix [fndg]     1.9888211
High frequency [tmco]     1.9888211
algorithm [inpr]     1.9888211
Problem [idcn]     1.9888211
Fatal [qlco]     1.9939609
Venous [bpoc]     1.9939609
Alpha [inpr]     1.9939609
Step [cnce]     1.9939609
Retention [menp]     1.9939609
PREVENT [ftcn]     1.9939609
Diffuse [qlco]     1.9939609
Short-term [tmco]     1.9939609
Relapse [phpr]     1.9939609
Developed Countries [qlco]     1.9939609
3 6 [fndg]     1.999162
Kaplan-Meier Analysis [qnco]     1.999162
Vessel [bpoc]     1.999162
Sera [bdsu]     1.999162
hepatic lesion [fndg]     1.999162
Remnant [emst]     1.999162
mg dl [qnco]     1.999162
Modification [ftcn]     1.999162
Example [cnce]     1.999162
Signal [phpr]     1.999162
Peripheral [spco]     2.0044262
Cancer Risk [qnco]     2.0044262
Gain [qnco]     2.0044262
Wild Type [orga]     2.0044262
radiologist [prog]     2.0044262
American Cancer Society [pros]     2.0044262
Diabetes Type 2 [dsyn]     2.0044262
Liver cell [cell]     2.0044262
Sensitivity and Specificity [qnco]     2.0044262
Power [hcpp]     2.0097551
Neoplasia [neop]     2.0097551
Cytoplasm [celc]     2.0097551
Thought [menp]     2.0097551
Surgeon [prog]     2.0097551
Mode [ftcn]     2.0097551
Evolution [genf]     2.0097551
Age Group [aggp]     2.0097551
Bear [mamm]     2.0097551
Family history [fndg]     2.0097551
Europe [geoa]     2.01515
Multiple tumors [neop]     2.01515
Parallel [qlco]     2.01515
statistical analysis [resa]     2.01515
Preservation [lbpr]     2.01515
Regular [qlco]     2.01515
Full [qlco]     2.01515
Rat [mamm]     2.01515
Lowest [qlco]     2.01515
Minimal [qlco]     2.01515
Survival time [clna]     2.01515
Capsule [bodm]     2.01515
Fast [fndg]     2.01515
Breast Cancer [neop]     2.01515
Cell Proliferation [celf]     2.020613
Well Differentiated [qlco]     2.020613
Form [ftcn]     2.020613
Stable [qlco]     2.020613
Daily [tmco]     2.020613
Allowance [socb]     2.020613
Transcript [genf]     2.020613
lesion liver [fndg]     2.020613
Action [ftcn]     2.020613
Cholangitis [dsyn]     2.020613
radiotherapy [inpr]     2.020613
Partial hepatectomy [topp]     2.020613
Oncologic [bmod]     2.0261455
Assign [ftcn]     2.0261455
Platelet [cell]     2.0261455
Clinical presentation [inpr]     2.0261455
ONGOING [idcn]     2.0261455
technologies [ocdi]     2.0261455
Tumor Marker [bacs]     2.0261455
Hospital Stay [tmco]     2.0261455
Begin [tmco]     2.0261455
properties [qlco]     2.0261455
male patient [orga]     2.0261455
HIV [virs]     2.0261455
virus infection [dsyn]     2.0261455
reactivate [qlco]     2.0317495
introduce [ftcn]     2.0317495
Hypervascular [qlco]     2.0317495
paediatric [bmod]     2.0317495
Find [fndg]     2.0317495
restrict [ftcn]     2.0317495
institute [orgt]     2.0317495
Alive [idcn]     2.0317495
Deficiency [ftcn]     2.0317495
Pool [cnce]     2.0374265
Interview [acty]     2.0374265
suppress [patf]     2.0374265
Create [acty]     2.0374265
Inhibitor [qlco]     2.0374265
Synergistic [qlco]     2.0374265
Call [menp]     2.0374265
Histopathologic [bmod]     2.0374265
Discussion [topp]     2.0374265
combination therapies [topp]     2.0431788
Initial [menp]     2.0431788
Medicine [phsu]     2.0431788
Hepatitis C Virus-Related Hepatocellular Carcinoma [neop]     2.0431788
causality [ftcn]     2.0431788
1B [inpr]     2.0431788
Hilar Cholangiocarcinoma [neop]     2.0431788
Cl - [elii]     2.0431788
Meaning [cnce]     2.0431788
Clearance [qlco]     2.0431788
Mutant [comd]     2.0431788
0.012" [qnco]     2.0431788
protein expression [genf]     2.0431788
Cardiovascular disease [dsyn]     2.0490084
Long-term Follow-up [hlca]     2.0490084
Natural [ftcn]     2.0490084
toxic [qlco]     2.0490084
next [spco]     2.0490084
Access [spco]     2.0490084
Network [prog]     2.0490084
Determinant [lbpr]     2.0490084
Anti HCV [imft]     2.0490084
Clinician [prog]     2.0490084
Diabetes [fndg]     2.0490084
3 4 [fndg]     2.0490084
Live [idcn]     2.0490084
0.018" [qnco]     2.0549173
Lanugo [bpoc]     2.0549173
Prognostic Marker [qlco]     2.0549173
Pathology, Surgical [bmod]     2.0549173
Cross-Sectional Studies [resa]     2.0549173
Construct [clas]     2.0549173
member [popg]     2.0549173
consideration [fndg]     2.0549173
liver metastases [neop]     2.0549173
Primary biliary cirrhosis [dsyn]     2.0609076
Colon [bpoc]     2.0609076
Distant [spco]     2.0609076
Start [tmco]     2.0609076
Southern [spco]     2.0609076
Pathologic findings [fndg]     2.0609076
General [acty]     2.0609076
Clinical stage [tmco]     2.0609076
Cost [qnco]     2.0609076
Diagnostic Accuracy [qlco]     2.0609076
Stomach [bpoc]     2.0669818
0.014" [qnco]     2.0669818
Macroscopic [qlco]     2.0669818
Copies [mnob]     2.0669818
Cancer, Hepatocellular [neop]     2.0669818
etiologies [ftcn]     2.0669818
Estimate [menp]     2.0669818
Reside [prog]     2.0669818
Chance [qlco]     2.0669818
Hilar [spco]     2.0669818
Metabolic [orgf]     2.073142
Staging system [inpr]     2.073142
Technical [ftcn]     2.073142
Correct [qlco]     2.073142
de novo [idcn]     2.073142
encounter [hlca]     2.073142
Sequence [inpr]     2.073142
Histologic grade [clas]     2.073142
Lymphocyte [cell]     2.079391
Lung Cancer [neop]     2.079391
Peak [qnco]     2.079391
Mix [ftcn]     2.079391
Precise [phsu]     2.079391
True [qlco]     2.079391
product [ocac]     2.079391
Node [bpoc]     2.079391
Clinical course [tmco]     2.079391
Dominance [ftcn]     2.079391
Pretreatment [sbst]     2.0857313
educate [edac]     2.0857313
examinations [hlca]     2.0857313
Largest [qnco]     2.0857313
Hbe Ag [imft]     2.0857313
Greatest [qnco]     2.0857313
mU/L [qnco]     2.0857313
Success [socb]     2.0857313
Models, Animal [anim]     2.0857313
Twelve [qnco]     2.0857313
Risk Ratio [qnco]     2.0857313
morphological [spco]     2.0857313
Predictive Value [qlco]     2.0857313
ELISA [lbpr]     2.0921652
Immune response [ortf]     2.0921652
Definite [idcn]     2.0921652
Drainage [bdsu]     2.0921652
Tumor suppressor gene [gngm]     2.0921652
Image Study [diap]     2.0921652
IU/mL [qnco]     2.0921652
Open [spco]     2.0921652
Nuclear [spco]     2.0921652
Epigenetic [bmod]     2.0921652
Trigger [clna]     2.0921652
Multicentric [spco]     2.0921652
Oral [spco]     2.0921652
Slightly [idcn]     2.0921652
criteria selection [qlco]     2.0921652
Virus, Human Immunodeficiency [virs]     2.0921652
Uptake [phsf]     2.0921652
Food [food]     2.0921652
USA [geoa]     2.0921652
Hepatocellular Adenoma [neop]     2.0921652
Foci [spco]     2.0921652
*Coefficient [qnco]     2.0986962
work ups [diap]     2.0986962
percutaneous ethanol injection [topp]     2.0986962
Environmental Factor [ftcn]     2.0986962
Cancer Mortality [qnco]     2.0986962
Blood sample [bdsu]     2.0986962
tumor growth [neop]     2.0986962
Genotype [lbpr]     2.0986962
Sufficient [qlco]     2.0986962
recur [phpr]     2.0986962
Classic [qlco]     2.0986962
radiating [npop]     2.0986962
CC [neop]     2.1053267
Cultural [idcn]     2.1053267
Initial [idcn]     2.1053267
Hepatoma [neop]     2.1053267
Sign [ftcn]     2.1053267
Pancreas [bpoc]     2.1053267
Exclude [ftcn]     2.1053267
population studies [popg]     2.1053267
INTERN [spco]     2.1053267
Adverse event [fndg]     2.1053267
Discover [acty]     2.1053267
liver surgeries [topp]     2.1053267
Cost Effectiveness [qnco]     2.1053267
Content [menp]     2.1053267
Maintain [acty]     2.1053267
Patient Outcome [idcn]     2.1053267
Focused [clna]     2.1053267
Dual [inpr]     2.1053267
Chemical [chem]     2.11206
Dysplasia [patf]     2.11206
Transient [popg]     2.11206
case control [hlca]     2.11206
circulate [ftcn]     2.11206
Intra [tmco]     2.11206
Distal [spco]     2.11206
histologic examination [lbpr]     2.11206
adjuvant therapy [topp]     2.11206
Syndrome [dsyn]     2.11206
Race [popg]     2.11206
Epithelium [tisu]     2.1188996
Liver Carcinogenesis [neop]     2.1188996
Tumor thrombus [dsyn]     2.1188996
intent [qlco]     2.1188996
Hepatitis C virus genotype [fndg]     2.1188996
0.016" [qnco]     2.1188996
Survival Analysis [resa]     2.1188996
Incomplete [qnco]     2.1188996
Unfavorable [qlco]     2.1188996
View [spco]     2.1188996
Frequencies [tmco]     2.1188996
High recurrence rate [fndg]     2.1188996
Drink [inbe]     2.1188996
Thailand [geoa]     2.1188996
Biology [bmod]     2.1258483
Cancer Cell [cell]     2.1258483
NON-NEOPLASTIC [dsyn]     2.1258483
Model for end-stage liver disease score [clna]     2.1258483
female patient [orga]     2.1258483
Decompensated [qlco]     2.1258483
Tract [bpoc]     2.1258483
Challenge [hlca]     2.1258483
Pancreatic [bpoc]     2.1258483
Lymph node [bpoc]     2.1258483
migrate [socb]     2.1258483
Real-Time PCR [mbrt]     2.1258483
5/5 [qnco]     2.1258483
Multinodular [qlco]     2.1258483
Symptomatic [ftcn]     2.1258483
debate [acty]     2.1258483
Alcohol Drinking [inbe]     2.1258483
Variability [cnce]     2.1329103
Decision [menp]     2.1329103
Cluster [idcn]     2.1329103
ALCOHOL USE [inbe]     2.1329103
Impaired [ftcn]     2.1329103
Surgical procedure [hlca]     2.1329103
Sometimes [tmco]     2.1329103
Direct [spco]     2.1329103
sonography [diap]     2.1329103
Hepatic Failure [dsyn]     2.1329103
post treatment [tmco]     2.1329103
Delete [comd]     2.1329103
Well defined [qlco]     2.1329103
Microarray [mnob]     2.1329103
Capacity [qnco]     2.1329103
Lipid [lipd]     2.1329103
Kidney [bpoc]     2.1329103
Tradition [ftcn]     2.1400888
Drive [menp]     2.1400888
Stain [qlco]     2.1400888
Parameter [spco]     2.1400888
Uncertain [idcn]     2.1400888
Gross [qlco]     2.1400888
Bile [bdsu]     2.1400888
3 groups [inpr]     2.1400888
Description [idcn]     2.1400888
Median Survival Time [tmco]     2.1400888
Inclusion Criteria [qlco]     2.1400888
Agreement [socb]     2.147388
1 Month [tmco]     2.147388
Egypt [geoa]     2.147388
RT-PCR [mbrt]     2.147388
Hepatitis, Autoimmune [dsyn]     2.147388
high-risk group [popg]     2.147388
Locus [gngm]     2.147388
Well Differentiated Hepatocellular Carcinoma [neop]     2.147388
Inclusion [qlco]     2.147388
Implementation [acty]     2.147388
Response Rate [tmco]     2.147388
Entry [inpr]     2.147388
Unusual [qlco]     2.147388
interpret [inpr]     2.147388
Prospective Cohort Study [resa]     2.147388
Regulated [medd]     2.147388
Maintain [ftcn]     2.147388
Reaction [ftcn]     2.147388
Likelihood [qnco]     2.147388
Diabetes Mellitus, Type 2 [dsyn]     2.154812
List [cnce]     2.154812
IU/L [qnco]     2.154812
origin [idcn]     2.154812
Liver function test [lbpr]     2.154812
PATHOLOGICAL EXAMINATION [ftcn]     2.154812
electrode [medd]     2.154812
Childhood [tmco]     2.154812
Outside [spco]     2.154812
Blood donor [popg]     2.154812
yr [tmco]     2.154812
Abdominal Pain [sosy]     2.154812
Concurrent [tmco]     2.154812
Acquisition [acty]     2.154812
SA [orch]     2.154812
Opisthorchis viverrini [euka]     2.154812
Protein level [lbtr]     2.154812
Reverse Transcription [genf]     2.154812
Woman [popg]     2.154812
Age [orgf]     2.154812
efficiencies [qlco]     2.154812
Absent [qnco]     2.154812
Proximal [spco]     2.1623652
Linear [spco]     2.1623652
Surgical Margin [bpoc]     2.1623652
negative predictive value [qnco]     2.1623652
Korea [geoa]     2.1623652
Adenoma [neop]     2.1623652
Hospitalization [hlca]     2.1623652
Zone [spco]     2.1623652
Resistance [menp]     2.1623652
Survival Rates, Cumulative [qnco]     2.170052
Time, Prothrombin [lbpr]     2.170052
applicable [qlco]     2.170052
Compound [qlco]     2.170052
methylated [moft]     2.170052
Angiographies [diap]     2.170052
Haemochromatosis [dsyn]     2.170052
Panel [idcn]     2.170052
Up [spco]     2.170052
Multifocal [spco]     2.170052
Varies [inpr]     2.170052
Separate [spco]     2.170052
Recognition [menp]     2.170052
PANCREATIC CANCER [neop]     2.1778774
Hepatitis Viruses [virs]     2.1778774
Intake [ftcn]     2.1778774
Serum Albumin [aapp]     2.1778774
human cell [lbtr]     2.1778774
Unrelated [fndg]     2.1778774
Breast [bpoc]     2.1778774
product [enty]     2.1778774
Northern [spco]     2.1778774
On [ftcn]     2.1778774
Multiple lesions [fndg]     2.1778774
Hepatic inflammation [fndg]     2.1778774
Inflammatory bowel disease [dsyn]     2.1778774
Post-Operative [tmco]     2.1778774
6/5 [fndg]     2.1778774
Stress [fndg]     2.1778774
Haemorrhage [patf]     2.1778774
Province [geoa]     2.1778774
Physician [prog]     2.1858463
Decompensated [fndg]     2.1858463
Laboratory Data [idcn]     2.1858463
Since [tmco]     2.1858463
Mouse [mamm]     2.1858463
Dimension [qnco]     2.1858463
Contraindicated [qlco]     2.1858463
Referral [hlca]     2.1858463
Distant metastasis [clas]     2.1858463
Always [tmco]     2.1858463
Surface [spco]     2.1858463
Magnetic Resonance [npop]     2.1858463
Aid [socb]     2.1858463
Viraemia [dsyn]     2.1858463
damage dna [comd]     2.1858463
Prominent [qlco]     2.1858463
Alanine level [lbpr]     2.1858463
minute [tmco]     2.1858463
Imaging Technique [diap]     2.1858463
Operative Time [tmco]     2.1858463
Hepatic vein [bpoc]     2.1939642
Angiogenesis [ortf]     2.1939642
Signal Pathway [moft]     2.1939642
Fish [fish]     2.1939642
excepting [idcn]     2.1939642
Child-Pugh Classification [inpr]     2.1939642
positive predictive value [qnco]     2.1939642
contain [ftcn]     2.1939642
bile leakage [patf]     2.1939642
Prospective Studies [resa]     2.1939642
Biliary Tract Cancer [neop]     2.1939642
Biliary Tree [bpoc]     2.1939642
Genetic Polymorphism [genf]     2.1939642
Meet [hlca]     2.1939642
Group I [inpr]     2.1939642
Geographic [spco]     2.1939642
Fibrosis stage [clna]     2.1939642
Chi [inpr]     2.1939642
des(gamma-carboxy)prothrombin [aapp]     2.1939642
U/L [qnco]     2.1939642
Principal [qlco]     2.1939642
exposures [inpo]     2.1939642
California [geoa]     2.2022367
Broad [spco]     2.2022367
3/9 [fndg]     2.2022367
Inject [ftcn]     2.2022367
mRNA Expression [genf]     2.2022367
low platelet count [fndg]     2.2022367
Palliative [qlco]     2.2022367
Upper [spco]     2.2022367
Environmental risk factor [qlco]     2.2022367
Medical [phsu]     2.2022367
Precursor [idcn]     2.2022367
Epithelial [qlco]     2.2022367
Clinical Studies [resa]     2.2022367
BY [geoa]     2.2022367
contained [ftcn]     2.2022367
Caucasian [popg]     2.2022367
Verified [ftcn]     2.2022367
Preparation [ftcn]     2.2022367
Defect [ftcn]     2.2022367
Oncogene [gngm]     2.2022367
Poorly differentiated [qlco]     2.2022367
Hope [menp]     2.2022367
5 6 [fndg]     2.2022367
Stricture [anab]     2.2022367
regenerate [ortf]     2.2022367
Graft Survival [ortf]     2.21067
Infant [aggp]     2.21067
Deposit [ftcn]     2.21067
Hepatitis B virus genotype [orga]     2.21067
Seroprevalence [resa]     2.21067
Black [popg]     2.21067
Laparotomies [topp]     2.21067
Homozygous [orga]     2.21067
Hepatic disease [dsyn]     2.21067
Quantify [qnco]     2.21067
Iron Overload [dsyn]     2.21067
Nucleus [celc]     2.21067
End Point [qlco]     2.21067
Resistance [ftcn]     2.21067
fibrotic [ftcn]     2.21067
Surg [tmco]     2.21067
Cell Cycle [celf]     2.21067
Eastern [spco]     2.21067
gastrointestinal [spco]     2.21067
viral replication [orgf]     2.21067
literature review [inpr]     2.21067
toxic [inpo]     2.21067
Viable [qlco]     2.21067
Residual [qlco]     2.21067
gradient [qnco]     2.21927
serum concentration [qnco]     2.21927
proteomic [bmod]     2.21927
Antioxidant [phsu]     2.21927
regulatory [rnlw]     2.21927
Attenuate [acty]     2.21927
Embolisation [topp]     2.21927
Weak [sosy]     2.21927
wait list [inpr]     2.21927
Immediate [tmco]     2.21927
Radio Frequency [npop]     2.21927
Actual [qlco]     2.21927
Definite [tmco]     2.21927
prophylaxis [inpr]     2.21927
Side Effect [ftcn]     2.21927
Maintenance [acty]     2.21927
Habit [inbe]     2.21927
Discriminate [qlco]     2.21927
Gall Bladder Cancer [neop]     2.21927
Lethal [fndg]     2.21927
bodies [humn]     2.21927
Hepatotoxicity [inpo]     2.228044
Codon [nusq]     2.228044
Tumor necrosis [neop]     2.228044
Molecule [sbst]     2.228044
Inhibitor [chvf]     2.228044
Weight Loss [fndg]     2.228044
densities [qnco]     2.228044
overlap [topp]     2.228044
Atypical [qlco]     2.228044
Capability [qlco]     2.228044
Lymphoma [neop]     2.228044
experience [resa]     2.228044
emergencies [idcn]     2.228044
Reversal [idcn]     2.228044
Small tumor [qlco]     2.228044
SD [fndg]     2.228044
TOPIC [ftcn]     2.228044
Imaging finding [lbtr]     2.228044
gold standard [qlco]     2.228044
Gastric Cancer [neop]     2.228044
Addition [qlco]     2.228044
Biologic [qlco]     2.228044
Liver Fluke [euka]     2.2369988
turn [fndg]     2.2369988
account [ocac]     2.2369988
Suspicion [menp]     2.2369988
10^3 [qnco]     2.2369988
Increment [qnco]     2.2369988
Sample [diap]     2.2369988
Gastroenterology [bmod]     2.2369988
Eleven [qnco]     2.2369988
AACR [pros]     2.2369988
Recovery [acty]     2.2369988
Human Cell Line [cell]     2.2369988
Physiologic [ftcn]     2.2369988
Widespread [spco]     2.2369988
Disseminate [spco]     2.2369988
Light [npop]     2.2369988
Report [hlca]     2.2369988
preference [idcn]     2.2369988
Above [spco]     2.2369988
code [ocac]     2.2369988
Complete Response [fndg]     2.2369988
Multifactorial [fndg]     2.2369988
insufficiencies [qlco]     2.2369988
Mouse Model [emod]     2.2369988
difficulties [fndg]     2.2369988
Liver Metastasis [neop]     2.2369988
Inactive [qlco]     2.2369988
Normal [resa]     2.2461421
Liver Dysfunction [patf]     2.2461421
France [geoa]     2.2461421
Needle [medd]     2.2461421
Sub- [spco]     2.2461421
Definite [qlco]     2.2461421
exert [orgf]     2.2461421
kg-m [qnco]     2.2461421
Hospital Mortalities [qlco]     2.2461421
Serum Marker [qlco]     2.2461421
Image Feature [qlco]     2.2461421
Common Tumor [neop]     2.2461421
proliferative [patf]     2.2461421
Stone [bdsu]     2.2461421
Duct [bpoc]     2.2461421
Abundance [qlco]     2.2461421
Survivor [podg]     2.2461421
HIV infection [dsyn]     2.2461421
Metabolite [bacs]     2.2461421
Slow [qlco]     2.2461421
Overweight [sosy]     2.2461421
Clinical Management [hlca]     2.2461421
Slide [resd]     2.2461421
Regimen [topp]     2.2461421
gene p53 [gngm]     2.2461421
Never [tmco]     2.2461421
Esophagus [bpoc]     2.2461421
Occult [idcn]     2.2461421
Block [patf]     2.2461421
Bridge [medd]     2.2554822
dysfunction [ftcn]     2.2554822
justify [ftcn]     2.2554822
recombinant [orgm]     2.2554822
Visit [bhvr]     2.2554822
Life Expectancies [grpa]     2.2554822
Life threatening [idcn]     2.2554822
Basic [ftcn]     2.2554822
Mother [famg]     2.2554822
Immediately [tmco]     2.2554822
Array [spco]     2.2554822
g/dL [qnco]     2.2554822
Lymphoma, Non-Hodgkin [neop]     2.2554822
metastatic tumor [neop]     2.2554822
Spontaneous [ftcn]     2.2554822
Venous Invasion [fndg]     2.2554822
Lobectomy [topp]     2.2554822
*Ranges [qnco]     2.2554822
P-Value [qnco]     2.2554822
Aid [dsyn]     2.2554822
archive [mnob]     2.2650275
Thrombosis [patf]     2.2650275
Non-specific [qlco]     2.2650275
fibrose [patf]     2.2650275
Preliminary [tmco]     2.2650275
Portion [spco]     2.2650275
Pathology, Clinical [bmod]     2.2650275
Reside [spco]     2.2650275
transit [comd]     2.2650275
Biliary drainage [topp]     2.2650275
metastasis tumor [neop]     2.2650275
susceptibilities [ftcn]     2.2650275
Tissue Sample [tisu]     2.2650275
ECHO [topp]     2.2650275
Strain [inpo]     2.2650275
DOI [clas]     2.2650275
Enzyme-Linked Immunosorbent Assay [lbpr]     2.2650275
Regression Analyses [inpr]     2.2650275
active hepatitis [fndg]     2.2650275
Mice, Transgenic [mamm]     2.2650275
CARDIOVASCULAR [bdsy]     2.2650275
6/4 [fndg]     2.2650275
Availability [ftcn]     2.2650275
Occasional [tmco]     2.2650275
Elevated alpha-fetoprotein [fndg]     2.2650275
Ethnic group [popg]     2.2650275
Pharmacologic [bmod]     2.2650275
Taiwanese [popg]     2.2650275
Serum albumin level [lbpr]     2.2650275
Branch [bpoc]     2.2747874
Tissue Microarray [resd]     2.2747874
Treatment outcome [qlco]     2.2747874
Birth [orgf]     2.2747874
Deregulated [acty]     2.2747874
signal intensity [qnco]     2.2747874
Temporal [spco]     2.2747874
0.022" [qnco]     2.2747874
base [inch]     2.2747874
Bind [ftcn]     2.2747874
evolved [ftcn]     2.2747874
Elastography [diap]     2.2747874
Hepatic Arteries [bpoc]     2.2747874
Gastric [bpoc]     2.2747874
Intratumor [spco]     2.2747874
outcome measure [qnco]     2.2747874
0.010" [qnco]     2.2747874
worsen [qlco]     2.2747874
O NOS [inpr]     2.2747874
Neutrophile [cell]     2.2747874
Expired [orgf]     2.2747874
deceased [orgf]     2.2747874
EXCLUSION [ftcn]     2.2747874
Beta [plnt]     2.2747874
DNA Methylation [moft]     2.2747874
inactivation [comd]     2.2847717
Cytologic [lbpr]     2.2847717
Irregular [qlco]     2.2847717
Metastatic Carcinoma [neop]     2.2847717
Non-Surgical [ftcn]     2.2847717
Threshold [qlco]     2.2847717
Insert [hlca]     2.2847717
Inadequate [qlco]     2.2847717
Priorities [tmco]     2.2847717
Homogeneity [qlco]     2.2847717
Between [spco]     2.2847717
Lost [ftcn]     2.2847717
Laboratory test [lbpr]     2.2847717
Mitochondrial [celc]     2.2847717
Nucleotide [nnon]     2.2847717
East [spco]     2.2847717
Coagulation [ortf]     2.2847717
Dysplastic nodule [anab]     2.2847717
Local Therapy [topp]     2.2847717
Episode [tmco]     2.2847717
Hyperlipidaemia [dsyn]     2.2847717
CT SCAN [diap]     2.2847717
Cell Growth [celf]     2.2847717
increasing incidence [ftcn]     2.2847717
Time period [tmco]     2.2949908
Basal [spco]     2.2949908
Thrombus [patf]     2.2949908
Degree [qnco]     2.2949908
Prostate [bpoc]     2.2949908
Real [qlco]     2.2949908
Restriction fragment length polymorphism [clna]     2.2949908
Actuary [prog]     2.2949908
Autopsies [diap]     2.2949908
Comprise [acty]     2.2949908
Contrast Agent [irda]     2.2949908
Patient Selection [resa]     2.2949908
Mandatory [ftcn]     2.2949908
cover [ftcn]     2.2949908
based case study [resa]     2.2949908
Equivalent [qlco]     2.2949908
FED [dsyn]     2.2949908
Cut [inpo]     2.2949908
Hemodynamic [ortf]     2.2949908
SNP [nusq]     2.2949908
Exact [qlco]     2.2949908
Dyslipidaemia [dsyn]     2.2949908
Pre-exist [qlco]     2.2949908
Grade III [qlco]     2.2949908
Chi-Square Test [inpr]     2.2949908
Resource [idcn]     2.2949908
Pleural Effusion [dsyn]     2.2949908
Cool [qlco]     2.2949908
1/24 [fndg]     2.2949908
Former [tmco]     2.2949908
Gallbladder Carcinoma [neop]     2.2949908
condition [qlco]     2.2949908
Hepatocarcinoma [neop]     2.2949908
Propensity Score [qnco]     2.2949908
oxidant [ftcn]     2.2949908
Parasite [euka]     2.3054562
SALVAGE [topp]     2.3054562
Robust [qlco]     2.3054562
Sexual [bhvr]     2.3054562
Domain [ftcn]     2.3054562
Offered [fndg]     2.3054562
Probe [medd]     2.3054562
prompt [ftcn]     2.3054562
intracellular [celc]     2.3054562
solid tumor [neop]     2.3054562
Mutate [comd]     2.3054562
Environ [spco]     2.3054562
gene polymorphism [genf]     2.3054562
Suggest [ftcn]     2.3054562
imaging modalities [ftcn]     2.3054562
Scientific [ocdi]     2.3054562
Hispanic [popg]     2.3054562
Oncogenesis [neop]     2.3054562
Easily [qlco]     2.3054562
HEALTHY SUBJECTS [popg]     2.3054562
Australia [geoa]     2.3054562
Satellite Nodule [fndg]     2.3054562
Risks, Relative [qnco]     2.3161802
Longitudinal [spco]     2.3161802
Persistence [idcn]     2.3161802
Encode [idcn]     2.3161802
Delete [acty]     2.3161802
macrophage [cell]     2.3161802
English [lang]     2.3161802
Multicenter Studies [resa]     2.3161802
Element [elii]     2.3161802
PLAN [menp]     2.3161802
Hepatic Encephalopathy [dsyn]     2.3161802
Washout [tmco]     2.3161802
Hepatitis B Core Antigen [imft]     2.3161802
Africa [geoa]     2.3161802
stabilities [qlco]     2.3161802
Twice [inpr]     2.3161802
small size [fndg]     2.3161802
Very high [fndg]     2.3161802
Reject [socb]     2.3161802
Renal [bpoc]     2.3161802
Targeted Therapy [topp]     2.3161802
Fulfill [idcn]     2.3161802
Single tumor [neop]     2.3161802
Draw [inpr]     2.3161802
genetic alteration [genf]     2.3161802
Flow Cytometries [lbpr]     2.3161802
AT-1 [gngm]     2.3161802
6/3 [fndg]     2.3161802
North [spco]     2.3271754
adopt [fndg]     2.3271754
Policies [inpr]     2.3271754
2 Months [tmco]     2.3271754
Shift [ftcn]     2.3271754
Extensibility [ftcn]     2.3271754
afb [bact]     2.3271754
Protection [fndg]     2.3271754
Blind [resa]     2.3271754
Primary Prevention [topp]     2.3271754
Inconsistent [qlco]     2.3271754
admission [hlca]     2.3271754
Rationale [idcn]     2.3271754
Start [qlco]     2.3271754
San Francisco [geoa]     2.3271754
Endoscopic Retrograde Cholangiopancreatography [diap]     2.3271754
Hepatitis B vaccination [topp]     2.3271754
Current Treatment [topp]     2.3271754
Therapeutic Effect [hlca]     2.3271754
Distributed [ftcn]     2.3271754
couple [ftcn]     2.3271754
Species [idcn]     2.3271754
Infrequent [tmco]     2.3271754
Segmentectomies [topp]     2.3271754
ROUTE [spco]     2.3271754
Body Weight [orga]     2.3271754
Titer [qnco]     2.3271754
linkage [moft]     2.3271754
deteriorate [phpr]     2.3271754
Cell Death [celf]     2.3384564
stimulant [npop]     2.3384564
GG [geoa]     2.3384564
Play [fndg]     2.3384564
Diffuse [npop]     2.3384564
Enrollment [hlca]     2.3384564
Early Stage [tmco]     2.3384564
Overcome [acty]     2.3384564
Data Set [inpr]     2.3384564
cross sections [spco]     2.3384564
Mu [inpr]     2.3384564
Bias [idcn]     2.3384564
ALCOHOL [mobd]     2.3384564
Registered [hlca]     2.3384564
Pilot Studies [resa]     2.3384564
Massive [qlco]     2.3384564
Incidental [ftcn]     2.3384564
West [spco]     2.3384564
peripheral blood [bdsu]     2.3384564
cover [medd]     2.3384564
Paraffin Embedded Tissue [tisu]     2.3384564
Physiologic [bmod]     2.3384564
Jaundice, Obstructive [dsyn]     2.3384564
Computation [lbpr]     2.3384564
Observational Study [resa]     2.3384564
HepG2 Cell [cell]     2.3384564
Removable [topp]     2.3384564
RUPTURE [phpr]     2.3384564
Satisfactory [inpr]     2.3384564
County [geoa]     2.3500383
Stage I [inpr]     2.3500383
Tobacco smoke [inbe]     2.3500383
Delivery [topp]     2.3500383
Informed Consent [rnlw]     2.3500383
Ultrasound examination [diap]     2.3500383
Membrane [tisu]     2.3500383
Most significant [qlco]     2.3500383
Submitted [ftcn]     2.3500383
Geographic Area [geoa]     2.3500383
Epithelial cell [cell]     2.3500383
Count [acty]     2.3500383
Very low [fndg]     2.3500383
contact [ftcn]     2.3500383
Cirrhosis, Cryptogenic [dsyn]     2.3500383
Sepsis [dsyn]     2.3500383
institute [idcn]     2.3500383
Transcript [nnon]     2.3500383
Schedule [inpr]     2.3500383
Identical [qlco]     2.3500383
Low Grade [qlco]     2.3500383
Tailor [prog]     2.3500383
Bile Ducts, Extrahepatic [bpoc]     2.3500383
Malignant disease [dsyn]     2.3500383
Late stage [tmco]     2.3500383
Primary Endpoint [irda]     2.3500383
Bile Duct Cancer [neop]     2.3500383
Balance [orgf]     2.3500383
Implant [medd]     2.3500383
Smoker [fndg]     2.3500383
collections data [resa]     2.3500383
Surveillance Program [resa]     2.3500383
Human tissue [tisu]     2.3500383
Hepatic function [ortf]     2.3500383
Participant [ftcn]     2.3500383
Perfuse [topp]     2.3619375
Ideal [qlco]     2.3619375
predisposed [ftcn]     2.3619375
Eliminated [phsf]     2.3619375
Intestinal [bpoc]     2.3619375
ELECTIVE [topp]     2.3619375
Therapeutic Intervention [topp]     2.3619375
India [geoa]     2.3619375
Signature [amas]     2.3619375
primary cancer [fndg]     2.3619375
Dysplastic [patf]     2.3619375
synthesis [biof]     2.3619375
*Constant [qnco]     2.3619375
Immunologic [ftcn]     2.3619375
Liver Abscess [dsyn]     2.3619375
Reconstructed [mcha]     2.3619375
hepatic nodule [fndg]     2.3619375
Discharge [bdsu]     2.3619375
Solid [qlco]     2.3619375
hepatic metastases [neop]     2.3619375
Sub-Saharan Africa [geoa]     2.3619375
Positive [spco]     2.3619375
Support [cnce]     2.3619375
Colon Cancer [neop]     2.3619375
Guidance [hlca]     2.3619375
Albumin level [lbtr]     2.3619375
Metabolic disorder [dsyn]     2.3619375
Northeast [spco]     2.3619375
Endogenous [ftcn]     2.3619375
Strike [ocac]     2.374172
Ill [sosy]     2.374172
AUC [qnco]     2.374172
Amplification [mbrt]     2.374172
Adolescence [aggp]     2.374172
Cities [geoa]     2.374172
R AW [ortf]     2.374172
South [spco]     2.374172
Murine [mamm]     2.374172
Shape [spco]     2.374172
Kappa [inpr]     2.374172
Sign [fndg]     2.374172
ADD [mobd]     2.374172
Southeast Asia [geoa]     2.374172
Predisposing Factor [tmco]     2.374172
Geographic Region [geoa]     2.374172
Bear [medd]     2.374172
Contaminant [hcpp]     2.374172
Protective Factor [biof]     2.374172
Abscess [dsyn]     2.374172
Recurrent disease [dsyn]     2.374172
diminish [qnco]     2.374172
hepatic complications [patf]     2.374172
File [ocac]     2.374172
final diagnosis [qlco]     2.374172
Histological finding [fndg]     2.374172
Common Bile Duct [bpoc]     2.374172
hepatoma cell [cell]     2.374172
Cholecystectomies [topp]     2.374172
magnitude [qnco]     2.374172
intent [menp]     2.374172
Chronic disease [dsyn]     2.374172
Vertical [spco]     2.3867612
Nested Case-Control Studies [resa]     2.3867612
Advanced cirrhosis [dsyn]     2.3867612
Homolog [gngm]     2.3867612
GGT [gngm]     2.3867612
CONSIST [qlco]     2.3867612
Impaired [patf]     2.3867612
Ki [gngm]     2.3867612
Cholangiocellular Carcinoma [neop]     2.3867612
Triple [qnco]     2.3867612
Apoptotic [qlco]     2.3867612
Iran [geoa]     2.3867612
Medium [inpr]     2.3867612
French [popg]     2.3867612
Id [fish]     2.3867612
Brain [bpoc]     2.3867612
High dose [qnco]     2.3867612
Progenitor [famg]     2.3867612
metastatic disease [neop]     2.3867612
Resolution [idcn]     2.3867612
Systemic Chemotherapy [topp]     2.3867612
asian countries [geoa]     2.3867612
External [spco]     2.3867612
Sequential [idcn]     2.3867612
diagnostic criteria [inpr]     2.3867612
Release [hlca]     2.3867612
Hepatitis B surface antigen negative [lbtr]     2.3867612
Repair, NOS [orgf]     2.3867612
HIV(+) patient [inpr]     2.3867612
donor liver [popg]     2.3867612
Infusion [topp]     2.3867612
Physical [hlca]     2.3867612
Multidisciplinary [ocac]     2.3867612
Real Time [idcn]     2.3867612
T-cell [cell]     2.3867612
Web [mnob]     2.3867612
meta-analyses [resa]     2.3867612
Store [ftcn]     2.3997262
Collaboration [socb]     2.3997262
Face [blor]     2.3997262
Pai [qnco]     2.3997262
centres [spco]     2.3997262
Case Series [resa]     2.3997262
Curative Surgery [topp]     2.3997262
Anastomosis [acab]     2.3997262
Neoadjuvant [topp]     2.3997262
Hepatitis C virus group [virs]     2.3997262
research [prog]     2.3997262
Cancer Control [hlca]     2.3997262
Kind [qlco]     2.3997262
Nodal [spco]     2.3997262
efficiencies [qnco]     2.3997262
urinary [qlco]     2.3997262
Return [qlco]     2.3997262
AD [ftcn]     2.3997262
SECRET [celf]     2.3997262
interpret [ftcn]     2.3997262
Chromosomal [celc]     2.3997262
Microwave [npop]     2.3997262
assist [socb]     2.3997262
Cervical Cancer [neop]     2.3997262
Minimum [qlco]     2.3997262
cancer recurrence [neop]     2.3997262
Cycle [tmco]     2.3997262
Cryptogenic [ftcn]     2.3997262
Interquartile Range [qnco]     2.3997262
antibodies hepatitis c [imft]     2.3997262
Cytologic [ftcn]     2.3997262
1/36 [fndg]     2.3997262
Hepatic Cell [cell]     2.3997262
Korean [popg]     2.3997262
Load [idcn]     2.3997262
Vital [qlco]     2.3997262
R1 [gngm]     2.3997262
Seronegative [qlco]     2.3997262
gene expression profile [qnco]     2.3997262
Chemoprevention [topp]     2.3997262
Transformation [patf]     2.3997262
Fourth [qnco]     2.3997262
Group [spco]     2.3997262
Ensure [food]     2.3997262
dissect [topp]     2.3997262
fragment [ftcn]     2.4130902
Phenomenon [phpr]     2.4130902
Somatic mutation [comd]     2.4130902
Satellite [spco]     2.4130902
Embedded [lbpr]     2.4130902
Pregnancies [orgf]     2.4130902
Tumor Pathology [bmod]     2.4130902
Urgent [tmco]     2.4130902
Thick [qlco]     2.4130902
Bone [bpoc]     2.4130902
Rule [idcn]     2.4130902
Tertiary [qnco]     2.4130902
Hold [idcn]     2.4130902
Chosen [acty]     2.4130902
serum ALT [lbpr]     2.4130902
Dose-dependent [qnco]     2.4130902
recover [qlco]     2.4130902
Borderline [qlco]     2.4130902
Urban [geoa]     2.4130902
silence [mobd]     2.4130902
Geography [ocdi]     2.4130902
Cholangiographies [diap]     2.4130902
1A [inpr]     2.4130902
Tumorigenicity [patf]     2.4130902
Middle [spco]     2.4130902
Resolve [idcn]     2.4130902
Pathology report [inpr]     2.4130902
inhibited [acty]     2.4130902
Metabolic disease [dsyn]     2.4130902
Visible [qlco]     2.4130902
Real-Time Polymerase Chain Reaction [mbrt]     2.4130902
Persistence [menp]     2.4130902
U S [geoa]     2.4130902
kill [socb]     2.4130902
Before [tmco]     2.4130902
F2 [qnco]     2.4130902
esophageal cancer [neop]     2.4130902
Hyperglycaemia [dsyn]     2.4130902
Haplotype [orga]     2.4130902
/dL [qnco]     2.4130902
Autoimmune [patf]     2.4130902
Laparoscopy [diap]     2.4130902
Subcapsular [spco]     2.4130902
Aa [plnt]     2.4130902
Harbor [mnob]     2.4130902
Wall [mnob]     2.4130902
Active chronic hepatitis [dsyn]     2.4268785
positive cells [qnco]     2.4268785
Demand [topp]     2.4268785
Comparative Studies [inpr]     2.4268785
Skin [bdsu]     2.4268785
Stent [medd]     2.4268785
Biliary disease [dsyn]     2.4268785
Near [fndg]     2.4268785
Rodent [mamm]     2.4268785
Pet [anim]     2.4268785
Habitual [tmco]     2.4268785
Helicobacter pylori [bact]     2.4268785
lateral left [spco]     2.4268785
Immunoblot assay [lbpr]     2.4268785
Allocation [acty]     2.4268785
Ranges, Normal [qnco]     2.4268785
associated disease [patf]     2.4268785
Good prognosis [qlco]     2.4268785
Hypermethylation [genf]     2.4268785
Clinical setting [spco]     2.4268785
Flow [npop]     2.4268785
Antitumor [qlco]     2.4268785
Bile Ducts, Intrahepatic [bpoc]     2.4268785
look [orga]     2.4268785
Distance [qnco]     2.4268785
Drink [food]     2.4268785
Liver Regeneration [ortf]     2.4268785
time wait [tmco]     2.4268785
Stage IV [inpr]     2.4268785
Cleanse [acty]     2.4268785
drug use [mobd]     2.4268785
Stage III [inpr]     2.4268785
Version [ftcn]     2.4268785
Fall [fndg]     2.4268785
Adverse Effect [ftcn]     2.4268785
Currency [mnob]     2.4268785
heavy drinking [mobd]     2.4268785
Hepatic stellate cell [cell]     2.4268785
Project [inpr]     2.4268785
Cancer Patient [podg]     2.4268785
degradation [ftcn]     2.4268785
Recruitment [acty]     2.4268785
Ductal [qlco]     2.4268785
Rural [fndg]     2.4268785
Pathology, Molecular [ocdi]     2.4268785
grafted [tisu]     2.4268785
Risk Assessment [hlca]     2.4268785
SECRET [biof]     2.4268785
B Virus [virs]     2.4268785
Absolute [qlco]     2.4268785
Arterial embolism [dsyn]     2.4268785
Decision Making [menp]     2.4268785
depleted [ftcn]     2.4411187
Permit [rnlw]     2.4411187
Phosphorylation [moft]     2.4411187
immunosuppressive therapies [topp]     2.4411187
concordance [socb]     2.4411187
Clinical information [clna]     2.4411187
Delta [inpr]     2.4411187
Opisthorchiasis [dsyn]     2.4411187
end stages [tmco]     2.4411187
Target Gene [gngm]     2.4411187
RFLP [clna]     2.4411187
Historical [idcn]     2.4411187
Advanced age [popg]     2.4411187
Academic [orgt]     2.4411187
Discriminate [menp]     2.4411187
Chemotherapy, Adjuvant [topp]     2.4411187
Tumor Sample [tisu]     2.4411187
Dilatation [topp]     2.4411187
compromise [fndg]     2.4411187
Adrenalectomy [topp]     2.4411187
document [inpr]     2.4411187
allograft [topp]     2.4411187
Serum alanine level [lbpr]     2.4411187
ROUTE [ftcn]     2.4411187
Bilirubin level [lbpr]     2.4411187
Diagnostic Marker [clna]     2.4411187
Individual [qlco]     2.4411187
new therapy [idcn]     2.4411187
Antagonist [ortf]     2.4411187
Correct [inpr]     2.4411187
Mutagen [hops]     2.4411187
antibody positive [lbtr]     2.4411187
Lobular [qlco]     2.4411187
Tumor Suppressor [gngm]     2.4411187
Cofactor [bacs]     2.4411187
Feed [hlca]     2.4411187
Architecture [ocdi]     2.4411187
Steroid [strd]     2.4411187
uncertainties [idcn]     2.4411187
egyptian [lang]     2.4411187
Tumor invasion [fndg]     2.4411187
Pivot [medd]     2.4411187
endpoints [qlco]     2.4411187
Cumulative Survival Rate [qnco]     2.4411187
National Health Insurance [hlca]     2.4411187
western blot analysis [lbpr]     2.4411187
abdominal ultrasound [diap]     2.4411187
Prognostic score [qnco]     2.4411187
6/6 [fndg]     2.4411187
Abstinent [inbe]     2.4411187
Unconditional [idcn]     2.4411187
Analog [chvs]     2.4411187
CD4 [lbpr]     2.4411187
College [mnob]     2.4411187
Liver mass [dsyn]     2.4411187
High risk factors [fndg]     2.4411187
Person [qlco]     2.455842
Clonorchis sinensis [euka]     2.455842
Ra [gngm]     2.455842
Pathology diagnosis [ftcn]     2.455842
Prophylactic [phsu]     2.455842
Health Care [hlca]     2.455842
Immune system [bdsy]     2.455842
most likely [idcn]     2.455842
PurE [moft]     2.455842
Localisation [ftcn]     2.455842
genetic risk factors [qlco]     2.455842
TT [geoa]     2.455842
Quantification [qnco]     2.455842
Indirect [qlco]     2.455842
Necrotic [ortf]     2.455842
Reader [prog]     2.455842
Raised [qnco]     2.455842
Surgical approach [ftcn]     2.455842
exacerbate [fndg]     2.455842
Specialist [prog]     2.455842
Hospitalization [fndg]     2.455842
Keyword [inpr]     2.455842
Native [ftcn]     2.455842
Rare Disease [dsyn]     2.455842
Infectious agent [orgm]     2.455842
Isolate [sbst]     2.455842
Thrombocytopenia [fndg]     2.455842
Replace [ftcn]     2.455842
Gross pathology [lbtr]     2.455842
Resectable Hepatocellular Carcinoma [neop]     2.455842
Fresh [qlco]     2.455842
Adrenal mass [dsyn]     2.455842
melanoma [neop]     2.455842
Sum [qnco]     2.455842
Surgical Management [hlca]     2.455842
Spain [geoa]     2.455842
Inferior [spco]     2.455842
Anti-HBs [lbpr]     2.455842
endoscopies [diap]     2.455842
digest [orgf]     2.455842
Non-Malignant [qlco]     2.455842
Fit [sosy]     2.455842
Maximal [qlco]     2.455842
Serologic [lbpr]     2.455842
Fever [fndg]     2.471082
Stage II [inpr]     2.471082
Attenuate [qlco]     2.471082
risk analysis [qlco]     2.471082
Vein [bpoc]     2.471082
Tumor Volume [qnco]     2.471082
American College of Surgeons [pros]     2.471082
Middle Age [aggp]     2.471082
Seed [lbpr]     2.471082
Person [orga]     2.471082
Diffusion weighted imaging [diap]     2.471082
mg% [qnco]     2.471082
Bilobar [spco]     2.471082
Abnormal [fndg]     2.471082
Signal Pathway [celf]     2.471082
Sequela [patf]     2.471082
Immigrant [popg]     2.471082
Prevention Measures [inpr]     2.471082
Project [cnce]     2.471082
Sample Size [qnco]     2.471082
Adrenal angiography [diap]     2.471082
HEP [gngm]     2.471082
g/day [qnco]     2.471082
Acute hepatitis [dsyn]     2.471082
At [spco]     2.471082
Not available [idcn]     2.471082
Prone [spco]     2.471082
Antibiotic [antb]     2.471082
Inflammatory Response [patf]     2.471082
Review Board, Institutional [prog]     2.471082
In the Field [spco]     2.471082
15 Minutes [tmco]     2.471082
Microscopic blood vessel [bpoc]     2.471082
Downstream [spco]     2.471082
Exploration [topp]     2.471082
Intra-operative [tmco]     2.471082
PREVENT [inpr]     2.471082
Visual [menp]     2.471082
Keep [ftcn]     2.471082
Homeostasis [biof]     2.471082
Progression-Free Survival [qnco]     2.471082
Pain [sosy]     2.471082
Income [qnco]     2.4868762
Worker [ftcn]     2.4868762
pre treatment [tmco]     2.4868762
Conversion [ftcn]     2.4868762
budd-chiari syndrome [dsyn]     2.4868762
Check [acty]     2.4868762
Indeterminate [idcn]     2.4868762
Infectious disease [dsyn]     2.4868762
4 Weeks [tmco]     2.4868762
Retain [ftcn]     2.4868762
African American [popg]     2.4868762
Disease Progression [neop]     2.4868762
High sensitivity [lbpr]     2.4868762
Train [edac]     2.4868762
Self [idcn]     2.4868762
Non-Hispanic [popg]     2.4868762
Bind [acty]     2.4868762
Genet [bmod]     2.4868762
North America [geoa]     2.4868762
Adhere [ftcn]     2.4868762
Map [mnob]     2.4868762
Cholestasis [dsyn]     2.4868762
6 9 [fndg]     2.4868762
Type 1 [clas]     2.4868762
fibrogenesis [orgf]     2.4868762
In Hospital Mortalities [qlco]     2.4868762
Complication, Postoperative [patf]     2.4868762
Tumor Burden [diap]     2.4868762
Tumor Response [idcn]     2.4868762
Associate [idcn]     2.4868762
Histologic type [clas]     2.4868762
Conflict [inbe]     2.4868762
GY [geoa]     2.4868762
Sporadic [tmco]     2.4868762
Sinusoid [spco]     2.4868762
Fatty Liver, Nonalcoholic [dsyn]     2.4868762
Anatomy [bmod]     2.4868762
Germany [geoa]     2.4868762
Palliative Treatment [hlca]     2.4868762
Service [ocac]     2.4868762
synergism [moft]     2.5032668
inpatient [podg]     2.5032668
DE [geoa]     2.5032668
liver studies [lbpr]     2.5032668
Prognoses [hlca]     2.5032668
Histopathology finding [lbtr]     2.5032668
Time Point [tmco]     2.5032668
Lymph node metastases [neop]     2.5032668
liver development [biof]     2.5032668
Regimen [inpr]     2.5032668
Clone [cell]     2.5032668
Ligation [topp]     2.5032668
Stain [irda]     2.5032668
Sixth [qnco]     2.5032668
Obstructed [patf]     2.5032668
Benign Tumors [neop]     2.5032668
Mayo [geoa]     2.5032668
Advance [ftcn]     2.5032668
Cholelithiasis [dsyn]     2.5032668
Judge [prog]     2.5032668
Variance [qlco]     2.5032668
Postoperative Period [tmco]     2.5032668
Low dose [qnco]     2.5032668
2 Weeks [tmco]     2.5032668
Very rare [fndg]     2.5032668
Put [acty]     2.5032668
elevated alt [fndg]     2.5032668
Interfere [qlco]     2.5032668
Unsatisfactory [qlco]     2.5032668
dose-response relationship [biof]     2.5032668
Inheritance [ftcn]     2.5032668
Sole [blor]     2.5032668
adduct [chvs]     2.5032668
Axis [bpoc]     2.5032668
normal control [qlco]     2.5032668
Abdomen [blor]     2.5032668
scenario [ftcn]     2.5032668
Hepatic Cirrhosis [dsyn]     2.5032668
Intrahepatic bile duct [bpoc]     2.5032668
Fibrosis score [clna]     2.5032668
Vena Cava, Inferior [bpoc]     2.5032668
Encephalopathy [dsyn]     2.5032668
Positron-Emission Tomography [diap]     2.5032668
Exercise [dora]     2.5032668
Visual [ftcn]     2.5032668
Hepatic Tissue [bpoc]     2.5032668
Slight [qlco]     2.5032668
Surgical specimen [sbst]     2.5032668
Recurrence Risk [qnco]     2.5032668
Determinant [gora]     2.5032668
stimulant [topp]     2.5032668
Haemodialysis [topp]     2.5032668
Homozygote [orga]     2.5032668
Enzyme Immunoassay [lbpr]     2.5032668
Unable [fndg]     2.5032668
Cholangitis, Sclerosing [dsyn]     2.5032668
7 days [tmco]     2.5032668
xenograft [topp]     2.5032668
Macroscopic blood vessel [bpoc]     2.5032668
Criterion [inpr]     2.5032668
infection complication [dsyn]     2.5032668
possess [mobd]     2.5032668
Null [qnco]     2.5032668
Hepatic injury [inpo]     2.5032668
Malignant neoplasm [neop]     2.5032668
Os [blor]     2.5032668
Study Subject [grup]     2.5032668
Squamous cell carcinoma [neop]     2.5032668
/10^6 [qnco]     2.5032668
Maternal [famg]     2.5203001
Diagnosis, clinical [qlco]     2.5203001
Compatibility [idcn]     2.5203001
Medical History [fndg]     2.5203001
Gastrointestinal bleeding [patf]     2.5203001
World Health Organization [hcro]     2.5203001
Haemangioma [neop]     2.5203001
vaccinate [fndg]     2.5203001
Radiograph [npop]     2.5203001
genotoxicity [comd]     2.5203001
Pool [geoa]     2.5203001
Hereditary haemochromatosis [dsyn]     2.5203001
liver steatosis [dsyn]     2.5203001
co-morbidity [idcn]     2.5203001
Rest [dora]     2.5203001
molecular pathway [moft]     2.5203001
Signal [biof]     2.5203001
Separate [fndg]     2.5203001
Opisthorchis Viverrini Infection [dsyn]     2.5203001
Answer [inpr]     2.5203001
Lesser [qlco]     2.5203001
Viral Marker [qlco]     2.5203001
error [qlco]     2.5203001
Blood test [lbpr]     2.5203001
Hyperbilirubinaemia [dsyn]     2.5203001
Bladder [bpoc]     2.5203001
Occlusion [ortf]     2.5203001
Cross [cnce]     2.5203001
Gradual [qlco]     2.5203001
Migration, Cell [celf]     2.5203001
paradigm [resa]     2.5203001
liver tumour [neop]     2.5203001
Supportive care [topp]     2.5203001
Synchronicities [tmco]     2.5203001
Art [ocdi]     2.5203001
Nodular Lesion [fndg]     2.5203001
Kaposi Sarcoma [neop]     2.5203001
Zero [qnco]     2.5203001
Follow-Up Studies [resa]     2.5203001
Exogenous [spco]     2.5203001
Stage 0 [inpr]     2.5203001
Symptom [sosy]     2.5203001
Brazil [geoa]     2.5203001
disease severity [qlco]     2.5203001
Low Prevalence [qnco]     2.5203001
Very Poor [inpr]     2.5203001
Distributed [spco]     2.5203001
Heterozygosity [orga]     2.5203001
Energy [fndg]     2.5203001
Declining [qlco]     2.5203001
cancer prevention [topp]     2.5203001
Intractable [ftcn]     2.5203001
portal vein embolization [topp]     2.5203001
Occupation [ocdi]     2.5203001
cancer progression [neop]     2.5203001
TOLERABILITY [fndg]     2.5203001
Anti-Hepatitis C Virus Antibodies [imft]     2.5203001
Physical Examination [hlca]     2.5203001
High resolution [lbpr]     2.5203001
Intravenous [spco]     2.5380287
Fetal [emst]     2.5380287
Data Analysis [ocac]     2.5380287
Opposite [spco]     2.5380287
discrepancies [fndg]     2.5380287
landscape [spco]     2.5380287
Transarterial [spco]     2.5380287
Long duration [qlco]     2.5380287
Hepatic Mass [dsyn]     2.5380287
5 Days [tmco]     2.5380287
Varices [dsyn]     2.5380287
Side [spco]     2.5380287
Contaminant [ftcn]     2.5380287
Type II [clas]     2.5380287
Mole [neop]     2.5380287
Discontinuation [fndg]     2.5380287
Longitudinal Studies [resa]     2.5380287
Ulcerative Colitis [dsyn]     2.5380287
Analogue [chvs]     2.5380287
suspicious [idcn]     2.5380287
Intra-arterial [spco]     2.5380287
Ablation Therapy [topp]     2.5380287
Inhibitory [acty]     2.5380287
Placement [hlca]     2.5380287
Predictability [menp]     2.5380287
Biopsy Specimen [tisu]     2.5380287
rural area [spco]     2.5380287
Bilateral [spco]     2.5380287
Renal dysfunction [fndg]     2.5380287
commercial [inpr]     2.5380287
biliary cancer [neop]     2.5380287
Certainty [qlco]     2.5380287
thermal ablation [topp]     2.5380287
Biochemistry [ocdi]     2.5380287
Unchanged [fndg]     2.5380287
Hong Kong [geoa]     2.5380287
genotype hcv [fndg]     2.5380287
Encode [menp]     2.5380287
Mice, Nude [mamm]     2.5380287
Advocate [ocdi]     2.5380287
Persistent infection [dsyn]     2.5380287
Hormonal [horm]     2.5380287
Depth [spco]     2.5380287
Non-recurrent [tmco]     2.5380287
Nutrition [bmod]     2.5380287
Mitochondria [celc]     2.5380287
Peritoneal [bpoc]     2.5380287
gender difference [orga]     2.5380287
Qualitative [qlco]     2.5380287
Female Gender [fndg]     2.5380287
Cystic [qlco]     2.5380287
Antiviral agent [phsu]     2.5380287
Ill [fndg]     2.5380287
ICC [neop]     2.5380287
PLAN [ftcn]     2.5380287
Composite [clna]     2.5380287
Oncologist [prog]     2.5380287
Spleen [bpoc]     2.5380287
Attendance [prog]     2.5380287
Collected [ftcn]     2.5380287
etiologic agent [sbst]     2.5380287
Discontinuation [hlca]     2.5380287
efficacy treatment [qlco]     2.5380287
Item [enty]     2.5380287
Cancer Diagnosis [diap]     2.5380287
Reversal [ftcn]     2.5380287
Molecular Marker [clna]     2.5380287
Papillary [qlco]     2.5380287
Stroma [bpoc]     2.5380287
malignant tumours [neop]     2.5380287
Candidate Gene [gngm]     2.5565124
Birth Cohort [qnco]     2.5565124
picture [mnob]     2.5565124
radiation therapies [inpr]     2.5565124
Bacteria [bact]     2.5565124
Registration [hlca]     2.5565124
Receive [medd]     2.5565124
Mammalian [mamm]     2.5565124
Liver Disorder [dsyn]     2.5565124
Canada [geoa]     2.5565124
p53 tumor suppressor gene [gngm]     2.5565124
Serum bilirubin NOS [lbpr]     2.5565124
palliation [hlca]     2.5565124
transect [topp]     2.5565124
Device [medd]     2.5565124
Data Sources [qnco]     2.5565124
Gastrointestinal Tract [bdsy]     2.5565124
Easy [qlco]     2.5565124
Delivered [acty]     2.5565124
Prostate Cancer [neop]     2.5565124
Hypertriglyceridaemia [fndg]     2.5565124
Occupation [ftcn]     2.5565124
Boy [aggp]     2.5565124
Endothelial cell [cell]     2.5565124
Instance [idcn]     2.5565124
pulmonary [bpoc]     2.5565124
simulate [bodm]     2.5565124
virol [lipd]     2.5565124
g l [qnco]     2.5565124
Village [geoa]     2.5565124
transmit [patf]     2.5565124
From [qlco]     2.5565124
Predominate [qlco]     2.5565124
Tip [medd]     2.5565124
immunoreaction [moft]     2.5565124
Clinical Research [resa]     2.5565124
Pakistan [geoa]     2.5565124
Antiretroviral Therapy, Highly Active [topp]     2.5565124
degenerating [patf]     2.5565124
Blood flow [orgf]     2.5565124
Gene Mutation [genf]     2.5565124
Systemic Therapy [topp]     2.5565124
Contraceptives, Oral [phsu]     2.5565124
drug injecting [topp]     2.5565124
Diaphragm [bpoc]     2.5565124
Bile duct carcinoma [neop]     2.5565124
Animal Model [anim]     2.5565124
Graft failure [patf]     2.5565124
Peri [tmco]     2.5565124
14 7 [qnco]     2.5565124
Greece [geoa]     2.5565124
comparative analysis [resa]     2.5565124
Deep [spco]     2.5565124
Confluent [qlco]     2.5565124
Total Cholesterol [lbpr]     2.5565124
Latent [qlco]     2.5565124
Pregnant Women [popg]     2.5565124
Ligand [chem]     2.5565124
retransplantation [topp]     2.5565124
Immunoassay [lbpr]     2.5565124
Therapeutic Efficacy [qlco]     2.5565124
Affiliated [qlco]     2.5758173
Human immunodeficiency virus infection [dsyn]     2.5758173
Labeling Index [lbtr]     2.5758173
Splenectomy [topp]     2.5758173
Rapid progression [fndg]     2.5758173
Five-year Survival Rate [qnco]     2.5758173
Consult [hlca]     2.5758173
Intraductal Papillary Neoplasm [neop]     2.5758173
Veteran [popg]     2.5758173
Small Lesion [fndg]     2.5758173
After [tmco]     2.5758173
circulate [phsf]     2.5758173
Hepatic parenchyma [bpoc]     2.5758173
Extract [sbst]     2.5758173
Portal tract [bpoc]     2.5758173
Reside [acty]     2.5758173
Inoperable [qlco]     2.5758173
Unit [bodm]     2.5758173
Laparoscopic approach [spco]     2.5758173
Heterozygous [orga]     2.5758173
ineffective [idcn]     2.5758173
informant [qlco]     2.5758173
Inverse [qlco]     2.5758173
UICC [inpr]     2.5758173
Extrahepatic bile duct [bpoc]     2.5758173
Transforming growth factor beta 1 [gngm]     2.5758173
RUPTURE [ftcn]     2.5758173
Stable Disease [fndg]     2.5758173
Frozen [npop]     2.5758173
Porphyria Cutanea Tarda [dsyn]     2.5758173
Extracellular Matrix [tisu]     2.5758173
PNPLA3 [gngm]     2.5758173
Once [inpr]     2.5758173
Point Mutation [comd]     2.5758173
Diet, High-Fat [topp]     2.5758173
long-term treatment [hlca]     2.5758173
Appropriate Treatment [clna]     2.5758173
Cysts, Choledochal [cgab]     2.5758173
Viral Hepatitis B [dsyn]     2.5758173
Flukes, Liver [euka]     2.5758173
African [popg]     2.5758173
Township [qnco]     2.5758173
Acute Rejection [fndg]     2.5758173
Pre-clinical [qlco]     2.5758173
Out-patient [podg]     2.5758173
in vitro study [resa]     2.5758173
Molecular Epidemiologies [bmod]     2.5758173
australian [fndg]     2.5758173
Detoxification [orgf]     2.5758173
Controlled Study [resa]     2.5758173
etc. [idcn]     2.5758173
NAFLD [dsyn]     2.5758173
intraabdominal [blor]     2.5758173
Replicate [ftcn]     2.5758173
Aggregate [ftcn]     2.5758173
Cyst [dsyn]     2.5758173
Occupational Exposure [inpo]     2.5758173
Primer [nnon]     2.5758173
Neuroblastoma [neop]     2.5758173
Preoperative diagnosis [fndg]     2.5758173
stage tumor [diap]     2.5758173
1 Week [tmco]     2.5758173
ENTER [qlco]     2.5758173
gray [qnco]     2.5758173
investigate [prog]     2.5758173
Eat [orgf]     2.5758173
Foundation [orgt]     2.5758173
experimental studies [resa]     2.5758173
Response [ftcn]     2.5758173
infestation [dsyn]     2.5758173
intravenous drug use [inbe]     2.5758173
Utilities [ftcn]     2.5758173
Edge [spco]     2.5960207
4 groups [inpr]     2.5960207
Avoidance [menp]     2.5960207
Publication Bias [qlco]     2.5960207
intervention [topp]     2.5960207
Excessive alcohol consumption [fndg]     2.5960207
Renal Cell Carcinoma [neop]     2.5960207
communes [socb]     2.5960207
disrupt [ftcn]     2.5960207
CD34 [lbpr]     2.5960207
Larynx [bpoc]     2.5960207
Pancreatic [dsyn]     2.5960207
Replace [idcn]     2.5960207
Early-onset [fndg]     2.5960207
Isoform [aapp]     2.5960207
Performance Status [clna]     2.5960207
Experimental Design [resa]     2.5960207
unknown etiology [fndg]     2.5960207
Coffee [food]     2.5960207
Liver Failure, Acute [dsyn]     2.5960207
Esophageal [spco]     2.5960207
Exclusion Criteria [ftcn]     2.5960207
Re-operation [topp]     2.5960207
Remission [fndg]     2.5960207
Embryonic [emst]     2.5960207
Statistic [qnco]     2.5960207
Enrich [food]     2.5960207
Word [idcn]     2.5960207
Leakage [patf]     2.5960207
Residual Tumor [neop]     2.5960207
Advanced Cancer [neop]     2.5960207
Type 2 [clas]     2.5960207
Urine [bdsu]     2.5960207
Sex Ratio [qnco]     2.5960207
Wild Type Mouse [mamm]     2.5960207
Infer [menp]     2.5960207
Analytes [resa]     2.5960207
diagnostic image [diap]     2.5960207
Liver neoplasms [neop]     2.5960207
Son [famg]     2.5960207
Cirrhosis, nonalcoholic [dsyn]     2.5960207
Han [lang]     2.5960207
Epithelial-Mesenchymal Transition [celf]     2.5960207
Cluster [resa]     2.5960207
successful treatment [clna]     2.5960207
Schistosomiasis [dsyn]     2.5960207
Stem cell [cell]     2.5960207
Trabecula [tisu]     2.5960207
Live [qlco]     2.5960207
3-Dimensional [spco]     2.5960207
Long-Term Effect [phpr]     2.5960207
Valid [qlco]     2.5960207
Pathology department [hcro]     2.5960207
Hepatitis, Alcoholic [dsyn]     2.5960207
First-Line Treatment [topp]     2.5960207
Atherosclerosis [dsyn]     2.5960207
Firstly [qlco]     2.5960207
% proof [qnco]     2.5960207
WWW [mnob]     2.5960207
Cancer Stem Cell [cell]     2.5960207
Hybridisation [genf]     2.5960207
Valid [qnco]     2.5960207
Economic [ocdi]     2.5960207
c myc [gngm]     2.5960207
low albumin [fndg]     2.5960207
Fusion [ftcn]     2.5960207
Oral cavity [bsoj]     2.5960207
Cea [euka]     2.5960207
Hyperplasia [patf]     2.5960207
Rose [plnt]     2.5960207
hepatic carcinoma [neop]     2.5960207
oxidant [moft]     2.5960207
cardiovascular risk factor [dsyn]     2.5960207
surgical intervention [fndg]     2.5960207
Network [cnce]     2.5960207
excision [topp]     2.5960207
parent [famg]     2.5960207
L3 [blor]     2.6172101
Agree [inpr]     2.6172101
opinion [menp]     2.6172101
Uniform [qlco]     2.6172101
Gastrointestinal Cancer [neop]     2.6172101
write [ocdi]     2.6172101
Implant [topp]     2.6172101
partial response [fndg]     2.6172101
Cigarette [mnob]     2.6172101
Abuse [fndg]     2.6172101
primary treatment [topp]     2.6172101
Postoperative chemotherapy [topp]     2.6172101
Formula [inpr]     2.6172101
Nutrition [qlco]     2.6172101
porcine [mamm]     2.6172101
International Normalized Ratio [lbpr]     2.6172101
Standard deviation [qnco]     2.6172101
COLL [inpr]     2.6172101
Immunisation [topp]     2.6172101
Molecular Analysis [mbrt]     2.6172101
Supplement [food]     2.6172101
TOLERABILITY [resa]     2.6172101
Assumed [inpr]     2.6172101
translate [ocac]     2.6172101
c stage [inpr]     2.6172101
Hepatitis B virus group [virs]     2.6172101
U/ml [qnco]     2.6172101
Extend [spco]     2.6172101
Gut [bdsy]     2.6172101
Eliminated [qlco]     2.6172101
Suboptimal [qlco]     2.6172101
Genetic Susceptibility [orga]     2.6172101
Cascade [mnob]     2.6172101
p16 [gngm]     2.6172101
American Joint Committee on Cancer [pros]     2.6172101
Type I [clas]     2.6172101
Antibody to hepatitis C virus [imft]     2.6172101
Positive Surgical Margin [fndg]     2.6172101
Right liver [bpoc]     2.6172101
Mesenchymal [qlco]     2.6172101
Dosage [qnco]     2.6172101
Family member [famg]     2.6172101
DNA Sequence [nusq]     2.6172101
Polymorphic [qlco]     2.6172101
HTTP [idcn]     2.6172101
Biliary stent [medd]     2.6172101
Lesion size [spco]     2.6172101
Perineural Invasion [fndg]     2.6172101
Copy Number [qnco]     2.6172101
Grade B [inpr]     2.6172101
Autoimmune Disease [dsyn]     2.6172101
Age-Adjusted Incidence Rate [qnco]     2.6172101
Diagnostic Method [diap]     2.6172101
Vegetable [food]     2.6172101
learn [menp]     2.6172101
Inverse Association [cnce]     2.6172101
Appearance [qlco]     2.6172101
Pre-operative evaluation [diap]     2.6172101
brought [ftcn]     2.6172101
Hepatic surface [blor]     2.6172101
Strength [qnco]     2.6172101
p21 [gngm]     2.6172101
drain [topp]     2.6172101
MICRO [lbpr]     2.6172101
Chemoprevention [qlco]     2.6172101
Lymphadenectomy [topp]     2.6172101
F/m [tmco]     2.6172101
Liver carcinoma [neop]     2.6172101
Lipid Metabolism [moft]     2.6172101
deteriorate [fndg]     2.6172101
Relapse [tmco]     2.6172101
Secondary Prevention [topp]     2.6172101
emergencies [phpr]     2.6172101
Census [qnco]     2.6172101
Bridging fibrosis [patf]     2.6172101
Antiretroviral therapy [topp]     2.6172101
Hepatic duct [bpoc]     2.6172101
hospital death [fndg]     2.6172101
Organ transplant [topp]     2.6172101
Chart review [hlca]     2.6172101
Head [blor]     2.6172101
Cholecystitis [dsyn]     2.6172101
Estimated blood loss [fndg]     2.6172101
Fresh Water [sbst]     2.6172101
EGG [food]     2.6172101
clinical aspects [clna]     2.6172101
Intended [qlco]     2.6172101
translate [genf]     2.6172101
Particle [chvs]     2.6172101
Reproducibility [qlco]     2.6172101
Connect [acty]     2.6172101
Cessation [acty]     2.6172101
Yearly [tmco]     2.6172101
PLAN [dsyn]     2.6394866
disrupt [qlco]     2.6394866
Outpatients [podg]     2.6394866
Drive [dora]     2.6394866
according [socb]     2.6394866
Liver fluke infection [dsyn]     2.6394866
Population-Based Registry [inpr]     2.6394866
brief [qlco]     2.6394866
Hepatitis B virus status [clna]     2.6394866
Mutagenesis [moft]     2.6394866
Band [medd]     2.6394866
Transcriptome [nusq]     2.6394866
Histopathologic Examination [bmod]     2.6394866
Pathologic stage [clna]     2.6394866
Pancreatic adenocarcinoma [neop]     2.6394866
Global Health [grpa]     2.6394866
Low serum albumin [fndg]     2.6394866
Build [cnce]     2.6394866
cancer site [spco]     2.6394866
Abstract [ocac]     2.6394866
Silent [qlco]     2.6394866
Genetic Predisposition [orga]     2.6394866
Hepatic metastasis [neop]     2.6394866
Classification system [clas]     2.6394866
female sex [fndg]     2.6394866
synthetic [acty]     2.6394866
Progressive liver disease [fndg]     2.6394866
Growth pattern [fndg]     2.6394866
Stage 4 [inpr]     2.6394866
RES [fndg]     2.6394866
dissect [ftcn]     2.6394866
Hepatic dysfunction [patf]     2.6394866
Cancer Research [resa]     2.6394866
Load [acty]     2.6394866
Gland [bpoc]     2.6394866
Organ [orgm]     2.6394866
Hepatitis C virus genotype 1 [virs]     2.6394866
Genome Wide Association Studies [mbrt]     2.6394866
Usual [qlco]     2.6394866
Wilson Disease [dsyn]     2.6394866
DNA Repair [genf]     2.6394866
Transplant [tisu]     2.6394866
Storage [ftcn]     2.6394866
Encode [acty]     2.6394866
Hyperplastic [patf]     2.6394866
Connect [inpr]     2.6394866
Surface Antigen [imft]     2.6394866
Layer [bpoc]     2.6394866
Cancer Center [hcro]     2.6394866
Binary [qlco]     2.6394866
Forward [spco]     2.6394866
Subunit [qnco]     2.6394866
User [humn]     2.6394866
adapt [orch]     2.6394866
treatment failure [qlco]     2.6394866
Hypoxia [patf]     2.6394866
Gamma [npop]     2.6394866
prev [idcn]     2.6394866
standard therapy [topp]     2.6394866
cancer gene [gngm]     2.6394866
Necropsy [diap]     2.6394866
ingest [biof]     2.6394866
Doppler [diap]     2.6394866
Fibrolamellar hepatocellular carcinoma [neop]     2.6394866
Team [grup]     2.6394866
Pathology specimen [bdsu]     2.6394866
Left side [spco]     2.6394866
quantities [qnco]     2.6394866
self reported [resa]     2.6394866
Stage B [inpr]     2.6394866
stand [phsf]     2.6394866
Operable [inpr]     2.6394866
Open surgery [topp]     2.6629677
Bacteraemia [dsyn]     2.6629677
Radiologic finding [fndg]     2.6629677
Immunoblot [lbpr]     2.6629677
Anaemia [dsyn]     2.6629677
Knock-out Mice [mamm]     2.6629677
Proliferating [ftcn]     2.6629677
Most Recent [tmco]     2.6629677
Inflammatory cell [cell]     2.6629677
Chromatin [aapp]     2.6629677
Scattered [spco]     2.6629677
Explanation [inpr]     2.6629677
Therapeutic agent [inpr]     2.6629677
Premalignant Lesion [neop]     2.6629677
Sarcoma [neop]     2.6629677
Red [fndg]     2.6629677
Empiric [qlco]     2.6629677
Epigenetic Mechanism [genf]     2.6629677
International Agency [orgt]     2.6629677
Patient data [inpr]     2.6629677
Acute infection [dsyn]     2.6629677
Partner [famg]     2.6629677
Prothrombin.activity [lbpr]     2.6629677
chemo [topp]     2.6629677
Eligibility [hlca]     2.6629677
hepatic damage [patf]     2.6629677
Mixture [sbst]     2.6629677
Wild [inpr]     2.6629677
Display [mnob]     2.6629677
chart [inpr]     2.6629677
Destruction [topp]     2.6629677
Platform [resd]     2.6629677
glycemia [carb]     2.6629677
New infection [tmco]     2.6629677
socioeconomic [cnce]     2.6629677
Medicare [gora]     2.6629677
Inter- [spco]     2.6629677
subcutaneous [spco]     2.6629677
Border [spco]     2.6629677
ROC Curve [qnco]     2.6629677
major surgeries [topp]     2.6629677
Leukaemia [neop]     2.6629677
Area Under Curve [qnco]     2.6629677
undefined [idcn]     2.6629677
Nested PCR [mbrt]     2.6629677
Microarray Analysis [lbpr]     2.6629677
Suppressor [mnob]     2.6629677
Bulk [food]     2.6629677
Report [prog]     2.6629677
Immune [phsf]     2.6629677
Space [spco]     2.6629677
Miss [idcn]     2.6629677
wait [ftcn]     2.6629677
Infrastructure [clas]     2.6629677
Neonatal [prog]     2.6629677
Adults, Young [aggp]     2.6629677
Donor organ [bpoc]     2.6629677
Sacrifice [idcn]     2.6629677
mg kg [qnco]     2.6629677
Hereditary [ftcn]     2.6629677
In situ [spco]     2.6629677
Contiguous [spco]     2.6629677
Follow-up examination [fndg]     2.6629677
National Cancer Institute [hcro]     2.6629677
Thin [qlco]     2.6629677
preceded [tmco]     2.6629677
Rat Liver [bpoc]     2.6629677
High Risk Populations [popg]     2.6629677
Smooth [qlco]     2.6629677
colonies [qnco]     2.6629677
aor [medd]     2.6629677
Quarter [qnco]     2.6629677
Fatigue [sosy]     2.6629677
Concentrate [mnob]     2.6629677
Healthy Volunteers [popg]     2.6629677
Aggressive behavior [mobd]     2.6629677
Fine-needle aspirate [diap]     2.6629677
chew [ortf]     2.6629677
Achievement [bhvr]     2.6629677
Fibrolamellar Carcinoma [neop]     2.6629677
methylated [phsu]     2.6629677
Revise [topp]     2.6629677
Pharynx [bpoc]     2.6629677
Socioeconomic Status [qlco]     2.6629677
splenic [bpoc]     2.6629677
Monocyte [cell]     2.6629677
Thai [popg]     2.6629677
Chain [mnob]     2.6629677
High grade dysplastic nodule [neop]     2.6629677
Weekly [tmco]     2.6629677
Epigenetic Change [genf]     2.6629677
serum total bilirubin [lbpr]     2.687791
Liver Cirrhosis, Alcoholic [dsyn]     2.687791
Provide [prog]     2.687791
Adipose tissue [tisu]     2.687791
Mucinous [qlco]     2.687791
shorten [qlco]     2.687791
diagnostic test [diap]     2.687791
Carcinogen [neop]     2.687791
Surrogate Marker [qlco]     2.687791
Cytotoxic [comd]     2.687791
Anti-inflammatory [phsu]     2.687791
Turkey [geoa]     2.687791
Rich [qlco]     2.687791
Liver nodule [fndg]     2.687791
Normal Range [qnco]     2.687791
Needs [qlco]     2.687791
past history [qlco]     2.687791
hepatobiliary disease [dsyn]     2.687791
Total Volume [qnco]     2.687791
East Asia [geoa]     2.687791
vertical transmission [patf]     2.687791
Under [spco]     2.687791
named [inpr]     2.687791
Rates, Death [qnco]     2.687791
Hepatocellular Injury [patf]     2.687791
CCA [cgab]     2.687791
Volume [qnco]     2.687791
Population Attributable Risk [qnco]     2.687791
PTEN [gngm]     2.687791
BARRIER [medd]     2.687791
Electron [mnob]     2.687791
Enhance [nnon]     2.687791
Division [topp]     2.687791
Demographic Factors [idcn]     2.687791
Glomerular Filtration Rate [diap]     2.687791
Non-infected [ftcn]     2.687791
hepatic arterial infusion [topp]     2.687791
treatment method [topp]     2.687791
Design [ftcn]     2.687791
Newborn [aggp]     2.687791
FLUID [bdsu]     2.687791
Statement [idcn]     2.687791
Immunotherapies [topp]     2.687791
Supplement [topp]     2.687791
Hepatic status [qlco]     2.687791
/wk [tmco]     2.687791
Carrier State [fndg]     2.687791
Late Diagnosis [qlco]     2.687791
Chronic alcohol abuse [mobd]     2.687791
Mucosa [tisu]     2.687791
Isointense [idcn]     2.687791
Cholangioscopy [diap]     2.687791
Revise [tmco]     2.687791
Coagulation necrosis [patf]     2.687791
Cellular proliferation [patf]     2.687791
lung metastases [neop]     2.687791
Cardiac [bpoc]     2.687791
worsen [fndg]     2.687791
dying [orgf]     2.687791
canadian [fndg]     2.687791
Rabbit [mamm]     2.687791
Subpopulation [popg]     2.687791
Courses [tmco]     2.687791
Equation [cnce]     2.687791
HFE [gngm]     2.687791
Biliary cirrhosis [dsyn]     2.687791
Dilatation [ftcn]     2.687791
Equilibrium [orgf]     2.687791
Diarrhea [sosy]     2.687791
Stenosis [patf]     2.687791
Texas [geoa]     2.687791
population studies [resa]     2.687791
Tumor Microenvironment [npop]     2.687791
Edit [inpr]     2.687791
Pancreaticoduodenectomy [topp]     2.687791
theories [idcn]     2.687791
Heterozygote [orga]     2.687791
Matrix [spco]     2.687791
temperature [orga]     2.687791
placebo [topp]     2.687791
Tumor Biology [resa]     2.687791
precancerous lesions [neop]     2.687791
Capsular [spco]     2.687791
Hepatitis B carrier [fndg]     2.687791
escape [menp]     2.687791
Wnt Pathway [moft]     2.687791
Surgical site infection [patf]     2.687791
Mount [medd]     2.687791
Moderately differentiated [qlco]     2.687791
Liver segment [bpoc]     2.687791
Causation [idcn]     2.687791
Highly significant [qlco]     2.687791
Review [qlco]     2.687791
Meaning [idcn]     2.687791
Gene Signature [ftcn]     2.687791
Hepatomegaly [sosy]     2.687791
Label [menp]     2.687791
Mass Spectrometry [lbpr]     2.687791
graft loss [patf]     2.687791
Laparoscopic Surgery [topp]     2.687791
liver graft [topp]     2.687791
New Agents [clas]     2.687791
assist [fndg]     2.687791
a t [topp]     2.687791
Immunofluorescence [lbpr]     2.687791
Block [mobd]     2.687791
ovarian cancer [neop]     2.687791
Worst [qlco]     2.687791
Transarterial embolisation [topp]     2.687791
Hodgkin Lymphoma [neop]     2.687791
Hepatic adenoma [neop]     2.687791
Peptide [aapp]     2.687791
Current Therapy [topp]     2.687791
Shunt [medd]     2.687791
ie [dsyn]     2.687791
Exposure to [clna]     2.687791
Joint [bsoj]     2.687791
Intact [qlco]     2.687791
eosinophilic [ftcn]     2.687791
Radioembolization [topp]     2.687791
Terminal [tmco]     2.687791
Cellular Process [celf]     2.687791
Mid [spco]     2.687791
see [orgf]     2.687791
Malignant Cell [cell]     2.687791
Transplantations, Liver [topp]     2.687791
Sharp [fndg]     2.687791
Study Objective [idcn]     2.7141201
Medical therapies [topp]     2.7141201
Infection, Bacterial [dsyn]     2.7141201
Exposures, Environmental [inpo]     2.7141201
Bile Duct Tumor [neop]     2.7141201
anti-apoptosis [celf]     2.7141201
Sensitive [fndg]     2.7141201
Precancerous [qlco]     2.7141201
Stomach Cancer [neop]     2.7141201
Acute Renal Failure [dsyn]     2.7141201
Drug resistance [biof]     2.7141201
Los Angeles [geoa]     2.7141201
1/60 [fndg]     2.7141201
Disturbance [qlco]     2.7141201
Mediterranean [popg]     2.7141201
hepatocyte proliferation [celf]     2.7141201
Liver decompensation [dsyn]     2.7141201
Total bilirubin level [lbpr]     2.7141201
Committee [grup]     2.7141201
Terminology [inpr]     2.7141201
g/g [qnco]     2.7141201
Quantitative Real-Time Polymerase Chain Reaction [mbrt]     2.7141201
Fibroblast [cell]     2.7141201
Pig [mamm]     2.7141201
kinetic [npop]     2.7141201
Substance [sbst]     2.7141201
Genesis [gngm]     2.7141201
Inoculate [topp]     2.7141201
Computation [mnob]     2.7141201
Chronic kidney disease [dsyn]     2.7141201
Unlikely [cnce]     2.7141201
Neuroendocrine [bdsy]     2.7141201
snail [euka]     2.7141201
Biased [idcn]     2.7141201
mL/min [qnco]     2.7141201
Bladder Cancer [neop]     2.7141201
Time Interval [tmco]     2.7141201
Standard [resa]     2.7141201
mmHg [qnco]     2.7141201
hepatic tumours [neop]     2.7141201
Human Papilloma Virus [virs]     2.7141201
Back [blor]     2.7141201
Hour [tmco]     2.7141201
Injecting drug user [fndg]     2.7141201
Bone Marrow [tisu]     2.7141201
prevention strategies [inpr]     2.7141201
Intraperitoneal [spco]     2.7141201
Adverse Effect [fndg]     2.7141201
Girl [aggp]     2.7141201
ORG [prog]     2.7141201
Adulthood [tmco]     2.7141201
Tumour size [spco]     2.7141201
Unaffected [cnce]     2.7141201
Stage 1 [inpr]     2.7141201
Transhepatic [spco]     2.7141201
Biopsy, Needle [diap]     2.7141201
patient care [hlca]     2.7141201
Blood product [phsu]     2.7141201
Language [lang]     2.7141201
Hyperinsulinaemia [dsyn]     2.7141201
Tuberculosis [dsyn]     2.7141201
expense [qnco]     2.7141201
Metastatic Lesion [fndg]     2.7141201
recall [menp]     2.7141201
donation [qnco]     2.7141201
Viewpoint [inpr]     2.7141201
Mexico [geoa]     2.7141201
fucosylation [moft]     2.7141201
RFA [gora]     2.7141201
Pancreatic carcinoma [neop]     2.7141201
Iso [fish]     2.7141201
Fatty acid [lipd]     2.7141201
Remote [spco]     2.7141201
Vector [nnon]     2.7141201
Top [spco]     2.7141201
Rupture, Spontaneous [patf]     2.7141201
Biological Process [phsf]     2.7141201
Hypoalbuminaemia [fndg]     2.7141201
MOLECULAR BASIS [idcn]     2.7141201
Ultrasound guided biopsy [diap]     2.7141201
excreted [phsf]     2.7141201
ex vivo [ftcn]     2.7141201
Industrial [ocac]     2.7141201
Inconclusive [idcn]     2.7141201
planning treatment [inpr]     2.7141201
Clinical findings [sosy]     2.7141201
RNA virus [virs]     2.7141201
Acquire [acty]     2.7141201
ENTER [spco]     2.7141201
Microbubble [medd]     2.7141201
Tobacco use NOS [fndg]     2.7141201
Blood Vessel [bpoc]     2.7141201
Endothelial [tisu]     2.7141201
Extended hepatic resection [topp]     2.7141201
Aggregate [qlco]     2.7141201
surgical complication [fndg]     2.7141201
3 Days [tmco]     2.7141201
CHC [gngm]     2.7141201
kPa [qnco]     2.7141201
MILDLY [idcn]     2.7141201
Indian [popg]     2.7141201
Renal insufficiency [dsyn]     2.7141201
Specialized Center [hcro]     2.7141201
Mono [popg]     2.7141201
Tattoo [hlca]     2.7141201
Exam [hlca]     2.7141201
Supplies [idcn]     2.7141201
Northeastern [spco]     2.7141201
Dietary Habits [inbe]     2.7141201
bile leak [patf]     2.7141201
non smokers [fndg]     2.7141201
Social [ftcn]     2.7141201
SMOOTH MUSCLE ACTIN [gngm]     2.7141201
Spontaneous bacterial peritonitis [dsyn]     2.7141201
Biliary System [bpoc]     2.7141201
Clamp [topp]     2.7141201
PIVKA-II [aapp]     2.7141201
Ovaries [bpoc]     2.7421489
Cholangiopancreatography, Magnetic Resonance [diap]     2.7421489
Plasma sample [bdsu]     2.7421489
Phylogenetic Analysis [resa]     2.7421489
Cis [euka]     2.7421489
5th [qnco]     2.7421489
Electron Microscopy [lbpr]     2.7421489
Stool [bdsu]     2.7421489
Intrinsic [spco]     2.7421489
Intrahepatic duct [bpoc]     2.7421489
Geographic Distribution [tmco]     2.7421489
CK7 [gngm]     2.7421489
Thickened [fndg]     2.7421489
Meta [euka]     2.7421489
LLC [celc]     2.7421489
Hepatic Cancer [neop]     2.7421489
Drinking Water [sbst]     2.7421489
Iatrogenic [qlco]     2.7421489
secondary tumor [neop]     2.7421489
coverage [idcn]     2.7421489
perinatal [tmco]     2.7421489
Clinical/Radiologic [ftcn]     2.7421489
Pesticide [hops]     2.7421489
Multidetector Computed Tomography [diap]     2.7421489
biliary carcinoma [neop]     2.7421489
education level [edac]     2.7421489
Maturation [tmco]     2.7421489
Reverse Transcriptase Polymerase Chain Reaction [mbrt]     2.7421489
Percutaneous approach [spco]     2.7421489
Serum creatinine [lbpr]     2.7421489
Refractory [ftcn]     2.7421489
Resolve [cnce]     2.7421489
Quantitative RTPCR [mbrt]     2.7421489
HBC [gngm]     2.7421489
Viral disease [dsyn]     2.7421489
Toxicologic [bmod]     2.7421489
Puncture [fndg]     2.7421489
Nation [orgt]     2.7421489
Newly Diagnosed [qlco]     2.7421489
adiposity [dsyn]     2.7421489
Nausea [sosy]     2.7421489
Hepatic haemangioma [neop]     2.7421489
Genomic DNA [nnon]     2.7421489
elevated transaminase [fndg]     2.7421489
Machinery [mnob]     2.7421489
extrahepatic bile duct cancer [neop]     2.7421489
Kupffer cell [cell]     2.7421489
Muscle [tisu]     2.7421489
simulate [resa]     2.7421489
Replace [topp]     2.7421489
Hypercholesterolaemia [dsyn]     2.7421489
Intravenous Drug Abuse [mobd]     2.7421489
Autoimmune liver disease [dsyn]     2.7421489
ERCP [diap]     2.7421489
Organisation [phsf]     2.7421489
Bismuth [elii]     2.7421489
Biological Function [phsf]     2.7421489
Seventh [qnco]     2.7421489
Transversal [comd]     2.7421489
Not Known [qlco]     2.7421489
Microsphere [medd]     2.7421489
2-19 [gngm]     2.7421489
student [prog]     2.7421489
Dietary Factors [ftcn]     2.7421489
Cholestatic liver disease [dsyn]     2.7421489
Solubility [celc]     2.7421489
Colorectal Carcinoma [neop]     2.7421489
viability [qlco]     2.7421489
screening test [hlca]     2.7421489
combined treatment [topp]     2.7421489
Gene Expression Analysis [mbrt]     2.7421489
VI [inpr]     2.7421489
Confirmatory [idcn]     2.7421489
Cytokeratin-7 [aapp]     2.7421489
Spot [dsyn]     2.7421489
American Society of Anesthesiologists [pros]     2.7421489
spatial [gngm]     2.7421489
Physical activity [dora]     2.7421489
Hierarchy [ftcn]     2.7421489
held [idcn]     2.7421489
Progenitor Cell [cell]     2.7421489
translate [inpr]     2.7421489
Acid [chem]     2.7421489
Risk Reduction [inbe]     2.7421489
Personalized Medicine [topp]     2.7421489
Household [famg]     2.7421489
chronic [ftcn]     2.7421489
Round [spco]     2.7421489
GO [gngm]     2.7421489
Sweden [geoa]     2.7421489
Somewhat [inpr]     2.7421489
Percutaneous Transhepatic Biliary Drainage [topp]     2.7421489
HFE gene [gngm]     2.7421489
regenerate [ftcn]     2.7421489
Unifocal [spco]     2.7421489
post transfusion [tmco]     2.7421489
turnover [qnco]     2.7421489
Patient Records [inpr]     2.7421489
Mouse Liver [tisu]     2.7421489
Orthotopic [spco]     2.7421489
Encapsulated [phpr]     2.7421489
cancer stage [diap]     2.7421489
Image analysis [lbpr]     2.7421489
Hepatitis C virus status [clna]     2.7421489
Stage 3 [inpr]     2.7421489
Male predominance [fndg]     2.7421489
Lymph Node Involvement [fndg]     2.7421489
Gallstones [dsyn]     2.7421489
Integral [qlco]     2.7421489
Crosstalk [moft]     2.7421489
Bile Duct Epithelium [tisu]     2.7421489
Saudi Arabia [geoa]     2.7721121
chronic hepatic [dsyn]     2.7721121
Pediatric Tumor [neop]     2.7721121
Undifferentiated [qlco]     2.7721121
Radio [inpr]     2.7721121
intermittency [tmco]     2.7721121
Translocation [comd]     2.7721121
Hypersplenism [dsyn]     2.7721121
DNA, Viral [nnon]     2.7721121
Grade IV [qlco]     2.7721121
Whole liver [bpoc]     2.7721121
Portography [diap]     2.7721121
Stroke [dsyn]     2.7721121
IL [geoa]     2.7721121
Pathway Analysis [inpr]     2.7721121
unadjusted [ftcn]     2.7721121
Predisposition [clna]     2.7721121
Microwave Therapy [topp]     2.7721121
Miss [qlco]     2.7721121
Facility [idcn]     2.7721121
Models, Experimental [inpr]     2.7721121
Neuroendocrine tumor [neop]     2.7721121
Confidence [menp]     2.7721121
congenital [qlco]     2.7721121
Discontinuation [tmco]     2.7721121
Uncontrolled [qlco]     2.7721121
Contrast-enhanced Magnetic Resonance Imaging [diap]     2.7721121
Artificial [qlco]     2.7721121
Inflammatory Pseudotumor [neop]     2.7721121
Solid organ [bpoc]     2.7721121
pacific island [popg]     2.7721121
Neoplasms, Hepatic [neop]     2.7721121
Interface [mnob]     2.7721121
chi square [qnco]     2.7721121
Area under the curve [qnco]     2.7721121
Renal Failure [dsyn]     2.7721121
Junction [spco]     2.7721121
Radioimmunoassay [lbpr]     2.7721121
Central Scar [fndg]     2.7721121
Disease Outcome [fndg]     2.7721121
liver test [lbpr]     2.7721121
premalignant [neop]     2.7721121
heavy drinker [mobd]     2.7721121
Fluorescence in situ hybridisation [mbrt]     2.7721121
Intraabdominal haemorrhage [fndg]     2.7721121
Optimum [qlco]     2.7721121
Arteriography [diap]     2.7721121
Viet Nam [geoa]     2.7721121
ENTER [ftcn]     2.7721121
Pneumothorax [dsyn]     2.7721121
Non - drinker [inbe]     2.7721121
Oil [lipd]     2.7721121
North American [fndg]     2.7721121
expertise [qlco]     2.7721121
DI [fndg]     2.7721121
elevate [spco]     2.7721121
5p [nusq]     2.7721121
Hepatic Insufficiency [patf]     2.7721121
Aspartate aminotransferase level [lbtr]     2.7721121
Not Defined [qlco]     2.7721121
Serum creatinine level [lbtr]     2.7721121
Differential Diagnoses [diap]     2.7721121
IU [qnco]     2.7721121
respiratory [ftcn]     2.7721121
Theoretical [idcn]     2.7721121
Neonatal [aggp]     2.7721121
Stop [qlco]     2.7721121
Drug-induced [ftcn]     2.7721121
6/12 [fndg]     2.7721121
Inflamed [ftcn]     2.7721121
Atrophy [patf]     2.7721121
Split [ftcn]     2.7721121
kDa [qnco]     2.7721121
Primary site [spco]     2.7721121
Hilum [bpoc]     2.7721121
Bacterial [qlco]     2.7721121
Microbiota [plnt]     2.7721121
Extreme [qlco]     2.7721121
Asian American [popg]     2.7721121
pTNM stage [clna]     2.7721121
haemoglobin level [lbtr]     2.7721121
Assemble [acty]     2.7721121
Fruit [food]     2.7721121
Usage [ftcn]     2.7721121
Bacterial Infections [dsyn]     2.7721121
contrast material [irda]     2.7721121
Matched Tissues [bdsu]     2.7721121
Iranian [popg]     2.7721121
prime [ftcn]     2.7721121
Scheme [inpr]     2.7721121
Viral hepatitis C [dsyn]     2.7721121
Molecular Biology [bmod]     2.7721121
Transfused [idcn]     2.7721121
portal thrombosis [dsyn]     2.7721121
genetic analysis [lbpr]     2.7721121
cent [qnco]     2.7721121
Citation [inpr]     2.7721121
Hepatocellular Damage [patf]     2.7721121
cancer therapies [topp]     2.7721121
Dialysis [npop]     2.7721121
Right side [spco]     2.7721121
Transgene [gngm]     2.7721121
Lobar [qlco]     2.7721121
1st [qnco]     2.7721121
prescribed [hlca]     2.7721121
childhood cancer [neop]     2.7721121
Access [qlco]     2.7721121
immunodeficiency virus [virs]     2.7721121
Text [inpr]     2.7721121
Clear cell [cell]     2.7721121
CD8 [lbpr]     2.7721121
Blood Glucose [carb]     2.7721121
RNA Interference [genf]     2.7721121
EG [geoa]     2.7721121
Government [orgt]     2.7721121
disease stage [diap]     2.7721121
s l [qnco]     2.7721121
Drop [acty]     2.7721121
Count [qnco]     2.7721121
Identifying patient [hlca]     2.7721121
Epstein-Barr Virus [virs]     2.7721121
Conference [hcpp]     2.7721121
Host response [ortf]     2.7721121
Hepatitis A [dsyn]     2.7721121
Irradiated [npop]     2.7721121
Pancreatic Ductal Adenocarcinoma [neop]     2.7721121
Biliary Fistula [patf]     2.7721121
Venous Pressure [orgf]     2.7721121
2b [inpr]     2.7721121
Steady [qlco]     2.7721121
Transgene [anim]     2.7721121
Early death [fndg]     2.7721121
Composite [qlco]     2.7721121
Save [mcha]     2.7721121
Clonorchiasis [dsyn]     2.7721121
Death rate [qnco]     2.7721121
Small Molecule [orch]     2.7721121
Angiogenic [ortf]     2.7721121
Cold Ischemia Time [tmco]     2.7721121
Imbalance [sosy]     2.7721121
compressed [ftcn]     2.7721121
Town [geoa]     2.7721121
Epidemiologic Factors [ftcn]     2.7721121
mU/kg [qnco]     2.8042967
Intravenous drug user [podg]     2.8042967
Organ [ftcn]     2.8042967
Contrast [diap]     2.8042967
degrees C [qnco]     2.8042967
Clinical examination [hlca]     2.8042967
Pedicle [bpoc]     2.8042967
Fatty change [patf]     2.8042967
Health education [edac]     2.8042967
coordinate [fndg]     2.8042967
Firm [qlco]     2.8042967
Contraindicated [fndg]     2.8042967
Standardized Mortality Ratio [qnco]     2.8042967
Hepatitis Delta Virus [virs]     2.8042967
Carcinogen effect [inpo]     2.8042967
Tag [neop]     2.8042967
grade 2 [inpr]     2.8042967
Li+ [elii]     2.8042967
Primary disease [dsyn]     2.8042967
IMPACT [anab]     2.8042967
Hepatic Involvement [clas]     2.8042967
Conclusion [qlco]     2.8042967
Inappropriate [qlco]     2.8042967
3D [spco]     2.8042967
Solution [sbst]     2.8042967
Transducer [medd]     2.8042967
Operable [qlco]     2.8042967
Sex Difference [orga]     2.8042967
Outer [spco]     2.8042967
Chemical Exposure [fndg]     2.8042967
calcific [ortf]     2.8042967
Stem [plnt]     2.8042967
Pancreatitis, Chronic [dsyn]     2.8042967
brush cytology [medd]     2.8042967
Posterior [spco]     2.8042967
knock out [inpo]     2.8042967
aggravate [fndg]     2.8042967
Pressure [phpr]     2.8042967
Wnt signaling [ftcn]     2.8042967
Anterior [spco]     2.8042967
Alkaline phosphatase level [lbtr]     2.8042967
epoxide [orch]     2.8042967
benign liver tumor [neop]     2.8042967
Read [dora]     2.8042967
Substitution [idcn]     2.8042967
Gastroenterologist [prog]     2.8042967
Cell Cycle Progression [celf]     2.8042967
Discordant [cnce]     2.8042967
free fatty acid [lipd]     2.8042967
Cell Viability [celf]     2.8042967
Digestive Tract [bdsy]     2.8042967
Mallory Bodies [fndg]     2.8042967
False Positive [lbtr]     2.8042967
English Language [lang]     2.8042967
Hormonal [qlco]     2.8042967
Tattoo [fndg]     2.8042967
HSC [celc]     2.8042967
carcinogenic chemicals [hops]     2.8042967
Variations, Genetic [npop]     2.8042967
SPIN [gngm]     2.8042967
Ring [spco]     2.8042967
Ulcer [patf]     2.8042967
Integral [qnco]     2.8042967
Switch [mnob]     2.8042967
Plasma glucose [lbpr]     2.8042967
early identification [topp]     2.8042967
Force [phpr]     2.8042967
Impaired glucose tolerance [dsyn]     2.8042967
hepatocyte apoptosis [celf]     2.8042967
Human Pathology [bmod]     2.8042967
Manipulate [topp]     2.8042967
EL [gngm]     2.8042967
Xenograft Model [emod]     2.8042967
Divergence [spco]     2.8042967
Lymph Node Dissection [topp]     2.8042967
Exome [gngm]     2.8042967
Choose [acty]     2.8042967
age difference [aggp]     2.8042967
Train [mnob]     2.8042967
Tumor Angiogenesis [neop]     2.8042967
Case Studies [inpr]     2.8042967
Subtlety [clna]     2.8042967
Metabolome [bmod]     2.8042967
Ischaemic [ftcn]     2.8042967
control population [ocdi]     2.8042967
accelerate [phpr]     2.8042967
T stage [clas]     2.8042967
Cell Survival [celf]     2.8042967
condition patient [fndg]     2.8042967
Single lesion [fndg]     2.8042967
Signal Transduction [celf]     2.8042967
pg/mL [qnco]     2.8042967
likelihood ratio [qnco]     2.8042967
Tokyo [geoa]     2.8042967
En Bloc [ftcn]     2.8042967
drug targets [medd]     2.8042967
Within [spco]     2.8042967
Withdraw [acty]     2.8042967
Dropout [popg]     2.8042967
gene therapy [topp]     2.8042967
Postoperative death [fndg]     2.8042967
Solitary Nodule [fndg]     2.8042967
Standardized Uptake Value [qnco]     2.8042967
bound [spco]     2.8042967
Central Obesity [dsyn]     2.8042967
biloma [dsyn]     2.8042967
Low Income [grpa]     2.8042967
scanner [medd]     2.8042967
Microvessel Density [qlco]     2.8042967
Thyroid, NOS [bpoc]     2.8042967
Target Population [popg]     2.8042967
Bcl-2 [gngm]     2.8042967
Additional information [tmco]     2.8042967
Minimally invasive procedure [ftcn]     2.8042967
Provisional [idcn]     2.8042967
Senescence [fndg]     2.8042967
Colonoscopies [diap]     2.8042967
chemically induced [patf]     2.8042967
Attributable Risk [qlco]     2.8042967
Injection therapy [topp]     2.8042967
anti hcv antibody [imft]     2.8042967
Birth Weight [orga]     2.8042967
Heart [bpoc]     2.8042967
KG [geoa]     2.8042967
Haemorrhage [qlco]     2.8042967
Ultrastructure [idcn]     2.8042967
Indolent [ftcn]     2.8042967
Treatment Regimen [topp]     2.8042967
anal cancer [neop]     2.8042967
Hepatitis C virus genotype 3 [virs]     2.8042967
Bifurcation [topp]     2.8042967
Cancer of the Liver [neop]     2.8042967
Standard [inpr]     2.8042967
wave [npop]     2.8042967
Nasopharyngeal carcinoma [neop]     2.8042967
Toxic effect [inpo]     2.8042967
Short Hairpin RNA [nnon]     2.8042967
Dedifferentiation [neop]     2.8042967
envelope [celc]     2.8042967
Precise [tmco]     2.8042967
t tests [inpr]     2.8042967
CLIN [inpr]     2.8042967
threat [idcn]     2.8042967
not eligible [inpr]     2.8042967
Clinical evaluation [hlca]     2.8042967
Biochemical test [lbpr]     2.8042967
Query [inpr]     2.8042967
Molecular Diagnosis [lbpr]     2.8042967
Natural killer cell [cell]     2.8042967
England [geoa]     2.8042967
Superior [socb]     2.8042967
Hypoxic [patf]     2.8042967
diagnostic procedure [diap]     2.8042967
Large Mass [fndg]     2.8042967
Chronic inflammatory disease [dsyn]     2.8042967
Wound Healing [orgf]     2.8042967
Cell Type [inpr]     2.8042967
PERIPHERAL CHOLANGIOCARCINOMA [neop]     2.8042967
Decompression [phpr]     2.8042967
fibrosis liver [dsyn]     2.8042967
FIB [gngm]     2.8042967
Subclinical [qlco]     2.8042967
3 Weeks [tmco]     2.8042967
Nomogram [inpr]     2.8042967
Syringe [medd]     2.8042967
Profound [qlco]     2.8042967
Insulin Sensitivity [patf]     2.8042967
Internal Medicine [bmod]     2.8390589
Union [clas]     2.8390589
due [ftcn]     2.8390589
Total score [qnco]     2.8390589
Sibling [famg]     2.8390589
HDV [virs]     2.8390589
Causative agent [fndg]     2.8390589
Sent [ftcn]     2.8390589
early disease [tmco]     2.8390589
Binding Site [rcpt]     2.8390589
Primary Liver Carcinoma [neop]     2.8390589
Tissue diagnosis [clas]     2.8390589
Slowly [qlco]     2.8390589
TNM Staging [clas]     2.8390589
Cell Differentiation [celf]     2.8390589
Process [acty]     2.8390589
Therapy, Palliative [hlca]     2.8390589
Quartile [qlco]     2.8390589
Equivocal [qlco]     2.8390589
Contrast Media [irda]     2.8390589
high platelet count [dsyn]     2.8390589
site specific [spco]     2.8390589
Renal Impairment [dsyn]     2.8390589
Scope [cnce]     2.8390589
disease rate [qnco]     2.8390589
Calcineurin inhibitor [moft]     2.8390589
Heat [npop]     2.8390589
Common Neoplasm [neop]     2.8390589
Relate [socb]     2.8390589
Giant [dsyn]     2.8390589
In Vivo Model [resa]     2.8390589
Rectum [bpoc]     2.8390589
Multimodality [diap]     2.8390589
care medication [fndg]     2.8390589
Next Generation Sequencing [mbrt]     2.8390589
Thoracoabdominal [spco]     2.8390589
Choledocholithiasis [dsyn]     2.8390589
Calibration [qnco]     2.8390589
Renal function [ortf]     2.8390589
Drop [qnco]     2.8390589
Pre-Therapy [tmco]     2.8390589
glucose metabolism [moft]     2.8390589
variceal hemorrhage [patf]     2.8390589
Neoplastic cells [cell]     2.8390589
Bad [qlco]     2.8390589
elevated liver enzyme [fndg]     2.8390589
3p [nusq]     2.8390589
Mortality, Excess [qnco]     2.8390589
Cardiovascular event [fndg]     2.8390589
Grade C [inpr]     2.8390589
Demonstrable [ftcn]     2.8390589
Invasive Carcinoma [neop]     2.8390589
Tissue specimen [tisu]     2.8390589
Arm [blor]     2.8390589
scholar [prog]     2.8390589
Environmental Exposure [inpo]     2.8390589
Color [npop]     2.8390589
Sinusoid [bsoj]     2.8390589
TC [geoa]     2.8390589
Chronic (viral) hepatitis B [dsyn]     2.8390589
La [elii]     2.8390589
Compliance [qnco]     2.8390589
Slice [sbst]     2.8390589
competition [socb]     2.8390589
Eastern Asia [geoa]     2.8390589
Tumor site [spco]     2.8390589
Kaplan-Meier Survival Curves [qnco]     2.8390589
Neck [blor]     2.8390589
Anticoagulant [topp]     2.8390589
Transactivation [genf]     2.8390589
Table [mnob]     2.8390589
glycosylation [npop]     2.8390589
Dilatation [patf]     2.8390589
Clonal [tisu]     2.8390589
Confused [mobd]     2.8390589
blood supply [bpoc]     2.8390589
Ancillary [idcn]     2.8390589
Western World [idcn]     2.8390589
coagulopathies [dsyn]     2.8390589
PAR-1 [gngm]     2.8390589
Geographic Location [geoa]     2.8390589
Monthly [tmco]     2.8390589
Second Malignancy [neop]     2.8390589
human hepatitis C virus [virs]     2.8390589
chemoradiation [topp]     2.8390589
hospital patients [podg]     2.8390589
Farm [geoa]     2.8390589
attack [socb]     2.8390589
Esophageal bleeding [patf]     2.8390589
Metabolic Pathway [ftcn]     2.8390589
Additional Therapy [fndg]     2.8390589
Human gene [gngm]     2.8390589
tumor classification [inpr]     2.8390589
histone modification [moft]     2.8390589
damage tissues [inpo]     2.8390589
Angiosarcoma [neop]     2.8390589
Plane [spco]     2.8390589
Database, Electronic [inpr]     2.8390589
Label [qlco]     2.8390589
surgical patients [podg]     2.8390589
Cellular Differentiation [clna]     2.8390589
Highly sensitive [qlco]     2.8390589
Grade I [qlco]     2.8390589
Retinoblastoma [neop]     2.8390589
copies/mL [qnco]     2.8390589
Lipid Peroxidation [moft]     2.8390589
bone metastases [neop]     2.8390589
Stage 2 [inpr]     2.8390589
Serum bilirubin level [lbpr]     2.8390589
Incision [topp]     2.8390589
End stage hepatic disease [dsyn]     2.8390589
Primary Care [hlca]     2.8390589
Portal Pressure [orgf]     2.8390589
Proton [elii]     2.8390589
radiation disease [dsyn]     2.8390589
NC [geoa]     2.8390589
Hepatocellular dysplasia [fndg]     2.8390589
Wash [acty]     2.8390589
Ischemia-Reperfusion Injury [inpo]     2.8390589
Histogenesis [ortf]     2.8390589
concomitant disease [patf]     2.8390589
Carbohydrate [carb]     2.8390589
Breakthrough [qlco]     2.8390589
betel quid [food]     2.8390589
Longest [qlco]     2.8390589
short period [fndg]     2.8390589
Quality-Adjusted Life Years [tmco]     2.8390589
Stop [acty]     2.8390589
Brush [topp]     2.8390589
Macro [cnce]     2.8390589
virtual [inpr]     2.8390589
new technologies [inpr]     2.8390589
relieve [ftcn]     2.8390589
HCA [neop]     2.8390589
Automatic [ftcn]     2.8390589
Frozen Section [tisu]     2.8390589
Hepatico-jejunostomy [topp]     2.8390589
HIV/AIDS [dsyn]     2.8390589
des-gamma-carboxyprothrombin [aapp]     2.8390589
Wedge resection [topp]     2.8390589
Cytomegalovirus [virs]     2.8390589
Arranged [idcn]     2.8390589
Narrow [qlco]     2.8390589
Plateau [qnco]     2.8390589
human studies [resa]     2.8390589
Migrant [popg]     2.8390589
Sexual transmission [ftcn]     2.8390589
Chromatography, High Performance Liquid [lbpr]     2.8390589
B-cell [cell]     2.8390589
Complex [chvs]     2.8390589
NM [celf]     2.8390589
Teaching [edac]     2.8390589
S2 [blor]     2.8390589
Beverage [food]     2.8390589
Oral Glucose Tolerance Test [diap]     2.8390589
ELECTRODE, NEEDLE [medd]     2.8390589
Normal cell [cell]     2.8390589
oval cell [cell]     2.8390589
Interventional radiology [bmod]     2.8390589
Satisfied [menp]     2.8390589
Bowel [bpoc]     2.8390589
Perforated [fndg]     2.8390589
Infancy [tmco]     2.8390589
Defense [cnce]     2.8390589
Ultrasound guidance [diap]     2.8390589
Rigor [sosy]     2.8390589
Ampullary carcinoma [neop]     2.8390589
incorporation [ftcn]     2.8390589
Carrier Rate [cnce]     2.8390589
Veterans Affairs [orgt]     2.8390589
Kaplan-Meier Estimate [qnco]     2.8390589
cDNA [nnon]     2.8390589
Nutrient [food]     2.8390589
Best value [qnco]     2.8390589
cancer screen [diap]     2.8390589
Swedish [popg]     2.8390589
Negligible [qlco]     2.8390589
Portal inflammation [fndg]     2.8768475
Emergency Department [hcro]     2.8768475
System, Health Care [hcro]     2.8768475
Mesenchymal hamartoma [dsyn]     2.8768475
Grade 4 [qlco]     2.8768475
detoxify [orgf]     2.8768475
regional difference [fndg]     2.8768475
Hepatitis B antigen [imft]     2.8768475
Span [cnce]     2.8768475
Unclassified [clas]     2.8768475
mg day [qnco]     2.8768475
Hepatitis C viruses [virs]     2.8768475
Axial [spco]     2.8768475
Endoplasmic Reticulum [celc]     2.8768475
Fluoroscopies [diap]     2.8768475
E-Mail [inpr]     2.8768475
immunoprophylaxis [topp]     2.8768475
AJCC [inpr]     2.8768475
Attendance [ftcn]     2.8768475
Benign condition [fndg]     2.8768475
Tree [plnt]     2.8768475
Carcinoma in Situ [neop]     2.8768475
Collateral [bpoc]     2.8768475
Carboxy [orch]     2.8768475
IR [geoa]     2.8768475
SUVmax [qnco]     2.8768475
vasculature [bpoc]     2.8768475
Cytogenetic [bmod]     2.8768475
front [spco]     2.8768475
breed [orgf]     2.8768475
Mean Survival Time [qnco]     2.8768475
chb [dsyn]     2.8768475
Coinfections [dsyn]     2.8768475
augment [qnco]     2.8768475
Glutathione s-transferases [moft]     2.8768475
mimics [topp]     2.8768475
Loop [medd]     2.8768475
Signal Transduction Pathway [moft]     2.8768475
Consumer [popg]     2.8768475
Industrialized Countries [qlco]     2.8768475
Contract [inpr]     2.8768475
Tobacco Consumption [inbe]     2.8768475
New Zealand [geoa]     2.8768475
Observation [prog]     2.8768475
Alarm [medd]     2.8768475
hot spot [dsyn]     2.8768475
bile duct injuries [inpo]     2.8768475
reality [idcn]     2.8768475
Transgenic Model [emod]     2.8768475
Congestion [patf]     2.8768475
heighten [qlco]     2.8768475
Haematology NOS [bmod]     2.8768475
Precautions [cnce]     2.8768475
factor treatment [inpr]     2.8768475
alpha protein [genf]     2.8768475
Procedure-related [fndg]     2.8768475
Disabilities [fndg]     2.8768475
Dead [orgf]     2.8768475
Million Unit [qnco]     2.8768475
Venous Thromboembolism [patf]     2.8768475
Endoplasmic Reticulum Stress [comd]     2.8768475
Transcatheter therapy [topp]     2.8768475
Genetic mutation [genf]     2.8768475
Genetic Change [comd]     2.8768475
Character [menp]     2.8768475
board [medd]     2.8768475
Lymphadenopathy [fndg]     2.8768475
plasma concentration [qnco]     2.8768475
Cross Validation [resa]     2.8768475
Map [acty]     2.8768475
Conventional Therapy [topp]     2.8768475
Capsular Invasion [fndg]     2.8768475
Pneumonia [dsyn]     2.8768475
Viral Genome [gngm]     2.8768475
The Netherlands [geoa]     2.8768475
Tumor status [qlco]     2.8768475
alpha 1-Antitrypsin Deficiency [dsyn]     2.8768475
Multifocal tumor [fndg]     2.8768475
m2 [qnco]     2.8768475
Liver Insufficiency [patf]     2.8768475
Affinity [npop]     2.8768475
Anticoagulant therapy [topp]     2.8768475
Cell Cycle Arrest [celf]     2.8768475
Caudate Lobe [bpoc]     2.8768475
bile ductule [bpoc]     2.8768475
Active Treatment [topp]     2.8768475
Interactions, Gene-Environment [genf]     2.8768475
Substrate [mnob]     2.8768475
Contrast Medium [irda]     2.8768475
Clarification [acty]     2.8768475
Pathology studies [clna]     2.8768475
Meat [food]     2.8768475
adopt [socb]     2.8768475
Fulminant hepatitis [dsyn]     2.8768475
Biliary tract disease [dsyn]     2.8768475
Allelic Loss [genf]     2.8768475
Scintigraphy [diap]     2.8768475
Contraception [phsu]     2.8768475
Type 3 [clas]     2.8768475
operative risk [idcn]     2.8768475
skill [inbe]     2.8768475
Ambiguity [orga]     2.8768475
Immigrant [acty]     2.8768475
Lipopolysaccharide [lipd]     2.8768475
Anatomic Location [blor]     2.8768475
Granular [celc]     2.8768475
Ischaemia [dsyn]     2.8768475
Recurrent hepatitis [dsyn]     2.8768475
Precipitating factor [clna]     2.8768475
JNK [moft]     2.8768475
Markers, Biochemical [qlco]     2.8768475
Tomography, Helical Computed [diap]     2.8768475
Adhesion [patf]     2.8768475
Survivals, Disease-Free [qnco]     2.8768475
Phenomena [phpr]     2.8768475
Chromosomal Instability [comd]     2.8768475
MHz [qnco]     2.8768475
River [npop]     2.8768475
Myofibroblast [cell]     2.8768475
Autophagy [celf]     2.8768475
PG [lbpr]     2.8768475
Long Term Survivor [podg]     2.8768475
Balloon [topp]     2.8768475
mU/g [qnco]     2.8768475
Decision Analysis [ocdi]     2.8768475
T-Cells, Regulatory [cell]     2.8768475
Stimuli [phpr]     2.8768475
Compliant [qlco]     2.8768475
Nomenclature [inpr]     2.8768475
Agriculture [ocdi]     2.8768475
Tumor Grading [diap]     2.8768475
effectiveness treatment [fndg]     2.8768475
metastatic cancer [neop]     2.8768475
postmortem [diap]     2.8768475
Familiar [qlco]     2.8768475
Adenomatous hyperplasia [patf]     2.8768475
MULTI-DISCIPLINARY TEAM [hlca]     2.8768475
seconds [tmco]     2.8768475
exchange [socb]     2.8768475
Ecologies [ocdi]     2.8768475
Catheter [medd]     2.8768475
Selection Bias [qnco]     2.8768475
3b [inpr]     2.8768475
Biliary anastomosis [topp]     2.8768475
Peripheral blood mononuclear cell [cell]     2.8768475
Specialty [bmod]     2.8768475
Pre-operative chemotherapy [topp]     2.8768475
Triglyceride level [lbtr]     2.8768475
increased activity [fndg]     2.8768475
Micrometastases [fndg]     2.8768475
Acute hepatitis B [dsyn]     2.8768475
Plant [plnt]     2.8768475
Anastomotic [spco]     2.8768475
Hepatitis C viral load [lbpr]     2.8768475
Technique, Ablation [topp]     2.8768475
Somatic [qlco]     2.8768475
Interfered [qlco]     2.8768475
alternate [ftcn]     2.8768475
TG [lbpr]     2.8768475
Western Europe [geoa]     2.8768475
Nutritional status [orga]     2.8768475
monoclonal [fndg]     2.8768475
KRAS [gngm]     2.8768475
Mobility [topp]     2.8768475
Regional Lymph Node [bpoc]     2.8768475
Genetic Variation [npop]     2.8768475
Africa, West [geoa]     2.8768475
Upper abdomen [blor]     2.8768475
Overall Response [fndg]     2.8768475
Circulatory [phsf]     2.8768475
Nosocomial infection [dsyn]     2.8768475
Superficial [spco]     2.8768475
Morphologic change [anab]     2.8768475
Gastric carcinoma [neop]     2.8768475
Study Participant [grup]     2.8768475
Current smoker [clna]     2.8768475
Morphometry [lbpr]     2.8768475
Helicobacter [bact]     2.8768475
Fluorescence [npop]     2.8768475
Fear [menp]     2.8768475
run [dora]     2.8768475
Home [cnce]     2.8768475
Portasystemic Shunt, Transjugular Intrahepatic [topp]     2.8768475
Linear Regression [qnco]     2.8768475
10 days [tmco]     2.8768475
Gastric Adenocarcinoma [neop]     2.8768475
British [popg]     2.8768475
Parenchymal cell [cell]     2.8768475
Residual [cnce]     2.8768475
Normal alpha fetoprotein [fndg]     2.8768475
Infection, Helicobacter [dsyn]     2.8768475
Quintile [clna]     2.8768475
Cholestases [dsyn]     2.8768475
Inflammatory disease [dsyn]     2.8768475
4 type [clas]     2.8768475
Wound Infection [patf]     2.8768475
dE-oxy [aapp]     2.8768475
Blood Pressure [orgf]     2.8768475
Immunoprecipitation [lbpr]     2.8768475
Institutional Review Board Approval [rnlw]     2.8768475
Height [orga]     2.8768475
Crop [bpoc]     2.8768475
3/12 [fndg]     2.8768475
p53 tumor suppressor [gngm]     2.8768475
Chromosomal Aberration [comd]     2.8768475
Repression [menp]     2.91824
Allogeneic [qlco]     2.91824
Growth rate [tmco]     2.91824
Outlines [inpr]     2.91824
HIV related [idcn]     2.91824
patent [inpr]     2.91824
TRANS [idcn]     2.91824
colo-rectal [bpoc]     2.91824
mate [famg]     2.91824
telomere [celc]     2.91824
protruding [anab]     2.91824
Pancreatoduodenectomy [topp]     2.91824
General practitioner [prog]     2.91824
Hydroxy [inch]     2.91824
Lymphocyte Count [lbpr]     2.91824
check up [fndg]     2.91824
secondary malignancies [neop]     2.91824
Austria [geoa]     2.91824
Therapeutic response [clna]     2.91824
Cumulative Dose [cnce]     2.91824
Microdissection [lbpr]     2.91824
DNA Ploidy [qnco]     2.91824
vigilance [menp]     2.91824
Discriminant Analysis [resa]     2.91824
Nuclear Grade [qlco]     2.91824
Ultrasonic [ftcn]     2.91824
Opisthorchis [euka]     2.91824
Helicobacter Pylori Infection [dsyn]     2.91824
Cup [medd]     2.91824
Tenth [qnco]     2.91824
Therapeutic procedure [topp]     2.91824
Dog [mamm]     2.91824
Phlebotomies [diap]     2.91824
Genetic Abnormality [fndg]     2.91824
Enlarged [qlco]     2.91824
Tissue specific [bdsu]     2.91824
CLINICAL SIGNS [fndg]     2.91824
lung metastasis [neop]     2.91824
Low frequency [tmco]     2.91824
RNA, Non-Coding [nnon]     2.91824
Hepatitis Virus, Woodchuck [virs]     2.91824
Developed Nations [qlco]     2.91824
Betel nut [plnt]     2.91824
Rats, Wistar [mamm]     2.91824
Immunopathology [bmod]     2.91824
Total hepatectomy [topp]     2.91824
PULSE [clna]     2.91824
Esophageal Squamous Cell Carcinoma [neop]     2.91824
recurrent infection [fndg]     2.91824
Tissue section [tisu]     2.91824
signaling cascade [celf]     2.91824
Nodular regenerative hyperplasia [patf]     2.91824
Hemangiomas [neop]     2.91824
Homeostasis model assessment [lbpr]     2.91824
Acute-on-chronic [tmco]     2.91824
TNM classification [clas]     2.91824
CE [idcn]     2.91824
First-Line Therapy [topp]     2.91824
Synthesized [acty]     2.91824
Neglect [fndg]     2.91824
LAO [geoa]     2.91824
Practitioner [prog]     2.91824
constituent [sbst]     2.91824
Hamartoma [neop]     2.91824
INT [orch]     2.91824
EXCLUSION [idcn]     2.91824
Cystic Lesion [fndg]     2.91824
Track [mnob]     2.91824
chow [mamm]     2.91824
request [ftcn]     2.91824
animal studies [anim]     2.91824
Conformal [spco]     2.91824
Adenocarcinoma, metastatic [neop]     2.91824
Short axis [spco]     2.91824
Calcineurin inhibitor [phsu]     2.91824
Narrative [socb]     2.91824
klatskin tumors [neop]     2.91824
Gambia [geoa]     2.91824
Waist Circumference [clna]     2.91824
Noise [phpr]     2.91824
Bipolar [spco]     2.91824
peer reviewed [hlca]     2.91824
Deprivation [qlco]     2.91824
Thyroid cancer [neop]     2.91824
depend [menp]     2.91824
Filter [mnob]     2.91824
False Negative [lbtr]     2.91824
Width [qnco]     2.91824
donor liver transplant [popg]     2.91824
code [clas]     2.91824
Terminal [inpr]     2.91824
Cytomegalovirus infection [dsyn]     2.91824
Frequencies, Allele [qnco]     2.91824
Operative procedure [ftcn]     2.91824
Bomb, Atomic [mnob]     2.91824
trauma [inpo]     2.91824
Haemophilia [dsyn]     2.91824
outbreak [phpr]     2.91824
Gauge [spco]     2.91824
Lumen [bsoj]     2.91824
Bypass [topp]     2.91824
Impaired liver function [patf]     2.91824
IMMUNO-DEFICIENCY [dsyn]     2.91824
Tube [medd]     2.91824
2D [spco]     2.91824
Linkage Disequilibrium [qnco]     2.91824
Question [qlco]     2.91824
liter [qnco]     2.91824
Early Childhood [tmco]     2.91824
Lymphovascular Invasion [fndg]     2.91824
interstitial [blor]     2.91824
nonsmokers [fndg]     2.91824
Sexual Partner [popg]     2.91824
Volumetric [spco]     2.91824
Body Fluids [bdsu]     2.91824
NAS [dsyn]     2.91824
SPP [gngm]     2.91824
Denmark [geoa]     2.91824
Hepatitis D Virus [virs]     2.91824
alanine aminotransferase activity [moft]     2.91824
disease control [topp]     2.91824
Destruction [inbe]     2.91824
Preliminary results [idcn]     2.91824
Escherichia coli [bact]     2.91824
Exophytic [spco]     2.91824
Translational Research [resa]     2.91824
Cell Culture [lbpr]     2.91824
Fresh frozen plasma [bdsu]     2.91824
shorten [topp]     2.91824
Dense [qlco]     2.91824
infect [qlco]     2.91824
Reservoir [geoa]     2.91824
witnessed [popg]     2.91824
Clear cell carcinoma [neop]     2.91824
Aneuploidy [comd]     2.91824
Hypertrophy [patf]     2.91824
Tip [topp]     2.91824
Cryoablation [topp]     2.91824
Mosaic [spco]     2.91824
Cell Invasion [patf]     2.91824
Comparative Genomic Hybridization [mbrt]     2.91824
Inflammatory reaction [patf]     2.91824
Small liver [fndg]     2.91824
Mutant Protein [aapp]     2.91824
Reconstructed [qlco]     2.91824
Object [phob]     2.91824
Slow progression [fndg]     2.91824
Reticular [spco]     2.91824
derivation [chvs]     2.91824
Miscellaneous [qlco]     2.91824
AIL [neop]     2.91824
Chemopreventive Agent [phsu]     2.91824
Administration [ftcn]     2.91824
spouse [famg]     2.91824
geographic difference [idcn]     2.91824
TNM Staging System [clas]     2.91824
Arrest [tmco]     2.91824
Endometrial [spco]     2.91824
Ultrasonography, Doppler [diap]     2.91824
E2 [gngm]     2.91824
Genome Instability [comd]     2.91824
Lineage [cnce]     2.91824
Animal Experiments [resa]     2.91824
Imaging method [ftcn]     2.91824
increased iron [fndg]     2.91824
Prefecture [geoa]     2.91824
Cancer Burden [qnco]     2.91824
arterial hypertension [dsyn]     2.91824
17p [nusq]     2.91824
Transfer [menp]     2.91824
Biliary duct [bpoc]     2.91824
Clear [ftcn]     2.91824
Mild to moderate [qlco]     2.91824
Intravenous injection [ftcn]     2.91824
shRNA [nnon]     2.91824
Late period [fndg]     2.91824
mmol/L [qnco]     2.91824
Cutaneous [spco]     2.91824
Volumetry [diap]     2.91824
schistosomal [ftcn]     2.91824
Post-Translational Modification [moft]     2.91824
Hepatic capsule [bpoc]     2.91824
Incidental Finding [fndg]     2.91824
Vomiting [sosy]     2.91824
Pulmonary Embolism [dsyn]     2.91824
Fold Change [qnco]     2.91824
Concentrate [bodm]     2.91824
septic [ftcn]     2.91824
Chronic alcoholism [mobd]     2.91824
Multimodal Treatment [topp]     2.91824
Carrier status [fndg]     2.91824
Rhabdomyosarcoma [neop]     2.91824
coil [spco]     2.91824
South Korea [geoa]     2.91824
Lipid accumulation [fndg]     2.91824
Attractive [qlco]     2.91824
1 Day [tmco]     2.91824
abnormal liver [fndg]     2.91824
Le [bdsy]     2.91824
Fill [acty]     2.91824
Cell Cycle Regulation [celf]     2.91824
Compartment [bsoj]     2.91824
Secondly [qnco]     2.91824
Perihepatic [spco]     2.91824
Risk Behavior [inbe]     2.91824
Cystic Duct [bpoc]     2.91824
metastatic liver cancer [neop]     2.91824
Clinical status [qlco]     2.91824
Malnutrition [dsyn]     2.91824
perturbation [ftcn]     2.91824
dictated [inpr]     2.91824
Biliary dysplasia [dsyn]     2.91824
Rule [qlco]     2.91824
Label [mnob]     2.91824
retard [qlco]     2.91824
Ease [menp]     2.91824
Computerized tomography [diap]     2.91824
Dataset [inpr]     2.91824
Medical Science [bmod]     2.91824
Operative procedure [hlca]     2.91824
qPCR [mbrt]     2.91824
Counsel [hlca]     2.91824
Optimal [acty]     2.91824
Hematologic [bmod]     2.91824
antiviral drug [phsu]     2.91824
stage tumor [clas]     2.91824
Cervix [bpoc]     2.91824
Animal Experimentation [anim]     2.91824
Heart disease [dsyn]     2.91824
Diagnostic Technique [diap]     2.91824
Acetaldehyde [orch]     2.91824
quick [qlco]     2.91824
common types [inpr]     2.91824
Serious Adverse Event [fndg]     2.91824
neoplastic transformation [neop]     2.91824
Drug abuse [mobd]     2.91824
Perioperative Period [tmco]     2.91824
KIT [medd]     2.91824
Splenomegaly [fndg]     2.91824
Survival Analyses [resa]     2.91824
Pulmonary Disease, Chronic Obstructive [dsyn]     2.91824
Hyperplastic nodule [patf]     2.91824
Lymph nodal status [qlco]     2.91824
primary infection nos [dsyn]     2.9639976
Port [food]     2.9639976
Prevail [phsu]     2.9639976
elastic [npop]     2.9639976
modulate [mnob]     2.9639976
Mexican [popg]     2.9639976
gene interaction [genf]     2.9639976
Guanine [nnon]     2.9639976
Low grade dysplastic nodule [neop]     2.9639976
Melting [npop]     2.9639976
parasitic infection [dsyn]     2.9639976
elective surgeries [topp]     2.9639976
Primary Lesion [dsyn]     2.9639976
Health Outcomes [inpr]     2.9639976
Woodchuck [mamm]     2.9639976
Endometrium [bpoc]     2.9639976
Mean score [qnco]     2.9639976
educate [inpr]     2.9639976
All [qnco]     2.9639976
liver MRI [diap]     2.9639976
Microvesicular steatosis [fndg]     2.9639976
Grade 1 [qlco]     2.9639976
Cancer Epidemiology [ocdi]     2.9639976
Corn [plnt]     2.9639976
evaluation criteria [inpr]     2.9639976
Northern Blot [mbrt]     2.9639976
Visceral [spco]     2.9639976
Armed Forces [prog]     2.9639976
Genetic Heterogeneity [orga]     2.9639976
Extracellular [celc]     2.9639976
Grade II [qlco]     2.9639976
Patient number [inpr]     2.9639976
Genetic Disorder [dsyn]     2.9639976
Contaminated food [food]     2.9639976
X-ray [ftcn]     2.9639976
Metastatic/Recurrent [qlco]     2.9639976
Associate [qlco]     2.9639976
elicit [qlco]     2.9639976
RITA [gngm]     2.9639976
Pilot [prog]     2.9639976
retracted [fndg]     2.9639976
VOL [qnco]     2.9639976
HBE [gngm]     2.9639976
Surgical exploration [diap]     2.9639976
Calculate [mnob]     2.9639976
Hepatic segment [bpoc]     2.9639976
cell motility [celf]     2.9639976
Nested Polymerase Chain Reaction [mbrt]     2.9639976
Vegetable intake [fndg]     2.9639976
Photodynamic Therapy [topp]     2.9639976
Crohn Disease [dsyn]     2.9639976
treatment duration [tmco]     2.9639976
Early Intervention [hlca]     2.9639976
Collected [inpr]     2.9639976
Age Distribution [qnco]     2.9639976
Mirror [mnob]     2.9639976
Vascularisation [patf]     2.9639976
stand [fndg]     2.9639976
Calendar [tmco]     2.9639976
national survey [resa]     2.9639976
Atlas [bpoc]     2.9639976
liver needle biopsy [diap]     2.9639976
Transplantation, Renal [topp]     2.9639976
brazilian [fndg]     2.9639976
omit [idcn]     2.9639976
Tumor Mass [fndg]     2.9639976
Contaminant [sbst]     2.9639976
Hepatitis B Virus, Duck [virs]     2.9639976
Toxicologic [ftcn]     2.9639976
Cytoskeleton [celc]     2.9639976
Microscopic examination [lbpr]     2.9639976
Serving [qnco]     2.9639976
Loss of Heterozygosity [genf]     2.9639976
Pre [phpr]     2.9639976
education level [fndg]     2.9639976
Dental [qlco]     2.9639976
Gestational Age [orga]     2.9639976
Lentivirus [virs]     2.9639976
Tumour marker level [lbpr]     2.9639976
Genetic Hemochromatosis [dsyn]     2.9639976
Happen [acty]     2.9639976
Strand [spco]     2.9639976
Hepatitis B screening [lbpr]     2.9639976
Message [inpr]     2.9639976
Bio-Informatics [bmod]     2.9639976
Care [inbe]     2.9639976
Rats, Sprague-Dawley [mamm]     2.9639976
Sexual Activities [bhvr]     2.9639976
End [qlco]     2.9639976
fluorodeoxyglucose positron emission tomography [diap]     2.9639976
KIT [qlco]     2.9639976
Non-A, Non-B Hepatitis [dsyn]     2.9639976
Sclerotherapy [topp]     2.9639976
Vision [orgf]     2.9639976
Hepatitis D Infection [dsyn]     2.9639976
Respondent [popg]     2.9639976
Dietary intake [orgf]     2.9639976
life span [grpa]     2.9639976
Handle [bhvr]     2.9639976
Hepatic Failure, Fulminant [dsyn]     2.9639976
Close Up [phsu]     2.9639976
Pack Year [inpr]     2.9639976
Significance Level [resa]     2.9639976
Endocrine [bdsy]     2.9639976
Hospital admission [hlca]     2.9639976
bile duct dilatation [topp]     2.9639976
Glass Syringe [mnob]     2.9639976
right hepatic lobe [bpoc]     2.9639976
virologic [bmod]     2.9639976
Recurrent cholangitis [dsyn]     2.9639976
professional [prog]     2.9639976
Inflammatory Hepatocellular Adenoma [neop]     2.9639976
Palliative Care [hlca]     2.9639976
Neoadjuvant Therapy [topp]     2.9639976
Constitutional [idcn]     2.9639976
Type III [clas]     2.9639976
Instability [fndg]     2.9639976
detection method [inpr]     2.9639976
Slope [qnco]     2.9639976
Risk Estimate [qnco]     2.9639976
Immunosuppressive drugs [clna]     2.9639976
2-21 [gngm]     2.9639976
Practice Guideline [inpr]     2.9639976
Semi-annual [tmco]     2.9639976
Close Relationship [fndg]     2.9639976
Reproduction [orgf]     2.9639976
Coffee intake [fndg]     2.9639976
Time to Progression [tmco]     2.9639976
Palliative procedure [topp]     2.9639976
Primary care physician [prog]     2.9639976
Adverse reaction [fndg]     2.9639976
Pediatric Oncology [bmod]     2.9639976
microsatellite instability [diap]     2.9639976
Hepatopathy [dsyn]     2.9639976
Transferrin saturation [lbpr]     2.9639976
invasive treatment [topp]     2.9639976
Voluntary [inbe]     2.9639976
Portal triad [bpoc]     2.9639976
mU/mL [qnco]     2.9639976
g d [qnco]     2.9639976
Postoperative infection [patf]     2.9639976
Drug Users [podg]     2.9639976
Vehicle [bodm]     2.9639976
Hard [qlco]     2.9639976
Muscle, Skeletal [tisu]     2.9639976
Sexually transmitted disease [dsyn]     2.9639976
Cell Adhesion [celf]     2.9639976
Computed tomography angiography [diap]     2.9639976
Patient status [fndg]     2.9639976
non b hepatitis [dsyn]     2.9639976
Models, Genetic [inpr]     2.9639976
Chronic Persistent Hepatitis [dsyn]     2.9639976
Urinary Bladder [bpoc]     2.9639976
Intervention Studies [resa]     2.9639976
Protein-Protein Interaction [moft]     2.9639976
At-Risk Population [popg]     2.9639976
Harvest [hlca]     2.9639976
postmenopausal [tmco]     2.9639976
healthcare workers [prog]     2.9639976
Hamster [mamm]     2.9639976
intervention therapy [topp]     2.9639976
Large vessel [bpoc]     2.9639976
Histogram [mnob]     2.9639976
Adhere [fndg]     2.9639976
Hypertension [fndg]     2.9639976
Image Guided Therapy [topp]     2.9639976
chromatin remodeling [genf]     2.9639976
Straightforward [qlco]     2.9639976
Synopsis [inpr]     2.9639976
National Health and Nutrition Examination Survey [resa]     2.9639976
Mouse, Transgenic [mamm]     2.9639976
PER [gngm]     2.9639976
Balance [ftcn]     2.9639976
Power tool [mnob]     2.9639976
addicted [mobd]     2.9639976
Tomography, Spiral Computed [diap]     2.9639976
Radiotherapy, Conformal [topp]     2.9639976
Anthropometry [resa]     2.9639976
Open Resection [diap]     2.9639976
Multiple tumours [neop]     2.9639976
occurrence [tmco]     2.9639976
Post-Therapy [tmco]     2.9639976
H. pylori [bact]     2.9639976
Wig [medd]     2.9639976
Hepatitis B surface antigen level [lbpr]     2.9639976
PSC [dsyn]     2.9639976
Fresh Tissue [tisu]     2.9639976
Preservation [ftcn]     2.9639976
Ninth [qnco]     2.9639976
hospital discharge [hlca]     2.9639976
Blockade [ftcn]     2.9639976
Hematopoietic Stem Cell Transplantation [topp]     2.9639976
Thrombi [patf]     2.9639976
Sound [npop]     2.9639976
Blood Cell Count, White [lbpr]     2.9639976
Oligonucleotide [nnon]     2.9639976
Normal liver function [fndg]     2.9639976
Singapore [geoa]     2.9639976
United Kingdom [geoa]     2.9639976
Instrument [medd]     2.9639976
Hygiene [bmod]     2.9639976
condition [menp]     2.9639976
grading system [hlca]     2.9639976
Dosimetry [lbpr]     2.9639976
In Vitro Model [resa]     2.9639976
Fluke [euka]     2.9639976
Mouth [bsoj]     2.9639976
Cell Count [lbpr]     2.9639976
Initial presentation [ftcn]     2.9639976
Foreign [idcn]     2.9639976
program treatment [hlca]     2.9639976
MTT Assay [resa]     2.9639976
Sun [npop]     2.9639976
Aneuploid [comd]     2.9639976
cooked [dora]     2.9639976
Outlook [menp]     2.9639976
viruses, Hepatitis B [virs]     2.9639976
Genome [bmod]     2.9639976
topography [clas]     2.9639976
Perpendicular [spco]     2.9639976
ETOH [orch]     2.9639976
Hepatic Disorder [dsyn]     2.9639976
Large tumour [qlco]     2.9639976
APC [gngm]     2.9639976
telomerase activity [genf]     2.9639976
International Classification of Diseases [inpr]     2.9639976
Mind [menp]     2.9639976
stellate cell [cell]     2.9639976
Prior Treatment [clna]     2.9639976
Build [ftcn]     2.9639976
Program, Immunization [hlca]     2.9639976
Automated [ftcn]     2.9639976
Acupuncture [bmod]     2.9639976
heal [orgf]     2.9639976
Lateral [spco]     2.9639976
Couinaud Segment [bpoc]     2.9639976
Two Hundred Fifty [qnco]     2.9639976
Lifestyle changes [socb]     2.9639976
Leak [ftcn]     2.9639976
THIRTY-DAY [inpr]     2.9639976
biliary tumor [neop]     2.9639976
Alcoholic Steatohepatitis [dsyn]     2.9639976
Pen [mnob]     2.9639976
Hepatitis B status [lbtr]     2.9639976
Kidney Cancer [neop]     2.9639976
TH1 [gngm]     2.9639976
Liver tissue sample [tisu]     2.9639976
Fluctuate [tmco]     2.9639976
positive serologies [lbtr]     2.9639976
Process [phpr]     2.9639976
Duck [bird]     2.9639976
Attached [fndg]     2.9639976
Morocco [geoa]     2.9639976
ng/dL [qnco]     2.9639976
4 Days [tmco]     2.9639976
Uncomplicated [qlco]     2.9639976
ST [inpr]     2.9639976
Nodule size [spco]     2.9639976
anastomose [acab]     2.9639976
European country [geoa]     2.9639976
SCI [prog]     2.9639976
Farmer [prog]     2.9639976
Preoperative Therapy [topp]     2.9639976
Maker [prog]     2.9639976
Ampulla of Vater [bpoc]     2.9639976
Horizontal [spco]     2.9639976
Adrenal gland [bpoc]     2.9639976
affect patients [qlco]     2.9639976
Left hepatic duct [bpoc]     2.9639976
Cervical [blor]     2.9639976
Carcinoma Cell [cell]     2.9639976
HEPATOCELLULAR CARCINOMA 1 [gngm]     2.9639976
Ovarian [bpoc]     2.9639976
Diabetes Type 1 [dsyn]     2.9639976
4q [nusq]     2.9639976
soft tissue [tisu]     2.9639976
Leucocyte [cell]     2.9639976
S-HAM [topp]     2.9639976
Alcoholic beverage [food]     2.9639976
prerequisite [idcn]     2.9639976
Diploid [orga]     2.9639976
Discrete [qlco]     3.01515
3/18 [fndg]     3.01515
Therapeutic regimen [topp]     3.01515
eN [gngm]     3.01515
Dried [qlco]     3.01515
Para [fndg]     3.01515
disease stage [inpr]     3.01515
radioactive [npop]     3.01515
Protein Induced by Vitamin K Absence/Antagonist-II [aapp]     3.01515
post surgery [tmco]     3.01515
Hepatitis C screening [topp]     3.01515
Health Care Provider [prog]     3.01515
symposium [hcpp]     3.01515
Hodgkin Disease [neop]     3.01515
Neural [ftcn]     3.01515
suspended [idcn]     3.01515
Invaded [qlco]     3.01515
Purified [ftcn]     3.01515
Hamsters, Syrian [mamm]     3.01515
print [ocac]     3.01515
Longevity [tmco]     3.01515
EU [diap]     3.01515
Polysomy [comd]     3.01515
Imaging guidance [diap]     3.01515
Immunocompetent [clna]     3.01515
cooperation [socb]     3.01515
Rice [food]     3.01515
Microscopies [lbpr]     3.01515
Survey, Community [resa]     3.01515
Iron deposition [patf]     3.01515
Penetrance [ftcn]     3.01515
Biomedical [bmod]     3.01515
Clinical Practice Guideline [inpr]     3.01515
Molecular Profile [clna]     3.01515
Parity [fndg]     3.01515
Exploratory laparotomy [diap]     3.01515
Intratumor [ftcn]     3.01515
Ectopic [spco]     3.01515
Anorexia [dsyn]     3.01515
Acute kidney injury [dsyn]     3.01515
LTS [podg]     3.01515
Vietnamese [popg]     3.01515
Clamp [medd]     3.01515
Multiple cancer [neop]     3.01515
feel [menp]     3.01515
Neoplastic Disease [neop]     3.01515
Bead [bodm]     3.01515
Response Evaluation Criteria in Solid Tumors [inpr]     3.01515
pulmonary complications [patf]     3.01515
Present Absent [cnce]     3.01515
Hepatic stem cell [cell]     3.01515
Open Reading Frame [gngm]     3.01515
Reader 1 [ocdi]     3.01515
Choledochal Cyst [cgab]     3.01515
Trabecular Pattern [fndg]     3.01515
Video [mnob]     3.01515
Restriction fragment length polymorphism analysis [lbpr]     3.01515
Insulin resistance syndrome [patf]     3.01515
spend [qnco]     3.01515
Catch [sosy]     3.01515
2nd [qnco]     3.01515
elevated ast [fndg]     3.01515
Intermediate Risk [cnce]     3.01515
Peritoneum [bpoc]     3.01515
doctors [prog]     3.01515
ethical [idcn]     3.01515
Centers for Disease Control and Prevention [hcro]     3.01515
Diuretic [phsu]     3.01515
Angiogenic Factor [bacs]     3.01515
Genome, Human [gngm]     3.01515
Disease, Cardiac [dsyn]     3.01515
Proto-Oncogene [gngm]     3.01515
pro-apoptosis [celf]     3.01515
Main portal vein [bpoc]     3.01515
Primary Outcome Measure [inpr]     3.01515
Haematoma [patf]     3.01515
Seldom [qlco]     3.01515
Molecular Signature [clna]     3.01515
migrate [ftcn]     3.01515
Metal [inch]     3.01515
Low birth weight [podg]     3.01515
small tumours [qlco]     3.01515
Chest [blor]     3.01515
Gas [chvs]     3.01515
unaware [resa]     3.01515
Cytosol [celc]     3.01515
Cancer of Liver [neop]     3.01515
treatment complications [patf]     3.01515
Daughter [famg]     3.01515
Cost Effectiveness Analysis [ocac]     3.01515
Vascular Tumor [neop]     3.01515
alpha fetoprotein test [lbpr]     3.01515
Very Good [inpr]     3.01515
Intravascular [spco]     3.01515
HBV Viral Load [lbpr]     3.01515
Immunophenotype [lbpr]     3.01515
Duplicate [ftcn]     3.01515
acute exacerbation [fndg]     3.01515
selective internal radiation therapy [topp]     3.01515
segmental resection [topp]     3.01515
Peripheral blood cell [cell]     3.01515
Weight Gain [fndg]     3.01515
scar [patf]     3.01515
Latino [popg]     3.01515
Mitotic Index [lbtr]     3.01515
pulmonary metastases [neop]     3.01515
immunogenic [ftcn]     3.01515
Interdisciplinary [ocac]     3.01515
Epithelioid haemangioendothelioma [neop]     3.01515
Endoscopic retrograde cholangiography [diap]     3.01515
too early [idcn]     3.01515
Helicobacter species [bact]     3.01515
Saline [sbst]     3.01515
Laboratory test result [fndg]     3.01515
Task [ocac]     3.01515
Kidney transplant [topp]     3.01515
Unresolved [qlco]     3.01515
von Meyenburg complex [neop]     3.01515
Lifetime Risk [qnco]     3.01515
Radiation Exposure [phpr]     3.01515
Veterans Administration [orgt]     3.01515
Mucosal [tisu]     3.01515
Skin Cancer [neop]     3.01515
protocol treatment [topp]     3.01515
Supplement [ftcn]     3.01515
national level [spco]     3.01515
IM [idcn]     3.01515
Unilateral [spco]     3.01515
age onset [qnco]     3.01515
PI [clna]     3.01515
PCR analysis [lbpr]     3.01515
Subcutaneous injection [ftcn]     3.01515
spanish [popg]     3.01515
bile duct stricture [acab]     3.01515
Refuse [idcn]     3.01515
Laser [mnob]     3.01515
demethylation [npop]     3.01515
Alaska [geoa]     3.01515
IVA [dsyn]     3.01515
PRECIPITATE [phpr]     3.01515
Total population [qnco]     3.01515
Mini [orga]     3.01515
Adjunctive [topp]     3.01515
Cord [bpoc]     3.01515
anomalies [fndg]     3.01515
Cell Membrane [celc]     3.01515
Functional Role [cnce]     3.01515
Tumor-like lesion [ftcn]     3.01515
Feedback [phpr]     3.01515
driver [popg]     3.01515
One Thousand [qnco]     3.01515
Glycolysis [moft]     3.01515
infarcted [patf]     3.01515
Dutch [popg]     3.01515
Motif [amas]     3.01515
Mass Screening [hlca]     3.01515
Post-Procedure [tmco]     3.01515
Immunologic [bmod]     3.01515
Fungal [ftcn]     3.01515
Plasma membrane [celc]     3.01515
adapt [ftcn]     3.01515
Formulation [resa]     3.01515
Velocities [qnco]     3.01515
Diffusion weighted magnetic resonance imaging [diap]     3.01515
Prophylactic treatment [topp]     3.01515
Oral use [ftcn]     3.01515
Misdiagnosis [fndg]     3.01515
Cancer Treatment [topp]     3.01515
Ectopic Expression [genf]     3.01515
Hyponatraemia [fndg]     3.01515
Heterosexual [socb]     3.01515
Systemic disease [dsyn]     3.01515
ovid [mamm]     3.01515
Flaviviridae [virs]     3.01515
Input [cnce]     3.01515
International Union Against Cancer [inpr]     3.01515
Clonal Expansion [patf]     3.01515
derivation [idcn]     3.01515
ED [idcn]     3.01515
Group P [inpr]     3.01515
24 hours [tmco]     3.01515
Adrenocortical carcinoma [neop]     3.01515
American College of Radiology [pros]     3.01515
ICD-9 [inpr]     3.01515
Organic Solvents [orch]     3.01515
descent [famg]     3.01515
Nephropathy [dsyn]     3.01515
Hematologic Malignancies [neop]     3.01515
Gastric mucosa [tisu]     3.01515
think [menp]     3.01515
SENSITIVITY SPECIFICITY [qnco]     3.01515
Mongolia [geoa]     3.01515
health screen [hlca]     3.01515
507 [inpr]     3.01515
Doppler ultrasound [diap]     3.01515
3/24 [fndg]     3.01515
Unspecified [qlco]     3.01515
change pattern [qlco]     3.01515
PC [gngm]     3.01515
Food Intake [orgf]     3.01515
Acute hepatitis C [dsyn]     3.01515
Extrahepatic Bile Duct Carcinoma [neop]     3.01515
PAVe [topp]     3.01515
Expert Opinion [cnce]     3.01515
Pruritus [sosy]     3.01515
GC [gngm]     3.01515
excreted [qnco]     3.01515
Definitive Treatment [topp]     3.01515
Prison [mnob]     3.01515
transit [spco]     3.01515
Porphyria [dsyn]     3.01515
Smoking Status [clna]     3.01515
Yes [idcn]     3.01515
Circular [spco]     3.01515
Older child [aggp]     3.01515
Depressed [mobd]     3.01515
Chromosomal region [cell]     3.01515
Passage [spco]     3.01515
Irradiated [ftcn]     3.01515
Fund [qnco]     3.01515
CDC [hcro]     3.01515
interrupt [qlco]     3.01515
Veins, Portal [bpoc]     3.01515
Texture [qlco]     3.01515
Imaging Technologies [bmod]     3.01515
Type [hlca]     3.01515
Pathogen [qlco]     3.01515
heal [ftcn]     3.01515
40 g [qnco]     3.01515
Coincident [tmco]     3.01515
Functional Status [fndg]     3.01515
Belief [idcn]     3.01515
America [geoa]     3.01515
Hepadnaviruses [virs]     3.01515
transduction [orgf]     3.01515
Acute bleeding [patf]     3.01515
Lymphatic Invasion [fndg]     3.01515
Modified [qlco]     3.01515
Dye [irda]     3.01515
Duodenum [bpoc]     3.01515
Leukocyte Count [lbpr]     3.01515
Renal Disease, End-Stage [dsyn]     3.01515
Menopausal [phsf]     3.01515
Glioma [neop]     3.01515
scar [fndg]     3.01515
gene expression profile [lbpr]     3.01515
test results [fndg]     3.01515
Biliary Intraepithelial Neoplasia [dsyn]     3.01515
Aspirate [hlca]     3.01515
IC [idcn]     3.01515
Offspring [famg]     3.01515
Oriental [popg]     3.01515
Molecular Profile [mbrt]     3.01515
License [rnlw]     3.01515
Perioperative death [fndg]     3.01515
Disproportionate [qlco]     3.01515
Closure [topp]     3.01515
popularity [socb]     3.01515
Normal Values [qnco]     3.01515
Central Nervous System [bdsy]     3.01515
Poor - grade [qlco]     3.01515
Immune Surveillance [orgf]     3.01515
new onset [fndg]     3.01515
Hawaii [geoa]     3.01515
Cytotoxic [topp]     3.01515
Exercise, Physical [dora]     3.01515
deviate [spco]     3.01515
abnormal liver test [fndg]     3.01515
Hepatic artery thrombosis [patf]     3.01515
Study, Matched Case-Control [resa]     3.01515
Multiply [ftcn]     3.01515
Red blood cell [lbpr]     3.01515
Diagnostic Sensitivity [qnco]     3.01515
Upper aerodigestive tract [blor]     3.01515
Arterial flow [fndg]     3.01515
Alpha Fetoprotein L3 [lbpr]     3.01515
cytopathology [ocdi]     3.01515
Heat [eehu]     3.01515
Blood culture [lbpr]     3.01515
Homozygosity [orga]     3.01515
Enhancing Lesion [fndg]     3.01515
Familial Adenomatous Polyposis [neop]     3.01515
1p [nusq]     3.01515
Reagent [irda]     3.01515
Increased stress [ftcn]     3.01515
Haemangioendothelioma [neop]     3.01515
Anti-Viral Response [orgf]     3.01515
Satellite [virs]     3.01515
gram [qnco]     3.01515
form type [inpr]     3.01515
Preexisting [qlco]     3.01515
Least Square [qnco]     3.01515
Bone Metastasis [neop]     3.01515
Fungal infection [dsyn]     3.01515
Local disease [dsyn]     3.01515
Steatohepatitides [dsyn]     3.01515
Organ Donation [inbe]     3.01515
Laboratory studies [lbpr]     3.01515
primary diagnosis [qlco]     3.01515
Scientists [prog]     3.01515
Treated with [topp]     3.01515
Hematogenous [qlco]     3.01515
Tail [bpoc]     3.01515
Strength [idcn]     3.01515
Southeast [spco]     3.01515
Suicide [fndg]     3.01515
p53 pathway [ftcn]     3.01515
Sarcopenia [fndg]     3.01515
Cross-Sectional Survey [resa]     3.01515
urban area [spco]     3.01515
Health Care Systems [hcro]     3.01515
Bariatric Surgery [topp]     3.01515
stress response [phsf]     3.01515
Neoadjuvant Treatment [topp]     3.01515
Specified [qlco]     3.01515
radiologic examination [diap]     3.01515
Placental [emst]     3.01515
Lifestyles [socb]     3.01515
Mitigate [idcn]     3.01515
Abnormal liver function [patf]     3.01515
Equipment [mnob]     3.01515
severe anemia [dsyn]     3.01515
Neighbor [spco]     3.01515
Staple [medd]     3.01515
chart [medd]     3.01515
Duodenal [bpoc]     3.01515
Gastric Tissue [tisu]     3.01515
warn [gora]     3.01515
Event-Free Survival [qnco]     3.01515
blood cancer [neop]     3.01515
HIV positive [fndg]     3.01515
Pakistani [popg]     3.01515
Maturation [orgf]     3.01515
homozygous genotype [orga]     3.01515
Bile duct adenoma [neop]     3.01515
Primate [mamm]     3.01515
Head and Neck Cancer [neop]     3.01515
Micrometastasis [fndg]     3.01515
Biphasic [tmco]     3.01515
Phase II Study [resa]     3.01515
Target cell [cell]     3.01515
Nuclear Translocation [moft]     3.01515
Mean deviation [clna]     3.01515
Consent [ftcn]     3.01515
CD56 [lbpr]     3.073142
Inaccurate [qlco]     3.073142
Image Quality [qlco]     3.073142
Network Analysis [inpr]     3.073142
Unidentified [qlco]     3.073142
Uncovered [ftcn]     3.073142
Hepatitis A Virus [virs]     3.073142
Population Analysis [resa]     3.073142
Forest [geoa]     3.073142
swelling [patf]     3.073142
Tumor Load [diap]     3.073142
Trocar [medd]     3.073142
Acinar [spco]     3.073142
Biliary cyst [acab]     3.073142
Human hepatitis B virus [virs]     3.073142
Pre-diabetes NOS [dsyn]     3.073142
exponential [qlco]     3.073142
Fine [qlco]     3.073142
antagonism [socb]     3.073142
Molecular Targeted Therapies [topp]     3.073142
Esophageal Adenocarcinoma [neop]     3.073142
Construct [topp]     3.073142
Isolate [topp]     3.073142
Sheet [qnco]     3.073142
RFS [dsyn]     3.073142
8p [nusq]     3.073142
Primary Neoplasm [neop]     3.073142
Stromal Cells [cell]     3.073142
WISH [gngm]     3.073142
absolute risk [qnco]     3.073142
Tumor tissue sample [tisu]     3.073142
8q [nusq]     3.073142
Daily Dose [qnco]     3.073142
categorization [clas]     3.073142
SUV [chvs]     3.073142
Hepatocellular carcinoma, scirrhous [neop]     3.073142
Homologue [gngm]     3.073142
Unsuccessful [qlco]     3.073142
Thalassaemia [dsyn]     3.073142
Wealthy [qlco]     3.073142
associated conditions [patf]     3.073142
Latin America [geoa]     3.073142
Discipline [hlca]     3.073142
Viable cells [cell]     3.073142
IFN-ALPHA [gngm]     3.073142
Health checkup [fndg]     3.073142
Neutropenia [fndg]     3.073142
quality control [ftcn]     3.073142
Cluster Analysis [resa]     3.073142
mg/kg/day [qnco]     3.073142
Lipid droplet [celc]     3.073142
Postoperative Care [hlca]     3.073142
Gastrointestinal Tumor [neop]     3.073142
Working Group [popg]     3.073142
Best Practice [idcn]     3.073142
population survey [resa]     3.073142
Anatomic Pathology [inpr]     3.073142
Pelvis [bpoc]     3.073142
Minnesota [geoa]     3.073142
infection liver [dsyn]     3.073142
Identical [menp]     3.073142
Lag [gngm]     3.073142
Cytokine Gene [gngm]     3.073142
Severe pain [sosy]     3.073142
HIT [dsyn]     3.073142
INK4a [gngm]     3.073142
Side Effect [patf]     3.073142
chapter [idcn]     3.073142
Rule [inpr]     3.073142
Trace [qnco]     3.073142
Sensitive to [ftcn]     3.073142
One Million [qnco]     3.073142
Motile [celf]     3.073142
Local-Regional [spco]     3.073142
Gas Chromatography [lbpr]     3.073142
grind [topp]     3.073142
Ultrasonography, Doppler, Color [diap]     3.073142
INTERLEUKIN 28B [gngm]     3.073142
Matched Group [grup]     3.073142
Polyp [anab]     3.073142
Carcinogens, Environmental [hops]     3.073142
cigarette smokers [fndg]     3.073142
Ovarian tumor [neop]     3.073142
IARC [hcro]     3.073142
Eighth [qnco]     3.073142
Myeloid cell [cell]     3.073142
Insensitivity [fndg]     3.073142
Metacercariae [euka]     3.073142
Immunosorbent Assays, Enzyme-Linked [lbpr]     3.073142
Bioassay [lbpr]     3.073142
Peritoneal [dsyn]     3.073142
Pathognomonic [cnce]     3.073142
Transport, NOS [celf]     3.073142
Corp. [orgt]     3.073142
Haemostasis [ortf]     3.073142
Patency [spco]     3.073142
RRS [dsyn]     3.073142
Engaged [fndg]     3.073142
factor V Leiden [aapp]     3.073142
Short duration [qlco]     3.073142
normal limit [qnco]     3.073142
Superfamily [cnce]     3.073142
Cue [idcn]     3.073142
Swiss [popg]     3.073142
Cardiac Failure [dsyn]     3.073142
Carcinoembryonic [imft]     3.073142
Cholecystolithiasis [dsyn]     3.073142
Radiology studies [diap]     3.073142
Touch [topp]     3.073142
Experimental Model [inpr]     3.073142
Polypoid [ftcn]     3.073142
Adenoviruses [virs]     3.073142
Small Non-Coding RNA [nnon]     3.073142
Channel [spco]     3.073142
Genetic Study [resa]     3.073142
DOUBLE BLIND [resa]     3.073142
secure [bodm]     3.073142
Tau [inpr]     3.073142
Haemoperitoneum [fndg]     3.073142
FNA [diap]     3.073142
sense [ortf]     3.073142
Europe, Eastern [geoa]     3.073142
disease risk [fndg]     3.073142
derivation [ftcn]     3.073142
Digestive System [bdsy]     3.073142
Argentina [geoa]     3.073142
PLT [lbpr]     3.073142
Undetermined [idcn]     3.073142
genome sequencing [mbrt]     3.073142
youth [aggp]     3.073142
Mobilisation [topp]     3.073142
Immune Function [ortf]     3.073142
except [ftcn]     3.073142
Unmet [acty]     3.073142
Stabilisation [topp]     3.073142
Intra-Abdominal Infection [dsyn]     3.073142
South America [geoa]     3.073142
DISH [dsyn]     3.073142
Transcription Activation [genf]     3.073142
B6C3F1 [mamm]     3.073142
B2 [bpoc]     3.073142
Arranged [spco]     3.073142
Liver Cell Carcinoma [neop]     3.073142
Rare Lesion [fndg]     3.073142
Image-Guided Biopsies [diap]     3.073142
New Diagnosis [diap]     3.073142
Smear [diap]     3.073142
Visceral Fat [tisu]     3.073142
HI [geoa]     3.073142
3D-CRT [topp]     3.073142
direct target [idcn]     3.073142
alcohol-related liver disease [dsyn]     3.073142
Mice, C57BL [mamm]     3.073142
First Step [bodm]     3.073142
Current state [inpr]     3.073142
Co-morbid conditions [fndg]     3.073142
Denied [qlco]     3.073142
mother child [socb]     3.073142
injured [ftcn]     3.073142
Possible diagnosis [qlco]     3.073142
pharmacologic therapy [ftcn]     3.073142
Chromosomal Alterations [comd]     3.073142
Hidden [qlco]     3.073142
Time course [tmco]     3.073142
Local Cancer [neop]     3.073142
Absorption [npop]     3.073142
Hepatic Venous Outflow Obstruction [dsyn]     3.073142
Portal System [bpoc]     3.073142
Tumor regression [orga]     3.073142
Cell Culture [cell]     3.073142
groundnut [food]     3.073142
Microorganisms [orgm]     3.073142
Perception [menp]     3.073142
Right upper quadrant pain [sosy]     3.073142
Null Mouse [mamm]     3.073142
Ass [mamm]     3.073142
Gallbladder Polyp [neop]     3.073142
C57BL [mamm]     3.073142
National Institutes of Health [hcro]     3.073142
breath hold [sosy]     3.073142
Stat [tmco]     3.073142
Electrophoretic Mobility Shift Assay [lbpr]     3.073142
ALDEHYDE DEHYDROGENASE 2 [gngm]     3.073142
Nitrogen [elii]     3.073142
Hypersensitivity [patf]     3.073142
Enlargement, NOS [patf]     3.073142
Chemoradiotherapy [topp]     3.073142
liver enzyme level [lbpr]     3.073142
Functional analysis [hlca]     3.073142
C57BL/6 Mouse [mamm]     3.073142
Laparoscopic procedure [diap]     3.073142
adenoviral [virs]     3.073142
Genus [clas]     3.073142
painless jaundice [fndg]     3.073142
Mathematical Model [inpr]     3.073142
Hepatitis B DNA [lbpr]     3.073142
Release [ftcn]     3.073142
tine [medd]     3.073142
Gall Stone [dsyn]     3.073142
Stent placement [topp]     3.073142
Fistula [anab]     3.073142
Blotting, Southern [mbrt]     3.073142
yeast [fngs]     3.073142
Aspirate [bdsu]     3.073142
Autocrine [ortf]     3.073142
FDG PET [diap]     3.073142
Diabetes status [orga]     3.073142
surgical intervention [hlca]     3.073142
Index case [tmco]     3.073142
Gastrointestinal Stromal Tumor [neop]     3.073142
gallstone disease [dsyn]     3.073142
Virus Replication [orgf]     3.073142
Developmental [qlco]     3.073142
Recanalisation [topp]     3.073142
Hepatocellular necrosis [dsyn]     3.073142
Hyalin [bdsu]     3.073142
Angioplasty [topp]     3.073142
Primitive [inpr]     3.073142
Relief [fndg]     3.073142
Host Cell [celc]     3.073142
Content [cnce]     3.073142
tomography [diap]     3.073142
Live [fndg]     3.073142
vitamin k antagonist [topp]     3.073142
Aberrant DNA Methylation [comd]     3.073142
MALS-1 [gngm]     3.073142
Bile duct proliferation [dsyn]     3.073142
Breast Carcinoma [neop]     3.073142
forecast [inpr]     3.073142
Vena cava [bpoc]     3.073142
South East Asian [popg]     3.073142
Pearson Correlation Coefficient [qnco]     3.073142
Specify [qlco]     3.073142
Subclass [clas]     3.073142
Displaced [menp]     3.073142
FACTORIAL [resa]     3.073142
Encapsulated [qlco]     3.073142
APP [lbpr]     3.073142
Hepatitis C virus genotype 2 [virs]     3.073142
Rare disorder [dsyn]     3.073142
Fibrous tissue [tisu]     3.073142
Shock [patf]     3.073142
Postcontrast [tmco]     3.073142
physiopathological [ftcn]     3.073142
Plate [medd]     3.073142
New York City [geoa]     3.073142
Superficial mass [fndg]     3.073142
oxidant [chvf]     3.073142
Primary carcinoma of liver [neop]     3.073142
Epidemiology, Descriptive [resa]     3.073142
aggressive cancer [neop]     3.073142
Pharmacological Treatment [topp]     3.073142
In Vitro Assay [resa]     3.073142
veno-occlusive disease [dsyn]     3.073142
Output [cnce]     3.073142
CD [idcn]     3.073142
Organ-space surgical site infection [patf]     3.073142
iron homeostasis [celf]     3.073142
Arm [neop]     3.073142
mild moderate [qlco]     3.073142
Temporary [tmco]     3.073142
face-to-face [idcn]     3.073142
Endoscopic Ultrasound [diap]     3.073142
eligibility criteria [qlco]     3.073142
Transplantation, Hepatic [topp]     3.073142
DNA Adduct Formation [comd]     3.073142
Fontan Procedure [topp]     3.073142
Fixation [topp]     3.073142
associated disorders [ftcn]     3.073142
Natural killer [cell]     3.073142
Triphasic [tmco]     3.073142
AIDS Population [popg]     3.073142
Systolic blood pressure [clna]     3.073142
Mesothelioma [neop]     3.073142
Sudan [geoa]     3.073142
surgeries [hlca]     3.073142
Peliosis [dsyn]     3.073142
VII [inpr]     3.073142
Oval [qlco]     3.073142
ethnic differences [fndg]     3.073142
Oceania [geoa]     3.073142
intravenous drug [phsu]     3.073142
Invasive procedure [ftcn]     3.073142
metastatic neoplasm [neop]     3.073142
Increased size [fndg]     3.073142
Mold [fngs]     3.073142
General Practice [bmod]     3.073142
Sonogram [diap]     3.073142
Diaphragmatic [bpoc]     3.073142
thermal therapy [topp]     3.073142
EMBRYONAL SARCOMA, UNDIFFERENTIATED [neop]     3.073142
Official [qlco]     3.073142
serosal [blor]     3.073142
hepatitis b exposure [fndg]     3.073142
contour [inch]     3.073142
serum cholesterol [lbpr]     3.073142
Brain tumor [neop]     3.073142
Hilar lymph node [bpoc]     3.073142
Trunk [blor]     3.073142
Spindle [celc]     3.073142
Long Non-Coding RNA [nnon]     3.073142
Yen [qnco]     3.073142
disease duration [tmco]     3.073142
Dangerousness [idcn]     3.073142
Health System [gora]     3.073142
compensatory [ftcn]     3.073142
Laboratory Finding [fndg]     3.073142
Serologic tests [lbpr]     3.073142
Gene Ontology [inpr]     3.073142
V-shaped [spco]     3.073142
Complete Remission [fndg]     3.073142
Incisional hernia [inpo]     3.073142
Atypia [fndg]     3.073142
Thrombophilia [dsyn]     3.073142
Hx [fndg]     3.073142
Food Frequency Questionnaire [inpr]     3.073142
Multidetector-Row Computed Tomography [diap]     3.073142
Scopus [bird]     3.073142
Stromal Invasion [fndg]     3.073142
Heritable [ftcn]     3.073142
Antibiotic Prophylaxis [topp]     3.073142
Elevated Bilirubin [fndg]     3.073142
Multimodal Therapy [topp]     3.073142
External beam radiotherapy [topp]     3.073142
Abscess, Hepatic [dsyn]     3.073142
Entire liver [bpoc]     3.073142
Pharmaceutical [bodm]     3.073142
research studies [resa]     3.073142
Sponsor [humn]     3.073142
6 Days [tmco]     3.073142
coronary artery disease [dsyn]     3.073142
Shunt [topp]     3.073142
Creatinine level [lbtr]     3.073142
Quality Improvement [ocac]     3.073142
Window [mnob]     3.073142
Postoperative bleeding [patf]     3.073142
RASSF1A [gngm]     3.073142
Splicing [genf]     3.073142
brain metastases [neop]     3.073142
Health policies [rnlw]     3.073142
Diagnostic Efficacy [qlco]     3.073142
Data Reporting [resa]     3.073142
Hepatitis D [dsyn]     3.073142
Anticancer Drugs [hlca]     3.073142
Epidemiologic Research [resa]     3.073142
Organelle [celc]     3.073142
Weight Reduction [fndg]     3.073142
Spot [fish]     3.073142
weight [qnco]     3.073142
Genetic Diversity [npop]     3.073142
METABOLIC FEATURES [clna]     3.073142
shear [medd]     3.073142
Life Cycle [tmco]     3.073142
Fibrosarcoma [neop]     3.073142
7s [bpoc]     3.073142
Superinfection [dsyn]     3.073142
Body Surface Area [orga]     3.073142
Pass [fndg]     3.073142
Leukocytes [cell]     3.073142
Mismatch [qlco]     3.073142
War [acty]     3.073142
CI 40 [inpr]     3.073142
Obesity, Visceral [sosy]     3.073142
calorie [qnco]     3.073142
Idiopathic [ftcn]     3.073142
Red color [fndg]     3.073142
Periportal fibrosis [fndg]     3.073142
Light microscopy [lbpr]     3.073142
Controlled Clinical Trial [inpr]     3.073142
Lymphoma, Malignant [neop]     3.073142
Postnatal [tmco]     3.073142
Acute viral hepatitis [dsyn]     3.073142
Hepatic Failure, Acute [dsyn]     3.073142
Audit [cnce]     3.073142
Wound [inpo]     3.073142
Telomere Shortening [comd]     3.073142
Base Pair [moft]     3.073142
Circumscribed [spco]     3.1400888
Mesenteric vein [bpoc]     3.1400888
Flare [sosy]     3.1400888
Adenoma, Liver Cell [neop]     3.1400888
DNA Binding [genf]     3.1400888
Cancer risk assessment [hlca]     3.1400888
Pregnant [fndg]     3.1400888
Grade 2/3 [clas]     3.1400888
DNA Microarray [resd]     3.1400888
physiologic process [phsf]     3.1400888
Germ Line [cell]     3.1400888
Mild inflammation [fndg]     3.1400888
digestive cancer [neop]     3.1400888
Study Protocol [inpr]     3.1400888
Whipple procedure [topp]     3.1400888
4c [inpr]     3.1400888
Cell Type [cell]     3.1400888
Wanted [fndg]     3.1400888
Anomalous [fndg]     3.1400888
Clone [resa]     3.1400888
Re-admission [idcn]     3.1400888
Secretory [celf]     3.1400888
Shrinkage [ftcn]     3.1400888
digest [phsf]     3.1400888
Wnt Signaling Pathway [moft]     3.1400888
NT [qlco]     3.1400888
Intraoperative Ultrasound [diap]     3.1400888
Configuration [spco]     3.1400888
Malignant Melanoma [neop]     3.1400888
Glass [mnob]     3.1400888
German [popg]     3.1400888
Organ [qlco]     3.1400888
Missense Mutation [genf]     3.1400888
Communicable disease [dsyn]     3.1400888
Standard Population [qnco]     3.1400888
Firmly [qlco]     3.1400888
Principal diagnosis [qlco]     3.1400888
Stellate [spco]     3.1400888
QALY [tmco]     3.1400888
Prior Therapy [clna]     3.1400888
Nephroblastoma [neop]     3.1400888
Chemotherapy Regimen [topp]     3.1400888
Fine needle aspiration biopsy [diap]     3.1400888
Vulnerable Population [popg]     3.1400888
base [qnco]     3.1400888
Subphrenic [bpoc]     3.1400888
Cystadenoma [neop]     3.1400888
%V/V [qnco]     3.1400888
hemophiliacs [podg]     3.1400888
pragmatic [socb]     3.1400888
MUC4 [gngm]     3.1400888
Ishak Score [clas]     3.1400888
Rapidly progressive [fndg]     3.1400888
Centrilobular [spco]     3.1400888
Multi-organ failure [patf]     3.1400888
Alpha1 [qlco]     3.1400888
polycyclic aromatic hydrocarbon [orch]     3.1400888
Multifaceted [spco]     3.1400888
PNPLA3 gene [gngm]     3.1400888
Carcinoma, Neuroendocrine [neop]     3.1400888
Expression Profiling [mbrt]     3.1400888
Shot [topp]     3.1400888
SMR [geoa]     3.1400888
Ethanol abuse [mobd]     3.1400888
Serum sodium [lbpr]     3.1400888
Hepatorenal Syndrome [dsyn]     3.1400888
Reader 2 [ocdi]     3.1400888
Alpha Value [qlco]     3.1400888
Contrast-enhanced MRI [diap]     3.1400888
prophylactic antibiotic [fndg]     3.1400888
In Person [idcn]     3.1400888
London [geoa]     3.1400888
Malondialdehyde [orch]     3.1400888
Left hemihepatectomy [topp]     3.1400888
Tumor Promoter [hops]     3.1400888
stereotactic body radiation therapy [topp]     3.1400888
gene promoters [gngm]     3.1400888
Paris [geoa]     3.1400888
reactivate [ftcn]     3.1400888
Serum ferritin [lbpr]     3.1400888
mIU [qnco]     3.1400888
Pre-Malignant [qlco]     3.1400888
NR [geoa]     3.1400888
Distribution pattern [spco]     3.1400888
Cytolysis [celf]     3.1400888
clearance rate [clna]     3.1400888
Energy Metabolism [phsf]     3.1400888
Opportunistic Infection [dsyn]     3.1400888
Slowly progressive [fndg]     3.1400888
Human immunodeficiency virus disease [dsyn]     3.1400888
Large Cell Dysplasia [fndg]     3.1400888
Intraluminal [spco]     3.1400888
Rural Communities [popg]     3.1400888
Editorial [inpr]     3.1400888
end stage disease [dsyn]     3.1400888
Lymphocyte [qlco]     3.1400888
Mutation Rate [qlco]     3.1400888
African country [geoa]     3.1400888
Premature [tmco]     3.1400888
Resistance.index [clna]     3.1400888
Beef [food]     3.1400888
American Society of Clinical Oncology [pros]     3.1400888
Perinatal period [tmco]     3.1400888
Managed [prog]     3.1400888
Hormone replacement therapy [topp]     3.1400888
Perceived [menp]     3.1400888
Correspondence [inpr]     3.1400888
Maternal Transmission [patf]     3.1400888
FOXP3 [gngm]     3.1400888
Blood Volume [orga]     3.1400888
FORMERLY [gngm]     3.1400888
Static [qlco]     3.1400888
low socioeconomic status [qnco]     3.1400888
Healthy adult [fndg]     3.1400888
Ubiquitination [moft]     3.1400888
In Utero [aggp]     3.1400888
Klebsiella pneumoniae [bact]     3.1400888
Chemical Agents [ftcn]     3.1400888
Distal Common Bile Duct [anst]     3.1400888
Volunteer blood donor [popg]     3.1400888
Peptic Ulcer [dsyn]     3.1400888
13q [nusq]     3.1400888
Upward [spco]     3.1400888
Nucleoside [nnon]     3.1400888
Long axis [spco]     3.1400888
Septicaemia [dsyn]     3.1400888
Host defence [ortf]     3.1400888
involuted [qlco]     3.1400888
Characteristics, Biological [grpa]     3.1400888
Chemistry [ocdi]     3.1400888
Liver Failure, Fulminant [dsyn]     3.1400888
Dissimilar [qlco]     3.1400888
Trait [orga]     3.1400888
Non-nodular [spco]     3.1400888
Common Toxicity Criteria [inpr]     3.1400888
Sizes, Sample [qnco]     3.1400888
Protein Synthesis [moft]     3.1400888
aminotransferase activity [moft]     3.1400888
warm [npop]     3.1400888
B-Cell Non-Hodgkin Lymphoma [neop]     3.1400888
nasopharyngeal cancer [neop]     3.1400888
Imaging Procedures [diap]     3.1400888
Massive blood loss [patf]     3.1400888
Pharmacotherapy [topp]     3.1400888
Microbiological [inpr]     3.1400888
hepatitis b surface [lbpr]     3.1400888
Orthopedic [bmod]     3.1400888
Soft [qlco]     3.1400888
Alimentary tract [bdsy]     3.1400888
Common Carcinoma [neop]     3.1400888
Nitrite [chvs]     3.1400888
land [mnob]     3.1400888
CCC [neop]     3.1400888
Backward [spco]     3.1400888
Immunogenetic [bmod]     3.1400888
Solitary mass [anab]     3.1400888
Hepatoduodenal ligament [bpoc]     3.1400888
First Degree Relative [qnco]     3.1400888
Cohort Effect [qlco]     3.1400888
Creation [topp]     3.1400888
metastatic colorectal cancer [neop]     3.1400888
Favorable Clinical Outcome [fndg]     3.1400888
Colitis [dsyn]     3.1400888
Vasoactive [qlco]     3.1400888
LC/MS/MS [lbpr]     3.1400888
Fiber [food]     3.1400888
2-Dimensional [spco]     3.1400888
SERO [lbpr]     3.1400888
Fatty metamorphosis [patf]     3.1400888
granulocyte [cell]     3.1400888
Bone marrow cell [cell]     3.1400888
Support Vector Machine [qnco]     3.1400888
MicroRNA Gene [gngm]     3.1400888
Cytotoxic T lymphocyte [cell]     3.1400888
General [mnob]     3.1400888
Consortium [prog]     3.1400888
Genes, p53 [gngm]     3.1400888
crush [topp]     3.1400888
Critical Illness [dsyn]     3.1400888
Low weight [fndg]     3.1400888
atherosclerotic [ftcn]     3.1400888
Autoimmune Response [patf]     3.1400888
Canine [mamm]     3.1400888
TOF [cgab]     3.1400888
Infection, Asymptomatic [dsyn]     3.1400888
Type IV [clas]     3.1400888
methylenetetrahydrofolate reductase activity [moft]     3.1400888
Calcified [qlco]     3.1400888
Bead [spco]     3.1400888
Increased blood flow [fndg]     3.1400888
Arab [popg]     3.1400888
Impaired fasting glucose [fndg]     3.1400888
Tumor Model [inpr]     3.1400888
Enucleation [topp]     3.1400888
elevated neutrophil [fndg]     3.1400888
Group [ftcn]     3.1400888
Lymphoproliferative disease [neop]     3.1400888
Biologic Markers [clna]     3.1400888
Hypersensitivity reactions [patf]     3.1400888
Initial [qlco]     3.1400888
Precontrast [tmco]     3.1400888
Permit [fish]     3.1400888
Acute pancreatitis [dsyn]     3.1400888
intraepithelial [spco]     3.1400888
Microsomal [qlco]     3.1400888
Pre-Existing Disease [rnlw]     3.1400888
Asian race [popg]     3.1400888
skeletal [bdsy]     3.1400888
Lithiasis [patf]     3.1400888
Habitual drinker [fndg]     3.1400888
Equivalent [qnco]     3.1400888
affluent [qlco]     3.1400888
New finding [fndg]     3.1400888
1 H [elii]     3.1400888
Ethnic population [popg]     3.1400888
Osteoporosis [dsyn]     3.1400888
Boil [dsyn]     3.1400888
Beta-blocker [phsu]     3.1400888
Connective Tissue [tisu]     3.1400888
SEER [hcro]     3.1400888
Anesthesia [topp]     3.1400888
Siderosis [dsyn]     3.1400888
Biologic Factors [bacs]     3.1400888
Genetic Markers [genf]     3.1400888
nuclear magnetic resonance [diap]     3.1400888
Early complication [sosy]     3.1400888
HCV status [clna]     3.1400888
Ectopic liver [cgab]     3.1400888
Trematode [euka]     3.1400888
Southern Blot Hybridization [mbrt]     3.1400888
Mutual [qlco]     3.1400888
MT [qnco]     3.1400888
immune suppression [topp]     3.1400888
Vital Statistics [qnco]     3.1400888
Basin [medd]     3.1400888
older adult [popg]     3.1400888
Mass Vaccination [topp]     3.1400888
prenatal [aggp]     3.1400888
Aspergillus flavus [fngs]     3.1400888
OPEN LABEL [resa]     3.1400888
MAL-5 [orch]     3.1400888
Molecular Diagnostic [lbpr]     3.1400888
Offset [qnco]     3.1400888
Phase II Trial [resa]     3.1400888
drug addiction [mobd]     3.1400888
whole blood [bdsu]     3.1400888
Right upper quadrant [spco]     3.1400888
Chip [resd]     3.1400888
CI-30 [gngm]     3.1400888
Movement [orgf]     3.1400888
Sector [geoa]     3.1400888
antigen specific [imft]     3.1400888
Auto [lbpr]     3.1400888
Retrieval [hlca]     3.1400888
Age Cohort [popg]     3.1400888
FNH [dsyn]     3.1400888
SLIM [gngm]     3.1400888
DNA Repair Gene [gngm]     3.1400888
Tongue [bpoc]     3.1400888
Neural network [orgf]     3.1400888
Cavities [dsyn]     3.1400888
Digit [inpr]     3.1400888
ERAS [gngm]     3.1400888
Polypeptide [aapp]     3.1400888
Marriage [fndg]     3.1400888
Anatomic Site [blor]     3.1400888
Ovarian Carcinoma [neop]     3.1400888
Continent [geoa]     3.1400888
16q [nusq]     3.1400888
patient safety [hlca]     3.1400888
EIA [lbpr]     3.1400888
viral reproduction [biof]     3.1400888
Alaska Native [popg]     3.1400888
Genetic Engineering [mbrt]     3.1400888
refer [cnce]     3.1400888
UPS [inpr]     3.1400888
cleavage [celf]     3.1400888
Prolonged prothrombin time [fndg]     3.1400888
Tumor, benign [neop]     3.1400888
Inflammatory cell infiltration [patf]     3.1400888
Hypothyroidism [dsyn]     3.1400888
Disease Presentation [clna]     3.1400888
Urinary Bladder Cancer [neop]     3.1400888
Ta [imft]     3.1400888
Large liver [sosy]     3.1400888
Ampulla [cnce]     3.1400888
Filling defect [ftcn]     3.1400888
Prison [popg]     3.1400888
KILLER [gngm]     3.1400888
control rates [ftcn]     3.1400888
Island [geoa]     3.1400888
Maintenance therapy [topp]     3.1400888
population risk [popg]     3.1400888
high glucose [fndg]     3.1400888
mug [inpo]     3.1400888
UND [gngm]     3.1400888
Hepatocyte Antigen [imft]     3.1400888
HIV-1 [virs]     3.1400888
Imaging Tool [medd]     3.1400888
GI [idcn]     3.1400888
SEVERE DYSFUNCTION [fndg]     3.1400888
Percutaneous needle biopsy [topp]     3.1400888
Thrice weekly [tmco]     3.1400888
impression [inbe]     3.1400888
Cardiac Death [patf]     3.1400888
Magnetic Resonance Spectroscopy [diap]     3.1400888
Chemical Carcinogenesis [neop]     3.1400888
Commence [acty]     3.1400888
Hypoglycaemia [dsyn]     3.1400888
NCI [hcro]     3.1400888
Great Britain [geoa]     3.1400888
Peanut [plnt]     3.1400888
Second stage [inpr]     3.1400888
Heart failure [dsyn]     3.1400888
Liver biopsy sample [tisu]     3.1400888
Neurologic [qlco]     3.1400888
Tyrosine Kinase Inhibitor [phsu]     3.1400888
HLE [gngm]     3.1400888
Cell surface [celc]     3.1400888
Mitotic Activity [fndg]     3.1400888
TUNEL [mbrt]     3.1400888
2 Days [tmco]     3.1400888
Immune status [phsf]     3.1400888
Liver stem cell [cell]     3.1400888
Epigenomic [bmod]     3.1400888
Artefact [hcpp]     3.1400888
Abstract [inpr]     3.1400888
Nosocomial transmission [ftcn]     3.1400888
epithelial to mesenchymal transition [celf]     3.1400888
ARID1A [gngm]     3.1400888
Ballooning degeneration [patf]     3.1400888
Statistical Tests [inpr]     3.1400888
Complaint [fndg]     3.1400888
Pathologic Process [patf]     3.1400888
DRB1 [gngm]     3.1400888
Acute phase [tmco]     3.1400888
surgical removal [topp]     3.1400888
RAF [gngm]     3.1400888
preclinical studies [resa]     3.1400888
Unreported [fndg]     3.1400888
chronology [inpr]     3.1400888
Histologic Progression [patf]     3.1400888
Porta hepatis [bsoj]     3.1400888
Demography [ocdi]     3.1400888
Swine [mamm]     3.1400888
Clinical Virology [bmod]     3.1400888
Molecular Abnormality [fndg]     3.1400888
False Discovery Rate [qnco]     3.1400888
Unfolded Protein Response [moft]     3.1400888
Inflammatory changes [ftcn]     3.1400888
National Center for Health Statistics [hcro]     3.1400888
adenovirus [virs]     3.1400888
driver [medd]     3.1400888
Story [geoa]     3.1400888
Cellular [qlco]     3.1400888
4a [inpr]     3.1400888
Very Low Birth Weight [sosy]     3.1400888
chromatin immunoprecipitation [lbpr]     3.1400888
Coarse [qlco]     3.1400888
Hepatitis C status [fndg]     3.1400888
Ploidy [qnco]     3.1400888
proliferation index [lbtr]     3.1400888
Fluctuate [sosy]     3.1400888
Gene Locus [gngm]     3.1400888
Semi-quantitative [qnco]     3.1400888
abdominal organs [bpoc]     3.1400888
Portal Venous System [bdsy]     3.1400888
Branched chain amino acid supplementation [phsu]     3.1400888
Infection-Related Cancer [neop]     3.1400888
abnormal liver function test [fndg]     3.1400888
Fine-Needle Biopsies [diap]     3.1400888
VIII [inpr]     3.1400888
Gastroenterology department [hcro]     3.1400888
Eye [bpoc]     3.1400888
Hepatic vein occlusion [dsyn]     3.1400888
Necrotic tumor [neop]     3.1400888
Immortalization [mbrt]     3.1400888
And [idcn]     3.1400888
Volunteer [prog]     3.1400888
6a [medd]     3.1400888
Mixed Infection [dsyn]     3.1400888
Data Bank [inpr]     3.1400888
benign tumours [neop]     3.1400888
MUC2 [gngm]     3.1400888
CI-20 [gngm]     3.1400888
Positive Lymph Node [fndg]     3.1400888
Fur [imft]     3.1400888
mg/d [qnco]     3.1400888
Downward [spco]     3.1400888
Spearman Correlation [inpr]     3.1400888
Histochemistry [lbpr]     3.1400888
CI-49 [gngm]     3.1400888
Prescription [hlca]     3.1400888
7 14 [qnco]     3.1400888
hepatic enzyme [lbpr]     3.1400888
Hepatic Angiomyolipoma [neop]     3.1400888
TRAIL [gngm]     3.1400888
Hepatocholangiocarcinoma [neop]     3.1400888
Neoplasm, Liver [neop]     3.1400888
Intestinal metaplasia [comd]     3.1400888
Cellular Stress [comd]     3.1400888
mass lesion [dsyn]     3.1400888
small group [grpa]     3.1400888
South Asian [popg]     3.1400888
no [idcn]     3.1400888
Human immunodeficiency virus 1 [virs]     3.1400888
FOAM [topp]     3.1400888
Iodinated contrast media [irda]     3.1400888
Mesh [medd]     3.1400888
Needed [ftcn]     3.1400888
Drug-Induced Liver Injury [patf]     3.1400888
Macrovesicular steatosis [fndg]     3.1400888
Hepatocyte necrosis [fndg]     3.1400888
leiomyosarcoma [neop]     3.1400888
ischaemic heart disease [dsyn]     3.1400888
Rev. [prog]     3.1400888
Vascular structure [bpoc]     3.1400888
Beta cell [cell]     3.1400888
Economic Burden [qnco]     3.1400888
Acute myeloid leukaemia [neop]     3.1400888
Unacceptable [qlco]     3.1400888
hepatitis delta [dsyn]     3.1400888
Sanitation [ocdi]     3.1400888
Hedgehog [mamm]     3.1400888
invasive growth [patf]     3.1400888
Cancer chemotherapy [topp]     3.1400888
RNA, Viral [nnon]     3.1400888
biliary dilatation [topp]     3.1400888
Pathology studies [lbpr]     3.1400888
low platelet [fndg]     3.1400888
sink [mnob]     3.1400888
CD4 Count [lbpr]     3.1400888
insufficiencies [ftcn]     3.1400888
Maize [plnt]     3.1400888
Total Dose [cnce]     3.1400888
Signature, Gene Expression [qnco]     3.1400888
repositories [mnob]     3.1400888
Clinical report [inpr]     3.1400888
protein expression profile [lbtr]     3.1400888
Peritoneal cavity [bsoj]     3.1400888
Autoimmune pancreatitis [dsyn]     3.1400888
Bile Duct Stone [bdsu]     3.1400888
serum AST [lbpr]     3.1400888
Pancreatic duct [bpoc]     3.1400888
Autologous [qlco]     3.1400888
Right posterior [spco]     3.1400888
ITA [geoa]     3.1400888
Serum sodium level [lbpr]     3.1400888
iron metabolism [moft]     3.1400888
Territory [geoa]     3.1400888
PPV [qnco]     3.1400888
Hepatic Metabolism [ortf]     3.1400888
consolidate [qlco]     3.1400888
Albumin concentration [lbtr]     3.1400888
Animals, Transgenic [anim]     3.1400888
Marital Status [grpa]     3.1400888
Extensive Necrosis [fndg]     3.1400888
Chronic Liver Failure [dsyn]     3.1400888
mTOR Inhibitor [moft]     3.1400888
9p [nusq]     3.1400888
Carbohydrate Metabolism [moft]     3.1400888
Catheterisation [topp]     3.1400888
Cutting, NOS [topp]     3.1400888
cell morphology [qlco]     3.1400888
Needle track [inpo]     3.1400888
Acute intermittent porphyria [dsyn]     3.1400888
rectal [spco]     3.1400888
B virus infection [dsyn]     3.1400888
Angiomyolipoma [neop]     3.1400888
Transfer [ftcn]     3.1400888
SOCS-1 [gngm]     3.1400888
Ultrasound scan [diap]     3.1400888
Inner [spco]     3.1400888
Glucose Intolerance [dsyn]     3.1400888
Increased alpha-fetoprotein [fndg]     3.1400888
Syrian hamster [mamm]     3.1400888
CC-3 [gngm]     3.1400888
Birth Year [tmco]     3.1400888
Reperfusion [topp]     3.1400888
Tumor Initiation [neop]     3.1400888
Conservative therapy [topp]     3.1400888
Developmental Process [ortf]     3.1400888
Fluoroscopic guidance [diap]     3.1400888
Lip [bpoc]     3.1400888
Liver size [clna]     3.1400888
Vascular disease [dsyn]     3.1400888
Allele Frequency [qnco]     3.1400888
Proxy [grup]     3.1400888
liver metabolism [ortf]     3.1400888
Subject [qlco]     3.1400888
Finnish [popg]     3.1400888
Glucose tolerance [phsf]     3.1400888
Helical CT [diap]     3.1400888
AD [inpr]     3.1400888
Ethnic Origin [popg]     3.1400888
Angiography, Digital Subtraction [diap]     3.1400888
babies [aggp]     3.1400888
Left liver [bpoc]     3.1400888
In Silico [mcha]     3.1400888
Ch. [prog]     3.1400888
Inspection [ftcn]     3.1400888
Gastrectomy [topp]     3.1400888
Row [idcn]     3.1400888
Dental procedure [hlca]     3.1400888
Tubular [spco]     3.1400888
parasite infestation [dsyn]     3.1400888
Edit [ocac]     3.1400888
Domestic [cnce]     3.1400888
Abscess, Intra-Abdominal [dsyn]     3.1400888
Pulmonary metastasis [neop]     3.1400888
Name [inpr]     3.1400888
Tracer [irda]     3.1400888
HIPAA [rnlw]     3.1400888
Suspension [bodm]     3.1400888
papilla [bpoc]     3.1400888
Mitosis [celf]     3.1400888
Childhood Tumor [neop]     3.1400888
embryonal tumor [neop]     3.1400888
ROC Analysis [qnco]     3.1400888
Grade 0 [fndg]     3.1400888
Proteinuria [fndg]     3.1400888
Insurance [idcn]     3.1400888
Terminal stage [tmco]     3.1400888
Epigenetic Silencing [genf]     3.1400888
Middle East [geoa]     3.1400888
Tumour volume [qnco]     3.1400888
Trial, Multicenter [resa]     3.1400888
Attitude [menp]     3.1400888
Epigenetic [genf]     3.1400888
placebo-controlled [resa]     3.1400888
one side [spco]     3.1400888
Comment [inpr]     3.1400888
Tumor destruction [topp]     3.21927
Gallbladder wall [bpoc]     3.21927
Bile ductal wall [bpoc]     3.21927
one time [inpr]     3.21927
Edema [patf]     3.21927
dwi [diap]     3.21927
Bright [fndg]     3.21927
DNA Integration [genf]     3.21927
Department of Veterans Affairs [hcro]     3.21927
Mimicry [mobd]     3.21927
toxic [hops]     3.21927
Pearson Correlation [inpr]     3.21927
Diameter 2 [qnco]     3.21927
Surgical Time [tmco]     3.21927
Radial [cnce]     3.21927
house [cnce]     3.21927
weaned [orgf]     3.21927
Radiation injury [inpo]     3.21927
L1 [fndg]     3.21927
Haematocrit [lbpr]     3.21927
Young Child [aggp]     3.21927
BEAM [topp]     3.21927
Red Cross [shro]     3.21927
incomplete data [idcn]     3.21927
intensive care [hlca]     3.21927
Fraction [qlco]     3.21927
DOT [topp]     3.21927
Interview [prog]     3.21927
Ductal plate malformation [fndg]     3.21927
blood type [clas]     3.21927
nucleotide analog [nnon]     3.21927
cardiovascular complications [patf]     3.21927
Infection status [fndg]     3.21927
Impedance [phsf]     3.21927
AXIN1 [gngm]     3.21927
Retrograde [spco]     3.21927
Scanty [qnco]     3.21927
Knob [mnob]     3.21927
effusion [patf]     3.21927
75 g [qnco]     3.21927
Flush [sosy]     3.21927
Right hemihepatectomy [topp]     3.21927
dispersed [spco]     3.21927
degenerative [patf]     3.21927
Urea Nitrogen, Blood [lbpr]     3.21927
Investment [mnob]     3.21927
Hyperplasias, Focal Nodular [dsyn]     3.21927
Developmental Stage [tmco]     3.21927
Schistosoma [euka]     3.21927
Central region [geoa]     3.21927
Fracture [inpo]     3.21927
Screening Method [inpr]     3.21927
Paired t-Test [inpr]     3.21927
CTC [lbpr]     3.21927
Cost Analysis [ocac]     3.21927
Mann-Whitney Test [inpr]     3.21927
lipophilic [qnco]     3.21927
Pack [medd]     3.21927
mg ml [qnco]     3.21927
enzyme activity [moft]     3.21927
temperature [qnco]     3.21927
Extracapsular [spco]     3.21927
Academy [orgt]     3.21927
Placenta [emst]     3.21927
Fibrous bands [acab]     3.21927
Phase III Trial [resa]     3.21927
Southern Europe [geoa]     3.21927
Major medical [idcn]     3.21927
Upper abdominal pain [sosy]     3.21927
Abdominal Wall [bpoc]     3.21927
N1 [fndg]     3.21927
ALC [gngm]     3.21927
Extended right hepatectomy [topp]     3.21927
Synonym [cnce]     3.21927
Fixed Block [sbst]     3.21927
Tumor viability [clna]     3.21927
steady state [npop]     3.21927
Sponge [euka]     3.21927
Open approach [topp]     3.21927
Mammalian Target of Rapamycin Inhibitors [moft]     3.21927
Homosexual [popg]     3.21927
White Cell [cell]     3.21927
Metaplastic [ftcn]     3.21927
Recurrence-free survival time [clna]     3.21927
centimeter [qnco]     3.21927
Pancreatic head [bpoc]     3.21927
Aggressive malignancies [fndg]     3.21927
Blood glucose level [lbtr]     3.21927
Radiocontrast Agent [irda]     3.21927
Mitotic [qlco]     3.21927
Abdominal Cavity [blor]     3.21927
Behaviours [inbe]     3.21927
Supernatant [bdsu]     3.21927
UGT1A7 [gngm]     3.21927
Aggressive course [tmco]     3.21927
Faculty [prog]     3.21927
BC [qnco]     3.21927
Genome Stability [genf]     3.21927
Hepatitis Virus-Related Hepatocellular Carcinoma [neop]     3.21927
Chemical ablation [topp]     3.21927
Pump [medd]     3.21927
Flat [spco]     3.21927
antidiabetic [phsu]     3.21927
Annual Percent Change [qnco]     3.21927
pei [inpr]     3.21927
/10 min [tmco]     3.21927
Herbal Medicine [plnt]     3.21927
cope [inbe]     3.21927
lipid homeostasis [phsf]     3.21927
alert [fndg]     3.21927
trap [medd]     3.21927
hepatic portal [bsoj]     3.21927
Scottish [popg]     3.21927
Venous flow [lbtr]     3.21927
Ps [gngm]     3.21927
Membrane receptor [rcpt]     3.21927
verification [resa]     3.21927
Bacterial culture [lbpr]     3.21927
Sexually Transmitted Infection [dsyn]     3.21927
Voting [inbe]     3.21927
in vivo study [resa]     3.21927
Per Annum [tmco]     3.21927
Catalytic Subunit [amas]     3.21927
Plaque [dsyn]     3.21927
Peripheral Blood Lymphocyte [cell]     3.21927
Mesohepatectomy [topp]     3.21927
Three times weekly [tmco]     3.21927
Carcinoid [neop]     3.21927
Cardiac cirrhosis [dsyn]     3.21927
Spatial Distribution [spco]     3.21927
Noncompliance [fndg]     3.21927
Cap [mnob]     3.21927
move [orgf]     3.21927
Bolus [topp]     3.21927
Obstructed [ftcn]     3.21927
Nonalcoholic Fatty Liver Disease [dsyn]     3.21927
Macroscopic Findings [idcn]     3.21927
Pain Control [topp]     3.21927
Knock-Out Mouse [mamm]     3.21927
Sclerosis [patf]     3.21927
ground squirrel [mamm]     3.21927
Foot [bpoc]     3.21927
hepatitis b serology [lbpr]     3.21927
Lymphoid [qlco]     3.21927
Detector [medd]     3.21927
Gene Alteration [genf]     3.21927
Alveolar [bpoc]     3.21927
mistake [qlco]     3.21927
Harbour [mnob]     3.21927
Accidental [ftcn]     3.21927
Fe+++ [elii]     3.21927
Bidirectional [qlco]     3.21927
Web Site [inpr]     3.21927
Gastroscopy [diap]     3.21927
Care management [clna]     3.21927
With type [qlco]     3.21927
Dark [qlco]     3.21927
Sinusoidal Obstruction Syndrome [dsyn]     3.21927
Stromal tumor [neop]     3.21927
TEMPLATE [medd]     3.21927
Disease susceptibility [clna]     3.21927
Green [qlco]     3.21927
San [gngm]     3.21927
Tumor Cell Lines [cell]     3.21927
Endothelium, Vascular [tisu]     3.21927
donor liver [fndg]     3.21927
Columnar [spco]     3.21927
Hepatobiliary Tumors [neop]     3.21927
contrast scan [diap]     3.21927
Wilcoxon Test [inpr]     3.21927
Post-Transcriptional Regulation [genf]     3.21927
financial [qnco]     3.21927
Haemobilia [dsyn]     3.21927
unreliable [idcn]     3.21927
Thermal energy [npop]     3.21927
Mitochondrial Damage [patf]     3.21927
Cholangiogram [diap]     3.21927
atypical cells [comd]     3.21927
TT Virus [virs]     3.21927
Analysis, Cohort [resa]     3.21927
GOV [gngm]     3.21927
golgi protein [gngm]     3.21927
General Surgery [bmod]     3.21927
Cambodia [geoa]     3.21927
Chronic disorder [dsyn]     3.21927
Stage II Hepatocellular Carcinoma [neop]     3.21927
Confidence [inbe]     3.21927
serum alkaline phosphatase [lbpr]     3.21927
study results [fndg]     3.21927
Delayed Diagnosis [qlco]     3.21927
disease management [ftcn]     3.21927
fuse [ftcn]     3.21927
fresh frozen plasma transfusion [topp]     3.21927
Prior Surgery [fndg]     3.21927
short stay [inpr]     3.21927
Graft dysfunction [patf]     3.21927
Viral Vector [phsu]     3.21927
[M]Gliomas [neop]     3.21927
Registered [inpr]     3.21927
Shortest [qnco]     3.21927
kcal [qnco]     3.21927
Contingency [qlco]     3.21927
Reclassified [qlco]     3.21927
Infantile [qlco]     3.21927
Chamber [bpoc]     3.21927
Combination Chemotherapy [topp]     3.21927
Cell Signaling [celf]     3.21927
12 hours [tmco]     3.21927
Hybrid [orgm]     3.21927
Agencies [orgt]     3.21927
Indeterminate result [fndg]     3.21927
coronary heart disease [dsyn]     3.21927
Doubling Time [tmco]     3.21927
JP [geoa]     3.21927
Solvents [irda]     3.21927
protein K [aapp]     3.21927
Papillary adenocarcinoma [neop]     3.21927
Western Blots [lbpr]     3.21927
DEN [qnco]     3.21927
Bovine [mamm]     3.21927
glucose level [lbtr]     3.21927
Representation [cnce]     3.21927
Conservative management [topp]     3.21927
Cellular Growth [celf]     3.21927
Cancer Pathway [ftcn]     3.21927
Stage I Hepatocellular Carcinoma [neop]     3.21927
pediatric cancer [neop]     3.21927
Internist [prog]     3.21927
Conceptual [cnce]     3.21927
Crete [geoa]     3.21927
Cell Biology [bmod]     3.21927
Plane [euka]     3.21927
Magnetic Resonance Imaging Scan [diap]     3.21927
Upper gastrointestinal haemorrhage [patf]     3.21927
Lateral segment [spco]     3.21927
Eastern Cooperative Oncology Group [hcro]     3.21927
Homeostatic Model Assessment of Insulin Resistance [lbpr]     3.21927
Married [fndg]     3.21927
Tesla [qnco]     3.21927
Steroid therapy [topp]     3.21927
age death [fndg]     3.21927
Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry [resa]     3.21927
Molecular Genetic [bmod]     3.21927
replication cycle [tmco]     3.21927
C57BL/6 [mamm]     3.21927
Emission [bdsu]     3.21927
mmol/kg [qnco]     3.21927
Great extent [qlco]     3.21927
Wet [qlco]     3.21927
Endoscopy finding [fndg]     3.21927
Staphylococcus aureus [bact]     3.21927
Logic [idcn]     3.21927
Methicillin-Resistant [orga]     3.21927
Compact [fndg]     3.21927
Enterococcus [bact]     3.21927
photograph [mnob]     3.21927
Annotated [idcn]     3.21927
Incarcerated [fndg]     3.21927
Immunocytochemistry [lbpr]     3.21927
Analyzed [medd]     3.21927
Southeastern [spco]     3.21927
high insulin [dsyn]     3.21927
Urine sample [bdsu]     3.21927
INR [lbpr]     3.21927
Stump [acab]     3.21927
Network, Gene [moft]     3.21927
arch [blor]     3.21927
Exogenous Factors [ftcn]     3.21927
Procurement [gora]     3.21927
Poorly Differentiated Lesion [fndg]     3.21927
Hepatitis B immunisation [topp]     3.21927
Primary Hepatic Lymphoma [neop]     3.21927
Tumors, Germ Cell [neop]     3.21927
Haemothorax [patf]     3.21927
Hepadnavirus [virs]     3.21927
Incisional [topp]     3.21927
Response [inbe]     3.21927
Epstein-Barr virus infection [dsyn]     3.21927
Hand skin [bpoc]     3.21927
Community acquired [qlco]     3.21927
Genetically Engineered Mouse [emod]     3.21927
Bleeding esophageal varices [dsyn]     3.21927
human papilloma viruses [virs]     3.21927
RNA, Noncoding [nnon]     3.21927
Codon, Start [nusq]     3.21927
disease prevention [topp]     3.21927
outcome prediction [hlca]     3.21927
72 Hours [tmco]     3.21927
ICD-10 [inpr]     3.21927
stone removal [topp]     3.21927
Cell Nuclei [celc]     3.21927
KO [gngm]     3.21927
Rectal Cancer [neop]     3.21927
High intensity focused ultrasound [topp]     3.21927
chromosomal analysis [lbpr]     3.21927
iron overload disorder [dsyn]     3.21927
Osteosarcoma [neop]     3.21927
Emergency Room [hcro]     3.21927
Biopsy needle [diap]     3.21927
Lymphatic Metastasis [neop]     3.21927
Calendar year [tmco]     3.21927
Ductal Adenocarcinoma [neop]     3.21927
metropolitan [spco]     3.21927
Multiple Organ Failure [patf]     3.21927
Thromboembolism [dsyn]     3.21927
Alcohol Drinking [food]     3.21927
TLR-4 [gngm]     3.21927
Dietary Iron [inch]     3.21927
% negative control [qnco]     3.21927
Data Quality [qlco]     3.21927
Intra-arterial injection [ftcn]     3.21927
[pH] [qnco]     3.21927
Deploy [acty]     3.21927
Sudden [qlco]     3.21927
Drinking habits [fndg]     3.21927
Proliferation Marker [qlco]     3.21927
Mucinous Neoplasm [neop]     3.21927
Never Smoker [fndg]     3.21927
Memorial Sloan-Kettering Cancer Center [hcro]     3.21927
Mammals [mamm]     3.21927
Liver structure [bpoc]     3.21927
Fatal Outcome [patf]     3.21927
Excite [acty]     3.21927
AR+ [fndg]     3.21927
Normal weight [fndg]     3.21927
Zebra Fish [fish]     3.21927
Branch [spco]     3.21927
Square [spco]     3.21927
Parkinson Disease [dsyn]     3.21927
Systems Biology [bmod]     3.21927
Rhabdoid Tumor [neop]     3.21927
Immunodeficiency Virus Type 1, Human [virs]     3.21927
Prothrombin level [lbpr]     3.21927
Afferent [spco]     3.21927
SPECT [diap]     3.21927
Granuloma [patf]     3.21927
Acute cholangitis [dsyn]     3.21927
Peak level [qnco]     3.21927
Bone disease [dsyn]     3.21927
Season [tmco]     3.21927
Group N [inpr]     3.21927
Stereotactic Body Radiotherapy [topp]     3.21927
doubt [menp]     3.21927
Cell Function [celf]     3.21927
6/45 [fndg]     3.21927
parasitological [qlco]     3.21927
Icteric [patf]     3.21927
Heterogeneity [idcn]     3.21927
disease etiology [ftcn]     3.21927
Hepatic margin [blor]     3.21927
Immune Diseases [dsyn]     3.21927
Policy Makers [prog]     3.21927
thrill [fndg]     3.21927
Destroy [idcn]     3.21927
Tumor embolus [neop]     3.21927
Retroperitoneum [bsoj]     3.21927
Cervical carcinoma [neop]     3.21927
Sex Workers [prog]     3.21927
Celiac Disease [dsyn]     3.21927
Readiness [fndg]     3.21927
liver ultrasound [diap]     3.21927
Nutritional deficiencies [dsyn]     3.21927
Proliferative Index [qnco]     3.21927
Migratory [ftcn]     3.21927
Oral contraception [topp]     3.21927
Diseases, Acute [dsyn]     3.21927
Anterior approach [spco]     3.21927
Headache [sosy]     3.21927
elevated value [spco]     3.21927
Gall Bladder Disease [dsyn]     3.21927
Increased body mass index [fndg]     3.21927
tissue homeostasis [orgf]     3.21927
Air [sbst]     3.21927
Oriental [spco]     3.21927
Nanoparticle [mnob]     3.21927
Computed tomography imaging [diap]     3.21927
Non-ruptured [qlco]     3.21927
Capillaries [bpoc]     3.21927
Adenomatosis [neop]     3.21927
Hand-Foot Syndrome [dsyn]     3.21927
Pekin duck [bird]     3.21927
Clinical investigation [hlca]     3.21927
metabolic effects [phsf]     3.21927
Percentile [qnco]     3.21927
Bile Duct Stenosis [dsyn]     3.21927
OILY [fndg]     3.21927
Pyrosequencing [lbpr]     3.21927
Statistical Power [resa]     3.21927
Lung Tumor [neop]     3.21927
Design [inpr]     3.21927
Import [ocac]     3.21927
Normal volume [qnco]     3.21927
Immune Tolerance [patf]     3.21927
HBcAg [imft]     3.21927
Pharmacologic Agent [phsu]     3.21927
Cancer, Second Primary [neop]     3.21927
alcohol metabolism [moft]     3.21927
Finland [geoa]     3.21927
adjunct therapy [topp]     3.21927
Note [inpr]     3.21927
Evaluable [dsyn]     3.21927
Lipid level [lbtr]     3.21927
heat effect [dsyn]     3.21927
Liver macrophage [cell]     3.21927
Belgium [geoa]     3.21927
Chicago [geoa]     3.21927
Thorax [blor]     3.21927
Multiple Myeloma [neop]     3.21927
Promiscuity [socb]     3.21927
Antimicrobial [phsu]     3.21927
genetic profile [lbpr]     3.21927
Suture, NOS [topp]     3.21927
DNA analysis [lbpr]     3.21927
Haemorrhagic shock [patf]     3.21927
Pan [mamm]     3.21927
Bone Marrow Transplant [topp]     3.21927
Model, Genetic [inpr]     3.21927
Malaysia [geoa]     3.21927
mutation analysis [lbpr]     3.21927
Red Cell [cell]     3.21927
2 phases [tmco]     3.21927
Imputation [qnco]     3.21927
Bilirubin concentration [lbpr]     3.21927
fenestration [topp]     3.21927
Tertiary Care [hlca]     3.21927
Metaplasia [comd]     3.21927
Co-Immunoprecipitation [lbpr]     3.21927
Forensic [inpr]     3.21927
Oncogenic Viruses [virs]     3.21927
small cell carcinoma [neop]     3.21927
Liver lobe [bpoc]     3.21927
Speed [qnco]     3.21927
Into [ftcn]     3.21927
Plasma transfusion [topp]     3.21927
Bed [mnob]     3.21927
new information [inpr]     3.21927
obliterated [ftcn]     3.21927
Health Department [hcro]     3.21927
Package [medd]     3.21927
Hypovolaemic shock [patf]     3.21927
Female breast [bpoc]     3.21927
Autoantigens [imft]     3.21927
Saturated [phpr]     3.21927
Physicians, Family [prog]     3.21927
ex smokers [fndg]     3.21927
NEO [gngm]     3.21927
High Power Field [qnco]     3.21927
Normal diet [dora]     3.21927
Lebanon [geoa]     3.21927
Big [qnco]     3.21927
In Vivo Imaging [lbpr]     3.21927
Hemi [inpr]     3.21927
Model, Linear [qnco]     3.21927
Dendritic [celc]     3.21927
Chromosomal DNA [nnon]     3.21927
Iatrogenic Disease [dsyn]     3.21927
Dendritic cell [cell]     3.21927
Embolism [patf]     3.21927
Follicular [qlco]     3.21927
Histocompatibilities [qlco]     3.21927
Ethanol intake [inbe]     3.21927
Nadir [qlco]     3.21927
mg/L [qnco]     3.21927
cholesterol level [lbpr]     3.21927
health professionals [prog]     3.21927
spindle cell [cell]     3.21927
Smallest [qnco]     3.21927
NE [qnco]     3.21927
Relaxation [acty]     3.21927
Oral Cancer [neop]     3.21927
Ultrasound Imaging [diap]     3.21927
descended [qlco]     3.21927
Robot [ocdi]     3.21927
Vascular abnormalities [fndg]     3.21927
POST-OPERATIVE HEMORRHAGE [patf]     3.21927
Tumor Promoter [neop]     3.21927
imprint [menp]     3.21927
Distal pancreatectomy [topp]     3.21927
Permeability [npop]     3.21927
Renal Cancer [neop]     3.21927
Gene-Environment Interaction [genf]     3.21927
Radiographic imaging [diap]     3.21927
TOLERABILITY [ftcn]     3.21927
Subacute [tmco]     3.21927
Hepatitis C virus genotype 4 [virs]     3.21927
Dichotomous [qlco]     3.21927
Acoustic [npop]     3.21927
Drug Development [bmod]     3.21927
Occupied [idcn]     3.21927
Whole Exome Sequencing [mbrt]     3.21927
Red Blood Cell Transfusion [topp]     3.21927
IL28B [gngm]     3.21927
Format [inpr]     3.21927
Inflammatory liver disease [dsyn]     3.21927
Both [spco]     3.21927
Single mass [anab]     3.21927
dental treatment [hlca]     3.21927
Enterobacter [bact]     3.21927
Surgical excision [topp]     3.21927
Household Contact [qlco]     3.21927
Ontario [geoa]     3.21927
Neuropathy [dsyn]     3.21927
solid tumour [neop]     3.21927
Susceptibility Gene [gngm]     3.21927
Ectopic Tissue [patf]     3.21927
Milk [bdsu]     3.21927
twist [phsf]     3.21927
Differential Gene Expression [genf]     3.21927
Psychosocial [ftcn]     3.21927
Extrahepatic biliary tree [bpoc]     3.21927
treatment guidelines [topp]     3.21927
Comorbidity Index [qnco]     3.21927
Humor [inpr]     3.21927
Negative Finding [fndg]     3.21927
Bile Duct Obstruction [dsyn]     3.21927
Painless [ftcn]     3.21927
Father [famg]     3.21927
Ethanol Metabolism [orgf]     3.21927
Times, Operative [tmco]     3.21927
18 gauge [qnco]     3.21927
cancer surgery [topp]     3.21927
Percutaneous transhepatic cholangioscopy [diap]     3.21927
antiapoptotic [chvf]     3.21927
AKR1B10 [gngm]     3.21927
Maternal Age [tmco]     3.21927
Distress [menp]     3.21927
aspartate aminotransferase activity [moft]     3.21927
Hepatoid adenocarcinoma [neop]     3.21927
successful treatment [qlco]     3.21927
Noncarrier [cnce]     3.21927
metastatic tumours [neop]     3.21927
Gestation [orgf]     3.21927
Proteolytic [moft]     3.21927
Restoration [inpr]     3.21927
INTRAMUSCULAR [ftcn]     3.21927
PET-CT Scan [diap]     3.21927
Republic of Korea [geoa]     3.21927
Endothelium [tisu]     3.21927
Fetal Liver [emst]     3.21927
Mexican American [popg]     3.21927
Cytology diagnosis [ftcn]     3.21927
Abnormal result [fndg]     3.21927
Perioperative Care [hlca]     3.21927
Continuous infusion [topp]     3.21927
Poor glycaemic control [patf]     3.21927
Geriatric [qlco]     3.21927
premenopausal [tmco]     3.21927
fatty acid oxidation [moft]     3.21927
MUC5AC [gngm]     3.21927
Fetus [emst]     3.21927
Renal transplant [topp]     3.21927
learn [edac]     3.21927
Lymphatic [bpoc]     3.21927
ALDH2 [gngm]     3.21927
Omentum [bpoc]     3.21927
Protein Binding [moft]     3.21927
microbial [orgm]     3.21927
Intestinal Flora [clas]     3.21927
Box [mnob]     3.21927
Seminal [clna]     3.21927
High priority [tmco]     3.21927
Cytotoxic T cell [cell]     3.21927
SEN [geoa]     3.21927
Confounding Variables [ftcn]     3.21927
Topology [bmod]     3.21927
Septic Shock [patf]     3.21927
WT [fish]     3.21927
c-Jun [gngm]     3.21927
Gene Expression Signatures [qnco]     3.21927
Page [inpr]     3.21927
Nodular Tumor [neop]     3.21927
Prognostic Nutritional Index [qnco]     3.21927
intracellular signaling pathway [celf]     3.21927
Hydatid disease [dsyn]     3.21927
parenteral therapy [topp]     3.21927
SAO [gngm]     3.21927
Non-neoplastic condition, NOS [dsyn]     3.21927
Virus-Related Carcinoma [neop]     3.21927
goat [mamm]     3.21927
Space-occupying lesion [ftcn]     3.21927
Linear Models [qnco]     3.21927
Syphilis [dsyn]     3.21927
trace amount [qnco]     3.21927
adenocarcinoma lung [neop]     3.21927
Reject [idcn]     3.21927
Autosomal recessive [inpr]     3.21927
Gel [bodm]     3.21927
Decreased platelet count [fndg]     3.21927
Patient Base [qnco]     3.21927
Unresectable Hepatoblastoma [neop]     3.21927
Unavailability [ftcn]     3.21927
lysosomal protein transmembrane 4 beta [gngm]     3.21927
Herbal [qlco]     3.21927
Cholecystectomy, Laparoscopic [topp]     3.21927
Squamous [qlco]     3.21927
Cellular Function [celf]     3.21927
tumor removal [topp]     3.21927
Radionuclide [elii]     3.21927
cl-2 [gngm]     3.21927
Fine needle [medd]     3.21927
Immunoassays, Enzyme [lbpr]     3.21927
Adenoviral infections [dsyn]     3.21927
Warm Ischemia Time [tmco]     3.21927
Chimpanzee [mamm]     3.21927
Mean Arterial Pressure [fndg]     3.21927
Graft-Versus-Host Disease [dsyn]     3.21927
Non-Target [qlco]     3.21927
Custom [idcn]     3.21927
Moderately Well Differentiated [qlco]     3.21927
Stasis [patf]     3.21927
Northern Europe [geoa]     3.21927
MI [idcn]     3.21927
Intolerance [orgf]     3.21927
antibody hcv [imft]     3.21927
regulatory T cell [cell]     3.21927
Agonist [phsu]     3.21927
left hepatic lobe [bpoc]     3.21927
Kinase Inhibitor [phsu]     3.21927
Adult Hepatocellular Carcinoma [neop]     3.21927
Ultrasound finding [lbtr]     3.21927
Kyushu [geoa]     3.21927
laboratory measurements [resa]     3.21927
Middle hepatic vein [bpoc]     3.21927
Caesarean Section [topp]     3.21927
Hepatic lobe [bpoc]     3.21927
Inclusion [ftcn]     3.21927
Staff [prog]     3.21927
reflux [dsyn]     3.21927
Acquired Immuno-Deficiency Syndrome [dsyn]     3.21927
NS3 [dsyn]     3.21927
Vital status [clna]     3.21927
Brachytherapy [topp]     3.21927
Schistosoma haematobium [euka]     3.21927
Molecular Technique [mbrt]     3.21927
organ failure [sosy]     3.21927
Roux-en-Y hepaticojejunostomy [topp]     3.21927
Novel Mutation [comd]     3.21927
PATH [lbpr]     3.21927
Stool sample [bdsu]     3.21927
Ia [mamm]     3.21927
single strand conformation polymorphism [lbtr]     3.21927
Core Biopsy [diap]     3.21927
Soft tissue sarcomas [neop]     3.21927
Psychiatric [ftcn]     3.21927
Hepatitis B virus e Antigen [imft]     3.21927
Hierarchical Cluster Analysis [resa]     3.21927
Resin [bodm]     3.21927
Weighing [diap]     3.21927
chemical interaction [npop]     3.21927
routine immunization [topp]     3.21927
Increased weight [fndg]     3.21927
Cholestasis, chronic [dsyn]     3.21927
Fasting blood glucose level [lbpr]     3.21927
Skin Cancer, Non-Melanoma [neop]     3.21927
Employer [qlco]     3.21927
Perfuse [ftcn]     3.21927
Notify [hlca]     3.21927
Gene Transfer [mbrt]     3.21927
Plastic [sbst]     3.21927
Human body [humn]     3.21927
Alcohol-Related Hepatocellular Carcinoma [neop]     3.21927
Profession [ocdi]     3.21927
Viral integration [biof]     3.21927
excess iron [dsyn]     3.21927
Hepatobiliary surgeon [prog]     3.21927
Cuboidal [spco]     3.21927
3-D [spco]     3.21927
Obesity, Abdominal [dsyn]     3.21927
microRNA 122 [gngm]     3.21927
cancer care [topp]     3.21927
Radiotherapy, Adjuvant [topp]     3.21927
liver cell damage [patf]     3.21927
Crown [medd]     3.21927
Stop Codon [nusq]     3.21927
Cerebellum [bpoc]     3.21927
Pre-condition [cnce]     3.21927
scalpel [medd]     3.21927
Body Composition [orga]     3.21927
Sexual Behavior [bhvr]     3.21927
Regressions, Logistic [resa]     3.21927
Resectable Cholangiocarcinoma [neop]     3.21927
Notch [bsoj]     3.21927
nuclear antigen [imft]     3.21927
modulate [cnce]     3.21927
CONGENITAL ANOMALIES [cgab]     3.21927
Stapler [mnob]     3.21927
marine [prog]     3.21927
Image Processing [mcha]     3.21927
report study [inpr]     3.21927
Sahara [geoa]     3.31618
Intervention Group [popg]     3.31618
CD147 [gngm]     3.31618
Mutation Spectra [ftcn]     3.31618
Track [spco]     3.31618
Fatty Liver, Alcoholic [dsyn]     3.31618
Hierarchical Clustering [resa]     3.31618
differences size [fndg]     3.31618
Assessed Patient [inpr]     3.31618
TH [geoa]     3.31618
Lethargy [sosy]     3.31618
health state [fndg]     3.31618
Transversion Mutation [comd]     3.31618
Chile [geoa]     3.31618
virus associated [virs]     3.31618
Total Body Irradiation [topp]     3.31618
lysosomal [celc]     3.31618
Retreatment [topp]     3.31618
Elastograms [diap]     3.31618
DN [neop]     3.31618
catabolic [ftcn]     3.31618
Salvage Therapy [topp]     3.31618
right liver lobe [bpoc]     3.31618
insulin use [fndg]     3.31618
Hepatic Artery Embolization [topp]     3.31618
Computation [acty]     3.31618
Liver Angiosarcoma [neop]     3.31618
Rapid disease progression [fndg]     3.31618
Erythroid [qlco]     3.31618
Advice [hlca]     3.31618
friend [popg]     3.31618
apoptotic cell death [celf]     3.31618
premalignant condition [neop]     3.31618
Hepatic Abscesses [dsyn]     3.31618
Marker, Biological [clna]     3.31618
Endoscopic Ultrasound-Guided Fine Needle Aspiration [diap]     3.31618
Embolisation procedure [topp]     3.31618
GB Virus C/ Hepatitis G Virus [virs]     3.31618
Neurologic Symptoms [sosy]     3.31618
Elevated alkaline phosphatase [fndg]     3.31618
Greek [popg]     3.31618
Black race [popg]     3.31618
hepatic stellate cell activation [celf]     3.31618
Vacuolated [fndg]     3.31618
serum triglyceride [lbpr]     3.31618
Standard Error [qnco]     3.31618
Dedications [acty]     3.31618
Cavernoma [neop]     3.31618
Schistosoma mansoni [euka]     3.31618
Regardless [qlco]     3.31618
Transcatheter Procedures [topp]     3.31618
good effect [fndg]     3.31618
Transversal [spco]     3.31618
Fungi [fngs]     3.31618
Unstable [fndg]     3.31618
Cystic dilatation [patf]     3.31618
T-tube [medd]     3.31618
LN [neop]     3.31618
Environ [orch]     3.31618
Basic Science [resa]     3.31618
elevated triglycerides [fndg]     3.31618
Litter [mnob]     3.31618
LN [dsyn]     3.31618
Micronodular cirrhosis [dsyn]     3.31618
Cardiomyopathy [dsyn]     3.31618
Neovascularisation [patf]     3.31618
Hepatitis G virus [virs]     3.31618
First episode [tmco]     3.31618
Nearest Neighbor [resa]     3.31618
LR [geoa]     3.31618
White meat [food]     3.31618
Hereditary Disease [dsyn]     3.31618
New Zealand Rabbits [mamm]     3.31618
AKT Signaling Pathway [moft]     3.31618
profit [orgt]     3.31618
stool examination [medd]     3.31618
radiology test [diap]     3.31618
Alpha Fetoprotein measurement [lbpr]     3.31618
Mutations, Germ-Line [genf]     3.31618
Antigen Presentation [celf]     3.31618
z scores [qnco]     3.31618
Northern European [popg]     3.31618
Hepatic schistosomiasis [dsyn]     3.31618
CC [qnco]     3.31618
Laparoscopic biopsy [diap]     3.31618
Ileus [dsyn]     3.31618
New South Wales [geoa]     3.31618
Intra-arterial infusion [topp]     3.31618
Exposed Population [popg]     3.31618
Heart transplant [topp]     3.31618
diol [orch]     3.31618
patient profile [hlca]     3.31618
Arteriole [bpoc]     3.31618
Cancer Death Rate [qnco]     3.31618
Cholangioma [neop]     3.31618
SH [geoa]     3.31618
Non-functional [ftcn]     3.31618
Acute alcoholic hepatitis [dsyn]     3.31618
Microarray Technology [lbpr]     3.31618
Random Sampling [resa]     3.31618
Upstream [spco]     3.31618
South east Asian country [geoa]     3.31618
Length of Stay [tmco]     3.31618
haematopoietic [bdsy]     3.31618
Food and Drug Administration [hcro]     3.31618
Biliary stone [bdsu]     3.31618
Higher education [inpr]     3.31618
2-D [spco]     3.31618
poly [nnon]     3.31618
abdominal scan [diap]     3.31618
Spinal Cord Compression [dsyn]     3.31618
Regression Method [inpr]     3.31618
Peripheral Intrahepatic Cholangiocarcinoma [neop]     3.31618
Constrain [cnce]     3.31618
Immature [tmco]     3.31618
Inflation [qnco]     3.31618
Ascending [qlco]     3.31618
Renal Failure, Chronic [dsyn]     3.31618
case finding [ocac]     3.31618
enlarged lymph node [fndg]     3.31618
Pathologic stage [inpr]     3.31618
Post-Translational Regulation [moft]     3.31618
Certified [gora]     3.31618
Traditional Chinese Medicine [bmod]     3.31618
Polypoid Lesion [fndg]     3.31618
Thrombectomy [topp]     3.31618
corticosteroid therapy [topp]     3.31618
Chronic congestion [patf]     3.31618
Neural network [inpr]     3.31618
Beef sausage [food]     3.31618
Common bile duct stone [bdsu]     3.31618
CVD, NOS [dsyn]     3.31618
IBD [dsyn]     3.31618
Insidious [qlco]     3.31618
M.D. [inpr]     3.31618
Mammalian Cell [cell]     3.31618
CD4 Cell Count [lbpr]     3.31618
Second Cancer [neop]     3.31618
Histopathologic Study [bmod]     3.31618
Data Management [resa]     3.31618
Pus [bdsu]     3.31618
Intragastric [spco]     3.31618
EUS-FNA [diap]     3.31618
Breslow [clna]     3.31618
Non-Resectable Hepatocellular Carcinoma [neop]     3.31618
cocarcinogen [patf]     3.31618
anthropometric measurements [qnco]     3.31618
Conjugate [imft]     3.31618
Carcinoid Tumor [neop]     3.31618
Spine [bpoc]     3.31618
Kidney disease [dsyn]     3.31618
Biliary Intraepithelial Neoplasia-1 [neop]     3.31618
Reference Range [qnco]     3.31618
Adaptive Immune Response [celf]     3.31618
Tomography, Emission-Computed, Single-Photon [diap]     3.31618
Vague [qlco]     3.31618
Urothelial carcinoma [neop]     3.31618
Drug usage [mobd]     3.31618
Poorly defined [qlco]     3.31618
liver adenoma [neop]     3.31618
Outlet [mnob]     3.31618
normal glucose [fndg]     3.31618
Core needle biopsy [diap]     3.31618
Renal disease [dsyn]     3.31618
primary therapy [topp]     3.31618
Non-Small Cell Lung Cancer [neop]     3.31618
Epithelial tumour, malignant [neop]     3.31618
Colectomy [topp]     3.31618
limited use [inpr]     3.31618
Environmental agent [phob]     3.31618
CL-6 [gngm]     3.31618
Epigenesis, Genetic [genf]     3.31618
Universal Precautions [topp]     3.31618
Website [inpr]     3.31618
Myeloproliferative disease [neop]     3.31618
Region of interest [clna]     3.31618
Flank [blor]     3.31618
endosonography [diap]     3.31618
6 Hours [tmco]     3.31618
Decedent [famg]     3.31618
Embolus [fndg]     3.31618
Subcategory [clas]     3.31618
Pandemic [phpr]     3.31618
Malformation [ftcn]     3.31618
Fertile [orgf]     3.31618
Whole body [anst]     3.31618
9p21 [celc]     3.31618
Polycystic [qlco]     3.31618
Tunisia [geoa]     3.31618
antibody test [lbpr]     3.31618
Pd [elii]     3.31618
Superoxide [elii]     3.31618
Creatinine clearance [fndg]     3.31618
Study Site [hcro]     3.31618
Colorectal Tumor [neop]     3.31618
FC [acty]     3.31618
Positive Control [cnce]     3.31618
high creatinine [fndg]     3.31618
Silent Mutation [genf]     3.31618
Immunoperoxidase [lbpr]     3.31618
liver sinusoids [bpoc]     3.31618
string [medd]     3.31618
Film [mnob]     3.31618
dimer [chvs]     3.31618
nephrotoxicity [inpo]     3.31618
Benchmark [qnco]     3.31618
Baseline Survey [resa]     3.31618
Acinar Cell Carcinoma [neop]     3.31618
Biliary papillomatosis [neop]     3.31618
Mainland China [geoa]     3.31618
Immune Responses, Cellular [celf]     3.31618
Decreased serum albumin [fndg]     3.31618
Milestone [cnce]     3.31618
Metastasectomy [topp]     3.31618
Embolism, Gas [inpo]     3.31618
Iodine- [inch]     3.31618
Elapse [tmco]     3.31618
CYTO [lbpr]     3.31618
Massive Hepatic Necrosis [patf]     3.31618
Incubated [lbpr]     3.31618
Computerised tomograph scan [diap]     3.31618
Counter [mnob]     3.31618
Fluid Therapy [topp]     3.31618
Lipolysis [orgf]     3.31618
Transposon [gngm]     3.31618
Suspected malignancy [fndg]     3.31618
Conventional Treatment [topp]     3.31618
Smoking Cessation [inbe]     3.31618
shrink [spco]     3.31618
Suicide Gene Therapy [topp]     3.31618
Fingerprint [mnob]     3.31618
Mucus [bdsu]     3.31618
Conversion to Open Surgery [topp]     3.31618
Early Cancer Detection [diap]     3.31618
unknown origin [ftcn]     3.31618
Copy Number Variation [nusq]     3.31618
turkish [popg]     3.31618
laboratory results [lbtr]     3.31618
Fecal [bdsu]     3.31618
Work Place [spco]     3.31618
transmembrane [celc]     3.31618
3rd [qnco]     3.31618
Hepatic Vein Thrombosis [dsyn]     3.31618
Transfusion History [fndg]     3.31618
Impulse [topp]     3.31618
antidiabetic drug [phsu]     3.31618
Cancer Cause [bmod]     3.31618
Chromosome 10 [celc]     3.31618
Gastritis [dsyn]     3.31618
Fork Head Box [amas]     3.31618
Sphere [orga]     3.31618
Dietary Fat [food]     3.31618
venous pressure measurement [diap]     3.31618
diagnostic use [diap]     3.31618
Genomic Profile [lbpr]     3.31618
Right adrenal gland [bpoc]     3.31618
Nucleolar Organizer Region [nusq]     3.31618
Hydrothorax [dsyn]     3.31618
P38 [gngm]     3.31618
Fungus [fngs]     3.31618
Nuclear Pleomorphism [fndg]     3.31618
Transmission Electron Microscopy [lbpr]     3.31618
Laboratory examination [fndg]     3.31618
Abdominal distension [fndg]     3.31618
Recombinant protein [aapp]     3.31618
RNAi [genf]     3.31618
Media [inpr]     3.31618
mEq/mL [qnco]     3.31618
medical record review [hlca]     3.31618
MS/MS [mbrt]     3.31618
secondary cancer [neop]     3.31618
Echography [diap]     3.31618
Mathematic [ocdi]     3.31618
Intracerebral [spco]     3.31618
SMAD4 [gngm]     3.31618
Environmental Pollutants [hops]     3.31618
reminiscence [menp]     3.31618
Lithotomy [topp]     3.31618
adapt [orgf]     3.31618
Experimental Result [fndg]     3.31618
Amplitude [spco]     3.31618
Massachusetts [geoa]     3.31618
Hypotension [fndg]     3.31618
Residual Disease [neop]     3.31618
Final report [inpr]     3.31618
BIRTHPLACE [fndg]     3.31618
Bean [food]     3.31618
Back Pain [sosy]     3.31618
cell fate [celf]     3.31618
Statistical Method [resa]     3.31618
Middle east country [geoa]     3.31618
personal experience [inbe]     3.31618
liver procedure [hlca]     3.31618
Subclone [cell]     3.31618
Monograph [inpr]     3.31618
trophoblast [emst]     3.31618
mild symptoms [fndg]     3.31618
Negative Staining [lbpr]     3.31618
Peripheral blood monocyte [cell]     3.31618
Master [qlco]     3.31618
Cardinal [bird]     3.31618
Motor vehicle [mnob]     3.31618
Calculi [bdsu]     3.31618
alcohol effect [dsyn]     3.31618
Gross tumor volume [qnco]     3.31618
Gastric ulcer [dsyn]     3.31618
Bilirubinaemia [dsyn]     3.31618
Nitrate [chvs]     3.31618
Immune clearance [phsf]     3.31618
Fix [irda]     3.31618
Penetrance [qnco]     3.31618
Gastrointestinal Tract Cancer [neop]     3.31618
false-positive result [lbtr]     3.31618
Protein Analysis [mbrt]     3.31618
Perivascular [spco]     3.31618
Health Campaigns [hlca]     3.31618
Hepatic trauma [inpo]     3.31618
Sexual exposure [fndg]     3.31618
Diabetes mellitus type 2 [dsyn]     3.31618
Not Applicable [qlco]     3.31618
DNA Mismatch Repair [genf]     3.31618
choledochal [bpoc]     3.31618
Carcinoma, Squamous [neop]     3.31618
Amino acid change [fndg]     3.31618
Colon Carcinoma [neop]     3.31618
Bloodstream [phsf]     3.31618
DNA Synthesis [genf]     3.31618
3 H [elii]     3.31618
Ti [elii]     3.31618
Pack [topp]     3.31618
20th century [tmco]     3.31618
Alcohol Abstinence [inbe]     3.31618
Sealer [sbst]     3.31618
Gene Transcription [genf]     3.31618
GSTA4 [gngm]     3.31618
Poverty [grpa]     3.31618
Nasopharynx [bpoc]     3.31618
21st century [tmco]     3.31618
Clinical Treatment [topp]     3.31618
Clinical Center [orgt]     3.31618
Hepatic Epithelioid Hemangioendothelioma [neop]     3.31618
ampullary cancer [neop]     3.31618
Repaired [ftcn]     3.31618
Romania [geoa]     3.31618
Fasting blood glucose [lbpr]     3.31618
Market [geoa]     3.31618
Necrotic Lesion [fndg]     3.31618
del [comd]     3.31618
Relative Survival [qnco]     3.31618
septum [celc]     3.31618
Population Surveillance [resa]     3.31618
Electrophoresis, Capillary [lbpr]     3.31618
Unload [idcn]     3.31618
Percutaneous liver biopsy [diap]     3.31618
Clear [idcn]     3.31618
helminth infections [dsyn]     3.31618
atrophy liver [dsyn]     3.31618
Tight [qlco]     3.31618
Mice, ICR [mamm]     3.31618
Cooperative Group [prog]     3.31618
Urban Hospital [hcro]     3.31618
Urinary tract infection [dsyn]     3.31618
Iron stores [lbpr]     3.31618
Reason [menp]     3.31618
Septal fibrosis [patf]     3.31618
D2 [gngm]     3.31618
Pleura [bpoc]     3.31618
Ipsilateral [spco]     3.31618
N0 [fndg]     3.31618
Branched DNA Assay [mbrt]     3.31618
Alagille Syndrome [cgab]     3.31618
Hungary [geoa]     3.31618
Hyperthermia [fndg]     3.31618
Compatibility [qlco]     3.31618
Speak [dora]     3.31618
urea cycle [moft]     3.31618
Moderate to severe [qlco]     3.31618
Gamma-glutamyl transferase level [lbpr]     3.31618
2 Dimensional Gel Electrophoresis [lbpr]     3.31618
Spinal [spco]     3.31618
Glandular [qlco]     3.31618
Borderline Lesion [fndg]     3.31618
Processor [mnob]     3.31618
Congestive heart failure [dsyn]     3.31618
Vascular disorder [dsyn]     3.31618
Collected [orgt]     3.31618
health care professionals [prog]     3.31618
Far East [geoa]     3.31618
Neoplasm, Hepatic [neop]     3.31618
Execute [acty]     3.31618
Residual volume [clna]     3.31618
Patient sex [orga]     3.31618
Anchorage-Independent Growth [lbpr]     3.31618
Uterus [bpoc]     3.31618
Cholestatic hepatitis [dsyn]     3.31618
Total protein [lbpr]     3.31618
GSTP [gngm]     3.31618
interrupt [ftcn]     3.31618
Karyotype [lbpr]     3.31618
Rearrangement [genf]     3.31618
argument [socb]     3.31618
Adjusted Life Years [tmco]     3.31618
Inverse [comd]     3.31618
Activation, Metabolic [moft]     3.31618
Reciprocal [qlco]     3.31618
Fine-needle aspirate [bdsu]     3.31618
follow up visits [hlca]     3.31618
Autoimmune disorders [dsyn]     3.31618
Renal Replacement Therapy [topp]     3.31618
Gonadal [bpoc]     3.31618
Medial [spco]     3.31618
poor performance status [patf]     3.31618
haem biosynthesis [moft]     3.31618
Hemorrhages [patf]     3.31618
Gross morphology [clna]     3.31618
Only Child [famg]     3.31618
DNA virus [virs]     3.31618
Circulating Tumor Cells [cell]     3.31618
human papillomaviruses [virs]     3.31618
Seizure [sosy]     3.31618
Pathology, Veterinary [bmod]     3.31618
/30 min [tmco]     3.31618
Qualifying [qlco]     3.31618
Occult carcinoma [neop]     3.31618
Antenna [mnob]     3.31618
Convenience Sampling [resa]     3.31618
Microcirculation [ortf]     3.31618
Cystic Fibrosis [dsyn]     3.31618
Imaging System [mnob]     3.31618
Hepatocyte ballooning [fndg]     3.31618
SECRET [bdsu]     3.31618
cs [qnco]     3.31618
common bile duct stricture [anab]     3.31618
Ideas [menp]     3.31618
Co-culture [lbpr]     3.31618
Slow disease progression [fndg]     3.31618
Plasma cell [cell]     3.31618
Gross blood [bdsu]     3.31618
American Society of Hematology [pros]     3.31618
affordability [qnco]     3.31618
Severe Sepsis [dsyn]     3.31618
reliance [bodm]     3.31618
Therapeutic phlebotomy [topp]     3.31618
Target lesion [dsyn]     3.31618
HPLC [lbpr]     3.31618
Gram-Negative Bacteria [bact]     3.31618
Neighborhood [geoa]     3.31618
DNA Image Cytometry [lbpr]     3.31618
Pathologies, Molecular [ocdi]     3.31618
Admixture [qlco]     3.31618
Occasional drinker [fndg]     3.31618
Low CD4+ count [fndg]     3.31618
interleukin-6 production [orgf]     3.31618
Polarity [clna]     3.31618
Neoplastic Nodule [fndg]     3.31618
Post-intervention [inpr]     3.31618
Short Forms [inpr]     3.31618
*Arbitrary [qnco]     3.31618
operative therapy [ftcn]     3.31618
Clinical Observation [idcn]     3.31618
screening techniques [fndg]     3.31618
Lake [geoa]     3.31618
ng/L [qnco]     3.31618
Catalonian [popg]     3.31618
Food Consumption [acty]     3.31618
Isogeneic [qlco]     3.31618
Risk Marker [qlco]     3.31618
Hepatitis C virus Ab [imft]     3.31618
Southwestern [spco]     3.31618
Bird [bird]     3.31618
After-Treatment [hlca]     3.31618
Femoral [bpoc]     3.31618
Gestation [tmco]     3.31618
collaborative study [resa]     3.31618
Diagnosis Code [inpr]     3.31618
Continual [tmco]     3.31618
Cell Polarity [spco]     3.31618
ultra [medd]     3.31618
Machine Learning [mcha]     3.31618
Tumors, Residual [neop]     3.31618
Economy [qnco]     3.31618
gallbladder stone [dsyn]     3.31618
molecularly targeted therapy [topp]     3.31618
Grain [food]     3.31618
Engraftment [phsf]     3.31618
diabetes insulin resistance [dsyn]     3.31618
Right hepatic artery [bpoc]     3.31618
Bone marrow biopsy [diap]     3.31618
Common Hepatic Duct [bpoc]     3.31618
alcohol use disorder [mobd]     3.31618
granulations [celc]     3.31618
Erroneous [idcn]     3.31618
Arterial thrombosis [dsyn]     3.31618
ecologic study [resa]     3.31618
low body mass index [fndg]     3.31618
Transcription Regulation [genf]     3.31618
Quadruple [qnco]     3.31618
skin metastases [neop]     3.31618
dystrophic [ftcn]     3.31618
Prior to [tmco]     3.31618
haemoglobin concentration [lbtr]     3.31618
One-way ANOVA [qnco]     3.31618
Platinum [elii]     3.31618
racial difference [fndg]     3.31618
Cerebrovascular [qlco]     3.31618
Phase contrast [lbpr]     3.31618
one-carbon metabolism [moft]     3.31618
Phase 1 [tmco]     3.31618
Neuroendocrine Carcinomas [neop]     3.31618
Twice weekly [tmco]     3.31618
schema [inpr]     3.31618
Hepatic iron index [clna]     3.31618
Risk Adjustment [qnco]     3.31618
Marginal Zone [tisu]     3.31618
Direct Treatment [topp]     3.31618
Macronodular cirrhosis [dsyn]     3.31618
Terminal [idcn]     3.31618
P s [ortf]     3.31618
GI Tract [bdsy]     3.31618
effect size [qnco]     3.31618
Tumor Subtype [clas]     3.31618
First stage [inpr]     3.31618
Microscopic Findings [idcn]     3.31618
EXP [gngm]     3.31618
invasive cancer [neop]     3.31618
Epithelial tumor [neop]     3.31618
Ventral [spco]     3.31618
Attendance [acty]     3.31618
former smokers [fndg]     3.31618
Choledochoscopy [diap]     3.31618
CTA [gngm]     3.31618
Premature Death [fndg]     3.31618
O group [clas]     3.31618
Clumped [qlco]     3.31618
Council [popg]     3.31618
Combined Oral Contraceptives [phsu]     3.31618
Grant [qnco]     3.31618
Realism [idcn]     3.31618
Reduced Activity [sosy]     3.31618
Ambulatory [ftcn]     3.31618
Satellitosis [comd]     3.31618
Lumbar [blor]     3.31618
mTOR Inhibitor [phsu]     3.31618
Diffuse Large B-Cell Lymphoma [neop]     3.31618
Central [idcn]     3.31618
Ratio value [qnco]     3.31618
Neurodegenerative Diseases [dsyn]     3.31618
Pylorus [bpoc]     3.31618
Cr [lbpr]     3.31618
South Africa [geoa]     3.31618
Fair [qlco]     3.31618
Genetic Testing [lbpr]     3.31618
transect [ftcn]     3.31618
viral transmission [celf]     3.31618
trafficking [celf]     3.31618
SCID, NOS [dsyn]     3.31618
Abnormal Finding [fndg]     3.31618
Hydrolysis [npop]     3.31618
Catheter Obstruction [phpr]     3.31618
Microscopy, Confocal [lbpr]     3.31618
Meal [dora]     3.31618
sFRP-1 [aapp]     3.31618
Volatile [lbpr]     3.31618
Elevated serum ferritin [fndg]     3.31618
Liver Cell Adenomas [neop]     3.31618
Restriction Site [nusq]     3.31618
receptor expression [genf]     3.31618
Stella [bact]     3.31618
Geographic Information System [inpr]     3.31618
Romanian [popg]     3.31618
Merge [acty]     3.31618
Complete excision [topp]     3.31618
ethanol ablation [topp]     3.31618
Gavage [topp]     3.31618
General Anesthesia [topp]     3.31618
high risk behavior [inbe]     3.31618
Control Animal [anim]     3.31618
PIK3CA [gngm]     3.31618
Brown [npop]     3.31618
Barrett Esophagus [dsyn]     3.31618
Schistosoma japonicum [euka]     3.31618
ailments [fndg]     3.31618
Post-chemotherapy [tmco]     3.31618
Older Population [popg]     3.31618
Clean [acty]     3.31618
Microscope [medd]     3.31618
Index Value [qnco]     3.31618
Diffusion Weighted MRI [diap]     3.31618
Salt [chvs]     3.31618
Delivery system [ftcn]     3.31618
Data Extraction [resa]     3.31618
Papillary thyroid carcinoma [neop]     3.31618
NL [geoa]     3.31618
Wales [geoa]     3.31618
Menarche [orgf]     3.31618
Obesity, Morbid [dsyn]     3.31618
Israel [geoa]     3.31618
blood units [qnco]     3.31618
Electronic Medical Records [inpr]     3.31618
Ion [elii]     3.31618
Self-Administered [ftcn]     3.31618
Right hepatic duct [bsoj]     3.31618
cryotherapy [topp]     3.31618
Surgical Manipulation [topp]     3.31618
Ethics Committee [prog]     3.31618
Post-processing [inpr]     3.31618
Every day [tmco]     3.31618
tissue type [lbpr]     3.31618
VS [idcn]     3.31618
Transplant surgeon [prog]     3.31618
Blood Donation [hlca]     3.31618
Africa, Southern [geoa]     3.31618
racial ethnic differences [fndg]     3.31618
Drug Discovery [resa]     3.31618
NKG2D [gngm]     3.31618
Yolk Sac Tumor [neop]     3.31618
HUB [gngm]     3.31618
Latency Period [tmco]     3.31618
Cell Proliferative Activity [lbtr]     3.31618
Clinical Series [resa]     3.31618
Metabolic [celf]     3.31618
poor health [fndg]     3.31618
e hepatitis [dsyn]     3.31618
Algeria [geoa]     3.31618
Helicobacter hepaticus [bact]     3.31618
FOE [gngm]     3.31618
quit [idcn]     3.31618
Manufacture [ocac]     3.31618
Epitope [imft]     3.31618
Once weekly [tmco]     3.31618
Health behavior [inbe]     3.31618
Cadaver [anst]     3.31618
Germ cell tumor [neop]     3.31618
Fischer Rats [mamm]     3.31618
Proteomic Profile [lbpr]     3.31618
RO [geoa]     3.31618
17p13 [celc]     3.31618
history patients [hlca]     3.31618
Organ system [bdsy]     3.31618
Dietary Questionnaire [inpr]     3.31618
Portal vein obstruction [dsyn]     3.31618
free time [dora]     3.31618
Transplant complications [patf]     3.31618
Anal [bpoc]     3.31618
Birth Order [qnco]     3.31618
Ultrastructural feature [celc]     3.31618
Mitochondrion [celc]     3.31618
gambian [popg]     3.31618
Living related donor [popg]     3.31618
combination drug [phsu]     3.31618
Second Opinion [inpr]     3.31618
Procedure complication [fndg]     3.31618
Portasystemic Shunt [topp]     3.31618
Ova [cell]     3.31618
Dimorphic [spco]     3.31618
Intramural [spco]     3.31618
Hot [qlco]     3.31618
Age-Adjusted Mortality Rate [qnco]     3.31618
Perfusion index [qnco]     3.31618
Transitional cell [cell]     3.31618
Disagreement [socb]     3.31618
Direct Costs [qnco]     3.31618
kinase activator [moft]     3.31618
cellular component [celc]     3.31618
Periampullary carcinoma [neop]     3.31618
Inherited disease [dsyn]     3.31618
triphosphate [inch]     3.31618
Health Status [qlco]     3.31618
Br. [cnce]     3.31618
Central venous pressure [clna]     3.31618
transit [ftcn]     3.31618
Unnecessary Surgery [topp]     3.31618
Diffuse Pattern [fndg]     3.31618
Gene Microarray [mbrt]     3.31618
Medical Problem [fndg]     3.31618
FAS gene [gngm]     3.31618
Negative Lymph Node [fndg]     3.31618
Basic Research [resa]     3.31618
Fatty infiltration [patf]     3.31618
insulin treatment [topp]     3.31618
Inner city [geoa]     3.31618
Mesenchymal Tumor [neop]     3.31618
kg body weight [orga]     3.31618
Denominator [qnco]     3.31618
Radiograph [diap]     3.31618
radiology reports [inpr]     3.31618
Learning Curve [menp]     3.31618
body mass [fndg]     3.31618
Soil [sbst]     3.31618
RESP [clna]     3.31618
Anecdotes [inpr]     3.31618
Sugar [carb]     3.31618
BREAK [phpr]     3.31618
Cambodian [popg]     3.31618
Respiration [phsf]     3.31618
Monocyte count [lbpr]     3.31618
Helminth [euka]     3.31618
hepatotoxin [hops]     3.31618
Distal Bile Duct Carcinoma [neop]     3.31618
Tea [food]     3.31618
Main bile duct [bpoc]     3.31618
VE [geoa]     3.31618
Arterial blood supply [phsf]     3.31618
Lung Tissue [tisu]     3.31618
Employ [ftcn]     3.31618
new mutation [comd]     3.31618
Massive necrosis [patf]     3.31618
Full spectrum [qlco]     3.31618
6q [nusq]     3.31618
DNA damage response [celf]     3.31618
normal liver enzymes [fndg]     3.31618
New York [geoa]     3.31618
CT angiography [diap]     3.31618
Multiple Birth [famg]     3.31618
Fig [food]     3.31618
Phylogenies [idcn]     3.31618
Pediatric Disease [dsyn]     3.31618
Colon Adenocarcinoma [neop]     3.31618
RNA molecule [sbst]     3.31618
Increased growth [patf]     3.31618
MALDI-MS [lbpr]     3.31618
Trabecular carcinoma [neop]     3.31618
Hepato-Pulmonary Syndrome [dsyn]     3.31618
History taking [hlca]     3.31618
Myocardial Infarction [dsyn]     3.31618
Recurrent pyogenic cholangitis [dsyn]     3.31618
Alternative Therapies [topp]     3.31618
Kilogram [qnco]     3.31618
Genes, Viral [gngm]     3.31618
Massive bleeding [patf]     3.31618
Candidiasis [dsyn]     3.31618
Metastatic to [ftcn]     3.31618
Membrane Potential, Mitochondrial [celf]     3.31618
Cachexia [sosy]     3.31618
transmit [ftcn]     3.31618
pediatric solid tumor [neop]     3.31618
Left liver lobe [bpoc]     3.31618
Right Atrium [bpoc]     3.31618
CBC [lbpr]     3.31618
Local resection [topp]     3.31618
Educational Attainment [fndg]     3.31618
health care resources [qnco]     3.31618
Metal [qlco]     3.31618
Routine procedure [topp]     3.31618
PR+ [lbtr]     3.31618
Cation [chvs]     3.31618
Bile sample [bdsu]     3.31618
Plastic [npop]     3.31618
arrival [idcn]     3.31618
gene mutants [gngm]     3.31618
B-Cell Activation [celf]     3.31618
Competence [qlco]     3.31618
Clostridium perfringens [bact]     3.31618
Year, Quality-Adjusted Life [tmco]     3.31618
ver [diap]     3.31618
Hydatid Cyst [dsyn]     3.31618
noninvasive diagnosis [diap]     3.31618
schistosomal [euka]     3.31618
Tree, Decision [inpr]     3.31618
digestive disease [dsyn]     3.31618
Health Disparities [fndg]     3.31618
American Diabetes Association [pros]     3.31618
Functional Imaging [diap]     3.31618
Social factor [grpa]     3.31618
C-reactive protein level [lbpr]     3.31618
cervix cancer [neop]     3.31618
cd4 cells [cell]     3.31618
Metabonomic [bmod]     3.31618
haemostatic [ortf]     3.31618
alcohol induced cirrhosis [dsyn]     3.31618
Lymph node sample [diap]     3.31618
HIT [fndg]     3.31618
Contralateral [spco]     3.31618
Intrahepatic Bile Duct Epithelium [tisu]     3.31618
Science, Life [ocdi]     3.31618
vitro [qlco]     3.31618
Sake [food]     3.31618
Worry [fndg]     3.31618
explanatory [inpr]     3.31618
Genetic disease [fndg]     3.31618
Schistosoma mansoni Infection [dsyn]     3.31618
American Indian [popg]     3.31618
Worm [dsyn]     3.31618
Birth Records [mnob]     3.31618
Antibody detection [lbpr]     3.31618
Venous Thrombosis [patf]     3.31618
TM6SF2 [gngm]     3.31618
Solid organ transplant [topp]     3.31618
antioxidant activity [moft]     3.31618
Clip [medd]     3.31618
Esophageal hemorrhage [patf]     3.31618
Left hepatic artery [bpoc]     3.31618
{VP} [qnco]     3.31618
Radiation Effect [biof]     3.31618
Accelerated Growth [fndg]     3.31618
Upper gastrointestinal bleeding [patf]     3.31618
Monocytes+Macrophages [cell]     3.31618
PULSE [phpr]     3.31618
Indigenous [grpa]     3.31618
disease risk factor [fndg]     3.31618
Chin [blor]     3.31618
sample collection [lbpr]     3.31618
Eukaryotic Cells [cell]     3.31618
Vascular Malformation [anab]     3.31618
G2 Phase [tmco]     3.31618
Immunization Programs [hlca]     3.31618
Intracranial [blor]     3.31618
Permanent [tmco]     3.31618
Rehabilitation [topp]     3.31618
heart rate [clna]     3.31618
Racial group [popg]     3.31618
RBC [cell]     3.31618
Aorta [bpoc]     3.31618
elevated protein [fndg]     3.31618
Consent [qlco]     3.31618
Vasovagal syncope [dsyn]     3.31618
system disorder [dsyn]     3.31618
tapered [hlca]     3.31618
Sex Distribution [qnco]     3.31618
First sign [inpr]     3.31618
Discomfort [sosy]     3.31618
Uterine Cervix [bpoc]     3.31618
Cold [npop]     3.31618
PA [tmco]     3.31618
mononuclear cell [cell]     3.31618
3/60 [fndg]     3.31618
Stays, Hospital [tmco]     3.31618
C-1 [gngm]     3.31618
type virus [inpr]     3.31618
counseling patients [hlca]     3.31618
cell l [qnco]     3.31618
Data Mining [mcha]     3.31618
Embryogenesis [ortf]     3.31618
Nepal [geoa]     3.31618
INFECTIOUS PROCESS [patf]     3.31618
LOH [genf]     3.31618
Oncolytic [qlco]     3.31618
Mixed cryoglobulinemia [dsyn]     3.31618
functional recovery [sosy]     3.31618
Genetics, Molecular [bmod]     3.31618
Bangladeshi [popg]     3.31618
Malfunction [ftcn]     3.31618
Fruit intake [fndg]     3.31618
Thermoablation [topp]     3.31618
Parasitic disease [dsyn]     3.31618
Growth arrest [patf]     3.31618
Tumor Process [neop]     3.31618
hTERT [gngm]     3.31618
Duplex [spco]     3.31618
Cat [mamm]     3.31618
Trough [qnco]     3.31618
Pseudo [qlco]     3.31618
Asthma [dsyn]     3.31618
Microvessel [bpoc]     3.31618
Micronutrients [bacs]     3.31618
5a [medd]     3.31618
diet renal disease [topp]     3.31618
Soft tissue mass [anab]     3.31618
epidemiologists [prog]     3.31618
Packed red blood cells [phsu]     3.31618
TX [idcn]     3.31618
Uninvolved [qlco]     3.31618
ii level [inpr]     3.31618
Religious [fndg]     3.31618
Class I [clas]     3.31618
commitment [menp]     3.31618
IC50 [qnco]     3.31618
Septal [spco]     3.31618
log10 [qnco]     3.31618
Mission [orgt]     3.31618
10q [nusq]     3.31618
Gap junction [bsoj]     3.31618
Cross [spco]     3.31618
Throat [bpoc]     3.31618
ATP7B [gngm]     3.31618
Recurrence type [clna]     3.31618
Underweight [fndg]     3.31618
Export [phpr]     3.31618
Judgement [menp]     3.31618
lysosomal [blor]     3.31618
Metastasis Gene [gngm]     3.31618
dot blot [lbpr]     3.31618
Maximum Intensity Projection [mnob]     3.31618
IgG4-Related Disease [dsyn]     3.31618
outreach [shro]     3.31618
Laser ablation [topp]     3.31618
Right portal vein [bpoc]     3.31618
Ear [bpoc]     3.31618
Donor graft [bodm]     3.31618
Pleomorphic [qlco]     3.31618
Barber [prog]     3.31618
Chronic nonalcoholic liver disease [dsyn]     3.31618
Flux [npop]     3.31618
Ligament [tisu]     3.31618
2-Dimensional Difference Gel Electrophoresis [lbpr]     3.31618
Carbon [elii]     3.31618
Very large [fndg]     3.31618
IRB [prog]     3.31618
Wnt beta-Catenin Signaling Pathway [moft]     3.31618
Parenteral route [ftcn]     3.31618
Tumor Suppression [moft]     3.31618
aboriginal [popg]     3.31618
Three dimensional conformal radiotherapy [topp]     3.31618
Active Surveillance [hlca]     3.31618
physicists [prog]     3.31618
induced infection [dsyn]     3.31618
Magnet [ocdi]     3.31618
Non-Parametric Test [inpr]     3.31618
Enzyme Assay [lbpr]     3.31618
Bite [inpo]     3.31618
Lung Carcinoma [neop]     3.31618
uses [ftcn]     3.31618
Interventions, Early [hlca]     3.31618
CLOCK [gngm]     3.31618
Amyloidosis [dsyn]     3.31618
Inject [bodm]     3.31618
New Zealand white rabbit [mamm]     3.31618
Counsel [prog]     3.31618
Hepatic Granuloma [dsyn]     3.31618
Clinical Events [idcn]     3.31618
chemists [prog]     3.31618
20/10 [fndg]     3.31618
Charge [qnco]     3.31618
Liquid [sbst]     3.4411187
English sole [fish]     3.4411187
PBMC [cell]     3.4411187
Basement membrane [tisu]     3.4411187
Biliary Intraepithelial Neoplasia-3 [neop]     3.4411187
Toluene [orch]     3.4411187
Large extent [qlco]     3.4411187
pull [fndg]     3.4411187
HeLa [cell]     3.4411187
Determinant [idcn]     3.4411187
Pork [food]     3.4411187
Spherical [spco]     3.4411187
Malignant Fibrous Histiocytoma [neop]     3.4411187
Intra-abdominal mass [fndg]     3.4411187
FALSE NEGATIVE RESULT [fndg]     3.4411187
Severe inflammation [fndg]     3.4411187
Markers, Clinical [qlco]     3.4411187
Peritoneal Carcinomatosis [neop]     3.4411187
Serum specimen [bdsu]     3.4411187
Functional assessment [diap]     3.4411187
Infection risk [fndg]     3.4411187
Aspiration needles [medd]     3.4411187
Processed meat [food]     3.4411187
Inferior vena cava obstruction [dsyn]     3.4411187
Observed Incidence [qnco]     3.4411187
possess [qnco]     3.4411187
Radiosurgery [topp]     3.4411187
AFC [diap]     3.4411187
48 hours [tmco]     3.4411187
Russia [geoa]     3.4411187
Turkish population [popg]     3.4411187
Normal concentration [fndg]     3.4411187
Naked [fndg]     3.4411187
Single strand [qlco]     3.4411187
sclerose [patf]     3.4411187
Fish Products [food]     3.4411187
Bone tumor [neop]     3.4411187
TNR [gngm]     3.4411187
low sodium [topp]     3.4411187
low cholesterol levels [fndg]     3.4411187
pre contrast [tmco]     3.4411187
Replacement therapy [topp]     3.4411187
personnel [ftcn]     3.4411187
Regional Chemotherapy [topp]     3.4411187
Forensic Pathology [bmod]     3.4411187
Microangiopathy [dsyn]     3.4411187
Ultrasonogram [diap]     3.4411187
Ionising radiation [npop]     3.4411187
outreach program [shro]     3.4411187
Retired [fndg]     3.4411187
Rat Cholangiocarcinoma [neop]     3.4411187
Sarcoma, Clear Cell [neop]     3.4411187
Mean pressure [qnco]     3.4411187
liver perfusion [topp]     3.4411187
Extubation [topp]     3.4411187
16/16 [qnco]     3.4411187
OH- [elii]     3.4411187
Power output [npop]     3.4411187
MYC Gene [gngm]     3.4411187
chimeric [orgm]     3.4411187
Colonic Dysplasia [dsyn]     3.4411187
N-ras [gngm]     3.4411187
SA [geoa]     3.4411187
Pre-existing conditions [clna]     3.4411187
HapMap [orga]     3.4411187
Echinococcosis, Hepatic Alveolar [dsyn]     3.4411187
Hepatitis A Infection [dsyn]     3.4411187
Early cirrhosis [dsyn]     3.4411187
magnetic beads [medd]     3.4411187
Combined radiotherapy [topp]     3.4411187
File, Data [inpr]     3.4411187
Pulmonary Disease [dsyn]     3.4411187
Disproportion NOS [anab]     3.4411187
Military [prog]     3.4411187
Preclinical Models [inpr]     3.4411187
long-term care [hlca]     3.4411187
Seroepidemiologic Studies [resa]     3.4411187
Aplastic Anemia [dsyn]     3.4411187
Mesenchymal cell [cell]     3.4411187
Adrenocortical [qlco]     3.4411187
Anaesthetic [phsu]     3.4411187
GLP-1 [aapp]     3.4411187
Human - origin [humn]     3.4411187
Defer [tmco]     3.4411187
RBE [qnco]     3.4411187
chemical compounds [chem]     3.4411187
Pancreatic parenchyma [bpoc]     3.4411187
Clinical measurements [hlca]     3.4411187
Anatomic Variation [npop]     3.4411187
water body [bdsu]     3.4411187
P62 [gngm]     3.4411187
appendicectomies [topp]     3.4411187
Crystal [bdsu]     3.4411187
periampullary cancer [neop]     3.4411187
CELL CELL INTERACTION [celf]     3.4411187
pg/mg [qnco]     3.4411187
SOCS-3 [gngm]     3.4411187
Abnormal distribution [qlco]     3.4411187
EMIT [lbpr]     3.4411187
Hyperchromasia [comd]     3.4411187
26a [medd]     3.4411187
Refractory Disease [fndg]     3.4411187
Tyrosine Kinase 2 Gene [gngm]     3.4411187
Enthusiasm [menp]     3.4411187
Narrow [spco]     3.4411187
Major Histocompatibility Complex [gngm]     3.4411187
Overgrowth [fndg]     3.4411187
S7 [gngm]     3.4411187
Tumor-Derived [ftcn]     3.4411187
radiation toxicity [inpo]     3.4411187
Extracranial [spco]     3.4411187
Embryonic Development [ortf]     3.4411187
3-Dimensional Conformal Radiation Therapy [topp]     3.4411187
IV drug use [fndg]     3.4411187
Yellow [qlco]     3.4411187
Coronary Disease [dsyn]     3.4411187
Short Oligonucleotide Mass Analysis [resa]     3.4411187
Electrical fitter [prog]     3.4411187
DNA index [qnco]     3.4411187
Study Category [inpr]     3.4411187
OM [fndg]     3.4411187
Yemen [geoa]     3.4411187
Helminth [ftcn]     3.4411187
Indonesia [geoa]     3.4411187
Epithelial Tumors, Malignant [neop]     3.4411187
Standardized technique [topp]     3.4411187
Microinvasive [neop]     3.4411187
Jejunum [bpoc]     3.4411187
Apical [spco]     3.4411187
Primary malignant neoplasm [fndg]     3.4411187
Rates, Mutation [qlco]     3.4411187
Staple [topp]     3.4411187
mainstream [edac]     3.4411187
Bleeding varices [patf]     3.4411187
Smoking, Passive [eehu]     3.4411187
Unified [idcn]     3.4411187
Copper deficiency [dsyn]     3.4411187
Protein-Energy Malnutrition [patf]     3.4411187
FA [dsyn]     3.4411187
Neutrophil count [lbpr]     3.4411187
insulin levels [lbpr]     3.4411187
General health [fndg]     3.4411187
Posttransplant diabetes mellitus [patf]     3.4411187
perinatal infection [dsyn]     3.4411187
RFLP analysis [lbpr]     3.4411187
heat treatment [topp]     3.4411187
Chronic cholecystitis [dsyn]     3.4411187
ppm [qnco]     3.4411187
Outcome Studies [resa]     3.4411187
Dwelling [cnce]     3.4411187
Vitamin D Deficiency [dsyn]     3.4411187
B6 [bpoc]     3.4411187
Invasive Breast Carcinoma [neop]     3.4411187
Drug drug interaction [moft]     3.4411187
neurological disease [dsyn]     3.4411187
Cellular Oncogenes [gngm]     3.4411187
Dermatologic [spco]     3.4411187
Transcription Mediated Amplification [lbpr]     3.4411187
immortalized cell [cell]     3.4411187
IDH1 [gngm]     3.4411187
Responses, Antibody [biof]     3.4411187
Secondary diagnosis [qlco]     3.4411187
weight measurement [qnco]     3.4411187
RUNX3 [gngm]     3.4411187
Germ-Line Mutation [genf]     3.4411187
Population Database [inpr]     3.4411187
Viral life cycle [biof]     3.4411187
Reticulin stain [lbpr]     3.4411187
hepatitis b core [fndg]     3.4411187
Mouse Carcinoma [neop]     3.4411187
Non-Neoplastic Disease [dsyn]     3.4411187
Field Workers [prog]     3.4411187
Gaucher cell [cell]     3.4411187
1q [nusq]     3.4411187
break down [qlco]     3.4411187
LM [bpoc]     3.4411187
Pelvic cavity [bsoj]     3.4411187
Inflammatory Infiltrate [fndg]     3.4411187
Posttransfusion hepatitis [dsyn]     3.4411187
Waist [blor]     3.4411187
Revolution [ftcn]     3.4411187
Magnetic Field [npop]     3.4411187
cellular pathology [comd]     3.4411187
*Volume Ratio [qnco]     3.4411187
hereditary disorders [dsyn]     3.4411187
Military Service [prog]     3.4411187
alcohol interaction [fndg]     3.4411187
Conscious Sedation [topp]     3.4411187
Nervous [sosy]     3.4411187
Oncology Group [prog]     3.4411187
Pancreatectomy [topp]     3.4411187
Doxorubicin-Eluting Beads [phsu]     3.4411187
MCF [imft]     3.4411187
Frame [nusq]     3.4411187
Conjugate [celf]     3.4411187
Dilated intrahepatic bile ducts [fndg]     3.4411187
Cellulitis [dsyn]     3.4411187
Colloid [bodm]     3.4411187
Unpaired [qlco]     3.4411187
severe symptoms [fndg]     3.4411187
Tissue culture [lbpr]     3.4411187
2p [nusq]     3.4411187
Spur [bpoc]     3.4411187
Mucinous cyst [anab]     3.4411187
Hepatitis C virus antigen [imft]     3.4411187
Beauty [qlco]     3.4411187
Biochemical Pathway [qlco]     3.4411187
catalyse [npop]     3.4411187
Appreciation [cnce]     3.4411187
Skin Rash [dsyn]     3.4411187
NY [geoa]     3.4411187
Lymphoproliferative disorder [neop]     3.4411187
Drop [bodm]     3.4411187
Pigment [chvf]     3.4411187
Disease model [inpr]     3.4411187
Time Factor [tmco]     3.4411187
Opisthorchis felineus [euka]     3.4411187
Toxicology studies [resa]     3.4411187
Social support [socb]     3.4411187
Aggressive Clinical Course [fndg]     3.4411187
Right hepatic vein [bpoc]     3.4411187
invasive cervical cancer [neop]     3.4411187
Indentation [spco]     3.4411187
Coin [mnob]     3.4411187
Times, Prothrombin [lbpr]     3.4411187
IHC [lbpr]     3.4411187
Multiplex PCR [mbrt]     3.4411187
Depressed [fndg]     3.4411187
prothrombin ratio [lbtr]     3.4411187
Anxiety [menp]     3.4411187
Chronic Illness [dsyn]     3.4411187
INCREASED SENSITIVITY [phpr]     3.4411187
CTL [cell]     3.4411187
Cost Benefit [qnco]     3.4411187
Apoptosis Induction [celf]     3.4411187
Genetic material [gngm]     3.4411187
Heredity [moft]     3.4411187
Liquid Chromatography Mass Spectrometry [lbpr]     3.4411187
Extreme [bpoc]     3.4411187
Gonorrhea [dsyn]     3.4411187
transplantation infection [patf]     3.4411187
PDR [dsyn]     3.4411187
Absolute Value [qlco]     3.4411187
Subtract [phpr]     3.4411187
Acute Disease [dsyn]     3.4411187
transaminitis [fndg]     3.4411187
Impending [tmco]     3.4411187
Lower third [spco]     3.4411187
Rhode Island [geoa]     3.4411187
Atelectasis [patf]     3.4411187
Right hepatic lobectomy [topp]     3.4411187
acute cellular rejection [ortf]     3.4411187
coronary [bpoc]     3.4411187
Boston [geoa]     3.4411187
Mixed Hepatocellular Cholangiocarcinoma [neop]     3.4411187
Administration, Oral [topp]     3.4411187
white American [popg]     3.4411187
Epigastric pain [sosy]     3.4411187
RC [gngm]     3.4411187
Focused Ultrasound [topp]     3.4411187
RNA sequencing [nusq]     3.4411187
immunosorbent [irda]     3.4411187
ASC [inpr]     3.4411187
Obesity, Severe [dsyn]     3.4411187
Smoking History [fndg]     3.4411187
Transfusions, Red Blood Cell [topp]     3.4411187
Hypergammaglobulinaemia [dsyn]     3.4411187
Unremarkable [qlco]     3.4411187
Debris [sbst]     3.4411187
Valencia [fish]     3.4411187
Anesthesiology [bmod]     3.4411187
Normal pancreas [fndg]     3.4411187
Ferret [mamm]     3.4411187
SS [geoa]     3.4411187
Active Site [ftcn]     3.4411187
Coding Sequence [gngm]     3.4411187
Splenic Infarction [dsyn]     3.4411187
20/25 [fndg]     3.4411187
True positive [qlco]     3.4411187
Circadian Rhythm [orgf]     3.4411187
j shape [spco]     3.4411187
Choledochojejunostomy [topp]     3.4411187
Upper Limit of Normal [qnco]     3.4411187
Red blood cell [cell]     3.4411187
Hepatitis B virus 2 [virs]     3.4411187
Cytology examination [lbpr]     3.4411187
Janus [cgab]     3.4411187
Double contrast [inpr]     3.4411187
Degenerative Disease [dsyn]     3.4411187
Immunochemistry [bmod]     3.4411187
Luminal [spco]     3.4411187
Washed out [sosy]     3.4411187
Immunocompromised [fndg]     3.4411187
B10 [bpoc]     3.4411187
Gene Amplification [genf]     3.4411187
Drug sensitivity [orga]     3.4411187
WA [geoa]     3.4411187
G1 Arrest [moft]     3.4411187
Marmota monax [mamm]     3.4411187
Starvation [fndg]     3.4411187
TCGA [resa]     3.4411187
couple [famg]     3.4411187
SOX9 [gngm]     3.4411187
Cancer Cell Growth [neop]     3.4411187
Polymerase chain reaction analysis [lbpr]     3.4411187
Looks [orga]     3.4411187
Cytometry [lbpr]     3.4411187
lncRNA [nnon]     3.4411187
Marmoset [mamm]     3.4411187
t-all [neop]     3.4411187
South African [popg]     3.4411187
SAW [medd]     3.4411187
Mammary [bpoc]     3.4411187
Sinusoidal endothelium [tisu]     3.4411187
Hydrophobic [qlco]     3.4411187
pyloric [bpoc]     3.4411187
Heat exposure [inpo]     3.4411187
septation [celf]     3.4411187
T-Lymphocyte [cell]     3.4411187
GE [gngm]     3.4411187
segregation [socb]     3.4411187
Active inflammation [fndg]     3.4411187
crowded [socb]     3.4411187
Therapies, Salvage [topp]     3.4411187
said [dsyn]     3.4411187
Malignant mesothelioma [neop]     3.4411187
aflatoxin metabolism [moft]     3.4411187
Covalent [moft]     3.4411187
MDR2 [gngm]     3.4411187
natural history study [ocdi]     3.4411187
PRC [gngm]     3.4411187
FDG-PET Scan [diap]     3.4411187
Margin involvement [clna]     3.4411187
Pleural [spco]     3.4411187
Carcinosarcoma [neop]     3.4411187
Acquired Immune Deficiency Syndrome [dsyn]     3.4411187
Blood Sugar [carb]     3.4411187
Post-transplant lymphoproliferative disorder [neop]     3.4411187
Other [qlco]     3.4411187
colon rectum [bpoc]     3.4411187
re-evaluation [resa]     3.4411187
Nasal Septum [bpoc]     3.4411187
Percentile value [qnco]     3.4411187
ADN [gngm]     3.4411187
Regional lymph node metastasis [fndg]     3.4411187
Personal risk factor [orga]     3.4411187
Order [qlco]     3.4411187
REG [gngm]     3.4411187
Hepatic Angiosarcoma [neop]     3.4411187
Kaposi Sarcoma Herpes Virus [virs]     3.4411187
radiolabel [qlco]     3.4411187
Sword [mnob]     3.4411187
disposable [acty]     3.4411187
protrusion [anab]     3.4411187
Party [cnce]     3.4411187
Subdivision [fndg]     3.4411187
degradation [phpr]     3.4411187
New type [idcn]     3.4411187
sorted [menp]     3.4411187
GSTM3 [gngm]     3.4411187
comply [food]     3.4411187
genital lesions [fndg]     3.4411187
Plasmacytoma [neop]     3.4411187
Stimulation test [lbpr]     3.4411187
Quantum Dot [mnob]     3.4411187
Sedentary lifestyle [fndg]     3.4411187
MUC6 [gngm]     3.4411187
Klebsiella [bact]     3.4411187
Oropharynx [blor]     3.4411187
Argon [elii]     3.4411187
Vesicular [qlco]     3.4411187
Intrahepatic bile duct carcinoma [neop]     3.4411187
3T MRI [diap]     3.4411187
Refractory ascites [fndg]     3.4411187
Death certification [hlca]     3.4411187
permission [inbe]     3.4411187
drug use [ftcn]     3.4411187
Hippocampus [bpoc]     3.4411187
Fluorescence-Activated Cell Sorting [lbpr]     3.4411187
DNA Alteration [genf]     3.4411187
Abdominal lymph node [bpoc]     3.4411187
Chronic passive congestion [patf]     3.4411187
childhood hepatocellular carcinoma [neop]     3.4411187
Microscopic observation [lbpr]     3.4411187
Ra [spco]     3.4411187
Morphometric analysis [lbpr]     3.4411187
bone marrow aspirate [bdsu]     3.4411187
intralesional [spco]     3.4411187
Stream [npop]     3.4411187
globe [bpoc]     3.4411187
Senescence, Cellular [celf]     3.4411187
Secondary Outcome Measure [inpr]     3.4411187
Elevated serum creatinine [fndg]     3.4411187
GSTM2 [gngm]     3.4411187
MYD88 [gngm]     3.4411187
Meeting Abstracts [inpr]     3.4411187
Mesenteric Artery, Superior [bpoc]     3.4411187
Tissue Differentiation [fndg]     3.4411187
Arterial blood [tisu]     3.4411187
Inbred [orgm]     3.4411187
Fontan Operation [topp]     3.4411187
Nutritional Therapy [topp]     3.4411187
Variable expression [fndg]     3.4411187
heterozygous genotype [orga]     3.4411187
ASPIRATOR, ULTRASONIC [medd]     3.4411187
Inequalities [qlco]     3.4411187
11q13 [celc]     3.4411187
metastatic breast cancer [neop]     3.4411187
Current drinker [inbe]     3.4411187
Liver Transplant [bpoc]     3.4411187
knockout animal [anim]     3.4411187
Suprachiasmatic Nucleus [bpoc]     3.4411187
Homologous Protein [aapp]     3.4411187
Positron Emission Tomography Scan [diap]     3.4411187
Progressive disorder [fndg]     3.4411187
Abdominal drain [medd]     3.4411187
Jurisdiction [idcn]     3.4411187
hypopharynx [blor]     3.4411187
Empyema [dsyn]     3.4411187
Therapeutic results [fndg]     3.4411187
Recurrent tumour [neop]     3.4411187
Group D [clas]     3.4411187
MIC [topp]     3.4411187
Cameroon [geoa]     3.4411187
physical function [fndg]     3.4411187
bioinformatic [bmod]     3.4411187
Drug Exposure [fndg]     3.4411187
Percutaneous techniques [topp]     3.4411187
Dichloropropane [orch]     3.4411187
Powder [bodm]     3.4411187
Gallbladder adenocarcinoma [neop]     3.4411187
First presentation [tmco]     3.4411187
Queensland [geoa]     3.4411187
Rio [inpr]     3.4411187
central location [spco]     3.4411187
Subcutaneous Tissue [tisu]     3.4411187
Lymphovascular [qlco]     3.4411187
Tumor Immunity [dsyn]     3.4411187
low folate [fndg]     3.4411187
Ordinal [inpr]     3.4411187
Occlusion [ftcn]     3.4411187
isolated hepatic perfusion [topp]     3.4411187
Hepatitis B Virus Antibodies [imft]     3.4411187
Adenosquamous carcinoma [neop]     3.4411187
Handle [cnce]     3.4411187
Preneoplastic Conditions [neop]     3.4411187
Memory [menp]     3.4411187
Culture medium [irda]     3.4411187
Portal obstruction [dsyn]     3.4411187
enzyme level [lbpr]     3.4411187
Embolisation material [bodm]     3.4411187
Infiltrative Growth [fndg]     3.4411187
Thalassaemia major [dsyn]     3.4411187
External Beam Radiation Therapy [topp]     3.4411187
Physical Trauma [inpo]     3.4411187
Bioavailability [qnco]     3.4411187
PEBP1 [gngm]     3.4411187
Enlarged Liver [sosy]     3.4411187
bed hospital [mnob]     3.4411187
Workshop [edac]     3.4411187
MFS [dsyn]     3.4411187
Vibration [topp]     3.4411187
Golgi [celc]     3.4411187
Sleeping [orgf]     3.4411187
SEVEN-DAY [inpr]     3.4411187
Ortho- [idcn]     3.4411187
Single Arm Study [resa]     3.4411187
Computer assisted [lbpr]     3.4411187
Single ventricle [cgab]     3.4411187
N Stage [inpr]     3.4411187
Dynamic Contrast Enhanced Computed Tomography [diap]     3.4411187
MU/day [qnco]     3.4411187
biliary neoplasm [neop]     3.4411187
Ischemic Pre-Conditioning [topp]     3.4411187
Fulfill [menp]     3.4411187
Presumptive diagnosis [qlco]     3.4411187
mothers smoking [fndg]     3.4411187
Suite [inpr]     3.4411187
Neurocognitive [inpr]     3.4411187
NOD [mamm]     3.4411187
Anticoagulant [phsu]     3.4411187
Planning target volume [qnco]     3.4411187
Infection, Community-Acquired [dsyn]     3.4411187
Kinase Inhibitor [moft]     3.4411187
herbs [plnt]     3.4411187
Liver imaging [diap]     3.4411187
Sentence [inpr]     3.4411187
Cardiac Surgery [topp]     3.4411187
Proctocolectomy [topp]     3.4411187
BEL [geoa]     3.4411187
Bacterial Translocation [celf]     3.4411187
Middle Eastern [popg]     3.4411187
move [ftcn]     3.4411187
Low body weight [fndg]     3.4411187
OC [gngm]     3.4411187
Magnetic Resonance Angiography [diap]     3.4411187
Search Engine [inpr]     3.4411187
Virulence [biof]     3.4411187
secular trends [tmco]     3.4411187
Reinfection [ftcn]     3.4411187
rigid [sosy]     3.4411187
Central Hepatectomy [topp]     3.4411187
Global [phpr]     3.4411187
Chemical reagents [irda]     3.4411187
Substance Abuse [mobd]     3.4411187
Environmental Epidemiology [bmod]     3.4411187
Xq [nusq]     3.4411187
Hepatic parenchymal cell [cell]     3.4411187
Soluble antigen [imft]     3.4411187
Condition, Asymptomatic [dsyn]     3.4411187
Positive Finding [fndg]     3.4411187
AML [neop]     3.4411187
Blood Cells [cell]     3.4411187
cushingoid [sosy]     3.4411187
lymphocytic infiltration [dsyn]     3.4411187
Surgical Procedures, Minor [topp]     3.4411187
Diastolic blood pressure [clna]     3.4411187
dissector [medd]     3.4411187
Skin Manifestations [sosy]     3.4411187
Sequences, Nucleotide [nusq]     3.4411187
raised alt [lbtr]     3.4411187
Washington [geoa]     3.4411187
Phase III Study [resa]     3.4411187
Cell Communication [celf]     3.4411187
Oral Mucosa [bpoc]     3.4411187
Sarcomatous Component [fndg]     3.4411187
Mediastinal [blor]     3.4411187
Total blood loss [patf]     3.4411187
Ribosomal [celc]     3.4411187
AH [dsyn]     3.4411187
History of - carcinoma [fndg]     3.4411187
PV [neop]     3.4411187
Commentary [inpr]     3.4411187
megacaryocyte [cell]     3.4411187
Embryo [emst]     3.4411187
Gene studies [lbpr]     3.4411187
B-Lymphocytes [cell]     3.4411187
Transfusion volume [clna]     3.4411187
Nu [inpr]     3.4411187
AE1 [gngm]     3.4411187
Breast Feeding [orgf]     3.4411187
Pleural Cavities [blor]     3.4411187
mg/g [qnco]     3.4411187
Atlanta [euka]     3.4411187
Indiana [geoa]     3.4411187
renal toxicity [dsyn]     3.4411187
Medical Image [inpr]     3.4411187
Cross link [npop]     3.4411187
infection site [dsyn]     3.4411187
Massive haemorrhage [patf]     3.4411187
Biomedicine [bmod]     3.4411187
Magnetic resonance study [diap]     3.4411187
UN [orgt]     3.4411187
Gram-Positive Bacteria [bact]     3.4411187
Root [bpoc]     3.4411187
Overlay [spco]     3.4411187
Slow acetylator [dsyn]     3.4411187
Clear Cell Renal Cell Carcinoma [neop]     3.4411187
Increased bilirubin level [fndg]     3.4411187
Methyl Group [orch]     3.4411187
Bile secretion [ortf]     3.4411187
Case Mix [qnco]     3.4411187
CRE [gngm]     3.4411187
Systemic infection [dsyn]     3.4411187
Victoria [geoa]     3.4411187
Granulomatous [qlco]     3.4411187
Peripheral oxygen saturation [ortf]     3.4411187
Familiar [menp]     3.4411187
BCC [neop]     3.4411187
Cholangiolocellular Carcinoma [neop]     3.4411187
Constipation [sosy]     3.4411187
p46 [gngm]     3.4411187
Chemosensitivity [fndg]     3.4411187
h pylori infection [dsyn]     3.4411187
Donor hepatectomy [topp]     3.4411187
ELISA assay [lbpr]     3.4411187
Anthropological [ftcn]     3.4411187
intracellular localization [celf]     3.4411187
muscle mass [fndg]     3.4411187
Glomerulonephritis [dsyn]     3.4411187
paracrine [phsf]     3.4411187
Polarity [qnco]     3.4411187
Biopsy sample [tisu]     3.4411187
End-Stage Kidney Disease [dsyn]     3.4411187
SONIC HEDGEHOG [gngm]     3.4411187
secondary malignancies [fndg]     3.4411187
Micro-organism [orgm]     3.4411187
Devascularisation [topp]     3.4411187
FP [gngm]     3.4411187
FLC [neop]     3.4411187
Microbe [orgm]     3.4411187
Slug [euka]     3.4411187
iatrogenic injury [inpo]     3.4411187
Global Change [phpr]     3.4411187
Histiocytosis, Langerhans-Cell [dsyn]     3.4411187
Bacterium [bact]     3.4411187
Worm [euka]     3.4411187
Aromatic Compounds [orch]     3.4411187
excessive drinking [mobd]     3.4411187
Oligo [nnon]     3.4411187
Patchy [qlco]     3.4411187
100 platelets [cell]     3.4411187
Machine tool operator [prog]     3.4411187
Radicular pain [sosy]     3.4411187
Posthepatitic cirrhosis [dsyn]     3.4411187
Normal renal function [fndg]     3.4411187
cellular metabolism [celf]     3.4411187
Paraneoplastic syndrome [neop]     3.4411187
Mid-brain [bpoc]     3.4411187
DX [idcn]     3.4411187
Left colon [bpoc]     3.4411187
Secondary to [tmco]     3.4411187
glutamate [aapp]     3.4411187
Color doppler ultrasound [diap]     3.4411187
Aspartate transaminase level [lbtr]     3.4411187
Multifocal Lesion [fndg]     3.4411187
kU/L [qnco]     3.4411187
Criminal Justice [idcn]     3.4411187
Autologous blood donation [topp]     3.4411187
Spearman Correlation Test [inpr]     3.4411187
Infantile Hemangioendothelioma [neop]     3.4411187
Microbiome [orgm]     3.4411187
checkups [hlca]     3.4411187
RPS6KA3 [gngm]     3.4411187
Aspergillus parasiticus [fngs]     3.4411187
supply vascular [ortf]     3.4411187
satellite tumor [patf]     3.4411187
Erythrocyte [cell]     3.4411187
Fir [plnt]     3.4411187
Spectrometry, Mass, Electrospray Ionization [lbpr]     3.4411187
husband [famg]     3.4411187
Alcohol Dependence [mobd]     3.4411187
Histone Deacetylation [moft]     3.4411187
Chromatographies [lbpr]     3.4411187
Bangladesh [geoa]     3.4411187
Cocktail [food]     3.4411187
Subset Analysis [resa]     3.4411187
Punctate [qlco]     3.4411187
Dissolve [ftcn]     3.4411187
Schistosomiasis japonica [dsyn]     3.4411187
Hepatic infarction [dsyn]     3.4411187
Stage IVa [clas]     3.4411187
Celiac Artery [bpoc]     3.4411187
Mutation Frequencies [qlco]     3.4411187
/30 minutes [tmco]     3.4411187
pT1 [fndg]     3.4411187
Papilloma [neop]     3.4411187
areca-nut [plnt]     3.4411187
social function [socb]     3.4411187
8q24 [celc]     3.4411187
Education, Medical [edac]     3.4411187
Serous [qlco]     3.4411187
Tissue Preservation [topp]     3.4411187
Seal [ftcn]     3.4411187
matrix assisted laser desorption ionization [lbpr]     3.4411187
Pediatric Oncology Group [hcro]     3.4411187
genetic trait [orga]     3.4411187
Virus, Defective [virs]     3.4411187
Hepatic lobectomy [topp]     3.4411187
Bone marrow donor [popg]     3.4411187
Provoked [qlco]     3.4411187
Gaucher Disease [dsyn]     3.4411187
CI-18 [gngm]     3.4411187
Rural Population [popg]     3.4411187
Western European [popg]     3.4411187
Health Insurance Portability and Accountability Act [rnlw]     3.4411187
Chromosome Segregation [genf]     3.4411187
bigger [qnco]     3.4411187
Adipocyte [cell]     3.4411187
Filipino [popg]     3.4411187
Poorly Differentiated Hepatocellular Carcinoma [neop]     3.4411187
Thymus [bpoc]     3.4411187
LOT [inpr]     3.4411187
Deoxyguanosine [nnon]     3.4411187
lifesaving [topp]     3.4411187
Determinant [qlco]     3.4411187
Libya [geoa]     3.4411187
Atherogenesis [patf]     3.4411187
5 stages [inpr]     3.4411187
MRI Scan [qnco]     3.4411187
Minimally Invasive Surgery [topp]     3.4411187
Caput [blor]     3.4411187
Multiple malignancy [neop]     3.4411187
Demyelination [patf]     3.4411187
Methicillin-resistant staphylococcus aureus [dsyn]     3.4411187
Neoangiogenesis [patf]     3.4411187
Fixed Specimen [bdsu]     3.4411187
Orbit [bsoj]     3.4411187
Rat Hepatocellular Carcinoma [neop]     3.4411187
Immunoblot Analysis [lbpr]     3.4411187
sex partner [popg]     3.4411187
Nodular regeneration [ortf]     3.4411187
Hyperthyroidism [dsyn]     3.4411187
ignored [idcn]     3.4411187
Time-of-Flight [qnco]     3.4411187
Centromere [celc]     3.4411187
Multidrug Resistance Gene [gngm]     3.4411187
Effector Cell [cell]     3.4411187
PM [tmco]     3.4411187
Paracentesis [hlca]     3.4411187
Recurrent Cholangiocarcinoma [neop]     3.4411187
Level 3 [inpr]     3.4411187
illegal drug use [inbe]     3.4411187
CGH [dsyn]     3.4411187
poorly differentiated cancer [neop]     3.4411187
Progressive liver failure [fndg]     3.4411187
Anaplastic [qlco]     3.4411187
Hepatic lithiasis [dsyn]     3.4411187
Decreased Activity [sosy]     3.4411187
Proton Beam Therapy [topp]     3.4411187
school children [aggp]     3.4411187
Total gastrectomy [topp]     3.4411187
Preventative treatment [topp]     3.4411187
Laminectomy [topp]     3.4411187
apoptosis signaling [celf]     3.4411187
Refugees [popg]     3.4411187
Spectroscopy, Nuclear Magnetic Resonance [diap]     3.4411187
nucleic acid sequence [nusq]     3.4411187
Arterial procedure [topp]     3.4411187
Socioeconomic Factor [grpa]     3.4411187
mol/L [qnco]     3.4411187
Sterile [topp]     3.4411187
Platelet Counts, Blood [lbpr]     3.4411187
DISC [medd]     3.4411187
Carcinogeneses [neop]     3.4411187
Eastern Cooperative Oncology Group performance status [clna]     3.4411187
ASPM [gngm]     3.4411187
5 minute [topp]     3.4411187
Multiple Sclerosis [dsyn]     3.4411187
Job [ocdi]     3.4411187
treatment evaluation [hlca]     3.4411187
Group L [inpr]     3.4411187
EU [orgt]     3.4411187
Optical Biopsy [diap]     3.4411187
urinary levels [ftcn]     3.4411187
Endocrine disorder [dsyn]     3.4411187
dg [qnco]     3.4411187
Energy Intake [qnco]     3.4411187
ABCB11 [gngm]     3.4411187
Densitometries [lbpr]     3.4411187
Non-Reactive [qlco]     3.4411187
Premalignant Change [fndg]     3.4411187
Vertebrate [vtbt]     3.4411187
Berlin [geoa]     3.4411187
audience [popg]     3.4411187
Cytologic Technique [lbpr]     3.4411187
high iron [fndg]     3.4411187
Colorectal resection [topp]     3.4411187
Transplant Waiting List [inpr]     3.4411187
REF [gngm]     3.4411187
Peliosis Hepatis [dsyn]     3.4411187
abbott [hcro]     3.4411187
Sudanese [popg]     3.4411187
chest tomography [diap]     3.4411187
Tower [mnob]     3.4411187
Modifications, Dietary [topp]     3.4411187
Markers, Risk [qlco]     3.4411187
Format [spco]     3.4411187
Body Piercing [inbe]     3.4411187
increased blood urea nitrogen [fndg]     3.4411187
Dark color [qlco]     3.4411187
Normal liver histology [fndg]     3.4411187
Verbal [qlco]     3.4411187
C-I [clas]     3.4411187
Hepatitis B virus core Antigen [imft]     3.4411187
disease characteristic [patf]     3.4411187
5q [nusq]     3.4411187
Nitrosation [moft]     3.4411187
Sida [euka]     3.4411187
REC [gngm]     3.4411187
Undifferentiated carcinoma [neop]     3.4411187
Oestradiol level [lbpr]     3.4411187
Staining method [lbpr]     3.4411187
Cytoskeletal [celc]     3.4411187
ATP8B1 [gngm]     3.4411187
hepatitis c rna [lbpr]     3.4411187
Seed [plnt]     3.4411187
therapy, hormonal [topp]     3.4411187
Shop [dora]     3.4411187
Blood Platelet Count [lbpr]     3.4411187
Willing [fndg]     3.4411187
SMAD3 [gngm]     3.4411187
Health conditions [clna]     3.4411187
Blast [npop]     3.4411187
Cerebrum [bpoc]     3.4411187
Quebec [geoa]     3.4411187
Dysglycemia [dsyn]     3.4411187
Panendoscopy [diap]     3.4411187
Neuronal [cell]     3.4411187
Haemangiosarcoma [neop]     3.4411187
Evidence-Based Medicine [bmod]     3.4411187
plasma glucose level [lbtr]     3.4411187
Treatment Study [resa]     3.4411187
Rats, F344 [mamm]     3.4411187
medication use [fndg]     3.4411187
Organ transplant [tisu]     3.4411187
Albino [cgab]     3.4411187
Reach [fndg]     3.4411187
Unresponsive [ftcn]     3.4411187
Cancer Survivor [podg]     3.4411187
Analysis, Factor [qnco]     3.4411187
Mouse, Nude [mamm]     3.4411187
Acute inflammation [fndg]     3.4411187
Extrahepatic Bile Duct Adenocarcinoma [neop]     3.4411187
Drainage procedure [topp]     3.4411187
skin burn [inpo]     3.4411187
Lager [food]     3.4411187
Speaker [mnob]     3.4411187
i d [topp]     3.4411187
Ethnic background [popg]     3.4411187
porphyrin metabolism [moft]     3.4411187
Cecal [bpoc]     3.4411187
Axillary lymph node [bpoc]     3.4411187
FATE [gngm]     3.4411187
Reprint [inpr]     3.4411187
Pancreatic Tumor [neop]     3.4411187
previous diagnosis [qlco]     3.4411187
Fatty Acid Metabolism [moft]     3.4411187
Overnight [tmco]     3.4411187
Liquid diet [topp]     3.4411187
Virilism [sosy]     3.4411187
batteries [mnob]     3.4411187
Siemens [qnco]     3.4411187
Latin American [popg]     3.4411187
Prairie Dogs [mamm]     3.4411187
MDM2 [gngm]     3.4411187
hypocellular [comd]     3.4411187
Disease-specific Survival Rate [qnco]     3.4411187
Congenital hemihypertrophy [cgab]     3.4411187
common procedure [topp]     3.4411187
Ground squirrel hepatitis virus [virs]     3.4411187
Hypoxaemia [fndg]     3.4411187
Serum triglyceride levels [lbpr]     3.4411187
Specific immune response [ortf]     3.4411187
Supplies [mnob]     3.4411187
Laryngeal Cancer [neop]     3.4411187
Amino Acid Sequence [amas]     3.4411187
Polyvinyl Alcohol [bodm]     3.4411187
via [idcn]     3.4411187
V 2 [inpr]     3.4411187
Pseudotumor [acab]     3.4411187
Cardiopulmonary [blor]     3.4411187
Biopsy forceps [medd]     3.4411187
Transmission mode [fndg]     3.4411187
Technetium 99m [irda]     3.4411187
Minerals [inch]     3.4411187
Haploinsufficiencies [comd]     3.4411187
Laotian [popg]     3.4411187
Drunk [mobd]     3.4411187
Incubation period [fndg]     3.4411187
Glycome [ocdi]     3.4411187
Serum alkaline phosphatase level [lbpr]     3.4411187
Increased serum alpha-fetoprotein [fndg]     3.4411187
Myeloid [qlco]     3.4411187
Immunologic Factors [imft]     3.4411187
7q [nusq]     3.4411187
physical condition [fndg]     3.4411187
Histopathology Grade [clas]     3.4411187
Cholangiole [bpoc]     3.4411187
Reporter Gene [gngm]     3.4411187
FDR [famg]     3.4411187
Polysomes [celc]     3.4411187
Serum insulin-like growth factor 1 level [lbpr]     3.4411187
Arterial [ortf]     3.4411187
Straight [spco]     3.4411187
available drug [fndg]     3.4411187
N-myc downstream regulated 1 [gngm]     3.4411187
Vein thrombosis [patf]     3.4411187
CATHETER, PERCUTANEOUS [medd]     3.4411187
hepato-renal [bpoc]     3.4411187
Wetland [npop]     3.4411187
binge [mobd]     3.4411187
Cancel [qlco]     3.4411187
Overlap syndrome [dsyn]     3.4411187
Invasive procedure [topp]     3.4411187
Nutritional Support [topp]     3.4411187
Stand alone [fndg]     3.4411187
Drug Cost [qnco]     3.4411187
PHARMACOKINETIC [phsf]     3.4411187
Mediterranean Region [geoa]     3.4411187
Angiogenesis Factor [bacs]     3.4411187
General Surgical Procedures [topp]     3.4411187
L/L [qnco]     3.4411187
Postoperative renal failure [patf]     3.4411187
Genome Wide Association Analysis [mbrt]     3.4411187
brain lesions [dsyn]     3.4411187
Hmong [popg]     3.4411187
Liver necrosis [dsyn]     3.4411187
Nano [qnco]     3.4411187
Postoperative Wound Infection [patf]     3.4411187
Hepatic impairment [dsyn]     3.4411187
Converge [acty]     3.4411187
Blood Screening [lbpr]     3.4411187
metabolic disturbance [dsyn]     3.4411187
Interim [tmco]     3.4411187
Medical Image [diap]     3.4411187
gleason score [clas]     3.4411187
vice [idcn]     3.4411187
Gastroduodenal [spco]     3.4411187
Health Care Costs [qnco]     3.4411187
ASTROCYTE ELEVATED GENE 1 [gngm]     3.4411187
Kava [plnt]     3.4411187
Adaptive Immune Response [orgf]     3.4411187
Palliative Surgery [topp]     3.4411187
Pelvic [blor]     3.4411187
Inflammatory pseudotumour [neop]     3.4411187
Monte Carlo [qnco]     3.4411187
Endoscopic biopsy [diap]     3.4411187
Tablet [bodm]     3.4411187
Environmental Factor [qlco]     3.4411187
increased ggt [fndg]     3.4411187
Bronchus [bpoc]     3.4411187
Drug Interactions [moft]     3.4411187
Food, Preserved [food]     3.4411187
welfare [shro]     3.4411187
PHARMACOKINETIC [resa]     3.4411187
Severe Combined Immunodeficiencies [dsyn]     3.4411187
oxidative metabolism [celf]     3.4411187
Traumatic [ftcn]     3.4411187
ornithine decarboxylase activity [moft]     3.4411187
Abdominal mass [fndg]     3.4411187
Tyrosine Kinase Inhibitor [moft]     3.4411187
Gallbladder Adenoma [neop]     3.4411187
NUC [gngm]     3.4411187
Intervention Trial [resa]     3.4411187
Congenital dilatation [cgab]     3.4411187
Immunodeficient [dsyn]     3.4411187
Varix [dsyn]     3.4411187
Through [ftcn]     3.4411187
Nose [bpoc]     3.4411187
Hyperuricaemia [dsyn]     3.4411187
Echocardiography [diap]     3.4411187
Rb Gene [gngm]     3.4411187
luciferase activity [moft]     3.4411187
Urban residential [spco]     3.4411187
viral therapy [topp]     3.4411187
Pruritis [sosy]     3.4411187
Growth retardation [patf]     3.4411187
Viral Pathogenesis [patf]     3.4411187
Zone 3 [blor]     3.4411187
Gastroesophageal [blor]     3.4411187
Serum total bilirubin level [lbpr]     3.4411187
alkyl [orch]     3.4411187
Alternative Therapies [bmod]     3.4411187
Malignancy, Hematological [neop]     3.4411187
Ascitic Fluid [bdsu]     3.4411187
Lithotripsy [topp]     3.4411187
High-Density Microarray [mnob]     3.4411187
cholesterol metabolism [moft]     3.4411187
ABO [topp]     3.4411187
Hepatic lobule [bpoc]     3.4411187
Lupus Erythematosus, Systemic [dsyn]     3.4411187
Iodide [inch]     3.4411187
Systolic [tmco]     3.4411187
Thermal techniques [topp]     3.4411187
Cholinesterase level [lbpr]     3.4411187
Human Papillomavirus Infection [dsyn]     3.4411187
Book [inpr]     3.4411187
Muscular [tisu]     3.4411187
benefit risk [qlco]     3.4411187
HER-2/NEU [gngm]     3.4411187
3 grade [qlco]     3.4411187
Virion [celc]     3.4411187
diabetes obesity [fndg]     3.4411187
Vital sign [clna]     3.4411187
Myeloproliferative disorder [neop]     3.4411187
Expenditure [qnco]     3.4411187
Acute Porphyria [dsyn]     3.4411187
Access [inpr]     3.4411187
Stigmata [fndg]     3.4411187
Thrombocyte [cell]     3.4411187
Goblet cell [cell]     3.4411187
System, Information [inpr]     3.4411187
Quotient [qnco]     3.4411187
Peak systolic [ortf]     3.4411187
FDG-Positron Emission Tomography [diap]     3.4411187
Gabon [geoa]     3.4411187
filtration [lbpr]     3.4411187
Kruskal-Wallis Test [inpr]     3.4411187
Skin lesion [dsyn]     3.4411187
Pollutant [eehu]     3.4411187
Cigarette consumption [fndg]     3.4411187
Congestion [qlco]     3.4411187
lactate [orgf]     3.4411187
Alopecia [fndg]     3.4411187
Aortic [bpoc]     3.4411187
Digital Image Analysis [diap]     3.4411187
Stage D [inpr]     3.4411187
tumor vasculature [neop]     3.4411187
Obstetrician [prog]     3.4411187
GSTP1 gene [gngm]     3.4411187
Analgesics [phsu]     3.4411187
Focal necrosis [patf]     3.4411187
Enzymatic Activity [moft]     3.4411187
Colon polyps [anab]     3.4411187
Plastic stent [medd]     3.4411187
Clinical infection [dsyn]     3.4411187
Nitroso Compounds [orch]     3.4411187
Chronic graft-versus-host disease [dsyn]     3.4411187
oral cavity cancer [neop]     3.4411187
increased insulin [dsyn]     3.4411187
Hemi-hypertrophy [cgab]     3.4411187
Thyroid disease [dsyn]     3.4411187
high haemoglobin [fndg]     3.4411187
Sequestered [ftcn]     3.4411187
Nigeria [geoa]     3.4411187
Quantitative PCR analysis [lbpr]     3.4411187
Anchorage [acty]     3.4411187
Increased fibrosis [fndg]     3.4411187
Spiral computed tomography scan [diap]     3.4411187
FDA [hcro]     3.4411187
angiogram [diap]     3.4411187
high albumin [fndg]     3.4411187
Estrogen Replacement Therapy [topp]     3.4411187
MMF [topp]     3.4411187
beneficiary [idcn]     3.4411187
CK8 [gngm]     3.4411187
Donor organ [popg]     3.4411187
Integer [qnco]     3.4411187
f group [clas]     3.4411187
adrenal metastases [neop]     3.4411187
Characteristics, Biologic [grpa]     3.4411187
Diabetes-Related Complications [patf]     3.4411187
Vacuolated [qlco]     3.4411187
addicted [podg]     3.4411187
Juvenile [aggp]     3.4411187
Gastric bleeding [dsyn]     3.4411187
Infrared [qlco]     3.4411187
encyclopedia [inpr]     3.4411187
6p [nusq]     3.4411187
Papillary tumor [neop]     3.4411187
Atrophic [patf]     3.4411187
Vmax [phpr]     3.4411187
Mutations, Missense [genf]     3.4411187
Lewis rat [mamm]     3.4411187
Postprandial [tmco]     3.4411187
Adenomatous Polyposis Coli, Familial [neop]     3.4411187
Pneumocystis carini [fngs]     3.4411187
GSTM1 gene [gngm]     3.4411187
Dull pain [sosy]     3.4411187
YAP [gngm]     3.4411187
Fragility [comd]     3.4411187
Frequency Distribution [qnco]     3.4411187
Hardware [mnob]     3.4411187
Matrices [mnob]     3.4411187
stent insertion [topp]     3.4411187
Ni [elii]     3.4411187
Interaction Analysis [qnco]     3.4411187
V1 [fndg]     3.4411187
taxonomy [ftcn]     3.4411187
Vena [bpoc]     3.4411187
Medulloblastoma [neop]     3.4411187
Musculoskeletal [ftcn]     3.4411187
Biotransformation [orgf]     3.4411187
Pinto [mamm]     3.4411187
thin section [lbpr]     3.4411187
Total Resection [topp]     3.4411187
ECM [tisu]     3.4411187
3D image [mnob]     3.4411187
Backbone [bpoc]     3.4411187
erythrocytosis [dsyn]     3.4411187
ATX [gngm]     3.4411187
White Adipose Tissue [tisu]     3.4411187
Peripancreatic [spco]     3.4411187
Continent [qlco]     3.4411187
Bioluminescence [biof]     3.4411187
United States of America [geoa]     3.4411187
Evidence-Based Practice [ftcn]     3.4411187
Peanut [food]     3.4411187
right shoulder pain [sosy]     3.4411187
Prison Inmates [popg]     3.4411187
Detection Limit [qnco]     3.4411187
Three-Dimensional Image [mnob]     3.4411187
fight [socb]     3.4411187
Posterosuperior [spco]     3.4411187
defense mechanism [menp]     3.4411187
M Stage [celf]     3.4411187
Marker, Clinical [qlco]     3.4411187
dysmetabolic syndrome [dsyn]     3.4411187
bay [inbe]     3.4411187
Cell Kinetics [ocdi]     3.4411187
Switzerland [geoa]     3.4411187
Biannually [tmco]     3.4411187
SJ [geoa]     3.4411187
Disease, Bile Duct [dsyn]     3.4411187
Psoas muscle [bpoc]     3.4411187
Calorimetry, Indirect [lbpr]     3.4411187
bore [qnco]     3.4411187
Natural Killer T-Cell [cell]     3.4411187
Hepatic atrophy [dsyn]     3.4411187
GALECTIN 9 [gngm]     3.4411187
Cold Ischemia [dsyn]     3.4411187
Worker [ocdi]     3.4411187
beta protein [genf]     3.4411187
Biliary Disorder [dsyn]     3.4411187
Glycogenosis [dsyn]     3.4411187
Electrical [npop]     3.4411187
Macrotrabecular Hepatoblastoma [neop]     3.4411187
elevated ggt [fndg]     3.4411187
Norway [geoa]     3.4411187
alternate [patf]     3.4411187
Metabolic Processes [orgf]     3.4411187
polyenylphosphatidylcholine [lipd]     3.4411187
Biliary Cirrhosis, Secondary [dsyn]     3.4411187
Lambda [blor]     3.4411187
Twice daily [tmco]     3.4411187
Epithelial ovarian cancer [neop]     3.4411187
Right anterior [spco]     3.4411187
recidivism [inbe]     3.4411187
Local [geoa]     3.4411187
Increased alanine aminotransferase [fndg]     3.4411187
stone extraction [topp]     3.4411187
prevention program [inpr]     3.4411187
hungarian [lang]     3.4411187
Conservation [qlco]     3.4411187
Confidence Limit [qnco]     3.4411187
Tertiary Prevention [topp]     3.4411187
Crude Survival [qnco]     3.4411187
Interdisciplinary Research [ocac]     3.4411187
Antibiotic therapy [topp]     3.4411187
Machine [mnob]     3.4411187
anticancer therapy [topp]     3.4411187
NANOG [gngm]     3.4411187
Caveat [gora]     3.4411187
Increased lipid [fndg]     3.4411187
Pancreas Cancer [neop]     3.4411187
Le [bpoc]     3.4411187
TWIST2 [gngm]     3.4411187
Poland [geoa]     3.4411187
Amino acid pattern [lbpr]     3.4411187
Leucopenia [dsyn]     3.4411187
Gelfoam [medd]     3.4411187
Portacaval [spco]     3.4411187
Induction Therapy [topp]     3.4411187
physical agents [phob]     3.4411187
Hospital Readmission [hlca]     3.4411187
Internal radiotherapy [topp]     3.4411187
Renal tumor [neop]     3.4411187
cancer associated gene [gngm]     3.4411187
Mammographies [diap]     3.4411187
disposable [medd]     3.4411187
Colombia [geoa]     3.4411187
genetic association [ocdi]     3.4411187
Abnormalities, Chromosomal [comd]     3.4411187
Overall status [fndg]     3.4411187
ATF6 [gngm]     3.4411187
Cytopathic effect [patf]     3.4411187
Graft infection [patf]     3.4411187
predictive validity [qlco]     3.4411187
Chinese herbal medicine [topp]     3.4411187
Low grade glioma [neop]     3.4411187
drug response [orgf]     3.4411187
travel [dora]     3.4411187
Resistant to [ftcn]     3.4411187
Transmembrane protein [aapp]     3.4411187
Diabetes mellitus type II [dsyn]     3.4411187
Postpartum [tmco]     3.4411187
Patient State [fndg]     3.4411187
Gross Pathological Examination [diap]     3.4411187
Palpation [diap]     3.4411187
Nuclear Atypia [fndg]     3.4411187
High molecular weight [qlco]     3.4411187
Anastomotic Leak [patf]     3.4411187
7p [nusq]     3.4411187
PSTI [gngm]     3.4411187
Endoscopic nasobiliary drainage [topp]     3.4411187
Paradoxical [qlco]     3.4411187
Progressive inflammation [patf]     3.4411187
NAT-2 [gngm]     3.4411187
ICD-9-CM [inpr]     3.4411187
17q [nusq]     3.4411187
Basal Ganglia [bpoc]     3.4411187
Ventilated [phsf]     3.4411187
normal patients [fndg]     3.4411187
Angle [spco]     3.4411187
Anatomical Abnormality [anab]     3.4411187
Condom [medd]     3.4411187
Venous stenosis [patf]     3.4411187
Disease Pathway [cnce]     3.4411187
Porphyria, Acute Hepatic [dsyn]     3.4411187
18 25 [qnco]     3.4411187
GLUCOSE CONTROL [irda]     3.4411187
Sun Exposure [fndg]     3.4411187
Catalog [inpr]     3.4411187
Palpable [qlco]     3.4411187
External drainage [topp]     3.4411187
Intercellular Communication [celf]     3.4411187
Burkitt Lymphoma [neop]     3.4411187
Cardiovascular Disorders [dsyn]     3.4411187
FFP [bdsu]     3.4411187
Exaggerated [qlco]     3.4411187
Redox [moft]     3.4411187
Pulmonary Hypertension [dsyn]     3.4411187
Sis. [cnce]     3.4411187
Partial Thromboplastin Time [lbpr]     3.4411187
Breast Cancer Cell [cell]     3.4411187
Adult Health [inpr]     3.4411187
detoxication [orgf]     3.4411187
Intronic SNP [nusq]     3.4411187
Thinking [menp]     3.4411187
Chest CT [diap]     3.4411187
Right hypochondrial pain [sosy]     3.4411187
Cranial [bpoc]     3.4411187
Cryosurgery [topp]     3.4411187
Dissociation [mobd]     3.4411187
MALDI-TOF Mass Spectrometry [resa]     3.4411187
cut needle [medd]     3.4411187
Preneoplastic Change [comd]     3.4411187
Liver Hemangioma [neop]     3.4411187
Thromboses [patf]     3.4411187
Non Adherence [fndg]     3.4411187
Urban Population [popg]     3.4411187
upper endoscopy [diap]     3.4411187
stage, neuroblastoma [neop]     3.4411187
national health institute [hcro]     3.4411187
Renal biopsy [diap]     3.4411187
North African country [geoa]     3.4411187
pre pregnancy [tmco]     3.4411187
Pulmonary embolus [dsyn]     3.4411187
Assessed Patient [hlca]     3.4411187
4s [bpoc]     3.4411187
Compensatory hypertrophy [comd]     3.4411187
Michigan [geoa]     3.4411187
miRNA biogenesis [genf]     3.4411187
Localisation [spco]     3.4411187
Benign Neoplasms [neop]     3.4411187
Pulsatile Flow [phpr]     3.4411187
Mismatch Repair [genf]     3.4411187
/10 minutes [tmco]     3.4411187
Sensor [medd]     3.4411187
Pancreatoblastoma [neop]     3.4411187
Explantation [hlca]     3.4411187
Constraint [ftcn]     3.4411187
stressors [idcn]     3.4411187
Radiochemotherapy [topp]     3.4411187
Venous Obstruction [patf]     3.4411187
Pathognomonic sign [sosy]     3.4411187
ECOG performance status [clna]     3.4411187
Reproductive Factors [fndg]     3.4411187
Young Adult [aggp]     3.4411187
S6 [gngm]     3.4411187
IRB Approval [rnlw]     3.4411187
high throughput technology [inpr]     3.4411187
NM23 [gngm]     3.4411187
Fat diet [topp]     3.4411187
Vaccine Therapy [topp]     3.4411187
PY [geoa]     3.4411187
Transcriptional Control [genf]     3.4411187
Simple cyst [anab]     3.4411187
Mail [mnob]     3.4411187
Bank [mnob]     3.4411187
FAPy [orch]     3.4411187
Tie [mnob]     3.4411187
arterio-venous [bpoc]     3.4411187
MCP1 [bpoc]     3.4411187
Dentistry [bmod]     3.4411187
ALD [dsyn]     3.4411187
Neutrophile [celf]     3.4411187
Chronic phase [tmco]     3.4411187
Labor [orgf]     3.4411187
Scale [fndg]     3.4411187
insulin secretion [celf]     3.4411187
Cell Cycle Checkpoint [celf]     3.4411187
Esophagogastric [blor]     3.4411187
Sphincterotomy, Endoscopic [topp]     3.4411187
Mutations, Deletion [genf]     3.4411187
Mesenteries [blor]     3.4411187
Brain Death [patf]     3.4411187
Portugal [geoa]     3.4411187
Freedom [idcn]     3.4411187
Patient chart [medd]     3.4411187
Treatments, Palliative [hlca]     3.4411187
dynamic contrast-enhanced magnetic resonance imaging [diap]     3.4411187
Level 1 [inpr]     3.4411187
disorders iron [dsyn]     3.4411187
Trichrome [qlco]     3.4411187
Hydration [fndg]     3.4411187
Overnutrition [dsyn]     3.4411187
Liver Abscess, Pyogenic [dsyn]     3.4411187
Thermal injury [inpo]     3.4411187
Iodinated Contrast Agent [irda]     3.4411187
V2 [fndg]     3.4411187
Abdominal infection [dsyn]     3.4411187
GenBank [inpr]     3.4411187
Infection Transmission [patf]     3.4411187
bone lesions [dsyn]     3.4411187
Acoustic radiation [bpoc]     3.4411187
Canonical Wnt Signaling Pathway [moft]     3.4411187
Mice, BALB C [mamm]     3.4411187
AMS [dsyn]     3.4411187
Ignore [idcn]     3.4411187
Serotype [inpr]     3.4411187
Nodular Pattern [fndg]     3.4411187
MVD [gngm]     3.4411187
Concurrent Chemoradiotherapy [topp]     3.4411187
Producer [humn]     3.4411187
Age-Months [orga]     3.4411187
Peritoneal adhesions [acab]     3.4411187
Elderly man [aggp]     3.4411187
Option [qlco]     3.4411187
Psychologic [ftcn]     3.4411187
Resected Mass [fndg]     3.4411187
General medicine [bmod]     3.4411187
Kidney Function Tests [lbpr]     3.4411187
Increased density [fndg]     3.4411187
Immune Dysfunction [dsyn]     3.4411187
respect [socb]     3.4411187
SIRS, NOS [dsyn]     3.4411187
Regulated [rnlw]     3.4411187
dietary intervention [topp]     3.4411187
virus load [lbpr]     3.4411187
pacific island [geoa]     3.4411187
Genetic Algorithm [inpr]     3.4411187
Morning [tmco]     3.4411187
NH3 [lbpr]     3.4411187
Glycogen storage disease type Ia [dsyn]     3.4411187
KIP1 [gngm]     3.4411187
Liver+Spleen [bpoc]     3.4411187
XRCC1 gene [gngm]     3.4411187
Blood Group [clas]     3.4411187
Lipodystrophy [dsyn]     3.4411187
hypoventilation [patf]     3.4411187
Scotland [geoa]     3.4411187
Loss of Heterozygosity Analysis [mbrt]     3.4411187
Candida [fngs]     3.4411187
Lymphocytes, Tumor-Infiltrating [cell]     3.4411187
Telangiectatic Hepatocellular Adenoma [neop]     3.4411187
MELAN A [gngm]     3.4411187
Associated mechanism [ftcn]     3.4411187
Infertility treatment [topp]     3.4411187
socio economic status [qlco]     3.4411187
Thermotherapy [topp]     3.4411187
Meat intake [fndg]     3.4411187
Tuberculosis, Hepatic [dsyn]     3.4411187
quality assurance [ocac]     3.4411187
HBV status [clna]     3.4411187
tumor blood vessel [neop]     3.4411187
Class II [inpr]     3.4411187
Asian origin [fndg]     3.4411187
Disease history [fndg]     3.4411187
DISEASE RELAPSE [dsyn]     3.4411187
inhalant [orgf]     3.4411187
TPTE2 [gngm]     3.4411187
Sequential Treatment [topp]     3.4411187
Quality of life [idcn]     3.4411187
Antibody Response [biof]     3.4411187
DOXORUBICIN RESISTANCE [gngm]     3.4411187
Care Delivery [hlca]     3.4411187
Antagonist [chvf]     3.4411187
GPS [dsyn]     3.4411187
Sea [geoa]     3.4411187
Diagnostic laparoscopy, NOS [diap]     3.4411187
Apathy [sosy]     3.4411187
Deep Sequencing [mbrt]     3.4411187
Unsolved [cnce]     3.4411187
HGV [virs]     3.4411187
alcoholic beverage consumption [inbe]     3.4411187
T3a [fndg]     3.4411187
Acetylation [moft]     3.4411187
Digestive Tumor [neop]     3.4411187
Genetic Risk [qnco]     3.4411187
Separate [patf]     3.4411187
cell free [cell]     3.4411187
Fisher [mamm]     3.4411187
abd [blor]     3.4411187
Metabolic Profile [npop]     3.4411187
REGAIN [food]     3.4411187
Blockage [fndg]     3.4411187
Neuronal [imft]     3.4411187
IgG antibody [celc]     3.4411187
newborn baby [aggp]     3.4411187
Blacksmith [fish]     3.4411187
Carcinogen Metabolism [moft]     3.4411187
Holistic [prog]     3.4411187
Instil [hlca]     3.4411187
Cell phenotype [lbpr]     3.4411187
Author [socb]     3.4411187
Blood Loss, Surgical [patf]     3.4411187
Bone scan [diap]     3.4411187
dietary restriction [fndg]     3.4411187
Central Vein [bpoc]     3.4411187
Extranodal [spco]     3.4411187
homeostatic [biof]     3.4411187
Protein Overexpression [genf]     3.4411187
lipogenesis [moft]     3.4411187
Comprehension [menp]     3.4411187
Appetite [orgf]     3.4411187
Congenital Abnormalities [cgab]     3.4411187
ISK [gngm]     3.4411187
Pre-Eclampsia [patf]     3.4411187
Phase 3 [tmco]     3.4411187
Gene Regulation [genf]     3.4411187
Balloon [mnob]     3.4411187
Plaque [acab]     3.4411187
Large bowel [bpoc]     3.4411187
Medical Examination [hlca]     3.4411187
Notification [hlca]     3.4411187
Gene cluster [gngm]     3.4411187
ov [inpr]     3.4411187
Mucinous Tumor [neop]     3.4411187
Personal History [fndg]     3.4411187
.5 L [qnco]     3.4411187
A-2 [gngm]     3.4411187
Rapid onset [fndg]     3.4411187
Time Dimension [tmco]     3.4411187
Repeatedly [ftcn]     3.4411187
Variegate Porphyria [dsyn]     3.4411187
Cholecystitis, Acute [dsyn]     3.4411187
Anatomical position [blor]     3.4411187
deficits [qlco]     3.4411187
foster [dora]     3.4411187
Splenic Vein [bpoc]     3.4411187
Ultrasonic Imaging [diap]     3.4411187
Choledochotomy [topp]     3.4411187
intervention programs [topp]     3.4411187
recombinant [genf]     3.4411187
Cervix Uteri [bpoc]     3.4411187
Nucleotide Sequence [nusq]     3.4411187
Cytoplasmic accumulation [comd]     3.4411187
Cognition [ftcn]     3.4411187
TJ-9 [phsu]     3.4411187
Fasting blood sugar [lbtr]     3.4411187
SMAD7 [gngm]     3.4411187
Decay [acab]     3.4411187
Autopsy report [clna]     3.4411187
ALPHA GENE [gngm]     3.4411187
Thorotrast Exposure [fndg]     3.4411187
gene methylation [fndg]     3.4411187
Percutaneous transhepatic cholangiography [diap]     3.4411187
Tyrosinaemia [dsyn]     3.4411187
nodule formation [ortf]     3.4411187
medical personnel [prog]     3.4411187
Pediatric Pathology [inpr]     3.4411187
Elevated fasting glucose [fndg]     3.4411187
Pixel [cnce]     3.4411187
Inventory [mnob]     3.4411187
Intubation [topp]     3.4411187
transdifferentiation [celf]     3.4411187
Pancreatic Neoplasms [neop]     3.4411187
Habitat [spco]     3.4411187
Staphylococcus [bact]     3.4411187
Bioenergetic [orgf]     3.4411187
Respiratory quotient [lbtr]     3.4411187
Intrahepatic biliary tree [bpoc]     3.4411187
Hormone-sensitive [ftcn]     3.4411187
Induction Chemotherapy [topp]     3.4411187
SSCP [lbtr]     3.4411187
Ultrasound elastography [diap]     3.4411187
Cross-Reference [inpr]     3.4411187
Spiral [spco]     3.4411187
Corn Oil [food]     3.4411187
Ultrasound procedure [diap]     3.4411187
Major Operative [idcn]     3.4411187
Gene Silencing [genf]     3.4411187
cell transformation [celf]     3.4411187
plasma lipid [lbpr]     3.4411187
Door [mnob]     3.4411187
Intrahepatic portal vein [bpoc]     3.4411187
Homeo Box [gngm]     3.4411187
LR [dsyn]     3.4411187
Class II MHC [gngm]     3.4411187
Urinary tract [bpoc]     3.4411187
Alcohol-Related Disorders [mobd]     3.4411187
Biliary Intraepithelial Neoplasia-2 [neop]     3.4411187
Nodular hyperplasia [patf]     3.4411187
fueled [mnob]     3.4411187
Level 2 [inpr]     3.4411187
Pain relief [topp]     3.4411187
Biliary Stasis [dsyn]     3.4411187
Bengal [inpr]     3.4411187
apparatus [mnob]     3.4411187
Clinical heterogeneity [fndg]     3.4411187
Hepatic vasculature [bpoc]     3.4411187
pancreatico [bpoc]     3.4411187
diagnostic classification [inpr]     3.4411187
Spiral CT [diap]     3.4411187
Emerging Technologies [qlco]     3.4411187
Northwest [spco]     3.4411187
Education, Patient [edac]     3.4411187
Distributions, Age [qnco]     3.4411187
Negative Surgical Margin [fndg]     3.4411187
pound [qnco]     3.4411187
Pre-Clinical Model [inpr]     3.4411187
Receptor Signaling [moft]     3.4411187
medical complication [patf]     3.4411187
superoxide dismutase activity [moft]     3.4411187
Imaging Information [qlco]     3.4411187
Multiple markers [clna]     3.4411187
Myocardial [spco]     3.4411187
Anat [bmod]     3.4411187
pmol/mg [qnco]     3.4411187
Intermittent administration [topp]     3.4411187
Large vein [bpoc]     3.4411187
Colorectal Adenocarcinoma [neop]     3.4411187
Life Table Analysis [ocac]     3.4411187
Cholestatic hepatic disorder [dsyn]     3.4411187
3rd trimester [tmco]     3.4411187
Lipid deposition [fndg]     3.6172101
Polygon [spco]     3.6172101
infection inflammation [patf]     3.6172101
Regulatory Pathway [ftcn]     3.6172101
CX26 [gngm]     3.6172101
Cross Sectional Analysis [resa]     3.6172101
PULSE [hlca]     3.6172101
Hypercalcaemia [dsyn]     3.6172101
IBM [dsyn]     3.6172101
Staphylococcus, coagulase negative [bact]     3.6172101
Normal size [qnco]     3.6172101
Group 2B [inpr]     3.6172101
45 Minutes [tmco]     3.6172101
Fusion Gene [mbrt]     3.6172101
molecular function [moft]     3.6172101
Biopsy gun [medd]     3.6172101
Periampullary Region [blor]     3.6172101
Fluke infection [dsyn]     3.6172101
GCKR [gngm]     3.6172101
Embryonic Cell [emst]     3.6172101
Centripetal [qlco]     3.6172101
Limanda limanda [fish]     3.6172101
hepatic neoplasias [neop]     3.6172101
cl-49 [gngm]     3.6172101
copper histidine [aapp]     3.6172101
Referenced [cnce]     3.6172101
MONOCARBOXYLATE TRANSPORTER 4 [gngm]     3.6172101
STXBP5L [gngm]     3.6172101
light examination [medd]     3.6172101
Mononuclear [clna]     3.6172101
estrogen use [fndg]     3.6172101
Center [menp]     3.6172101
DH [dsyn]     3.6172101
Islet Cells [bpoc]     3.6172101
Pleural fluid [bdsu]     3.6172101
Peritoneal Dialysis [topp]     3.6172101
Prevalence Studies [qnco]     3.6172101
Aleuria aurantia [fngs]     3.6172101
Globule [bodm]     3.6172101
Bone Tissue [tisu]     3.6172101
Hypercoagulabilities [dsyn]     3.6172101
Collimation [medd]     3.6172101
Chimney sweep [prog]     3.6172101
Primary tumour site [clna]     3.6172101
Complete Recovery [fndg]     3.6172101
RNA-mediated gene silencing [genf]     3.6172101
Nuclear Import [celf]     3.6172101
Increased liver function tests [fndg]     3.6172101
Accrual [ftcn]     3.6172101
Moderate epithelial dysplasia [comd]     3.6172101
petroleum products [orch]     3.6172101
Papillotomy [topp]     3.6172101
Lung disease NOS [dsyn]     3.6172101
Brain Dead [patf]     3.6172101
growth regulation [orgf]     3.6172101
chop [acty]     3.6172101
Encapsulated tumor [fndg]     3.6172101
Tea intake [fndg]     3.6172101
blood vessel remodeling [ortf]     3.6172101
CHOLANGIOCARCINOMA, MALIGNANT [neop]     3.6172101
bacterial overgrowth [patf]     3.6172101
Medical equipment [medd]     3.6172101
Pharmacoepidemiology [bmod]     3.6172101
Lung Biopsy [diap]     3.6172101
Diagram [inpr]     3.6172101
Mill [mnob]     3.6172101
Hybridization Protection Assay [lbpr]     3.6172101
Nurses [prog]     3.6172101
Homo [mamm]     3.6172101
diabetes risk [qnco]     3.6172101
Chromosome 22 [celc]     3.6172101
Non-steroidal Antiinflammatory Drug [phsu]     3.6172101
Serum uric acid [lbpr]     3.6172101
Immunofluorescence Assay [lbpr]     3.6172101
Brain Cancer [neop]     3.6172101
Performance Status 1 [clna]     3.6172101
Serum lipids NOS [lbpr]     3.6172101
JEN [gngm]     3.6172101
Mask [medd]     3.6172101
Delirium [mobd]     3.6172101
Superior mesenteric vein [bpoc]     3.6172101
breast cancer diagnosis [neop]     3.6172101
Echo-Planar Imaging [diap]     3.6172101
Decreased appetite [sosy]     3.6172101
Histopathologic Type [clas]     3.6172101
A,B [imft]     3.6172101
Colorectal Adenoma [neop]     3.6172101
EX [idcn]     3.6172101
Survey, Health [resa]     3.6172101
Peroxisome Proliferator Receptor gamma Agonist [phsu]     3.6172101
Triglyceride Metabolism [moft]     3.6172101
hospital organization [hlca]     3.6172101
Balloon catheter [medd]     3.6172101
Biliary Tract Hemorrhage [dsyn]     3.6172101
Pancreatic Diseases [dsyn]     3.6172101
Extravasation [patf]     3.6172101
PAR [gngm]     3.6172101
Sulfate [inch]     3.6172101
PET Scan [diap]     3.6172101
cervical cancer screening [topp]     3.6172101
Schistosoma japonicum infection [dsyn]     3.6172101
Conventional Surgery [topp]     3.6172101
Institutional Ethics Committee [prog]     3.6172101
Subfamily [clas]     3.6172101
Permutation [qlco]     3.6172101
Phase III Clinical Trial [resa]     3.6172101
hospital utilization [qnco]     3.6172101
CHD [topp]     3.6172101
Ovarian Surface Epithelium [tisu]     3.6172101
Local [ftcn]     3.6172101
Gastric Cardia Adenocarcinoma [neop]     3.6172101
Antibody titer [lbpr]     3.6172101
RNA Expression [genf]     3.6172101
IRF2 [gngm]     3.6172101
Acute Pain [sosy]     3.6172101
euro [qnco]     3.6172101
coagulation profile [lbpr]     3.6172101
Microbiological [bmod]     3.6172101
Hepatobiliary System [bdsy]     3.6172101
Macronutrients [resa]     3.6172101
Invasive Ductal Carcinoma, Not Otherwise Specified [neop]     3.6172101
Angular [spco]     3.6172101
scientific research [resa]     3.6172101
Wnt Pathway, Canonical [moft]     3.6172101
mL/day [qnco]     3.6172101
Response, Acute-Phase [patf]     3.6172101
PPAR-gamma Agonists [moft]     3.6172101
BAP31 [gngm]     3.6172101
sexual dimorphism [ortf]     3.6172101
Mediastinal lymph node [bpoc]     3.6172101
Anti-Carcinogenic Effect [phsf]     3.6172101
Surgical department [hcro]     3.6172101
cognitive function [menp]     3.6172101
Analysis of Variance [qnco]     3.6172101
Venacavography [diap]     3.6172101
perineural [spco]     3.6172101
Cytokine Signaling [moft]     3.6172101
neuroendocrine tumours [neop]     3.6172101
pyruvate [orch]     3.6172101
JAK [moft]     3.6172101
anti-tumor necrosis factor therapy [topp]     3.6172101
Myocardium [tisu]     3.6172101
health history [fndg]     3.6172101
Genes, Reporter [gngm]     3.6172101
Therapy, Innovative [topp]     3.6172101
Hepatitis C virus genotype 6 [virs]     3.6172101
Female Breast Cancer [neop]     3.6172101
Liposome [lipd]     3.6172101
high folate [fndg]     3.6172101
alaskan [popg]     3.6172101
CIB [gngm]     3.6172101
Cholangiohepatitis [dsyn]     3.6172101
Abdominal incision [topp]     3.6172101
post albumin [aapp]     3.6172101
Body Temperature [orga]     3.6172101
Heel [blor]     3.6172101
gallbladder lesions [fndg]     3.6172101
OPCML [gngm]     3.6172101
Ulcers, Duodenal [dsyn]     3.6172101
Native Hawaiian [popg]     3.6172101
late-stage cancer [tmco]     3.6172101
Surgical repair [topp]     3.6172101
Tissue Microarray Analysis [lbpr]     3.6172101
Stage 4S neuroblastoma [neop]     3.6172101
Non-pigmented [fndg]     3.6172101
Second Line Therapy [topp]     3.6172101
credibility [qlco]     3.6172101
Extracellular Matrix Degradation [celf]     3.6172101
Kriging [resa]     3.6172101
Anti-Retroviral Agents [phsu]     3.6172101
Tumour, secondary [neop]     3.6172101
Trapezoidal [clna]     3.6172101
Histocompatibility Antigen [imft]     3.6172101
Chest Wall [bpoc]     3.6172101
Motion [npop]     3.6172101
Regulatory Gene [gngm]     3.6172101
Special Population [popg]     3.6172101
Main diagnosis [qlco]     3.6172101
Contaminated equipment [phpr]     3.6172101
Mount [fndg]     3.6172101
Infertile [dsyn]     3.6172101
Primary Cell Culture [lbpr]     3.6172101
PFS [qnco]     3.6172101
Population Growth [qnco]     3.6172101
precinct [idcn]     3.6172101
Image [mnob]     3.6172101
Thalassaemia intermedia [dsyn]     3.6172101
Bulge [fndg]     3.6172101
Antenatal [tmco]     3.6172101
Foreign material [inpo]     3.6172101
Metabolome [npop]     3.6172101
Miami [popg]     3.6172101
Haematoxylin and eosin stain [lbpr]     3.6172101
Percutaneous choledochoscopy [hlca]     3.6172101
wasted [dsyn]     3.6172101
Scholarship [idcn]     3.6172101
methylenetetrahydrofolate reductase gene [gngm]     3.6172101
Multicenter Trials [resa]     3.6172101
Biomedical Research [resa]     3.6172101
biosynthesis [ftcn]     3.6172101
Incisional hernia repair [topp]     3.6172101
Hepatitis C virus subtype 1b [virs]     3.6172101
Ectatic [ftcn]     3.6172101
CT [dsyn]     3.6172101
H-ras [gngm]     3.6172101
Subject Heading, Medical [inpr]     3.6172101
ENDOTHELIAL CELL-SPECIFIC MOLECULE 1 [gngm]     3.6172101
IL17A Gene [gngm]     3.6172101
Connecticut [geoa]     3.6172101
General Public [popg]     3.6172101
KIU/mL [qnco]     3.6172101
Anus [bpoc]     3.6172101
Clear Cell Renal Carcinoma [neop]     3.6172101
Secondary Lesion [fndg]     3.6172101
advertised [ocac]     3.6172101
Intima [tisu]     3.6172101
HCT [lbpr]     3.6172101
Portal lymph node [bpoc]     3.6172101
Human immunodeficiency virus negative [fndg]     3.6172101
B mode ultrasound [diap]     3.6172101
Down [spco]     3.6172101
Clinical target volume [qnco]     3.6172101
5 Hours [tmco]     3.6172101
Polymerase Gene [gngm]     3.6172101
Menstrual [orgf]     3.6172101
Hounsfield unit [qnco]     3.6172101
Glucuronidation [phpr]     3.6172101
Neural Network Model [inpr]     3.6172101
AI [geoa]     3.6172101
Gamma Ray [npop]     3.6172101
DPC4 [gngm]     3.6172101
16S rRNA [nnon]     3.6172101
Very-Low-Birth-Weight Infants [dsyn]     3.6172101
Genetic, Biochemical [bmod]     3.6172101
Multinodular Lesion [fndg]     3.6172101
Hyalinosis [patf]     3.6172101
Complex procedure [hlca]     3.6172101
Flow Rate [qnco]     3.6172101
austrian [popg]     3.6172101
Advanced adenomas [clna]     3.6172101
Manipulations NOS [topp]     3.6172101
calcific [qlco]     3.6172101
International Agency for Research on Cancer [hcro]     3.6172101
analysis system [ocac]     3.6172101
TT virus DNA [nnon]     3.6172101
gastric duodenal [patf]     3.6172101
Mucinous Adenocarcinoma [neop]     3.6172101
Gear [qlco]     3.6172101
Tradition [socb]     3.6172101
News [inpr]     3.6172101
Rotated [ftcn]     3.6172101
hypovitaminosis d [dsyn]     3.6172101
Adaptor [mnob]     3.6172101
8 Hours [tmco]     3.6172101
Psychosocial Factors [qlco]     3.6172101
Mining [ocac]     3.6172101
WISE [gngm]     3.6172101
Concrete [mnob]     3.6172101
Flavonoids [orch]     3.6172101
Genetics, Population [ocdi]     3.6172101
Elastic Modulus [qnco]     3.6172101
Flatus [sosy]     3.6172101
Eosinophilic infiltration [patf]     3.6172101
Gastric Tumor [neop]     3.6172101
Nuclear Membrane [celc]     3.6172101
Gestational Diabetes [dsyn]     3.6172101
AIH [topp]     3.6172101
FACTORIAL [mnob]     3.6172101
DM2 [gngm]     3.6172101
Breeder [inpr]     3.6172101
serologic diagnosis [diap]     3.6172101
Array Comparative Genomic Hybridization [mbrt]     3.6172101
Amputation [topp]     3.6172101
Pharmaceutical Agent [phsu]     3.6172101
Inheritance [qnco]     3.6172101
Duodenopancreatectomy [topp]     3.6172101
housewives [prog]     3.6172101
Moderate-Dose [resa]     3.6172101
Rheumatology [bmod]     3.6172101
PPP1R3B [gngm]     3.6172101
Technology Development [inpr]     3.6172101
Lymphoma, Follicular [neop]     3.6172101
Pleomorphic [genf]     3.6172101
lipid synthesis [orgf]     3.6172101
Group H [clna]     3.6172101
indonesian [lang]     3.6172101
6H [tmco]     3.6172101
Asp [rept]     3.6172101
Fasciola hepatica infection [dsyn]     3.6172101
Induced Mutation [genf]     3.6172101
Mortality, Premature [fndg]     3.6172101
Pancreatic intraepithelial neoplasia [neop]     3.6172101
Alpha 2 [qlco]     3.6172101
Ercs [diap]     3.6172101
XIAP [gngm]     3.6172101
GBV-C [virs]     3.6172101
Abdomen, Acute [sosy]     3.6172101
pro drug [chvf]     3.6172101
Dyspnea [sosy]     3.6172101
Mice, NOD [mamm]     3.6172101
Jet lag [dsyn]     3.6172101
Neurodegeneration [comd]     3.6172101
South American [popg]     3.6172101
MDM2 gene [gngm]     3.6172101
fatty acid biosynthesis [moft]     3.6172101
Normal liver function tests [fndg]     3.6172101
grasp [orgf]     3.6172101
Laser Capture Microdissection [lbpr]     3.6172101
Curb [dsyn]     3.6172101
Peanut butter [food]     3.6172101
Chilean [popg]     3.6172101
Splenocyte [cell]     3.6172101
Volume Measurement [lbpr]     3.6172101
Model Number [inpr]     3.6172101
DNA Methyltransferase Inhibitor [phsu]     3.6172101
Hepatic angiogram [diap]     3.6172101
effectiveness use [idcn]     3.6172101
SWI/SNF complex [celc]     3.6172101
repetition [ftcn]     3.6172101
biological regulation [biof]     3.6172101
MUL [gngm]     3.6172101
Demographic change [qlco]     3.6172101
Catholic [popg]     3.6172101
Intraperitoneal injection [topp]     3.6172101
Yttrium [elii]     3.6172101
Hepatic Coma [dsyn]     3.6172101
PVe [topp]     3.6172101
Starry flounder [fish]     3.6172101
VIR [geoa]     3.6172101
GSTA1 [gngm]     3.6172101
citizens [popg]     3.6172101
Potential [topp]     3.6172101
ENTER [dsyn]     3.6172101
Reduced life expectancy [fndg]     3.6172101
Hokkaido [geoa]     3.6172101
B3+ [elii]     3.6172101
Acquired disorder [fndg]     3.6172101
Platelet-derived Growth Factor Receptor Inhibitors [moft]     3.6172101
Chemotherapy cycle [topp]     3.6172101
Optic Nerve [bpoc]     3.6172101
Factor Analyses [qnco]     3.6172101
Cryptosporidium parvum [euka]     3.6172101
Cells/mL [qnco]     3.6172101
organ rejection [patf]     3.6172101
saliva [bdsu]     3.6172101
precis [euka]     3.6172101
Critical Care [hlca]     3.6172101
Electrohydraulic lithotripsy [topp]     3.6172101
Stage IIA [clas]     3.6172101
mammary tumors [neop]     3.6172101
Water Quality [qlco]     3.6172101
Pancytokeratin [aapp]     3.6172101
elevated total bilirubin [fndg]     3.6172101
Inflammatory Infiltrate [patf]     3.6172101
Pro-Pro [aapp]     3.6172101
Medical Staff [prog]     3.6172101
Tomographic imaging [diap]     3.6172101
Salivary Gland Virus Disease [dsyn]     3.6172101
severe back pain [sosy]     3.6172101
Pancreatic tail [bpoc]     3.6172101
Negated [ftcn]     3.6172101
international center [mnob]     3.6172101
Ultraviolet [qlco]     3.6172101
Basal cell carcinoma [neop]     3.6172101
Diagnostics, Cancer [resa]     3.6172101
monitoring patients [hlca]     3.6172101
Public Domain [popg]     3.6172101
Phantoms [mnob]     3.6172101
dollars [qnco]     3.6172101
ASL [gngm]     3.6172101
Mast Cells [cell]     3.6172101
Chest Wall Mass [fndg]     3.6172101
cic [topp]     3.6172101
GN [geoa]     3.6172101
Vacuolar degeneration [fndg]     3.6172101
Abscess drainage NOS [topp]     3.6172101
Chest X-ray [diap]     3.6172101
Iceberg [npop]     3.6172101
C3H [mamm]     3.6172101
FIGO Stage [inpr]     3.6172101
PBS [dsyn]     3.6172101
LGR5 [gngm]     3.6172101
Yoghurt [food]     3.6172101
Therapeutic Trials [resa]     3.6172101
engineered [ocdi]     3.6172101
Venous blood [tisu]     3.6172101
Secondary carcinoma [neop]     3.6172101
Arteriovenous fistula [anab]     3.6172101
Dry weight [orga]     3.6172101
Positive [inpr]     3.6172101
myeloproliferative neoplasm [neop]     3.6172101
Very Much [inpr]     3.6172101
Renal Tissue [tisu]     3.6172101
Nearest [spco]     3.6172101
Occipital horn syndrome [cgab]     3.6172101
population census [qnco]     3.6172101
Spastic Paraplegia [dsyn]     3.6172101
Test, Rank-Sum [qnco]     3.6172101
Drug Therapy [topp]     3.6172101
Visceral Adipose Tissue [tisu]     3.6172101
Goes [euka]     3.6172101
family studies [diap]     3.6172101
Non-Resectable Cholangiocarcinoma [neop]     3.6172101
Increased serum transaminases [fndg]     3.6172101
prosimians [mamm]     3.6172101
Certificate [inpr]     3.6172101
health care worker [prog]     3.6172101
Remark [inpr]     3.6172101
subtotal [qnco]     3.6172101
Pistachios [food]     3.6172101
Bottom [spco]     3.6172101
cisplatin gemcitabine [topp]     3.6172101
Anti-Hypertensive Drugs [phsu]     3.6172101
Knowledge level [menp]     3.6172101
Cassette [medd]     3.6172101
General status [fndg]     3.6172101
Asian Indian [popg]     3.6172101
Terrorism [socb]     3.6172101
Focal Adhesion [celc]     3.6172101
Albuminuria [fndg]     3.6172101
urinary organs [bpoc]     3.6172101
Desmoplastic Small Round Cell Tumor [neop]     3.6172101
Respiratory symptoms NOS [sosy]     3.6172101
Femoral head [bpoc]     3.6172101
genetic manipulation [mbrt]     3.6172101
Thrombocytosis [dsyn]     3.6172101
Lung Neoplasms [neop]     3.6172101
high systolic blood pressure [fndg]     3.6172101
Iron stain [lbpr]     3.6172101
Joint disease [dsyn]     3.6172101
Macrotrabecular Pattern [fndg]     3.6172101
Perinatal risk [fndg]     3.6172101
Contract [patf]     3.6172101
Biliary drainage (procedure) [topp]     3.6172101
Duodenal carcinoma [neop]     3.6172101
Irradiated volume [qnco]     3.6172101
Frail [fndg]     3.6172101
extirpation [topp]     3.6172101
phenyl [chvs]     3.6172101
S100A10 [gngm]     3.6172101
telephone survey [resa]     3.6172101
Tissues, Ectopic [patf]     3.6172101
M Phase [celf]     3.6172101
Tissue Arrays [resd]     3.6172101
hippo signaling pathway [celf]     3.6172101
Polyploidy [comd]     3.6172101
Mitochondrial Swelling [celf]     3.6172101
skin tumors [neop]     3.6172101
T7 [blor]     3.6172101
Surveys, Cross-Sectional [resa]     3.6172101
fatty acid synthesis [moft]     3.6172101
Balanced diet [topp]     3.6172101
Fasciola hepatica [euka]     3.6172101
Stem cell transplant [topp]     3.6172101
Hoa [euka]     3.6172101
Carboxyl [orch]     3.6172101
Leopardus pardalis [mamm]     3.6172101
Shadow [ftcn]     3.6172101
Chills [sosy]     3.6172101
L2 [blor]     3.6172101
Statistical Study [inpr]     3.6172101
surgical history [fndg]     3.6172101
Abnormally low [qlco]     3.6172101
basophilic [ftcn]     3.6172101
AIN [neop]     3.6172101
initial assessment [fndg]     3.6172101
Endocrine organ [bpoc]     3.6172101
GSTO1 [gngm]     3.6172101
Six monthly [tmco]     3.6172101
Mass Spectrometer [medd]     3.6172101
Hyperglobulinaemia [fndg]     3.6172101
BETA-3 [gngm]     3.6172101
MPE [gngm]     3.6172101
SIX1 [gngm]     3.6172101
NEF [gngm]     3.6172101
of child [famg]     3.6172101
OGG1 [gngm]     3.6172101
True negative [qlco]     3.6172101
Stratified Random Sampling [resa]     3.6172101
Checkpoint [celf]     3.6172101
Gram-Negative Bacterial Infections [dsyn]     3.6172101
abdominal x rays [diap]     3.6172101
TAK1 [gngm]     3.6172101
Computation [resa]     3.6172101
Magnet [mnob]     3.6172101
Gynecologic [bmod]     3.6172101
Radiology techniques [diap]     3.6172101
Cysts, Congenital Choledochal [cgab]     3.6172101
Herpes Virus [virs]     3.6172101
Author [inpr]     3.6172101
Enhanced Activity [qnco]     3.6172101
1011 [inpr]     3.6172101
WIN [gngm]     3.6172101
Sea-Food [food]     3.6172101
Tuner [mnob]     3.6172101
Gastric wall [bpoc]     3.6172101
cell l [cell]     3.6172101
Obstructive sleep apnoea syndrome [dsyn]     3.6172101
embolization therapy [topp]     3.6172101
Polyomaviruses [virs]     3.6172101
MeSH Headings [inpr]     3.6172101
Flowchart [inpr]     3.6172101
Vascular clamp [medd]     3.6172101
Passive haemagglutination assay [lbpr]     3.6172101
Graph [inpr]     3.6172101
fibres [phsu]     3.6172101
civilian [popg]     3.6172101
Human Factors [inpr]     3.6172101
Acinar Cell [cell]     3.6172101
Groove [bsoj]     3.6172101
Dismissed [acty]     3.6172101
Sales [ocac]     3.6172101
Carcinomas, Acinar Cell [neop]     3.6172101
Chromosome Arm [nusq]     3.6172101
Plague [dsyn]     3.6172101
Brain Stem [bpoc]     3.6172101
Primitive Neuroectodermal Tumor [neop]     3.6172101
Respiratory Failure [dsyn]     3.6172101
Crystalline [chvs]     3.6172101
Subsite [spco]     3.6172101
With grade [clas]     3.6172101
INSULIN-LIKE GROWTH FACTOR II RECEPTOR [gngm]     3.6172101
ZEB1 [gngm]     3.6172101
Ototoxicity [inpo]     3.6172101
4d [inpr]     3.6172101
Postoperative delirium [mobd]     3.6172101
Deer [mamm]     3.6172101
MIR122 [gngm]     3.6172101
Thromboembolism, Pulmonary [dsyn]     3.6172101
Middle Age [tmco]     3.6172101
Staphylococcus infection [dsyn]     3.6172101
lymph node disease [dsyn]     3.6172101
Bed rest [topp]     3.6172101
biopsy findings [lbtr]     3.6172101
Nearby [qlco]     3.6172101
Boost [ftcn]     3.6172101
injection needle [medd]     3.6172101
Centrifugal [medd]     3.6172101
General [phsu]     3.6172101
Insurance [inpr]     3.6172101
Christian [idcn]     3.6172101
Hepatic hemangioma [neop]     3.6172101
field work [prog]     3.6172101
Connective Tissue Disorders [dsyn]     3.6172101
neoplastic process [neop]     3.6172101
Testicular Tumors [neop]     3.6172101
mediated response [menp]     3.6172101
System, Real-Time [mnob]     3.6172101
Latino Population [popg]     3.6172101
Stage IB [clas]     3.6172101
disease transmission [patf]     3.6172101
animal disease [dsyn]     3.6172101
normal endometrium [fndg]     3.6172101
Fistulography [diap]     3.6172101
associated symptoms [sosy]     3.6172101
Liver edge [fndg]     3.6172101
Urban [hcpp]     3.6172101
Manufacture [inpr]     3.6172101
Autosomal dominant [inpr]     3.6172101
Gingival [bpoc]     3.6172101
discharge diagnosis [inpr]     3.6172101
Signaling Molecule [bacs]     3.6172101
oropharyngeal cancer [neop]     3.6172101
MDR3 [gngm]     3.6172101
Radiofrequency generator [medd]     3.6172101
Emmonsia [fngs]     3.6172101
TCM [topp]     3.6172101
Cell Density [qnco]     3.6172101
Pulmonary Arteries [bpoc]     3.6172101
Portal circulation [bdsy]     3.6172101
Mucous Membranes [tisu]     3.6172101
Imagery [topp]     3.6172101
PIE [chvf]     3.6172101
Intraepithelial Neoplasia [neop]     3.6172101
Correlated [resa]     3.6172101
Ablation Techniques [topp]     3.6172101
Alternate days [tmco]     3.6172101
research question [idcn]     3.6172101
epigastric discomfort [fndg]     3.6172101
Room [spco]     3.6172101
Atom [elii]     3.6172101
Pre-Procedure [tmco]     3.6172101
yes/no [clas]     3.6172101
Polycystic Ovary Syndrome [dsyn]     3.6172101
Small bowel [bpoc]     3.6172101
Medical Oncology [bmod]     3.6172101
Mid-zone [spco]     3.6172101
Weight control [topp]     3.6172101
Substitution Mutation [genf]     3.6172101
Epilepsies [dsyn]     3.6172101
mL/kg [qnco]     3.6172101
Valley [spco]     3.6172101
Horse [mamm]     3.6172101
Epithelioid Cells [cell]     3.6172101
Biotherapy [topp]     3.6172101
Cytomegalovirus hepatitis [dsyn]     3.6172101
BETA-C [gngm]     3.6172101
Basic Reproduction Number [qnco]     3.6172101
Optimal [menp]     3.6172101
o blood group [fndg]     3.6172101
Cell Cycle Control [celf]     3.6172101
Orifice [bsoj]     3.6172101
Test, Serologic [lbpr]     3.6172101
Geographic Factors [cnce]     3.6172101
Chronic inflammatory disorder [dsyn]     3.6172101
Hypothermia [fndg]     3.6172101
African origin [fndg]     3.6172101
Recurrent Carcinoma [neop]     3.6172101
chromosome 17p [nusq]     3.6172101
contagion [npop]     3.6172101
kahweol [orch]     3.6172101
Infantile haemangioma [neop]     3.6172101
diet reduced [topp]     3.6172101
Decreased albumin [fndg]     3.6172101
Hormonal Contraception [topp]     3.6172101
Normal kidneys [fndg]     3.6172101
literature survey [inpr]     3.6172101
monolayer [clnd]     3.6172101
Telangiectatic Adenoma [neop]     3.6172101
Congenital Choledochal Cyst [cgab]     3.6172101
Desmoplastic Reaction [dsyn]     3.6172101
Toxic substance [hops]     3.6172101
KAPOSIS SARCOMA ASSOCIATED HERPESVIRUS [virs]     3.6172101
Tobacco smoke [hops]     3.6172101
Cancer Model [emod]     3.6172101
DKK4 [gngm]     3.6172101
coexistent disease [patf]     3.6172101
Catalytic [npop]     3.6172101
Class 2 [inpr]     3.6172101
S5 [blor]     3.6172101
MCV - NOS [lbtr]     3.6172101
Palliative intent [qlco]     3.6172101
Electrophoresis, Gel, 2D [lbpr]     3.6172101
Familial form [fndg]     3.6172101
Dynamic Scan [diap]     3.6172101
Adenovirus Vector [nnon]     3.6172101
milliliter [qnco]     3.6172101
Malformation [cgab]     3.6172101
Medicine, Modern [tmco]     3.6172101
Normal platelet count [fndg]     3.6172101
Third Party Payer [hcro]     3.6172101
Chemical Industry [orgt]     3.6172101
Abdominal discomfort [sosy]     3.6172101
Glycan Analysis [lbpr]     3.6172101
Multiple calculi [bdsu]     3.6172101
T/N [qnco]     3.6172101
Hair abnormalities NOS [fndg]     3.6172101
Bomb [mnob]     3.6172101
specialist referral [hlca]     3.6172101
Tumor Virus [virs]     3.6172101
Multiracial [popg]     3.6172101
1019 [inpr]     3.6172101
Thoracoscopic [spco]     3.6172101
Scarification [topp]     3.6172101
Endoscopic Procedure [diap]     3.6172101
How Much [qnco]     3.6172101
Therapies, Biological [topp]     3.6172101
High antibody titer [fndg]     3.6172101
FLR [gngm]     3.6172101
Inner Mongolia [geoa]     3.6172101
Roux-en-Y [topp]     3.6172101
Tuberculosis, Miliary [dsyn]     3.6172101
Nephrogenic Systemic Fibrosis [dsyn]     3.6172101
Alcoholic liver damage [dsyn]     3.6172101
Birth History [fndg]     3.6172101
Let-7 [nusq]     3.6172101
Low hemoglobin [fndg]     3.6172101
ft. [ftcn]     3.6172101
Mesenteric [blor]     3.6172101
CyberKnife [medd]     3.6172101
Chemoprevention Study [resa]     3.6172101
Adenocarcinoma, intestinal type [neop]     3.6172101
Falciform ligament [bpoc]     3.6172101
White croaker [fish]     3.6172101
polyamine metabolism [moft]     3.6172101
UBC [gngm]     3.6172101
Granulation Tissue [tisu]     3.6172101
Chromosome 4 [celc]     3.6172101
Market [ocac]     3.6172101
fluorodeoxyglucose PET [diap]     3.6172101
ng/mg [qnco]     3.6172101
Genotype-Phenotype Correlation [fndg]     3.6172101
Extrinsic [spco]     3.6172101
Cephalic [spco]     3.6172101
Proportionate [qlco]     3.6172101
PRKACA [gngm]     3.6172101
apoptotic signaling pathway [celf]     3.6172101
/mcL [qnco]     3.6172101
Pathological aspects [ftcn]     3.6172101
Proteomic Profile [lbtr]     3.6172101
bouts [tmco]     3.6172101
Normal body mass index [orga]     3.6172101
Morphological type [inpr]     3.6172101
alcohol users [inbe]     3.6172101
Renal carcinoma [neop]     3.6172101
endocrinologists [prog]     3.6172101
CRL [gngm]     3.6172101
Coding Region [gngm]     3.6172101
Biliary Anastomotic Leakage [patf]     3.6172101
Phase Analysis [ocac]     3.6172101
Endobronchial [spco]     3.6172101
Agglutinin [imft]     3.6172101
Death Cause [fndg]     3.6172101
VWF [gngm]     3.6172101
Adjuvant Trial [resa]     3.6172101
Immune Marker [qlco]     3.6172101
Endocarditis [dsyn]     3.6172101
16p [nusq]     3.6172101
Gases [chvs]     3.6172101
Spectral [qnco]     3.6172101
Maru [inpr]     3.6172101
LON [gngm]     3.6172101
With time [tmco]     3.6172101
CTCAE [inpr]     3.6172101
Nuclear Extract [bodm]     3.6172101
Input Function [inpr]     3.6172101
Heterologous [qlco]     3.6172101
spleen lesion [dsyn]     3.6172101
Central Reviewer [prog]     3.6172101
Sludge [eehu]     3.6172101
TCBLR [gngm]     3.6172101
SUPPRESSOR OF CYTOKINE SIGNALING 3 [gngm]     3.6172101
Circulating Endothelial Cells [lbpr]     3.6172101
Zoological garden [mnob]     3.6172101
INTERN [prog]     3.6172101
Helicobacter bilis [bact]     3.6172101
HSCT [topp]     3.6172101
disease onset [tmco]     3.6172101
BECLIN 1 [gngm]     3.6172101
Peru [geoa]     3.6172101
Phase 3 Study [resa]     3.6172101
T0 [fndg]     3.6172101
c-myc Genes [gngm]     3.6172101
Klebsiella species [bact]     3.6172101
Minimal lesion [anab]     3.6172101
Not Responsive [fndg]     3.6172101
Office [mnob]     3.6172101
Gastroenterology clinic [inpr]     3.6172101
Advocacy [socb]     3.6172101
Chromosomal Stability [genf]     3.6172101
Febrile [fndg]     3.6172101
Interphase [celf]     3.6172101
Alberta [geoa]     3.6172101
Asia, Central [geoa]     3.6172101
M-5 [imft]     3.6172101
1.0 mg/mL [qnco]     3.6172101
Alternative Splicing [genf]     3.6172101
Postoperative status [fndg]     3.6172101
c chronic hepatitis [dsyn]     3.6172101
insulin-like growth factor 2 receptor [gngm]     3.6172101
tan [inbe]     3.6172101
Acquired disease [dsyn]     3.6172101
Acute abdominal pain [sosy]     3.6172101
Biosynthetic [biof]     3.6172101
Outcomes, Fatal [patf]     3.6172101
Hepatic Infection [dsyn]     3.6172101
Direct Method [topp]     3.6172101
Scandinavian [popg]     3.6172101
Disadvantaged [popg]     3.6172101
HAV [dsyn]     3.6172101
Echinococcosis [dsyn]     3.6172101
Chronic Lymphocytic Leukemia [neop]     3.6172101
catalytic activity [moft]     3.6172101
reference interval [qnco]     3.6172101
Hepatitis B antibody [imft]     3.6172101
Hypercellularity [patf]     3.6172101
ATP7A [gngm]     3.6172101
lexicon [inpr]     3.6172101
Study, Intervention [resa]     3.6172101
RICTOR [gngm]     3.6172101
JUN N-terminal kinase [gngm]     3.6172101
Glycome [carb]     3.6172101
Human immunodeficiency virus status [fndg]     3.6172101
Hepatitis G Infection [dsyn]     3.6172101
Patients, Immunocompromised [fndg]     3.6172101
SINE [nusq]     3.6172101
electrocoagulation [topp]     3.6172101
ABCB4 [gngm]     3.6172101
Makeup [mnob]     3.6172101
Saline Solution [sbst]     3.6172101
CDC2 [gngm]     3.6172101
GP73 [gngm]     3.6172101
symbol [idcn]     3.6172101
Acute haemorrhagic pancreatitis [dsyn]     3.6172101
Haemosiderosis [dsyn]     3.6172101
millimeter [qnco]     3.6172101
Indian childhood cirrhosis [dsyn]     3.6172101
Clinical Medicine [bmod]     3.6172101
500ml [qnco]     3.6172101
Endoscope [medd]     3.6172101
Cellular Matrix [celc]     3.6172101
whole-brain radiation therapy [topp]     3.6172101
Undernutrition [dsyn]     3.6172101
Portacaval Shunt [topp]     3.6172101
Right inferior phrenic artery [bpoc]     3.6172101
MAC [celc]     3.6172101
Spinal Cord [bpoc]     3.6172101
victoria blue [irda]     3.6172101
model development [inpr]     3.6172101
Hydronephrosis [dsyn]     3.6172101
Bone Marrow Stem Cell Transplantation [topp]     3.6172101
Gender Relations [socb]     3.6172101
fetal exposure [fndg]     3.6172101
Folate Metabolism [moft]     3.6172101
Interactions, Cell [celf]     3.6172101
Localized Carcinoma [neop]     3.6172101
Light chain level [lbpr]     3.6172101
Astrocytomas [neop]     3.6172101
DNA hypomethylation [genf]     3.6172101
Magnetic resonance technique [diap]     3.6172101
Oxygen therapy [topp]     3.6172101
screening examination [diap]     3.6172101
Porcelain gallbladder [dsyn]     3.6172101
Body Fat Distribution [fndg]     3.6172101
STAT1 [gngm]     3.6172101
Pediatric Hematology/Oncology [bmod]     3.6172101
Parametrial [blor]     3.6172101
Stage II Colon Cancer [neop]     3.6172101
Duodenal cancer [neop]     3.6172101
Flattened [ftcn]     3.6172101
Hepatitis B virus surface [imft]     3.6172101
mL/d [qnco]     3.6172101
Macaque [mamm]     3.6172101
house [mnob]     3.6172101
Point in time [tmco]     3.6172101
Surname [inpr]     3.6172101
Fetuses [emst]     3.6172101
Colorectal Neoplasm [neop]     3.6172101
Nervous System [bdsy]     3.6172101
Malays [popg]     3.6172101
Bisexual [socb]     3.6172101
Narrow [qnco]     3.6172101
Upon [ftcn]     3.6172101
Spectrum Analysis [lbpr]     3.6172101
appendiceal [ftcn]     3.6172101
27a [medd]     3.6172101
Excessive weight gain [fndg]     3.6172101
antibiotic administration [topp]     3.6172101
Erythrocyte [lbpr]     3.6172101
Internal Radiation [topp]     3.6172101
Volumetric-Modulated Arc Therapy [topp]     3.6172101
CYB5B [gngm]     3.6172101
protein target [moft]     3.6172101
GTP [nnon]     3.6172101
Tar [orch]     3.6172101
Hepatitis, Drug-Induced [dsyn]     3.6172101
Adrenals [bpoc]     3.6172101
lipid oxidation [moft]     3.6172101
dually diagnosed [podg]     3.6172101
Contraception [topp]     3.6172101
Clonal [diap]     3.6172101
Pension [qnco]     3.6172101
papillary neoplasms [neop]     3.6172101
Paediatric gastroenterologist [prog]     3.6172101
Cyprus [geoa]     3.6172101
Locomotion [orgf]     3.6172101
parasitological [ocdi]     3.6172101
Radiation, Whole-Body [topp]     3.6172101
Adenoviral Vector [nnon]     3.6172101
widened [spco]     3.6172101
Tumor Lysis Syndrome [dsyn]     3.6172101
CAM [dsyn]     3.6172101
High Throughput Screening [diap]     3.6172101
Undertaking [ocdi]     3.6172101
Medicare HMO [hcro]     3.6172101
Cell feature [orga]     3.6172101
Titre [qnco]     3.6172101
Instrument [qlco]     3.6172101
DR [prog]     3.6172101
Push [ftcn]     3.6172101
blood transfusion history [fndg]     3.6172101
1D [gngm]     3.6172101
Renin-angiotensin system [bdsy]     3.6172101
Gynecologic [spco]     3.6172101
Nucleotide Excision Repair [genf]     3.6172101
Africa, Central [geoa]     3.6172101
LPS [lipd]     3.6172101
Corner - [lbpr]     3.6172101
Brush [mnob]     3.6172101
Genetic disease [dsyn]     3.6172101
Bile formation [ortf]     3.6172101
Time Range [idcn]     3.6172101
Cellular Immunity [orgf]     3.6172101
Upstream Region [nusq]     3.6172101
interleukin-12 production [orgf]     3.6172101
Fishery [orgt]     3.6172101
AP3S2 [gngm]     3.6172101
Xi [inpr]     3.6172101
Wheel [mnob]     3.6172101
HINT [gngm]     3.6172101
JAK2 Mutation [comd]     3.6172101
diethylthiourea [orch]     3.6172101
Tumor Debulking [topp]     3.6172101
Adequate Knowledge [fndg]     3.6172101
% fetal cells [qnco]     3.6172101
Time frame [tmco]     3.6172101
Nigerian [popg]     3.6172101
Acute hyperglycaemia [patf]     3.6172101
Indifferent [qlco]     3.6172101
Cytotoxic Therapy [topp]     3.6172101
20 Pack [qnco]     3.6172101
Disabilities [podg]     3.6172101
Evacuation [topp]     3.6172101
Carcinoma, Signet Ring Cell [neop]     3.6172101
Secondary Care [hlca]     3.6172101
Needle Sharing [socb]     3.6172101
Lung Transplantation [topp]     3.6172101
audiograms [diap]     3.6172101
Increased diameter [qlco]     3.6172101
Multi-Stage Sampling [qnco]     3.6172101
Voxel [cnce]     3.6172101
T reg [cell]     3.6172101
Pseudotumour [acab]     3.6172101
ESCC [neop]     3.6172101
time series [tmco]     3.6172101
Cause Specific Survival [qnco]     3.6172101
Liver dysfunction, mild [fndg]     3.6172101
bile acid metabolism [moft]     3.6172101
Image Enhancement [mcha]     3.6172101
Reintroduction [topp]     3.6172101
infection risk factor [fndg]     3.6172101
Theses [inpr]     3.6172101
Anaesthesia management [topp]     3.6172101
F-Test [inpr]     3.6172101
Variable Characteristic [cnce]     3.6172101
Yolk Sac [emst]     3.6172101
Epidural Anesthesia [topp]     3.6172101
Denied [acty]     3.6172101
Chemoprotective [qlco]     3.6172101
KIAA0101 [gngm]     3.6172101
Flu-like symptoms [sosy]     3.6172101
Inflammatory disorder [dsyn]     3.6172101
Physical environment [spco]     3.6172101
Emotional [menp]     3.6172101
Safe Sex [socb]     3.6172101
anticarcinogenic [qlco]     3.6172101
miriplatin [orch]     3.6172101
Follicular Adenoma [neop]     3.6172101
extracellular region [celc]     3.6172101
Retro- [spco]     3.6172101
Coated [qlco]     3.6172101
Gross Domestic Product [qnco]     3.6172101
Afro-Caribbean [popg]     3.6172101
Parenteral transmission [ftcn]     3.6172101
Injected Dose [ftcn]     3.6172101
Chromosomal Deletion [comd]     3.6172101
Solid Neoplasm [neop]     3.6172101
Non-Hematologic Malignancy [neop]     3.6172101
Tin [elii]     3.6172101
Tender [qlco]     3.6172101
Lymphoid follicle [bpoc]     3.6172101
Hepatic Arterial Occlusion [dsyn]     3.6172101
CDK14 [gngm]     3.6172101
ICD9 [inpr]     3.6172101
benign breast tumors [neop]     3.6172101
day year [tmco]     3.6172101
ITGB1 [gngm]     3.6172101
LU [bdsy]     3.6172101
Emulsion [chvs]     3.6172101
Injection, parenteral [ftcn]     3.6172101
Lineages, Cell [idcn]     3.6172101
Giant Hemangioma [neop]     3.6172101
Glean [orch]     3.6172101
T1 stage [fndg]     3.6172101
Off [qlco]     3.6172101
Pedunculated [spco]     3.6172101
First Degree Relative [famg]     3.6172101
ABA [inpr]     3.6172101
Portal-Systemic Encephalopathy [dsyn]     3.6172101
conceal [qlco]     3.6172101
uterine myoma [neop]     3.6172101
skip [fndg]     3.6172101
Alveolar echinococcosis [dsyn]     3.6172101
pilot program [inpr]     3.6172101
Nutrition Intervention [topp]     3.6172101
high white blood cell count [fndg]     3.6172101
Section [lbpr]     3.6172101
ad libitum [qlco]     3.6172101
Mismatch Repair Deficiency [dsyn]     3.6172101
Physiologic motion [clna]     3.6172101
bowl [dora]     3.6172101
Organ Procurement [hlca]     3.6172101
Cyclin G1 [aapp]     3.6172101
Viral antigen [imft]     3.6172101
alloimmunity [ortf]     3.6172101
Ophthalmologic [bmod]     3.6172101
Oral contraceptive pill [phsu]     3.6172101
Necrotising [ftcn]     3.6172101
KEAP1 [gngm]     3.6172101
adeno associated virus [virs]     3.6172101
P2 [imft]     3.6172101
SCT [diap]     3.6172101
mTORC1 [celc]     3.6172101
Abort [ftcn]     3.6172101
Haematemesis [sosy]     3.6172101
Neurotransmitter [nsba]     3.6172101
Migration Assays [lbpr]     3.6172101
Typhoid [dsyn]     3.6172101
Hepatic Carcinosarcoma [neop]     3.6172101
DNA Copy Number Changes [genf]     3.6172101
Temperature Probe [mnob]     3.6172101
Full thickness [qnco]     3.6172101
Preventive Intervention [topp]     3.6172101
Gaucher Disease, Type 1 [dsyn]     3.6172101
intestinal parasitic infection [dsyn]     3.6172101
Oxidative Phosphorylation [moft]     3.6172101
beta-5 [gngm]     3.6172101
Health Sciences [bmod]     3.6172101
Hernia [anab]     3.6172101
Inosine Monophosphate Dehydrogenase Inhibitor [phsu]     3.6172101
Incipient [tmco]     3.6172101
Short gastric vein [bpoc]     3.6172101
Arteriosclerosis [dsyn]     3.6172101
Myanma [geoa]     3.6172101
hang [inpo]     3.6172101
Warm Ischemic Time [tmco]     3.6172101
ECOG Score [clna]     3.6172101
drug dependence [mobd]     3.6172101
pelvic tumors [neop]     3.6172101
Phlebitis [dsyn]     3.6172101
Purine [orch]     3.6172101
Low Columnar Cell [cell]     3.6172101
Hematopoietic stem cells [cell]     3.6172101
Wedge [spco]     3.6172101
Volume 2 [qnco]     3.6172101
Mirizzi Syndrome [dsyn]     3.6172101
cDNA Microarray Analysis [resa]     3.6172101
Clonorchis [euka]     3.6172101
Ambient [qlco]     3.6172101
Phenotypic variation [fndg]     3.6172101
AMD [dsyn]     3.6172101
Folate intake [fndg]     3.6172101
stabilities [ortf]     3.6172101
Rotated [spco]     3.6172101
Next to [spco]     3.6172101
Hematopoietic cell [cell]     3.6172101
Concentrate [spco]     3.6172101
Mcl-1 [gngm]     3.6172101
leucine rich alpha 2 glycoprotein [gngm]     3.6172101
Personal hygiene [inbe]     3.6172101
Bile stasis [dsyn]     3.6172101
Follicular thyroid carcinoma [neop]     3.6172101
Primary cholangitis [dsyn]     3.6172101
reverse transcriptase activity [genf]     3.6172101
normal bilirubin [fndg]     3.6172101
ivalon [orch]     3.6172101
Historical Cohort [popg]     3.6172101
High birth weight [fndg]     3.6172101
Heart study [diap]     3.6172101
fusion transcript [genf]     3.6172101
Esophagus Cancer [neop]     3.6172101
300ml [qnco]     3.6172101
Feline Disease [dsyn]     3.6172101
Retinal [bpoc]     3.6172101
Antimetabolite [phsu]     3.6172101
Chromosomal Abnormality [comd]     3.6172101
Study Characteristics [inpr]     3.6172101
neonatal period [tmco]     3.6172101
PBC [dsyn]     3.6172101
Dephosphorylation [moft]     3.6172101
GPM6A [gngm]     3.6172101
PAH [orch]     3.6172101
Cattle [mamm]     3.6172101
SETTLE [neop]     3.6172101
Basal Diet [food]     3.6172101
Complication, Intraoperative [patf]     3.6172101
Parallel Study [resa]     3.6172101
SLC22A7 [gngm]     3.6172101
Diabetes Complications [patf]     3.6172101
Unresectable [clas]     3.6172101
Platichthys flesus [fish]     3.6172101
ENH [gngm]     3.6172101
Environmental Carcinogenesis [neop]     3.6172101
GSD Ia [dsyn]     3.6172101
Mucous gland [bpoc]     3.6172101
black American [popg]     3.6172101
Acculturation [socb]     3.6172101
Mammary gland [bpoc]     3.6172101
Neuroendocrine Differentiation [fndg]     3.6172101
Intraoperative Injury [inpo]     3.6172101
Osteopenia [patf]     3.6172101
Diagnostic Imaging Technique [diap]     3.6172101
mile [qnco]     3.6172101
Naso [fish]     3.6172101
dermatological diseases [dsyn]     3.6172101
pregnancy infection [dsyn]     3.6172101
Rue [plnt]     3.6172101
CTNNB1 gene [gngm]     3.6172101
Warburg Effect [comd]     3.6172101
Vaccine Development [resa]     3.6172101
SINGLE GROUP [resa]     3.6172101
NUANCE [gngm]     3.6172101
Paired Comparison [qnco]     3.6172101
adenopathies [fndg]     3.6172101
contrast ct scan [diap]     3.6172101
European American [popg]     3.6172101
Value, Normal [qnco]     3.6172101
Inferior phrenic artery [bpoc]     3.6172101
Editor [ocdi]     3.6172101
Twelfth [qnco]     3.6172101
Central Nervous System Metastasis [neop]     3.6172101
Thrombolysis [clna]     3.6172101
Streptococcus pneumoniae [bact]     3.6172101
HEPATIC PROTEIN [gngm]     3.6172101
Half-Life [tmco]     3.6172101
VL [bpoc]     3.6172101
Microinvasive carcinoma [neop]     3.6172101
NIH [hcro]     3.6172101
Green tea [food]     3.6172101
Sphincter [bpoc]     3.6172101
High Grade Lesion [fndg]     3.6172101
B Viruses [virs]     3.6172101
CMV [dsyn]     3.6172101
Mild pain [sosy]     3.6172101
Factor V Leiden mutation [dsyn]     3.6172101
cDNA Expression [mbrt]     3.6172101
Iron level [lbpr]     3.6172101
Fermented food [food]     3.6172101
Internet [mnob]     3.6172101
DNA Fragmentation [moft]     3.6172101
Regular drinker [fndg]     3.6172101
Fisherman [prog]     3.6172101
Local excision [topp]     3.6172101
Secondary Neoplasm [neop]     3.6172101
metastasis associated in colon cancer 1 [gngm]     3.6172101
Chronic non-A non-B hepatitis [dsyn]     3.6172101
Exercise Therapy [topp]     3.6172101
Reverse Transcriptase PCR [mbrt]     3.6172101
Diabetes Mellitus, Insulin-Dependent [dsyn]     3.6172101
Residual Cancer [neop]     3.6172101
onset time [tmco]     3.6172101
Arterial blood gas analysis [lbpr]     3.6172101
Caspase Inhibitor [phsu]     3.6172101
Pepper [plnt]     3.6172101
liver cancer prevention [topp]     3.6172101
Primary Care Provider [idcn]     3.6172101
Has [qlco]     3.6172101
IL-6 production [orgf]     3.6172101
pulmonary granulomatosis [dsyn]     3.6172101
European Union [orgt]     3.6172101
Biweekly [tmco]     3.6172101
fragment [anab]     3.6172101
Pulmonary Pathology [dsyn]     3.6172101
Nuclear chromatin [celc]     3.6172101
Markov Chain [qnco]     3.6172101
Colombian [popg]     3.6172101
Faint [sosy]     3.6172101
Sight [orgf]     3.6172101
Stomach Contents [bdsu]     3.6172101
Human T-cell lymphotropic virus type 1 [virs]     3.6172101
Monomer [chvs]     3.6172101
Apoptosis Pathway [celf]     3.6172101
Africa, Western [geoa]     3.6172101
Hepatoid carcinoma [neop]     3.6172101
ATOMIC ABSORPTION SPECTROMETRY [lbpr]     3.6172101
calcium antagonist [phsu]     3.6172101
Oriental [menp]     3.6172101
Respiratory disease [dsyn]     3.6172101
Surveillance Methods [resa]     3.6172101
Microarray platform [inpr]     3.6172101
Anal intercourse [socb]     3.6172101
ICD Code [inpr]     3.6172101
Right quadriceps [bpoc]     3.6172101
V-1 [gngm]     3.6172101
Cynomolgus [mamm]     3.6172101
patient review [topp]     3.6172101
hear [phsf]     3.6172101
Synchronous Lesion [fndg]     3.6172101
Center for Disease Control [hcro]     3.6172101
Attending physician [prog]     3.6172101
electronic data [idcn]     3.6172101
flash [medd]     3.6172101
sialylation [phpr]     3.6172101
Sign [inpr]     3.6172101
Public Policy [gora]     3.6172101
G1 Cell Cycle Arrest [celf]     3.6172101
Title [idcn]     3.6172101
Blood Pressure, High [dsyn]     3.6172101
Inferior [socb]     3.6172101
MTA1 [gngm]     3.6172101
UI [gngm]     3.6172101
Septal formation [fndg]     3.6172101
Annotated [inpr]     3.6172101
Disposable Needle [medd]     3.6172101
EV [neop]     3.6172101
EBV [virs]     3.6172101
cl-5 [gngm]     3.6172101
therapeutic aspects [ftcn]     3.6172101
Epigastric [blor]     3.6172101
Empty [qlco]     3.6172101
Excel [phsu]     3.6172101
GPM6B [gngm]     3.6172101
Lymphomagenesis [neop]     3.6172101
Lymphoma, B-Cell [neop]     3.6172101
SHP-1 [gngm]     3.6172101
Africa, Northern [geoa]     3.6172101
VSIG4 [gngm]     3.6172101
TSPAN7 [gngm]     3.6172101
Neurotoxicity [inpo]     3.6172101
Malaise [sosy]     3.6172101
collateral vessels [bpoc]     3.6172101
Pre-study [tmco]     3.6172101
eosinophilic pneumonia [dsyn]     3.6172101
Celiotomy [topp]     3.6172101
Task Force [gora]     3.6172101
Fat intake [clna]     3.6172101
G6PC [gngm]     3.6172101
Regional center [mnob]     3.6172101
Adrenal Cortical Adenoma [neop]     3.6172101
Fluorescent in Situ Hybridization [mbrt]     3.6172101
Phial [medd]     3.6172101
Liver drainage [topp]     3.6172101
Endoplasm [celc]     3.6172101
radiography [ftcn]     3.6172101
CB1 [gngm]     3.6172101
Recurrent fever [dsyn]     3.6172101
Cytophotometry [lbpr]     3.6172101
Tight junction [bsoj]     3.6172101
Tremor [sosy]     3.6172101
Large Intestine [bpoc]     3.6172101
SEM [medd]     3.6172101
Bile Tract [bpoc]     3.6172101
Pluripotent [ftcn]     3.6172101
Molecular pathology studies [mbrt]     3.6172101
Jejunal [bpoc]     3.6172101
diagnostic study [diap]     3.6172101
DNA Binding Domain [amas]     3.6172101
lung lesion [fndg]     3.6172101
research data [resa]     3.6172101
twin study [resa]     3.6172101
exhaust [sosy]     3.6172101
Carcinoma, diffuse type [neop]     3.6172101
Tropism [phsf]     3.6172101
Chest Radiography [diap]     3.6172101
chemical analysis [ftcn]     3.6172101
Nonmetastatic [qlco]     3.6172101
Tumor Initiating Cells [cell]     3.6172101
Rhabdomyosarcoma, Embryonal [neop]     3.6172101
Magnetic Resonance Elastography [diap]     3.6172101
Injection site [inpo]     3.6172101
Stage IIIB [clas]     3.6172101
Ocular [bpoc]     3.6172101
Black African [popg]     3.6172101
Temperatures, Body [orga]     3.6172101
thymidine phosphorylase activity [moft]     3.6172101
1 Minute [qnco]     3.6172101
Life Changes [orgf]     3.6172101
Drug-Induced Liver Disease [patf]     3.6172101
CATHETER, DRAINAGE [medd]     3.6172101
appealing [gora]     3.6172101
Blood transfusion service [hlca]     3.6172101
Neutrophil Infiltration [fndg]     3.6172101
Mammographic Density [dsyn]     3.6172101
Donor Screening [hlca]     3.6172101
PRECIPITATE [npop]     3.6172101
Transverse plane [spco]     3.6172101
Birth Defect [cgab]     3.6172101
chimeric [orga]     3.6172101
Hypoglycaemic [phsu]     3.6172101
anticipation [menp]     3.6172101
Abnormal cell [cell]     3.6172101
Lichen Planus, Oral [dsyn]     3.6172101
Metastatic melanoma [neop]     3.6172101
Equal To [qlco]     3.6172101
Conduit [medd]     3.6172101
precursor cell [cell]     3.6172101
chemical toxicity [inpo]     3.6172101
Valid Biomarker [irda]     3.6172101
Blue [qlco]     3.6172101
Esophagography [diap]     3.6172101
Epidermal growth factor receptor inhibitor [phsu]     3.6172101
epithelial ovarian carcinoma [neop]     3.6172101
Elder [plnt]     3.6172101
Experimental [resa]     3.6172101
infarcted [ftcn]     3.6172101
Unresponsive [fndg]     3.6172101
soft tissue metastasis [neop]     3.6172101
Molecular Model [inpr]     3.6172101
Cerebral Embolism [dsyn]     3.6172101
internal control [menp]     3.6172101
Wound Complication [inpo]     3.6172101
Prior diagnosis [qlco]     3.6172101
Avian [bird]     3.6172101
cooperation [orgt]     3.6172101
HSPA9 [gngm]     3.6172101
Gastrointestinal Diseases [dsyn]     3.6172101
Streptozotocin Diabetes [emod]     3.6172101
Memory T Cells [cell]     3.6172101
Early Regeneration [ortf]     3.6172101
Times, Mean Survival [qnco]     3.6172101
Pigment [qlco]     3.6172101
Hepatic zone [blor]     3.6172101
MBq [qnco]     3.6172101
hepatitis testing [lbpr]     3.6172101
low protein [topp]     3.6172101
cystic mass [dsyn]     3.6172101
RNA, circular [nnon]     3.6172101
poorly differentiated carcinoma [neop]     3.6172101
Phosphorus [elii]     3.6172101
cholesterol synthesis [moft]     3.6172101
FGF19 [gngm]     3.6172101
Cell Cycle Gene [gngm]     3.6172101
cellular transcription [celf]     3.6172101
Cancer Prognosis [clna]     3.6172101
Chen [bird]     3.6172101
Unequal [qlco]     3.6172101
Cardiac complications [patf]     3.6172101
Golgi Apparatus [celc]     3.6172101
Carcinomatosis [neop]     3.6172101
Level I [inpr]     3.6172101
Double structure [cgab]     3.6172101
Microcephaly [cgab]     3.6172101
Hyperbaric Oxygen Therapy [topp]     3.6172101
Lens [bpoc]     3.6172101
Transplant Procedure [topp]     3.6172101
8-nitroguanine [nnon]     3.6172101
RECK [gngm]     3.6172101
retinoblastoma 1 [gngm]     3.6172101
Antimitotic Drugs [phsu]     3.6172101
tissue remodeling [biof]     3.6172101
Continual [qlco]     3.6172101
Two Times [qnco]     3.6172101
Usually asymptomatic [fndg]     3.6172101
Phase I Study [resa]     3.6172101
Primary Hepatic Neuroendocrine Carcinoma [neop]     3.6172101
widow [fndg]     3.6172101
Emigrants [popg]     3.6172101
cripto [gngm]     3.6172101
Needle-Stick [inpo]     3.6172101
substance use [mobd]     3.6172101
3+ Score [qnco]     3.6172101
Non-Invasive Detection [hlca]     3.6172101
splenic lesion [dsyn]     3.6172101
14q [nusq]     3.6172101
pulmonary carcinoma [neop]     3.6172101
Time Activity Curve [qnco]     3.6172101
Integral Membrane Proteins [aapp]     3.6172101
Invasive Breast Cancer [neop]     3.6172101
CD11B [lbpr]     3.6172101
geriatric patients [podg]     3.6172101
Normal number [qlco]     3.6172101
Bone pain [sosy]     3.6172101
Needle Biopsies, Core [diap]     3.6172101
Primary tumor site [clna]     3.6172101
Initial Volume [inpr]     3.6172101
Serum testosterone level [lbpr]     3.6172101
Solid Pattern [fndg]     3.6172101
decision support [inpr]     3.6172101
Greatest Diameter [qnco]     3.6172101
EH [geoa]     3.6172101
EBP [gngm]     3.6172101
Heat Sink [mnob]     3.6172101
Lung field [blor]     3.6172101
MICRO RNA 34B [gngm]     3.6172101
cytostatic [phsu]     3.6172101
Matched Case-Control Studies [resa]     3.6172101
LC/MS [lbpr]     3.6172101
Intensity modulated radiation therapy [topp]     3.6172101
protein activation [genf]     3.6172101
CHEM [lbpr]     3.6172101
Health Promotion [hlca]     3.6172101
Midline [spco]     3.6172101
Fluid Balance [orgf]     3.6172101
Flounder [fish]     3.6172101
Adoptive Transfer [topp]     3.6172101
Liver Cirrhosis, Biliary [dsyn]     3.6172101
Hepatitis B virus core [imft]     3.6172101
Markers, Disease [idcn]     3.6172101
Indian subcontinent [geoa]     3.6172101
DU [idcn]     3.6172101
APR [gngm]     3.6172101
Motile [fndg]     3.6172101
Membranous obstruction [patf]     3.6172101
Lower abdominal pain [sosy]     3.6172101
BV [geoa]     3.6172101
Recurrent abdominal pain [sosy]     3.6172101
Africa, Eastern [geoa]     3.6172101
Hepatic sinusoid endothelium [tisu]     3.6172101
Giga [qnco]     3.6172101
Central African Republic [geoa]     3.6172101
RIZ1 [gngm]     3.6172101
Radiobiology [bmod]     3.6172101
LEUCINE-RICH ALPHA-2-GLYCOPROTEIN 1 [gngm]     3.6172101
sphincterotomy [topp]     3.6172101
Intracerebral Hemorrhage [patf]     3.6172101
Hepatic cord [bpoc]     3.6172101
Arising in [qlco]     3.6172101
Acute myocardial infarction [dsyn]     3.6172101
Cytotoxic Chemotherapy [topp]     3.6172101
Index [ocac]     3.6172101
Fat Droplet [celc]     3.6172101
Clarity [clna]     3.6172101
Intermediate filament cytoskeleton [celc]     3.6172101
childhood solid tumor [neop]     3.6172101
Bile duct adenocarcinoma [neop]     3.6172101
INTERLEUKIN 6 SIGNAL TRANSDUCER [gngm]     3.6172101
pulmonary nodule [fndg]     3.6172101
chloride intracellular channel 1 [gngm]     3.6172101
guideline recommendation [inpr]     3.6172101
Regressing [ftcn]     3.6172101
mIU/mL [qnco]     3.6172101
SMAD1 [gngm]     3.6172101
Oceanian [popg]     3.6172101
Angioma [neop]     3.6172101
exhaust [hops]     3.6172101
Hypoperfusion [ftcn]     3.6172101
Education programs [edac]     3.6172101
CHITINASE 3-LIKE 1 [gngm]     3.6172101
Chromosome 3 [celc]     3.6172101
Essential Hypertension [dsyn]     3.6172101
Spotty [qlco]     3.6172101
Trachea [bpoc]     3.6172101
Color doppler flow [diap]     3.6172101
Antelope [mamm]     3.6172101
Ku80 [gngm]     3.6172101
Therapeutic Clinical Trial [resa]     3.6172101
high cholesterol level [fndg]     3.6172101
CD1D [gngm]     3.6172101
abasia [fndg]     3.6172101
lesion types [inpr]     3.6172101
Protein Glycosylation [moft]     3.6172101
Zinc Finger [amas]     3.6172101
Cyclic [tmco]     3.6172101
Catheter related infection [patf]     3.6172101
vascular factor [aapp]     3.6172101
triglyceride synthesis [moft]     3.6172101
Spurious [qlco]     3.6172101
research opportunity [resa]     3.6172101
8p12 [celc]     3.6172101
DISLODGED [phpr]     3.6172101
Joinpoint Model [resa]     3.6172101
Gingiva [bpoc]     3.6172101
Emergency treatment [topp]     3.6172101
Squamous Cell Cancer [neop]     3.6172101
Western blot assay [lbpr]     3.6172101
Polyamine [orch]     3.6172101
Small Hairpin RNA [nnon]     3.6172101
Ambient temperature [npop]     3.6172101
lipid retention [celf]     3.6172101
Rhenium [elii]     3.6172101
Candidate Tumor Suppressor Gene [gngm]     3.6172101
paracrine signal [celf]     3.6172101
injection volume [qnco]     3.6172101
Pulmonary resection [topp]     3.6172101
Highly active anti-retroviral therapy [topp]     3.6172101
MMP gene [gngm]     3.6172101
Guinea [geoa]     3.6172101
Colorado [geoa]     3.6172101
Allelic Imbalance [comd]     3.6172101
Search Criteria [cnce]     3.6172101
acceptor [popg]     3.6172101
Pathway, Biosynthetic [moft]     3.6172101
IMPRECISION [phpr]     3.6172101
Nucleolar Organizer Region [celc]     3.6172101
Triage [topp]     3.6172101
2q [nusq]     3.6172101
Serum hepatitis virus [virs]     3.6172101
chronic care [hlca]     3.6172101
Mongolian [mamm]     3.6172101
Tumors, Central Nervous System [neop]     3.6172101
Dipeptidyl Peptidase 4 Inhibitor [phsu]     3.6172101
Letter [inpr]     3.6172101
Patient-Controlled Analgesia [topp]     3.6172101
Image Plane [spco]     3.6172101
Hematopoietic Malignancies [neop]     3.6172101
Somalia [geoa]     3.6172101
Prothrombin gene mutation [dsyn]     3.6172101
Phase I Trial [resa]     3.6172101
THO [blor]     3.6172101
Portal vein flow [fndg]     3.6172101
4e [inpr]     3.6172101
Molecular Carcinogenesis [bmod]     3.6172101
caucasian American [popg]     3.6172101
surgical diagnosis [diap]     3.6172101
Retrotransposon [nnon]     3.6172101
East Asian country [geoa]     3.6172101
mai [bact]     3.6172101
Tachycardia [fndg]     3.6172101
Endometrial Carcinoma [neop]     3.6172101
disease classification [inpr]     3.6172101
Total pancreatectomy [topp]     3.6172101
urinary system [bdsy]     3.6172101
Perisinusoidal cell [cell]     3.6172101
Yellowish red color [qlco]     3.6172101
natural product [bacs]     3.6172101
informed patient [inpr]     3.6172101
ferritin levels [lbtr]     3.6172101
HIV negative [fndg]     3.6172101
Arthropathy [dsyn]     3.6172101
Ground-Water [spco]     3.6172101
keratin 7 [aapp]     3.6172101
DNAJB1 [gngm]     3.6172101
Purulent [qlco]     3.6172101
Shell [bpoc]     3.6172101
7 chromosome [celc]     3.6172101
Pituitary, NOS [bpoc]     3.6172101
Liver cell plate [bpoc]     3.6172101
Follow-up 1 year [fndg]     3.6172101
A9 [bpoc]     3.6172101
Pub [mnob]     3.6172101
K-ras Oncogene [gngm]     3.6172101
hospital patients [fndg]     3.6172101
Kappa Light Chain Gene [gngm]     3.6172101
Food culture [lbpr]     3.6172101
hepatitis serology [lbpr]     3.6172101
pmol [qnco]     3.6172101
integrations, Viral [biof]     3.6172101
DNA hypermethylation [genf]     3.6172101
APO-1 [gngm]     3.6172101
Sequestration [ftcn]     3.6172101
Circumcision [topp]     3.6172101
Usually fatal [fndg]     3.6172101
round cell [cell]     3.6172101
PCCA [orch]     3.6172101
Legal [inpr]     3.6172101
Male Breast Cancer [neop]     3.6172101
Frozen Specimen [qlco]     3.6172101
Displaced [spco]     3.6172101
Ethiodised oil [irda]     3.6172101
Serous carcinoma [neop]     3.6172101
Reticular Pattern [fndg]     3.6172101
RDW [lbpr]     3.6172101
Razor [mnob]     3.6172101
Disease model [emod]     3.6172101
Caspase Activation [moft]     3.6172101
Pattern Recognition [menp]     3.6172101
GSTO2 [gngm]     3.6172101
Thermocouple [medd]     3.6172101
GWAS [mbrt]     3.6172101
Maori [popg]     3.6172101
Neuropathology [bmod]     3.6172101
Precancerous Condition [neop]     3.6172101
Autoradiography [lbpr]     3.6172101
Stage 4S [inpr]     3.6172101
Thromboembolic events [patf]     3.6172101
Xenobiotic Metabolism [moft]     3.6172101
Non-steroidal anti-inflammatory drug [phsu]     3.6172101
Telangiectasia [dsyn]     3.6172101
Rutilus rutilus [fish]     3.6172101
Cardiac Arrest [dsyn]     3.6172101
retail [ocac]     3.6172101
growth regulation [celf]     3.6172101
effectiveness programs [qlco]     3.6172101
Dilute [ftcn]     3.6172101
Intimate [qlco]     3.6172101
Spacial Analysis [resa]     3.6172101
Tandem Mass Spectrometry [mbrt]     3.6172101
Bromide [inch]     3.6172101
dementia [mobd]     3.6172101
Secondary erythrocytosis [dsyn]     3.6172101
Fanconi Anemia [dsyn]     3.6172101
RAB [gngm]     3.6172101
drug concentration [qnco]     3.6172101
Gastrostomy [topp]     3.6172101
Intrathoracic [ftcn]     3.6172101
Sequence Variation [npop]     3.6172101
Blood pressure elevation [fndg]     3.6172101
Dose Regimen [topp]     3.6172101
acetaminophen toxicity [inpo]     3.6172101
employees [ftcn]     3.6172101
Flow cytometry study [clna]     3.6172101
Sedated [fndg]     3.6172101
Clients [popg]     3.6172101
discount [inpr]     3.6172101
Biometrics [ocdi]     3.6172101
Not related [idcn]     3.6172101
nonsense [idcn]     3.6172101
Essential thrombocythaemia [dsyn]     3.6172101
degrees F [qnco]     3.6172101
Perimeter [medd]     3.6172101
Interlobular bile duct [bpoc]     3.6172101
Li+ [moft]     3.6172101
experimental research [resa]     3.6172101
Sigma [inpr]     3.6172101
mL/cm [qnco]     3.6172101
WNT4 [gngm]     3.6172101
Biochemical Marker [qlco]     3.6172101
Ile-Val [aapp]     3.6172101
aflatoxin B1-DNA adduct [nnon]     3.6172101
Knee jerk [ortf]     3.6172101
fatty acid transport [celf]     3.6172101
Undifferentiated sarcoma [neop]     3.6172101
Arthralgia [sosy]     3.6172101
peroxisomal [celc]     3.6172101
Tarda [ftcn]     3.6172101
Research Design [resa]     3.6172101
Hepatitides [dsyn]     3.6172101
retroviral [virs]     3.6172101
kg/m2 [qnco]     3.6172101
public health program [hlca]     3.6172101
Alpha 1 [aapp]     3.6172101
puzzling [fndg]     3.6172101
cytokine production [orgf]     3.6172101
Marrow [food]     3.6172101
HLF [gngm]     3.6172101
Asia, Western [geoa]     3.6172101
NSCLC [neop]     3.6172101
Waveform [npop]     3.6172101
X Chromosome [celc]     3.6172101
Serosa [tisu]     3.6172101
Transverse colon [bpoc]     3.6172101
Giant Cells [cell]     3.6172101
Allergen [imft]     3.6172101
university student [qlco]     3.6172101
Ventricular Dysfunction [patf]     3.6172101
Hypothermia, Accidental [inpo]     3.6172101
gastro-intestinal [spco]     3.6172101
Subject Age [orga]     3.6172101
Delta Infection [dsyn]     3.6172101
Proband [orga]     3.6172101
CXCL5 [gngm]     3.6172101
intravenous administration [spco]     3.6172101
Cancer Etiology [bmod]     3.6172101
Anion [elii]     3.6172101
International Classification of Disease Codes [inpr]     3.6172101
epidural [bsoj]     3.6172101
Skin Metastasis [neop]     3.6172101
Integument [bdsy]     3.6172101
Toxicology: Carcinogenicity [rnlw]     3.6172101
X-linked [genf]     3.6172101
Bone Formation [ortf]     3.6172101
Inferior vena cavography [diap]     3.6172101
Respiratory distress [sosy]     3.6172101
F344 [mamm]     3.6172101
Medical contraindication [fndg]     3.6172101
Cutaneous metastasis [neop]     3.6172101
viral transcription [genf]     3.6172101
structural molecule activity [moft]     3.6172101
HIV testing [lbpr]     3.6172101
external-beam radiation [topp]     3.6172101
Molar [bpoc]     3.6172101
Acalculous Cholecystitis [dsyn]     3.6172101
Intermediate filament [celc]     3.6172101
Shop [geoa]     3.6172101
Sutured [medd]     3.6172101
HOGG1 [gngm]     3.6172101
Pyogenic granuloma [dsyn]     3.6172101
Interviews, Telephone [resa]     3.6172101
Wound Repair [orgf]     3.6172101
GenHevac B [aapp]     3.6172101
Specialty Group [hcro]     3.6172101
Morality [idcn]     3.6172101
convex [spco]     3.6172101
Gastric Glands [bpoc]     3.6172101
Artifacts [hcpp]     3.6172101
Late pregnancy [patf]     3.6172101
Wb [qnco]     3.6172101
mm3 [qnco]     3.6172101
Blood Vessel Thrombosis [patf]     3.6172101
ks [qnco]     3.6172101
North Africa [geoa]     3.6172101
dome [spco]     3.6172101
CD90 [gngm]     3.6172101
Hematopoietic Cell Transplantation [topp]     3.6172101
IFNL3 [gngm]     3.6172101
Persistent inflammation [patf]     3.6172101
CARCINOMA, HEPATOCELLULAR, MALIGNANT [neop]     3.6172101
Silver [elii]     3.6172101
Coagulation [topp]     3.6172101
high weight [sosy]     3.6172101
case load [qnco]     3.6172101
Moldavia [geoa]     3.6172101
Barcelona Criteria [sosy]     3.6172101
Ercs [qnco]     3.6172101
Cortical [bpoc]     3.6172101
Pancreatic Intraductal Papillary-Mucinous Neoplasm [neop]     3.6172101
Renal Cell Cancer [neop]     3.6172101
Insomnia [sosy]     3.6172101
Acute lymphoblastic leukaemia [neop]     3.6172101
cafestol [orch]     3.6172101
Metastatic Breast Carcinoma [neop]     3.6172101
Adrenal tissue [tisu]     3.6172101
Crisis [fndg]     3.6172101
Nasal [bpoc]     3.6172101
Longest Perpendicular [qnco]     3.6172101
HPV [virs]     3.6172101
Bile fluid [bdsu]     3.6172101
MIR-21 [gngm]     3.6172101
liver repair [topp]     3.6172101
Breast sample [bdsu]     3.6172101
Buildup [sbst]     3.6172101
coordinate [phsf]     3.6172101
peroxidation [phpr]     3.6172101
compensate [menp]     3.6172101
Normoglycaemic [fndg]     3.6172101
Pollutant [hops]     3.6172101
comparative genomic analysis [mbrt]     3.6172101
contour [spco]     3.6172101
Cholangiectasis [dsyn]     3.6172101
adenosine synthesis [moft]     3.6172101
Primary tumor size [clna]     3.6172101
Head and neck region [blor]     3.6172101
Bile Duct Tissue [tisu]     3.6172101
Healthy child [fndg]     3.6172101
Native [popg]     3.6172101
Disseminated Intravascular Coagulation [dsyn]     3.6172101
Weights, Birth [orga]     3.6172101
Temperature change [qlco]     3.6172101
Intravenous Bolus [ftcn]     3.6172101
Cylindrical [spco]     3.6172101
connective fibrous tissue [tisu]     3.6172101
Contaminated food [phpr]     3.6172101
20q [nusq]     3.6172101
Lesion Number [qnco]     3.6172101
Feline [mamm]     3.6172101
triglyceride storage [celf]     3.6172101
ABCB4 gene [gngm]     3.6172101
Iceland [geoa]     3.6172101
disease factors [ftcn]     3.6172101
Factors, Economic [qnco]     3.6172101
roche [hcro]     3.6172101
18q [nusq]     3.6172101
Psychiatric disorders [mobd]     3.6172101
shift work [fndg]     3.6172101
teenager [aggp]     3.6172101
MICRO RNA 34A [gngm]     3.6172101
Execute [prog]     3.6172101
Pleuronectes vetulus [fish]     3.6172101
Artificial Intelligence [ocdi]     3.6172101
pTNM classification [clas]     3.6172101
Osteolytic lesion [fndg]     3.6172101
Samia [euka]     3.6172101
GIST [neop]     3.6172101
Arterial perfusion [topp]     3.6172101
endocrine cancer [neop]     3.6172101
Capital [qnco]     3.6172101
CyberKnife Radiosurgery [topp]     3.6172101
incisional infection [dsyn]     3.6172101
Up to [spco]     3.6172101
factory workers [prog]     3.6172101
Endoscopic dilatation [topp]     3.6172101
Aspirate [patf]     3.6172101
Soft tissue tumor [neop]     3.6172101
Biliary Tract Neoplasm [neop]     3.6172101
GSTS [carb]     3.6172101
X RECEPTOR [gngm]     3.6172101
AE3 [gngm]     3.6172101
Egg White [food]     3.6172101
INTERLEUKIN 33 [gngm]     3.6172101
Postoperative monitoring [topp]     3.6172101
per oral [ftcn]     3.6172101
Hydrodynamic [npop]     3.6172101
genotype phenotype [orga]     3.6172101
Intervention Strategies [topp]     3.6172101
Cervical Squamous Cell Carcinoma [neop]     3.6172101
Embolic Agent [chvf]     3.6172101
Infiltrative Growth Pattern [fndg]     3.6172101
Parameter Value [spco]     3.6172101
Resume [idcn]     3.6172101
Puberty [phsf]     3.6172101
Sanger Sequencing [mbrt]     3.6172101
Venous blood sample [bdsu]     3.6172101
Sexual Intercourse [orgf]     3.6172101
Oncologic Surgeon [prog]     3.6172101
dade [orch]     3.6172101
DEPDC5 [gngm]     3.6172101
Columnar Cells [cell]     3.6172101
Mouse Osteoblast [cell]     3.6172101
Needs Assessment [hlca]     3.6172101
Sarcoidosis [dsyn]     3.6172101
PIVKA [aapp]     3.6172101
Postoperative pneumonia [dsyn]     3.6172101
Hematologic Neoplasms [neop]     3.6172101
Pluripotent stem cell [cell]     3.6172101
Total body [ffas]     3.6172101
microglial [blor]     3.6172101
ADV [virs]     3.6172101
ERB-B [gngm]     3.6172101
SCID Mice [mamm]     3.6172101
Bile canaliculus [bpoc]     3.6172101
Risk identification [hlca]     3.6172101
Glioblastoma multiforme [neop]     3.6172101
seeing [orgf]     3.6172101
Ground Glass Hepatocyte [cell]     3.6172101
Tap [hlca]     3.6172101
MISUSE [fndg]     3.6172101
Circle [spco]     3.6172101
Autoimmune chronic active hepatitis [dsyn]     3.6172101
Motor [ftcn]     3.6172101
Skeleton [bdsy]     3.6172101
Viral Particles [celc]     3.6172101
Portopulmonary hypertension [dsyn]     3.6172101
Monitoring Device [medd]     3.6172101
BSEP [gngm]     3.6172101
Physical examination, complete [hlca]     3.6172101
Dialysis Center [hcro]     3.6172101
Astrocyte [cell]     3.6172101
ERS [clna]     3.6172101
High-Fat Diets [topp]     3.6172101
Duct system [bdsy]     3.6172101
Sambucus nigra [plnt]     3.6172101
2 H [elii]     3.6172101
annual screening [diap]     3.6172101
Defective DNA repair [fndg]     3.6172101
Inter-Observer Variation [qnco]     3.6172101
Genes, Regulator [gngm]     3.6172101
Outdated concept [ftcn]     3.6172101
Tumor Bed [spco]     3.6172101
Respiratory ratio [fndg]     3.6172101
Pancreatic Acinar Cell Carcinoma [neop]     3.6172101
Neonatal Intensive Care [hlca]     3.6172101
GLUCOSE TRANSPORTER 1 [gngm]     3.6172101
Mesenteric vein thrombosis [dsyn]     3.6172101
Medical service [hlca]     3.6172101
quality health care [qlco]     3.6172101
Medial approach [spco]     3.6172101
CX32 [gngm]     3.6172101
Human Papillomaviruses, High Risk [virs]     3.6172101
Smooth Muscle Cells [cell]     3.6172101
Frailty [fndg]     3.6172101
Porphyrias, Acute [dsyn]     3.6172101
Bile Duct Papillary Neoplasm [neop]     3.6172101
Bile Duct Neoplasm [neop]     3.6172101
liver transplantation procedure [topp]     3.6172101
Phase II Detoxification [orgf]     3.6172101
population health [hlca]     3.6172101
rehabilitation program [topp]     3.6172101
Colon mucosa [bpoc]     3.6172101
Teratoma [neop]     3.6172101
First degree [qlco]     3.6172101
patient evaluation [hlca]     3.6172101
Metabolic symptoms [sosy]     3.6172101
Injection, intratumor [ftcn]     3.6172101
Hypoplasia [patf]     3.6172101
Chronic cholangitis [dsyn]     3.6172101
Transplantation, Cardiac [topp]     3.6172101
Dendritic Cell Sarcoma, Follicular [neop]     3.6172101
Array-Based Comparative Genomic Hybridization [mbrt]     3.6172101
Pseudoglandular Pattern [fndg]     3.6172101
Muscularis [tisu]     3.6172101
Paired Analysis [idcn]     3.6172101
ovary cancer [neop]     3.6172101
Stage 4 Neuroblastoma [neop]     3.6172101
Sodium level [lbtr]     3.6172101
product [qnco]     3.6172101
General pathologist [prog]     3.6172101
Model, Log-Linear [qnco]     3.6172101
holistic approach [idcn]     3.6172101
Normal adrenal function [fndg]     3.6172101
Plasma albumin level [lbpr]     3.6172101
en masse [topp]     3.6172101
Omental [bpoc]     3.6172101
Drain insertion [topp]     3.6172101
Increased Lipogenesis [moft]     3.6172101
Singular [qnco]     3.6172101
g/kg [qnco]     3.6172101
Logarithm [ocac]     3.6172101
Tomogram [diap]     3.6172101
Eastern European [popg]     3.6172101
Intravenous infusion [topp]     3.6172101
Metastatic Pancreatic Carcinoma [neop]     3.6172101
DNA Viruses [virs]     3.6172101
Nuclear Structure [celc]     3.6172101
Suspected diagnosis [qlco]     3.6172101
Sequence Homology [qnco]     3.6172101
Abandoned [qlco]     3.6172101
DNA Replication [genf]     3.6172101
filter paper [medd]     3.6172101
Immunodeficient Mouse [mamm]     3.6172101
Pulsatile [tmco]     3.6172101
Gastric vein [bpoc]     3.6172101
Serotonin Degradation [moft]     3.6172101
CT-1 [gngm]     3.6172101
Agitated [sosy]     3.6172101
Lymphoid Cells [cell]     3.6172101
DEMETHYLASE [gngm]     3.6172101
Right colon [bpoc]     3.6172101
Physical Exam [hlca]     3.6172101
Remyelination [ortf]     3.6172101
Confluent necrosis [patf]     3.6172101
Preoperative Period [tmco]     3.6172101
Hemodilution [topp]     3.6172101
subcutaneous mass [fndg]     3.6172101
Very Often [inpr]     3.6172101
PH4 [gngm]     3.6172101
Lamellar [fndg]     3.6172101
Dust [sbst]     3.6172101
Counts, Complete Blood [lbpr]     3.6172101
positive test result [fndg]     3.6172101
Percutaneous transhepatic cholangiogram [diap]     3.6172101
GP210 [gngm]     3.6172101
Autoimmune Process [patf]     3.6172101
PARP1 [gngm]     3.6172101
Severe viral infections [fndg]     3.6172101
Parenteral Nutrition [topp]     3.6172101
/24h [tmco]     3.6172101
6-16 [gngm]     3.6172101
Cardiopulmonary Bypass [topp]     3.6172101
T-Cell Depletion [topp]     3.6172101
Sarcoma of the Liver [neop]     3.6172101
mental health [menp]     3.6172101
Hematologic system [bdsy]     3.6172101
Tech [gngm]     3.6172101
MEDIUM, CONTRAST, RADIOLOGIC [irda]     3.6172101
Maternal Health [qnco]     3.6172101
GHz [qnco]     3.6172101
ACHN [gngm]     3.6172101
cd8 cells [cell]     3.6172101
SP [tmco]     3.6172101
Left masseter [bpoc]     3.6172101
3/36 [fndg]     3.6172101
Atrial Fibrillation [patf]     3.6172101
Cumulative Exposure [phpr]     3.6172101
Pin [medd]     3.6172101
Hotel [mnob]     3.6172101
Extracorporeal [spco]     3.6172101
deoxyuridine triphosphate [nnon]     3.6172101
respiratory tract [bdsy]     3.6172101
Florida [geoa]     3.6172101
Mitotic Count [lbtr]     3.6172101
sterol binding [moft]     3.6172101
Raw food [food]     3.6172101
CV [idcn]     3.6172101
Radiation gastritis [patf]     3.6172101
specialised [qlco]     3.6172101
Ecosystem [npop]     3.6172101
Last Screening [tmco]     3.6172101
Pulmonary Edema [dsyn]     3.6172101
Psoriasis [dsyn]     3.6172101
JNK1 [gngm]     3.6172101
Rats, Zucker [mamm]     3.6172101
Policy Development [gora]     3.6172101
Intolerance [ftcn]     3.6172101
Research Methods [resa]     3.6172101
Screening surveillance [hlca]     3.6172101
fiction [inpr]     3.6172101
Colorimetry [lbpr]     3.6172101
Recursive [idcn]     3.6172101
PV [gngm]     3.6172101
Intussusception [dsyn]     3.6172101
early experience [menp]     3.6172101
BPDE-DNA [orch]     3.6172101
1853 [inpr]     3.6172101
pT2 [fndg]     3.6172101
Right shoulder [blor]     3.6172101
human plasma [phsu]     3.6172101
Arginase Deficiency [dsyn]     3.6172101
increased copper [fndg]     3.6172101
Impaired health [patf]     3.6172101
miR-217 [gngm]     3.6172101
lactate [orch]     3.6172101
Single Stranded DNA Virus [virs]     3.6172101
Renal tubule [bpoc]     3.6172101
alpha-1 anti-trypsin deficiency [dsyn]     3.6172101
Patient Compliance [inbe]     3.6172101
adult diseases [dsyn]     3.6172101
Paint [mnob]     3.6172101
Positive Selection [lbpr]     3.6172101
Gastric biopsy [diap]     3.6172101
ZETA [gngm]     3.6172101
Hat [mnob]     3.6172101
Adiaspiromycosis [dsyn]     3.6172101
Gastrointestinal Hemorrhage [patf]     3.6172101
Oral contraception [phsu]     3.6172101
Gallbladder Inflammation [dsyn]     3.6172101
Schwannoma [neop]     3.6172101
BL6 [blor]     3.6172101
SD-1 [imft]     3.6172101
Staging laparoscopy [diap]     3.6172101
Lymphoid aggregate [bpoc]     3.6172101
Cavernous [spco]     3.6172101
CADHERIN 17 [gngm]     3.6172101
Allergic [ftcn]     3.6172101
O-(6)-methylguanine [nnon]     3.6172101
Ossification [ortf]     3.6172101
Asbestos Exposure [inpo]     3.6172101
collection period [tmco]     3.6172101
alcoholic cirrhosis liver [dsyn]     3.6172101
Biliary tract infection [dsyn]     3.6172101
Cytologic material [bdsu]     3.6172101
Treatments, Neoadjuvant [topp]     3.6172101
Tag [irda]     3.6172101
ABO incompatibility [dsyn]     3.6172101
secondary liver cancer [neop]     3.6172101
Idiopathic portal hypertension [dsyn]     3.6172101
Cyanoacrylate [orch]     3.6172101
Avidity [qlco]     3.6172101
Ventricular Septal Defect [anab]     3.6172101
MAPK signaling [moft]     3.6172101
Bolt [mnob]     3.6172101
Distension [patf]     3.6172101
Markers, Laboratory [qlco]     3.6172101
Glycoconjugate [carb]     3.6172101
Nerve [tisu]     3.6172101
Unresectable Mass [fndg]     3.6172101
N-myc Gene [gngm]     3.6172101
Immunostimulation [topp]     3.6172101
Public Health Surveillance [hlca]     3.6172101
Adenomatous Polyposis Coli [neop]     3.6172101
Health Authority [hcro]     3.6172101
Line Probe Assay [lbpr]     3.6172101
Dehydrated [dsyn]     3.6172101
Resorption [orgf]     3.6172101
Faeces [bdsu]     3.6172101
Homogeneous pattern [spco]     3.6172101
Charity [shro]     3.6172101
Tissue Model [emod]     3.6172101
Send [ftcn]     3.6172101
high ferritin [fndg]     3.6172101
B3GNT [gngm]     3.6172101
Utah [geoa]     3.6172101
Echocardiogram [diap]     3.6172101
Neighbor [popg]     3.6172101
Clotting [ortf]     3.6172101
Toxocariasis [dsyn]     3.6172101
Obliterative [qlco]     3.6172101
Epidural catheter [medd]     3.6172101
Scalp [bpoc]     3.6172101
Adenocarcinoma Cell [cell]     3.6172101
Drosophila [euka]     3.6172101
MEN 1 [neop]     3.6172101
scaffolding [mnob]     3.6172101
High dose rate brachytherapy [qnco]     3.6172101
X- linked recessive [fndg]     3.6172101
L3 level [blor]     3.6172101
Unexpected death [fndg]     3.6172101
stage colon cancer [neop]     3.6172101
SELDI-TOF-MS [diap]     3.6172101
methadone maintenance [topp]     3.6172101
therapeutic alternative [inpr]     3.6172101
Cytoplasmic Inclusions [celc]     3.6172101
Sternum [bpoc]     3.6172101
Epithelial dysplasia [neop]     3.6172101
neural function [phsf]     3.6172101
Power Plant [mnob]     3.6172101
MP [neop]     3.6172101
Bone Loss [patf]     3.6172101
divert [ftcn]     3.6172101
Microcyst [fndg]     3.6172101
Sphere [spco]     3.6172101
Site-Specific Mutagenesis [genf]     3.6172101
Sickle Cell Disease [dsyn]     3.6172101
Lymphoepithelioma-like carcinoma [neop]     3.6172101
Etiology aspects [ftcn]     3.6172101
SMH [gngm]     3.6172101
immunoreaction [orgf]     3.6172101
Impaired Renal Function [dsyn]     3.6172101
Hepato-Biliary Neoplasm [neop]     3.6172101
Digit [topp]     3.6172101
Extrahepatic Bile Duct Tumor [neop]     3.6172101
Organ [orgt]     3.6172101
Tag [medd]     3.6172101
Platinum-Based [qlco]     3.6172101
disease type [inpr]     3.6172101
Brain Metastasis [neop]     3.6172101
piercings [topp]     3.6172101
Tissue, Paraffin [tisu]     3.6172101
colon perforation [inpo]     3.6172101
DV [topp]     3.6172101
Group H [inpr]     3.6172101
Hepato-Biliary Tumor [neop]     3.6172101
GBq [qnco]     3.6172101
serum zinc [lbpr]     3.6172101
Non-Small Cell Lung Carcinoma [neop]     3.6172101
Transition Mutations [comd]     3.6172101
RECIST [inpr]     3.6172101
STAM [gngm]     3.6172101
Atresia [cgab]     3.6172101
c-fos Gene [gngm]     3.6172101
Statistical Technique [resa]     3.6172101
MSH2 [gngm]     3.6172101
cellular atypia [comd]     3.6172101
Relative ratio [qnco]     3.6172101
Cellular necrosis [ortf]     3.6172101
Pedigree [inpr]     3.6172101
socioeconomic differences [fndg]     3.6172101
Papanicolaou smear [diap]     3.6172101
Nuclear medicine physician [prog]     3.6172101
PAPILLARY STENOSIS [dsyn]     3.6172101
Compartmental Model [inpr]     3.6172101
Microtubules [celc]     3.6172101
NK Cells [cell]     3.6172101
Discrete Distribution [qnco]     3.6172101
Predispositions, Genetic [orga]     3.6172101
Integer Value [qnco]     3.6172101
Laser technique [topp]     3.6172101
Antimitochondrial Antibodies [lbpr]     3.6172101
Endoscopic approach [spco]     3.6172101
Conditioned Medium [irda]     3.6172101
N-nitrosamine [chvs]     3.6172101
Cell division [celf]     3.6172101
dietary control [topp]     3.6172101
Cleaved [spco]     3.6172101
Adenocarcinoma, Renal [neop]     3.6172101
Less-Developed Countries [qlco]     3.6172101
mRNA transcription [genf]     3.6172101
Native Americans [popg]     3.6172101
UGT1A9 gene [gngm]     3.6172101
SLC10A1 [gngm]     3.6172101
Widespread Disease [dsyn]     3.6172101
Malignant Bone Tumor [neop]     3.6172101
donor selection [celf]     3.6172101
Pointer [mamm]     3.6172101
Stomach Tumor [neop]     3.6172101
Original report [inpr]     3.6172101
Electron transfer [moft]     3.6172101
Chromatography, Reversed-Phase Liquid [lbpr]     3.6172101
Anti-Angiogenesis [topp]     3.6172101
Left eye [bpoc]     3.6172101
recurrent gastric cancer [neop]     3.6172101
Muscle Strength [ortf]     3.6172101
p50 [gngm]     3.6172101
c 2 [lipd]     3.6172101
CRC [neop]     3.6172101
Essence [orch]     3.6172101
NL [amas]     3.6172101
Vitamin intake [fndg]     3.6172101
Rearrangements, DNA [genf]     3.6172101
Estrogen receptor negative [lbtr]     3.6172101
plasma serum [clna]     3.6172101
Sensitisation [menp]     3.6172101
Delta Viruses [virs]     3.6172101
Renal cell [cell]     3.6172101
Massive edema [sosy]     3.6172101
Eruption [dsyn]     3.6172101
High carcinoembryonic antigen level [fndg]     3.6172101
HIGH BLOOD GLUCOSE [dsyn]     3.6172101
coagulation disorders [dsyn]     3.6172101
high lipid [fndg]     3.6172101
Expression Signature [mbrt]     3.6172101
Breast Metastases [neop]     3.6172101
distorted [ftcn]     3.6172101
Virus-Cell Interaction [moft]     3.6172101
Fatty degeneration [patf]     3.6172101
Sickness [fndg]     3.6172101
Gene Family [gngm]     3.6172101
Plasmalemma [celc]     3.6172101
Severe Adverse Event [fndg]     3.6172101
TZ [geoa]     3.6172101
Sustained Release [bodm]     3.6172101
retest [idcn]     3.6172101
Sediment [bdsu]     3.6172101
First pregnancy [fndg]     3.6172101
monitoring program [idcn]     3.6172101
Fascioliasis [dsyn]     3.6172101
Associated finding [fndg]     3.6172101
benign liver tumours [neop]     3.6172101
infection ascites [dsyn]     3.6172101
PMS2 [gngm]     3.6172101
distorted [anab]     3.6172101
XBP1 [gngm]     3.6172101
Glasgow coma score [fndg]     3.6172101
IP [gngm]     3.6172101
Blood Type B [lbtr]     3.6172101
Screening colonoscopy [diap]     3.6172101
HALO [sosy]     3.6172101
Attached [topp]     3.6172101
Untranslated Region [nnon]     3.6172101
Caudal [blor]     3.6172101
Indirect Immunofluorescence [lbpr]     3.6172101
Relatively benign course [fndg]     3.6172101
14-3-3-EPSILON [gngm]     3.6172101
travel [popg]     3.6172101
Mastectomy [topp]     3.6172101
Haematopoiesis [ortf]     3.6172101
Coefficient of Variation [qnco]     3.6172101
Minor Axis [spco]     3.6172101
Society, Hospital [pros]     3.6172101
career [ocac]     3.6172101
biological adhesion [biof]     3.6172101
cologne [sbst]     3.6172101
Reservation [geoa]     3.6172101
Paternal [qlco]     3.6172101
Achilles [bpoc]     3.6172101
PDX1 [gngm]     3.6172101
Subcutaneous nodule [patf]     3.6172101
PAS staining [lbpr]     3.6172101
Knock-in [resa]     3.6172101
Adjuvant Radiation Therapy [topp]     3.6172101
Acute respiratory failure [dsyn]     3.6172101
A16 [inpr]     3.6172101
Echoplanar Imaging [diap]     3.6172101
Revascularisation [topp]     3.6172101
Respiratory Insufficiency [patf]     3.6172101
17/25 [qnco]     3.6172101
Chemical Structure [inpr]     3.6172101
DIGE [lbpr]     3.6172101
PEARL [hcro]     3.6172101
Bioelectrical Impedance Analysis [diap]     3.6172101
Autopsy examination [diap]     3.6172101
Illicit [ftcn]     3.6172101
Hypotension, Controlled [topp]     3.6172101
stage t3 [fndg]     3.6172101
vena caval [bpoc]     3.6172101
Allogeneic Hematopoietic Stem Cell Transplantation [topp]     3.6172101
Acute upper gastrointestinal bleeding [patf]     3.6172101
Cancer, Viral [bmod]     3.6172101
Cervical Intraepithelial Neoplasia [neop]     3.6172101
renal disorders [dsyn]     3.6172101
Hypocholesterolaemia [patf]     3.6172101
Consistency finding [qlco]     3.6172101
RNA Editing [genf]     3.6172101
Supine Position [spco]     3.6172101
Volume Percentage [qnco]     3.6172101
Glucose tolerance test [diap]     3.6172101
Diffuse Lesion [fndg]     3.6172101
Sampling Method [inpr]     3.6172101
Cease [acty]     3.6172101
Bilis [mobd]     3.6172101
Hyperammonaemia [patf]     3.6172101
Callithrix jacchus [mamm]     3.6172101
Malaya [geoa]     3.6172101
Hepatic haemosiderosis [dsyn]     3.6172101
Dairy Products [food]     3.6172101
physical pressure [phpr]     3.6172101
drug assay [lbpr]     3.6172101
Meters [medd]     3.6172101
MA [idcn]     3.6172101
ADENOCARCINOMA, MALIGNANT [neop]     3.6172101
Vasculitis [dsyn]     3.6172101
node-positive [fndg]     3.6172101
Warehouse [mnob]     3.6172101
Hemoglobinopathies [dsyn]     3.6172101
OCIAD1 [gngm]     3.6172101
Associated inflammatory bowel disease [fndg]     3.6172101
Mechanical [npop]     3.6172101
Crude Extracts [chem]     3.6172101
Multiple masses [anab]     3.6172101
augment [topp]     3.6172101
Proton Therapy [topp]     3.6172101
Germ cell tumour [neop]     3.6172101
acute inflammatory response [patf]     3.6172101
Hepatic cyst [dsyn]     3.6172101
Limited area [spco]     3.6172101
Cell Migration Assay [lbpr]     3.6172101
Dose Level [qnco]     3.6172101
Right lung [bpoc]     3.6172101
BILE SALT EXPORT PUMP [gngm]     3.6172101
Hematomas [patf]     3.6172101
Pneumonitis [dsyn]     3.6172101
Gene Networks [moft]     3.6172101
match [mnob]     3.6172101
Sharp instrument [medd]     3.6172101
Proteasome inhibitor [phsu]     3.6172101
cosmic [bodm]     3.6172101
Herbal Supplement [topp]     3.6172101
Anthocyanins [orch]     3.6172101
Pancytopenia [dsyn]     3.6172101
20/400 [fndg]     3.6172101
glucose level [lbpr]     3.6172101
Upper gastrointestinal endoscopy [diap]     3.6172101
Upper third [spco]     3.6172101
communes [ftcn]     3.6172101
Cavernous haemangioma [neop]     3.6172101
active immunization [topp]     3.6172101
Immunomodulation [orgf]     3.6172101
Hormone Therapy [topp]     3.6172101
MAL [gngm]     3.6172101
ESI [gngm]     3.6172101
phrase [inpr]     3.6172101
evidence level [fndg]     3.6172101
Mitochondrial mutation [genf]     3.6172101
Sheet [spco]     3.6172101
blood type [clna]     3.6172101
Estrogen receptor positive [lbtr]     3.6172101
imaging pet [diap]     3.6172101
Gastro-Esophageal Reflux [dsyn]     3.6172101
Stage IIIA [clas]     3.6172101
Drug reaction [inpo]     3.6172101
upper gastrointestinal [anst]     3.6172101
Gastrointestinal Neoplasms [neop]     3.6172101
Functional Relationship [cnce]     3.6172101
Arab Countries [geoa]     3.6172101
Community Health [ocdi]     3.6172101
condom use [inbe]     3.6172101
Systems, Nervous [bdsy]     3.6172101
RN [gngm]     3.6172101
days month [tmco]     3.6172101
Cytogenetic Analysis [mbrt]     3.6172101
Oropharyngeal [blor]     3.6172101
Summation [ortf]     3.6172101
Spinal cord injury [inpo]     3.6172101
Solubility [qlco]     3.6172101
With frequency [qnco]     3.6172101
Anatomic Landmarks [blor]     3.6172101
Pseudomonas aeruginosa [bact]     3.6172101
HIV diagnosis [diap]     3.6172101
egyptian [popg]     3.6172101
Passenger [popg]     3.6172101
Base Excision Repair Pathway [ftcn]     3.6172101
Glass [medd]     3.6172101
Portal cirrhosis [dsyn]     3.6172101
Telomere Maintenance [genf]     3.6172101
Biogenesis [npop]     3.6172101
CII [rnlw]     3.6172101
Once daily [tmco]     3.6172101
typology [hlca]     3.6172101
Clear Cell Hepatocellular Carcinoma [neop]     3.6172101
Acute gastric ulcer [dsyn]     3.6172101
Amazon [bird]     3.6172101
bile duct reconstruction [topp]     3.6172101
Wavelength [qnco]     3.6172101
related compounds [chvs]     3.6172101
Skin tissue [tisu]     3.6172101
Mesenchyma [emst]     3.6172101
Lysosomal Protein Transmembrane 4 Beta Gene [gngm]     3.6172101
Pancreatic disease NOS [dsyn]     3.6172101
IGA [gngm]     3.6172101
Prostitutes [prog]     3.6172101
Serum Glucose [lbpr]     3.6172101
UGT1A9 [gngm]     3.6172101
Vitiligo [dsyn]     3.6172101
Concomitant Therapy [topp]     3.6172101
14-3-3-ZETA [gngm]     3.6172101
Moderate drinker [fndg]     3.6172101
endocan [gngm]     3.6172101
Immunoglobulin G level [lbpr]     3.6172101
Transfusion-Transmitted Virus [virs]     3.6172101
VCAM1 [gngm]     3.6172101
ASCO [pros]     3.6172101
20s [bpoc]     3.6172101
Manipulate [orgf]     3.6172101
ultrasound device [medd]     3.6172101
Private [orgt]     3.6172101
Skeletal system [bdsy]     3.6172101
Cryptosporidiosis [dsyn]     3.6172101
uterus cervix [blor]     3.6172101
myristoylation [moft]     3.6172101
S-1 [topp]     3.6172101
Intracardiac [bsoj]     3.6172101
Cancer Induction [neop]     3.6172101
Candida species [fngs]     3.6172101
ADH1B [gngm]     3.6172101
Blood Circulation [phsf]     3.6172101
Glomerulopathy [dsyn]     3.6172101
Drug Side Effects [inpo]     3.6172101
Duodenectomy [topp]     3.6172101
Adipose Tissue, Subcutaneous [tisu]     3.6172101
Uncontrolled Study [resa]     3.6172101
Graft Rejection [ortf]     3.6172101
Stenoses [anab]     3.6172101
Medical oncologist [prog]     3.6172101
Two Hybrid [mbrt]     3.6172101
BW [orga]     3.6172101
Hispanic American [popg]     3.6172101
expression vector [nnon]     3.6172101
Intrauterine [bsoj]     3.6172101
Hepar [bpoc]     3.6172101
Thing [enty]     3.6172101
Tesla - unit [qnco]     3.6172101
ng/kg [qnco]     3.6172101
institutional care [hlca]     3.6172101
Shin [blor]     3.6172101
Ocelot [mamm]     3.6172101
With staging [ftcn]     3.6172101
Tong [medd]     3.6172101
Senescence, Replicative [celf]     3.6172101
Canal [geoa]     3.6172101
Hydrophilic [qlco]     3.6172101
External diameter [qnco]     3.6172101
8-oxoguanine [nnon]     3.6172101
Fold [topp]     3.6172101
RAB27B [gngm]     3.6172101
Puerto Rico [geoa]     3.6172101
Speckled [qlco]     3.6172101
Follow-up 1 month [fndg]     3.6172101
Moderate Activity [dora]     3.6172101
chest tube placement [topp]     3.6172101
Diaphragmatic Hernia [anab]     3.6172101
Condition, Preneoplastic [neop]     3.6172101
DCP [hcro]     3.6172101
Drug Metabolism [moft]     3.6172101
Protein profiling [lbpr]     3.6172101
CLDN10 [gngm]     3.6172101
p-dioxin [orch]     3.6172101
Glucose-6-Phosphatase Deficiency [dsyn]     3.6172101
21/25 [qnco]     3.6172101
Hepatic macrophage [cell]     3.6172101
Deployment [acty]     3.6172101
Cover-up [bodm]     3.6172101
Core needle biopsy [medd]     3.6172101
Duodenoscope [medd]     3.6172101
Referring Physician [prog]     3.6172101
retinoid metabolism [moft]     3.6172101
Hepatic congestion [dsyn]     3.6172101
Frameshift [comd]     3.6172101
Lipid Peroxidation [lipd]     3.6172101
Discoloration [fndg]     3.6172101
Skull [bpoc]     3.6172101
Mouse Cell Line [cell]     3.6172101
army [orgt]     3.6172101
MLEC [gngm]     3.6172101
6/36 [fndg]     3.6172101
Intestine, Small [bpoc]     3.6172101
Quarterly [tmco]     3.6172101
Performed Procedure [resa]     3.6172101
Liquid Chromatography [lbpr]     3.6172101
Chemoprotective Agent [phsu]     3.6172101
Skin biopsy [diap]     3.6172101
PATERNALLY EXPRESSED GENE 10 [gngm]     3.6172101
Small intestinal [bpoc]     3.6172101
Amyloid, Beta [lbpr]     3.6172101
Hickman line [medd]     3.6172101
EIF3H [gngm]     3.6172101
Sweep [hlca]     3.6172101
Pleural Effusion, Malignant [dsyn]     3.6172101
PMEPA1 [gngm]     3.6172101
Health Resources [idcn]     3.6172101
LacZ [gngm]     3.6172101
blood components [topp]     3.6172101
Microsecond [tmco]     3.6172101
Pool [ftcn]     3.6172101
Flaviviruses [virs]     3.6172101
Clostridium [bact]     3.6172101
Treatment Arm [resa]     3.6172101
ROI [clna]     3.6172101
Radiation Tolerance [orga]     3.6172101
clinical syndromes [clas]     3.6172101
metastatic liver carcinoma [neop]     3.6172101
DI [gngm]     3.6172101
benign prostate hyperplasia [patf]     3.6172101
Reference Standards [qnco]     3.6172101
encircled [spco]     3.6172101
Prenylation [genf]     3.6172101
World Standard Population [popg]     3.6172101
MECHANISTIC STUDIES [rnlw]     3.6172101
16/22 [qnco]     3.6172101
facets [blor]     3.6172101
Withdrawn [fndg]     3.6172101
Flowmetry [lbpr]     3.6172101
Mean Corpuscular Volume [lbtr]     3.6172101
Pituitary Gland [bpoc]     3.6172101
Behavioral Interventions [topp]     3.6172101
Discernible [qlco]     3.6172101
LTP [ortf]     3.6172101
biopsy procedure [diap]     3.6172101
WIF1 [gngm]     3.6172101
Ultrasonic dissection [topp]     3.6172101
plasty [topp]     3.6172101
Viral Carcinogenesis [neop]     3.6172101
Lavage [topp]     3.6172101
Anchoring [topp]     3.6172101
Regulatory sequence [nusq]     3.6172101
Endo [dsyn]     3.6172101
Antifungal Agents [phsu]     3.6172101
Mauritania [geoa]     3.6172101
T6 [blor]     3.6172101
ABO Blood Group [bdsy]     3.6172101
Spontaneous Regression [fndg]     3.6172101
HRAS [gngm]     3.6172101
twinning [famg]     3.6172101
Bone Mineral Density [clna]     3.6172101
Chicken [bird]     3.6172101
GSA [gngm]     3.6172101
Fat metabolism [moft]     3.6172101
Abnormal liver enzymes [fndg]     3.6172101
Anti-inflammatory effect [qlco]     3.6172101
Immunosurveillance [hlca]     3.6172101
Subcostal incision [topp]     3.6172101
Sexually Transmitted Diseases, Viral [dsyn]     3.6172101
mRNA Translation [moft]     3.6172101
Desmoplastic [dsyn]     3.6172101
cigarette use [inbe]     3.6172101
Tropical Medicine [bmod]     3.6172101
Central America [geoa]     3.6172101
npv [virs]     3.6172101
Injections, Intraperitoneal [topp]     3.6172101
MDR1 [gngm]     3.6172101
6/24 [fndg]     3.6172101
postgraduate education [edac]     3.6172101
HAAH [gngm]     3.6172101
Piece [qnco]     3.6172101
9-MG [nnon]     3.6172101
SIC [clas]     3.6172101
Collagenous [qlco]     3.6172101
Staphylococcus aureus infection [dsyn]     3.6172101
Stir [acty]     3.6172101
Zonal Pattern [fndg]     3.6172101
kink [ftcn]     3.6172101
Hepatitis, Toxic [inpo]     3.6172101
GSTT2 [gngm]     3.6172101
Hospital Costs [qnco]     3.6172101
Serum prealbumin level [lbpr]     3.6172101
Pennsylvania [geoa]     3.6172101
World War II [evnt]     3.6172101
Prostate gland [bpoc]     3.6172101
prostatic adenocarcinoma [neop]     3.6172101
Genetic Condition [dsyn]     3.6172101
Ruler [medd]     3.6172101
Ascending cholangitis [dsyn]     3.6172101
Streptococcus species [bact]     3.6172101
Acquiring information [menp]     3.6172101
adrenergic [ftcn]     3.6172101
PIN1 [gngm]     3.6172101
Rib [bpoc]     3.6172101
S Phase [tmco]     3.6172101
Leucoplakia [neop]     3.6172101
Surgical Pathology Report [inpr]     3.6172101
Parasite [npop]     3.6172101
T3b [fndg]     3.6172101
appropriateness [qlco]     3.6172101
lymph node size [clna]     3.6172101
disease mortality [qnco]     3.6172101
Second Line Treatment [topp]     3.6172101
transaminase activity [moft]     3.6172101
Chlamydia [bact]     3.6172101
Justice [qlco]     3.6172101
Blood Cell Count [lbpr]     3.6172101
Toxicogenomics [bmod]     3.6172101
Recycling [hcpp]     3.6172101
gray [qlco]     3.6172101
nordic countries [geoa]     3.6172101
Tumor to Normal [qnco]     3.6172101
Juice [food]     3.6172101
Collision [inpo]     3.6172101
Prevention Study [resa]     3.6172101
mL/mL [qnco]     3.6172101
Phylogeography [ocdi]     3.6172101
SSA [neop]     3.6172101
Deamination [npop]     3.6172101
Number [qnco]     3.6172101
Secondary sclerosing cholangitis [dsyn]     3.6172101
Erosion [acab]     3.6172101
Annual checkup [topp]     3.6172101
Verrucous carcinoma [neop]     3.6172101
Breast Milk [bdsu]     3.6172101
Left portal vein [bpoc]     3.6172101
K-ras gene [gngm]     3.6172101
Endometrial Cancer [neop]     3.6172101
Truncation [comd]     3.6172101
Stock [idcn]     3.6172101
Inflammatory Myofibroblastic Tumor [neop]     3.6172101
Bleeding gastric varices [dsyn]     3.6172101
Repeat Surgery [topp]     3.6172101
hypothermic [fndg]     3.6172101
LIT [gngm]     3.6172101
Senior [idcn]     3.6172101
rER [celc]     3.6172101
8H [tmco]     3.6172101
Inter-Observer Variability [qnco]     3.6172101
P0 [gngm]     3.6172101
cristae [bpoc]     3.6172101
Beta subunit [qlco]     3.6172101
Curative procedure [topp]     3.6172101
Ischaemic stroke [dsyn]     3.6172101
Seminoma [neop]     3.6172101
Entrance [spco]     3.6172101
Beagle [mamm]     3.6172101
HEPATOCYTE NUCLEAR FACTOR 4-ALPHA [gngm]     3.6172101
Regional lymph node involvement [clas]     3.6172101
Celiac trunk [bpoc]     3.6172101
Mucin-4 [aapp]     3.6172101
Rome [geoa]     3.6172101
Transportation [orgt]     3.6172101
venopathy [dsyn]     3.6172101
Hepatica [plnt]     3.6172101
Nona [inpr]     3.6172101
ng/h [qnco]     3.6172101
Human Development [phsf]     3.6172101
Ethiopia [geoa]     3.6172101
CCR1 [gngm]     3.6172101
Folate deficiency [dsyn]     3.6172101
NHL, NOS [neop]     3.6172101
extrahepatic biliary obstruction [dsyn]     3.6172101
Serbia [geoa]     3.6172101
Multiple polyps [neop]     3.6172101
In Vivo Result [cnce]     3.6172101
Enthusiastic [menp]     3.6172101
doubt [cnce]     3.6172101
MHCAT [clas]     3.6172101
Cerebral Hemorrhage [patf]     3.6172101
Class III [inpr]     3.6172101
Confocal Laser Scanning Microscopy [lbpr]     3.6172101
Trichrome staining [lbpr]     3.6172101
tissue markers [medd]     3.6172101
Discriminant Function [resa]     3.6172101
Human Herpes Virus 8 Infection [dsyn]     3.6172101
Health Care Utilization [hlca]     3.6172101
Left Ventricle [bpoc]     3.6172101
Positron [qnco]     3.6172101
Arthritis [dsyn]     3.6172101
blended [hcpp]     3.6172101
Surgical Oncologist [prog]     3.6172101
Sparingly [inpr]     3.6172101
Ectasia [patf]     3.6172101
glucose homeostasis [phsf]     3.6172101
Elderly person [popg]     3.6172101
Drug administration [hlca]     3.6172101
transmembrane glycoprotein [gngm]     3.6172101
Technetium [elii]     3.6172101
LABORATORY ABNORMALITIES [lbtr]     3.6172101
gastric mass [neop]     3.6172101
Endocytosis [celf]     3.6172101
childhood hepatoblastoma [neop]     3.6172101
Immunofluorescence [irda]     3.6172101
Autoimmune reaction [patf]     3.6172101
ST2 [blor]     3.6172101
Oral Medication [topp]     3.6172101
Biliary Tract Surgery [topp]     3.6172101
aflatoxin formation [moft]     3.6172101
Kenya [geoa]     3.6172101
Hypothalamus [bpoc]     3.6172101
Fee [qnco]     3.6172101
Luciferase Gene [gngm]     3.6172101
KIF1B [gngm]     3.6172101
Enveloped Virus [virs]     3.6172101
Bile Duct Diseases [dsyn]     3.6172101
Multidrug Resistance 1 Gene [gngm]     3.6172101
Neoplasms, Epithelial [neop]     3.6172101
Aspiration Biopsy [diap]     3.6172101
choline metabolism [moft]     3.6172101
thermal ablation therapy [topp]     3.6172101
LRT [blor]     3.6172101
Ovarian Yolk Sac Tumor [neop]     3.6172101
aroused [menp]     3.6172101
Insulin Signaling Pathway [moft]     3.6172101
von Gierke Disease [dsyn]     3.6172101
Glycogen Storage Disease [dsyn]     3.6172101
Lymphoma, Mantle-Cell [neop]     3.6172101
Red Cell Distribution Width [lbpr]     3.6172101
Non-Neoplastic Hepatic Disease [dsyn]     3.6172101
occult malignancy [neop]     3.6172101
Activated macrophage [cell]     3.6172101
Secondary Reason [idcn]     3.6172101
genital cancer [neop]     3.6172101
MBL2 [gngm]     3.6172101
Thoracic Surgery [bmod]     3.6172101
Toxicity Testing [diap]     3.6172101
Anatomical feature [spco]     3.6172101
Retinopathy [dsyn]     3.6172101
Platelet indices [lbpr]     3.6172101
Datura stramonium [plnt]     3.6172101
Cancer Family [neop]     3.6172101
Optics [ocdi]     3.91824
mg/h [qnco]     3.91824
SCR [gngm]     3.91824
Supra- [spco]     3.91824
Ribavirin 200 MG [clnd]     3.91824
Chemical pathology [bmod]     3.91824
Eire [geoa]     3.91824
Phlebosclerosis [dsyn]     3.91824
Epstein-Barr virus disease [dsyn]     3.91824
Glycogen storage disease, type I [dsyn]     3.91824
Canine Diseases [dsyn]     3.91824
Postoperative jaundice [patf]     3.91824
Congolese [popg]     3.91824
Chronic active [ftcn]     3.91824
Prostate cancer risk [fndg]     3.91824
EIF3G [gngm]     3.91824
fascinate [bhvr]     3.91824
Pheochromocytoma [neop]     3.91824
American Heart Association [hcro]     3.91824
Marine sponge [euka]     3.91824
Blood alcohol concentration [fndg]     3.91824
VAS [diap]     3.91824
Mucinous Cystadenomas [neop]     3.91824
7q11.2 [celc]     3.91824
Leaf [plnt]     3.91824
GAD [mobd]     3.91824
LV [geoa]     3.91824
basal signaling [celf]     3.91824
GLUTATHIONE S-TRANSFERASE M3 [gngm]     3.91824
Cerebrovascular accident [dsyn]     3.91824
communication system [mnob]     3.91824
CULLIN 4B [gngm]     3.91824
Bacteroides vulgatus [bact]     3.91824
Control Type [resa]     3.91824
Biliary hamartoma [neop]     3.91824
healthy habits [inbe]     3.91824
stain tissue [irda]     3.91824
Soup [food]     3.91824
OH- [cgab]     3.91824
Intersection [idcn]     3.91824
adrenal diseases [dsyn]     3.91824
BMT [topp]     3.91824
Therapy-Related Toxicity [fndg]     3.91824
7-methoxyresorufin [orch]     3.91824
Cerebellar syndrome [dsyn]     3.91824
Biliary Stent Implantation [topp]     3.91824
intestinal ischaemia [dsyn]     3.91824
PKM [gngm]     3.91824
Right atrial pressure [lbtr]     3.91824
hormone levels [lbtr]     3.91824
IRAK1 [gngm]     3.91824
PAX7-FKHR Fusion Protein [aapp]     3.91824
KIF18A [gngm]     3.91824
Conditioned Media [irda]     3.91824
Amino Acids, Aromatic [aapp]     3.91824
Medication Adherence [fndg]     3.91824
Hyalin [ftcn]     3.91824
Card [inpr]     3.91824
Feathery degeneration [patf]     3.91824
delivery mode [idcn]     3.91824
Infant, Newborn [aggp]     3.91824
Angiogenesis Inhibition [topp]     3.91824
TMEM176B [gngm]     3.91824
Fasting Hypoglycemia [dsyn]     3.91824
Hepatitis B Virus Surface Antibody [lbpr]     3.91824
Shoulder [blor]     3.91824
hsa-mir-124a [nnon]     3.91824
Chemistry, Clinical [bmod]     3.91824
Intestinal infarction [dsyn]     3.91824
lipid digestion [orgf]     3.91824
Ductus cysticus [bpoc]     3.91824
Transition Zone [blor]     3.91824
Maternal history [fndg]     3.91824
P5 [gngm]     3.91824
Citrate [orch]     3.91824
Stage IV Lesion [fndg]     3.91824
TRANSCRIPTION FACTOR-LIKE 5 [gngm]     3.91824
Periods, Latency [tmco]     3.91824
Stress [ftcn]     3.91824
Proteolysis [moft]     3.91824
graphy [fngs]     3.91824
Beta-Catenin-Activated Hepatocellular Adenoma [neop]     3.91824
Papillon [mamm]     3.91824
Reactive fibrosis [patf]     3.91824
Lymphopenia [dsyn]     3.91824
Camera [medd]     3.91824
SMARCAD1 [gngm]     3.91824
Felon [patf]     3.91824
mmu-mir-134 [nnon]     3.91824
cancer immunodiagnosis [diap]     3.91824
Miserable [fndg]     3.91824
Endocervical [bpoc]     3.91824
Normal glucose level [fndg]     3.91824
Finger fracture [inpo]     3.91824
Upper back pain [sosy]     3.91824
marginal zone lymphoma [neop]     3.91824
Malignant Vascular Tumor [neop]     3.91824
Cell Strain [cell]     3.91824
Duodenal Ulcer [dsyn]     3.91824
SOD-1 [moft]     3.91824
Dermatologic disorders [dsyn]     3.91824
Spatial Autocorrelation [resa]     3.91824
stoves [mnob]     3.91824
Pro-Apolipoprotein A-I [aapp]     3.91824
Computerized axial tomography [diap]     3.91824
Quarantine [topp]     3.91824
Military Personnel [prog]     3.91824
Thymoma [neop]     3.91824
Scratch [acty]     3.91824
Uncooperative [inbe]     3.91824
system disorder [ftcn]     3.91824
Integumentary Systems [bdsy]     3.91824
Superficial bone [bpoc]     3.91824
Clinical Trials, Therapy [resa]     3.91824
Regulatory T-Lymphocytes [cell]     3.91824
Unipolar [spco]     3.91824
adapt [medd]     3.91824
Limited time [tmco]     3.91824
Mesothelial hyperplasia [patf]     3.91824
biocontrol [hcpp]     3.91824
Therapeutic Method [topp]     3.91824
Department of Defense [orgt]     3.91824
Microcapsules [bodm]     3.91824
Forensic autopsy [diap]     3.91824
Homeo Box Gene [gngm]     3.91824
Desmoplasia [patf]     3.91824
Opposite [fndg]     3.91824
Desulfovibrio [bact]     3.91824
Adhesiolysis [topp]     3.91824
Coastal water [geoa]     3.91824
Solitary fibrous tumor [neop]     3.91824
Reovirus Infection [dsyn]     3.91824
vesicular stomatitis virus [virs]     3.91824
T cell mediated immunity [orgf]     3.91824
Atherectomy [topp]     3.91824
electrolyte disorder [patf]     3.91824
Senior [grpa]     3.91824
Killer Cell, Cytokine-Induced [cell]     3.91824
over-exposure [inpo]     3.91824
reproductive development [orgf]     3.91824
of presence [qnco]     3.91824
Plural [qnco]     3.91824
Heritage [clas]     3.91824
Immunoradiometry [lbpr]     3.91824
congenital malformations [cgab]     3.91824
Tropical Diseases [dsyn]     3.91824
anaerobes [bact]     3.91824
venous disease [dsyn]     3.91824
Microvesicular hepatic steatosis [fndg]     3.91824
Lymphomas, Follicular [neop]     3.91824
Aorta, Abdominal [bpoc]     3.91824
hydroxyhydroquinone [orch]     3.91824
Cave [geoa]     3.91824
Agrochemical [chvf]     3.91824
10^3/dL [qnco]     3.91824
Zar [mobd]     3.91824
Nonocclusion [anab]     3.91824
Aurora B signaling [ftcn]     3.91824
MGAT5 [gngm]     3.91824
PTPL1 [gngm]     3.91824
Lysosomal Storage Disorder [dsyn]     3.91824
sialic acid binding [moft]     3.91824
POT1 [gngm]     3.91824
cellular polarity [spco]     3.91824
Cerebrovascular disease [patf]     3.91824
Decreased Oncotic Pressure [phsf]     3.91824
Subtotal hepatectomy [topp]     3.91824
Maternal drug use [patf]     3.91824
Heat effects NOS [dsyn]     3.91824
North American Association of Central Cancer Registries [prog]     3.91824
Proton-Motive Force [moft]     3.91824
Xanthogranulomatous cholecystitis [dsyn]     3.91824
Ileal Disease [dsyn]     3.91824
Diuresis [ortf]     3.91824
Mild Adverse Event [fndg]     3.91824
KIR2DS4 [gngm]     3.91824
Cytogenetic Abnormalities [comd]     3.91824
Oropharyngeal Carcinoma [neop]     3.91824
Human Activity [acty]     3.91824
Split [fndg]     3.91824
HIV viral load [lbpr]     3.91824
Identifiable [inpr]     3.91824
Hepatitis G virus E2 [virs]     3.91824
Idiopathic Pulmonary Fibrosis [dsyn]     3.91824
Left hepatic vein [bpoc]     3.91824
Postmortem Diagnosis [fndg]     3.91824
NTI [gngm]     3.91824
Defense [inbe]     3.91824
distended [ftcn]     3.91824
Smooth Muscle Tumor [neop]     3.91824
Burkholderia multivorans [bact]     3.91824
CO4 [gngm]     3.91824
Suppurative inflammation [patf]     3.91824
misbehavior [inbe]     3.91824
KU55933 [orch]     3.91824
gender preference [inbe]     3.91824
Human herpes simplex virus [virs]     3.91824
Percutaneous cholangiography [diap]     3.91824
MICRO RNA 429 [gngm]     3.91824
asymptomatic HIV [dsyn]     3.91824
grantees [prog]     3.91824
Phone [cnce]     3.91824
Social Environment [idcn]     3.91824
TPM1 [gngm]     3.91824
Legitimacy [rnlw]     3.91824
Shoulder lesions [dsyn]     3.91824
Nasal cavity [bsoj]     3.91824
Evoked [qlco]     3.91824
serum iron level [lbtr]     3.91824
Tumors, Granulosa Cell [neop]     3.91824
recombinant peptide [aapp]     3.91824
Papillary Pattern [fndg]     3.91824
pascal [qnco]     3.91824
N-ras Gene [gngm]     3.91824
Ascites [qlco]     3.91824
Organophosphorus Compounds [opco]     3.91824
Normal breast [fndg]     3.91824
ENIGMA [gngm]     3.91824
Kasai portoenterostomy [topp]     3.91824
Insurance Coverage [idcn]     3.91824
Vasovagal [ftcn]     3.91824
Psittacines [bird]     3.91824
7-60 [gngm]     3.91824
Sessile [qlco]     3.91824
Noninflammatory [fndg]     3.91824
Inferior vena cava wall [bpoc]     3.91824
Third degree burn [inpo]     3.91824
Laparoscopic adrenalectomy [topp]     3.91824
Prominent nucleoli [fndg]     3.91824
Allowance [qnco]     3.91824
Acetaminophen poisoning [inpo]     3.91824
RAD18 [gngm]     3.91824
Abnormal histology findings [fndg]     3.91824
Philippines [geoa]     3.91824
chromosome 8p22 [celc]     3.91824
Multiple therapy [topp]     3.91824
Cardiac Surgical Procedures [topp]     3.91824
Second Degree Relative [famg]     3.91824
Aspirate [menp]     3.91824
Heart.chambers [bsoj]     3.91824
liver problems [fndg]     3.91824
mixed race [fndg]     3.91824
Gallbladder bed [blor]     3.91824
HCC-4 [gngm]     3.91824
B-Cell Lymphomas [neop]     3.91824
microkatal [qnco]     3.91824
Great Lakes Region [geoa]     3.91824
OST [gngm]     3.91824
metabolism regulation [orgf]     3.91824
Illinois [geoa]     3.91824
<90 degrees [qnco]     3.91824
Flip Angle [qlco]     3.91824
air bubbles [sbst]     3.91824
Study, Concurrent [qnco]     3.91824
Heavy Ion Radiotherapy [topp]     3.91824
Cuboidal Cells [cell]     3.91824
nutritional care [topp]     3.91824
Unidentified cell [cell]     3.91824
CES1 [gngm]     3.91824
Hexoses [carb]     3.91824
ocular melanoma [neop]     3.91824
V9 [bpoc]     3.91824
Zambia [geoa]     3.91824
Evaluation Studies [inpr]     3.91824
gallbladder removal [topp]     3.91824
Neoplasms, Multiple Primary [neop]     3.91824
cpq [inpr]     3.91824
Major Depression [mobd]     3.91824
General treatment [hlca]     3.91824
Arterial ischaemia [patf]     3.91824
Scrofula [dsyn]     3.91824
Study, Closed Cohort [qnco]     3.91824
history physical examination [hlca]     3.91824
Pharmacists [prog]     3.91824
special senses [bdsy]     3.91824
performance status 2 [qnco]     3.91824
Spindle Cell Tumor [neop]     3.91824
arsenic exposure [fndg]     3.91824
Tubular Adenocarcinomas [neop]     3.91824
Birth outcome [clna]     3.91824
Low 25-OH-vitamin D level [fndg]     3.91824
Resectable Hepatoma [neop]     3.91824
Spindle Cell Neoplasm [neop]     3.91824
times day [qnco]     3.91824
Surgical intensive care unit [mnob]     3.91824
Psychosis [mobd]     3.91824
RAP1 [gngm]     3.91824
Antisocial behavior [mobd]     3.91824
Blood flukes NOS [dsyn]     3.91824
Sarcoma, Soft Tissue [neop]     3.91824
Chromosome 8 [celc]     3.91824
ileum [bpoc]     3.91824
nodal signaling [moft]     3.91824
target of rapamycin complex 1 [celc]     3.91824
Pigment [phsf]     3.91824
Mouse Leukemia [neop]     3.91824
YE [geoa]     3.91824
Colorectal cancer, early onset [fndg]     3.91824
CCNG1 [gngm]     3.91824
Good [mnob]     3.91824
Intercostal artery [bpoc]     3.91824
Magnesium [elii]     3.91824
small value [qlco]     3.91824
Visual disturbances [sosy]     3.91824
Cell Lysate [phob]     3.91824
Viral Burden [fndg]     3.91824
S8 [gngm]     3.91824
Osteopenia/osteoporosis [dsyn]     3.91824
epithelial tissues [tisu]     3.91824
Group therapy [topp]     3.91824
Dermatology department [hcro]     3.91824
Time-Resolved Immunofluorometric Assay [lbpr]     3.91824
Tryptophan Metabolism [moft]     3.91824
Hemodialysis, Home [topp]     3.91824
Intracellular Space [bsoj]     3.91824
Hyperalimentation NOS [mobd]     3.91824
Intestinal Obstruction [dsyn]     3.91824
FBP1 [gngm]     3.91824
Adipose Tissue, Brown [tisu]     3.91824
Human Breast Cancer Cell [cell]     3.91824
rewarding [menp]     3.91824
Shellfish [food]     3.91824
Therapy Outcome [fndg]     3.91824
pretest [hlca]     3.91824
DRG [inpr]     3.91824
Medical practitioners NOS [prog]     3.91824
Minimal inflammation [fndg]     3.91824
Hypertrophic scar [acab]     3.91824
Intranuclear Inclusions [celc]     3.91824
CD68 gene [gngm]     3.91824
drugs infection [phsu]     3.91824
Soundex [inpr]     3.91824
PDXDC1 [gngm]     3.91824
Endemic Tyrolean Infantile Cirrhosis [dsyn]     3.91824
National Institute of Environmental Health Sciences [hcro]     3.91824
Maintenance Chemotherapy [fndg]     3.91824
stress granule [celc]     3.91824
Vocal system [bdsy]     3.91824
Malabsorption [dsyn]     3.91824
PHB2 [gngm]     3.91824
Wound dehiscence [acab]     3.91824
Esophageal squamous cell [cell]     3.91824
Cancer Gene Mutation [comd]     3.91824
Gestation period [fndg]     3.91824
Hepatic portal vein obstruction [dsyn]     3.91824
Patient died [fndg]     3.91824
Panic Disorder [mobd]     3.91824
HNF4G [gngm]     3.91824
Placental tissue sample [tisu]     3.91824
caudal type homeobox 1 [gngm]     3.91824
fatty acid beta-oxidation [moft]     3.91824
Adrenal cortical tumor [neop]     3.91824
Group R [inpr]     3.91824
Guinea Pigs [mamm]     3.91824
Organ process [bpoc]     3.91824
laparoscopy procedure [diap]     3.91824
WI [geoa]     3.91824
MACROGLOSSIA [cgab]     3.91824
Immune Cell Function [resa]     3.91824
Benin [geoa]     3.91824
Study Agent [inpr]     3.91824
Breast examination [diap]     3.91824
Gamma globulin level [lbpr]     3.91824
TMPRSS4 [gngm]     3.91824
cytokine secretion [celf]     3.91824
Bowel preparation [hlca]     3.91824
Epithelial tumour [neop]     3.91824
Rat Carcinoma [neop]     3.91824
Pharmacological stress [phpr]     3.91824
LX [fndg]     3.91824
Neuritic Plaques [acab]     3.91824
Basal rate [clna]     3.91824
Heterophil [cell]     3.91824
Mask [resa]     3.91824
Maackia amurensis [plnt]     3.91824
Female prostitute [prog]     3.91824
Substance Use Disorders [mobd]     3.91824
DNA Adduction [comd]     3.91824
Health Fairs [hlca]     3.91824
interferon production [orgf]     3.91824
Diffuse Hemangioma [dsyn]     3.91824
pancreatic mass [fndg]     3.91824
Squamous cell carcinoma antigen level [lbpr]     3.91824
Reduced concentration [fndg]     3.91824
HCCS-1 [gngm]     3.91824
Hepatitis G virus ribonucleic acid [nnon]     3.91824
Timespan [tmco]     3.91824
SOCI [gngm]     3.91824
portosystemic shunting [topp]     3.91824
Charge [orga]     3.91824
Caregiver Stress [fndg]     3.91824
Squamous cell carcinoma of the head and neck [neop]     3.91824
TSPX [gngm]     3.91824
chronic ulcerative colitis [dsyn]     3.91824
Food Supply [qnco]     3.91824
Alpha particle [npop]     3.91824
100 IU/mL [qnco]     3.91824
Physiotherapy [topp]     3.91824
5-methyltetrahydrofolate [orch]     3.91824
FAAH2 [gngm]     3.91824
Preconception [clna]     3.91824
Abdominal Fat [tisu]     3.91824
Caribbean [geoa]     3.91824
Possibly Related [qlco]     3.91824
Hyperglycemia, Postprandial [fndg]     3.91824
Microcebus murinus [mamm]     3.91824
8p21.3 [celc]     3.91824
Acoustic Radiation Force Impulse Imaging [diap]     3.91824
oxygenation [ortf]     3.91824
Anisocytosis [fndg]     3.91824
Roma [inpr]     3.91824
Swallow [bird]     3.91824
Diffuse inflammation [sosy]     3.91824
Cohabiting [socb]     3.91824
Salt - food [food]     3.91824
Core needle [medd]     3.91824
NX [fndg]     3.91824
STORAGE PROBLEM [ftcn]     3.91824
secular [idcn]     3.91824
Electronic Health Records [inpr]     3.91824
Non-English speaking [fndg]     3.91824
Excisional biopsy [diap]     3.91824
protein location [celc]     3.91824
Dilution technique [lbpr]     3.91824
RHOC [gngm]     3.91824
Food Policy [inpr]     3.91824
70% Ethanol [clnd]     3.91824
DNA glycosylase activity [genf]     3.91824
UTR [nnon]     3.91824
Skin abscess [patf]     3.91824
Inflorescence [plnt]     3.91824
Journal Article [inpr]     3.91824
SNP309 [nusq]     3.91824
crystalloid [phsu]     3.91824
Ampulla of Vater Cancer [neop]     3.91824
normal triglyceride [fndg]     3.91824
Systemic poison [hops]     3.91824
DR3 [gngm]     3.91824
ALR Mouse [mamm]     3.91824
protein structure [aapp]     3.91824
Pfannenstiel incision [topp]     3.91824
Polyneuropathy, Familial [dsyn]     3.91824
Vanilloid [phsu]     3.91824
Urogenital System [bdsy]     3.91824
NN [dsyn]     3.91824
Athymic Nude Mouse [mamm]     3.91824
Life partner [idcn]     3.91824
MA [qnco]     3.91824
cytosine methylation [genf]     3.91824
Phase 0 [resa]     3.91824
Helicobacter Infections [dsyn]     3.91824
Clinical Lot [inpr]     3.91824
Esophageal Tissue [tisu]     3.91824
Tc 99m [irda]     3.91824
Cholera [dsyn]     3.91824
Community Oncology [hlca]     3.91824
Scientific Study [lbpr]     3.91824
Needle Shape [spco]     3.91824
Antigens, Viral [imft]     3.91824
Decreased white blood cell count [fndg]     3.91824
Consensus Sequence [nusq]     3.91824
Extended Family [famg]     3.91824
hsa-mir-885 [gngm]     3.91824
Glutathione Metabolism [moft]     3.91824
research agenda [resa]     3.91824
Age Categories [aggp]     3.91824
Plant Pathology [ocdi]     3.91824
NK-1 [gngm]     3.91824
Para-umbilical vein [bpoc]     3.91824
Warm Ischemia [dsyn]     3.91824
arsenical [chvs]     3.91824
Educational Curriculum [inpr]     3.91824
Dina [euka]     3.91824
SRR [gngm]     3.91824
Neoplasm of the Pancreas [neop]     3.91824
OLD_CHILD [idcn]     3.91824
Acute hepatic necrosis [patf]     3.91824
Therapeutic Area [cnce]     3.91824
Sheep [mamm]     3.91824
tested urine [lbpr]     3.91824
abdominal tumours [neop]     3.91824
v-myc Oncogenes [gngm]     3.91824
hormonal changes [fndg]     3.91824
TUNEL Assay [mbrt]     3.91824
DNA, Complementary [nnon]     3.91824
SALL4 [gngm]     3.91824
Saint [cnce]     3.91824
Pre-dose [tmco]     3.91824
MACROPHAGE CAPPING PROTEIN [gngm]     3.91824
POC [gngm]     3.91824
hypothalamic-pituitary-adrenal axis [bdsy]     3.91824
NALT [tisu]     3.91824
Melanoma Cell [cell]     3.91824
EPH [gngm]     3.91824
HSV [dsyn]     3.91824
Exocytosis [celf]     3.91824
Kaplan-Meier Test [qnco]     3.91824
VASCULAR ADHESION PROTEIN 1 [gngm]     3.91824
motivation treatment [inbe]     3.91824
Serum lysine level [lbpr]     3.91824
Re-exploration [diap]     3.91824
bed capacity [qnco]     3.91824
Dormancy [phsf]     3.91824
NS4 [dsyn]     3.91824
Secondary Infection [dsyn]     3.91824
Telomere analysis [lbpr]     3.91824
CXCR2 [gngm]     3.91824
plasma insulin [lbpr]     3.91824
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma [neop]     3.91824
Hematology+Oncology [bmod]     3.91824
dysmorphism [cgab]     3.91824
Health Care Organization [hcro]     3.91824
Freely [qlco]     3.91824
laboratory methods [inpr]     3.91824
CCNG2 [gngm]     3.91824
Mutagenic Process [comd]     3.91824
Cryptocotyle [euka]     3.91824
Somatic stem cell [cell]     3.91824
Allotype [genf]     3.91824
cardiovascular imaging [diap]     3.91824
FOXM1 transcription factor network [ftcn]     3.91824
Cuboidal Epithelium [tisu]     3.91824
Leucocytosis [patf]     3.91824
Abdominal operations NOS [topp]     3.91824
facsimile [mcha]     3.91824
Life-threatening infections [fndg]     3.91824
Limited cutaneous systemic sclerosis [dsyn]     3.91824
Census Region [geoa]     3.91824
injection complication [patf]     3.91824
Relative Density [qnco]     3.91824
Familial disease [dsyn]     3.91824
Myxofibrosarcoma [neop]     3.91824
Oliguria [sosy]     3.91824
pests [anim]     3.91824
phospholipid homeostasis [phsf]     3.91824
Post-surgical anatomy [bpoc]     3.91824
VEGF Signaling Pathway [ftcn]     3.91824
Decreased cardiac output [fndg]     3.91824
angiography procedure [diap]     3.91824
milliequivalents [qnco]     3.91824
Tupaia belangeri chinensis [mamm]     3.91824
Harm Reduction [topp]     3.91824
N2 [fndg]     3.91824
PC [dsyn]     3.91824
Severe course [fndg]     3.91824
Radiation Pneumonitis [inpo]     3.91824
hepatic vein obstruction [dsyn]     3.91824
Insufficient sample [fndg]     3.91824
Endoplasmic Reticulum-Associated Degradation [moft]     3.91824
Fractures, Bone [inpo]     3.91824
Entire placental membrane [emst]     3.91824
Vascular stasis [fndg]     3.91824
ale [food]     3.91824
Increased venous pressure [fndg]     3.91824
Lymphoma, T-Cell, Cutaneous [neop]     3.91824
Past Medical History [fndg]     3.91824
Plastic surgeon [prog]     3.91824
LGALS9 gene [gngm]     3.91824
Population Mode [qnco]     3.91824
phantom model [inpr]     3.91824
Scirrhous Adenocarcinomas [neop]     3.91824
Pore [celc]     3.91824
Nucleoside Reverse Transcriptase Inhibitors [moft]     3.91824
MUTATED IN COLORECTAL CANCERS [gngm]     3.91824
Infusion-Related Reaction [sosy]     3.91824
normal neonate [fndg]     3.91824
millisecond [tmco]     3.91824
cestodes [dsyn]     3.91824
Single-Strand Conformation Polymorphism Analysis [mbrt]     3.91824
Nuclear Accidents, Fukushima [hcpp]     3.91824
thymoquinone [orch]     3.91824
Glioblastoma [neop]     3.91824
Oxidative Stress Pathway [moft]     3.91824
3D image [diap]     3.91824
Severe Combined Immunodeficient Mice [mamm]     3.91824
J-Pouch [acab]     3.91824
Athletes [prog]     3.91824
mL/kg/h [qnco]     3.91824
chemical synthesis [npop]     3.91824
ERO [gngm]     3.91824
Recurrent Hepatoma [neop]     3.91824
buttock muscles [bpoc]     3.91824
Study recommendation [clna]     3.91824
CXCR4 gene [gngm]     3.91824
Drought [npop]     3.91824
V35 [gngm]     3.91824
work related [fndg]     3.91824
Dracocephalum [plnt]     3.91824
Theta [inpr]     3.91824
coumarin 7 [orch]     3.91824
Microscopy, Phase-Contrast [lbpr]     3.91824
Night [tmco]     3.91824
Strangulated [ftcn]     3.91824
NANOG gene [gngm]     3.91824
BRCA2 Mutation [comd]     3.91824
Multilevel Analysis [resa]     3.91824
p53 Signaling Pathway [moft]     3.91824
Pericyte [cell]     3.91824
functional capacity [topp]     3.91824
serum creatine [lbpr]     3.91824
these [inpr]     3.91824
patients report [inpr]     3.91824
Oriental cholangiohepatitis [dsyn]     3.91824
Acute Renal Injury [inpo]     3.91824
Bonferroni Adjustment [qnco]     3.91824
ADH2 [gngm]     3.91824
NEUROENDOCRINE TUMOR, MALIGNANT [neop]     3.91824
Image Registration [mcha]     3.91824
PM [dsyn]     3.91824
Pancolitis [dsyn]     3.91824
Processed food [food]     3.91824
Vena Cavas, Inferior [bpoc]     3.91824
Suicide prevention [topp]     3.91824
Cystadenocarcinoma [neop]     3.91824
Visible To [cnce]     3.91824
urate oxidase activity [moft]     3.91824
delayed gastric emptying [dsyn]     3.91824
pediatric hepatoblastoma [neop]     3.91824
Health Services [hlca]     3.91824
HEMIHYPERPLASIA, ISOLATED [dsyn]     3.91824
NME1 [gngm]     3.91824
RUPTURE [inpo]     3.91824
PPARA [gngm]     3.91824
twinning [ftcn]     3.91824
Telephone [mnob]     3.91824
Overtime [phsu]     3.91824
ADIPOR2 [gngm]     3.91824
Synovia [bdsu]     3.91824
Low Cardiac Output [fndg]     3.91824
conformal radiation therapy [topp]     3.91824
Genetic Status [orga]     3.91824
Curettages [topp]     3.91824
Hepatitis Virus, Infectious [virs]     3.91824
anti-c antibody [imft]     3.91824
peritoneal carcinoma [neop]     3.91824
Information Extraction [ocac]     3.91824
SGE [moft]     3.91824
ANS [bdsy]     3.91824
EGR2 [gngm]     3.91824
E coli [bact]     3.91824
MscS [moft]     3.91824
Osteolytic [qlco]     3.91824
Tubulovillous adenoma [neop]     3.91824
Allergy [bmod]     3.91824
Gingival Index [lbtr]     3.91824
Viscosity [npop]     3.91824
liver parts [bpoc]     3.91824
Suprahepatic [spco]     3.91824
Right internal thoracic artery [bpoc]     3.91824
Blood vessel wall [bpoc]     3.91824
Tubulointerstitial fibrosis [fndg]     3.91824
CO3 [gngm]     3.91824
CN-I [gngm]     3.91824
cancer chemoprevention [topp]     3.91824
Substrate Specificities [qnco]     3.91824
treatment completion [hlca]     3.91824
disseminated tb [dsyn]     3.91824
School Teachers [prog]     3.91824
Bacteria, Anaerobic [bact]     3.91824
alcohol abuse history [fndg]     3.91824
MASP2 gene [gngm]     3.91824
Bacterial cholangitis [dsyn]     3.91824
Respiratory air [bdsu]     3.91824
Cytoplasmic Structures [celc]     3.91824
Axons [celc]     3.91824
Inefficiency [ftcn]     3.91824
p72 [gngm]     3.91824
Gene Expression Alteration [genf]     3.91824
Ovariectomy [topp]     3.91824
Vascular flow [orgf]     3.91824
Eosinophilia, mild [fndg]     3.91824
FTC [neop]     3.91824
Boyd [inpr]     3.91824
Stevens-Johnson Syndrome [dsyn]     3.91824
Ebola virus [virs]     3.91824
LYMPHOMA, LARGE CELL, MALIGNANT [neop]     3.91824
Intestinal intussusception [dsyn]     3.91824
Chanodichthys erythropterus [fish]     3.91824
HLA locus [gngm]     3.91824
Cervical Adenocarcinoma [neop]     3.91824
Toll-Like Receptor 2 Gene [gngm]     3.91824
Radioactive implantation [topp]     3.91824
FISH Technique [mbrt]     3.91824
General Population Cohort [popg]     3.91824
Anti-Microbial Agents [phsu]     3.91824
ESRD [dsyn]     3.91824
normal folate [fndg]     3.91824
Indirect Immunofluorescence Assay [lbpr]     3.91824
unborn [aggp]     3.91824
Heavy particle therapy [topp]     3.91824
Low cholesterol diet [topp]     3.91824
FOLFOX-4 Regimen [topp]     3.91824
Antibiotic susceptibility [fndg]     3.91824
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [lbpr]     3.91824
Pneumonia, Bacterial [dsyn]     3.91824
cisplatin/fluorouracil [topp]     3.91824
throw [fndg]     3.91824
Amyloid deposition [patf]     3.91824
Realm [idcn]     3.91824
tetraspanin-enriched microdomain [dsyn]     3.91824
Body Fat [tisu]     3.91824
Case Report Form [mnob]     3.91824
Environmental Pollutants [eehu]     3.91824
Gastric Hemangioma [neop]     3.91824
Vibrio vulnificus infection [dsyn]     3.91824
Classification Scheme [cnce]     3.91824
Storage Disorders, Iron [dsyn]     3.91824
soy [food]     3.91824
incidence of cases [ftcn]     3.91824
USSR [geoa]     3.91824
CDH [cgab]     3.91824
Th cell [cell]     3.91824
Tumescence [fndg]     3.91824
economic cost [qnco]     3.91824
Aspergillus species [fngs]     3.91824
Stage IVB Hepatocellular Carcinoma [neop]     3.91824
Tibias [bpoc]     3.91824
Regimen B [topp]     3.91824
Mouse Cerebral Cortex [tisu]     3.91824
Premature Birth [patf]     3.91824
gonadotrophin secretion [ortf]     3.91824
OM [geoa]     3.91824
Increased testosterone [fndg]     3.91824
second messengers [moft]     3.91824
stage I non-small cell lung cancer [neop]     3.91824
Germinal Center [tisu]     3.91824
Procedure type [clas]     3.91824
Therapeutic Index [qnco]     3.91824
Cardiac Hypertrophy [patf]     3.91824
mol/s [qnco]     3.91824
Eosinophilic cholangitis [dsyn]     3.91824
Tuberous Sclerosis Complex [neop]     3.91824
Parvovirus B19 [virs]     3.91824
bleeding disorder [dsyn]     3.91824
Linguistic [ocdi]     3.91824
gadobutrol [irda]     3.91824
fibrosis, radiation-induced [inpo]     3.91824
PRMT6 [gngm]     3.91824
sexual compulsivity [mobd]     3.91824
Parasitic Liver Disease [dsyn]     3.91824
Central Pathology Review [diap]     3.91824
Capillary refill [ortf]     3.91824
NAT Gene [gngm]     3.91824
4 Hours [tmco]     3.91824
Increased pressure [ftcn]     3.91824
Liquor [bdsu]     3.91824
T2 category [fndg]     3.91824
Social status [qlco]     3.91824
Fused Image [mnob]     3.91824
muCL [gngm]     3.91824
FRY [gngm]     3.91824
Band [topp]     3.91824
alcohol ingestion [inbe]     3.91824
Follow-up 2 weeks [fndg]     3.91824
Haemolytic [qlco]     3.91824
PDIA3 [gngm]     3.91824
Relative Biological Effectiveness [qnco]     3.91824
Apis mellifera [euka]     3.91824
Tumour weight [qnco]     3.91824
GSTA2 gene [gngm]     3.91824
Current sample [sbst]     3.91824
Genetic Locus [gngm]     3.91824
Uterine adenocarcinoma [neop]     3.91824
fibrillarin [aapp]     3.91824
Meigs Syndrome [neop]     3.91824
VEGF binding [moft]     3.91824
Transtracheal aspirate [bdsu]     3.91824
Venography [diap]     3.91824
Align [phsu]     3.91824
Primary procedure [ftcn]     3.91824
CNS TUMORS [neop]     3.91824
major artery [bpoc]     3.91824
Rat, August [mamm]     3.91824
Ablation power [clna]     3.91824
cultural differences [qlco]     3.91824
bioimaging [inpr]     3.91824
Neurological deficit [fndg]     3.91824
MAP2K1 [gngm]     3.91824
SLC2A4 [gngm]     3.91824
PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 1 [gngm]     3.91824
Pressure Sore [dsyn]     3.91824
Mild thrombocytopenia [fndg]     3.91824
Periodontal disease [dsyn]     3.91824
past treatment [fndg]     3.91824
Taenia [euka]     3.91824
Small intestinal infarction [dsyn]     3.91824
Inflammatory necrosis [patf]     3.91824
Dab [food]     3.91824
Life support [topp]     3.91824
Carcinoma, Intraepithelial [neop]     3.91824
Nemia [euka]     3.91824
Dull [qlco]     3.91824
Riot [socb]     3.91824
DNA Topoisomerase II Inhibitors [phsu]     3.91824
Stress - value [fndg]     3.91824
Speculating [menp]     3.91824
Spices [food]     3.91824
environmental stress [phpr]     3.91824
cot [medd]     3.91824
2-styrylindolium [orch]     3.91824
Sterol [strd]     3.91824
LHB [gngm]     3.91824
antimitotic [phsu]     3.91824
Nerve Diseases [dsyn]     3.91824
Two-Hybrid Method [mbrt]     3.91824
Oncocytoma, renal [neop]     3.91824
Lock [idcn]     3.91824
Drinking pattern [fndg]     3.91824
Physical activity [fndg]     3.91824
Genetic screen [diap]     3.91824
Arsenical keratosis [inpo]     3.91824
t-helper cells [cell]     3.91824
Sensation [ortf]     3.91824
Not detected [fndg]     3.91824
Patient Navigator [prog]     3.91824
Skin disease [dsyn]     3.91824
stenotic [ftcn]     3.91824
DAPK1 [gngm]     3.91824
Health Care Sector [idcn]     3.91824
FGFR2 gene [gngm]     3.91824
safety system [inpr]     3.91824
Stapler [medd]     3.91824
Bile peritonitis [dsyn]     3.91824
IMP1 [gngm]     3.91824
Sex Cord-Like Pattern [fndg]     3.91824
Fc-epsilon receptor signaling pathway [moft]     3.91824
Osler-Weber-Rendu Syndrome [dsyn]     3.91824
Shaft [spco]     3.91824
Low-grade astrocytoma, NOS [neop]     3.91824
color food [chvf]     3.91824
4q34 [celc]     3.91824
hospital analysis [ocac]     3.91824
stage II nephroblastoma [neop]     3.91824
Cost Savings [qnco]     3.91824
Shoulder Pain [sosy]     3.91824
Arterial system [bdsy]     3.91824
Tumor marker level [lbpr]     3.91824
Antitumor Response [ortf]     3.91824
3705 [inpr]     3.91824
Monitoring, Epidemiologic [ocac]     3.91824
Hepatitis, Infectious [dsyn]     3.91824
motels [mnob]     3.91824
Virus-Related Malignancy [neop]     3.91824
Review status [clna]     3.91824
FXR [gngm]     3.91824
Pain-Free [orch]     3.91824
Mammary Cancer [neop]     3.91824
Multiple sexual partners [fndg]     3.91824
Bench-to-Bedside [clas]     3.91824
Kidney Failure, Chronic [dsyn]     3.91824
Rectum Cancer [neop]     3.91824
Clara cell [cell]     3.91824
Markers, DNA [nusq]     3.91824
Carcinoma, Pancreatic Ductal [neop]     3.91824
Auditory Canal, External [bsoj]     3.91824
lung base [bpoc]     3.91824
Thyroid disorders [dsyn]     3.91824
chromosome 1q [nusq]     3.91824
ctt [diap]     3.91824
Right sided heart [cgab]     3.91824
Phase Transition [npop]     3.91824
Hepatocellular loss [fndg]     3.91824
Mitoses [celf]     3.91824
Splenic Rupture [inpo]     3.91824
Dividing cell [cell]     3.91824
Chronic kidney disease stage 4 [dsyn]     3.91824
CYP24A1 [gngm]     3.91824
GST Gene [gngm]     3.91824
MIA2 [gngm]     3.91824
b-all [neop]     3.91824
Clonal Deletion [ortf]     3.91824
phenomenology [idcn]     3.91824
Yamamoto [blor]     3.91824
Hepatoprotective Drugs [phsu]     3.91824
Syndromes, Acute Coronary [dsyn]     3.91824
Ileo-anal anastomosis [topp]     3.91824
Costa [bpoc]     3.91824
Coronary heart disease risk [inpr]     3.91824
Still birth [patf]     3.91824
Molecular Weight [qnco]     3.91824
disease registry [inpr]     3.91824
Diastolic flow [ortf]     3.91824
Moxibustion [topp]     3.91824
HRSA [hcro]     3.91824
Chad [geoa]     3.91824
Sump Syndrome [dsyn]     3.91824
Toy poodle [mamm]     3.91824
Vaginal douching [topp]     3.91824
Married Status [fndg]     3.91824
Scutellaria barbata [phsu]     3.91824
Unifocal tumor [fndg]     3.91824
CYP gene [gngm]     3.91824
FOXC1 [gngm]     3.91824
Fetal Development [phsf]     3.91824
Co-Carcinogenesis [resa]     3.91824
Hepatic node [bpoc]     3.91824
Choline Deficiency [dsyn]     3.91824
Spaniards [popg]     3.91824
Blood Loss, Postoperative [patf]     3.91824
Social Activities [socb]     3.91824
fired [fndg]     3.91824
State transition [idcn]     3.91824
Seated [fndg]     3.91824
Bergmann glia [cell]     3.91824
buccal mucosa [bpoc]     3.91824
F10 [gngm]     3.91824
A2M [gngm]     3.91824
chemical dependence [mobd]     3.91824
Paraspinal Muscle [bpoc]     3.91824
TLR signaling pathway [moft]     3.91824
Salmonella [bact]     3.91824
retroviral infection [dsyn]     3.91824
Neutrophils, Segmented [lbpr]     3.91824
Cholan [phsu]     3.91824
Vascular shunt [fndg]     3.91824
Phospholipid Metabolism [moft]     3.91824
stomach mucosa [tisu]     3.91824
Natural regeneration [ortf]     3.91824
5 level [qlco]     3.91824
acute retention [sosy]     3.91824
lipid storage [celf]     3.91824
Low motivation [fndg]     3.91824
Calciphylaxis [dsyn]     3.91824
Calorimetry [lbpr]     3.91824
13 chromosome [celc]     3.91824
Sonication [resa]     3.91824
drug free [qnco]     3.91824
polyamine biosynthesis [moft]     3.91824
Partial splenectomy [topp]     3.91824
Dietary Supplementation [topp]     3.91824
Nucleotide Excision Repair Pathway [ftcn]     3.91824
1 Hour [tmco]     3.91824
ERT [topp]     3.91824
Drum [qnco]     3.91824
Carcinoid syndrome [dsyn]     3.91824
Cumin, Black [plnt]     3.91824
Surgical site [spco]     3.91824
Talking [fndg]     3.91824
nonmalignant condition [neop]     3.91824
Enzyme Replacement Therapy [topp]     3.91824
K19 [gngm]     3.91824
Eversion [ftcn]     3.91824
Newborn Screening [diap]     3.91824
scrotal cancer [neop]     3.91824
Hypothesizing [menp]     3.91824
serum K+ [lbpr]     3.91824
Air Pollution, Indoor [eehu]     3.91824
Cone-Beam CT [diap]     3.91824
Chronic Obstructive Lung Disease [dsyn]     3.91824
Drug use history [fndg]     3.91824
Authorship [ocac]     3.91824
gastric surgery [topp]     3.91824
Acute pulmonary edema [dsyn]     3.91824
Fibrovascular [ftcn]     3.91824
Cross Reactivity [moft]     3.91824
NF2 [neop]     3.91824
EMSA [diap]     3.91824
bony metastases [neop]     3.91824
cryosurgical ablation [topp]     3.91824
Hive [dsyn]     3.91824
NME2 [gngm]     3.91824
Primary Hepatic Neuroendocrine Tumor [neop]     3.91824
Pulmonary lymph node [bpoc]     3.91824
Psychiatrist [prog]     3.91824
Alkaline Comet Assay [mbrt]     3.91824
Alveolar hydatid [euka]     3.91824
Hospice Care [hlca]     3.91824
purchased [acty]     3.91824
TIP30 [gngm]     3.91824
Hepatic artery proper [bpoc]     3.91824
Trial Design [inpr]     3.91824
Quinoxaline [orch]     3.91824
EFS [qnco]     3.91824
Anastomotic biliary stricture [anab]     3.91824
coronaviruses [virs]     3.91824
Infection-Related Malignancy [neop]     3.91824
HGFA [gngm]     3.91824
Moderate Exercise [dora]     3.91824
Matrigel Invasion Assay [lbpr]     3.91824
nan [inpr]     3.91824
Recreation [dora]     3.91824
Not pregnant [fndg]     3.91824
Biliary Stone Extraction [hlca]     3.91824
Calcineurin activity [moft]     3.91824
Eating Behaviors [inbe]     3.91824
agonists antagonists [phsu]     3.91824
Sulfate [phpr]     3.91824
Thrombophlebitis [dsyn]     3.91824
auxotrophy [celf]     3.91824
Schizophrenia [mobd]     3.91824
B-MYB [gngm]     3.91824
TIE-2 [gngm]     3.91824
Adoptive Immunotherapy [topp]     3.91824
Congress [orgt]     3.91824
European origin [fndg]     3.91824
Oxyntic cell [cell]     3.91824
Bone marrow sample [bdsu]     3.91824
In addition to [qlco]     3.91824
Familial Hemochromatosis [dsyn]     3.91824
Normal reticulin [fndg]     3.91824
Snp1 [gngm]     3.91824
Epithelioid granuloma [patf]     3.91824
Hepatic Mesenchymal Hamartoma [neop]     3.91824
Bone Development [ortf]     3.91824
Length 2 [qnco]     3.91824
Jews [popg]     3.91824
Ovarian Clear Cell Adenocarcinoma [neop]     3.91824
primary surgeon [prog]     3.91824
HLA class II antigen [imft]     3.91824
Protein Degradation [moft]     3.91824
Textile Industry [orgt]     3.91824
granulations [fndg]     3.91824
gaol [mnob]     3.91824
Personal Behavior [inbe]     3.91824
fibroma [neop]     3.91824
Bladder Urothelial Carcinoma [neop]     3.91824
Seminal vesicle [bpoc]     3.91824
Psychological function [menp]     3.91824
Garbage [eehu]     3.91824
RIN1 [gngm]     3.91824
Primary Data [idcn]     3.91824
Susceptibilities, Genetic [orga]     3.91824
Lighter [mnob]     3.91824
Caenorhabditis elegans [euka]     3.91824
Binding Activity [moft]     3.91824
High density lesion [fndg]     3.91824
Aortic Valve Replacement [topp]     3.91824
Karnofsky Performance Status [diap]     3.91824
Multidisciplinary assessment [diap]     3.91824
lung formation [ortf]     3.91824
Stem Cell Niche [bdsy]     3.91824
Lichen Planus [dsyn]     3.91824
cm3 [qnco]     3.91824
Gleason score 8 [clas]     3.91824
Soot [elii]     3.91824
Column [bpoc]     3.91824
bile acid synthesis [moft]     3.91824
Pharmacokinetic Parameters [idcn]     3.91824
Photon Correlation Spectroscopy [lbpr]     3.91824
Parietal [spco]     3.91824
Periampullary Adenocarcinoma [neop]     3.91824
silver impregnation [lbpr]     3.91824
Beta Catenin Gene Mutation [comd]     3.91824
TYPE2 [fndg]     3.91824
HIC [gngm]     3.91824
Pyrexia [fndg]     3.91824
gamma protein [genf]     3.91824
ganglioside synthesis [moft]     3.91824
Embryological development [ortf]     3.91824
Sperm [cell]     3.91824
[M]Haemangiopericytoma NOS [neop]     3.91824
PRCC [gngm]     3.91824
Hemopoiesis [ortf]     3.91824
Weissella confusa [bact]     3.91824
Military activity [inpo]     3.91824
Doxorubicin Preparation [phsu]     3.91824
ORAL GAVAGE [ftcn]     3.91824
Problem Solving [menp]     3.91824
Food sample [sbst]     3.91824
Chromosome 9 [celc]     3.91824
Interleukin 21 Gene [gngm]     3.91824
Epidemiologic Surveillance [hlca]     3.91824
Prostate Tumor [neop]     3.91824
Sclerosis, Systemic [dsyn]     3.91824
Intranasal [spco]     3.91824
chorioallantoic membrane [emst]     3.91824
Partial obstruction [patf]     3.91824
CAV3 [gngm]     3.91824
Left lateral wall [spco]     3.91824
SPARK [phpr]     3.91824
Virus, Helper [virs]     3.91824
Caloric Restriction [topp]     3.91824
Two-Hybrid Assay [mbrt]     3.91824
Affinity, Antibody [moft]     3.91824
Urology [bmod]     3.91824
prothrombin precursor [aapp]     3.91824
Trisomy 8 [cgab]     3.91824
Lamellipodium [celc]     3.91824
cell processes [celc]     3.91824
insulin administration [topp]     3.91824
Poison [inpo]     3.91824
Proximal site [spco]     3.91824
Visual Acuity [clna]     3.91824
cardiovascular functioning [ortf]     3.91824
Urinary Tract Neoplasms [neop]     3.91824
B17 [gngm]     3.91824
Oriental [fndg]     3.91824
Canalicular Pattern [fndg]     3.91824
Medicine, Folk [topp]     3.91824
NP [gngm]     3.91824
Lod [moft]     3.91824
Correlation Test [inpr]     3.91824
Thiols [orch]     3.91824
Excision Repair [genf]     3.91824
Immune dysregulation [fndg]     3.91824
Massive blood transfusion [topp]     3.91824
X11 [gngm]     3.91824
POPE [lipd]     3.91824
g/hr [qnco]     3.91824
X4 [qnco]     3.91824
Cause of Death [fndg]     3.91824
Lactate dehydrogenase level [lbpr]     3.91824
IgA antibody [celc]     3.91824
Self-Help Groups [shro]     3.91824
tuberculoid granuloma [patf]     3.91824
Uniform Distribution [qnco]     3.91824
Ankle edema [fndg]     3.91824
Medical-Surgical [prog]     3.91824
Rib fracture [inpo]     3.91824
nitrotyrosine [aapp]     3.91824
Non-obstructive [ftcn]     3.91824
BREAKPOINT CLUSTER REGION [gngm]     3.91824
Immunoradiometric Assay [lbpr]     3.91824
Polypharmacy [fndg]     3.91824
Normal development [fndg]     3.91824
PPI [phsu]     3.91824
Axillary Lymphadenectomy [topp]     3.91824
Tumor Bank [mnob]     3.91824
oleate [lipd]     3.91824
abdominal exploration [diap]     3.91824
common bile duct dilatation [anab]     3.91824
Post-Transcriptional Gene Silencing [genf]     3.91824
sliding scale [topp]     3.91824
Respiratory Disorders [dsyn]     3.91824
Northern blot assay [mbrt]     3.91824
SYSTEM, NUCLEAR MAGNETIC RESONANCE SPECTROSCOPIC [medd]     3.91824
Cyclohexane [orch]     3.91824
Heartburn [sosy]     3.91824
Primary closure [topp]     3.91824
KCA3.1 [gngm]     3.91824
F5 [gngm]     3.91824
Diet, Atherogenic [resa]     3.91824
Stage 4C [clas]     3.91824
Serum cholesterol level [lbpr]     3.91824
During [tmco]     3.91824
human resource [ftcn]     3.91824
Petrol station [mnob]     3.91824
Epidermoid Cyst [anab]     3.91824
industrial worker [prog]     3.91824
Non-nodal [spco]     3.91824
psychiatric patients [podg]     3.91824
Inclusion cyst [anab]     3.91824
Ascending Aorta [bpoc]     3.91824
Mitotic cell [cell]     3.91824
Cord compression NOS [dsyn]     3.91824
naphthenic acids [orch]     3.91824
Lazio [inpr]     3.91824
Small artery [bpoc]     3.91824
Unpaired Data [idcn]     3.91824
FIVE-DAY [inpr]     3.91824
Rimming [fndg]     3.91824
Thecoma, luteinized [neop]     3.91824
Organ region [bpoc]     3.91824
donor skin [fndg]     3.91824
Abducens Palsy [dsyn]     3.91824
microsomal prostaglandin E synthase-1 [gngm]     3.91824
Bile Juice [bdsu]     3.91824
Stick [bodm]     3.91824
Translational Medicine [resa]     3.91824
Regenerative Medicine [bmod]     3.91824
Oral candidiasis [dsyn]     3.91824
debulking [topp]     3.91824
Online Mendelian Inheritance In Man [inpr]     3.91824
Amber [orch]     3.91824
Molecular Mass [qnco]     3.91824
synthetic peptide [aapp]     3.91824
Preventing injury [topp]     3.91824
soluble liver antigen/liver pancreas antigen [gngm]     3.91824
Surgical pathology studies [clna]     3.91824
Technology, Pharmaceutical [bmod]     3.91824
Gamma Irradiation [topp]     3.91824
Modulus [euka]     3.91824
Relatively slow progression [fndg]     3.91824
Gel Shift Assay [lbpr]     3.91824
activin activity [moft]     3.91824
Cardiovascular morbidity [dsyn]     3.91824
Base Ratio [qnco]     3.91824
MICRO RNA 221 [gngm]     3.91824
Resequencing [mbrt]     3.91824
KRUPPEL-LIKE FACTOR 17 [gngm]     3.91824
gallbladder agenesis [cgab]     3.91824
Nepalese [popg]     3.91824
Lipid-Laden Macrophage [cell]     3.91824
Host-Parasite Interactions [npop]     3.91824
Hydropic degeneration [patf]     3.91824
Adenosyl homocysteine hydrolase [enzy]     3.91824
kHz [qnco]     3.91824
cryosection [lbpr]     3.91824
iodophor [phsu]     3.91824
NFATC1 [gngm]     3.91824
Endocrine system [bdsy]     3.91824
performance test [diap]     3.91824
liver haemangioma [neop]     3.91824
Vaccine Administration [topp]     3.91824
Operative report [inpr]     3.91824
Immune-complex glomerulonephritis [dsyn]     3.91824
salicyluric acid [orch]     3.91824
PIP [topp]     3.91824
heart tumours [neop]     3.91824
Soviet Union [geoa]     3.91824
Umbilical incision [topp]     3.91824
Facial [blor]     3.91824
Local Government [orgt]     3.91824
hepatocellular disease [dsyn]     3.91824
nucleic acid purification [lbpr]     3.91824
Iron measurement [lbpr]     3.91824
metastatic colon cancer [neop]     3.91824
tissue death [ortf]     3.91824
Efferent [spco]     3.91824
myelopathy [dsyn]     3.91824
Subsidiary [orgt]     3.91824
TK [geoa]     3.91824
Polyunsaturated fatty acid supplementation [phsu]     3.91824
Bradycardia [patf]     3.91824
Kidney Stones [dsyn]     3.91824
VEL [qnco]     3.91824
Urinary Retention [fndg]     3.91824
raised bilirubin [fndg]     3.91824
wed [evnt]     3.91824
American College of Obstetricians and Gynecologists [pros]     3.91824
Ionization [qlco]     3.91824
Scurvy [dsyn]     3.91824
PROKINETICIN 2 [gngm]     3.91824
Bone Marrow Involvement [fndg]     3.91824
Androgen level [lbpr]     3.91824
lipid mediator [bacs]     3.91824
p4 [gngm]     3.91824
Bridging necrosis [patf]     3.91824
Respiratory complications [patf]     3.91824
white people [popg]     3.91824
Iris [bpoc]     3.91824
co-treatment [hlca]     3.91824
Japanese Americans [popg]     3.91824
Cardioplegia [topp]     3.91824
Maturation [qlco]     3.91824
Population Statistics [qnco]     3.91824
Liver lobectomy [topp]     3.91824
cups/day [qnco]     3.91824
albino mice [mamm]     3.91824
blood test results [lbtr]     3.91824
Molecular Fingerprint [clna]     3.91824
Congo [geoa]     3.91824
Urokinase-type plasminogen activator activity [moft]     3.91824
Interlobular Duct [bpoc]     3.91824
IL-1RN [gngm]     3.91824
Toxoplasma gondii [euka]     3.91824
After image [menp]     3.91824
HMBS [gngm]     3.91824
Bulky Disease [fndg]     3.91824
Lymph node group [bpoc]     3.91824
Clostridium difficile colitis [dsyn]     3.91824
Chemotaxis [celf]     3.91824
CD15 [gngm]     3.91824
Leukocyte Counts, Differential [lbpr]     3.91824
SID [dsyn]     3.91824
Candida albicans [fngs]     3.91824
Noroviruses [virs]     3.91824
Reactive Hyperemia [patf]     3.91824
blinded study [resa]     3.91824
Right direction [spco]     3.91824
Serodiagnosis [lbpr]     3.91824
ICD9-CM [inpr]     3.91824
Abdominal Muscles [bpoc]     3.91824
Gastrointestinal disturbances [fndg]     3.91824
Vascular measure [lbtr]     3.91824
JTE 013 [orch]     3.91824
LZIP [gngm]     3.91824
Local anaesthesia [topp]     3.91824
Budget [inpr]     3.91824
spectroscopy [lbpr]     3.91824
Serum C reactive protein level [lbpr]     3.91824
Transcatheter oily chemoembolisation [topp]     3.91824
Vena cava filter [medd]     3.91824
Viral load measurement [lbpr]     3.91824
MAP4K4 [gngm]     3.91824
P40 [gngm]     3.91824
ABI [clna]     3.91824
high low density lipoprotein [fndg]     3.91824
Principle Component [qnco]     3.91824
Prunus [plnt]     3.91824
low lymphocyte count [fndg]     3.91824
Urban Health [idcn]     3.91824
FIBULIN 1 [gngm]     3.91824
catabolic state [dsyn]     3.91824
Rural Hospital [hcro]     3.91824
major trauma [inpo]     3.91824
Medicaid [gora]     3.91824
Cellular Immune Response [celf]     3.91824
On Study [qlco]     3.91824
ganglioside metabolism [moft]     3.91824
arterial injuries [inpo]     3.91824
Low iron diet [topp]     3.91824
Haemoglobin electrophoresis [lbpr]     3.91824
B4GALT1 [gngm]     3.91824
Instil [ftcn]     3.91824
Nonspecific reactive hepatitis [dsyn]     3.91824
MICRO RNA 373 [gngm]     3.91824
Mechanical irritation [inpo]     3.91824
catheter removal [topp]     3.91824
Polyploid Cells [cell]     3.91824
New growth [neop]     3.91824
Lung parenchyma [tisu]     3.91824
Adult care [topp]     3.91824
XB130 [gngm]     3.91824
F/m [qnco]     3.91824
Photon [sbst]     3.91824
MAGE [orgt]     3.91824
Suburban Population [popg]     3.91824
Plastic surgery department [hcro]     3.91824
SDHD [gngm]     3.91824
Sensitized cell [cell]     3.91824
Johnson & Johnson [hcro]     3.91824
TRIB1 [gngm]     3.91824
Forehead surface [blor]     3.91824
Amebiasis [dsyn]     3.91824
Muscle Fatigue [ortf]     3.91824
EPHX [gngm]     3.91824
Subcapsular haemorrhage [patf]     3.91824
Skin Specimen [bdsu]     3.91824
Resolve [medd]     3.91824
Balloon Dilatation [topp]     3.91824
Adaptive Immunity [phsf]     3.91824
Esophagogastrectomy [topp]     3.91824
Spontaneous abortion [patf]     3.91824
Labrador retriever [mamm]     3.91824
Substance Dependence [mobd]     3.91824
DNA METHYLTRANSFERASE 1 [gngm]     3.91824
GB [geoa]     3.91824
Conserved Sequence [nusq]     3.91824
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4 [gngm]     3.91824
Crus [blor]     3.91824
pT3a [fndg]     3.91824
Station [mnob]     3.91824
Low-Protein Diet [topp]     3.91824
Miller [prog]     3.91824
Diacetate [orch]     3.91824
Transplant risk factors [clna]     3.91824
Reservoir (environment) [geoa]     3.91824
bile duct development [ortf]     3.91824
protists [orgm]     3.91824
Soya [food]     3.91824
American cocker spaniel [mamm]     3.91824
MICRO RNA 152 [gngm]     3.91824
Living organism [orgm]     3.91824
Opportunistic screening [hlca]     3.91824
NED [fndg]     3.91824
low copper [dsyn]     3.91824
ileal ulcers [dsyn]     3.91824
Chromosomal Rearrangement [comd]     3.91824
Hepatitis Virus, Mouse [virs]     3.91824
RAC1 gene [gngm]     3.91824
WNT10A [gngm]     3.91824
care medication [hlca]     3.91824
adnexal neoplasm [neop]     3.91824
Enclosed [spco]     3.91824
Dislocation [inpo]     3.91824
protein folding [moft]     3.91824
TU [qnco]     3.91824
Scrape [topp]     3.91824
euro [mamm]     3.91824
High density lipoprotein cholesterol level [lbpr]     3.91824
Splenic parenchyma [bpoc]     3.91824
Biological Profile [cnce]     3.91824
Serum.total [lbtr]     3.91824
macromolecule [chvs]     3.91824
system review [hlca]     3.91824
staging laparotomy [diap]     3.91824
Intercourse [orgf]     3.91824
Bone volume [orga]     3.91824
TIP47 [gngm]     3.91824
AU [qnco]     3.91824
Associated Study [resa]     3.91824
Appendiceal Neoplasms [neop]     3.91824
GABRG2 [gngm]     3.91824
Endocrinology [bmod]     3.91824
increased platelet count [dsyn]     3.91824
Alpha-1 antitrypsin phenotype [lbtr]     3.91824
Multifactor Dimensionality Reduction [inpr]     3.91824
dopamine neurons [cell]     3.91824
Cclp1 [gngm]     3.91824
Spectrophotometry, Atomic Absorption [lbpr]     3.91824
succinate dehydrogenase activity [moft]     3.91824
XPO5 [gngm]     3.91824
polymorphic microsatellite markers [diap]     3.91824
Hoechst 33342 [phsu]     3.91824
Abort [inpr]     3.91824
Intrahepatic portal system [bdsy]     3.91824
Gangrenous cholecystitis [dsyn]     3.91824
Care management [hlca]     3.91824
OSTERIX [gngm]     3.91824
ovum parasite [cell]     3.91824
Radiation ulcer [inpo]     3.91824
13a [medd]     3.91824
Hep G2 Cells [cell]     3.91824
Intrahepatic Cholestasis [dsyn]     3.91824
Sarcoma, Ewing [neop]     3.91824
Rioja [inpr]     3.91824
Talking [orgf]     3.91824
Huntington Disease [dsyn]     3.91824
Primary graft failure [patf]     3.91824
Cone-Beam Computed Tomography [diap]     3.91824
ECG NOS [diap]     3.91824
needle exchange [hlca]     3.91824
antigen challenge [topp]     3.91824
Acute peptic ulcer [dsyn]     3.91824
Anticonvulsants [phsu]     3.91824
amps [qnco]     3.91824
surgical aspirator [medd]     3.91824
MYH [gngm]     3.91824
Patch [medd]     3.91824
Myelosuppression [dsyn]     3.91824
Melanesia [geoa]     3.91824
Syringe-Exchange Program [topp]     3.91824
Systemic amyloidosis [dsyn]     3.91824
Endosomes [celc]     3.91824
k-12 [qlco]     3.91824
Wilcoxon Rank Test [qnco]     3.91824
Intoxication [fndg]     3.91824
Right Ventricle [bpoc]     3.91824
Foam cell [cell]     3.91824
Liver Cirrhosis, Experimental [emod]     3.91824
CSF [topp]     3.91824
Immunocyte [cell]     3.91824
Mathematical Product [qnco]     3.91824
Dubin-Johnson Syndrome [dsyn]     3.91824
patient confidentiality [idcn]     3.91824
Uzbekistan [geoa]     3.91824
ST3GAL4 [gngm]     3.91824
gun [mnob]     3.91824
intermittency [fndg]     3.91824
HLA-H gene [gngm]     3.91824
Smokeless Tobacco [sbst]     3.91824
Illicit drug use [inbe]     3.91824
Pharmacopoeia [inpr]     3.91824
lung squamous cell carcinoma [neop]     3.91824
Symmetry [spco]     3.91824
Pre-Clinical Trial [resa]     3.91824
Arterial insufficiency [dsyn]     3.91824
Pseudomonas [bact]     3.91824
Osteolyses [patf]     3.91824
Laminar [spco]     3.91824
Model, Computerized [mcha]     3.91824
Coronary Vein [bpoc]     3.91824
Protein S Deficiency [dsyn]     3.91824
Stokes [qnco]     3.91824
DCS [dsyn]     3.91824
Pancreatic ductule [bpoc]     3.91824
Primary hypertriglyceridaemia [cgab]     3.91824
Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma [neop]     3.91824
Papular eruption [fndg]     3.91824
Dark urine [sosy]     3.91824
Fetal Distress [dsyn]     3.91824
Electrophoreses [lbpr]     3.91824
Hygiene Hypothesis [inpr]     3.91824
First Birth [tmco]     3.91824
gynecologic cancer [neop]     3.91824
Sprague-Dawley [mamm]     3.91824
hypophyseal [bpoc]     3.91824
Syria [geoa]     3.91824
mitochondrial membrane permeabilization [celf]     3.91824
Excretion Rate [qnco]     3.91824
autologous hematopoietic stem cell transplantation [topp]     3.91824
stress test [diap]     3.91824
Trainers [mnob]     3.91824
Ubiquitin-Proteasomal Pathway [moft]     3.91824
Organ Size [orga]     3.91824
neurological complication [patf]     3.91824
lymph node swelling [fndg]     3.91824
Genome Scan [mbrt]     3.91824
communes [popg]     3.91824
Alkaline [qlco]     3.91824
External Beam RT [topp]     3.91824
Progeny [famg]     3.91824
Zu [fish]     3.91824
simple sugars [carb]     3.91824
analysis sample [lbpr]     3.91824
Methotrexate Toxicity [inpo]     3.91824
Viral Oncogene [gngm]     3.91824
rhenium sulfur colloid [elii]     3.91824
gastrointestinal distress [sosy]     3.91824
stage IIA cervical cancer [neop]     3.91824
PRO-PEPTIDE [food]     3.91824
Genet [mamm]     3.91824
Immobilisation [topp]     3.91824
occult cancer [neop]     3.91824
BCD [topp]     3.91824
DNA hybridisation [mbrt]     3.91824
Pneumonia, Pneumocystis carinii [dsyn]     3.91824
defend [socb]     3.91824
SCAN-1 [gngm]     3.91824
LAK Cells [cell]     3.91824
Cushing Syndrome [dsyn]     3.91824
sodium transport [celf]     3.91824
T classification [clas]     3.91824
Enzymatic Assays [lbpr]     3.91824
Severe cytopenia [fndg]     3.91824
breast self-exam [diap]     3.91824
Bloodstream infection [patf]     3.91824
REAL-TIME POLYMERASE CHAIN REACTION ASSAY [mbrt]     3.91824
analysis factors [qnco]     3.91824
Specialized physician [prog]     3.91824
Palpable abdominal mass [fndg]     3.91824
Thyroid follicular cell [cell]     3.91824
Adenocarcinoma, Clear Cell [neop]     3.91824
Chip [food]     3.91824
Recurrent Hepatoblastoma [neop]     3.91824
Supportive therapy [topp]     3.91824
Informed Consent Form [inpr]     3.91824
BALB/C [mamm]     3.91824
PENK [gngm]     3.91824
Bilateral Disease [fndg]     3.91824
NME1-NME2 gene [gngm]     3.91824
SOX17 [gngm]     3.91824
Heavy Ions [elii]     3.91824
Genotype determination [lbpr]     3.91824
Acute leukemias [neop]     3.91824
Obstetric [ftcn]     3.91824
Mitochondrial Biogenesis [celf]     3.91824
Geriatric Assessment [hlca]     3.91824
Hereditary tyrosinaemia type I [dsyn]     3.91824
Type 5 [inpr]     3.91824
Stereotactic Radiosurgery [topp]     3.91824
GADD45BETA [gngm]     3.91824
Acclimatisation [orgf]     3.91824
Morphologic alteration [anab]     3.91824
NNRTI [phsu]     3.91824
RECK gene [gngm]     3.91824
Faecal peritonitis [dsyn]     3.91824
PIGF [gngm]     3.91824
Ball [mnob]     3.91824
Micro-tubule [celc]     3.91824
Angiotensin II Type 1 Receptor Blockers [phsu]     3.91824
Gel Electrophoresis [lbpr]     3.91824
Neuroradiologist [prog]     3.91824
Functional system [bdsy]     3.91824
Abdominal pain, epigastric [sosy]     3.91824
high blood sugar level [dsyn]     3.91824
Intra-Observer Variability [qnco]     3.91824
Orchidectomy [topp]     3.91824
Hereditary Coproporphyria [dsyn]     3.91824
Endoderm [emst]     3.91824
Bacterial Vaginosis [dsyn]     3.91824
PIK3R1 gene [gngm]     3.91824
Haemorrhagic cystitis [dsyn]     3.91824
Hepatic artery stenosis [dsyn]     3.91824
Tyrosine Phosphorylation [moft]     3.91824
Multiparametric Analysis [resa]     3.91824
Physiological Aging [orgf]     3.91824
Mesenchymal Differentiation [fndg]     3.91824
Hyperandrogenemia [fndg]     3.91824
Candida albicans infection [dsyn]     3.91824
Thermocoagulation [topp]     3.91824
cholecysto [spco]     3.91824
Vascular Endothelial Cells [cell]     3.91824
Images, 3-D [mnob]     3.91824
Chromosome 11 [celc]     3.91824
Astrogliosis [patf]     3.91824
SMCC [gngm]     3.91824
Plant, Medicinal [plnt]     3.91824
keratin filament [celc]     3.91824
Air Pollutants [hops]     3.91824
Fusion Gene [gngm]     3.91824
histone lysine methylation [moft]     3.91824
public education [edac]     3.91824
Humidity [npop]     3.91824
interrogation [gora]     3.91824
Angioedema, Hereditary [dsyn]     3.91824
Esophageal [dsyn]     3.91824
Active Inpatient [inpr]     3.91824
DNA probe method [lbpr]     3.91824
HEMO [ftcn]     3.91824
Coculture [lbpr]     3.91824
Tiredness [sosy]     3.91824
brewing [ocac]     3.91824
Non-Insulin Dependent Diabetes [dsyn]     3.91824
Score, Organ Failure [qnco]     3.91824
Chloride, NOS [inch]     3.91824
FOXN1 [gngm]     3.91824
lymphohistiocytosis [dsyn]     3.91824
Testis [bpoc]     3.91824
log10/ml [qnco]     3.91824
Anisokaryosis [comd]     3.91824
Nits [dsyn]     3.91824
12q24 [celc]     3.91824
Hf [elii]     3.91824
Parathyroid Glands [bpoc]     3.91824
Hepaticoenterostomy [topp]     3.91824
Hidden Markov Model [resa]     3.91824
CD276 [gngm]     3.91824
catheter placement [topp]     3.91824
simulate [medd]     3.91824
Scores, Propensity [qnco]     3.91824
G2A [gngm]     3.91824
Variable phenotypic expression [fndg]     3.91824
Differentiation Markers [imft]     3.91824
NGM [qnco]     3.91824
V3 [bpoc]     3.91824
PLF [fndg]     3.91824
Posterior wall [spco]     3.91824
Awake [fndg]     3.91824
UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I [gngm]     3.91824
Asia, Southeastern [geoa]     3.91824
glucose uptake [celf]     3.91824
melanoma-associated antigen [gngm]     3.91824
IL-6 secretion [celf]     3.91824
V/m [qnco]     3.91824
cytochrome c oxidase subunit Va [gngm]     3.91824
dimethylnitrosamine demethylase activity [moft]     3.91824
DNA Double Strand Break [comd]     3.91824
Specimen size [clna]     3.91824
Superimposition [fndg]     3.91824
Java [geoa]     3.91824
Left hip [blor]     3.91824
ASGR1 [gngm]     3.91824
pT3 [fndg]     3.91824
Skin symptoms [sosy]     3.91824
Acute heart failure [dsyn]     3.91824
Cardia [blor]     3.91824
Tumour site [spco]     3.91824
Dilatation of bile duct [topp]     3.91824
Dissecting Abdominal Aortic Aneurysm [dsyn]     3.91824
Homologous Recombination [genf]     3.91824
Clear cell tumor [neop]     3.91824
Salmonella infections [dsyn]     3.91824
Tobacco Dependence [mobd]     3.91824
Neuroendocrine tissue [tisu]     3.91824
White blood cell [lbpr]     3.91824
Rectosigmoid Cancer [neop]     3.91824
Plasma derivative [bdsu]     3.91824
Adrenal Rest Tumor [neop]     3.91824
Bilio-Pancreatic Diversion [topp]     3.91824
Brain Pathology [patf]     3.91824
Safflower [plnt]     3.91824
HMB-45 [imft]     3.91824
JNK2 [gngm]     3.91824
Abdominal tenderness [sosy]     3.91824
EGFR Gene [gngm]     3.91824
FIC1 [gngm]     3.91824
Radionuclide therapy [topp]     3.91824
blood dyscrasias [dsyn]     3.91824
Best estimate [lbpr]     3.91824
Adrenal Insufficiency [dsyn]     3.91824
Sonic Hedgehog Pathway [moft]     3.91824
growth factor activity [moft]     3.91824
Autism Spectrum Disorder [mobd]     3.91824
Ha-ras Oncogene [gngm]     3.91824
micronuclei [celc]     3.91824
N/C [qnco]     3.91824
ambition [menp]     3.91824
Economic deprivation [grpa]     3.91824
Neurofibrillary Tangles [acab]     3.91824
Transcriptional Networks [moft]     3.91824
discharge summaries [inpr]     3.91824
Diagnostic imaging study [clna]     3.91824
Dialysis Therapy [topp]     3.91824
Gastric haemorrhage [dsyn]     3.91824
Bone Marrow Stem Cells [cell]     3.91824
Subcontinent [geoa]     3.91824
Site Investigator [prog]     3.91824
Internal Radiation Therapy [topp]     3.91824
HEED [gngm]     3.91824
Social exclusion [fndg]     3.91824
CREB-H [gngm]     3.91824
Trabecular bone [tisu]     3.91824
Viral screening [topp]     3.91824
Decreased haemoglobin [fndg]     3.91824
regulated product [idcn]     3.91824
Carbohydrate intake [clna]     3.91824
viral test [lbpr]     3.91824
factor A [orch]     3.91824
COC [prog]     3.91824
Dermatopathology [inpr]     3.91824
Ultrasound therapy [topp]     3.91824
Acute hepatitis E [dsyn]     3.91824
MOB [gngm]     3.91824
NOX2 [gngm]     3.91824
Human leucocyte antigen Bw4 [imft]     3.91824
Health Care Access [qlco]     3.91824
protein S-nitrosylation [moft]     3.91824
Abnormal development [cgab]     3.91824
HEAT-SHOCK FACTOR 1 [gngm]     3.91824
Watchful Waiting [hlca]     3.91824
Intermittent fever [sosy]     3.91824
Labiatae [plnt]     3.91824
10 Hours [tmco]     3.91824
Promyelocytic Leukemia [neop]     3.91824
MICRO RNA 183 [gngm]     3.91824
Clinical Practice Patterns [ocac]     3.91824
Space [qnco]     3.91824
phaseolus vulgaris [food]     3.91824
P52 [gngm]     3.91824
Molecular Cytogenetics [bmod]     3.91824
Adipose cell [cell]     3.91824
Decreased Phagocytosis [celf]     3.91824
Hospital, City [hcro]     3.91824
NSFL1C [gngm]     3.91824
descarboxyprothrombin [aapp]     3.91824
Lobule [bpoc]     3.91824
FAR UPSTREAM ELEMENT-BINDING PROTEIN [gngm]     3.91824
cation binding [moft]     3.91824
TP [idcn]     3.91824
measurement error [qnco]     3.91824
Dimorphic [ortf]     3.91824
PD-L1 [gngm]     3.91824
Provisional diagnosis [qlco]     3.91824
Use of [ftcn]     3.91824
radiosensitization [topp]     3.91824
kasai procedure [topp]     3.91824
Quantitative Reverse Transcriptase PCR [mbrt]     3.91824
sobriety [inbe]     3.91824
Data Pooling [resa]     3.91824
Scratch [inpo]     3.91824
Dorsal [spco]     3.91824
Navigation [acty]     3.91824
V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1 [gngm]     3.91824
T12 vertebra [bpoc]     3.91824
Clear Cell Adenocarcinomas [neop]     3.91824
MMP14 gene [gngm]     3.91824
cardiac events [dsyn]     3.91824
MAL-3 [orch]     3.91824
laser spectrometry [lbpr]     3.91824
prenatal exposure [fndg]     3.91824
Ovarian Sex Cord-Stromal Tumor [neop]     3.91824
Thyroiditis [dsyn]     3.91824
SOM [geoa]     3.91824
TMD [gngm]     3.91824
nematodes [euka]     3.91824
Mixed Neoplasm [neop]     3.91824
Insurance Status [idcn]     3.91824
Baseline pressure [qnco]     3.91824
Decision Trees [inpr]     3.91824
Reimplantation [topp]     3.91824
Ovarian Adenocarcinoma [neop]     3.91824
Neurofibrosarcoma [neop]     3.91824
PRDM2 [gngm]     3.91824
Primary Angiosarcoma [neop]     3.91824
recombinant virus [virs]     3.91824
Ulcers, Gastroduodenal [dsyn]     3.91824
Protein Translation [moft]     3.91824
R4 [gngm]     3.91824
Leptomeninx [bpoc]     3.91824
29a [medd]     3.91824
mum [plnt]     3.91824
clay [inch]     3.91824
Jr [idcn]     3.91824
Medication treatment [hlca]     3.91824
American pacific islander [popg]     3.91824
Anterior segment [spco]     3.91824
Toe nail [bpoc]     3.91824
Lipogranuloma [dsyn]     3.91824
Arctic [geoa]     3.91824
Study, Seroepidemiologic [resa]     3.91824
Yemen Arab Republic [geoa]     3.91824
Cancer immunotherapy [topp]     3.91824
Hypokalaemia [fndg]     3.91824
XRCC6 [gngm]     3.91824
1051 [inpr]     3.91824
Chemokine Receptor Gene [gngm]     3.91824
HH15 [dsyn]     3.91824
HDAC9 [gngm]     3.91824
Nuclear body [celc]     3.91824
Clinical Nutrition [bmod]     3.91824
oil droplet [ftcn]     3.91824
NADC [orch]     3.91824
Base Sequence [nusq]     3.91824
bowel diseases [dsyn]     3.91824
Cholecystocolic fistula [anab]     3.91824
Plain film [diap]     3.91824
6/18 [fndg]     3.91824
drainage catheters [medd]     3.91824
PARVA [gngm]     3.91824
NEK2 [gngm]     3.91824
Regulatory Process [biof]     3.91824
Dynamic Contrast Enhanced CT [diap]     3.91824
Microcalcification [patf]     3.91824
RAN gene [gngm]     3.91824
Numbers, Cell [lbpr]     3.91824
Lymphoepithelioma [neop]     3.91824
Personal status [orga]     3.91824
Adenocarcinoma, Tubular [neop]     3.91824
long-term screening [diap]     3.91824
Two stage procedure [tmco]     3.91824
care environment [spco]     3.91824
Rapid plasma reagin test [lbpr]     3.91824
4b [inpr]     3.91824
Teratogen [hops]     3.91824
Adenomatous polyposis [neop]     3.91824
A1a [bpoc]     3.91824
C3H/HeN [mamm]     3.91824
Actinomycosis [dsyn]     3.91824
Thailand virus [virs]     3.91824
acetaldehyde metabolism [moft]     3.91824
Haemogram [lbpr]     3.91824
Lab Findings [fndg]     3.91824
VITA [lbpr]     3.91824
JC Virus [virs]     3.91824
Specific [cnce]     3.91824
Gadobenate [phsu]     3.91824
KLHDC7B gene [gngm]     3.91824
Central retinal vein occlusion [dsyn]     3.91824
amyloid precursor protein [aapp]     3.91824
Digit [bpoc]     3.91824
Progress Report [inpr]     3.91824
Reassuring [hlca]     3.91824
Elation [fndg]     3.91824
Sarcomatous Hepatocellular Carcinoma [neop]     3.91824
ABCC2 [gngm]     3.91824
Anterior wall [spco]     3.91824
GSTM [gngm]     3.91824
Antigen assay [lbpr]     3.91824
starvation-induced autophagy [celf]     3.91824
Epithelial Damage [fndg]     3.91824
serum folate [lbpr]     3.91824
RAB23 [gngm]     3.91824
Inter-rater Reliability [qnco]     3.91824
Appendectomy [topp]     3.91824
Filament [qlco]     3.91824
B18 [gngm]     3.91824
cytologic sampling [bdsu]     3.91824
Semiquantitative Method [ocac]     3.91824
medication side effects [inpo]     3.91824
complex II [moft]     3.91824
Overdose [inpo]     3.91824
high blood sugar [dsyn]     3.91824
Bone Resorption [ortf]     3.91824
phosphonate [chvs]     3.91824
Streptococcus viridans [bact]     3.91824
Sympathetic Nervous System [bdsy]     3.91824
Clastogens [hops]     3.91824
ABCG8 [gngm]     3.91824
white race [popg]     3.91824
Pleural space [bsoj]     3.91824
Cholangitides [dsyn]     3.91824
Infrequent Tumor [neop]     3.91824
Decalcification [lbpr]     3.91824
Peripheral ICC [neop]     3.91824
Gene Abnormality [comd]     3.91824
Non-Homologous End Joining [genf]     3.91824
Ingredient [chvf]     3.91824
ultrasound energy [topp]     3.91824
Cytokinesis [celf]     3.91824
Synthetic Genes [gngm]     3.91824
Truck [mnob]     3.91824
Social Impact [qlco]     3.91824
elevated enzymes [fndg]     3.91824
CYCLIN-DEPENDENT KINASE 10 [gngm]     3.91824
spliceosome [celc]     3.91824
Altered behavior [fndg]     3.91824
q.s. [qnco]     3.91824
Group 1B [inpr]     3.91824
Gallbladder Perforation [inpo]     3.91824
Social therapy [topp]     3.91824
Indridae [mamm]     3.91824
Vacuum [npop]     3.91824
Brown tumor [dsyn]     3.91824
Pai [idcn]     3.91824
CD3+ cell [cell]     3.91824
Wall [spco]     3.91824
Increased vitamin D [fndg]     3.91824
Generalized pruritus [sosy]     3.91824
Cor [bpoc]     3.91824
Lipid Metabolism Disorders [dsyn]     3.91824
Ovoid [spco]     3.91824
Mineral supplementation [food]     3.91824
TLE4 [gngm]     3.91824
IL-13 production [orgf]     3.91824
tents [medd]     3.91824
Rat Cell Line [cell]     3.91824
membrane model [inpr]     3.91824
CNV [nusq]     3.91824
Ankle Brachial Index [clna]     3.91824
V A [clna]     3.91824
Tissue specific [ortf]     3.91824
DCLK1 [gngm]     3.91824
Behavior Therapy [topp]     3.91824
Bone neoplasms [neop]     3.91824
Apoptotic Process [celf]     3.91824
Nut [food]     3.91824
Pole [blor]     3.91824
OPTN [gngm]     3.91824
Loose [qlco]     3.91824
Pericardial Tamponade [dsyn]     3.91824
early growth response protein 1 [gngm]     3.91824
Site, Incision/Surgical [inpr]     3.91824
LDT [moft]     3.91824
Oral lesion [fndg]     3.91824
Irritation [phpr]     3.91824
Hyperkeratosis [dsyn]     3.91824
organ development [biof]     3.91824
Ant [euka]     3.91824
Embryologic [emst]     3.91824
ANALYZER, BODY COMPOSITION [medd]     3.91824
Hydrocarbons, Chlorinated [orch]     3.91824
Central Laboratory [orgt]     3.91824
Alo [phsu]     3.91824
antegrade [spco]     3.91824
Methylation Site [nusq]     3.91824
Periodic acid-Schiff staining [lbpr]     3.91824
Health Priorities [qlco]     3.91824
therapeutic process [topp]     3.91824
Transfer [fndg]     3.91824
entecavir 0.5 MG [clnd]     3.91824
Stress tolerance [menp]     3.91824
Areca [plnt]     3.91824
Liposarcoma, Myxoid [neop]     3.91824
Spectrophotometry [lbpr]     3.91824
Hepatic Inflammatory Myofibroblastic Tumor [neop]     3.91824
Fast food [food]     3.91824
hematologic cancer [neop]     3.91824
Hepatic Porphyria [dsyn]     3.91824
cutaneous tumors [neop]     3.91824
Mascot [inpr]     3.91824
Fish intake [fndg]     3.91824
Diagnostic Ultrasound [diap]     3.91824
PRY [geoa]     3.91824
Hypertension, mild [fndg]     3.91824
Enterocytes [cell]     3.91824
Passive congestion [patf]     3.91824
White sucker [fish]     3.91824
Shaving [topp]     3.91824
MEMBER 3 [gngm]     3.91824
IL2RG [gngm]     3.91824
Chromosome 1 [celc]     3.91824
Benjamini [inpr]     3.91824
MSH5 [gngm]     3.91824
pathology procedures [lbpr]     3.91824
gel mobility shift assay [diap]     3.91824
Sarcocystis hominis [euka]     3.91824
Elevated testosterone [fndg]     3.91824
Oscillator [mnob]     3.91824
cross over [genf]     3.91824
nuclear transfer [celf]     3.91824
SM22 [gngm]     3.91824
Progressive cerebellar ataxia [dsyn]     3.91824
exposition [inpr]     3.91824
Fucose [carb]     3.91824
Time Difference [tmco]     3.91824
fluid volume [qnco]     3.91824
Atheromatosis [dsyn]     3.91824
Computer Graphics [mcha]     3.91824
Image Reconstruction [mcha]     3.91824
Not Obtained [qlco]     3.91824
Fistulas, Biliary [patf]     3.91824
WW45 [gngm]     3.91824
Memory deficit [mobd]     3.91824
stage I breast cancer [neop]     3.91824
Indigent [popg]     3.91824
Chapters, Book [inpr]     3.91824
Cichlid [fish]     3.91824
Cervical lymph nodes [bpoc]     3.91824
Mass Media [hcpp]     3.91824
Malignant Lung Tumor [neop]     3.91824
Cytosolic ribosome [celc]     3.91824
Vibrio vulnificus [bact]     3.91824
Serologic [bmod]     3.91824
APOBEC3A [gngm]     3.91824
CYP3A4 gene [gngm]     3.91824
disulfide [chvs]     3.91824
MUT [gngm]     3.91824
Blood Component Transfusion [topp]     3.91824
Pulmonary Circulation [ortf]     3.91824
Filiform [spco]     3.91824
Decarboxylation [npop]     3.91824
Cheirogaleidae [mamm]     3.91824
ECoG [diap]     3.91824
Pancreatic acinus [bpoc]     3.91824
Congenital overgrowth [cgab]     3.91824
vesicles [acab]     3.91824
p25 [gngm]     3.91824
diabetes mellitus risk [dsyn]     3.91824
Solanum [plnt]     3.91824
labor induced [fndg]     3.91824
Spot [patf]     3.91824
ALPS [dsyn]     3.91824
Grading values [inpr]     3.91824
Hyperlipidemias [dsyn]     3.91824
radiosensitization [phsu]     3.91824
PBM [topp]     3.91824
infiltrating cancer [neop]     3.91824
Serum growth hormone [lbpr]     3.91824
mtt [lipd]     3.91824
Abnormally high [qlco]     3.91824
Gastric Bypass [topp]     3.91824
Tuberculosis, Pulmonary [dsyn]     3.91824
Project, Pilot [resa]     3.91824
Intestinal Absorption [ortf]     3.91824
MALS-2 [gngm]     3.91824
Vaginal [bpoc]     3.91824
Dietary salt intake [fndg]     3.91824
Burnt out [fndg]     3.91824
4q35 [celc]     3.91824
Seroma [patf]     3.91824
Serum zinc level [lbpr]     3.91824
Canalicular cholestasis [fndg]     3.91824
Gastrointestinal system [bdsy]     3.91824
inhalant [topp]     3.91824
Dermatophyte [fngs]     3.91824
Biliary apparatus [bpoc]     3.91824
cellular localisation [celf]     3.91824
Latent Infection [dsyn]     3.91824
AII [gngm]     3.91824
FOM [topp]     3.91824
Antiinflammatory [phsu]     3.91824
Bile Duct Mucinous Cystic Neoplasm [neop]     3.91824
Immune [topp]     3.91824
Chelation Therapy [topp]     3.91824
Genetic Anomaly [fndg]     3.91824
Precirrhotic haemochromatosis [dsyn]     3.91824
Infusion procedures [topp]     3.91824
Polymeric Microsphere [bodm]     3.91824
Estrogen Receptor Agonists [moft]     3.91824
Heart Tumor [neop]     3.91824
Tumor stage T3 [fndg]     3.91824
Ovarian Neoplasms [neop]     3.91824
Viral syndrome [dsyn]     3.91824
Honeycomb appearance [qlco]     3.91824
Insulation [mnob]     3.91824
3q [nusq]     3.91824
Diterpenoids [orch]     3.91824
Acute myelogenous leukaemia [neop]     3.91824
9q [nusq]     3.91824
Acute Promyelocytic Leukemia [neop]     3.91824
Thoracic surgeon [prog]     3.91824
Ink [mnob]     3.91824
Oligodendrocyte [cell]     3.91824
p22 [gngm]     3.91824
Confocal microscope [medd]     3.91824
Lipidaemia [dsyn]     3.91824
Cerebrovascular Disorders [patf]     3.91824
luck [qlco]     3.91824
Dual-Phase Spiral CT [diap]     3.91824
node-negative [fndg]     3.91824
HLA-DR3 [imft]     3.91824
Neurocytoma [neop]     3.91824
Primary immunodeficiency [dsyn]     3.91824
struma [dsyn]     3.91824
T-Cell Proliferation [celf]     3.91824
Hepatic portal vein [bpoc]     3.91824
Hyperactivity [fndg]     3.91824
SSBP2 [gngm]     3.91824
Gastrointestinal System Cancer [neop]     3.91824
Vitamin K Deficiency [dsyn]     3.91824
Caecum [bpoc]     3.91824
Small bowel obstruction [dsyn]     3.91824
TRANSCRIPTION ELONGATION FACTOR A-LIKE 7 [gngm]     3.91824
T-Cell Leukemias [neop]     3.91824
Esophagus+Stomach [bpoc]     3.91824
Adeno-Associated Viruses [virs]     3.91824
Superior phrenic artery [bpoc]     3.91824
Service, Health [hlca]     3.91824
Periodontal [ftcn]     3.91824
Pentagon [qlco]     3.91824
GRL [gngm]     3.91824
oxidoreductase activity [moft]     3.91824
Silver stain [irda]     3.91824
toxic reaction [fndg]     3.91824
medical referral [ocac]     3.91824
Overwork [fndg]     3.91824
birth type [hlca]     3.91824
head neck cancer [neop]     3.91824
Not used [ftcn]     3.91824
Malignant Gliomas [neop]     3.91824
Trichomoniasis [dsyn]     3.91824
Chest Pain [sosy]     3.91824
Jordan [geoa]     3.91824
Paravertebral muscles [bpoc]     3.91824
CD4+ CD25+ Regulatory T Cells [cell]     3.91824
Pancreatic Insufficiency [dsyn]     3.91824
high monocyte count [fndg]     3.91824
Temporal resolution [lbtr]     3.91824
Premature Stop Codon [nusq]     3.91824
Autophagic Cell Death [celf]     3.91824
Laser Microscopy [lbpr]     3.91824
Galagidae [mamm]     3.91824
Disasters [phpr]     3.91824
National citizen [inpr]     3.91824
health care program [hlca]     3.91824
Pharmacology, Clinical [bmod]     3.91824
C-Cell [cell]     3.91824
Distribution Volume [qnco]     3.91824
drug injecting [phsu]     3.91824
increased lymphocyte [fndg]     3.91824
Accessory liver [cgab]     3.91824
Hospitals, City [hcro]     3.91824
Motivation [menp]     3.91824
6712 [inpr]     3.91824
Mediastinal node [bpoc]     3.91824
Grocery Store [mnob]     3.91824
preneoplastic state [neop]     3.91824
External catheter [medd]     3.91824
Arterial catheter [medd]     3.91824
Arteriotomy [topp]     3.91824
Recurrent Liver Cancer [neop]     3.91824
Animal Cancer Model [emod]     3.91824
Derived value [idcn]     3.91824
Page [idcn]     3.91824
punching [medd]     3.91824
Cell Number [lbpr]     3.91824
computer technology [inpr]     3.91824
Aortic body [bpoc]     3.91824
Follicles [bpoc]     3.91824
Chronic GVHD [dsyn]     3.91824
pmt [dsyn]     3.91824
Endometrial Serous Adenocarcinoma [neop]     3.91824
Image Segmentation [mcha]     3.91824
Aerosols [mnob]     3.91824
Pertinent information [qnco]     3.91824
Dry dock [mnob]     3.91824
combinatorial chemistry [npop]     3.91824
NMR [diap]     3.91824
COCH [gngm]     3.91824
Population Intervention [hlca]     3.91824
Intron Mutation [genf]     3.91824
Sum of Diameters [qnco]     3.91824
Low serum ceruloplasmin [fndg]     3.91824
Pimelic Acid [orch]     3.91824
Monounsaturated fat [food]     3.91824
raised liver enzymes [fndg]     3.91824
Necrotising pancreatitis [dsyn]     3.91824
Speech [orgf]     3.91824
Pancreas, Artificial [medd]     3.91824
X-Ray Cross Complementing Group [gngm]     3.91824
access information [ftcn]     3.91824
Central fat distribution [fndg]     3.91824
SELDI [lbpr]     3.91824
Electrophoresis, Gel, 2-D [lbpr]     3.91824
ALG1L [gngm]     3.91824
Community Practice [hlca]     3.91824
RNA-BINDING MOTIF PROTEIN 4 [gngm]     3.91824
adenylyl cyclase activity [moft]     3.91824
Hemorrhagic Change [qlco]     3.91824
Nurse Practitioners [prog]     3.91824
Plant food [mnob]     3.91824
Blood Clotting [ortf]     3.91824
MICRO RNA 17 [gngm]     3.91824
MICRO RNA 214 [gngm]     3.91824
Hepatitis E antigen [imft]     3.91824
Age-related cataract [acab]     3.91824
Stigmatization [idcn]     3.91824
Small Cell Dysplasia [fndg]     3.91824
GEO [geoa]     3.91824
Antidiabetic Agents [phsu]     3.91824
Health education [prog]     3.91824
Cripto-1 [gngm]     3.91824
Hospital Note [clna]     3.91824
RPL10L [gngm]     3.91824
6/30 [fndg]     3.91824
MICAL3 [gngm]     3.91824
education group [edac]     3.91824
Aspirate [medd]     3.91824
MUC5 [gngm]     3.91824
Patient Reported Outcome [inpr]     3.91824
Tryptophan 500 MG [clnd]     3.91824
waterborne [inpr]     3.91824
cd34 cells [cell]     3.91824
Paraneoplastic [imft]     3.91824
human leukocyte antigen gene [gngm]     3.91824
Intestinal Mucosa [tisu]     3.91824
Cephalad [spco]     3.91824
vitamin D metabolism [moft]     3.91824
Polyunsaturated fat [food]     3.91824
T1c [clas]     3.91824
Oral submucosal fibrosis [dsyn]     3.91824
Alien [popg]     3.91824
Persistent alcohol abuse [mobd]     3.91824
Malignant effusion [dsyn]     3.91824
SEP [gngm]     3.91824
T-4 [spco]     3.91824
Nihilism [mobd]     3.91824
T4a [fndg]     3.91824
Anthocyanidins [orch]     3.91824
Gallbladder Carcinoma in situ [neop]     3.91824
Hydroxylation [npop]     3.91824
Tyrosinemia, Hereditary [dsyn]     3.91824
protein transport [celf]     3.91824
MFH [neop]     3.91824
N-acetylornithine [orch]     3.91824
Respiratory function [phsf]     3.91824
Explosive, NOS [mnob]     3.91824
associated disease [tmco]     3.91824
Entameba [euka]     3.91824
Fcgamma receptor-mediated phagocytosis [moft]     3.91824
Robot [mnob]     3.91824
A3b [bpoc]     3.91824
Microscopic exam [lbpr]     3.91824
Gray color [qlco]     3.91824
Hepaciviruses [virs]     3.91824
Postoperative fistula [patf]     3.91824
Cognitive impairment [mobd]     3.91824
NFKB1 [gngm]     3.91824
creatine kinase activity [moft]     3.91824
ORGANIC ANION TRANSPORTER 2 [gngm]     3.91824
Biliary Sludge [dsyn]     3.91824
ZZ [qlco]     3.91824
v p [topp]     3.91824
GPLD1 [gngm]     3.91824
Multidisciplinary Collaboration [ocac]     3.91824
Loneliness [fndg]     3.91824
Wives [famg]     3.91824
Dry cough [sosy]     3.91824
Melaena [patf]     3.91824
Tumor Vascular Invasion [fndg]     3.91824
Celiac angiogram [diap]     3.91824
DGCR8 [gngm]     3.91824
Increased ALT [fndg]     3.91824
reoperations [topp]     3.91824
gastrointestinal stromal tumours [neop]     3.91824
elevated creatinine [fndg]     3.91824
Tree Nut [food]     3.91824
North Carolina [geoa]     3.91824
income level [qlco]     3.91824
Therapies, Targeted Molecular [topp]     3.91824
MCT1 [gngm]     3.91824
time of day [tmco]     3.91824
MEG3 [gngm]     3.91824
p7 [gngm]     3.91824
anti inflammatory drugs [phsu]     3.91824
TFA [orch]     3.91824
LF [gngm]     3.91824
Hypofractionated Radiotherapy [topp]     3.91824
GAB1 [gngm]     3.91824
Spectroscopy, Mass [lbpr]     3.91824
Non regenerative anaemia [dsyn]     3.91824
Resistant infection [dsyn]     3.91824
Negative attitude [menp]     3.91824
Bacterial product [bacs]     3.91824
Dp44mt [orch]     3.91824
Carney Triad [dsyn]     3.91824
Macroscopy [lbpr]     3.91824
% normal forms [qnco]     3.91824
medical patient [podg]     3.91824
estrous cycle [orgf]     3.91824
defence response [orgf]     3.91824
isolated perfusion [topp]     3.91824
operational definition [resa]     3.91824
Angiogenesis, Pathological [patf]     3.91824
Undernourished [dsyn]     3.91824
Diet, Mediterranean [topp]     3.91824
mg reduced [fndg]     3.91824
Muscle, Smooth [tisu]     3.91824
Pacific Islander Health [grpa]     3.91824
tumor excision [topp]     3.91824
elevated uric acid [fndg]     3.91824
Myelomas, Multiple [neop]     3.91824
Antigen Processing [celf]     3.91824
Norwegian [popg]     3.91824
Decreased body mass index [fndg]     3.91824
Medical assessment [hlca]     3.91824
Sequences, Conserved [nusq]     3.91824
NK [cell]     3.91824
Clear consciousness [fndg]     3.91824
Anastomotic Leakage [patf]     3.91824
Anatomical base [blor]     3.91824
pH level [lbtr]     3.91824
Polymerisation [phpr]     3.91824
Urtica dioica [plnt]     3.91824
Diacetic acid [orch]     3.91824
normal white blood cell count [fndg]     3.91824
RAR [neop]     3.91824
Helicobacter suis [bact]     3.91824
Interstitial brachytherapy [topp]     3.91824
Redundancy [ftcn]     3.91824
Euthyroid [fndg]     3.91824
Neonatal Jaundice [sosy]     3.91824
electron density [mosq]     3.91824
Hippa [euka]     3.91824
PNS [bdsy]     3.91824
Patch [fndg]     3.91824
Liver transplant infection [inpo]     3.91824
anti ulcer drug [phsu]     3.91824
Single tumour [neop]     3.91824
Therapy, Experimental [topp]     3.91824
Hookworms [euka]     3.91824
Autism [mobd]     3.91824
CFS [dsyn]     3.91824
Clonal Evolution [neop]     3.91824
Instrumentation engineer [prog]     3.91824
Ku70 [gngm]     3.91824
Unevaluable [qnco]     3.91824
early diagnoses [diap]     3.91824
Disease regression [patf]     3.91824
Minus [qlco]     3.91824
hooks [medd]     3.91824
discount rate [qnco]     3.91824
Monosomy 7 [comd]     3.91824
UV [npop]     3.91824
Interstitial thickening [fndg]     3.91824
histone methylation [moft]     3.91824
Hemangioendotheliomas [neop]     3.91824
Southeast Asian liver fluke [euka]     3.91824
cognitive disorders [mobd]     3.91824
PRA [gngm]     3.91824
Erythrocytapheresis [topp]     3.91824
Numerical range [qnco]     3.91824
v myc [gngm]     3.91824
Architectural Distortion [fndg]     3.91824
chronic dialysis [topp]     3.91824
VCC [hcro]     3.91824
Body positions [orga]     3.91824
Ontology [ocdi]     3.91824
HGDN [neop]     3.91824
Safety Study [resa]     3.91824
Urinary Bladder Carcinoma [neop]     3.91824
Chromosome structure [celc]     3.91824
LincRNA [nnon]     3.91824
Vascular proliferation [patf]     3.91824
carboxylic acid transport [celf]     3.91824
manual control [ftcn]     3.91824
IL 6 signaling pathway [celf]     3.91824
Hemagglutinating Virus of Japan [virs]     3.91824
{NOS} [qlco]     3.91824
Hakka [euka]     3.91824
KRUPPEL-LIKE FACTOR 5 [gngm]     3.91824
Saline [lbtr]     3.91824
Pituicytoma [neop]     3.91824
nodular parenchyma [tisu]     3.91824
Triglyceride Measurement [lbpr]     3.91824
Esophagectomy [topp]     3.91824
infection sources [fndg]     3.91824
TGFB1 [gngm]     3.91824
post operative (finding) [fndg]     3.91824
PVA [bodm]     3.91824
Histological term [cnce]     3.91824
Hypoxemias [fndg]     3.91824
missing work [inbe]     3.91824
information sources [fndg]     3.91824
Neutrophil migration [celf]     3.91824
IV injection [ftcn]     3.91824
DNA Therapy [topp]     3.91824
Microsomes, Liver [celc]     3.91824
Right CM [blor]     3.91824
Systemic lymphangiomatosis [neop]     3.91824
MU-2 [gngm]     3.91824
Salty food [food]     3.91824
HNF1alpha-Inactivated Hepatocellular Adenoma [neop]     3.91824
Semen [plnt]     3.91824
LIM-1 [gngm]     3.91824
Complete heart block [dsyn]     3.91824
Restricted Diffusion [celf]     3.91824
metalloproteinase activity [moft]     3.91824
Primary tumor.pathology [fndg]     3.91824
Hyperdiploidy [comd]     3.91824
HSPA1B [gngm]     3.91824
Miniature schnauzer [mamm]     3.91824
Cell-Mediated Cytotoxicity [celf]     3.91824
ALPHA-1-B-GLYCOPROTEIN [gngm]     3.91824
Biliary ascariasis [dsyn]     3.91824
MICRO RNA 378 [gngm]     3.91824
Venous segment [bpoc]     3.91824
Organic Synthesis [ocdi]     3.91824
Cell physiology [celf]     3.91824
Hep G2 Cell Line [cell]     3.91824
Radionuclide Imaging [diap]     3.91824
IMAGE INSPECTION [ftcn]     3.91824
TRP53 [gngm]     3.91824
Sewage [eehu]     3.91824
Hypotriploidy [comd]     3.91824
Shave biopsy [diap]     3.91824
Radiation cystitis [dsyn]     3.91824
Years of Potential Life Lost [qnco]     3.91824
EQ [qlco]     3.91824
hepatic ischemia [patf]     3.91824
Arab World [idcn]     3.91824
Nephrotic Syndrome [dsyn]     3.91824
dose-response curve [qnco]     3.91824
Pituitary Adenoma [neop]     3.91824
pT0 [fndg]     3.91824
Clavicle [bpoc]     3.91824
Increased erythrocyte sedimentation rate [fndg]     3.91824
collectors [medd]     3.91824
Haemangioblastoma [neop]     3.91824
PAX [gngm]     3.91824
Trematoda [euka]     3.91824
low monocyte count [fndg]     3.91824
Musculoskeletal procedure [topp]     3.91824
Leydig Cell Tumor [neop]     3.91824
nuclear division [celf]     3.91824
kV [qnco]     3.91824
mL/min/g [qnco]     3.91824
Anemia, profound [dsyn]     3.91824
ultrasound report [inpr]     3.91824
White - ethnic group [popg]     3.91824
peers [popg]     3.91824
Puerperium [tmco]     3.91824
Sicily [geoa]     3.91824
CKD [dsyn]     3.91824
Longest Diameter [qnco]     3.91824
Adipocytes, White [cell]     3.91824
Arrhythmia [patf]     3.91824
High Throughput Assay [diap]     3.91824
Southern Blot [mbrt]     3.91824
growth promoting activity [aapp]     3.91824
Partial thrombosis [acab]     3.91824
Hepatic colic [dsyn]     3.91824
Ataxia [sosy]     3.91824
Mumps [dsyn]     3.91824
Splenic hamartoma [dsyn]     3.91824
abnormal bilirubin [fndg]     3.91824
Retrotransposition [genf]     3.91824
Hydrops [patf]     3.91824
Lima [euka]     3.91824
Comprehensive Cancer Center [hcro]     3.91824
Lymphocytopenia [dsyn]     3.91824
Energy Balance [orgf]     3.91824
b-Carotene [lbpr]     3.91824
Singaporean [popg]     3.91824
Lipomatous tumor [neop]     3.91824
Body fat mass [orga]     3.91824
Nucleated [qlco]     3.91824
Case Management [hlca]     3.91824
Government Funding [gora]     3.91824
androgen therapy [topp]     3.91824
DNA studies [lbpr]     3.91824
menopausal hormone therapy [topp]     3.91824
Decreased size [qlco]     3.91824
Peritoneo-Venous Shunt [topp]     3.91824
Cutaneous necrosis [patf]     3.91824
kBq [qnco]     3.91824
ADJ [chvf]     3.91824
surface-enhanced laser desorption/ionization-time of flight mass spectrometry [diap]     3.91824
Radiation-Related Cancer [neop]     3.91824
Study year [tmco]     3.91824
Cardiomyocyte [cell]     3.91824
insulin metabolism [moft]     3.91824
Left ventricular diastolic dysfunction [dsyn]     3.91824
biopsy nodule [diap]     3.91824
Gene, Ki-ras [gngm]     3.91824
Disease management program [topp]     3.91824
cell-mediated immune response [celf]     3.91824
Characteristic type [inpr]     3.91824
comorbid condition [fndg]     3.91824
Hispanic, white [fndg]     3.91824
Oral Disease [dsyn]     3.91824
Motor Development [orgf]     3.91824
Entropy [phpr]     3.91824
phthalimide [orch]     3.91824
Palmar erythema [fndg]     3.91824
fibrils [celc]     3.91824
Gradient method [topp]     3.91824
Opioid Substitution Treatment [topp]     3.91824
Diagnosis Classification [clas]     3.91824
National Cancer Program [hcro]     3.91824
PHOSPHOGLUCOMUTASE 1 [gngm]     3.91824
Transaxial [spco]     3.91824
Paracolic gutters [bsoj]     3.91824
Toxicosis [dsyn]     3.91824
coil insertion [topp]     3.91824
ATRIAL ENLARGEMENT [dsyn]     3.91824
endovascular [blor]     3.91824
serum lipid [lbpr]     3.91824
pM0 [fndg]     3.91824
Taxation [gora]     3.91824
Relatedness Assessment [idcn]     3.91824
Mustela putorius furo [mamm]     3.91824
glucose-6-phosphatase activity [moft]     3.91824
Increased serum alkaline phosphatase [fndg]     3.91824
23a [medd]     3.91824
Established diagnosis [qlco]     3.91824
tissue tropism [phsf]     3.91824
fatty acid homeostasis [phsf]     3.91824
Mesenteric infarction [dsyn]     3.91824
Protein Interaction Networks [ftcn]     3.91824
rumor [socb]     3.91824
Pulmonary arteriovenous fistula [anab]     3.91824
genetic aspects [biof]     3.91824
Liquefaction [lbtr]     3.91824
Intuition [menp]     3.91824
GNAS [gngm]     3.91824
Protein intake [clna]     3.91824
Inapparent Infection [dsyn]     3.91824
Trypanosoma cruzi [euka]     3.91824
Squirrel [mamm]     3.91824
glutathione S-transferase activity [moft]     3.91824
Anal canal [bpoc]     3.91824
Death Records [mnob]     3.91824
cisplatin/doxorubicin [topp]     3.91824
invasive aspergillosis [dsyn]     3.91824
FADS1 [gngm]     3.91824
Arterial finding [fndg]     3.91824
Targeted Mutation [genf]     3.91824
Tissues, Fetal [tisu]     3.91824
Faculty, Medical [prog]     3.91824
Middle Aged Adult [aggp]     3.91824
Therapeutic exposure [qlco]     3.91824
Plasmapheresis [topp]     3.91824
mucus production [celf]     3.91824
Follicular dendritic cell tumour [neop]     3.91824
UL16-BINDING PROTEIN 1 [gngm]     3.91824
Society, Medical [pros]     3.91824
Apolipoprotein J Gene [gngm]     3.91824
Invasive Lesion [fndg]     3.91824
DNA-methyltransferase activity [genf]     3.91824
IDH2 gene [gngm]     3.91824
Trisomy [dsyn]     3.91824
Crystal [npop]     3.91824
Enterococcus faecium [bact]     3.91824
Ottawa [popg]     3.91824
Cyanobacteria [bact]     3.91824
Renal vessels [bpoc]     3.91824
Brain Biopsy [diap]     3.91824
Sib [famg]     3.91824
Cell-Cell Signaling [celf]     3.91824
Murex [euka]     3.91824
Icterus [patf]     3.91824
Bacteriological [ftcn]     3.91824
Transfusion transmission [ftcn]     3.91824
Maternal infection [fndg]     3.91824
Gluconeogenesis [moft]     3.91824
Dexterity [fndg]     3.91824
PTPN6 [gngm]     3.91824
Overgrowth Syndrome [dsyn]     3.91824
Elevated venous pressure [fndg]     3.91824
Private Sector [popg]     3.91824
Fish Diseases [dsyn]     3.91824
GOLPH2 [gngm]     3.91824
Protein Interaction Domains [spco]     3.91824
Disease, Canine [dsyn]     3.91824
Role Playing [topp]     3.91824
M-75 [orch]     3.91824
mountains [geoa]     3.91824
PK2 [gngm]     3.91824
Excessive activity [clna]     3.91824
HBV polymerase [aapp]     3.91824
Amorphous [qlco]     3.91824
Cholesterolosis [fndg]     3.91824
tooth brush [topp]     3.91824
storage vacuole [celc]     3.91824
Product-Limit Method [qnco]     3.91824
Breast Adenocarcinoma [neop]     3.91824
Polyubiquitination [moft]     3.91824
Whisky [food]     3.91824
Severe cognitive impairment [fndg]     3.91824
OIs [dsyn]     3.91824
venous drainage [phsf]     3.91824
EPHA10 [gngm]     3.91824
Antidepressant [phsu]     3.91824
of primary liver cancer [neop]     3.91824
Micelle [lipd]     3.91824
Mandibular [bpoc]     3.91824
Yin-Yang [idcn]     3.91824
Pathogen, Blood-Borne [orgm]     3.91824
Kcal/kg/day [qnco]     3.91824
GSD IIIA [dsyn]     3.91824
PRL [gngm]     3.91824
flavone [orch]     3.91824
Herpesvirus [virs]     3.91824
CT arterioportography [diap]     3.91824
Third edition [inpr]     3.91824
5-DES [moft]     3.91824
FAM83D [gngm]     3.91824
Syphilis, secondary [dsyn]     3.91824
Blood chemistry [lbpr]     3.91824
Bx [diap]     3.91824
Toxic metabolic encephalopathy [inpo]     3.91824
Therapy, Emergency [topp]     3.91824
Cellular Biology [bmod]     3.91824
Nylon suture [medd]     3.91824
Lymphocyte Subsets [clas]     3.91824
Malignant Pleural Mesothelioma [neop]     3.91824
System, Geographical Information [inpr]     3.91824
Disseminated carcinomatosis [neop]     3.91824
Carbapenem resistant Klebsiella pneumoniae [bact]     3.91824
Compensatory regeneration [phsf]     3.91824
Intraoperative echography [diap]     3.91824
MYCL1 [gngm]     3.91824
Whole food [food]     3.91824
Fourthly [qnco]     3.91824
Ancestor [famg]     3.91824
Experimental Animal Model [anim]     3.91824
Variable, Confounding [ftcn]     3.91824
Biliary tract dysplasia [dsyn]     3.91824
Neuroectoderm [emst]     3.91824
Non-Nucleoside Analog [phsu]     3.91824
LIN28B [gngm]     3.91824
Evolution, Molecular [biof]     3.91824
Issue, Ethical [idcn]     3.91824
GNE [gngm]     3.91824
mCi [qnco]     3.91824
Concentration measurement [qnco]     3.91824
GC MS [lbpr]     3.91824
cholesterol absorption [celf]     3.91824
RNF7 [gngm]     3.91824
Polymicrobial Infections [dsyn]     3.91824
Tumor Escape [patf]     3.91824
Intellectual Disabilities [mobd]     3.91824
Pericardial Fluid [dsyn]     3.91824
Measles [dsyn]     3.91824
Puerto Rican [popg]     3.91824
Prenatal Testing [hlca]     3.91824
Hemangioendotheliomas, Epithelioid [neop]     3.91824
Severe disorder [fndg]     3.91824
MHC Class I [gngm]     3.91824
yu [plnt]     3.91824
Ultrasound Radiation [npop]     3.91824
AFG [geoa]     3.91824
APC gene [gngm]     3.91824
Bronchoscopist [prog]     3.91824
Hops [plnt]     3.91824
Fluid, Ascites [bdsu]     3.91824
hTERT Gene [gngm]     3.91824
Postnecrotic cirrhosis [dsyn]     3.91824
Tubular Neoplasm [neop]     3.91824
Controlled ventilation [topp]     3.91824
Ductal Carcinomas, Pancreatic [neop]     3.91824
Diffuse hyperplasia [patf]     3.91824
Splenosis [dsyn]     3.91824
Sessile polyp [dsyn]     3.91824
Family Characteristics [grpa]     3.91824
cell cycle transition [celf]     3.91824
Symbiont [orgm]     3.91824
Major Axis [spco]     3.91824
postnatal human [aggp]     3.91824
Depressed Mood [mobd]     3.91824
MCT2 [gngm]     3.91824
Primata [mamm]     3.91824
podosome assembly [moft]     3.91824
TMEM9 [gngm]     3.91824
Malignant Germ Cell Tumor [neop]     3.91824
Single birth NOS [fndg]     3.91824
Event outcome [clna]     3.91824
Image Analysis, Computer-Assisted [mcha]     3.91824
cerebral injury [inpo]     3.91824
NEUTERED [fndg]     3.91824
Ambiguity [qlco]     3.91824
Lengthening [topp]     3.91824
hederagenin [strd]     3.91824
Interleukin 10 Gene [gngm]     3.91824
Fatty Acids, Essential [lipd]     3.91824
White blood cell [cell]     3.91824
GNAS COMPLEX LOCUS [gngm]     3.91824
SPO [gngm]     3.91824
rccs [neop]     3.91824
Breath [orgf]     3.91824
Intraperitoneal hemorrhage [fndg]     3.91824
TBC [celc]     3.91824
virus pathogenesis [comd]     3.91824
CTCAE Grade 2 [fndg]     3.91824
Species Specificity [npop]     3.91824
Medium Risk [fndg]     3.91824
ubiquitin ligase complex [celc]     3.91824
Primary practitioner [prog]     3.91824
forkhead box J2 [gngm]     3.91824
NEU signaling [moft]     3.91824
Indolent Clinical Course [fndg]     3.91824
Tumor margin status [fndg]     3.91824
grafted [ftcn]     3.91824
Sebaceous Tumor [neop]     3.91824
Breast Imaging Reporting and Data System [diap]     3.91824
compressed [medd]     3.91824
Behcet Disease [dsyn]     3.91824
RNA, Non-Protein-Coding [nnon]     3.91824
Medial segment [spco]     3.91824
Epidermal [tisu]     3.91824
Laboratory procedure [lbpr]     3.91824
DENN [gngm]     3.91824
Clinical function [fndg]     3.91824
Routine antenatal care [topp]     3.91824
Croup [dsyn]     3.91824
Right breast [bpoc]     3.91824
Lactobacillus casei [bact]     3.91824
Deltavirus [virs]     3.91824
Hematopoietic Cancer [neop]     3.91824
Gene Sequencing [lbpr]     3.91824
Maxilla [bpoc]     3.91824
Villous [qlco]     3.91824
License [gora]     3.91824
Adjuvant response [orgf]     3.91824
6p21.33 [celc]     3.91824
GLP-1 Analogue [chvf]     3.91824
plasma cholesterol [lbpr]     3.91824
Pancreatic islet cell [cell]     3.91824
Portal Venous Pressure [orgf]     3.91824
Left hepatic lobectomy [topp]     3.91824
Sus [mamm]     3.91824
Low Power Field [qnco]     3.91824
Decreased HDL cholesterol [fndg]     3.91824
Conjunctival [ftcn]     3.91824
virus host [virs]     3.91824
Trout, Rainbow [fish]     3.91824
Columnar epithelium [tisu]     3.91824
Employer [prog]     3.91824
Age Appropriate Screening [diap]     3.91824
Swimbladder [bpoc]     3.91824
ADK [gngm]     3.91824
Lab Test [lbpr]     3.91824
Regulatory B-Cells [cell]     3.91824
Breast Metastasis [neop]     3.91824
Lentiviruses [virs]     3.91824
Setter [mamm]     3.91824
low triglyceride [fndg]     3.91824
Archaea [arch]     3.91824
PSVT [dsyn]     3.91824
Stigma [fndg]     3.91824
tissue development [ortf]     3.91824
Anemia, Hemolytic [dsyn]     3.91824
NLRP3 [gngm]     3.91824
Infratentorial [spco]     3.91824
ionising radiation exposure [inpo]     3.91824
Verified [inpr]     3.91824
With duration [tmco]     3.91824
Three-dimensional reconstruction [diap]     3.91824
Photofluorographies [diap]     3.91824
DELETED IN LIVER CANCER 1 [gngm]     3.91824
Mastocytoma [neop]     3.91824
phase II metabolism [moft]     3.91824
Attendance [idcn]     3.91824
Pancreatic Serous Cystadenoma [neop]     3.91824
copper levels [lbtr]     3.91824
Herpes Zoster [dsyn]     3.91824
Family doctor [prog]     3.91824
Intervertebral Disc [bpoc]     3.91824
Solid carcinoma [neop]     3.91824
Study Date [tmco]     3.91824
Percutaneous route [ftcn]     3.91824
Unspecified Site [blor]     3.91824
serum ca [lbpr]     3.91824
Experimental Organism [orgm]     3.91824
drugs evaluation [resa]     3.91824
Deceleration [npop]     3.91824
virus virus interaction [orgf]     3.91824
Biogenic Amine Metabolism [moft]     3.91824
SPECT imaging [diap]     3.91824
Pneumothorax, Artificial [topp]     3.91824
Document response [idcn]     3.91824
Glasgow coma scale [inpr]     3.91824
Computer Simulation [mcha]     3.91824
Constriction [topp]     3.91824
factor V G1691A [aapp]     3.91824
Thoracoabdominal approach [spco]     3.91824
Energy Dispersive X-Ray Spectroscopy [lbpr]     3.91824
Sexual relationships [socb]     3.91824
Corporation [orgt]     3.91824
Contracture [acab]     3.91824
AIC [dsyn]     3.91824
Gastric Resection [topp]     3.91824
Carotid [bpoc]     3.91824
Helicobacter felis [bact]     3.91824
antibodies titre [lbpr]     3.91824
palmar-plantar erythrodysesthesia [dsyn]     3.91824
Hernias, Diaphragmatic [anab]     3.91824
Transcription Factor Gene [gngm]     3.91824
PDGF-C [aapp]     3.91824
Curcuma longa [plnt]     3.91824
low hdl [fndg]     3.91824
Pacific States [geoa]     3.91824
anti-TNF therapy [topp]     3.91824
Extrapyramidal system [bdsy]     3.91824
artery stenosis [dsyn]     3.91824
Fibromatosis [neop]     3.91824
GADD45 [gngm]     3.91824
Congenital absence of portal vein [cgab]     3.91824
6p21.1 [celc]     3.91824
osler weber rendu [dsyn]     3.91824
Thermal Destruction [hcpp]     3.91824
g/month [qnco]     3.91824
Time Series Analysis [resa]     3.91824
Transarterial technique [qlco]     3.91824
GSTA3 [gngm]     3.91824
Whole-Body Scintigraphy [diap]     3.91824
Support Groups [shro]     3.91824
Carbamates [orch]     3.91824
non healing [ftcn]     3.91824
TYROSINE KINASE 2 [gngm]     3.91824
Medium vessels, NOS [bpoc]     3.91824
Hematological Tumor [neop]     3.91824
CD8-Positive Lymphocytes [cell]     3.91824
Oldest Old [aggp]     3.91824
hamartomatous [neop]     3.91824
mg/kg/d [qnco]     3.91824
Fetal Examination [diap]     3.91824
Mental disorders [mobd]     3.91824
ultrasonography liver [diap]     3.91824
BEEF HEART [phsu]     3.91824
helicase activity [genf]     3.91824
Peripheral Neuropathy [dsyn]     3.91824
Prostate carcinoma [neop]     3.91824
condensation [mobd]     3.91824
Low Grade Lesion [fndg]     3.91824
Whole Body Imaging [diap]     3.91824
Pathological fracture [patf]     3.91824
MU-4 [gngm]     3.91824
HCC-3 [gngm]     3.91824
UES [neop]     3.91824
Gall bladder epithelium [tisu]     3.91824
CI 928 [orch]     3.91824
13q12 [celc]     3.91824
NFKB Signaling Pathway [genf]     3.91824
Nucleolus [celc]     3.91824
Helical Tomotherapy [topp]     3.91824
Denaturation [moft]     3.91824
Disseminated carcinoma [neop]     3.91824
Gastrointestinal infections [dsyn]     3.91824
Diploid Cells [cell]     3.91824
Duct carcinoma [neop]     3.91824
Lifetime Drinking History [fndg]     3.91824
Liver PEComa [neop]     3.91824
Cynomys ludovicianus [mamm]     3.91824
Invariant Natural Killer T-Cells [cell]     3.91824
Nested Pattern [fndg]     3.91824
Myxoid degeneration [patf]     3.91824
snore [sosy]     3.91824
new strength [idcn]     3.91824
Live Births [qlco]     3.91824
AGO4 [gngm]     3.91824
Pre-Existing Illness [rnlw]     3.91824
Pericholangitis [dsyn]     3.91824
Epithelial phenotype [orga]     3.91824
Entire duct [bpoc]     3.91824
Angiotensin Receptor Blockers [phsu]     3.91824
Naturopathic Therapy [topp]     3.91824
heat stress [inpo]     3.91824
Follicular dendritic cell tumor [neop]     3.91824
IGH [gngm]     3.91824
Structural analysis [topp]     3.91824
Endemic disease [dsyn]     3.91824
Hepatic Neuroendocrine Tumor [neop]     3.91824
Radiations, Ionizing [npop]     3.91824
DISCONNECT [phpr]     3.91824
Diastolic [clna]     3.91824
Deep-Venous Thrombosis [dsyn]     3.91824
Reference Values [qnco]     3.91824
ADAMTS7 [gngm]     3.91824
Data Linkage [resa]     3.91824
Multislice Computed Tomography [diap]     3.91824
Serum insulin [lbpr]     3.91824
mol/g [qnco]     3.91824
globular [spco]     3.91824
Catchment Area [geoa]     3.91824
Marmosets, Common [mamm]     3.91824
incoherent [fndg]     3.91824
Phosphorylation Deficiency, Oxidative [dsyn]     3.91824
reticuloendothelial [bdsy]     3.91824
Optic Chiasm [bpoc]     3.91824
Nucleic Acid Testing [lbpr]     3.91824
Sedentary [qlco]     3.91824
AR1 [gngm]     3.91824
IFG [gngm]     3.91824
Duodenal biopsy [diap]     3.91824
Vet [prog]     3.91824
Cell Aging [celf]     3.91824
Telangiectases [dsyn]     3.91824
increased growth hormone [fndg]     3.91824
Anorexic [dsyn]     3.91824
Surgery clinic [inpr]     3.91824
Limited Stage [clas]     3.91824
Acute non-lymphocytic leukaemia [neop]     3.91824
Functional single ventricle [cgab]     3.91824
Decreased blood volume [fndg]     3.91824
arterial reconstruction [topp]     3.91824
Altitude Sickness [dsyn]     3.91824
HLA-DQB [imft]     3.91824
body organs [bpoc]     3.91824
Extramural [spco]     3.91824
Formalin-fixed paraffin-embedded tissue specimen [tisu]     3.91824
THE SYNDROME [dsyn]     3.91824
Grade 1 Nausea [fndg]     3.91824
hsa-mir-126 [gngm]     3.91824
HIV disease [dsyn]     3.91824
reovirus [virs]     3.91824
Impaired wound healing [patf]     3.91824
Pathology service [hcro]     3.91824
immune modulation [orgf]     3.91824
anti-Fas monoclonal antibody [aapp]     3.91824
Glomerulonephritis, Membranoproliferative [dsyn]     3.91824
MRC [gngm]     3.91824
Pseudolymphoma [neop]     3.91824
Teen-age [aggp]     3.91824
30M [tmco]     3.91824
Centrifugal [lbpr]     3.91824
Renal perfusion [topp]     3.91824
Venovenous shunt [anab]     3.91824
lysine degradation [moft]     3.91824
Disulfide Bond [amas]     3.91824
physical insult [inpo]     3.91824
Focal inflammation [fndg]     3.91824
Antihypertensive [phsu]     3.91824
bronchus cancer [neop]     3.91824
mitochondrial respiratory chain complex I [celc]     3.91824
shiba [plnt]     3.91824
Class 3 [inpr]     3.91824
SRXN1 [gngm]     3.91824
lactate [fndg]     3.91824
ErbB signaling pathway [moft]     3.91824
Labs [fndg]     3.91824
Viral core [celc]     3.91824
research project [resa]     3.91824
vortexed [spco]     3.91824
Paget Disease, Extramammary [neop]     3.91824
Cancer education [hlca]     3.91824
hyperglycemic agent [phsu]     3.91824
HES1 [gngm]     3.91824
Workplaces [spco]     3.91824
Scirrhous Pattern [fndg]     3.91824
TACC3 [gngm]     3.91824
acute renal insufficiency [dsyn]     3.91824
Left gastric vein [bpoc]     3.91824
Language Ability [menp]     3.91824
perk [qnco]     3.91824
Epstein-Barr virus hepatitis [dsyn]     3.91824
Percutaneous balloon angioplasty [topp]     3.91824
Recommended Dietary Allowances [inpr]     3.91824
BDC [neop]     3.91824
Aneurysm [dsyn]     3.91824
Stage IV Hepatocellular Carcinoma [neop]     3.91824
voice box [bpoc]     3.91824
Drug Resistance, Multiple [orga]     3.91824
Crigler-Najar Syndrome [dsyn]     3.91824
Exogenous Hormone Use [topp]     3.91824
Stage IIIC Gastric Cancer [neop]     3.91824
Telephone Interview [resa]     3.91824
Moderately Differentiated Hepatocellular Carcinoma [neop]     3.91824
stent occlusion [patf]     3.91824
DUOX1 [gngm]     3.91824
polymorphism analysis [diap]     3.91824
Endocrine Diseases [dsyn]     3.91824
Nipple [bpoc]     3.91824
Trematode Infections [dsyn]     3.91824
Per os [ftcn]     3.91824
Parietal cell [cell]     3.91824
Inlet [geoa]     3.91824
National Library of Medicine [hcro]     3.91824
instructions [inpr]     3.91824
Gallbladder Neoplasms [neop]     3.91824
Central nervous system finding [fndg]     3.91824
Cell Matrix [celc]     3.91824
/LPF [qnco]     3.91824
Liver Cirrhoses [dsyn]     3.91824
Psychiatry [prog]     3.91824
Serum testosterone [lbpr]     3.91824
NIDDK [hcro]     3.91824
Ethical Issues [idcn]     3.91824
N-acetylglycine [aapp]     3.91824
Chief complaint [fndg]     3.91824
MJ [medd]     3.91824
TAK1-BINDING PROTEIN 2 [gngm]     3.91824
Chronic renal insufficiency [dsyn]     3.91824
Nuclear Medicine [bmod]     3.91824
Replication Error [comd]     3.91824
MicroCT [diap]     3.91824
Drink intake [fndg]     3.91824
2 Hours [tmco]     3.91824
Temperature Mapping [diap]     3.91824
GW [geoa]     3.91824
User [idcn]     3.91824
Immunoperoxidase stain [lbpr]     3.91824
Cardiovascular Pathology [dsyn]     3.91824
ICR [mamm]     3.91824
Cystic duct stump [bpoc]     3.91824
hepatitis infectious virus [virs]     3.91824
CCG [hcro]     3.91824
Right clavicle [bpoc]     3.91824
MODY3 [dsyn]     3.91824
mock [fndg]     3.91824
DNA-protein complex [celc]     3.91824
Unpaired t-Test [inpr]     3.91824
Bile Duct Perforation [dsyn]     3.91824
New Mexico [geoa]     3.91824
Clinical Endpoint [clna]     3.91824
Pancreatic Hepatoid Carcinoma [neop]     3.91824
Prosimii [mamm]     3.91824
Endoscopy device [medd]     3.91824
Placental membrane [emst]     3.91824
Transmembrane Domain [amas]     3.91824
Epidural Space [bsoj]     3.91824
Proton Pump Inhibitors [phsu]     3.91824
WNT3 [gngm]     3.91824
established cell line [cell]     3.91824
Cleveland [geoa]     3.91824
Fresh Specimen [bdsu]     3.91824
motor deficit [patf]     3.91824
Brain Abscesses [dsyn]     3.91824
Regional office [hcro]     3.91824
Endometrial Stromal Tumors [neop]     3.91824
Insecticides [hops]     3.91824
Prevention Measures [topp]     3.91824
Regional Disease [fndg]     3.91824
Micromole [qnco]     3.91824
NQO1 [gngm]     3.91824
knife [medd]     3.91824
Ito cell [cell]     3.91824
Myalgia [sosy]     3.91824
Salmonella typhimurium [bact]     3.91824
Invisible [qlco]     3.91824
VARS2 gene [gngm]     3.91824
Smooth Endoplasmic Reticulum [celc]     3.91824
Mitotic Figure [fndg]     3.91824
Tubular Pattern [fndg]     3.91824
Amines [orch]     3.91824
Affected Area [fndg]     3.91824
Companion [popg]     3.91824
Church [mnob]     3.91824
Glandular Pattern [fndg]     3.91824
Lymphoma, Large-Cell, Diffuse [neop]     3.91824
degrees Celsius [qnco]     3.91824
Myeloid Leukemia [neop]     3.91824
Candidemia [dsyn]     3.91824
OA [dsyn]     3.91824
129S6/SvEvTac [mamm]     3.91824
Cytopenia [patf]     3.91824
Submucosa [tisu]     3.91824
B8 [bpoc]     3.91824
Endobronchial ultrasonography [diap]     3.91824
Renal replacement [topp]     3.91824
18th century [tmco]     3.91824
Relational problem NOS [mobd]     3.91824
Medicare/Medicaid [hcro]     3.91824
right rib [bpoc]     3.91824
DNA formation [genf]     3.91824
health care policy [rnlw]     3.91824
Phase I/II Trial [resa]     3.91824
Standardized Uptake Value Maximum [qnco]     3.91824
Regional Lymph Node Dissection [topp]     3.91824
Vitamin B12 level [lbtr]     3.91824
nephrologists [prog]     3.91824
Sexual function [orgf]     3.91824
Cellular Regulation [celf]     3.91824
In progress [ftcn]     3.91824
shoulder soft tissue [bpoc]     3.91824
cancer, AIDS related [neop]     3.91824
Cross-talk [celf]     3.91824
pancreas tumors [neop]     3.91824
Framingham [inpr]     3.91824
Refuse [eehu]     3.91824
Hedera helix [plnt]     3.91824
BALB/c Mouse [mamm]     3.91824
DNA Loop [celc]     3.91824
LRG1 [gngm]     3.91824
perilipin 2 [aapp]     3.91824
Blood Flow Velocity [lbtr]     3.91824
lymphocyte proliferation [celf]     3.91824
Sample Median [qnco]     3.91824
Grand-mother [famg]     3.91824
demethylcantharidin [orch]     3.91824
Mitochondria, Liver [celc]     3.91824
Serum vitamin B12 level [lbpr]     3.91824
Duct Cyst, Bile [cgab]     3.91824
Peninsular Malaysia [geoa]     3.91824
Short trunk [acab]     3.91824
p43 [gngm]     3.91824
Caspase-8 Gene [gngm]     3.91824
Plate assay [lbpr]     3.91824
choke [fndg]     3.91824
surgical biopsy [diap]     3.91824
DNA Chip [resd]     3.91824
sore [sosy]     3.91824
Network, Community [socb]     3.91824
Databases, Bibliographic [inpr]     3.91824
Mechanical ventilation [medd]     3.91824
natural killer cell mediated cytotoxicity [celf]     3.91824
DENND2D [gngm]     3.91824
transmembrane 6 superfamily member 2 [gngm]     3.91824
Extended family member [famg]     3.91824
With contraindication [qlco]     3.91824
Medullary carcinoma [neop]     3.91824
Intestinal Cancer [neop]     3.91824
ENOLASE, ALPHA [gngm]     3.91824
Annular [spco]     3.91824
ovarian neoplasia [neop]     3.91824
CDH6 [gngm]     3.91824
Professional Practice [ocac]     3.91824
Ultrasonographic echogenicity [clna]     3.91824
RDR [inpr]     3.91824
therapy duration [tmco]     3.91824
Healthy Food Environment [ftcn]     3.91824
Follicular carcinoma [neop]     3.91824
Photosensitizer [phsu]     3.91824
Contiguous Disease [fndg]     3.91824
FIBROBLAST GROWTH FACTOR 19 [gngm]     3.91824
LPAR3 [gngm]     3.91824
Baltimore [geoa]     3.91824
Gastrointestinal carcinoma [neop]     3.91824
GNE gene [gngm]     3.91824
HSP70-2 [gngm]     3.91824
Diaphragma [bpoc]     3.91824
Screening Study [resa]     3.91824
fuzzy [fndg]     3.91824
interstitial cell [cell]     3.91824
Unclassified Hepatocellular Adenoma [neop]     3.91824
Older sibling [famg]     3.91824
Fasciocutaneous [bpoc]     3.91824
Small Noncoding RNA [nnon]     3.91824
nasal drainage [sosy]     3.91824
Stable isotope [elii]     3.91824
Food Habits [inbe]     3.91824
mmu-mir-223 [nnon]     3.91824
ethyl glucuronide [carb]     3.91824
vascular problem [dsyn]     3.91824
Asp-Asp [aapp]     3.91824
Saltatory conduction [celf]     3.91824
Disorders, Depressive [mobd]     3.91824
Cardiac Arrhythmia [patf]     3.91824
Folk Remedies [topp]     3.91824
Nanotechnology [ocdi]     3.91824
Duplex ultrasound [diap]     3.91824
lung tumours [neop]     3.91824
RAMP3 [gngm]     3.91824
sphincteroplasty [topp]     3.91824
Chronic fibrosis [patf]     3.91824
Whole blood sample [bdsu]     3.91824
Latent Tuberculosis Infection [dsyn]     3.91824
Observer Bias [qlco]     3.91824
ACTG1 [gngm]     3.91824
Internal oblique [bpoc]     3.91824
Panoramic [qlco]     3.91824
Glycogenoses [dsyn]     3.91824
Duodenal Adenoma [dsyn]     3.91824
Hypometabolism [fndg]     3.91824
Cardiac Output [clna]     3.91824
World Health [idcn]     3.91824
Occlusion [patf]     3.91824
health care plan [hlca]     3.91824
Pain, Postoperative [sosy]     3.91824
Thyroid cancer, anaplastic [neop]     3.91824
vivo [spco]     3.91824
Age at menarche [fndg]     3.91824
Acinetobacter lwoffi [bact]     3.91824
IPMN [neop]     3.91824
AACT [gngm]     3.91824
Traditional Birth Attendants [prog]     3.91824
DRE [diap]     3.91824
bronchial brushing [diap]     3.91824
fidelity [socb]     3.91824
DIG [neop]     3.91824
Leiomyomatosis [neop]     3.91824
Liver firm [fndg]     3.91824
cell injury [comd]     3.91824
outsourced [phpr]     3.91824
6/60 [fndg]     3.91824
Economic status [grpa]     3.91824
Child Health [hlca]     3.91824
Blood hormone levels [lbtr]     3.91824
Mega [qnco]     3.91824
Rhesus Monkey [mamm]     3.91824
resistant cancer [neop]     3.91824
Lecithin Acyltransferase Deficiency [dsyn]     3.91824
Run-in Period [tmco]     3.91824
KVP [qlco]     3.91824
ZC3H15 [gngm]     3.91824
high temperature [fndg]     3.91824
wad [medd]     3.91824
Biliary tract disorders NOS [dsyn]     3.91824
slow potential [celf]     3.91824
Molecular Procedure [mbrt]     3.91824
Ischaemic hepatitis [dsyn]     3.91824
Rechallenge [topp]     3.91824
Cast [medd]     3.91824
Antirejection Therapy [topp]     3.91824
Spontaneous perforation [acab]     3.91824
increased platelet [dsyn]     3.91824
Roadmap [inpr]     3.91824
Fore [spco]     3.91824
Cribriform Pattern [fndg]     3.91824
REUSE [ftcn]     3.91824
Choline / Methionine [phsu]     3.91824
Batch [idcn]     3.91824
TMEM176A [gngm]     3.91824
Aortic Valve [bpoc]     3.91824
FOXO3 [gngm]     3.91824
Pulmonary Disorders [dsyn]     3.91824
Animal Viruses [virs]     3.91824
Pancreatic Cyst [dsyn]     3.91824
Beer [food]     3.91824
Low-Fat Diets [topp]     3.91824
Pancreaticojejunostomy [topp]     3.91824
diagnostic image [idcn]     3.91824
adrenal carcinoma [neop]     3.91824
PROKINETICIN RECEPTOR 1 [gngm]     3.91824
peritoneovenous shunting [topp]     3.91824
Morphology findings [fndg]     3.91824
Unaltered [qlco]     3.91824
Transfer Technique [acty]     3.91824
Carlos [inpr]     3.91824
Computerised tomography [diap]     3.91824
Nevi [neop]     3.91824
Venous plexus [bdsy]     3.91824
IJO [dsyn]     3.91824
Gallbladder mucosa [bpoc]     3.91824
Cavitation [anab]     3.91824
14-3-3-GAMMA [gngm]     3.91824
Ring pattern [spco]     3.91824
Multisection [fndg]     3.91824
Alpha cell [cell]     3.91824
Life Table Analyses [ocac]     3.91824
dust exposure [fndg]     3.91824
nonesterified fatty acid [lipd]     3.91824
Tim-3 [gngm]     3.91824
Wound [qlco]     3.91824
Alveolar sac [bpoc]     3.91824
serum iron [lbpr]     3.91824
DDY Mouse [mamm]     3.91824
postoperative analgesia [topp]     3.91824
PTEN Loss [comd]     3.91824
cyst removal [topp]     3.91824
Marfan Syndrome [dsyn]     3.91824
Time Study [inpr]     3.91824
Linear Energy Transfer [phpr]     3.91824
National Institute on Alcohol Abuse and Alcoholism [hcro]     3.91824
grey mouse lemur [mamm]     3.91824
CIP2A [gngm]     3.91824
control bleeding [topp]     3.91824
FILIP1L [gngm]     3.91824
Poise [qnco]     3.91824
Orbit [spco]     3.91824
HER-2 Gene Amplification [comd]     3.91824
QAT [geoa]     3.91824
CB2 [gngm]     3.91824
Ligand Binding [moft]     3.91824
adenocarcinoma of the lung [neop]     3.91824
molecular diagnostic methods [mbrt]     3.91824
Birth Date [fndg]     3.91824
LPC [gngm]     3.91824
Marker, Genetic [genf]     3.91824
Fukushima Nuclear Accident [hcpp]     3.91824
Schistosome Granuloma [fndg]     3.91824
DKK4 gene [gngm]     3.91824
LCD [dsyn]     3.91824
Caco-2 Cells [cell]     3.91824
Tumors, Sex Cord-Stromal [neop]     3.91824
Karnofsky [diap]     3.91824
HIWI [gngm]     3.91824
Malignant Spindle Cell Tumor [neop]     3.91824
Connect [ftcn]     3.91824
high temperature [phpr]     3.91824
Viral Interference [npop]     3.91824
MEN 3 [neop]     3.91824
Solid Growth Pattern [fndg]     3.91824
SDHD gene [gngm]     3.91824
eating habits [inbe]     3.91824
Irish [popg]     3.91824
HRD1 [gngm]     3.91824
Visualisation technique [topp]     3.91824
D1 [gngm]     3.91824
Chemoradiotherapy, Adjuvant [topp]     3.91824
Intestinal Dysplasia [neop]     3.91824
KSHV [virs]     3.91824
Epithelioid haemangioendothelioma, malignant [neop]     3.91824
Omega [inpr]     3.91824
Reconstructed [topp]     3.91824
Percutaneous aspiration [topp]     3.91824
129 Mouse [mamm]     3.91824
Mullerian duct [emst]     3.91824
Postgraduate [cnce]     3.91824
Flight [inpr]     3.91824
Deep Vein Thrombosis [dsyn]     3.91824
EPIC [lbpr]     3.91824
Glomerulosclerosis, Focal Segmental [dsyn]     3.91824
Gear [mnob]     3.91824
rDNA [nnon]     3.91824
Salmonid [fish]     3.91824
Ivy [plnt]     3.91824
biologists [prog]     3.91824
Colorful appearance [orga]     3.91824
hereditary factors [genf]     3.91824
Multinucleate cell [cell]     3.91824
HIV therapy [topp]     3.91824
Social Security Administration [orgt]     3.91824
serum high density lipoprotein [lbpr]     3.91824
Justification [idcn]     3.91824
protooncogenes [gngm]     3.91824
BB [geoa]     3.91824
Persistent Disease [fndg]     3.91824
Mitochondrial Toxicity [patf]     3.91824
Hepatic Lymphoma [neop]     3.91824
Latvia [geoa]     3.91824
Mononuclear phagocyte [cell]     3.91824
microRNA processing [genf]     3.91824
Hockey stick [mnob]     3.91824
legacy [qnco]     3.91824
Cold Ischemic Time [tmco]     3.91824
Extend [cnce]     3.91824
Urinary concentration [ortf]     3.91824
Bovine astrovirus [virs]     3.91824
DNA Repair-Deficiency [patf]     3.91824
MLXIPL [gngm]     3.91824
Vegetable [anab]     3.91824
Palatine Tonsil [bpoc]     3.91824
GAPDH [gngm]     3.91824
Helper T-lymphocyte [cell]     3.91824
Ascariasis [dsyn]     3.91824
search words [inpr]     3.91824
TV [inpr]     3.91824
NT [bpoc]     3.91824
drug levels [lbtr]     3.91824
Paralytic Ileus [dsyn]     3.91824
estrogen therapy [topp]     3.91824
Necrotising granuloma [patf]     3.91824
Dial [mnob]     3.91824
Basic Science Research [resa]     3.91824
11q22 [celc]     3.91824
Urological Disorders [dsyn]     3.91824
Tumor Oxygenation [ortf]     3.91824
Normal alkaline phosphatase [fndg]     3.91824
Protocol entry [inpr]     3.91824
transcriptional gene silencing [genf]     3.91824
Pregnancy Outcomes [fndg]     3.91824
MCA [bpoc]     3.91824
Echo Time [tmco]     3.91824
Shield [medd]     3.91824
Aortography [diap]     3.91824
Surrogate Endpoint [qlco]     3.91824
Human Females [popg]     3.91824
Metabolic Clearance Rate [clna]     3.91824
PHOSPHOGLYCERATE MUTASE 1 [gngm]     3.91824
ETB [gngm]     3.91824
DD [fndg]     3.91824
Frustration [menp]     3.91824
Cis-Acting Sequence [nusq]     3.91824
Death Domain [amas]     3.91824
SPHINGOSINE 1-PHOSPHATE RECEPTOR 2 [gngm]     3.91824
RPS6 [gngm]     3.91824
Safe-Guard [phsu]     3.91824
Volumes, Blood [orga]     3.91824
Cyclotron [medd]     3.91824
FAT Gene [gngm]     3.91824
Urine albumin [lbpr]     3.91824
HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR [gngm]     3.91824
Pharmaceutical Industry [hcro]     3.91824
natural killer cell mediated cytolysis [celf]     3.91824
Papillary tumour [neop]     3.91824
Tubular adenoma [neop]     3.91824
Arg-Arg [aapp]     3.91824
Axoneme [celc]     3.91824
Oral health [idcn]     3.91824
HP [neop]     3.91824
Chromosomes, Human [celc]     3.91824
drug program [hcro]     3.91824
Vertebrae [bpoc]     3.91824
patient examination [hlca]     3.91824
Trophoblastic disease [dsyn]     3.91824
DAPK [gngm]     3.91824
Excite [menp]     3.91824
pT3b [fndg]     3.91824
Omphalitis [dsyn]     3.91824
Granulomatous inflammation [patf]     3.91824
Aspergillus [fngs]     3.91824
Right lateral wall [spco]     3.91824
HEPATOCELLULAR CARCINOMA-RELATED PROTEIN 1 [gngm]     3.91824
LAR [gngm]     3.91824
Graft-vs-Host Disease [dsyn]     3.91824
Pessimistic [menp]     3.91824
Antibody to hepatitis C [imft]     3.91824
Herpesvirus 6, Human [virs]     3.91824
Recent weight loss [fndg]     3.91824
Dental Plaque [dsyn]     3.91824
POL [gngm]     3.91824
empowering [menp]     3.91824
Standard precautions [topp]     3.91824
Polyposis Coli [neop]     3.91824
MTD [qnco]     3.91824
Exposure Time [qnco]     3.91824
Abdominal lymphadenopathy [dsyn]     3.91824
Oncology nurse [prog]     3.91824
Complete Blood Count [lbpr]     3.91824
Paraplegic [fndg]     3.91824
ID1 [gngm]     3.91824
Funding Source [ftcn]     3.91824
diagnostic radiologists [prog]     3.91824
SPINT2 [gngm]     3.91824
Hepatocellular carcinoma, clear cell type [neop]     3.91824
ammonia levels [lbtr]     3.91824
Intraductal papillary carcinoma [neop]     3.91824
Jejunostomy [topp]     3.91824
LEUKEMIAS [neop]     3.91824
Chronic gastritis [dsyn]     3.91824
B-cell Antigen [imft]     3.91824
Gastrointestinal System Neoplasm [neop]     3.91824
Microbial agent [phsu]     3.91824
Oblique [spco]     3.91824
Harderian Gland [bpoc]     3.91824
Hepatic amyloidosis [dsyn]     3.91824
Group I [clna]     3.91824
heroin addicted [mobd]     3.91824
SERPINA1 [gngm]     3.91824
Abscesses, Pyogenic Liver [dsyn]     3.91824
protease activity [moft]     3.91824
Edematous [patf]     3.91824
RBC count [lbpr]     3.91824
spleen metastasis [neop]     3.91824
NS5 [dsyn]     3.91824
chinese medicine [bmod]     3.91824
TAC [topp]     3.91824
FOP [gngm]     3.91824
hepatitis screening [lbpr]     3.91824
Latent Tuberculosis [dsyn]     3.91824
Sorcery [idcn]     3.91824
Receptor Inhibition [celf]     3.91824
Refraction [fndg]     3.91824
Robinson [inpr]     3.91824
Southern Asia [geoa]     3.91824
abo blood type [lbpr]     3.91824
SLC40A1 [gngm]     3.91824
Health Literacy [edac]     3.91824
Severe Aplastic Anemia [dsyn]     3.91824
Permeability [ftcn]     3.91824
LAPTM4B [gngm]     3.91824
angiotomography [diap]     3.91824
Hospitals, Metropolitan [hcro]     3.91824
Blunt trauma [inpo]     3.91824
ethylene-vinyl alcohol copolymer [orch]     3.91824
Mandatory Screening [gora]     3.91824
haloalkane [orch]     3.91824
Gallbladder Papillary Neoplasm [neop]     3.91824
Biliary Cystadenocarcinoma [neop]     3.91824
Rosemary [food]     3.91824
Gram-Positive Cocci [bact]     3.91824
Nulliparity [orgf]     3.91824
lipid degradation [orgf]     3.91824
Fraction [lbpr]     3.91824
ATP6 [gngm]     3.91824
Douche [medd]     3.91824
Atypical Epithelioid Cell [cell]     3.91824
prevalence incidence [qnco]     3.91824
Internal Comparison Group [grup]     3.91824
Paternal Age [tmco]     3.91824
Hepatitis B screening test [lbpr]     3.91824
Uteri [bpoc]     3.91824
VARS2 [gngm]     3.91824
Samoan [popg]     3.91824
Osteonecrosis [patf]     3.91824
IDC [dsyn]     3.91824
ozonide [orch]     3.91824
Antithrombin III Activity [lbpr]     3.91824
Attenuation Correction [qnco]     3.91824
C-KIT Gene [gngm]     3.91824
Biliary operations [topp]     3.91824
National Comprehensive Cancer Network [hcro]     3.91824
PXDN [nnon]     3.91824
liver rupture [inpo]     3.91824
bolster [medd]     3.91824
Spongiosis [patf]     3.91824
Presumptive [qlco]     3.91824
Malaria [dsyn]     3.91824
FAM [gngm]     3.91824
Total patient population [qnco]     3.91824
Fin [bpoc]     3.91824
Splenic fossa [bsoj]     3.91824
TDS [orch]     3.91824
cancer resection [topp]     3.91824
prophylactic use [inbe]     3.91824
NMOLE [qnco]     3.91824
TMEM9 gene [gngm]     3.91824
of family history [fndg]     3.91824
Present procedure [topp]     3.91824
CYP26A1 [gngm]     3.91824
seriousness [inbe]     3.91824
IRISIN [gngm]     3.91824
Increased erythropoietin [fndg]     3.91824
Health Benefits [qnco]     3.91824
Viruses, Human [virs]     3.91824
Genetic Information Processing [genf]     3.91824
Wound Infections, Postoperative [patf]     3.91824
GROSS LESION [fndg]     3.91824
Right renal artery [bpoc]     3.91824
Intestinal Glands [bpoc]     3.91824
Degenerative change [patf]     3.91824
summit [hcro]     3.91824
Relocated [acty]     3.91824
princeton [hcro]     3.91824
Radiation hepatitis [dsyn]     3.91824
5-alpha Reductase Inhibitor [moft]     3.91824
Germ cell [cell]     3.91824
restricted diet [fndg]     3.91824
hormonal imbalance [fndg]     3.91824
SIRT [topp]     3.91824
antibody screening [lbpr]     3.91824
BMP9 [gngm]     3.91824
Rapport [qlco]     3.91824
Severe thrombus [fndg]     3.91824
sweet [food]     3.91824
store food [mnob]     3.91824
Tissues, Bone [tisu]     3.91824
Lower Extremity [blor]     3.91824
Thyroid follicle [bpoc]     3.91824
IGF2R [gngm]     3.91824
Yorkie [mamm]     3.91824
CD3G [gngm]     3.91824
Bacteroides stercoris [bact]     3.91824
Oryzias latipes [fish]     3.91824
Hepatic Carcinoid Tumor [neop]     3.91824
Antigen detection [lbpr]     3.91824
Inorganic [cnce]     3.91824
FOXO1 [gngm]     3.91824
Sprague-Dawley rat [mamm]     3.91824
fibrinogen beta chain [celc]     3.91824
Tracheal bronchus [bpoc]     3.91824
intraperitoneal infusion [topp]     3.91824
frosty [food]     3.91824
Type II Golgi Membrane Protein [aapp]     3.91824
Electroporation Therapy [topp]     3.91824
Strip [medd]     3.91824
Sclerosing Hepatocellular Carcinoma [neop]     3.91824
Recurrent pancreatitis [dsyn]     3.91824
breast cancer prevention [topp]     3.91824
OXYSTEROL-BINDING PROTEIN 2 [gngm]     3.91824
PIK3R1 [gngm]     3.91824
Celiac angiography [diap]     3.91824
Well adult [fndg]     3.91824
Mist. [ftcn]     3.91824
VRE [bact]     3.91824
sponsorship [socb]     3.91824
ano-rectal [bpoc]     3.91824
SSX [gngm]     3.91824
cryptococcus neoformans [dsyn]     3.91824
Intestinal Diseases [dsyn]     3.91824
radiology contrast [diap]     3.91824
lover [popg]     3.91824
Lax abdominal musculature [fndg]     3.91824
Spleen Tissue [tisu]     3.91824
Healthy diet [topp]     3.91824
MEG [diap]     3.91824
Sphingolipid [lipd]     3.91824
ALCOHOL DEHYDROGENASE 2 [gngm]     3.91824
MSH6 gene [gngm]     3.91824
Fourier Transform [qnco]     3.91824
CCT4 [gngm]     3.91824
veterinary [qlco]     3.91824
Bush Baby [mamm]     3.91824
Lipid Mobilization [ortf]     3.91824
Breast Diseases [dsyn]     3.91824
insulin infusion [topp]     3.91824
Radiotherapy, Intensity-Modulated [topp]     3.91824
catabolic process [orgf]     3.91824
INVESTIGATIONAL AGENTS [phsu]     3.91824
Musculocutaneous Flap [tisu]     3.91824
Burning NOS [phpr]     3.91824
HCV Viral Load [lbpr]     3.91824
Jejunal mesentery [bpoc]     3.91824
Bypass Surgery [topp]     3.91824
19p [nusq]     3.91824
Prolyl Hydroxylases [moft]     3.91824
Antibody to hepatitis B [imft]     3.91824
Casual Contact [qlco]     3.91824
Nutritional state, NOS [orga]     3.91824
Cytostatic Drugs [phsu]     3.91824
Anonymous [qlco]     3.91824
Haemodynamic instability [dsyn]     3.91824
Brachial Plexus [bpoc]     3.91824
Methodist [idcn]     3.91824
imaging brain [diap]     3.91824
Grade 2 Diarrhea [fndg]     3.91824
Sampling Design [inpr]     3.91824
Maximum Likelihood Estimation [resa]     3.91824
cells movement [celf]     3.91824
2M [qnco]     3.91824
Biomonitoring [ocac]     3.91824
assisted ventilation [topp]     3.91824
Liver scan [diap]     3.91824
Counterbalance [mnob]     3.91824
Steroid hormone level [lbpr]     3.91824
gastro [bpoc]     3.91824
BSC [gngm]     3.91824
Estrogen Replacement [topp]     3.91824
Citrobacter species [bact]     3.91824
G5 [gngm]     3.91824
Hepatojejunostomy [topp]     3.91824
Thick Smear Technique [lbpr]     3.91824
Infection Control [hlca]     3.91824
Peganum harmala [plnt]     3.91824
damaged DNA binding [genf]     3.91824
APOBEC3F [gngm]     3.91824
Hemolysis [patf]     3.91824
Systemic vascular Resistance [clna]     3.91824
Subfulminant hepatic failure [dsyn]     3.91824
fluid accumulation [ftcn]     3.91824
Blood vessel tumour [neop]     3.91824
Vasoconstrictor [phsu]     3.91824
Trout [fish]     3.91824
Decreased reticulin [anab]     3.91824
Catastrophic Illness [dsyn]     3.91824
receptor function [moft]     3.91824
Herpes Simplex Virus [virs]     3.91824
Processed meat intake [fndg]     3.91824
Thyroid carcinoma [neop]     3.91824
Anti-Phospholipid Syndrome [dsyn]     3.91824
Resonance [fndg]     3.91824
HEPATITIS B VIRUS X-ASSOCIATED PROTEIN [gngm]     3.91824
Rapid infusion device [medd]     3.91824
RETINOL-BINDING PROTEIN 4 [gngm]     3.91824
Congenital cystic dilatation [cgab]     3.91824
Cytologic test [lbpr]     3.91824
Sulfur Hexafluoride [inch]     3.91824
Endogenous endophthalmitis [dsyn]     3.91824
Submission [ftcn]     3.91824
gastrointestinal surgeries [topp]     3.91824
Vitamin supplementation [phsu]     3.91824
EEC [orgt]     3.91824
HEPATOBILIARY/PANCREAS [fndg]     3.91824
ras gene family [gngm]     3.91824
NS2 [dsyn]     3.91824
Probiotics [bact]     3.91824
TCEAL7 [gngm]     3.91824
Phenotype [lbpr]     3.91824
abdominal tumors [neop]     3.91824
TLC [clna]     3.91824
NEIL1 gene [gngm]     3.91824
Colonic Neoplasm [neop]     3.91824
Pulmonary haemorrhage [patf]     3.91824
DNAH1 [gngm]     3.91824
Cardiac index [fndg]     3.91824
Behavioral Risk Factor Surveillance System [hlca]     3.91824
home address [inpr]     3.91824
p17 [gngm]     3.91824
Metabolic bone disease [dsyn]     3.91824
Unhappy [fndg]     3.91824
terbinafine 250 MG [clnd]     3.91824
host-pathogen interaction [orgf]     3.91824
Adult Stem Cells [cell]     3.91824
Histological grading systems [inpr]     3.91824
TIE2 [gngm]     3.91824
SPIO [phob]     3.91824
Secondary thrombocytosis [dsyn]     3.91824
Specialized surgeon [prog]     3.91824
Human leukocyte antigen class II [imft]     3.91824
weight train [dora]     3.91824
PPP3CA [gngm]     3.91824
6p21.3 [celc]     3.91824
Abnormal behavior [mobd]     3.91824
SPATA20 [gngm]     3.91824
Eyelash [bpoc]     3.91824
blood drugs [phsu]     3.91824
Observed Survival [qnco]     3.91824
Diabetic Foot [dsyn]     3.91824
Varicella-Zoster Virus [virs]     3.91824
4+ Score [fndg]     3.91824
Acute inflammatory reaction [fndg]     3.91824
Tumor Grading System [clas]     3.91824
Genes, Onco-Suppressor [gngm]     3.91824
Orbital Tumor [neop]     3.91824
Ischaemic necrosis [patf]     3.91824
T category [clas]     3.91824
Intestinal lymphoma [neop]     3.91824
HHV 8 [neop]     3.91824
ECHS1 [gngm]     3.91824
2D-DIGE [lbpr]     3.91824
Mice, C3H [mamm]     3.91824
Esophageal epithelium [bpoc]     3.91824
Intranodal [ftcn]     3.91824
Stage IIIA Hepatocellular Carcinoma [neop]     3.91824
Clostridium cocleatum [bact]     3.91824
Epithelial Differentiation [fndg]     3.91824
SLIT3 [gngm]     3.91824
Transrectal [spco]     3.91824
Resource Allocation [qnco]     3.91824
Renal Tubular Epithelial Cells [lbpr]     3.91824
Armpit [blor]     3.91824
Extramedullary Plasmacytoma [neop]     3.91824
Terminal Disease [dsyn]     3.91824
DNA Recombination [genf]     3.91824
Translational Medical Research [resa]     3.91824
chest findings [fndg]     3.91824
Consequence of [ftcn]     3.91824
Gene Circuit [moft]     3.91824
cryptosporidium [clna]     3.91824
Intravenous Hyperalimentation [topp]     3.91824
Low muscle mass [fndg]     3.91824
time year [qnco]     3.91824
Ovarian mass [fndg]     3.91824
Dopaminergic Neurons [cell]     3.91824
Pill [phsu]     3.91824
CADM2 [gngm]     3.91824
Inuit population [popg]     3.91824
Arteriosclerotic vascular disease [dsyn]     3.91824
Atomic Absorption Spectroscopy [lbpr]     3.91824
Polyomavirus, JC [virs]     3.91824
Hedgehog Pathway Inhibitor [phsu]     3.91824
Distantly [spco]     3.91824
Progressive neurodegeneration [fndg]     3.91824
CD66b [gngm]     3.91824
Capacity Building [hlca]     3.91824
Sartans [phsu]     3.91824
Rectovesical [spco]     3.91824
zoledronic acid [phsu]     3.91824
Ascending colon [bpoc]     3.91824
abnormal semen [fndg]     3.91824
Class 6 [inpr]     3.91824
GSD1A [dsyn]     3.91824
PLEXIN B2 [gngm]     3.91824
MBOAT7 [gngm]     3.91824
Epileptic [dsyn]     3.91824
Nausea and vomiting [sosy]     3.91824
height decrease [fndg]     3.91824
Domestic Animal [anim]     3.91824
Familial haemophagocytic lymphohistiocytosis [patf]     3.91824
Gene, c-myc [gngm]     3.91824
injection air [topp]     3.91824
cells/uL [qnco]     3.91824
Analyses, Actuarial [ocac]     3.91824
Autoimmune Thyroiditis [dsyn]     3.91824
Surgical Incision [topp]     3.91824
Cerebral Palsy [dsyn]     3.91824
Antigen level [lbpr]     3.91824
Diverticula [patf]     3.91824
Biopsy needle [medd]     3.91824
electrolyte abnormality [fndg]     3.91824
Parvoviruses [virs]     3.91824
African race [popg]     3.91824
Phase I Clinical Trials [resa]     3.91824
kidney injury [inpo]     3.91824
Cannula [medd]     3.91824
Viet Nam War [acty]     3.91824
Fatty acid level [lbpr]     3.91824
PA28-GAMMA [gngm]     3.91824
Congruent [qlco]     3.91824
belgian [popg]     3.91824
p85 [gngm]     3.91824
Mixed portal cirrhosis [dsyn]     3.91824
brain function [ortf]     3.91824
Outlier [qnco]     3.91824
BV8 [gngm]     3.91824
Umbilical hernia [anab]     3.91824
Parasitosis [dsyn]     3.91824
prevention trials [resa]     3.91824
Seq [nusq]     3.91824
Abetalipoproteinaemia [dsyn]     3.91824
Ammonium [inch]     3.91824
Perirenal fat [bpoc]     3.91824
Physical sign [fndg]     3.91824
enhancer binding [genf]     3.91824
Astrocyte [blor]     3.91824
Measurement method [ftcn]     3.91824
DNA stability [diap]     3.91824
Indirect Enzyme Assay [lbpr]     3.91824
parent education [edac]     3.91824
Is gene [gngm]     3.91824
Lens cortex [bpoc]     3.91824
Petri dish [medd]     3.91824
Radiation Dosimetry [lbpr]     3.91824
Venous Pressures, Central [clna]     3.91824
furospinosulin-1 [orch]     3.91824
Poor education [fndg]     3.91824
CTX [gngm]     3.91824
MMOLE [qnco]     3.91824
Winter flounder [fish]     3.91824
IR [nusq]     3.91824
Infected pancreatic pseudocyst [dsyn]     3.91824
Baculovirus [virs]     3.91824
colorectal surgeons [bmod]     3.91824
shelves [medd]     3.91824
hydroxyl group [inch]     3.91824
Uraemia [dsyn]     3.91824
AC133 [gngm]     3.91824
Knowledge Management [ocac]     3.91824
Dehiscence [fndg]     3.91824
Hyperpyrexia [patf]     3.91824
End-to-end anastomosis [topp]     3.91824
Common Terminology Criteria for Adverse Events [inpr]     3.91824
Drug Overdose [inpo]     3.91824
Homeless persons [popg]     3.91824
microtubule dynamics [celf]     3.91824
developmental disorders [mobd]     3.91824
French Franc [qnco]     3.91824
ATP synthesis [moft]     3.91824
Statistical Distributions [qnco]     3.91824
colonic biopsy [diap]     3.91824
Granulocytic Sarcoma [neop]     3.91824
severe reaction [qlco]     3.91824
Lymph Node Cancer [neop]     3.91824
pancreas disease [dsyn]     3.91824
New medications [phsu]     3.91824
Meningeal [dsyn]     3.91824
carrots [plnt]     3.91824
Fluorescence Polarization Immunoassay [lbpr]     3.91824
Thrombocytoses [dsyn]     3.91824
Stage IVB Intrahepatic Cholangiocarcinoma [neop]     3.91824
clinical guide [inpr]     3.91824
animal subjects [anim]     3.91824
Oncogene Activation [comd]     3.91824
SEL1L [gngm]     3.91824
Divorced Status [fndg]     3.91824
Pathologic TNM stage [clna]     3.91824
Lymphatic Spread [fndg]     3.91824
Radiation Oncology [bmod]     3.91824
Surgical Anastomoses [topp]     3.91824
IFNL4 [gngm]     3.91824
Lymph [bdsu]     3.91824
Working Memory [menp]     3.91824
excepting [ftcn]     3.91824
screening intervention [resa]     3.91824
Port [mnob]     3.91824
TLN1 [gngm]     3.91824
Reference Number [inpr]     3.91824
Intraoperative haemorrhage [patf]     3.91824
Normal blood flow [fndg]     3.91824
Patient disposition [hlca]     3.91824
PTBD [orch]     3.91824
Gallbladder Dysplasia [neop]     3.91824
Congenital absence [cgab]     3.91824
Ishak Score 5 [clas]     3.91824
hamilton depression rating scale [inpr]     3.91824
Vacuolated [celc]     3.91824
Caloric Intake [qnco]     3.91824
Cyclin-Dependent Kinase Inhibitor Gene [gngm]     3.91824
Summary Report [inpr]     3.91824
Wistaria [plnt]     3.91824
Suppressor of Cytokine Signaling 1 Gene [gngm]     3.91824
ITGA1 [gngm]     3.91824
purification [ftcn]     3.91824
linkage analysis [lbpr]     3.91824
intestinal adenocarcinoma [neop]     3.91824
SLC2A2 [gngm]     3.91824
Proband [famg]     3.91824
autologous transfusion [topp]     3.91824
Cotton Fiber [sbst]     3.91824
colorectal cancer screening [topp]     3.91824
Influenza [dsyn]     3.91824
Ventilated [medd]     3.91824
independent study [edac]     3.91824
Practice Experience [menp]     3.91824
lactate dehydrogenase activity [moft]     3.91824
Femurs [bpoc]     3.91824
miniaturize [qlco]     3.91824
CLOCK gene [gngm]     3.91824
Lys-Lys [orch]     3.91824
pg/g [qnco]     3.91824
Human, Adult [aggp]     3.91824
biliary pain [dsyn]     3.91824
Leaves [plnt]     3.91824
Well-being [idcn]     3.91824
Microbleeds [fndg]     3.91824
Hiccups [fndg]     3.91824
Multiple emboli [patf]     3.91824
Hepatosplenomegaly [sosy]     3.91824
Viral gene [gngm]     3.91824
Perinatal Care [hlca]     3.91824
Ribonucleic Acid [nnon]     3.91824
Health belief [fndg]     3.91824
Rat Strains [mamm]     3.91824
SEN virus [virs]     3.91824
Onychomycosis [dsyn]     3.91824
VI [topp]     3.91824
EMERGENCY SERVICES [hlca]     3.91824
Pomeranian [mamm]     3.91824
GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 [gngm]     3.91824
Pancreatic metastasis [neop]     3.91824
Glucose Metabolism Disorders [dsyn]     3.91824
Group 2C [inpr]     3.91824
Clinical function [qlco]     3.91824
animal food [food]     3.91824
Spring [tmco]     3.91824
Duke [lbpr]     3.91824
Acquired Image [inpr]     3.91824
Elective caesarean section [topp]     3.91824
E2F TRANSCRIPTION FACTOR 1 [gngm]     3.91824
FVB/N [mamm]     3.91824
Biliary sclerosis [dsyn]     3.91824
Profiles, Metabolic [npop]     3.91824
DAPP1 [gngm]     3.91824
Crypt [bpoc]     3.91824
Environmental Health [bmod]     3.91824
Traverse [cnce]     3.91824
impregnation [orgf]     3.91824
Tracheal [spco]     3.91824
NGF [gngm]     3.91824
T7 vertebra [bpoc]     3.91824
Readability [qlco]     3.91824
Western Immunoblot [lbpr]     3.91824
mental [menp]     3.91824
Tension [mobd]     3.91824
Molecular Genetic Pathology [inpr]     3.91824
ABI [plnt]     3.91824
Carboxyl [npop]     3.91824
Epidural haematoma [inpo]     3.91824
g ratio [lbpr]     3.91824
NS5 protein, hepatitis C virus [aapp]     3.91824
SLC [gngm]     3.91824
ZNF827 [gngm]     3.91824
EIN [neop]     3.91824
histopathologists [prog]     3.91824
Tonsil Cancer [neop]     3.91824
liver bile duct [bpoc]     3.91824
violent [mobd]     3.91824
Clonality Analysis [mbrt]     3.91824
Acute appendicitis [dsyn]     3.91824
EAC [neop]     3.91824
DNA Construct [nnon]     3.91824
Orthopaedic department [hcro]     3.91824
Urgency [tmco]     3.91824
Examination Method [diap]     3.91824
animal data [inpr]     3.91824
Pond water [sbst]     3.91824
Calcinosis cutis [dsyn]     3.91824
SLK [gngm]     3.91824
Dietary Nitrosamine [chvs]     3.91824
HNSCC [neop]     3.91824
Activated Protein C Resistance [dsyn]     3.91824
glycation [phpr]     3.91824
cellular lipid metabolism [celf]     3.91824
After Surgery [fndg]     3.91824
SH2 Domain [amas]     3.91824
Trust [inbe]     3.91824
Chir99021 [orch]     3.91824
General surgeon [prog]     3.91824
GPD1 [gngm]     3.91824
Perianal [blor]     3.91824
Asynchronous [tmco]     3.91824
ANKRD11 [gngm]     3.91824
ADAMTS13 [gngm]     3.91824
biliary pancreatitis [dsyn]     3.91824
ELOVL2 [gngm]     3.91824
T-Cell Subsets [cell]     3.91824
Strongyloides stercoralis [euka]     3.91824
Anatomy aspects [qlco]     3.91824
OB [gngm]     3.91824
APOBEC3G [gngm]     3.91824
clinical resistance [neop]     3.91824
hepatitis symptoms [dsyn]     3.91824
Generalised [spco]     3.91824
Myocardial fibrosis [patf]     3.91824
Ultrasonography, Endoscopic [diap]     3.91824
gene delivery [genf]     3.91824
G9A [gngm]     3.91824
Cobalt [elii]     3.91824
Hospital Units [hcro]     3.91824
xanthine oxidoreductase activity [moft]     3.91824
lung nodules [fndg]     3.91824
Vital staining [lbpr]     3.91824
Hypotension [phsu]     3.91824
foster [famg]     3.91824
PET protocol [topp]     3.91824
Ultrasound control [diap]     3.91824
I-11 [orch]     3.91824
Hepatitis C Virus NS3/4A Protease Inhibitors [moft]     3.91824
11q [nusq]     3.91824
Main presenting symptom [sosy]     3.91824
Left hepatic trisegmentectomy [topp]     3.91824
Host Range [npop]     3.91824
Cytologic atypia [comd]     3.91824
Tuna [fish]     3.91824
Neoplasms, Intraepithelial [neop]     3.91824
Labor Complications [dsyn]     3.91824
MLPA [inpr]     3.91824
general screening [topp]     3.91824
Immune deficiency [dsyn]     3.91824
Lemur [mamm]     3.91824
iv set [medd]     3.91824
Cisplatin Dose [clna]     3.91824
Renal Artery Stenosis [dsyn]     3.91824
Shotgun Sequencing [mbrt]     3.91824
Information Technology [ocdi]     3.91824
Post-dose [tmco]     3.91824
TGR5 [gngm]     3.91824
Yupik Eskimo [popg]     3.91824
Animal Experimentation [resa]     3.91824
XHIM [dsyn]     3.91824
day week [tmco]     3.91824
Candida Esophagitis [dsyn]     3.91824
Primed In Situ Labeling [mbrt]     3.91824
Sterile [qlco]     3.91824
Whole Body Scan [diap]     3.91824
Over the counter medications [clna]     3.91824
DNA demethylation [genf]     3.91824
Systems, Cardiovascular [bdsy]     3.91824
Birth Certificates [inpr]     3.91824
hollow viscera [bpoc]     3.91824
D.P. [inpr]     3.91824
Intrathoracic Lymph Node [bpoc]     3.91824
Epsilon [inpr]     3.91824
Drug Carrier [bodm]     3.91824
Vision loss [dsyn]     3.91824
transmethylation [phpr]     3.91824
Dose Frequency [ftcn]     3.91824
raw vegetables [food]     3.91824
Acute leukaemia [neop]     3.91824
cisplatin/doxorubicin/fluorouracil [topp]     3.91824
TRP3 [gngm]     3.91824
T3a Stage [fndg]     3.91824
health review [hlca]     3.91824
jury [grup]     3.91824
cytotoxic drugs [phsu]     3.91824
perilipin 1 [aapp]     3.91824
Mesenteric venous thrombosis [dsyn]     3.91824
collagen degradation [moft]     3.91824
Transfusion hepatitis [dsyn]     3.91824
Virus Entry [biof]     3.91824
Pulmonary Atelectasis [patf]     3.91824
COIL gene [gngm]     3.91824
packed red blood cell transfusion [topp]     3.91824
High-Intensity Focused Ultrasound Ablation [topp]     3.91824
Steatorrhea [dsyn]     3.91824
Larynx Tumor [neop]     3.91824
recto [spco]     3.91824
Abdominal angiography [diap]     3.91824
Alaria [euka]     3.91824
Cow [mamm]     3.91824
c d [topp]     3.91824
Postoperative biliary stricture [dsyn]     3.91824
Velocity-time integral [orga]     3.91824
Extended spectrum beta-lactamase producing Escherichia coli [bact]     3.91824
official registry [inpr]     3.91824
Double-Blind Study [resa]     3.91824
Group, Focus [grup]     3.91824
Lactobacillus [bact]     3.91824
Affected animal [ftcn]     3.91824
TAB3 [gngm]     3.91824
Paragonimiasis [dsyn]     3.91824
contralateral breast cancer [neop]     3.91824
HAF [gngm]     3.91824
Recurrent acute pancreatitis [dsyn]     3.91824
prism [inpr]     3.91824
Atypical lymphocytes [cell]     3.91824
prostate development [ortf]     3.91824
JMJD1C [gngm]     3.91824
Personality Traits [fndg]     3.91824
Therapies, Carbon Ion [topp]     3.91824
Taxes [qnco]     3.91824
Gelatin Sponge, Absorbable [medd]     3.91824
Mozambique [geoa]     3.91824
Pneumatosis [patf]     3.91824
Multifocal hyperplasia [patf]     3.91824
NOAEL [diap]     3.91824
guanidine [orch]     3.91824
litre [qnco]     3.91824
lesion destruction [topp]     3.91824
Mexicano [popg]     3.91824
Yorkshire terrier [mamm]     3.91824
HEAT-SHOCK TRANSCRIPTION FACTOR 1 [gngm]     3.91824
Bath [topp]     3.91824
GNPAT [gngm]     3.91824
Intermediate Grade [clas]     3.91824
Decubitus Ulcer [dsyn]     3.91824
Chimera [orgm]     3.91824
Risk Management [hlca]     3.91824
severe moderate [qlco]     3.91824
APPL [plnt]     3.91824
Toxic Epidermal Necrolysis [dsyn]     3.91824
Chemotherapy treatment Cancer [clna]     3.91824
zinc ion homeostasis [orgf]     3.91824
Reintubation [topp]     3.91824
phosphate level [lbtr]     3.91824
Tomography, Optical Coherence [diap]     3.91824
delta Cells [cell]     3.91824
intrapulmonary shunting [fndg]     3.91824
Trif [gngm]     3.91824
Funnel shape [spco]     3.91824
Ionization [phpr]     3.91824
PEComa [neop]     3.91824
Ej [imft]     3.91824
Metabolic Marker [bacs]     3.91824
Eyelids [bpoc]     3.91824
Hind limb [bpoc]     3.91824
Stage IA [clas]     3.91824
Cardiopulmonary Arrest [patf]     3.91824
patient register [ftcn]     3.91824
spike fever [fndg]     3.91824
Body Weight Gain [fndg]     3.91824
CDH1 gene [gngm]     3.91824
methionine metabolism [moft]     3.91824
Nonspecific abdominal pain [sosy]     3.91824
MDS [neop]     3.91824
CHRNA3 [gngm]     3.91824
Group 2A [inpr]     3.91824
Health Expenditure [qnco]     3.91824
hla type [lbpr]     3.91824
Insertion site [spco]     3.91824
Suborder [clas]     3.91824
complimentary [qnco]     3.91824
Group Practice [hcro]     3.91824
Angulated [spco]     3.91824
SNA [gngm]     3.91824
Duodenal Adenocarcinoma [neop]     3.91824
Hepatic Fibrosarcoma [neop]     3.91824
Experimental Finding [fndg]     3.91824
Technique, Elasticity Imaging [diap]     3.91824
Breast Cancer Risk Factor [qlco]     3.91824
Transpapillary [spco]     3.91824
Oligopeptides [aapp]     3.91824
NZ [geoa]     3.91824
DIRT [bpoc]     3.91824
OATP8 [gngm]     3.91824
Drug toxicity [inpo]     3.91824
der [comd]     3.91824
Preventive surgery [topp]     3.91824
Adipogenesis [moft]     3.91824
CALC [gngm]     3.91824
Pain level [fndg]     3.91824
Diffuse dysplasia [comd]     3.91824
Veterinarian [prog]     3.91824
MALAT1 [gngm]     3.91824
Serum Calcium Level [lbtr]     3.91824
cribriform [qlco]     3.91824
Statistical Reliability [resa]     3.91824
Oral Contraceptives, Low-Dose [phsu]     3.91824
Finns [popg]     3.91824
middle ear [bsoj]     3.91824
Analysis method [lbpr]     3.91824
SSP [neop]     3.91824
Granular cell tumor [neop]     3.91824
Patent ductus arteriosus [cgab]     3.91824
American Society of Anesthesiologists physical status classification [inpr]     3.91824
Deep Lesion [fndg]     3.91824
Diastolic dysfunction [patf]     3.91824
H19 [gngm]     3.91824
Prothrombin G20210A mutation [dsyn]     3.91824
prothrombin test [lbpr]     3.91824
Childhood obesity [dsyn]     3.91824
cost lives [qnco]     3.91824
Increased sister chromatid exchange [fndg]     3.91824
yd [qnco]     3.91824
Tumors, Malignant Mixed [neop]     3.91824
FLRG [gngm]     3.91824
Surgical Procedures, Laparoscopic [topp]     3.91824
HISTONE DEACETYLASE 1 [gngm]     3.91824
Fetal haemorrhage [dsyn]     3.91824
Beam angle [spco]     3.91824
Interferon Regulatory Factor 1 Gene [gngm]     3.91824
In between [spco]     3.91824
GLUTATHIONE S-TRANSFERASE A3 [gngm]     3.91824
testicular yolk sac tumor [neop]     3.91824
cholesterol lowering drugs [phsu]     3.91824
sievert [qnco]     3.91824
YAP1 [gngm]     3.91824
Safety-net Clinics [hcro]     3.91824
MEIA [lbpr]     3.91824
Balantidium [euka]     3.91824
blades [medd]     3.91824
bDNA Assay [mbrt]     3.91824
surgical shunt [medd]     3.91824
16s [bpoc]     3.91824
BIS [tmco]     3.91824
pediatric surgeons [prog]     3.91824
Morphometry, quantitative [lbpr]     3.91824
relieve [qlco]     3.91824
Collagenolysis [patf]     3.91824
anthropometric measurements [clna]     3.91824
Chronic proliferative inflammation [patf]     3.91824
PON1 [gngm]     3.91824
Dense fibrous connective tissue [tisu]     3.91824
Biliary adenoma [neop]     3.91824
Cliff [spco]     3.91824
Perivascular Tumor [neop]     3.91824
Firm mass [anab]     3.91824
Autotransplantation [topp]     3.91824
S4+ [elii]     3.91824
millilitre [qnco]     3.91824
Reverse passive haemagglutination [lbpr]     3.91824
underactive [fndg]     3.91824
Cu,Zn-SOD [moft]     3.91824
Membranous Obstruction of Inferior Vena Cava [patf]     3.91824
Survivorship [acty]     3.91824
MTRR gene [gngm]     3.91824
Macaca fascicularis [mamm]     3.91824
Primary Liver Lymphoma [neop]     3.91824
noncompliance medication [fndg]     3.91824
Kea [bird]     3.91824
Diagnostic Quality [qlco]     3.91824
Corridor [mnob]     3.91824
sensibility [qlco]     3.91824
glycogen metabolism [moft]     3.91824
Extracellular Domain [spco]     3.91824
education resources [hlca]     3.91824
Known present [qlco]     3.91824
Autoimmune haemolytic anaemia [dsyn]     3.91824
Ankylosing spondylitis [dsyn]     3.91824
Common duct exploration [diap]     3.91824
18s [bpoc]     3.91824
Multiplanar reconstruction [topp]     3.91824
Nutraceutical [food]     3.91824
Organ Survival [ortf]     3.91824
HO [gngm]     3.91824
Microfluidic [ocdi]     3.91824
Acute urinary retention [sosy]     3.91824
Poor communication [fndg]     3.91824
genetic technology [mbrt]     3.91824
bca [gngm]     3.91824
HUMBUG [gngm]     3.91824
Childhood Acute Lymphoid Leukemia [neop]     3.91824
FADS2 [gngm]     3.91824
TIM3 [gngm]     3.91824
Mrs. [cnce]     3.91824
anemia hemoglobin [dsyn]     3.91824
Chemical Analyses, Blood [lbpr]     3.91824
Technician, Pathology [prog]     3.91824
Ghana [geoa]     3.91824
Tanzania [geoa]     3.91824
Recipient, Transplant [podg]     3.91824
Sequela [fndg]     3.91824
Pediatric Lesion [fndg]     3.91824
Arteriovenous Malformations [cgab]     3.91824
Receptor Activation [celf]     3.91824
Heavy Ion Therapy [topp]     3.91824
TW [geoa]     3.91824
Interval cancer [fndg]     3.91824
Orthohepadnaviruses [virs]     3.91824
Nurses [orgf]     3.91824
hsa-mir-141 [gngm]     3.91824
Knees [bpoc]     3.91824
U/mg protein [qnco]     3.91824
clinical information system [inpr]     3.91824
wife [famg]     3.91824
SH2 domain containing 4A [gngm]     3.91824
SPC24 [gngm]     3.91824
Net Survival [qnco]     3.91824
Glucose Clamp [resd]     3.91824
Fat cell [cell]     3.91824
Responsible to [fndg]     3.91824
heat exchanger [medd]     3.91824
cm/sec [qnco]     3.91824
AFG2 [gngm]     3.91824
Clinical sepsis [dsyn]     3.91824
Fourth thoracic vertebra [bpoc]     3.91824
Time 2 [fndg]     3.91824
Urine protein NOS [lbpr]     3.91824
Signet ring carcinoma [neop]     3.91824
Catostomus commersonii [fish]     3.91824
Far east country [geoa]     3.91824
Greater saphenous vein [bpoc]     3.91824
green yellow [clas]     3.91824
Type 6 [inpr]     3.91824
Models, Molecular [inpr]     3.91824
Gastroenteritis [dsyn]     3.91824
Hypoplastic spleen [fndg]     3.91824
G cell [cell]     3.91824
IUGR [patf]     3.91824
Monitoring, Immune [hlca]     3.91824
PESKY [gngm]     3.91824
PROC [gngm]     3.91824
Molecular Virology [bmod]     3.91824
Junctional Region [blor]     3.91824
Pancreatic necrosectomy [topp]     3.91824
SFTA2 gene [gngm]     3.91824
Unresectable Malignant Tumor [neop]     3.91824
Gerbils [mamm]     3.91824
Toll-Like Receptor 4 Gene [gngm]     3.91824
Obstructions, Duodenal [dsyn]     3.91824
tyrosine-tubulin [aapp]     3.91824
Stage III Hepatocellular Carcinoma [neop]     3.91824
Peripheral Nerves [bpoc]     3.91824
Radiation-Induced Cancer [neop]     3.91824
intracavitary [spco]     3.91824
Photosynthesis [npop]     3.91824
Micrographia [fndg]     3.91824
Lipid lowering drug [phsu]     3.91824
reorganization [idcn]     3.91824
peroxidation [inch]     3.91824
Chronic constipation [sosy]     3.91824
Vacuolar [celc]     3.91824
Perisplenic space [bsoj]     3.91824
radiolabel [irda]     3.91824
infection prevention [topp]     3.91824
Colorectal High-Grade Dysplasia [neop]     3.91824
endothelial dysfunction [dsyn]     3.91824
Endometriosis [dsyn]     3.91824
IFN-Lambda-2 [aapp]     3.91824
Immunodiagnosis [lbpr]     3.91824
Hepatitis C virus subtype 4e [virs]     3.91824
Cell structure [celc]     3.91824
Level 4 [qlco]     3.91824
Subacute necrosis [patf]     3.91824
Data Files [inpr]     3.91824
17-KDa protein [gngm]     3.91824
Graduate [popg]     3.91824
Deconvolution [mcha]     3.91824
serum studies [bmod]     3.91824
Phagocytosis [celf]     3.91824
schooling [edac]     3.91824
ITO [gngm]     3.91824
Renal function test [lbpr]     3.91824
Academia [orgt]     3.91824
Body Weight Changes [fndg]     3.91824
Glucuronidation [carb]     3.91824
secreted frizzled related protein-1 [aapp]     3.91824
Rich food [food]     3.91824
APACHE II [qnco]     3.91824
Partial thickness [qnco]     3.91824
Metaphase [celf]     3.91824
Breakthrough Bleeding [patf]     3.91824
Cardiology [bmod]     3.91824
Assemble [prog]     3.91824
Decreased protein C [fndg]     3.91824
pregnant patient [fndg]     3.91824
fibrinogen alpha chain [celc]     3.91824
Shih Tzu [mamm]     3.91824
Extracellular Communication [celf]     3.91824
Uterine carcinoma [neop]     3.91824
tyrosine autophosphorylation [moft]     3.91824
development aspects [phsf]     3.91824
Deleted in Liver Cancer 1 Gene [gngm]     3.91824
helicobacter bacteria [bact]     3.91824
lyse [patf]     3.91824
vein obstruction [patf]     3.91824
DNA end binding [genf]     3.91824
Pigment deposition [phsf]     3.91824
Therapeutic Radiology [bmod]     3.91824
Contrast-Enhanced Spiral CT [diap]     3.91824
positive tuberculin test [lbtr]     3.91824
Female reproductive function [orgf]     3.91824
Carcinoma, Endometrioid [neop]     3.91824
Pain Index [inpr]     3.91824
phosphor [chvf]     3.91824
miRNA146A [gngm]     3.91824
X-ray [diap]     3.91824
normal placenta [fndg]     3.91824
LOXL2 [gngm]     3.91824
Portal shunt [topp]     3.91824
sensation seeking [inbe]     3.91824
Disseminated tuberculosis [dsyn]     3.91824
family system [famg]     3.91824
ELL [gngm]     3.91824
Corynebacterium urealyticum [bact]     3.91824
TULP1 [gngm]     3.91824
Stromal Sarcomas, Endometrial [neop]     3.91824
Adrenal Cortex [bpoc]     3.91824
crosslinking [npop]     3.91824
IgG4-Related Sclerosing Disease [dsyn]     3.91824
Carbon Ion Therapy [topp]     3.91824
MATRIX METALLOPROTEINASE 21 [gngm]     3.91824
dietary constituent [sbst]     3.91824
Rates, Glomerular Filtration [diap]     3.91824
decaffeinated coffee [food]     3.91824
Peripheral edema [fndg]     3.91824
TNM category [clas]     3.91824
Pancreatography [diap]     3.91824
Tomography, Volume Computed [diap]     3.91824
Not Otherwise Specified [qlco]     3.91824
osmotic [npop]     3.91824
ERRFI1 [gngm]     3.91824
Desmoid-Type Fibromatosis [neop]     3.91824
Caregivers [prog]     3.91824
incurable disease [dsyn]     3.91824
DNA ploidy analysis [diap]     3.91824
abnormal platelet count [fndg]     3.91824
russian [lang]     3.91824
Immune Reconstitution Inflammatory Syndrome [dsyn]     3.91824
Haematopoietic factor [horm]     3.91824
Vena Cava, Superior [bpoc]     3.91824
OSTEONECROSIS OF FEMORAL HEAD [patf]     3.91824
Donations, Blood [hlca]     3.91824
bursal [spco]     3.91824
Black lemur [mamm]     3.91824
natural killer cell therapy [topp]     3.91824
SLC22A7 gene [gngm]     3.91824
Cultured Cell Line [cell]     3.91824
SRY [gngm]     3.91824
Genetic Loci [gngm]     3.91824
Natural Orifice Transluminal Endoscopic Surgery [topp]     3.91824
Alcohol Toxicity [inpo]     3.91824
Antacids [phsu]     3.91824
Fife [geoa]     3.91824
Desert [geoa]     3.91824
Extracellular material [bdsu]     3.91824
Public Facility [mnob]     3.91824
medical models [inpr]     3.91824
Water sample [inch]     3.91824
Tree Shrew [mamm]     3.91824
Castration [topp]     3.91824
persian [popg]     3.91824
Viral Genetics [bmod]     3.91824
Conscious [menp]     3.91824
Age Factors [tmco]     3.91824
Lingual [bpoc]     3.91824
WT [gngm]     3.91824
southern blot analysis [lbtr]     3.91824
Myocarditis [dsyn]     3.91824
Cholemic nephrosis [dsyn]     3.91824
Histone Acetylation [moft]     3.91824
Cebu [geoa]     3.91824
Paraplegia [dsyn]     3.91824
Polycythaemia vera [neop]     3.91824
Arterial site [spco]     3.91824
RAP [gngm]     3.91824
SSP411 [gngm]     3.91824
DNA Microarray Analysis [mbrt]     3.91824
Stop [mnob]     3.91824
Post-Procedural Pain [sosy]     3.91824
pregnancy hepatitis b [fndg]     3.91824
Total pancreaticoduodenectomy [topp]     3.91824
blood alcohol level [fndg]     3.91824
Human adenovirus [virs]     3.91824
cancer classification [inpr]     3.91824
Anesthetics [bmod]     3.91824
Antiemetic Agents [phsu]     3.91824
elderly infection [dsyn]     3.91824
Blind eye [dsyn]     3.91824
Fractal [cnce]     3.91824
Bronchopleural fistula [dsyn]     3.91824
Cancer Causing Agents [hops]     3.91824
rottlerin [orch]     3.91824
Computer Analysis [mcha]     3.91824
Genetic Structures [gngm]     3.91824
T1P [dsyn]     3.91824
MICRO RNA 217 [gngm]     3.91824
First pass [tmco]     3.91824
Cannulation [topp]     3.91824
Increased creatinine [fndg]     3.91824
Due Process [rnlw]     3.91824
Barricade [mnob]     3.91824
quad [phsu]     3.91824
Tangentiality [mobd]     3.91824
cGy [qnco]     3.91824
Cell phase [tmco]     3.91824
SIX1 gene [gngm]     3.91824
Celiac lymphadenopathy [patf]     3.91824
pre {event} [clna]     3.91824
Pharmaceutical [bmod]     3.91824
WAF1 [gngm]     3.91824
Q-Value [qlco]     3.91824
Friendly [qlco]     3.91824
primary growth [orgf]     3.91824
Cancer Family [famg]     3.91824
epithelium development [ortf]     3.91824
Suicide risk [fndg]     3.91824
Natural death [fndg]     3.91824
Individualized Medicine [topp]     3.91824
catalase activity [moft]     3.91824
Liver Kidney Microsomal Type 1 Antibody [lbpr]     3.91824
Exposed to [clna]     3.91824
Superior Mesenteric Arteries [bpoc]     3.91824
cmv infection [dsyn]     3.91824
Meningitis, Cryptococcal [dsyn]     3.91824
Lumbar nerve root [bpoc]     3.91824
Good Clinical Practice [inpr]     3.91824
Male Circumcision [topp]     3.91824
pregnant female [popg]     3.91824
Geometric Mean [qnco]     3.91824
Low absolute lymphocyte count [fndg]     3.91824
MAL gene [gngm]     3.91824
Unexpected Adverse Event [fndg]     3.91824
Electrocautery [topp]     3.91824
Penile Cancer [neop]     3.91824
South American country [geoa]     3.91824
Dose Adjustment [hlca]     3.91824
model design [inpr]     3.91824
Hematopoietic Tumor [neop]     3.91824
DNMT3B [gngm]     3.91824
Common Variable Immune Deficiency [dsyn]     3.91824
Ethics, Research [idcn]     3.91824
Physical performance [orga]     3.91824
pN1 [fndg]     3.91824
hepatocyte differentiation [celf]     3.91824
Extremities, Lower [blor]     3.91824
C. parvum [bact]     3.91824
Pulsatility index [clna]     3.91824
Malignant melanoma, metastatic [neop]     3.91824
teleost [fish]     3.91824
BACE [gngm]     3.91824
Polygamous [socb]     3.91824
Poison [hops]     3.91824
amino acid metabolism [moft]     3.91824
Unexplained abdominal pain [sosy]     3.91824
Document Status [qlco]     3.91824
MGMT gene [gngm]     3.91824
Hemihyperplasia [cgab]     3.91824
ICCA [gngm]     3.91824
SDHC [gngm]     3.91824
Schwannoma, Malignant [neop]     3.91824
Home Care [hlca]     3.91824
Grade 5 [inpr]     3.91824
Medicine, Traditional [bmod]     3.91824
Night sweats [sosy]     3.91824
Parental Age [grpa]     3.91824
neoplasm/cancer [neop]     3.91824
passivity [inbe]     3.91824
Nucleic Acid Hybridization [npop]     3.91824
Surgery, Gastrointestinal [topp]     3.91824
NECTIN 2 [gngm]     3.91824
Cord blood sample [bdsu]     3.91824
kidney tumors [neop]     3.91824
N-ACETYLTRANSFERASE 2 [gngm]     3.91824
human T cell leukemia virus [virs]     3.91824
ICD-O-2 [inpr]     3.91824
Diagnostic endoscopy [diap]     3.91824
Antigens, Bacterial [imft]     3.91824
Cell Therapy [topp]     3.91824
named [menp]     3.91824
metal stents [medd]     3.91824
Bacteroides acidifaciens [bact]     3.91824
Biometry [resa]     3.91824
Sialuria [dsyn]     3.91824
Urography [diap]     3.91824
testosterone level [lbtr]     3.91824
Lesion feature [clna]     3.91824
portrait [inpr]     3.91824
cell plate [celc]     3.91824
bloodstains [bdsu]     3.91824
Chinese Hamster [mamm]     3.91824
Health insurance coverage [fndg]     3.91824
Cutaneous Disorders [dsyn]     3.91824
Tumor stage T4 [fndg]     3.91824
Esophageal Epidermoid Carcinoma [neop]     3.91824
Nucleic acid analysis [lbpr]     3.91824
Fragrance [mnob]     3.91824
Pancreas Cyst [dsyn]     3.91824
Until [inpr]     3.91824
herpes viral infection [dsyn]     3.91824
MHC gene [gngm]     3.91824
Upstaging [diap]     3.91824
Acute graft-versus-host disease [dsyn]     3.91824
Tra1 [gngm]     3.91824
Normal pregnancy [fndg]     3.91824
Gallbladder zone [blor]     3.91824
human subjects [resa]     3.91824
Occupational Health Physicians [prog]     3.91824
ENOLASE, NEURON-SPECIFIC [gngm]     3.91824
Bone cell [cell]     3.91824
sleep disorder [sosy]     3.91824
vasculature development [ortf]     3.91824
cellular morphology [qlco]     3.91824
Canton [geoa]     3.91824
African iron overload [dsyn]     3.91824
SLC5A3 [gngm]     3.91824
Malignant Epithelial Cell [cell]     3.91824
Cervical intraepithelial neoplasia grade 1 [neop]     3.91824
Hepatobiliary Tissue [tisu]     3.91824
pmol/g [qnco]     3.91824
study drug [resa]     3.91824
RPB5-MEDIATING PROTEIN [gngm]     3.91824
Single-Stranded RNA [nnon]     3.91824
Abnormal hepatic function [patf]     3.91824
Chronic gastrointestinal bleeding [patf]     3.91824
Municipalities [geoa]     3.91824
Gastric cardia [blor]     3.91824
WD [dsyn]     3.91824
Papillitis [dsyn]     3.91824
Gastroesophageal Junction Adenocarcinoma [neop]     3.91824
lawsuits [rnlw]     3.91824
Statistical Estimation [qnco]     3.91824
Aldehyde [orch]     3.91824
Autologous graft [bodm]     3.91824
Iliopsoas muscle [bpoc]     3.91824
17q12 [celc]     3.91824
Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma [neop]     3.91824
Gastric Perforation [dsyn]     3.91824
Empty [acty]     3.91824
Pearson Product-moment Correlation Coefficient [qnco]     3.91824
Accentuated [qlco]     3.91824
AIDS patients [podg]     3.91824
Otolemur crassicaudatus [mamm]     3.91824
frightening [menp]     3.91824
Buccal [spco]     3.91824
Psammoma [neop]     3.91824
ULBP1 [gngm]     3.91824
Regulation, Drug [rnlw]     3.91824
Broccoli [plnt]     3.91824
KPS [diap]     3.91824
Paramedian [spco]     3.91824
Lice [euka]     3.91824
miRNA149 [gngm]     3.91824
Hereditary haemorrhagic telangiectasia [dsyn]     3.91824
Bile Duct Cysts [cgab]     3.91824
ATP5G1 [gngm]     3.91824
Scientific Method [resa]     3.91824
Hesitancy [sosy]     3.91824
Data Cutoff Date [tmco]     3.91824
CTG [medd]     3.91824
PST1 [gngm]     3.91824
EIF4EBP1 [gngm]     3.91824
sin [idcn]     3.91824
Multinodular Mass [fndg]     3.91824
Aqueous [qlco]     3.91824
medical malpractice [qlco]     3.91824
Circumferential [spco]     3.91824
Circumference [qnco]     3.91824
Genomic Biomarker [irda]     3.91824
Disease, Asymptomatic [dsyn]     3.91824
De novo mutation [comd]     3.91824
adiponutrin [aapp]     3.91824
Hydramnios [patf]     3.91824
Teratomas, Immature [neop]     3.91824
bronchogenic cancer [neop]     3.91824
Blood Chemistry Study [lbpr]     3.91824
Isotope [elii]     3.91824
Group T [edac]     3.91824
Thyrotoxicosis [dsyn]     3.91824
Sequences, Consensus [nusq]     3.91824
10^8/mL [qnco]     3.91824
increased glucose [fndg]     3.91824
Rationalization [menp]     3.91824
Exposed Group [popg]     3.91824
Antimalarials [phsu]     3.91824
Vascular surgery [topp]     3.91824
HULC [gngm]     3.91824
Blood glucose concentration [fndg]     3.91824
AMP-activated protein kinase activity [moft]     3.91824
drug effects [ftcn]     3.91824
Red meat intake [fndg]     3.91824
Abated [acty]     3.91824
hMRE11B [gngm]     3.91824
50mm [qnco]     3.91824
Donor artery [spco]     3.91824
medaka [fish]     3.91824
Positive [topp]     3.91824
Subtotal gastrectomy [topp]     3.91824
Intentional injury [inpo]     3.91824
Sarcoma, metastatic [neop]     3.91824
CCL [dsyn]     3.91824
care planning [inpr]     3.91824
Chromosome 12 [celc]     3.91824
MACC1 [gngm]     3.91824
colon cancer liver metastasis [neop]     3.91824
Radical prostatectomy [topp]     3.91824
Biological Sample [cnce]     3.91824
Splenic vein thrombosis [dsyn]     3.91824
ONCOGENE MYC [gngm]     3.91824
CD8 lymphocyte [cell]     3.91824
Multidimensional [spco]     3.91824
Hospital, County [hcro]     3.91824
Downstream Region [nusq]     3.91824
Systematic Sampling [qnco]     3.91824
WT1 [neop]     3.91824
Large peak [qlco]     3.91824
Preterm Birth [patf]     3.91824
FATTY ACID-BINDING PROTEIN, ADIPOCYTE [gngm]     3.91824
Microemboli [acab]     3.91824
sigmoid polyp [neop]     3.91824
pet scanners [medd]     3.91824
Geum [plnt]     3.91824
Mural [spco]     3.91824
Lymphoma, Large-Cell, Anaplastic [neop]     3.91824
V4+ [elii]     3.91824
Acyl carnitine [orch]     3.91824
Preconditioning [menp]     3.91824
Lake whitefish [fish]     3.91824
GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [gngm]     3.91824
Waste Products [sbst]     3.91824
White matter [tisu]     3.91824
TAK1-BINDING PROTEIN 3 [gngm]     3.91824
Immunological Tests [lbpr]     3.91824
Protein Deficiency [dsyn]     3.91824
Inquiry [acty]     3.91824
Hypopituitarism [dsyn]     3.91824
Mouse Macrophage [cell]     3.91824
intravital microscopy [lbpr]     3.91824
Applied Research [resa]     3.91824
Clusterin Gene [gngm]     3.91824
microRNA 188 [gngm]     3.91824
Injection Port [medd]     3.91824
sere [euka]     3.91824
ZBP-89 [gngm]     3.91824
Reside [edac]     3.91824
%W/W [qnco]     3.91824
Pleckstrin-Homology Domain [amas]     3.91824
Fibrinolysis [phsf]     3.91824
Chara [plnt]     3.91824
drug weight loss [phsu]     3.91824
4q13.3 [celc]     3.91824
KLB [gngm]     3.91824
Inefficiency [fndg]     3.91824
Gastric Adenosquamous Carcinoma [neop]     3.91824
Pancreatic beta cell [cell]     3.91824
IU/kg [qnco]     3.91824
Skull Base [blor]     3.91824
Prolonged Surgery [hlca]     3.91824
Aggravating factor [fndg]     3.91824
Therapies, Neoadjuvant [topp]     3.91824
p68 [gngm]     3.91824
Aquatic Ecology [ocdi]     3.91824
Infantile hemangioma [neop]     3.91824
Immune Response Genes [gngm]     3.91824
Leukemias, Lymphoid [neop]     3.91824
sex male [fndg]     3.91824
Autophagosome [celc]     3.91824
Cytologic finding [fndg]     3.91824
translesion synthesis [genf]     3.91824
Bladder Stones [dsyn]     3.91824
Ileocaecal valve [bpoc]     3.91824
Macrosomia [fndg]     3.91824
early adulthood [aggp]     3.91824
subject - specimen [idcn]     3.91824
Curiosity [inbe]     3.91824
Tunica Media [tisu]     3.91824
Abdominal fascia [bpoc]     3.91824
Bipolar Disorder [mobd]     3.91824
T4 stage [fndg]     3.91824
Lens epithelial cell [cell]     3.91824
CTHRC1 [gngm]     3.91824
Overeating [mobd]     3.91824
Adenomatous Polyps [neop]     3.91824
Alveolar rhabdomyosarcoma [neop]     3.91824
Inuit [popg]     3.91824
L/h [qnco]     3.91824
oral hypoglycemic agent [phsu]     3.91824
Large-Scale Sequencing [mbrt]     3.91824
family origins [famg]     3.91824
Elevated serum protein [fndg]     3.91824
Endoscopic mucosal resection [topp]     3.91824
public healthcare [inpr]     3.91824
Aortic Aneurysm, Abdominal [dsyn]     3.91824
Image Cytometry [lbpr]     3.91824
Hematopoiesis, Extramedullary [ortf]     3.91824
Usually progressive [fndg]     3.91824
Retinoblastoma Gene [gngm]     3.91824
lobular carcinoma in situ [neop]     3.91824
Vegetarian [fndg]     3.91824
muscle weakness [sosy]     3.91824
Accessory Cell [cell]     3.91824
Anatomic measurement [diap]     3.91824
Draft [inpr]     3.91824
HPC [dsyn]     3.91824
IGF2BP3 [gngm]     3.91824
Choroid [bpoc]     3.91824
Associated procedure [clas]     3.91824
Lamella [inpr]     3.91824
Roux-en-Y Gastric Bypass [topp]     3.91824
Disease, Gastrointestinal [dsyn]     3.91824
Transcription Factor CREB-H [aapp]     3.91824
Laser photocoagulation [topp]     3.91824
dichloroacetic anhydride [orch]     3.91824
TMS1 [gngm]     3.91824
Alveolar macrophage [cell]     3.91824
conditioning regimen [topp]     3.91824
Emotional Stress [mobd]     3.91824
Anicteric [fndg]     3.91824
Cell Components [celc]     3.91824
Gram positive coccobacillus [bact]     3.91824
Paresis [sosy]     3.91824
Estrogen Effects [fndg]     3.91824
Best Response [fndg]     3.91824
G0 Phase [tmco]     3.91824
Nidus [lbtr]     3.91824
Parkinsonism [dsyn]     3.91824
Pulmonary vessels [bpoc]     3.91824
Death-Associated Protein Kinase 1 [gngm]     3.91824
LIVER CONNEXIN [gngm]     3.91824
braf genes [gngm]     3.91824
Gingival mucosa [bpoc]     3.91824
Rod [cell]     3.91824
nucleic acid metabolism [moft]     3.91824
Intrahepatic cholelithiasis [fndg]     3.91824
Antisocial Personality Disorder [mobd]     3.91824
Israeli [popg]     3.91824
Substantia nigra pars compacta [bpoc]     3.91824
Triceps Skinfold Thickness [clna]     3.91824
INTEGRATOR COMPLEX SUBUNIT 1 [gngm]     3.91824
Color finding [fndg]     3.91824
RAI [aapp]     3.91824
Erysipelas [dsyn]     3.91824
Beta + thalassaemia [dsyn]     3.91824
Plagiorchis [euka]     3.91824
Long arm [fndg]     3.91824
HVS [moft]     3.91824
Round Ligaments [bpoc]     3.91824
Oral contraceptive agent [phsu]     3.91824
Lemuridae [mamm]     3.91824
Non-Synonymous Mutation [genf]     3.91824
CPT1A [gngm]     3.91824
Activity level [fndg]     3.91824
Estimate [prog]     3.91824
Treatments, Multimodal [topp]     3.91824
167-B [orch]     3.91824
pseudoaneurysm [patf]     3.91824
Enterocolitis, Necrotizing [dsyn]     3.91824
Environmental Tobacco Smoke [hops]     3.91824
DMR [gngm]     3.91824
C1S [gngm]     3.91824
control experiments [grup]     3.91824
Neoplasms, Mammary [neop]     3.91824
MAPK Signaling Pathway [celf]     3.91824
group living [socb]     3.91824
Elapsed Time [tmco]     3.91824
Modem [mnob]     3.91824
PSMD12 [gngm]     3.91824
iron absorption [lbtr]     3.91824
helicobacter pylori gastritis [dsyn]     3.91824
Osteomalacia [dsyn]     3.91824
Extracellular Space [bsoj]     3.91824
General physical condition [fndg]     3.91824
Atheromatous Plaques [patf]     3.91824
Occupational hazard [phpr]     3.91824
Resistance, Natural [orga]     3.91824
Screening Result [cnce]     3.91824
radiation therapies [topp]     3.91824
cis acting element [nusq]     3.91824
Lipidosis [dsyn]     3.91824
Cytokine Signal Transduction [moft]     3.91824
PIN1 gene [gngm]     3.91824
Lacrimal Glands [bpoc]     3.91824
parathyroid hormone level [lbpr]     3.91824
Inbred Strain [orgm]     3.91824
GP1 [gngm]     3.91824
Booster vaccination [topp]     3.91824
Hypocalcaemia [patf]     3.91824
RIG-I [gngm]     3.91824
Schistosomiasis haematobium [dsyn]     3.91824
Immunological Surveillance [orgf]     3.91824
Motor Activities [dora]     3.91824
NK cell apoptosis [celf]     3.91824
Bile plug [bdsu]     3.91824
Altruism [socb]     3.91824
Decreased fertility [orga]     3.91824
Blood pressure response [clna]     3.91824
Surgical Revision [topp]     3.91824
Maximum Tolerated Dose [qnco]     3.91824
INTERLEUKIN 34 [gngm]     3.91824
Phosphorylation Site [amas]     3.91824
Common bile ductal wall [bpoc]     3.91824
Social Medicine [bmod]     3.91824
Hospital Ethics Committee [prog]     3.91824
Chemical technique [lbpr]     3.91824
Return Migration [acty]     3.91824
LC3-II [aapp]     3.91824
TCD [geoa]     3.91824
Science, Natural [ocdi]     3.91824
Cryptococcosis [dsyn]     3.91824
S6K1 [gngm]     3.91824
Squamous metaplasia [comd]     3.91824
decoded [menp]     3.91824
PSMA6 [gngm]     3.91824
TRANSCRIPTION FACTOR 3 [gngm]     3.91824
Mitochondrial DNA depletion [dsyn]     3.91824
KD [dsyn]     3.91824
Hypertriglyceridemia, transient [fndg]     3.91824
Acute onset [qlco]     3.91824
TRPM3 [gngm]     3.91824
complex III [celc]     3.91824
Pre-eclamptic NOS [patf]     3.91824
Compensatory Hyperinsulinemia [dsyn]     3.91824
Program, National Health [hlca]     3.91824
platelet-derived growth factor C [aapp]     3.91824
West Virginia [geoa]     3.91824
APOBEC3B gene [gngm]     3.91824
chiron [phsu]     3.91824
Mucinous Lesion [fndg]     3.91824
A/G ratio [lbpr]     3.91824
growth factor receptor binding [moft]     3.91824
CDO1 [gngm]     3.91824
neutrophilic dermatosis [dsyn]     3.91824
p aeruginosa [bact]     3.91824
DNA Microchips [resd]     3.91824
human resource [qnco]     3.91824
Paediatric oncologist [prog]     3.91824
Miss [cnce]     3.91824
PST [moft]     3.91824
Oncogene, NEU [gngm]     3.91824
Senegal [geoa]     3.91824
Organ Model [resa]     3.91824
cancer angiogenesis [neop]     3.91824
4q22 [celc]     3.91824
Area Ratio [qnco]     3.91824
Mutations, Frame Shift [comd]     3.91824
electrolyte imbalances [patf]     3.91824
Genital ulcers [dsyn]     3.91824
nulliparas [orgf]     3.91824
elevated platelet count [dsyn]     3.91824
Recombinant DNA Technology [mbrt]     3.91824
Wilcoxon Signed Rank Test [inpr]     3.91824
Genital Tract Infections [dsyn]     3.91824
Diamine [orch]     3.91824
PIK3 [gngm]     3.91824
WILMS TUMOR 2 [gngm]     3.91824
EFHD1 [gngm]     3.91824
MDR1 Gene [gngm]     3.91824
O3 [chem]     3.91824
Ejaculation [orgf]     3.91824
Image Series [inpr]     3.91824
Not Reported [idcn]     3.91824
concurrent therapy [topp]     3.91824
Corpus [bpoc]     3.91824
Cautery [topp]     3.91824
New Jersey [geoa]     3.91824
Cultural Backgrounds [idcn]     3.91824
Increased insulin level [fndg]     3.91824
S3 [blor]     3.91824
Chronic lung disease [dsyn]     3.91824
GSD III [dsyn]     3.91824
Chromosomal Gain [comd]     3.91824
Anaesthesiologist [prog]     3.91824
PPNET [neop]     3.91824
INHIBITOR OF GROWTH 4 [gngm]     3.91824
Telomerase Reverse Transcriptase Gene [gngm]     3.91824
Absorbable suture [medd]     3.91824
Exploration [medd]     3.91824
s typhi [bact]     3.91824
Cmax [qnco]     3.91824
Kilodalton [qnco]     3.91824
Coronal [spco]     3.91824
Gallbladder function [ortf]     3.91824
drape [medd]     3.91824
Screening procedures [hlca]     3.91824
Sudden onset [inpr]     3.91824
Healthy Aging [grpa]     3.91824
positive blood culture [lbtr]     3.91824
Angiogenesis, Physiological [phsf]     3.91824
international units [qnco]     3.91824
Thrombocytoses, Primary [dsyn]     3.91824
Serous Cystadenocarcinomas [neop]     3.91824
SERPINA11 [gngm]     3.91824
ct liver [diap]     3.91824
Adult-onset obesity [dsyn]     3.91824
Endometrioses [dsyn]     3.91824
clinical genetic [bmod]     3.91824
Hyperproteinaemia [dsyn]     3.91824
Canal of Hering [bsoj]     3.91824
Supermarket [mnob]     3.91824
Genome, Mitochondrial [gngm]     3.91824
high-dose radiation [topp]     3.91824
DNA Rearrangement [genf]     3.91824
Fluorescent Probes [irda]     3.91824
Genes, X-Linked [gngm]     3.91824
fistula closure [topp]     3.91824
Burns [inpo]     3.91824
Host (organism) [orgm]     3.91824
Hyalinisation [patf]     3.91824
CLAUDIN 7 [gngm]     3.91824
Cytoplasmic Tail [celc]     3.91824
Bronchial Epithelial Cell [cell]     3.91824
Gram-Positive Bacterial Infections [dsyn]     3.91824
Osteoid [bdsu]     3.91824
Pap smear [diap]     3.91824
Endoscopic Examination [diap]     3.91824
Retroviral Vector [nnon]     3.91824
Endocrine Syndrome [dsyn]     3.91824
Dietary Supplementation [food]     3.91824
22q [nusq]     3.91824
Hypercoagulabilities [lbtr]     3.91824
high triglycerides [fndg]     3.91824
gram negative bacteremia [dsyn]     3.91824
MAPK activation [moft]     3.91824
Cigars [mnob]     3.91824
decreased lymphocyte [dsyn]     3.91824
Sclerotic [patf]     3.91824
Cystadenoma, Mucinous [neop]     3.91824
Dagger [mnob]     3.91824
Theileriosis [dsyn]     3.91824
Aortic Stenosis [dsyn]     3.91824
AT 10 [phsu]     3.91824
negative antibody [lbtr]     3.91824
Allelic Heterogeneity [qlco]     3.91824
Consult [prog]     3.91824
Antidote [phsu]     3.91824
cytologic sampling [lbpr]     3.91824
CDGSH iron sulfur domain 2 [gngm]     3.91824
conglomerate [orgt]     3.91824
Bony metastasis [neop]     3.91824
Finger [blor]     3.91824
11 Pack [qnco]     3.91824
Tumor Weight [qnco]     3.91824
hyperthermia treatment [topp]     3.91824
/mL [dsyn]     3.91824
Living Conditions [qlco]     3.91824
breast development [fndg]     3.91824
PKCdelta [moft]     3.91824
Left oculomotor nerve [bpoc]     3.91824
cryptococcal [fngs]     3.91824
Choledochoduodenostomy [topp]     3.91824
Tissue Breakdown [inpo]     3.91824
Immunoglobulin Therapy [topp]     3.91824
desmoid tumors [neop]     3.91824
Domestic Ferret [mamm]     3.91824
Trucut needle [medd]     3.91824
protein tag [moft]     3.91824
Truncal obesity [dsyn]     3.91824
Cool [npop]     3.91824
Extrahepatic Biliary System [bpoc]     3.91824
Muscularis Mucosa [bpoc]     3.91824
Gaussian [qnco]     3.91824
Pulmonary artery stenosis [anab]     3.91824
Accidental exposure [phpr]     3.91824
Reading Frames [nusq]     3.91824
microvasculature [ortf]     3.91824
ROX [gngm]     3.91824
Intercurrent disease [dsyn]     3.91824
Subclinical Infections [dsyn]     3.91824
Family medicine [bmod]     3.91824
unit/week [qnco]     3.91824
Humoral Immune Response [orgf]     3.91824
Circe [euka]     3.91824
collection specimens [lbpr]     3.91824
Genetic Drift [genf]     3.91824
Coronary Arteries [bpoc]     3.91824
Postoperative visit [fndg]     3.91824
Purkinje Cells [cell]     3.91824
total serum protein [lbtr]     3.91824
American, Korean [popg]     3.91824
Second Primary Cancers [neop]     3.91824
North Island [geoa]     3.91824
CONTAMINATION, BACTERIAL [phpr]     3.91824
Transplant immunosuppression [topp]     3.91824
Myelolipoma [neop]     3.91824
Intestinal protozoa [euka]     3.91824
Hyaline body [acab]     3.91824
early-stage breast cancer [neop]     3.91824
Poor growth [fndg]     3.91824
PPARGC1A [gngm]     3.91824
Transpulmonary [spco]     3.91824
DIR [topp]     3.91824
Blastocystis hominis [euka]     3.91824
Randomized Controlled Clinical Trial [resa]     3.91824
Progressive Clinical Course [fndg]     3.91824
Open biopsy [diap]     3.91824
Mice, Obese [mamm]     3.91824
ROBO1 [gngm]     3.91824
Lavage Fluid [bdsu]     3.91824
Cotton [plnt]     3.91824
Serum hepatitis [dsyn]     3.91824
Subsection [idcn]     3.91824
blood vessel development [ortf]     3.91824
Miso [food]     3.91824
Prebiotics [carb]     3.91824
kitchens [mnob]     3.91824
Acidosis, Lactic [dsyn]     3.91824
Total colectomy [topp]     3.91824
Central City [geoa]     3.91824
Converge [spco]     3.91824
Diffuse fibrosis [patf]     3.91824
Gall [plnt]     3.91824
mmol/kg body weight [qnco]     3.91824
Gastric Adenoma [neop]     3.91824
Group E [clas]     3.91824
1H [tmco]     3.91824
Stage 4A [clas]     3.91824
Prostate MRI [clna]     3.91824
Physiological Effects [phsf]     3.91824
Pre-specified [qlco]     3.91824
MIME [topp]     3.91824
3q27 [celc]     3.91824
MODY [ftcn]     3.91824
drug dependence [fndg]     3.91824
Intra-Abdominal Fat [tisu]     3.91824
Effector T Cells [cell]     3.91824
Visual Impairment [dsyn]     3.91824
Human Umbilical Vein Endothelial Cells [cell]     3.91824
White color [qlco]     3.91824
Class 1 [clas]     3.91824
Residence.status [fndg]     3.91824
Parotid [bpoc]     3.91824
Diabetic Nephropathy [dsyn]     3.91824
Accent [food]     3.91824
PERATIVE [food]     3.91824
Mechanical ventilation [topp]     3.91824
intracellular organelle [celc]     3.91824
Osteomas, Osteoid [neop]     3.91824
forgetting [mobd]     3.91824
CI 953 [orch]     3.91824
Tender [sosy]     3.91824
Nephropathy, Membranous [dsyn]     3.91824
Viral envelope [celc]     3.91824
RIA [lbpr]     3.91824
Osteoclasts [cell]     3.91824
Developmental abnormality [cgab]     3.91824
Mobility Shift Assay [lbpr]     3.91824
Multiparous [fndg]     3.91824
TUBULIN POLYMERIZATION-PROMOTING PROTEIN [gngm]     3.91824
Abnormal bleeding [patf]     3.91824
Rh [elii]     3.91824
Rectal gonorrhea [dsyn]     3.91824
Pulmonary function [ortf]     3.91824
arginine ethyl ester [aapp]     3.91824
literature citation [inpr]     3.91824
Lai [inpr]     3.91824
Intestinal fluke infection [dsyn]     3.91824
Vasa Vasorum [bpoc]     3.91824
Biliary Colic [dsyn]     3.91824
Cape [mnob]     3.91824
Klippel-Trenaunay Syndrome [cgab]     3.91824
Intestinal Epithelium [tisu]     3.91824
Adipocytokine Signaling Pathway [celf]     3.91824
Insect [euka]     3.91824
Disclosure [inbe]     3.91824
Roux-en-Y Anastomosis [topp]     3.91824
Anti-diabetics [phsu]     3.91824
Dominance [idcn]     3.91824
Eulemur macaco [mamm]     3.91824
August Rats [mamm]     3.91824
Measurement procedure [ftcn]     3.91824
Skin Melanoma [neop]     3.91824
Exosome [celc]     3.91824
Abdominal veins [bpoc]     3.91824
patient positioning [topp]     3.91824
Indecision [fndg]     3.91824
purpuric [ftcn]     3.91824
Gestational trophoblastic lesion [anab]     3.91824
diabetes prevention [edac]     3.91824
LSR [gngm]     3.91824
Newly diagnosed diabetes [fndg]     3.91824
Obesity Surgery [topp]     3.91824
Cane [medd]     3.91824
Chromophobe cell renal carcinoma [neop]     3.91824
Cachectic [sosy]     3.91824
Spheroids [fndg]     3.91824
Prolonged hospitalization [fndg]     3.91824
Lymphoid Tumor [neop]     3.91824
Unstained Slide [sbst]     3.91824
Cervical Atypia [neop]     3.91824
Topical haemostatic agent [phsu]     3.91824
pale [sosy]     3.91824
DUO [gngm]     3.91824
Microscopy, Fluorescence [lbpr]     3.91824
Tumor State [qlco]     3.91824
Snuff [hops]     3.91824
vascular [ftcn]     3.91824
Trough Concentration [qnco]     3.91824
Study, Genetic Association [mbrt]     3.91824
FHIT [gngm]     3.91824
Fresh fruit [food]     3.91824
Corynebacterium [bact]     3.91824
Intra Uterine Device [medd]     3.91824
Subcuticular [spco]     3.91824
Tung [plnt]     3.91824
crest [ftcn]     3.91824
stereotyped [menp]     3.91824
Pubic [bpoc]     3.91824
ras-related protein [gngm]     3.91824
Van [mnob]     3.91824
Agricultural Workers [prog]     3.91824
CHIP assay [lbpr]     3.91824
Io [euka]     3.91824
departure [idcn]     3.91824
Variations, Inter-Observer [qnco]     3.91824
cryptogenic hepatitis [dsyn]     3.91824
M6 [gngm]     3.91824
Antiallergic [phsu]     3.91824
Law [rnlw]     3.91824
pN0 [fndg]     3.91824
Matched-Pair Analysis [qlco]     3.91824
ssRNA [nnon]     3.91824
growth hormone secretion [celf]     3.91824
Non-A, non-B hepatitis virus [virs]     3.91824
Drug Withdrawal [mobd]     3.91824
Multiple Partners [popg]     3.91824
PIK3CD [gngm]     3.91824
Sinus Node Dysfunction [dsyn]     3.91824
Tissue Distribution [qnco]     3.91824
EAD [gngm]     3.91824
Chromophobe cell [cell]     3.91824
cd56 cells [cell]     3.91824
Vascular lesions [dsyn]     3.91824
Hemizygous [qlco]     3.91824
estrogen deficiency [dsyn]     3.91824
liver cell cancer [neop]     3.91824
household survey [resa]     3.91824
Cyst Formation [fndg]     3.91824
Huichol [popg]     3.91824
needles syringes [medd]     3.91824
PHD2 [gngm]     3.91824
Suction drainage [topp]     3.91824
chronic myeloproliferative disorders [neop]     3.91824
Nephrosis [dsyn]     3.91824
Health Statistics [qnco]     3.91824
mini pigs [mamm]     3.91824
Consent Form [inpr]     3.91824
Needlesticks [inpo]     3.91824
KLF8 [gngm]     3.91824
study trials [resa]     3.91824
Hospitals, Pediatric [hcro]     3.91824
Sister Chromatid Exchange [genf]     3.91824
Miniaturisation [hcpp]     3.91824
miRNA processing [genf]     3.91824
Nation [grpa]     3.91824
Para-aortic lymph node [bpoc]     3.91824
Apgar [diap]     3.91824
Alveolitis, Fibrosing [dsyn]     3.91824
IRE1-ALPHA [gngm]     3.91824
Feeding practice [topp]     3.91824
KIR [geoa]     3.91824
Nutrient intake [qnco]     3.91824
Tubercular [ftcn]     3.91824
Sarcoma, Epithelioid [neop]     3.91824
Staining (finding) [fndg]     3.91824
Bacteroides [bact]     3.91824
Dispute [socb]     3.91824
Ki-ras Oncogene [gngm]     3.91824
Syncytia [cell]     3.91824
Modal Number [qnco]     3.91824
Allosteric Site [ftcn]     3.91824
Tonga [geoa]     3.91824
Degradation Pathway [cnce]     3.91824
Nephrectomy [topp]     3.91824
Immunosuppressed Host [fndg]     3.91824
Microwave oven [mnob]     3.91824
Spear [mnob]     3.91824
Sigmoid Cancer [neop]     3.91824
P GENE [gngm]     3.91824
Multi-organ involvement [qnco]     3.91824
Extended left hemihepatectomy [topp]     3.91824
apoptotic body [celc]     3.91824
Unmarried [popg]     3.91824
Weapons [mnob]     3.91824
Lens culinaris [plnt]     3.91824
Therapeutic Research [resa]     3.91824
rapid diagnosis [diap]     3.91824
MVR [qlco]     3.91824
indonesian [popg]     3.91824
Putamen [bpoc]     3.91824
aerobic glycolysis [moft]     3.91824
Mycobacterium tuberculosis [bact]     3.91824
Polycythaemia [dsyn]     3.91824
Temporal relationship [tmco]     3.91824
Nutritionist [prog]     3.91824
RAB23 gene [gngm]     3.91824
Excessive weight [fndg]     3.91824
Dysequilibrium [fndg]     3.91824
Physician code [inpr]     3.91824
Phase 5 [tmco]     3.91824
metabolism proteins [moft]     3.91824
Anterior chest wall [blor]     3.91824
Primary leiomyosarcoma [neop]     3.91824
CYP2C19, wild-type [gngm]     3.91824
Skin capillary [bpoc]     3.91824
Transplantations, Lung [topp]     3.91824
Croatia [geoa]     3.91824
NCAN [gngm]     3.91824
Cotton-top tamarin [mamm]     3.91824
Modified radical mastectomy [topp]     3.91824
Chronic venous insufficiency [dsyn]     3.91824
Self Esteem [menp]     3.91824
Tongan [popg]     3.91824
Neurotransmission [celf]     3.91824
Exposed Cohort [popg]     3.91824
Post-Traumatic Stress Disorder [mobd]     3.91824
PENUMBRA [gngm]     3.91824
immune hepatitis [dsyn]     3.91824
Myopathy [dsyn]     3.91824
Blood coagulation [ortf]     3.91824
Th17 Cells [cell]     3.91824
Second look laparotomy [diap]     3.91824
Pseudomyxoma Peritonei [neop]     3.91824
Intravenous use [ftcn]     3.91824
Bahia [plnt]     3.91824
Brisk [qlco]     3.91824
death-inducing signaling complex [celc]     3.91824
Wedge excision [topp]     3.91824
LRP [gngm]     3.91824
Bland Embolization [topp]     3.91824
Dietary regime [topp]     3.91824
Serous acinus [bpoc]     3.91824
Pre-Hypertension [dsyn]     3.91824
Respiratory Chain Deficiency [dsyn]     3.91824
Protozoa [euka]     3.91824
Argentinean [popg]     3.91824
Follicular neoplasm [neop]     3.91824
COL15A1 [gngm]     3.91824
Tomography, Optical [diap]     3.91824
Nil [qnco]     3.91824
Rhizoma [plnt]     3.91824
INSUFFICIENCY, CARDIAC [dsyn]     3.91824
Monozygotic twins [famg]     3.91824
preventive services [hlca]     3.91824
Tumors, Granular Cell [neop]     3.91824
Business [ocac]     3.91824
Musculoskeletal System [bdsy]     3.91824
Molina [euka]     3.91824
Recurrent inflammation [patf]     3.91824
Delegated [acty]     3.91824
Vancomycin resistant enterococcus [bact]     3.91824
ABCB1-T [gngm]     3.91824
Growth hormone deficiency [dsyn]     3.91824
body secretions [bdsu]     3.91824
Diagnostic Equipment [medd]     3.91824
AFT [gngm]     3.91824
mU/hr [qnco]     3.91824
peripheral arterial disease [dsyn]     3.91824
RAG-1 [gngm]     3.91824
high-dose chemotherapy [topp]     3.91824
Osteoblasts [cell]     3.91824
Ethnic category [popg]     3.91824
baltic [geoa]     3.91824
management plan [ocac]     3.91824
Leukoencephalopathy [dsyn]     3.91824
Coma [dsyn]     3.91824
CO-DOMINANT [fndg]     3.91824
Multiple ulcers [patf]     3.91824
Prefrontal Cortex [bpoc]     3.91824
Cavities, Abdominal [blor]     3.91824
Axillary lymph node dissection [topp]     3.91824
Rokitansky-Aschoff Sinus [dsyn]     3.91824
Limited period [tmco]     3.91824
Hospital course [clna]     3.91824
NB [gngm]     3.91824
Post-Exposure Prophylaxis [topp]     3.91824
Orphan [popg]     3.91824
FMS-RELATED TYROSINE KINASE 1 [gngm]     3.91824
18/22 [qnco]     3.91824
Tooth Extraction [topp]     3.91824
Wire [medd]     3.91824
Diabetes Mellitus, Non-Insulin-Dependent [dsyn]     3.91824
Staphylococcus epidermidis [bact]     3.91824
Therapeutic evaluation [diap]     3.91824
G protein-coupled estrogen receptor 1 [gngm]     3.91824
SAA [gngm]     3.91824
Diet, Elemental [topp]     3.91824
FAM83D gene [gngm]     3.91824
Pusher [medd]     3.91824
Dermoid Cyst [neop]     3.91824
coil embolization [medd]     3.91824
Search Tool [inpr]     3.91824
bums [popg]     3.91824
Anti-Oxidant Effects [phsf]     3.91824
Complete response to treatment [fndg]     3.91824
Sarcomas, Epithelioid [neop]     3.91824
Politics [ocdi]     3.91824
communes [fndg]     3.91824
APPL [gngm]     3.91824
end organ damage [dsyn]     3.91824
TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II [gngm]     3.91824
testicular [spco]     3.91824
Thrombolytic Therapies [topp]     3.91824
Aberrant Crypt Foci [fndg]     3.91824
11p15 [celc]     3.91824
Tachyarrhythmia [fndg]     3.91824
slab [medd]     3.91824
Diseases, Coronary [dsyn]     3.91824
rads [qnco]     3.91824
jet [mnob]     3.91824
HN [geoa]     3.91824
Medullary [bpoc]     3.91824
Birth Rate [qnco]     3.91824
B-RAF Gene Mutation [comd]     3.91824
CYP2D6 gene [gngm]     3.91824
KRT19 [gngm]     3.91824
Anal Dysplasia [neop]     3.91824
Fasciola [euka]     3.91824
DNA Aptamers [nnon]     3.91824
protein sequences [amas]     3.91824
Insulin-Like Growth Factor 2 Receptor Gene [gngm]     3.91824
Hepatic sinusoid [bpoc]     3.91824
IVD [gngm]     3.91824
Bacteriological [bmod]     3.91824
Cytoplasmic inclusion bodies [fndg]     3.91824
sugar cane [food]     3.91824
Animal - origin [fndg]     3.91824
Gradual progression [fndg]     3.91824
YT [gngm]     3.91824
beta-galactoside [carb]     3.91824
DNA, Bacterial [nnon]     3.91824
Portal tract fibrosis [fndg]     3.91824
Organ Procurement System [hlca]     3.91824
Plasma glucose concentration [fndg]     3.91824
Sutured [topp]     3.91824
problem drinking [mobd]     3.91824
Theatre [mnob]     3.91824
Diterpenes [orch]     3.91824
Southwest [spco]     3.91824
Visual Fields [spco]     3.91824
Ulcers, Gastric [dsyn]     3.91824
Genes, Cancer Suppressor [gngm]     3.91824
PARKIN [gngm]     3.91824
Qi [idcn]     3.91824
Malpractice [qlco]     3.91824
historical overview [inpr]     3.91824
ex vivo gene therapy [topp]     3.91824
Cost aspects [qnco]     3.91824
Transabdominal [spco]     3.91824
19A [gngm]     3.91824
Sebaceous adenoma [neop]     3.91824
Asymptomatic ischaemia [dsyn]     3.91824
p16 Gene [gngm]     3.91824
Wound [ftcn]     3.91824
Report types [inpr]     3.91824
Disease phases [tmco]     3.91824
Normal phosphate level [fndg]     3.91824
antiangiogenesis therapy [topp]     3.91824
Blood disease NOS [dsyn]     3.91824
Chemotherapy Drugs [topp]     3.91824
Thromboxane B2 [eico]     3.91824
Nephritis [dsyn]     3.91824
iob [topp]     3.91824
Ccta [gngm]     3.91824
hospital program [hlca]     3.91824
Biliary malformation [cgab]     3.91824
SFR [qnco]     3.91824
DNA mapping [inpr]     3.91824
p35 [gngm]     3.91824
Free-floating [qlco]     3.91824
RNA copies/mL [qnco]     3.91824
In-Dwelling Catheter [medd]     3.91824
early disease onset [dsyn]     3.91824
Trisomy 20 [dsyn]     3.91824
F>1< generation [famg]     3.91824
Poor personal hygiene [inbe]     3.91824
Parasite sample [euka]     3.91824
Distal third [spco]     3.91824
land [celc]     3.91824
Laryngeal Squamous Cell Carcinoma [neop]     3.91824
carbohydrate binding [moft]     3.91824
Giant cell transformation [fndg]     3.91824
glial tumors [neop]     3.91824
Agouti [mamm]     3.91824
holmium laser [medd]     3.91824
TBI [inpo]     3.91824
Disorientation [mobd]     3.91824
Skin Temperature [orga]     3.91824
Portal bile ductule [bpoc]     3.91824
Fast Green [orch]     3.91824
drug transporter activity [moft]     3.91824
Adrenocortical Tumor [neop]     3.91824
Anti-inflammatory agent [phsu]     3.91824
Chronic Renal Disease [dsyn]     3.91824
FKHR [gngm]     3.91824
educate [prog]     3.91824
Monodermal teratoma [neop]     3.91824
Staging procedure [ftcn]     3.91824
Therapeutic Technique [topp]     3.91824
Breast Biopsy [diap]     3.91824
Simian virus 40 [virs]     3.91824
Internal fistula [acab]     3.91824
Long Island [popg]     3.91824
Monocarboxylate [orch]     3.91824
APOBEC3C [gngm]     3.91824
Flores [geoa]     3.91824
Abnormal biliary-pancreatic junction [fndg]     3.91824
Neutral [lbpr]     3.91824
Thymidine Kinase Gene [gngm]     3.91824
Organic Chemicals [orch]     3.91824
Helicobacter heilmanii [bact]     3.91824
OPT [gngm]     3.91824
Opisthorchiidae [euka]     3.91824
Antileukemic Agent [phsu]     3.91824
Followed by [tmco]     3.91824
Glycol [orch]     3.91824
Rum [food]     3.91824
abnormal lft [fndg]     3.91824
Suppurative cholangitis [dsyn]     3.91824
Nigella sativa [plnt]     3.91824
Kinetochore [celc]     3.91824
Median Income [qnco]     3.91824
Extrahepatic Bile Duct Epithelium [tisu]     3.91824
Ventilator care [hlca]     3.91824
blood donor screening [topp]     3.91824
geriatricians [prog]     3.91824
Elevated lactate dehydrogenase [fndg]     3.91824
GLP [geoa]     3.91824
L30 [gngm]     3.91824
Phase 2 Study [resa]     3.91824
Serum cholinesterase level [lbpr]     3.91824
T4b [fndg]     3.91824
Enteropathy [dsyn]     3.91824
Serotonin Agonist [phsu]     3.91824
transcription factor binding [genf]     3.91824
Not abnormal [inpr]     3.91824
Blood Vessel Tissue [tisu]     3.91824
Consolidation Therapy [topp]     3.91824
Maturity-Onset Diabetes [dsyn]     3.91824
Quitting Smoking [inbe]     3.91824
MTS1 [gngm]     3.91824
focus attention [menp]     3.91824
assist [hlca]     3.91824
metastatic lung cancer [neop]     3.91824
Inflammatory Bowel Disease 1 [dsyn]     3.91824
Particulate [sbst]     3.91824
LY [spco]     3.91824
Perimenopausal [tmco]     3.91824
Curcuma longa extract [phsu]     3.91824
Base Excision Repair [genf]     3.91824
illness severity [qlco]     3.91824
lipid biosynthesis [orgf]     3.91824
MZ [geoa]     3.91824
Third lumbar vertebra [bpoc]     3.91824
Light Activity [dora]     3.91824
Blood [popg]     3.91824
LCC [neop]     3.91824
Respiratory rate [clna]     3.91824
eukaryotic initiation factor 4E binding [genf]     3.91824
Chromosome 17 deletion [comd]     3.91824
Straight electrode [medd]     3.91824
p85-ALPHA [gngm]     3.91824
Clonorchis sinensis egg [euka]     3.91824
Opisthorchiosis [dsyn]     3.91824
ODD [gngm]     3.91824
12a [medd]     3.91824
Organismal [orgm]     3.91824
SD [gngm]     3.91824
Large cell neuroendocrine carcinoma [neop]     3.91824
Behavior Therapy, Cognitive [topp]     3.91824
autografts [topp]     3.91824
DKK1 [gngm]     3.91824
Id [idcn]     3.91824
Car [mnob]     3.91824
Chemokine Ligand 1 [lbpr]     3.91824
Food Diaries [inpr]     3.91824
Iron intake [fndg]     3.91824
Hepatitis, Delta [dsyn]     3.91824
SINGLE DOSE TOXICITY [rnlw]     3.91824
Inductively-Coupled Plasma Mass Spectrometry [lbpr]     3.91824
Allelotyping [mbrt]     3.91824
PW [geoa]     3.91824
FOXA2 [gngm]     3.91824
TNF gene [gngm]     3.91824
Refractive Index [qnco]     3.91824
Hypomagnesaemia [fndg]     3.91824
Platinum Compounds [inch]     3.91824
Mixed Lymphocyte Reaction [lbpr]     3.91824
Vascular Endothelial Growth Factor Inhibitor [moft]     3.91824
Pancreatic Endocrine Neoplasm [neop]     3.91824
PEX7 [moft]     3.91824
Cytogenetic Studies [lbpr]     3.91824
Interventional Radiology Procedure [topp]     3.91824
Physical Interaction [moft]     3.91824
Stent patency [spco]     3.91824
Osseous [bpoc]     3.91824
Stationary [qlco]     3.91824
BRAF V600E [comd]     3.91824
Denial [mobd]     3.91824
Cell (compartment) [spco]     3.91824
Coronary Stenosis [dsyn]     3.91824
tissue healing [fndg]     3.91824
Diagnostic colonoscopy [diap]     3.91824
Gastrointestinal symptoms NOS [sosy]     3.91824
Serum uric acid level [lbpr]     3.91824
Molecular Imaging [diap]     3.91824
astrocyte cells [cell]     3.91824
Chewing Tobacco [sbst]     3.91824
COL4A1 [gngm]     3.91824
Hyperviscosity [fndg]     3.91824
Plethora [fndg]     3.91824
Extensive Disease [dsyn]     3.91824
Human leucocyte antigen allele [imft]     3.91824
Intestinal secretion [bdsu]     3.91824
Liver cyst [dsyn]     3.91824
Unlock [idcn]     3.91824
catheterized [topp]     3.91824
PRKDC [gngm]     3.91824
Liver transplant status [fndg]     3.91824
Diffuse Cutaneous Systemic Sclerosis [dsyn]     3.91824
Renal cysts [cgab]     3.91824
Ward, General [mnob]     3.91824
Root [plnt]     3.91824
Wingless signalling pathway [moft]     3.91824
Gallbladder body [bpoc]     3.91824
RABL [gngm]     3.91824
Research Base [orgt]     3.91824
Alimentary System [bdsy]     3.91824
Mammary Carcinoma [neop]     3.91824
Deacetylation [moft]     3.91824
Intracellular Transport [celf]     3.91824
Firmicutes [bact]     3.91824
Ovarian Germ Cell Tumor [neop]     3.91824
hMLH1 [gngm]     3.91824
blood alcohol [lbpr]     3.91824
Osteopontin Gene [gngm]     3.91824
agenda [inpr]     3.91824
Suppressor of Cytokine Signaling 3 Gene [gngm]     3.91824
Drop Metastasis [fndg]     3.91824
hepatic immune response [orgf]     3.91824
10^5/mL [qnco]     3.91824
MEK Inhibitor [phsu]     3.91824
Alveolar Soft Part Sarcoma [neop]     3.91824
GSD IV [dsyn]     3.91824
multidrug-resistance protein [moft]     3.91824
Radiation Field [blor]     3.91824
AU/mL [qnco]     3.91824
master file [inpr]     3.91824
Group Y [clas]     3.91824
MICRO RNA 22 [gngm]     3.91824
height loss [fndg]     3.91824
Metabolic encephalopathy [dsyn]     3.91824
HEPATIC NUCLEAR FACTOR-1-ALPHA [gngm]     3.91824
Krukenberg Tumor [neop]     3.91824
Seminal vesiculectomy [topp]     3.91824
PPOX gene [gngm]     3.91824
Morphogenesis [orgf]     3.91824
Override [acty]     3.91824
Technical Expertise [qlco]     3.91824
Lymph node sample [bdsu]     3.91824
Haematologic disease [dsyn]     3.91824
Accidental death [fndg]     3.91824
brain ct [diap]     3.91824
Bile duct stone removal [topp]     3.91824
collapse [patf]     3.91824
APC [dsyn]     3.91824
p300 [gngm]     3.91824
Data Analyses [ocac]     3.91824
Lead Indicator [qlco]     3.91824
kinship [idcn]     3.91824
drainage tube [medd]     3.91824
Serum lactate [lbpr]     3.91824
Comparative Pathology [bmod]     3.91824
Marburg virus [virs]     3.91824
Dress [mnob]     3.91824
ATP-BINDING CASSETTE 1 [gngm]     3.91824
Cell Cycle Phase [celf]     3.91824
Secondary procedure [topp]     3.91824
Abdominal swelling [fndg]     3.91824
Analytes [chvf]     3.91824
Continuous wave [qlco]     3.91824
T2 stage [fndg]     3.91824
Clinical Failure [fndg]     3.91824
Resistance Genes, Multidrug [gngm]     3.91824
Blood group B [lbtr]     3.91824
nonhuman primate [mamm]     3.91824
Liposarcoma, Dedifferentiated [neop]     3.91824
thyroid cancer, metastatic follicular [neop]     3.91824
Melatonin 2.5 MG [clnd]     3.91824
Arterial stasis [patf]     3.91824
Schistosoma species [euka]     3.91824
Phase II Clinical Trial [resa]     3.91824
Hydrocolloid Dressings [medd]     3.91824
Adventitia [tisu]     3.91824
MAP3K [moft]     3.91824
Interaction, Host-Parasite [npop]     3.91824
cancer gallbladder [neop]     3.91824
Raspberry [food]     3.91824
Discriminant Analyses [resa]     3.91824
zinc binding [moft]     3.91824
APOA2 [lbpr]     3.91824
calcified nodules [ftcn]     3.91824
Never attended school [fndg]     3.91824
Propeptide [aapp]     3.91824
Ber-EP4 [imft]     3.91824
lung function [ortf]     3.91824
Sclera [bpoc]     3.91824
HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE [dsyn]     3.91824
Mouse Strains [mamm]     3.91824
Non-alcoholic cirrhosis NOS [dsyn]     3.91824
Liver finding [fndg]     3.91824
Neutral [qlco]     3.91824
Peroxisome Proliferator-Activated Receptor Signaling Pathway [moft]     3.91824
Therapies, Immunomodulatory [topp]     3.91824
retinal vein thrombosis [dsyn]     3.91824
MASP2 [gngm]     3.91824
MICRO RNA 122A [gngm]     3.91824
Small vessel [bpoc]     3.91824
milliampere [qnco]     3.91824
Multiple infarcts [patf]     3.91824
Microenvironments, Cellular [npop]     3.91824
Deep muscle [bpoc]     3.91824
thyroid tumors [neop]     3.91824
ZSCAN18 [gngm]     3.91824
Arterial embolism [patf]     3.91824
PROTOCADHERIN 20 [gngm]     3.91824
Dermatomyositis [dsyn]     3.91824
Proptoses [dsyn]     3.91824
Thermal coagulation [topp]     3.91824
Low Mitotic Activity [fndg]     3.91824
Amniotic Fluid [bdsu]     3.91824
vascular grafts [medd]     3.91824
Perfusion Magnetic Resonance Imaging [diap]     3.91824
mcg [qnco]     3.91824
Improbable [idcn]     3.91824
Erythroblast [cell]     3.91824
Intrahepatic Bile Duct Adenoma [neop]     3.91824
Booster [topp]     3.91824
2-oxo-4-hydroxy-4-carboxy--5-ureidoimidazoline [orch]     3.91824
Comet Assay [mbrt]     3.91824
Hepatitis B antigen screening [lbpr]     3.91824
Glandular Differentiation [fndg]     3.91824
Isthmus [cnce]     3.91824
Sunlight [npop]     3.91824
MIB1 [gngm]     3.91824
Life Threatening Adverse Event [fndg]     3.91824
Relapsed Hepatocellular Carcinoma [neop]     3.91824
Eosinophilic esophagitis [dsyn]     3.91824
SF-36 [inpr]     3.91824
staging tumours [clna]     3.91824
Lumpectomy [topp]     3.91824
P90 [gngm]     3.91824
Increased liver enzymes [fndg]     3.91824
Centrifugal [qlco]     3.91824
Oncocytic Tumor [neop]     3.91824
Chronic malnutrition [fndg]     3.91824
CO1 [gngm]     3.91824
EMD [dsyn]     3.91824
Gastroduodenal artery [bpoc]     3.91824
Iowa [geoa]     3.91824
Gynecological disease [dsyn]     3.91824
ZNF483 [gngm]     3.91824
Glycobiology [ocdi]     3.91824
MR-1 [gngm]     3.91824
Netherlands [geoa]     3.91824
Treatment site [spco]     3.91824
GBV-B [virs]     3.91824
Hapten [imft]     3.91824
Treatment Costs [qnco]     3.91824
Pancreatic Islets [bpoc]     3.91824
PPP [dsyn]     3.91824
Recurrent Liposarcoma [neop]     3.91824
Typhoid infection [dsyn]     3.91824
high fever [fndg]     3.91824
cerebral circulation [ortf]     3.91824
Diabetes Insipidus [dsyn]     3.91824
Lymph-vascular invasion [fndg]     3.91824
Oral pharynx [blor]     3.91824
Chick Embryo [emst]     3.91824
NYHA Class [fndg]     3.91824
Supplementary Information [inpr]     3.91824
CQ [qnco]     3.91824
Abundant cytoplasm [fndg]     3.91824
Centrosomes [celc]     3.91824
Superior mesenteric vein thrombosis [dsyn]     3.91824
3 grade [inpr]     3.91824
SNAI1 [gngm]     3.91824
congenital cysts [cgab]     3.91824
desire [menp]     3.91824
cell-cell adhesion [celf]     3.91824
MRA [diap]     3.91824
Maternal Exposure [inpo]     3.91824
Peeling [ftcn]     3.91824
Cerebellar abscess [dsyn]     3.91824
Moores [inpr]     3.91824
circulating cancer cell [cell]     3.91824
LGALS9 [gngm]     3.91824
proteasome activity [moft]     3.91824
Benign Chemodectoma [neop]     3.91824
Binge Drinking [inbe]     3.91824
Human leucocyte antigen DR3 [imft]     3.91824
Electrophoresis, Agarose Gel [lbpr]     3.91824
Glomerular [bpoc]     3.91824
Mouse Hepatocyte [tisu]     3.91824
Cytotoxic cell [cell]     3.91824
Maternal [socb]     3.91824
Ling [food]     3.91824
adult female? [popg]     3.91824
poison control [ocac]     3.91824
Voltage [qnco]     3.91824
skeletal deformity [fndg]     3.91824
Tonsil [bpoc]     3.91824
TUMOR PROTEIN p53 [gngm]     3.91824
sedative hypnotic [phsu]     3.91824
12q [nusq]     3.91824
HEX [gngm]     3.91824
electric fields [npop]     3.91824
Antiparasitic Drugs [phsu]     3.91824
Carcinoma, intestinal type [neop]     3.91824
AFP measurement [lbpr]     3.91824
flavanoids [orch]     3.91824
Tic NOS [mobd]     3.91824
South Asian country [geoa]     3.91824
Diverse [topp]     3.91824
Portocaval node [bpoc]     3.91824
Alexandra [plnt]     3.91824
Adhesion [mnob]     3.91824
Electrocardiograms [fndg]     3.91824
Premature Labor [patf]     3.91824
LacZ Gene [gngm]     3.91824
Self-expanding stent [medd]     3.91824
Chiron Corporation [hcro]     3.91824
Clear fluid [food]     3.91824
Recurrent Colorectal Cancer [neop]     3.91824
Familial risk factor [qlco]     3.91824
Diabetic Retinopathy [dsyn]     3.91824
sialyl Lewis x [carb]     3.91824
PAH-DNA adduct [nnon]     3.91824
Lower Gastrointestinal Tract [bdsy]     3.91824
5 dextrose [clnd]     3.91824
Subcutaneous Abscess [patf]     3.91824
ZNF765 [gngm]     3.91824
Immunofluorescent stain [irda]     3.91824
pT3 stage [fndg]     3.91824
Abdominal musculature [bpoc]     3.91824
1q21 [celc]     3.91824
Crustaceans [euka]     3.91824
Transplantation, Autologous [topp]     3.91824
LFT [lbpr]     3.91824
ductile [qnco]     3.91824
cervical lesion [patf]     3.91824
Third National Health and Nutrition Examination Survey [inpr]     3.91824
Hemolytic anemias NOS [dsyn]     3.91824
End Date [tmco]     3.91824
Manganese [elii]     3.91824
Proteinuria, severe [fndg]     3.91824
McGill Pain Questionnaire [diap]     3.91824
Family Hepadnaviridae [virs]     3.91824
medical information system [inpr]     3.91824
Metaphase Spread [lbpr]     3.91824
Otolaryngology [bmod]     3.91824
Storage disease [dsyn]     3.91824
mTORC2 [celc]     3.91824
SHMT1 [gngm]     3.91824
IU/dL [qnco]     3.91824
plasminogen activator inhibitor, type I [gngm]     3.91824
tumor blood supply [ortf]     3.91824
VOD [dsyn]     3.91824
HCRP1 [gngm]     3.91824
pharmacodynamic [biof]     3.91824
IFS [neop]     3.91824
HJV [gngm]     3.91824
SECRET [gngm]     3.91824
Viral Inactivation [lbpr]     3.91824
Prescribed medications [clna]     3.91824
needle size [spco]     3.91824
Andrographis paniculata [plnt]     3.91824
Pre-Menopause [phsf]     3.91824
epizootiology [ocdi]     3.91824
candida infections [dsyn]     3.91824
pre surgery [tmco]     3.91824
Regulatory Authority [gora]     3.91824
parts per million [qnco]     3.91824
uroporphyrinogen decarboxylase activity [moft]     3.91824
CpG Island Methylator Phenotype [clna]     3.91824
Respiratory tuberculosis [dsyn]     3.91824
Mobile Phase [irda]     3.91824
Transthoracic approach [spco]     3.91824
ADA deficiency [dsyn]     3.91824
Protein malnutrition [dsyn]     3.91824
Anthelmintics [phsu]     3.91824
Thyroid cancer, papillary [neop]     3.91824
SEER Program [hcro]     3.91824
Non structural gene [gngm]     3.91824
Embryonal sarcoma [neop]     3.91824
Radiations, Gamma [npop]     3.91824
Lothian [geoa]     3.91824
Transjugular liver biopsy [diap]     3.91824
Turbo [euka]     3.91824
Vasodilation [phsf]     3.91824
Hemangiosarcomas [neop]     3.91824
Antigen [rnlw]     3.91824
CH 11 [inpr]     3.91824
Multisection dynamic [clna]     3.91824
Critical Pathways [inpr]     3.91824
Procedures, Preoperative [hlca]     3.91824
Qualitative Research [resa]     3.91824
ROOM TEMPERATURE [qlco]     3.91824
Flies [euka]     3.91824
Derived Data [mcha]     3.91824
abdomen scan [diap]     3.91824
Safety equipment [mnob]     3.91824
head ct scan [diap]     3.91824
WG [dsyn]     3.91824
Identification number [inpr]     3.91824
Process, Metabolic [orgf]     3.91824
SUPPRESSOR OF CYTOKINE SIGNALING 1 [gngm]     3.91824
Population Characteristics [grpa]     3.91824
Needle stick injury [inpo]     3.91824
22q12 [celc]     3.91824
Enzyme-Linked Immunospot Assay [lbpr]     3.91824
Conformational change [moft]     3.91824
brain metabolism [ortf]     3.91824
Xanthochromia [qlco]     3.91824
TPH1 [gngm]     3.91824
syllables [inpr]     3.91824
Malignant Lung Neoplasm [neop]     3.91824
protein function [aapp]     3.91824
tobacco users [fndg]     3.91824
Modifications, Diet [topp]     3.91824
Geometry [spco]     3.91824
14a [medd]     3.91824
Biliary procedure [topp]     3.91824
Cardiac Septum [bpoc]     3.91824
Severe beta thalassemia [dsyn]     3.91824
Incidence Studies [qnco]     3.91824
Clostridium xylanolyticum [bact]     3.91824
surgical team [qlco]     3.91824
Destitute [fndg]     3.91824
procreation [orgf]     3.91824
Arcuate [spco]     3.91824
Disinfection [topp]     3.91824
Gastric Neuroendocrine Carcinoma [neop]     3.91824
Pulmonary infection [dsyn]     3.91824
OCP [dsyn]     3.91824
Silicate [inch]     3.91824
Detached [ftcn]     3.91824
XO [gngm]     3.91824
Rates, Age-Specific Death [qnco]     3.91824
Info [idcn]     3.91824
Elastic Waves [npop]     3.91824
tortoise [rept]     3.91824
Uterine Cancer [neop]     3.91824
Dynamic Enhanced Computed Tomography [diap]     3.91824
international trade [ftcn]     3.91824
Genes, Modifier [gngm]     3.91824
Leukoplakia, Oral [neop]     3.91824
Tissue Fixation [lbpr]     3.91824
Home birth [fndg]     3.91824
Gastrointestinal Intraepithelial Neoplasia [neop]     3.91824
Immunosuppressive Effect [orgf]     3.91824
Peptic ulcer disease [dsyn]     3.91824
Severe dysplasia [comd]     3.91824
MW [geoa]     3.91824
Tortuosity [spco]     3.91824
[Cal] [qnco]     3.91824
nordic [hcro]     3.91824
Natural Selection [npop]     3.91824
Patient type [clas]     3.91824
Retroperitoneal liposarcoma [neop]     3.91824
Conventional angiography [diap]     3.91824
Ambulation [dora]     3.91824
Infection, Clostridium [dsyn]     3.91824
ossifying [ftcn]     3.91824
treatment goals [inpr]     3.91824
aquatic [topp]     3.91824
Sporadic porphyria cutanea tarda [dsyn]     3.91824
prothrombin time ratio [lbtr]     3.91824
Haemosiderin deposition [patf]     3.91824
Ethnopharmacology [bmod]     3.91824
nitric oxide formation [moft]     3.91824
Left breast [bpoc]     3.91824
Estrogen Receptor Status [clna]     3.91824
Primitive germ cell [cell]     3.91824
Cerebral cortex [bpoc]     3.91824
lilacs [plnt]     3.91824
Restaurants [mnob]     3.91824
membrane-bounded vesicle [celc]     3.91824
Sudden death [patf]     3.91824
Respiratory Distress Syndrome, Acute [dsyn]     3.91824
apgar scores [orga]     3.91824
C3H/HeN Mouse [mamm]     3.91824
gall bladder development [ortf]     3.91824
Pneumococcal vaccination [topp]     3.91824
Osteomyelitis [dsyn]     3.91824
HEINZ [lbpr]     3.91824
Test [bpoc]     3.91824
Teratoma - category [clas]     3.91824
Human papilloma virus 11 [virs]     3.91824
testis-specific protein [gngm]     3.91824
patients education [edac]     3.91824
trip [phpr]     3.91824
Mongrel [mamm]     3.91824
Heterogeneous Echotexture [fndg]     3.91824
{Spray} [qnco]     3.91824
Atypical adenomatous hyperplasia [patf]     3.91824
Lipid Transport [celf]     3.91824
Selection Biases [qnco]     3.91824
Spontaneous Ruptures [patf]     3.91824
mEq/L [qnco]     3.91824
Social security number [inpr]     3.91824
Venous shunt [topp]     3.91824
Mean Life [phpr]     3.91824
ABHD12 [gngm]     3.91824
Adenocarcinoma, pancreatobiliary-type [neop]     3.91824
Package Inserts [mnob]     3.91824
Ascitis [bdsu]     3.91824
FVL [gngm]     3.91824
Friendship [socb]     3.91824
Technique, Immunoperoxidase [lbpr]     3.91824
Morning nausea [sosy]     3.91824
SUPEROXIDE DISMUTASE, COPPER-ZINC [gngm]     3.91824
Parietal peritoneum [tisu]     3.91824
Arterial malformation [cgab]     3.91824
Attending clinic [fndg]     3.91824
albumin transfusion [topp]     3.91824
Mean Cell Volume [lbtr]     3.91824
Liver sectors [inpr]     3.91824
GSTA2 [gngm]     3.91824
hepatosis [dsyn]     3.91824
Indefinite [qlco]     3.91824
Some [qnco]     3.91824
JAZF1 [gngm]     3.91824
RAD50 [gngm]     3.91824
cryptosporidium infection [dsyn]     3.91824
5621 [inpr]     3.91824
Baker [prog]     3.91824
Perinatal Exposure [hcpp]     3.91824
threonine metabolism [moft]     3.91824
Detoxification Process [moft]     3.91824
Calorie intake [clna]     3.91824
Mobility [fndg]     3.91824
conceived [ftcn]     3.91824
Chemiluminescence [npop]     3.91824
CSD2 [gngm]     3.91824
Enema [topp]     3.91824
Age at diagnosis [clna]     3.91824
Black Caribbean [popg]     3.91824
/HPF [qnco]     3.91824
Federated States of Micronesia [geoa]     3.91824
Common hepatic artery [bpoc]     3.91824
External wall [mnob]     3.91824
Digestive neoplasm NOS [neop]     3.91824
Familial hypercholesterolaemia [dsyn]     3.91824
Percutaneous Transluminal Angioplasty [topp]     3.91824
Trophoblast cell [cell]     3.91824
Dyslipidemias [dsyn]     3.91824
La Raza [popg]     3.91824
Chromatography, Affinity [lbpr]     3.91824
7p12 [celc]     3.91824
protein kinase cascade [moft]     3.91824
Field Survey [resa]     3.91824
Bag [mnob]     3.91824
RTEL1 [gngm]     3.91824
Neutrophil Infiltration [phsf]     3.91824
Beta thalassemia minor [dsyn]     3.91824
Joules [qnco]     3.91824
Coercion [socb]     3.91824
hsa-mir-122 [gngm]     3.91824
Risk-Benefit Assessment [resa]     3.91824
Suricata suricatta [mamm]     3.91824
Population Dynamics [qnco]     3.91824
Interphase nucleus [celc]     3.91824
Golden retriever [mamm]     3.91824
Lightly [qlco]     3.91824
tumor necrosis factor-alpha production [orgf]     3.91824
receptor ligand [moft]     3.91824
Ishak Score 3 [clas]     3.91824
Hardware, Computer [mnob]     3.91824
Turkey hepatitis virus [virs]     3.91824
ACTIVATION-INDUCED CYTIDINE DEAMINASE [gngm]     3.91824
oral supplements [phsu]     3.91824
Hg+2 [elii]     3.91824
Root canal, not otherwise specified [topp]     3.91824
Precocious [tmco]     3.91824
Acute lymphocytic leukaemia [neop]     3.91824
Diet, Low-Fat [topp]     3.91824
Intestinal disorders NOS [dsyn]     3.91824
PDHB [gngm]     3.91824
pharmacodynamic [ftcn]     3.91824
Recurrent Laryngeal Nerves [bpoc]     3.91824
Scrotal [bpoc]     3.91824
Breastfeeding [orgf]     3.91824
Orthologous [qlco]     3.91824
correctional facilities [mnob]     3.91824
Altitude [qnco]     3.91824
Proprietary [inpr]     3.91824
Prolactin deficiency [dsyn]     3.91824
Hypodynamia [orgf]     3.91824
Environmental management [topp]     3.91824
scale assessment [inpr]     3.91824
FAM123A [gngm]     3.91824
international scientific organization [hcro]     3.91824
T5 [blor]     3.91824
NF-E2 [gngm]     3.91824
Drinking frequency [fndg]     3.91824
Thoracic diaphragm [bpoc]     3.91824
Microproteinuria [dsyn]     3.91824
Antibody Affinity Chromatography [lbpr]     3.91824
Flavivirus [virs]     3.91824
Hepatico-duodenostomy [topp]     3.91824
Growth Medium [irda]     3.91824
Physical assessment [hlca]     3.91824
Tight Junction Protein 1 [gngm]     3.91824
CTNNB1 Gene Mutation [comd]     3.91824
bioelectricity [phsf]     3.91824
Renaissance [bodm]     3.91824
Blood Circulation [bdsu]     3.91824
Meningeal [spco]     3.91824
ORGANIC ANION TRANSPORTER 1 [gngm]     3.91824
Metals, Heavy [elii]     3.91824
void urine [orgf]     3.91824
Platelet Transfusion [topp]     3.91824
A3C [gngm]     3.91824
treatment model [inpr]     3.91824
toxin biosynthesis [moft]     3.91824
Subcutaneous Fat [tisu]     3.91824
Coinsurance [inpr]     3.91824
Nerve plexus [bpoc]     3.91824
Intrapulmonary [spco]     3.91824
Lymphoid Hyperplasia, Reactive [neop]     3.91824
duct dilation [topp]     3.91824
Anoikis [celf]     3.91824
multiple pathologies [dsyn]     3.91824
Hormonal Method [topp]     3.91824
Pulmonary Emphysema [dsyn]     3.91824
Heart Failure, Right-Sided [dsyn]     3.91824
PIWIL4 [gngm]     3.91824
Intrahepatic Bile Duct Dysplasia [neop]     3.91824
Pharmaceutical Services [hlca]     3.91824
FLUORESCENT MICROSCOPY [lbpr]     3.91824
NTCP [gngm]     3.91824
Japonica [euka]     3.91824
Effective Decision Making [fndg]     3.91824
Communications, Cell [celf]     3.91824
msec [tmco]     3.91824
Childhood onset [fndg]     3.91824
Current Procedural Terminology [inpr]     3.91824
Postoperative hypotension [patf]     3.91824
Pancreatic Serous Cystadenocarcinoma [neop]     3.91824
Lancet [medd]     3.91824
FERROPORTIN 1 [gngm]     3.91824
METASTASIS-ASSOCIATED GENE 1 [gngm]     3.91824
Dystonia, progressive [fndg]     3.91824
Right arm [bpoc]     3.91824
Tagging SNP [nusq]     3.91824
bcl-2 Gene [gngm]     3.91824
symptomatic relief [idcn]     3.91824
Pears [food]     3.91824
WHO [qlco]     3.91824
ARG1 [gngm]     3.91824
Claudin-5 [gngm]     3.91824
Pancreatobiliary-type carcinoma [neop]     3.91824
gastrointestinal disorders [dsyn]     3.91824
alcohol hepatitis [dsyn]     3.91824
kielin [gngm]     3.91824
NUDE [gngm]     3.91824
Amino Acids, Basic [aapp]     3.91824
Wood [sbst]     3.91824
tools use [fndg]     3.91824
kBq/kg [qnco]     3.91824
premalignant state [neop]     3.91824
Syngeneic [qlco]     3.91824
Safety-net Hospital [hcro]     3.91824
HIV-2 [virs]     3.91824
nach [menp]     3.91824
Neovascularity [patf]     3.91824
Lithiases [patf]     3.91824
Genetic Research [resa]     3.91824
NETS [gngm]     3.91824
Blood specimen [bdsu]     3.91824
REP [moft]     3.91824
Multiple symptoms [sosy]     3.91824
Marked heterogeneity [fndg]     3.91824
Gene Knock-In [mbrt]     3.91824
adipophilin [aapp]     3.91824
Immunization data [inpr]     3.91824
Naturopathy [topp]     3.91824
Bile Acid Sequestrants [phsu]     3.91824
Esophageal carcinoma [neop]     3.91824
Tr1 Cells [cell]     3.91824
Cerebellopontine Angle [bsoj]     3.91824
Bronchial Asthma [dsyn]     3.91824
volcano [npop]     3.91824
United States Food and Drug Administration [hcro]     3.91824
LC3 [gngm]     3.91824
Enzyme Gene [gngm]     3.91824
Gynaecomastia [dsyn]     3.91824
Mood [menp]     3.91824
scavenger [medd]     3.91824
SFTA2 [gngm]     3.91824
Wine [food]     3.91824
Seal [mamm]     3.91824
Water Movement [npop]     3.91824
Perivascular epithelioid cell tumor [neop]     3.91824
Cognition [menp]     3.91824
European Organization for Research and Treatment of Cancer [hcro]     3.91824
Extent of resection [qlco]     3.91824
Antitype [euka]     3.91824
Involvement patterns [clna]     3.91824
Carbon Ion Radiotherapy [topp]     3.91824
Magnetisation transfer imaging [diap]     3.91824
Study, Prevalence [qnco]     3.91824
Diabetes Mellitus, Type 1 [dsyn]     3.91824
Left cavernous sinus [bsoj]     3.91824
17q21 [celc]     3.91824
Choledochus [bpoc]     3.91824
osteoblast differentiation [celf]     3.91824
Kidney Cortex [bpoc]     3.91824
radiating [ftcn]     3.91824
Neuropathies, Cranial [dsyn]     3.91824
Palsy [fndg]     3.91824
Uterine Cervical Cancer [neop]     3.91824
Iron deficiency [dsyn]     3.91824
Hepatico-jejunal anastomosis [topp]     3.91824
NF-kB Signaling Pathway [genf]     3.91824
Th0 [cell]     3.91824
Treatment Status [fndg]     3.91824
Skin atrophy [dsyn]     3.91824
HNF4-ALPHA [gngm]     3.91824
Procedure Duration [tmco]     3.91824
Gene Knock Out [mbrt]     3.91824
Acute intestinal ischaemia [dsyn]     3.91824
MU-5 [gngm]     3.91824
mcg/kg [qnco]     3.91824
Ex-drinker [fndg]     3.91824
Right hip [blor]     3.91824
Pancreatic lobule [bpoc]     3.91824
Pleomorphic Cell [cell]     3.91824
In prison [fndg]     3.91824
TAPE [medd]     3.91824
hearing loss [dsyn]     3.91824
oz [qnco]     3.91824
married couples [famg]     3.91824
Low Grade Intraepithelial Neoplasia [comd]     3.91824
Jump graft [topp]     3.91824
X3 [gngm]     3.91824
Cough [sosy]     3.91824
Childhood Leukemia [neop]     3.91824
Governing Board [popg]     3.91824
Heterogeneous disorder [fndg]     3.91824
Partial Remission [fndg]     3.91824
porphyrin biosynthesis [moft]     3.91824
Biological Sciences [ocdi]     3.91824
Undifferentiated Neuroblastoma [neop]     3.91824
Nutritional Assessment [diap]     3.91824
Enteropathy, Protein-Losing [dsyn]     3.91824
Slovakia [geoa]     3.91824
Prescription Drugs [phsu]     3.91824
WNT INHIBITORY FACTOR 1 [gngm]     3.91824
Brittle [qlco]     3.91824
indole-3-lactic acid [orch]     3.91824
UCA1 [gngm]     3.91824
Metabolic rate [phsf]     3.91824
p73 [gngm]     3.91824
Short Noncoding RNA [nnon]     3.91824
Klebsiella Infection [dsyn]     3.91824
Immunotherapy, Active [topp]     3.91824
Secondary polycythaemia [dsyn]     3.91824
16q21 [celc]     3.91824
Mixed carcinoid-adenocarcinoma [neop]     3.91824
normal blood test [fndg]     3.91824
ECO [dsyn]     3.91824
Transitions, Epithelial-Mesenchymal [celf]     3.91824
FZD1 [gngm]     3.91824
RPA [celc]     3.91824
FUT1 [gngm]     3.91824
RADIOLOGIC EVALUATION [ftcn]     3.91824
22q11 [celc]     3.91824
Enumeration [qlco]     3.91824
A-BETA [gngm]     3.91824
Comprehensive Care [hlca]     3.91824
Cell Surface Antigen [imft]     3.91824
Systems, Ecological [npop]     3.91824
Keratinous cyst [anab]     3.91824
mL/sec [qnco]     3.91824
Pathologic TNM classification [clas]     3.91824
Symptom Management [hlca]     3.91824
Power doppler ultrasound [diap]     3.91824
Mood alteration [fndg]     3.91824
Circulatory Failure [patf]     3.91824
Map group [inpr]     3.91824
Gastric Outlet Obstruction [fndg]     3.91824
Almost Never [inpr]     3.91824
Exocrine pancreas [bpoc]     3.91824
Centrally located liver [fndg]     3.91824
Stout [food]     3.91824
Dose Fractionation [topp]     3.91824
Mycobacterial Infections [dsyn]     3.91824
Infectious Diseases Research [resa]     3.91824
engraved [mnob]     3.91824
DNA Arrays [resd]     3.91824
alphabets [inpr]     3.91824
autophosphorylation [moft]     3.91824
Conformal [socb]     3.91824
rosetting [celf]     3.91824
Pancreatic ductal cell [cell]     3.91824
Small Cell Lung Cancer [neop]     3.91824
Occupational Disease [dsyn]     3.91824
Spongiform encephalopathy [dsyn]     3.91824
6/120 [fndg]     3.91824
Non-Protocol [ftcn]     3.91824
Dietary Patterns [resa]     3.91824
Cotton seed [plnt]     3.91824
Argininosuccinate Synthetase Deficiency [dsyn]     3.91824
Oligonucleotide Primers [nnon]     3.91824
essential nutrient [chvf]     3.91824
bowel surgery [topp]     3.91824
Eukaryotes [euka]     3.91824
Cytodiagnoses [lbpr]     3.91824
serum copper [lbpr]     3.91824
interdisciplinary collaboration [hlca]     3.91824
Standard plate [medd]     3.91824
benign cyst [dsyn]     3.91824
American College of Physicians [prog]     3.91824
Specimen length [qnco]     3.91824
EXPORTIN 4 [gngm]     3.91824
Consumptive coagulopathy [dsyn]     3.91824
L27 [gngm]     3.91824
Flavan [orch]     3.91824
care seeking [inbe]     3.91824
Bilateral Cryptorchidism [cgab]     3.91824
elevated liver function [fndg]     3.91824
T-Cell Marker [irda]     3.91824
GUY [geoa]     3.91824
T cell differentiation [celf]     3.91824
brain tumours [neop]     3.91824
Acidophilic body [acab]     3.91824
Appendix [bpoc]     3.91824
guess [ftcn]     3.91824
5-alpha Reductase Inhibitor [phsu]     3.91824
Reproductive Technology, Assisted [topp]     3.91824
BNC [gngm]     3.91824
Lysis [patf]     3.91824
butyrate [lipd]     3.91824
Prosthesis [medd]     3.91824
PML nuclear body [celc]     3.91824
gene induction [genf]     3.91824
Critical [socb]     3.91824
Quality of life score [clna]     3.91824
Lipolyses [orgf]     3.91824
GL [geoa]     3.91824
Venoocclusive disease [dsyn]     3.91824
Financial status [fndg]     3.91824
Alloantigens [imft]     3.91824
Radio-Opaque [bodm]     3.91824
Laribacter hongkongensis [bact]     3.91824
Type B Virus [virs]     3.91824
Gold Therapy [topp]     3.91824
Orphan Disease [dsyn]     3.91824
Mesenteric angiogram [diap]     3.91824
Silver stain [lbpr]     3.91824
Tyrosinaemia type I [dsyn]     3.91824
14q32 [celc]     3.91824
acquired immune response [orgf]     3.91824
Brazil Nuts [food]     3.91824
Mucinous Colon Adenocarcinoma [neop]     3.91824
APOBEC3H [gngm]     3.91824
Esophageal biopsy [diap]     3.91824
tourists [popg]     3.91824
16q12.1 [celc]     3.91824
FETUIN B [gngm]     3.91824
Lower abdomen [blor]     3.91824
Conjunctival Kaposi Sarcoma [neop]     3.91824
Service, Indian Health [hcro]     3.91824
TRIO [gngm]     3.91824
Gastrointestinal Ulcers [dsyn]     3.91824
symptomatic aortic stenosis [dsyn]     3.91824
Synapse [bsoj]     3.91824
Clock, Circadian [orgf]     3.91824
MIR219-1 [gngm]     3.91824
Kidney Failure [dsyn]     3.91824
ER Status [clna]     3.91824
Weibull Distribution [qnco]     3.91824
MALDI-TOF [resa]     3.91824
Type C viral hepatitis [dsyn]     3.91824
Blepharoconjunctivitis [dsyn]     3.91824
Neuroglial Cells [cell]     3.91824
medical doctors [prog]     3.91824
arabian [fndg]     3.91824
Type 1 T-helper cell [cell]     3.91824
Study, Historical Cohort [qnco]     3.91824
Sedentary life style [fndg]     3.91824
copper binding [moft]     3.91824
Anoxia [patf]     3.91824
Pyrimidine [orch]     3.91824
Glutamate+Glutamine [orch]     3.91824
HSPD1 [gngm]     3.91824
fibrocytes [cell]     3.91824
Toe [bpoc]     3.91824
4q34-q35 [celc]     3.91824
5-hydroxyisourate [orch]     3.91824
citrate test [lbpr]     3.91824
gamma-glutamyl transpeptidase activity [moft]     3.91824
predatory carp [fish]     3.91824
Safety procedure [topp]     3.91824
ulcer healing [acab]     3.91824
IMP-3 [gngm]     3.91824
Pediatric Death [fndg]     3.91824
S. AUREUS [bact]     3.91824
Chronic sclerosing sialadenitis [dsyn]     3.91824
NO3 [gngm]     3.91824
Endotoxaemia [fndg]     3.91824
Hepatic Circulation [ortf]     3.91824
mitogen-activated protein kinase cascade [moft]     3.91824
Three-dimensional [spco]     3.91824
Myxococcus xanthus [bact]     3.91824
Alpha-haemolytic streptococcus [bact]     3.91824
investigate [qlco]     3.91824
Pulmonary node [bpoc]     3.91824
Corona [euka]     3.91824
Storm NOS [inpo]     3.91824
Controlled Clinical Trials, Randomized [resa]     3.91824
PODOCALYXIN-LIKE [gngm]     3.91824
Antiviral Drug Resistance [orga]     3.91824
Tumor Viruses [virs]     3.91824
Mild Chronic Inflammation [fndg]     3.91824
PTI [gngm]     3.91824
aerobes [bact]     3.91824
Oral chemotherapy [topp]     3.91824
EuroSCORE [inpr]     3.91824
Palpable mass [fndg]     3.91824
suzuki [fish]     3.91824
MODERATE DYSFUNCTION [fndg]     3.91824
androgen receptor activity [moft]     3.91824
Retinol binding protein level [lbpr]     3.91824
Metabolic Control [moft]     3.91824
Chemokine Ligand 3 [lbpr]     3.91824
Mesenchymal Stem Cells [cell]     3.91824
Legs [blor]     3.91824
Spherical shape [spco]     3.91824
Doberman pinscher [mamm]     3.91824
Malaysian [popg]     3.91824
Anoxic Encephalopathy [patf]     3.91824
Injury assessment [hlca]     3.91824
Functional modification [topp]     3.91824
Lysate [phob]     3.91824
month time [qnco]     3.91824
Diagonal [spco]     3.91824
hypercoagulable states [dsyn]     3.91824
COS-7 Cells [cell]     3.91824
Caudate Nucleus [bpoc]     3.91824
JNK Pathway [moft]     3.91824
Lipemia [fndg]     3.91824
Bone Cancer [neop]     3.91824
Tissue repair [orgf]     3.91824
Hispanic, black [fndg]     3.91824
Stress management [hlca]     3.91824
Portoenterostomy [topp]     3.91824
Systemic Reaction [biof]     3.91824
Public Sector [popg]     3.91824
DNA Methyltransferase 3B Gene [gngm]     3.91824
Hematological Diseases [dsyn]     3.91824
Walk [dora]     3.91824
B Cell Receptor Signaling Pathway [moft]     3.91824
lysophosphatidic acid [lipd]     3.91824
penis [bpoc]     3.91824
Structure, Genetic [gngm]     3.91824
Mosque [mnob]     3.91824
Indirect Costs [qnco]     3.91824
Cecal Cancer [neop]     3.91824
Cancer Prevention, Primary [topp]     3.91824
colo-rectal cancer [neop]     3.91824
Autosomal recessive inheritance [inpr]     3.91824
Feeds, Animal [food]     3.91824
North Asia [geoa]     3.91824
Bilateral Carcinoma [neop]     3.91824
Parametric Image [diap]     3.91824
XAP2 [gngm]     3.91824
hepatobiliary scan [diap]     3.91824
Intramucosal Adenocarcinoma [neop]     3.91824
Photon [clas]     3.91824
Ultrasound angiography [diap]     3.91824
General wellbeing [fndg]     3.91824
assist [prog]     3.91824
Cholestatic cirrhosis [dsyn]     3.91824
Dream [menp]     3.91824
brief interventions [hlca]     3.91824
cause injury [fndg]     3.91824
Vasodilatation [phsf]     3.91824
Computed tomography guided biopsy [diap]     3.91824
Complex I [celc]     3.91824
remind [topp]     3.91824
RX [gngm]     3.91824
Intentional weight loss [fndg]     3.91824
12q13 [celc]     3.91824
Recommended follow-up [hlca]     3.91824
Tyrosine Kinase Domain [amas]     3.91824
Medicine, Naturopathic [topp]     3.91824
control systems [rnlw]     3.91824
PO [spco]     3.91824
radioprotection [topp]     3.91824
Pickled food [food]     3.91824
alpha subgroup [bact]     3.91824
online search [ocac]     3.91824
Peritoneoscopy [diap]     3.91824
Lower respiratory tract [bdsy]     3.91824
interferon-gamma production [orgf]     3.91824
Natural Killer Cell Activation [celf]     3.91824
Hepatosplenic schistosomiasis [dsyn]     3.91824
Hyperplastic polyps [neop]     3.91824
Unfiltered [qlco]     3.91824
Urinary output [clna]     3.91824
Cost, Hospital [qnco]     3.91824
methionine sulfoxide [aapp]     3.91824
Irrigate [ftcn]     3.91824
Bacteroides uniformis [bact]     3.91824
Study Type [resa]     3.91824
Peruvian [popg]     3.91824
Maghreb [geoa]     3.91824
Visual Aid [mnob]     3.91824
NR1H4 [gngm]     3.91824
abnormal blood vessels [fndg]     3.91824
septum [clas]     3.91824
inferior vena cava thrombosis [dsyn]     3.91824
ioversol [irda]     3.91824
Liver Carcinosarcoma [neop]     3.91824
IMN [geoa]     3.91824
Systemic illness [dsyn]     3.91824
Maternal death [qnco]     3.91824
cold storage [lbpr]     3.91824
Estrogen hormone therapy [topp]     3.91824
Trisomy 2 [dsyn]     3.91824
Albania [geoa]     3.91824
PDCD4 [gngm]     3.91824
Ozone [chem]     3.91824
NUDT1 [gngm]     3.91824
Right kidney [bpoc]     3.91824
Associated with [qlco]     3.91824
neck tumour [neop]     3.91824
Djibouti [geoa]     3.91824
Perivascular dermatitis [dsyn]     3.91824
Familial porphyria cutanea tarda [dsyn]     3.91824
Pylorus preserving pancreaticoduodenectomy [topp]     3.91824
Subtract [inpr]     3.91824
Actin Filaments [celc]     3.91824
Hepatitis B virus basal core promoter mutation [dsyn]     3.91824
Hepatic haemorrhage [patf]     3.91824
Clusters of differentiation [clna]     3.91824
Bithynia [euka]     3.91824
chemotherapy administration [topp]     3.91824
Blood sugar management [topp]     3.91824
CA10 [gngm]     3.91824
MICRO RNA 146A [gngm]     3.91824
Nipah Virus [virs]     3.91824
Virus, Associated [virs]     3.91824
WAVE2 [gngm]     3.91824
KLOTHO, BETA [gngm]     3.91824
mm2 [qnco]     3.91824
DNA-BINDING PROTEIN A [gngm]     3.91824
Radioisotope [elii]     3.91824
RKIP [gngm]     3.91824
MAT1A [gngm]     3.91824
GPC [gngm]     3.91824
FUBP1 [gngm]     3.91824
Tricarboxylic Acid Cycle [moft]     3.91824
fumarylacetoacetate hydrolase activity [moft]     3.91824
Hepatogastrostomy [topp]     3.91824
AE2 [gngm]     3.91824
Primary ciliary dyskinesia [dsyn]     3.91824
Clinical Overview [rnlw]     3.91824
Hysterectomies [topp]     3.91824
Blood Chemistry Test [lbpr]     3.91824
U/d [qnco]     3.91824
NTHL1 [gngm]     3.91824
Papillary Thyroid Microcarcinoma [neop]     3.91824
Herpes simplex 2 [dsyn]     3.91824
Oral hypoglycaemic [phsu]     3.91824
Population Pressure [qnco]     3.91824
Euthanasia [hlca]     3.91824
diazo compound [orch]     3.91824
100 cells [cell]     3.91824
Identical twin brother [famg]     3.91824
monocyte activation [celf]     3.91824
neoandrographolide [carb]     3.91824
farnesylthiosalicylic acid [orch]     3.91824
Philosophical [qlco]     3.91824
Esophageal candidiasis [dsyn]     3.91824
Jejuno-Ileal Bypass [topp]     3.91824
Iritis [dsyn]     3.91824
NF-KAPPA-B-ACTIVATING KINASE [gngm]     3.91824
CD57 [gngm]     3.91824
Metabolic acidosis [patf]     3.91824
Oligodendroglial Tumors [inpr]     3.91824
vascular bed [bpoc]     3.91824
gallbladder wall thickening [fndg]     3.91824
Hospital Charges [qnco]     3.91824
LENTIL AGGLUTININ BINDING [gngm]     3.91824
Prostaglandin Production [phsf]     3.91824
Primigravida [fndg]     3.91824
Heme Iron [elii]     3.91824
Endogenous Factors [ftcn]     3.91824
LTBP3 [gngm]     3.91824
ACOX1 [gngm]     3.91824
Piecemeal necrosis [patf]     3.91824
vascular reactivity [clna]     3.91824
Cardiac Tumor [neop]     3.91824
Bronchial [bpoc]     3.91824
Atopobium [bact]     3.91824
undetermined significance [fndg]     3.91824
Low-Dose Treatment [resa]     3.91824
Muscle biopsy [diap]     3.91824
NCRNA [cgab]     3.91824
false-positive test result [lbtr]     3.91824
WR [gngm]     3.91824
virotherapy [topp]     3.91824
Family Size [grpa]     3.91824
work out [fndg]     3.91824
platelets/L [qnco]     3.91824
Single [qnco]     3.91824
antihyperlipidemic [phsu]     3.91824
permission [qlco]     3.91824
Heat Production [orgf]     3.91824
remind [cnce]     3.91824
Radioimmunotherapy [topp]     3.91824
positive hcg [lbtr]     3.91824
FOXJ2 [gngm]     3.91824
precancerous state [neop]     3.91824
Abdominal wall muscle [bpoc]     3.91824
peritoneal lesion [dsyn]     3.91824
KIP [gngm]     3.91824
subculture [lbpr]     3.91824
convention [hcpp]     3.91824
foodborne [inpr]     3.91824
SLE NOS [dsyn]     3.91824
widow [famg]     3.91824
LAMC1 [gngm]     3.91824
Severe [topp]     3.91824
tab [bodm]     3.91824
Platichthys stellatus [fish]     3.91824
Hepatitis C carrier [fndg]     3.91824
digestive tract disease [dsyn]     3.91824
129S4/SvJae [mamm]     3.91824
Serum homocystine level [lbpr]     3.91824
ABCB1 gene [gngm]     3.91824
Uninsured [popg]     3.91824
Cryptococcus [fngs]     3.91824
Infectious disease specialist [prog]     3.91824
Red meat [food]     3.91824
Testicular Cancers [neop]     3.91824
prophylactic surgery [fndg]     3.91824
AIDS Epidemiology [bmod]     3.91824
Genetic Epidemiologies [ocdi]     3.91824
Ventilated [ftcn]     3.91824
Hostilities [menp]     3.91824
miRNA499 [gngm]     3.91824
ecg findings [fndg]     3.91824
Mastocytosis, Systemic [dsyn]     3.91824
Incidental Discovery [fndg]     3.91824
DRA [gngm]     3.91824
thiopurines [phsu]     3.91824
SJA [fish]     3.91824
functional group [chvf]     3.91824
Fee Schedules [qnco]     3.91824
emotional dysfunction [mobd]     3.91824
Stable status [qlco]     3.91824
Left superior [spco]     3.91824
Overactive [qlco]     3.91824
Time-to-Treatment [tmco]     3.91824
Inferior mesenteric vein [bpoc]     3.91824
swabs [sbst]     3.91824
Iodamoeba [euka]     3.91824
integrator complex subunit 6 pseudogene 1 [gngm]     3.91824
Natal [geoa]     3.91824
VLDL [lbpr]     3.91824
Nucleo-cytoplasmic Transport [celf]     3.91824
Bladder Tumor [neop]     3.91824
Tobacco abuse [fndg]     3.91824
exposure history [fndg]     3.91824
Daily Activity [dora]     3.91824
Vascular sinusoid [bpoc]     3.91824
Extramedullary [spco]     3.91824
Head CT [diap]     3.91824
methadone treatment [topp]     3.91824
PI-9 [aapp]     3.91824
validity reliability [qlco]     3.91824
Aliquot [qnco]     3.91824
micromolar [qnco]     3.91824
Epidermal Growth Factor Receptor Overexpression [comd]     3.91824
Preclinical Testing [resa]     3.91824
Sex Chromosomes [celc]     3.91824
Conjugate [spco]     3.91824
Chronic viral hepatitis C [dsyn]     3.91824
MRP3 [gngm]     3.91824
Clinical Oncology [bmod]     3.91824
Knowledge [fndg]     3.91824
Mammography - screening [topp]     3.91824
Align [qnco]     3.91824
Radiology Procedures [diap]     3.91824
Aberrant vessel [cgab]     3.91824
Patient Class [clas]     3.91824
Unprocessed [qlco]     3.91824
digital imaging [mcha]     3.91824
Acinetobacter baumannii [bact]     3.91824
Ara [bird]     3.91824
Airway, NOS [medd]     3.91824
budding [celf]     3.91824
Electron [qnco]     3.91824
high cholesterol [fndg]     3.91824
Venovenous [spco]     3.91824
predictive variables [inpr]     3.91824
Intestinal schistosomiasis [dsyn]     3.91824
Maternal care NOS [hlca]     3.91824
steroid use [inbe]     3.91824
Acute physiology and chronic health evaluation II [qnco]     3.91824
Abdomen+Pelvis [bpoc]     3.91824
Plum [plnt]     3.91824
EPIDERMAL GROWTH FACTOR-LIKE 7 [gngm]     3.91824
stimulant [phsu]     3.91824
Sister [famg]     3.91824
Futility [qlco]     3.91824
TP53 gene [gngm]     3.91824
Hepatoprotective Agent [phsu]     3.91824
Self Medication [inbe]     3.91824
Third-World Countries [qlco]     3.91824
isotope studies [diap]     3.91824
Cellular Transformation [patf]     3.91824
chronic inflammatory response [patf]     3.91824
Transgenesis [resa]     3.91824
male sex hormone [lbpr]     3.91824
tube formation [ortf]     3.91824
alcohol ablation [topp]     3.91824
CYLD [gngm]     3.91824
M-cell [cell]     3.91824
Systemic hypertension [dsyn]     3.91824
Salad [food]     3.91824
Receptor Gene [gngm]     3.91824
5 minute Apgar Score [clna]     3.91824
Hinge [medd]     3.91824
Imprisonment [fndg]     3.91824
Mammary Tumorigenesis [neop]     3.91824
PNKD [gngm]     3.91824
Hip circumference [clna]     3.91824
SOLT [gngm]     3.91824
salvador [gngm]     3.91824
Lithotomy position [spco]     3.91824
Weight change [fndg]     3.91824
Spinach [food]     3.91824
TROP2 [gngm]     3.91824
Summer [tmco]     3.91824
Familial Hypobetalipoproteinemia [dsyn]     3.91824
Technique, Molecular Diagnostic [mbrt]     3.91824
Mycoplasma [bact]     3.91824
Data points [clna]     3.91824
DPP4 [gngm]     3.91824
Nutritional supplementation [food]     3.91824
Biliary tract reconstruction [topp]     3.91824
cation transporting ATPase [gngm]     3.91824
Genes, Developmental [gngm]     3.91824
Toxoplasma [euka]     3.91824
Assessment service [hcro]     3.91824
Genomic Imprinting [genf]     3.91824
Monkeys, Old World [mamm]     3.91824
Infections, Focal [dsyn]     3.91824
Monitoring, Intraoperative [diap]     3.91824
gastrin levels [lbtr]     3.91824
KIM-1 [lbpr]     3.91824
Splenorenal Shunt [topp]     3.91824
Cervical swab [bdsu]     3.91824
Smooth Muscles [tisu]     3.91824
Health Service Area [geoa]     3.91824
Cardiac structure [bpoc]     3.91824
Polyarteritis [dsyn]     3.91824
Cancer Prevention, Secondary [topp]     3.91824
Colorectal Surgery [bmod]     3.91824
Echinococcus [euka]     3.91824
Rosette formation [fndg]     3.91824
low prothrombin time [fndg]     3.91824
EV [qnco]     3.91824
vietnam veteran [popg]     3.91824
anomalies [ftcn]     3.91824
Hepatitis C virus genotype (finding) [fndg]     3.91824
chromatin organisation [genf]     3.91824
surgical pathology immunohistochemistry [diap]     3.91824
Virus Release [npop]     3.91824
Soft tissue lesion [patf]     3.91824
Tumor Identification [diap]     3.91824
Sutured [ftcn]     3.91824
sbp [diap]     3.91824
Appendicitis [dsyn]     3.91824
SPA [gngm]     3.91824
Uncertain diagnosis [fndg]     3.91824
ATR [gngm]     3.91824
Venous catheterisation [hlca]     3.91824
Dose Modification [resa]     3.91824
Microvilli [celc]     3.91824
In Vitro Fertilization [topp]     3.91824
Community-Acquired Infections [dsyn]     3.91824
Copper intake [fndg]     3.91824
spindle microtubule [celc]     3.91824
FLAME [gngm]     3.91824
Hemiliver [bpoc]     3.91824
ARNTL [gngm]     3.91824
Poll [bpoc]     3.91824
Uroporphyria [dsyn]     3.91824
Xeloda [phsu]     3.91824
Sustainable Development [npop]     3.91824
Flakes [bodm]     3.91824
c. perfringens [bact]     3.91824
erythematous [ftcn]     3.91824
Glycoprotein Biosynthesis [moft]     3.91824
tumor antigen gene [gngm]     3.91824
lung resection [topp]     3.91824
Accident [inpo]     3.91824
Open heart surgery [topp]     3.91824
cytokeratin 10 [gngm]     3.91824
vasoactive agent [phsu]     3.91824
Normothermic [qlco]     3.91824
Human leucocyte antigen DRB1 allele [gngm]     3.91824
Eubacterium lentum [bact]     3.91824
Phototherapy [topp]     3.91824
Decreased visual acuity [fndg]     3.91824
Secondary Structure [spco]     3.91824
genome database [inpr]     3.91824
MODS [patf]     3.91824
TOD [dsyn]     3.91824
Disease remission [fndg]     3.91824
I 6 [cell]     3.91824
ACAN [gngm]     3.91824
Coregonus [fish]     3.91824
Splenic abscess [dsyn]     3.91824
Intraoperative death [fndg]     3.91824
Services, Pharmacy [hlca]     3.91824
Imam [prog]     3.91824
Transbronchial [spco]     3.91824
Ductal Epithelium [tisu]     3.91824
Osteoid tissue [tisu]     3.91824
Clone Cells [cell]     3.91824
Rex [mamm]     3.91824
Hypocomplementemia [patf]     3.91824
MAPK/ERK Kinase Inhibitor [phsu]     3.91824
FUT2 [gngm]     3.91824
Translational Inhibition [genf]     3.91824
Fetal Alcohol Syndrome [dsyn]     3.91824
GFER [gngm]     3.91824
Arbitrary unit [qnco]     3.91824
Host Defense Mechanism [ortf]     3.91824
Female Reproductive Tract [bdsy]     3.91824
PPL [gngm]     3.91824
Salivary [spco]     3.91824
Due to [ftcn]     3.91824
CMR [geoa]     3.91824
Peptic Esophagitis [dsyn]     3.91824
HA-1 [gngm]     3.91824
HCC - Hepatocellular carcinoma [neop]     3.91824
intestinal infections [dsyn]     3.91824
luzindole [orch]     3.91824
life skills [inbe]     3.91824
Organogenesis [biof]     3.91824
biliary cystadenoma [neop]     3.91824
Native-Born [popg]     3.91824
Bioreactors [phob]     3.91824
transmembrane protein 9 [gngm]     3.91824
giant cell reaction [patf]     3.91824
Radiographies, Abdominal [diap]     3.91824
Fistulogram [diap]     3.91824
TO MRI [clna]     3.91824
Twins, Dizygotic [famg]     3.91824
Non-Nucleoside Reverse Transcriptase Inhibitors [moft]     3.91824
GNMT [moft]     3.91824
Epidemiologic Surveillance [ocac]     3.91824
Pneumoperitoneum [dsyn]     3.91824
Exercise Tests [diap]     3.91824
Fibrinogen level [lbpr]     3.91824
Inorganic arsenic [inch]     3.91824
Syncytiotrophoblast cell [cell]     3.91824
Isocenter [spco]     3.91824
Missouri [geoa]     3.91824
Herniation [anab]     3.91824
Post-Mortem Examination [diap]     3.91824
lecture [inpr]     3.91824
health care referral [ocac]     3.91824
LAT [ftcn]     3.91824
micrometer [qnco]     3.91824
response radiation [orgf]     3.91824
Neuroblastic Tumor [neop]     3.91824
Mice, 129 [mamm]     3.91824
Normal histology findings [fndg]     3.91824
Neuroectodermal Tumors, Primitive [neop]     3.91824
Angiotensin I-Converting Enzyme Inhibitors [phsu]     3.91824
Special [ocdi]     3.91824
Reflex [ortf]     3.91824
adolescent girls [aggp]     3.91824
STERILIZATION, INADEQUATE [phpr]     3.91824
Large spleen [fndg]     3.91824
Rheumatoid Arthritis [dsyn]     3.91824
Con A assay [lbpr]     3.91824
Rage [menp]     3.91824
Gene Deletion [genf]     3.91824
Tennessee [geoa]     3.91824
emergency procedures [topp]     3.91824
Gadolinium-based Contrast Agent [irda]     3.91824
Haemopoietic tissue [tisu]     3.91824
CCDC85A [gngm]     3.91824
Septic arthritis [dsyn]     3.91824
Vena hepatica [bpoc]     3.91824
Whole Genome Amplification [mbrt]     3.91824
Splenic Tissue [tisu]     3.91824
Bladder mucosa [bpoc]     3.91824
health information [hlca]     3.91824
Rhesus [mamm]     3.91824
IL-6R [moft]     3.91824
Polynomial [qnco]     3.91824
SV 40 [virs]     3.91824
Antero-inferior [spco]     3.91824
Solid Phase Microextraction [lbpr]     3.91824
Estrogen Receptor Antagonist [phsu]     3.91824
Fetal growth restriction [patf]     3.91824
Monophasic [tmco]     3.91824
High risk tumor [qlco]     3.91824
Guide wire [medd]     3.91824
rhythms [fndg]     3.91824
Haemorrhagic necrosis [patf]     3.91824
Air Travel [dora]     3.91824
FAC [dsyn]     3.91824
Sector [spco]     3.91824
Blood sample [diap]     3.91824
Mann-Whitney U Test [qnco]     3.91824
protein phosphatase 4 complex [celc]     3.91824
HERC3 [gngm]     3.91824
organ growth [orgf]     3.91824
Transplantation, Allogeneic [topp]     3.91824
Proximal tubulopathy [fndg]     3.91824
Hyperhomocysteinemia [dsyn]     3.91824
Null Allele [comd]     3.91824
Human Chromosome [celc]     3.91824
MKP-4 [gngm]     3.91824
Peroperative cholangiogram [diap]     3.91824
Distal site [spco]     3.91824
nmol/L [qnco]     3.91824
blood perfusion [ortf]     3.91824
Thyroid Gland [bpoc]     3.91824
Alpha2 [qlco]     3.91824
GTA [gngm]     3.91824
Experimental Pathology [bmod]     3.91824
CD206 [gngm]     3.91824
Antibody Production [biof]     3.91824
Smallpox [dsyn]     3.91824
Cancer Susceptibility Gene [gngm]     3.91824
macular [spco]     3.91824
NJ [geoa]     3.91824
Mycobacteria, Atypical [bact]     3.91824
Roux-en-Y choledochojejunostomy [topp]     3.91824
Lymphography [diap]     3.91824
population migration [socb]     3.91824
anatomic variant [orga]     3.91824
Unexposed Group [popg]     3.91824
relative survival rate [qnco]     3.91824
TFIIH [gngm]     3.91824
Early Therapy [topp]     3.91824
I1 [gngm]     3.91824
glutamyl transpeptidase activity [moft]     3.91824
Histone Deacetylase 6 Gene [gngm]     3.91824
Fetal Growth [phsf]     3.91824
Cage [mnob]     3.91824
Pooled Sample [cnce]     3.91824
6 chromosome [celc]     3.91824
Osteolysis [patf]     3.91824
Societal Factors [ftcn]     3.91824
International Cooperation [gora]     3.91824
Gate-keeper [prog]     3.91824
Multimedia [inpr]     3.91824
Indwelling [ftcn]     3.91824
Filament [celc]     3.91824
LY [geoa]     3.91824
Left inferior phrenic artery [bpoc]     3.91824
Cyclopentane [orch]     3.91824
Non-Ionizing Radiation [npop]     3.91824
Canadian Dollar [qnco]     3.91824
VISUAL INSPECTION [ftcn]     3.91824
HAE [dsyn]     3.91824
Collagen fiber [tisu]     3.91824
contextual factors [ftcn]     3.91824
Assays, Biological [lbpr]     3.91824
hormone administration [topp]     3.91824
antibiotic side effects [inpo]     3.91824
NSAIDs [phsu]     3.91824
Subphrenic region [blor]     3.91824
Median Sternotomy [topp]     3.91824
venesection [topp]     3.91824
Ventriculus [bpoc]     3.91824
Candidacidal activity [lbpr]     3.91824
alkaline phosphatase activity [moft]     3.91824
Haematochezia [fndg]     3.91824
Radiculopathy [dsyn]     3.91824
Unwilling [menp]     3.91824
PATE [gngm]     3.91824
Angiomatous [qlco]     3.91824
Hemorrhage, Intracranial [patf]     3.91824
Trichoepithelioma [neop]     3.91824
liver hemorrhage [patf]     3.91824
Knowledge Base [inpr]     3.91824
Iraq [geoa]     3.91824
Architect [prog]     3.91824
AFG1 [gngm]     3.91824
Mucosal [patf]     3.91824
cleaners [medd]     3.91824
Organ Preservation [topp]     3.91824
Sarcomatoid carcinoma [neop]     3.91824
cell activation [celf]     3.91824
Gray syndrome [dsyn]     3.91824
Enzyme immunoassay method [lbpr]     3.91824
Tissue Extracts [bacs]     3.91824
active state [fndg]     3.91824
With onset [qlco]     3.91824
in situ adenocarcinoma [neop]     3.91824
Typhi [orgm]     3.91824
IV Infusion [topp]     3.91824
Glutathione S-Transferase Theta 1 Gene [gngm]     3.91824
suppurative [patf]     3.91824
Orbital mass [fndg]     3.91824
GatA [gngm]     3.91824
Comparison.study [clna]     3.91824
TMEM82 [gngm]     3.91824
blood function [ortf]     3.91824
Striatum [bpoc]     3.91824
Whole milk [food]     3.91824
protein tumor markers [irda]     3.91824
Fundus [blor]     3.91824
rectification [hcpp]     3.91824
AJCC staging system [clas]     3.91824
soft tissues tumours [neop]     3.91824
False [qlco]     3.91824
Enteral Nutrition [topp]     3.91824
Privilege [idcn]     3.91824
Infinity [qnco]     3.91824
Low cholesterol [fndg]     3.91824
Malignant Soft Tissue Neoplasm [neop]     3.91824
Afghanistan [geoa]     3.91824
Hyperaemia [patf]     3.91824
plasmocytes [cell]     3.91824
Financial Support [idcn]     3.91824
Plasma cell infiltration [dsyn]     3.91824
argon beam [medd]     3.91824
janssen [hcro]     3.91824
brain controls [menp]     3.91824
Mitochondrial DNA deletions [comd]     3.91824
Paraesthesia [sosy]     3.91824
Trefoil [plnt]     3.91824
F1 generation [famg]     3.91824
Portosystemic Encephalopathy [dsyn]     3.91824
3p25 [celc]     3.91824
Unassessed [qlco]     3.91824
upsetting [mobd]     3.91824
geographic population [qnco]     3.91824
Pancreatic NET [neop]     3.91824
pineal [bpoc]     3.91824
Vein, Pulmonary [bpoc]     3.91824
Streptococcus salivarius [bact]     3.91824
RACGAP1 [gngm]     3.91824
RSPO2 [gngm]     3.91824
Agriculture Department [orgt]     3.91824
Vascular System [bdsy]     3.91824
LogE [qnco]     3.91824
Organizational [orgt]     3.91824
cocaine use [mobd]     3.91824
Spontaneous fistula [acab]     3.91824
PS20 [gngm]     3.91824
engorged [ftcn]     3.91824
Sedation, Moderate [topp]     3.91824
L protein, hepatitis B virus [aapp]     3.91824
Urea Cycle Metabolism Disorder [dsyn]     3.91824
Bilharziasis [dsyn]     3.91824
JUN ACTIVATION DOMAIN-BINDING PROTEIN [gngm]     3.91824
Bahrain [geoa]     3.91824
Aortic dissection [dsyn]     3.91824
Liver Neuroendocrine Tumor [neop]     3.91824
high throughput analysis [diap]     3.91824
Interphase Cell [cell]     3.91824
Serum electrolytes [lbpr]     3.91824
Health Costs [qnco]     3.91824
Power Source [mnob]     3.91824
NME7 gene [gngm]     3.91824
CDX1 [gngm]     3.91824
NME7 [gngm]     3.91824
Episcleritis [dsyn]     3.91824
9p22 [celc]     3.91824
Staphylococcus sp [bact]     3.91824
Liver Fibroses [dsyn]     3.91824
Floor [mnob]     3.91824
Pond [geoa]     3.91824
Invagination [anab]     3.91824
Preputial gland [bpoc]     3.91824
Peripheral Resistance [phsf]     3.91824
Intraoperative Radiation Therapy [topp]     3.91824
Multiplex Polymerase Chain Reaction [mbrt]     3.91824
Stereotactic [spco]     3.91824
Breast tissue [bpoc]     3.91824
Population Size [qnco]     3.91824
Coronary angiography [diap]     3.91824
pancreatic juice [bdsu]     3.91824
bilirubin testing [medd]     3.91824
Neoplastic Fibroblast [cell]     3.91824
DDX3 [gngm]     3.91824
hepatic duct stenosis [dsyn]     3.91824
Blur [qlco]     3.91824
Biotechnology [bmod]     3.91824
Spinal metastases [neop]     3.91824
Failure to Thrive [dsyn]     3.91824
Bronchiectasis [dsyn]     3.91824
Cardiac Diseases [dsyn]     3.91824
Mesenchymal Stem Cell Transplantation [topp]     3.91824
Stool microscopy [lbpr]     3.91824
Immunofluorescence Microscopy [lbpr]     3.91824
Rarely malignant [fndg]     3.91824
Serum ferritin level [lbpr]     3.91824
MCM2 [gngm]     3.91824
Tofu [food]     3.91824
contrast dye [irda]     3.91824
NLM [hcro]     3.91824
Person [mobd]     3.91824
abdominal wall closure [topp]     3.91824
N-terminal pro-Brain Natriuretic Peptide [lbpr]     3.91824
Normal transferrin saturation [fndg]     3.91824
Celibate [inbe]     3.91824
DNA repair protein [moft]     3.91824
Hemoglobin Subunit Beta [aapp]     3.91824
X-gal [carb]     3.91824
Hepatic Sarcoma [neop]     3.91824
Chimney [mnob]     3.91824
Abnormalities, Multiple [cgab]     3.91824
PR+ [gngm]     3.91824
Intravenous therapy [topp]     3.91824
shunt occlusion [patf]     3.91824
Random blood glucose level [lbpr]     3.91824
embalmed [ocac]     3.91824
Stoma [anst]     3.91824
Pulmonary hypoplasia [cgab]     3.91824
Drug Delivery Systems [medd]     3.91824
accelerate [mnob]     3.91824
EVALUATION RESULT [idcn]     3.91824
Epithelial Cell Proliferation [celf]     3.91824
Grand multiparity [fndg]     3.91824
shear stress [npop]     3.91824
Haemocholecyst [patf]     3.91824
Premature Infants [aggp]     3.91824
Candidate Gene Association Study [mbrt]     3.91824
KINESIN FAMILY MEMBER 20A [gngm]     3.91824
Posterior segment [blor]     3.91824
Community Integration [socb]     3.91824
Abdominal pain, right upper quadrant [sosy]     3.91824
HSD [dsyn]     3.91824
Sport [dora]     3.91824
human urine [phsu]     3.91824
KIELIN/CHORDIN-LIKE PROTEIN [gngm]     3.91824
Acute lymphoid leukaemia [neop]     3.91824
Only Children [famg]     3.91824
Decreased serum ferritin [fndg]     3.91824
Liver schistosomiasis [dsyn]     3.91824
Viral serologic study [lbpr]     3.91824
Choledochoenterostomy [topp]     3.91824
Lung Abscess [dsyn]     3.91824
RAR [gngm]     3.91824
COPPER TOXICOSIS, IDIOPATHIC [dsyn]     3.91824
Anti-Hypertensive Agents [phsu]     3.91824
Struma Ovarii [neop]     3.91824
diagnostic radiology [diap]     3.91824
Unknown Primary Tumor [neop]     3.91824
aesthetic [ocdi]     3.91824
Health Related Behaviors [inbe]     3.91824
Partum [clna]     3.91824
kJ [qnco]     3.91824
Lorisidae [mamm]     3.91824
Strain [phsf]     3.91824
Cardiomegaly [fndg]     3.91824
podosome [celc]     3.91824
SFRP5 [gngm]     3.91824
Respiratory tract infection [dsyn]     3.91824
Arteriovenous shunt [anab]     3.91824
Prunus salicina [plnt]     3.91824
cohesion [npop]     3.91824
Direct Repeat [nusq]     3.91824
Anterior chest [blor]     3.91824
Left temple [blor]     3.91824
Cell structure [cell]     3.91824
Float [qlco]     3.91824
Lung Injury [inpo]     3.91824
Remission Induction [topp]     3.91824
transporter activity [moft]     3.91824
Neonatal cholestasis [dsyn]     3.91824
Genus Helicobacter [bact]     3.91824
Published [ocdi]     3.91824
Mitochondrial alteration [comd]     3.91824
Leishmania donovani [euka]     3.91824
Swedes [popg]     3.91824
Spermatogenesis [celf]     3.91824
Cannabis Dependence [mobd]     3.91824
HIV seropositive [fndg]     3.91824
IDH [gngm]     3.91824
patient registries [inpr]     3.91824
Gastro-esophageal reflux disease [dsyn]     3.91824
Cow [inpr]     3.91824
Peritoneal Fluid [bdsu]     3.91824
caspase-3 activity [moft]     3.91824
mild reaction [qlco]     3.91824
Mean blood pressure [fndg]     3.91824
Snack [food]     3.91824
Physical [ocdi]     3.91824
Extended radical [qlco]     3.91824
Screw [medd]     3.91824
Pharmacologic Management [hlca]     3.91824
cardiopulmonary disease [dsyn]     3.91824
Enlisted [idcn]     3.91824
citrate synthase activity [moft]     3.91824
Contrast Sensitivity [menp]     3.91824
Stilt [bird]     3.91824
unintentional injury [inpo]     3.91824
parks [mnob]     3.91824
Autologous Tumor Cell [cell]     3.91824
Serum prothrombin time [lbpr]     3.91824
Isodose [qnco]     3.91824
Defaecation [orgf]     3.91824
Anesthetics [fndg]     3.91824
Caliper [medd]     3.91824
Presenting complaint [fndg]     3.91824
Malignant neoplastic disease [neop]     3.91824
AGO3 [gngm]     3.91824
steroid treatment [topp]     3.91824
DC1 [gngm]     3.91824
Survey, Nutrition [resa]     3.91824
IC [inch]     3.91824
Passive smoker [fndg]     3.91824
jails [mnob]     3.91824
GCK [gngm]     3.91824
Vacuolisation [fndg]     3.91824
Ventricular volume [qnco]     3.91824
bleeding tendency [dsyn]     3.91824
Renal Tubule Necrosis [dsyn]     3.91824
terminal cancer [neop]     3.91824
Carcinoma, Lobular [neop]     3.91824
pre-s proteins [aapp]     3.91824
chromosome 1p [nusq]     3.91824
Central Artery [bpoc]     3.91824
Respiratory infection [dsyn]     3.91824
Pseudohyponatraemia [fndg]     3.91824
Inherited Bone Marrow Failure Syndrome [dsyn]     3.91824
Behavior Modification [topp]     3.91824
empiric treatment [fndg]     3.91824
Target vessel [blor]     3.91824
Hepatitis G virus RNA [nnon]     3.91824
adrenocortical cancer [neop]     3.91824
sinus tract [patf]     3.91824
Off Treatment [ftcn]     3.91824
regional cancer [neop]     3.91824
Androgen Metabolism [moft]     3.91824
g/week [qnco]     3.91824
Normal Distribution [qnco]     3.91824
SPIB [gngm]     3.91824
PSMC2 [gngm]     3.91824
CEB1 [gngm]     3.91824
Metabolic Stress [orga]     3.91824
Small Non-Protein-Coding RNA [nnon]     3.91824
Transrectal Biopsy [diap]     3.91824
Intravenous Catheters [medd]     3.91824
THANK [gngm]     3.91824
Xp [nusq]     3.91824
Veterinary pathologist [prog]     3.91824
neurologic problems [fndg]     3.91824
Urinalysis [lbpr]     3.91824
Secondary lysosome [celc]     3.91824
Waist-Hip Ratio [orga]     3.91824
Normal blood glucose [fndg]     3.91824
Oligodendrogliomas [neop]     3.91824
Spreadsheet [mnob]     3.91824
protein kinase activity [moft]     3.91824
VCAP [topp]     3.91824
decreased sodium [fndg]     3.91824
Surgical pathology studies [lbpr]     3.91824
STAT5B [gngm]     3.91824
Injection device [medd]     3.91824
First degree burn [inpo]     3.91824
Transcend [bodm]     3.91824
Guilty [menp]     3.91824
Visual Analog Scale [diap]     3.91824
XPO4 [gngm]     3.91824
Mitochondrial hyperplasia [comd]     3.91824
PAH [dsyn]     3.91824
Except for [ftcn]     3.91824
Blood Oxygen Level Dependent Imaging [diap]     3.91824
Gastroduodenal Ulcer [dsyn]     3.91824
BALB/c Nude Mouse [mamm]     3.91824
Mouse, C57BL [mamm]     3.91824
Vaccine Testing [resa]     3.91824
Psychosocial status [qlco]     3.91824
Prolonged periods [fndg]     3.91824
Breath [bdsu]     3.91824
Continuous fever [fndg]     3.91824
dietary management [ftcn]     3.91824
myth [idcn]     3.91824
Dentist [prog]     3.91824
Mouse, ICR [mamm]     3.91824
Cerebral Infarction [dsyn]     3.91824
Upper digestive tract [anst]     3.91824
GI [inpr]     3.91824
textile workers [prog]     3.91824
pseudomonas bacteremia [dsyn]     3.91824
Hospital Design [ocac]     3.91824
Maximum Concentration [qnco]     3.91824
Emergency operation [topp]     3.91824
Hepatitis E virus [virs]     3.91824
IL-33 [moft]     3.91824
Oral liquid [bodm]     3.91824
Endometria [bpoc]     3.91824
kg/day [qnco]     3.91824
type diabetes [fndg]     3.91824
Dermatologic [bmod]     3.91824
G2/M Arrest [moft]     3.91824
program use [idcn]     3.91824
collagen vascular diseases [dsyn]     3.91824
Nasal Septum Perforation [anab]     3.91824
HC/HCC [gngm]     3.91824
Genyonemus lineatus [fish]     3.91824
RS [idcn]     3.91824
Medical Error [qlco]     3.91824
iron chelation therapy [topp]     3.91824
Nanopore [spco]     3.91824
Second Look [topp]     3.91824
Cystic Tumor [neop]     3.91824
Bioavailability [qlco]     3.91824
Infection, Hospital [dsyn]     3.91824
RAI [fish]     3.91824
Primary tuberculosis [dsyn]     3.91824
Dysplastic bile ducts [fndg]     3.91824
Haemangiomatosis [neop]     3.91824
Intercellular Junctions [bsoj]     3.91824
11q12 [celc]     3.91824
Bioaccumulation [ortf]     3.91824
Lesser omentum [bpoc]     3.91824
Tubular Epithelial Cells [lbpr]     3.91824
Financial cost [qnco]     3.91824
deviant [qlco]     3.91824
founders [dsyn]     3.91824
real-time contrast-enhanced ultrasonography [diap]     3.91824
microRNA 1204 [gngm]     3.91824
HPR [gngm]     3.91824
Chemodectoma [neop]     3.91824
cell-to-cell signaling [celf]     3.91824
RM [blor]     3.91824
Phase 4 [tmco]     3.91824
Anatomic pathologist [prog]     3.91824
Elective Surgical Procedures [topp]     3.91824
cerebral lesions [dsyn]     3.91824
Illiterate [fndg]     3.91824
Social problem [fndg]     3.91824
Walker [medd]     3.91824
C3H/HeJ Mouse [mamm]     3.91824
NM23 Gene [gngm]     3.91824
DSRCT [neop]     3.91824
Bioptic [medd]     3.91824
conjunctiva [bpoc]     3.91824
Close observation [topp]     3.91824
co-habitation [socb]     3.91824
Average Concentration [qnco]     3.91824
KB Cells [cell]     3.91824
Hepatic bleeding [patf]     3.91824
breast cancer screening [topp]     3.91824
Alanine measurement [lbpr]     3.91824
Hepatic peliosis [dsyn]     3.91824
Fetal Hydrops [dsyn]     3.91824
DISIDA [irda]     3.91824
lipid disorders [dsyn]     3.91824
burned out [fndg]     3.91824
TRYPTOPHAN HYDROXYLASE 1 [gngm]     3.91824
Transplantation assay [lbpr]     3.91824
Total porphyrin [lbtr]     3.91824
thesis [inpr]     3.91824
employment history [fndg]     3.91824
mmol/g [qnco]     3.91824
cmH2O [qnco]     3.91824
Vocal Cord Dysfunction [fndg]     3.91824
Adverse Experience [fndg]     3.91824
hospital visits [hlca]     3.91824
SH2D4A [gngm]     3.91824
refined carbohydrates [carb]     3.91824
aptamers [nnon]     3.91824
LPAR1 [gngm]     3.91824
INHIBITOR OF GROWTH 2 [gngm]     3.91824
splenic trauma [inpo]     3.91824
tube placement [topp]     3.91824
Apparent age [orga]     3.91824
Bone histomorphometry [lbpr]     3.91824
chemotherapy effects [patf]     3.91824
Northwestern [spco]     3.91824
Preparedness [fndg]     3.91824
engineered [prog]     3.91824
Mammary adenocarcinoma [neop]     3.91824
Vitamin level [lbpr]     3.91824
Job Title [inpr]     3.91824
Tumor Cell Invasion [fndg]     3.91824
choluria [fndg]     3.91824
HMGCS1 [gngm]     3.91824
dL/dL [qnco]     3.91824
ayurveda [bmod]     3.91824
Pregnancy History [fndg]     3.91824
ICER [gngm]     3.91824
galactose test [lbpr]     3.91824
Genomic Segment [cnce]     3.91824
Fly [euka]     3.91824
Cardiovascular system [bdsy]     3.91824
infiltrating breast cancer [neop]     3.91824
Entameba histolytica [euka]     3.91824
Chemotaxis assay [lbpr]     3.91824
acholia [dsyn]     3.91824
Plug [mnob]     3.91824
Heterocyclic Amines [orch]     3.91824
Cystic artery [bpoc]     3.91824
Postpartum Care [hlca]     3.91824
Excessive alcohol use [fndg]     3.91824
Pseudotumors, Inflammatory [neop]     3.91824
Kernel [inpr]     3.91824
Gait disturbance [sosy]     3.91824
Interleukin 6 Measurement [lbpr]     3.91824
Liver function failure [dsyn]     3.91824
consciousness [fndg]     3.91824
greet [fndg]     3.91824
Hepatorenal failure [dsyn]     3.91824
Superoxide Anion [elii]     3.91824
Bone marrow hyperplasia [patf]     3.91824
Ocular adnexa [bpoc]     3.91824
V-KI-RAS2 KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG [gngm]     3.91824
banned [socb]     3.91824
Tissues, Heterotopic [patf]     3.91824
Latex agglutination [lbpr]     3.91824
nucleus localisation [biof]     3.91824
experimental drug [phsu]     3.91824
microRNA biogenesis [genf]     3.91824
Micropapillary Pattern [fndg]     3.91824
Amyloidogenesis [comd]     3.91824
vte [orch]     3.91824
Antibody titer, elevated [fndg]     3.91824
Cell-Derived Microparticles [celc]     3.91824
informed patient [hlca]     3.91824
Postoperative Hemorrhage [patf]     3.91824
drug mechanism [patf]     3.91824
Sufficient Quantity [qnco]     3.91824
ileo-rectal [blor]     3.91824
andrographolide [phsu]     3.91824
Venous injury [inpo]     3.91824
NIH 3T3 Cells [cell]     3.91824
Planned procedure [hlca]     3.91824
Ovulation [ortf]     3.91824
Human immunodeficiency virus 1 RNA [nnon]     3.91824
Interleukin Gene [gngm]     3.91824
Gastroenterological referral [hlca]     3.91824
Eosinophilia [dsyn]     3.91824
Polypectomy [topp]     3.91824
DNA deamination [genf]     3.91824
Cancer Radiotherapy [topp]     3.91824
Haemoptysis [sosy]     3.91824
CIR [gngm]     3.91824
Antiparasitic [phsu]     3.91824
Accelerated atherosclerosis [fndg]     3.91824
Clival Chordoma [neop]     3.91824
Triangular [cnce]     3.91824
organic compounds [orch]     3.91824
IGFBP1 gene [gngm]     3.91824
control test [irda]     3.91824
protein expression profile [lbpr]     3.91824
Philadelphia negative [fndg]     3.91824
5-1-1 [qlco]     3.91824
Blood vessel injuries [inpo]     3.91824
g/capsule [qnco]     3.91824
Heat Shock [phsf]     3.91824
Duodenal [dsyn]     3.91824
Intravenous chemotherapy [topp]     3.91824
SIRTUIN 3 [gngm]     3.91824
GLUTATHIONE S-TRANSFERASE A2 [gngm]     3.91824
Chromosomal Loss [comd]     3.91824
Perceptron [inpr]     3.91824
Porphyrias, Hepatic [dsyn]     3.91824
Eye Carcinoma [neop]     3.91824
Volume Unit [qnco]     3.91824
Ash [plnt]     3.91824
Plasma donor [popg]     3.91824
Adult T-cell leukaemia/lymphoma [neop]     3.91824
MRI Scan [diap]     3.91824
Bronchiolitis Obliterans [dsyn]     3.91824
Renal stone [dsyn]     3.91824
chaperone activity [moft]     3.91824
Gradual onset [qlco]     3.91824
Reinsertion [topp]     3.91824
disease causation [ftcn]     3.91824
Plasmablast [cell]     3.91824
Supplementary Material [inpr]     3.91824
Beef Tallow [phsu]     3.91824
7-ethoxyresorufin [orch]     3.91824
Tumor Stage Classification [clas]     3.91824
Foetus [anst]     3.91824
normal blood chemistry [fndg]     3.91824
Culture Media [irda]     3.91824
Nucleic acid detection [lbpr]     3.91824
Serious health problems [inpr]     3.91824
Areca catechu [plnt]     3.91824
Not found [fndg]     3.91824
Venereal Diseases [dsyn]     3.91824
metastatic renal carcinoma [neop]     3.91824
sphingosine 1-phosphate [orch]     3.91824
Philadelphia [geoa]     3.91824
Reduced creatinine clearance [fndg]     3.91824
Occupational Epidemiology [bmod]     3.91824
ethyl nitrite [orch]     3.91824
Repetitive Element [nusq]     3.91824
increased triglycerides [fndg]     3.91824
chemoattractant [bacs]     3.91824
FDA Approval [inpr]     3.91824
Dementia, Lewy Body [dsyn]     3.91824
Electrophoresis [lbpr]     3.91824
Hawaiian [popg]     3.91824
Intraductal Lesion [fndg]     3.91824
BARRETT ESOPHAGUS/ESOPHAGEAL ADENOCARCINOMA [gngm]     3.91824
Nephromegaly [fndg]     3.91824
GSD I [dsyn]     3.91824
FRG [gngm]     3.91824
Gastric Stasis [dsyn]     3.91824
RLV [lbtr]     3.91824
Thiazolidinedione Antidiabetic Agent [chvf]     3.91824
blood sugar levels [lbpr]     3.91824
Osseous metastasis [neop]     3.91824
Long bone [bpoc]     3.91824
rib resection [topp]     3.91824
alaskan natives [popg]     3.91824
MALDI [lbpr]     3.91824
Corynebacterium Infections [dsyn]     3.91824
Optical density [qnco]     3.91824
Obstructions, Bile Duct [dsyn]     3.91824
lymphoid organs [bpoc]     3.91824
Area X [bpoc]     3.91824
egg-laying [orgf]     3.91824
*Mass Ratio [qnco]     3.91824
abdominal scar [fndg]     3.91824
pullulan [carb]     3.91824
medex [prog]     3.91824
Isle of Wight [geoa]     3.91824
Pleural Effusions, Malignant [dsyn]     3.91824
A/J [mamm]     3.91824
Clinical Trials, Phase III [resa]     3.91824
KLF6 [gngm]     3.91824
the cell [cell]     3.91824
Body Burden [qnco]     3.91824
Fiber [tisu]     3.91824
Systems, Portal [bpoc]     3.91824
Immune disorder, NOS [dsyn]     3.91824
Valsalva Maneuver [diap]     3.91824
Early-Stage Cancer [clas]     3.91824
Support System [grup]     3.91824
Partnership [orgt]     3.91824
Subserosa [tisu]     3.91824
arterio-venous fistula [anab]     3.91824
Pregnancies, Multiple [patf]     3.91824
30mm [qnco]     3.91824
Radical gastrectomy [topp]     3.91824
Porphyrin Precursor [phsu]     3.91824
Pseudogene [gngm]     3.91824
Chloracne [dsyn]     3.91824
revenue [qnco]     3.91824
K562 Cells [cell]     3.91824
ULN [qnco]     3.91824
Afraid [menp]     3.91824
Lamina Propria [tisu]     3.91824
alpha radiation [npop]     3.91824
acylating agent [chvf]     3.91824
Order Clostridiales [bact]     3.91824
Syrian golden hamsters [mamm]     3.91824
Lump [fndg]     3.91824
Testicular Germ Cell Tumor [neop]     3.91824
Hyperfibrinogenaemia [fndg]     3.91824
Jelly [food]     3.91824
Paragonimus [euka]     3.91824
Dark skin pigmentation [fndg]     3.91824
Body wall [bpoc]     3.91824
starling [bird]     3.91824
129S6/SvEvTac Mouse [mamm]     3.91824
Claims Analysis [hlca]     3.91824
Paraesophageal [spco]     3.91824
TAB2 [gngm]     3.91824
SARS [dsyn]     3.91824
High approach [spco]     3.91824
Glycolysis/Gluconeogenesis Pathway [moft]     3.91824
bowel ischaemia [dsyn]     3.91824
Iron Chelator [phsu]     3.91824
Carassius auratus [fish]     3.91824
Canal [bsoj]     3.91824
CT protocol [topp]     3.91824
Infective Agent [orgm]     3.91824
Abdominal paracentesis [topp]     3.91824
hypomotility [patf]     3.91824
FRE [gngm]     3.91824
R-CHOP Regimen [topp]     3.91824
Institutionalized [fndg]     3.91824
Urological Cancer [neop]     3.91824
Carcinogenic Aromatic Amine [clas]     3.91824
Rat Bone Marrow [bpoc]     3.91824
lipoprotein metabolism [moft]     3.91824
Encephalitis [dsyn]     3.91824
Molecular Biology Technique [mbrt]     3.91824
Hyaline inclusions [celc]     3.91824
Theileria annulata [euka]     3.91824
Keen [menp]     3.91824
elastic [ftcn]     3.91824
Deep incisional surgical site infection [patf]     3.91824
DNA Damage Repair [genf]     3.91824
TOLERABILITY [menp]     3.91824
Exudate [bdsu]     3.91824
Esophageal disorders [dsyn]     3.91824
Hepatitis C virus IB [imft]     3.91824
3H [tmco]     3.91824
HFE2 [dsyn]     3.91824
Perisinusoidal Space [bsoj]     3.91824
Prophylactic chemotherapy [topp]     3.91824
Peduncle [plnt]     3.91824
F-Distribution [qnco]     3.91824
physical properties [npop]     3.91824
liver parenchymal disease [dsyn]     3.91824
keratinocyte [cell]     3.91824
Mountain Village [popg]     3.91824
Excessive sun exposure [inbe]     3.91824
Monogamous [socb]     3.91824
Case Histories [inpr]     3.91824
Colonic epithelium [bpoc]     3.91824
2q22 [celc]     3.91824
PERILIPIN 3 [gngm]     3.91824
Intestinal fluke [euka]     3.91824
Institutionalised [fndg]     3.91824
Brown Norway rat [mamm]     3.91824
cancer radiation therapy [topp]     3.91824
Hearing Loss, High-Frequency [dsyn]     3.91824
Mass Immunization [topp]     3.91824
7p21 [celc]     3.91824
PSMB4 [gngm]     3.91824
Cost Analyses [ocac]     3.91824
Huasteco [popg]     3.91824
Macrophages, Peritoneal [cell]     3.91824
Hepatitis C virus Ag [imft]     3.91824
Oxygen supply [clna]     3.91824
Interleukin-6 Gene [gngm]     3.91824
nonspecific hepatitis [dsyn]     3.91824
abdominal sepsis [dsyn]     3.91824
Molecular Typing [resa]     3.91824
Coregonus clupeaformis [fish]     3.91824
Pigment cirrhosis [dsyn]     3.91824
Curate [acty]     3.91824
IL28B gene [gngm]     3.91824
Dermatofibroma [neop]     3.91824
involuted [orgf]     3.91824
Water Supply [qnco]     3.91824
Metastatic Mass [fndg]     3.91824
MOVC [patf]     3.91824
shipped [mnob]     3.91824
Image Acquisition [mcha]     3.91824
Continuous capillary vessel [bpoc]     3.91824
Dracocephalum kotschyi [plnt]     3.91824
terminal deoxynucleotidyl transferase nick end labeling [mbrt]     3.91824
Polyaromatic hydrocarbon [orch]     3.91824
HRI [gngm]     3.91824
Hepatitis D Viruses [virs]     3.91824
Ivory Coast [geoa]     3.91824
Paroxysmal nocturnal haemoglobinuria [dsyn]     3.91824
p34 [gngm]     3.91824
Palm [blor]     3.91824
Glycemic Index [qnco]     3.91824
CC chemokine 3 [gngm]     3.91824
CLU [gngm]     3.91824
Spirits [food]     3.91824
LYSOPHOSPHATIDIC ACID RECEPTOR 1 [gngm]     3.91824
Vulnerable child [fndg]     3.91824
Food Chain [npop]     3.91824
Atherosclerotic heart disease NOS [dsyn]     3.91824
Relative Value [qlco]     3.91824
HINT [inpr]     3.91824
SPIDER NEVI [acab]     3.91824
GRGDSP [aapp]     3.91824
HSF1 [gngm]     3.91824
KCP [gngm]     3.91824
Prostate Neoplasm [neop]     3.91824
Below [spco]     3.91824
Helicobacter pullorum [bact]     3.91824
new media [hcpp]     3.91824
Low birth weight [fndg]     3.91824
Preferences, Patient [qlco]     3.91824
Laparoscopic liver biopsy [diap]     3.91824
13q33 [celc]     3.91824
Brassica [plnt]     3.91824
Irrigate [topp]     3.91824
MEK1 [moft]     3.91824
EFNA1 [gngm]     3.91824
Cytomegalovirus immediate-early [fndg]     3.91824
high-intensity focused ultrasound therapy [topp]     3.91824
Normal hearing [fndg]     3.91824
Prevention Research [resa]     3.91824
Caseous necrosis [patf]     3.91824
Duodenal Obstruction [dsyn]     3.91824
liver cancer, pediatric [neop]     3.91824
steroidogenesis [moft]     3.91824
LYSINE-SPECIFIC DEMETHYLASE 1 [gngm]     3.91824
Purpura, Thrombotic Thrombocytopenic [dsyn]     3.91824
Distant Cancer [clas]     3.91824
Interpolation [qnco]     3.91824
Ear Piercing [topp]     3.91824
PROGRAMMED CELL DEATH 1 [gngm]     3.91824
hiv risk factor [fndg]     3.91824
Tubular cells [cell]     3.91824
Passive Smoke Exposure [eehu]     3.91824
ii dm [aapp]     3.91824
Cellular Pleomorphism [fndg]     3.91824
CYP2C19 gene [gngm]     3.91824
Cytoplasmic inclusion, crystalline [celc]     3.91824
transurethral bladder resection [topp]     3.91824
MRP2 [gngm]     3.91824
Hypovolaemia [fndg]     3.91824
Anatomical plane [spco]     3.91824
homocysteine metabolism [moft]     3.91824
Celiac lymph nodes [bpoc]     3.91824
hsa-mir-200c [gngm]     3.91824
Total Proctocolectomy [topp]     3.91824
S11 [gngm]     3.91824
RG [gngm]     3.91824
NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN [gngm]     3.91824
Indian origin [fndg]     3.91824
SVC [lbtr]     3.91824
HSP70-HOM [gngm]     3.91824
Repetitive Sequences [nusq]     3.91824
RAC1 [gngm]     3.91824
Infusion Pump [medd]     3.91824
alanine transaminase activity [moft]     3.91824
Abdominal Compartment Syndrome [dsyn]     3.91824
perilipin [aapp]     3.91824
times/week [qnco]     3.91824
human herpesvirus 8 [virs]     3.91824
Geographical feature [spco]     3.91824
Radar [mnob]     3.91824
MONOCARBOXYLATE TRANSPORTER 1 [gngm]     3.91824
HK [geoa]     3.91824
Mobile Application [inpr]     3.91824
nmol/mg [qnco]     3.91824
Hormone Responsive [ftcn]     3.91824
dehydroxymethylepoxyquinomicin [orch]     3.91824
preventive therapy [inpr]     3.91824
Myelin [tisu]     3.91824
CLR [gngm]     3.91824
LARGE gene [gngm]     3.91824
[M]Neurofibromas [neop]     3.91824
Sia [euka]     3.91824
Appointments [idcn]     3.91824
moderate drinking [inbe]     3.91824
Decision Analyses [ocdi]     3.91824
Idiopathic Thrombocytopenia [dsyn]     3.91824
Hepatic biliary tree [bpoc]     3.91824
Critique [resa]     3.91824
Gliosis [patf]     3.91824
Terminally Ill [podg]     3.91824
Steroid biosynthesis [moft]     3.91824
Done [qlco]     3.91824
pro-gastrin [aapp]     3.91824
Nebraska [geoa]     3.91824
IGF2 gene [gngm]     3.91824
Semicircular [qlco]     3.91824
Conceptual Entity [cnce]     3.91824
Lymph Node Tissue [tisu]     3.91824
Livistona chinensis [plnt]     3.91824
MKK3 [gngm]     3.91824
fructose metabolism [moft]     3.91824
liver adenocarcinoma [neop]     3.91824
XX [orga]     3.91824
Subgroup B [virs]     3.91824
Normal Body Weight [clna]     3.91824
Cholestasis, Extrahepatic [dsyn]     3.91824
Antibacterial [antb]     3.91824
Larvae [euka]     3.91824
analgesia [topp]     3.91824
Mouse Lymphoma [neop]     3.91824
Adrenal tumor [neop]     3.91824
Significance values [qlco]     3.91824
DEGRADATION PROBLEM [ftcn]     3.91824
Miscarriages [patf]     3.91824
Marrow Transplantation [topp]     3.91824
Autumn [tmco]     3.91824
Evening [tmco]     3.91824
Allergic reactions [patf]     3.91824
pro-survival [celf]     3.91824
Immediate family [famg]     3.91824
Rats, Spontaneously Hypertensive [mamm]     3.91824
NAVAJO NEUROHEPATOPATHY [dsyn]     3.91824
infrared thermography [diap]     3.91824
affinity purification [lbpr]     3.91824
SIR-Spheres [phsu]     3.91824
PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE [gngm]     3.91824
Raman Scattering [npop]     3.91824
diseases exposure [fndg]     3.91824
CASSETTES, TISSUE [medd]     3.91824
T-Cell Epitope [imft]     3.91824
lung malignancies [neop]     3.91824
ROU [geoa]     3.91824
S-Phase Fraction [lbtr]     3.91824
Lung fluke [euka]     3.91824
Cancer Biology [bmod]     3.91824
Renal fibrosis [dsyn]     3.91824
PINX1 [gngm]     3.91824
CCR2 [gngm]     3.91824
enlarged ovaries [fndg]     3.91824
PROTEASOME ACTIVATOR 28-GAMMA [gngm]     3.91824
2i [medd]     3.91824
Reversal [tmco]     3.91824
Plum [food]     3.91824
Ovarian metastasis [neop]     3.91824
Cervical Vertebrae [bpoc]     3.91824
Blisters [patf]     3.91824
finances [ocac]     3.91824
toxin formation [moft]     3.91824
DTE [gngm]     3.91824
Primary Brain Tumors [neop]     3.91824
Duodenal perforation [dsyn]     3.91824
hypnotic drug [phsu]     3.91824
ACTA2 [gngm]     3.91824
thyme [plnt]     3.91824
metabolic study [diap]     3.91824
fibrous scar [fndg]     3.91824
Abnormal blood flow [patf]     3.91824
bad behavior [mobd]     3.91824
LYPLAL1 [gngm]     3.91824
Stromal Neoplasm [neop]     3.91824
MYC Gene Amplification [comd]     3.91824
V7 [bpoc]     3.91824
Exempt [cnce]     3.91824
Plaque, Atherosclerotic [bdsu]     3.91824
Intestinal Bypass [topp]     3.91824
Polish [popg]     3.91824
Wegener Granulomatosis [dsyn]     3.91824
Cystadenocarcinoma, Serous [neop]     3.91824
Tumor Expansion [neop]     3.91824
Clinical interview [hlca]     3.91824
DNA Methylation Analysis [mbrt]     3.91824
Cytoplasmic vacuolation [fndg]     3.91824
collapse [fndg]     3.91824
Quinolones [orch]     3.91824
Hemagglutination test [lbpr]     3.91824
Placental Development [ortf]     3.91824
Relaxation [qlco]     3.91824
Lira [qnco]     3.91824
CCCA [gngm]     3.91824
VCP [topp]     3.91824
FLIP [gngm]     3.91824
DGCR5 [gngm]     3.91824
SEC62 [gngm]     3.91824
Taxon [cnce]     3.91824
Principal Component Analysis [qnco]     3.91824
Greenland [geoa]     3.91824
caspase-8 activity [moft]     3.91824
PKD1 [gngm]     3.91824
Cholangitis, Chronic Nonsuppurative Destructive [dsyn]     3.91824
Clivus [bsoj]     3.91824
Raf Kinase Inhibitor [phsu]     3.91824
Social well being [socb]     3.91824
inferior right [spco]     3.91824
BILE ACID RECEPTOR [gngm]     3.91824
Water Pollution [eehu]     3.91824
NH2 [orch]     3.91824
immunologic assay [lbpr]     3.91824
Radiation Therapy Oncology Group [hcro]     3.91824
S100A6 [gngm]     3.91824
stellar [hcro]     3.91824
Serum tumor marker level [lbtr]     3.91824
MICRO RNA 144 [gngm]     3.91824
pol Gene [gngm]     3.91824
ISLET 1 [gngm]     3.91824
CPT [gngm]     3.91824
B-CELL TRANSLOCATION GENE 1 [gngm]     3.91824
INTERLEUKIN 23 RECEPTOR [gngm]     3.91824
Allograft rejection [ftcn]     3.91824
HSD17B13 [gngm]     3.91824
Adrenal artery [bpoc]     3.91824
hyperthermic [fndg]     3.91824
PAX3 [gngm]     3.91824
Transcatheter Aortic Valve Implantation [topp]     3.91824
Mesothelial [qlco]     3.91824
Gastrointestinal Stromal Neoplasms [neop]     3.91824
endocrine effects [phsf]     3.91824
Direct needle [medd]     3.91824
Metastatic malignant disease [neop]     3.91824
ZFH [gngm]     3.91824
Blue color [qlco]     3.91824
SAGE1 [gngm]     3.91824
Prejudice [inbe]     3.91824
Cirrhosis, Familial [dsyn]     3.91824
bile salt transport [celf]     3.91824
Serology studies [lbpr]     3.91824
FVB/N Mouse [mamm]     3.91824
Chromosome number [cell]     3.91824
Right pulmonary artery [bpoc]     3.91824
Somatic cell [cell]     3.91824
Laboratory Personnel [prog]     3.91824
IL6ST [gngm]     3.91824
PKM2 [gngm]     3.91824
Mean Platelet Volume [lbpr]     3.91824
Glucagon-like Peptide-1 Receptor Agonist [phsu]     3.91824
Kirgizstan [geoa]     3.91824
Ultrasonography, Doppler, Duplex [diap]     3.91824
Variable progression [fndg]     3.91824
Lipid droplet accumulation [fndg]     3.91824
elevated hemoglobin [fndg]     3.91824
Turmeric [food]     3.91824
FOXM1 [gngm]     3.91824
Social Justice [qlco]     3.91824
blood relatives [famg]     3.91824
Chronic inflammatory reaction [patf]     3.91824
CGK733 [orch]     3.91824
Temperature Gradient Gel Electrophoresis [lbpr]     3.91824
fatty liver infiltration [dsyn]     3.91824
SYT [gngm]     3.91824
Primary Effusion Lymphomas [neop]     3.91824
Mouse Hepatic Stellate Cell [cell]     3.91824
Environmental assessment [hlca]     3.91824
Arsenical toxicity [inpo]     3.91824
stereotypies [mobd]     3.91824
Gasoline [mnob]     3.91824
Congenital Heart Defects [cgab]     3.91824
NEIL1 [gngm]     3.91824
biological drugs [clas]     3.91824
Nutritional Indices [qnco]     3.91824
Patient Documentation [hlca]     3.91824
Computed tomography technique [diap]     3.91824
Epithelial hyperplasia [dsyn]     3.91824
Tissue Array Analysis [lbpr]     3.91824
Second degree burn [inpo]     3.91824
Thunbergia laurifolia [plnt]     3.91824
Myocytes [cell]     3.91824
HBOC 201 [phsu]     3.91824
SHO [gngm]     3.91824
Arca [euka]     3.91824
Skin test [diap]     3.91824
Null Cells [cell]     3.91824
Right to left [ftcn]     3.91824
Thyroid Nodules [neop]     3.91824
nitric-oxide synthase activity [moft]     3.91824
Homosexual [socb]     3.91824
Nutritional Index [qnco]     3.91824
Gastric Intestinal Metaplasia [dsyn]     3.91824
Neglected Diseases [dsyn]     3.91824
Plain x-ray [diap]     3.91824
Rectal Disease [dsyn]     3.91824
Moisture [sbst]     3.91824
Quantitative Evaluations [qnco]     3.91824
Cryoglobulinaemia [dsyn]     3.91824
Cardiac CT [diap]     3.91824
concave [spco]     3.91824
Thoracic Wall [bpoc]     3.91824
Transplant Rejection [ortf]     3.91824
psychological care [topp]     3.91824
Umbilical vein [emst]     3.91824
pancreas surgery [topp]     3.91824
respiratory distress syndrome [dsyn]     3.91824
Sonoelastography [diap]     3.91824
vascular ultrasound [diap]     3.91824
HOX TRANSCRIPT ANTISENSE RNA [gngm]     3.91824
Haemorrhagic stroke [patf]     3.91824
ectoderm development [ortf]     3.91824
Translational Repression [genf]     3.91824
Ib/c [inpr]     3.91824
Glucagon-Like Peptide 1 [aapp]     3.91824
FIFTEEN-DAY [inpr]     3.91824
Cesarean Delivery [topp]     3.91824
Hepatic arteriogram [diap]     3.91824
Prunus domestica [plnt]     3.91824
Enterovirus [virs]     3.91824
Cellular structures [cell]     3.91824
Bronchi [bpoc]     3.91824
exomphalos [anab]     3.91824
Oral granules [bodm]     3.91824
Group Number [qnco]     3.91824
hospital length of stay [tmco]     3.91824
Biomaterial [bodm]     3.91824
Fatty Acids, Unsaturated [lipd]     3.91824
Acute-Phase Reaction [patf]     3.91824
T11 [blor]     3.91824
estrogen receptor activity [moft]     3.91824
Mononucleosis syndrome [dsyn]     3.91824
Enterobacteriaceae [bact]     3.91824
full term [fndg]     3.91824
Asphyxia [patf]     3.91824
Neutropenic sepsis [dsyn]     3.91824
Transudate [bdsu]     3.91824
Siberia [geoa]     3.91824
hail [npop]     3.91824
7q21 [celc]     3.91824
Oral fluid specimen [bdsu]     3.91824
Fibroadenoma [neop]     3.91824
Mineral Fibers [inch]     3.91824
Alcohol Addiction [mobd]     3.91824
biochips [resd]     3.91824
milk fat globule [lipd]     3.91824
lymph vessels [bpoc]     3.91824
BAK [gngm]     3.91824
Thirdly [qnco]     3.91824
Injection, intravenous, bolus [ftcn]     3.91824
energy homeostasis [biof]     3.91824
Anatomic structures [anst]     3.91824
infrared light [npop]     3.91824
Serotonin Receptor Agonists [phsu]     3.91824
EDX [lbpr]     3.91824
Remission, Spontaneous [npop]     3.91824
Bile Canaliculi [bpoc]     3.91824
ARCS [dsyn]     3.91824
Hyperargininaemia [dsyn]     3.91824
MCT4 [gngm]     3.91824
Mitophagy [celf]     3.91824
Assessment information [fndg]     3.91824
B-cell acute lymphoblastic leukaemia [neop]     3.91824
Uploaded [mcha]     3.91824
Monkey, Cynomolgus [mamm]     3.91824
Stress, Mechanical [npop]     3.91824
Exit [spco]     3.91824
TMEM38B [gngm]     3.91824
Pancreatitis, Alcoholic [dsyn]     3.91824
MTH-68-B [bacs]     3.91824
Cutaneous cyst [dsyn]     3.91824
Combined result [inpr]     3.91824
Microwave probe [medd]     3.91824
Dissatisfied [menp]     3.91824
Genome Wide Association Scan [mbrt]     3.91824
Marital [fndg]     3.91824
19G [qnco]     3.91824
Sampling Error [qnco]     3.91824
Digestive organ [bpoc]     3.91824
Adenomatous nodule [patf]     3.91824
ORM [gngm]     3.91824
Consanguinities [fndg]     3.91824
Juvenile haemochromatosis [dsyn]     3.91824
Myofibroblastic Differentiation [fndg]     3.91824
Biochemical Pathway [moft]     3.91824
Carcinoma, Giant Cell [neop]     3.91824
MUTM [gngm]     3.91824
Tethered [ftcn]     3.91824
Abdominal wall operations [topp]     3.91824
Herpesvirus 6A, Human [virs]     3.91824
Hepacivirus [virs]     3.91824
Eruption [patf]     3.91824
TRK [gngm]     3.91824
C19ORF10 [gngm]     3.91824
MHCS [resa]     3.91824
Hepatic artery injury [inpo]     3.91824
Right heart failure [dsyn]     3.91824
DN [dsyn]     3.91824
Human Respiratory Syncytial Virus [virs]     3.91824
Absolute Change [idcn]     3.91824
Mediastinum [blor]     3.91824
